Clustering O 0 0.08627147972583771
of O 0 0.01281278021633625
missense O 1 0.9988879561424255
mutations O 1 0.9974033236503601
in O 0 0.004734106361865997
the O 0 0.010072736069560051
ataxia B-Disease 1 0.9999974966049194
- I-Disease 1 0.9977453351020813
telangiectasia I-Disease 1 0.9999949932098389
gene O 1 0.9941970109939575
in O 0 0.004798875190317631
a O 0 0.01311993133276701
sporadic B-Disease 1 0.990711510181427
T I-Disease 1 0.9996922016143799
- I-Disease 0 0.40032315254211426
cell I-Disease 1 0.9550224542617798
leukaemia I-Disease 1 0.999940037727356
. O 0 0.022591907531023026

Ataxia B-Disease 1 0.9999904632568359
- I-Disease 1 0.9936918020248413
telangiectasia I-Disease 1 0.9999927282333374
( O 0 0.015642406418919563
A B-Disease 1 0.5734075903892517
- I-Disease 1 0.8483307957649231
T I-Disease 1 0.9986532926559448
) O 0 0.004115861374884844
is O 0 0.0035102118272334337
a O 0 0.012420104816555977
recessive B-Disease 1 0.9999934434890747
multi I-Disease 1 0.9902680516242981
- I-Disease 1 0.9068984985351562
system I-Disease 1 0.5271745324134827
disorder I-Disease 1 0.9999996423721313
caused O 1 0.9978342652320862
by O 0 0.007537050172686577
mutations O 1 0.9993333220481873
in O 0 0.00268982513807714
the O 0 0.004422913305461407
ATM O 1 0.6467032432556152
gene O 1 0.9360499382019043
at O 0 0.011141334660351276
11q22 O 1 0.9952930808067322
- O 0 0.1243090033531189
q23 O 1 0.9789039492607117
( O 0 0.016373224556446075
ref O 1 0.955252468585968
. O 0 0.005770356860011816
3 O 0 0.012636656872928143
) O 0 0.007841960527002811
. O 0 0.009968914091587067

The O 0 0.011586871929466724
risk O 1 0.9290398359298706
of O 0 0.009255927056074142
cancer B-Disease 1 0.9999972581863403
, O 0 0.004780396819114685
especially O 0 0.016077525913715363
lymphoid B-Disease 1 0.9999709129333496
neoplasias I-Disease 1 0.9990569949150085
, O 0 0.0033485160674899817
is O 0 0.0037291646003723145
substantially O 0 0.02485136315226555
elevated O 1 0.5188923478126526
in O 0 0.00338857714086771
A B-Disease 1 0.863074004650116
- I-Disease 1 0.9982306361198425
T I-Disease 1 0.9999895095825195
patients O 1 0.9998818635940552
and O 0 0.002264602342620492
has O 0 0.0034577420447021723
long O 0 0.006749338936060667
been O 0 0.0033864036668092012
associated O 0 0.008458942174911499
with O 0 0.006980967242270708
chromosomal O 1 0.9999090433120728
instability O 1 0.9972750544548035
. O 0 0.017437361180782318

By O 0 0.014429591596126556
analysing O 0 0.41263389587402344
tumour B-Disease 1 0.999995231628418
DNA O 0 0.3616865277290344
from O 0 0.009716246277093887
patients O 1 0.9993958473205566
with O 0 0.006906385067850351
sporadic B-Disease 1 0.986158549785614
T I-Disease 1 0.999415397644043
- I-Disease 1 0.6680716276168823
cell I-Disease 1 0.9389011859893799
prolymphocytic I-Disease 1 0.9997323155403137
leukaemia I-Disease 1 0.9999831914901733
( O 0 0.03546660766005516
T B-Disease 1 0.9990406632423401
- I-Disease 0 0.37282395362854004
PLL I-Disease 1 0.9986976385116577
) O 0 0.0062403688207268715
, O 0 0.0023642010055482388
a O 0 0.008003558963537216
rare O 0 0.09499192237854004
clonal B-Disease 1 0.999256432056427
malignancy I-Disease 1 0.9999876022338867
with O 0 0.003021982265636325
similarities O 0 0.008812707848846912
to O 0 0.0020086599979549646
a O 0 0.008889758959412575
mature B-Disease 1 0.9841252565383911
T I-Disease 1 0.9991639852523804
- I-Disease 0 0.48608633875846863
cell I-Disease 1 0.9597325921058655
leukaemia I-Disease 1 0.999984622001648
seen O 0 0.014103306457400322
in O 0 0.0037634873297065496
A B-Disease 1 0.628291666507721
- I-Disease 1 0.9784064292907715
T I-Disease 1 0.9991514682769775
, O 0 0.00191841262858361
we O 0 0.0016396349528804421
demonstrate O 0 0.005574805196374655
a O 0 0.003831493202596903
high O 0 0.005626163445413113
frequency O 0 0.016517091542482376
of O 0 0.004112700000405312
ATM O 1 0.8069292306900024
mutations O 1 0.9978183507919312
in O 0 0.012967193499207497
T B-Disease 1 0.9984756112098694
- I-Disease 0 0.4003702700138092
PLL I-Disease 1 0.9943126440048218
. O 0 0.022951681166887283

In O 0 0.007284420542418957
marked O 0 0.016843650490045547
contrast O 0 0.008127076551318169
to O 0 0.002056289929896593
the O 0 0.0041569070890545845
ATM O 1 0.9073317050933838
mutation O 1 0.9989977478981018
pattern O 0 0.02462303824722767
in O 0 0.0038293751422315836
A B-Disease 0 0.4360767602920532
- I-Disease 1 0.9272456765174866
T I-Disease 1 0.9990654587745667
, O 0 0.002310568932443857
the O 0 0.0021641890052706003
most O 0 0.0032193076331168413
frequent O 0 0.022532954812049866
nucleotide O 0 0.04691183194518089
changes O 0 0.0064450884237885475
in O 0 0.002498545218259096
this O 0 0.00534710381180048
leukaemia B-Disease 1 0.9999836683273315
were O 0 0.010094220750033855
missense O 1 0.9991315007209778
mutations O 1 0.9981368780136108
. O 0 0.015279419720172882

These O 0 0.005257304757833481
clustered O 0 0.017820149660110474
in O 0 0.002040023449808359
the O 0 0.0020630054641515017
region O 0 0.006273971404880285
corresponding O 0 0.005593313369899988
to O 0 0.0014823024393990636
the O 0 0.003951873164623976
kinase O 1 0.985205352306366
domain O 0 0.014795620925724506
, O 0 0.0017796092433854938
which O 0 0.001488226349465549
is O 0 0.0024095720145851374
highly O 0 0.007265721447765827
conserved O 0 0.01572924666106701
in O 0 0.003491912502795458
ATM O 0 0.13186728954315186
- O 0 0.022553978487849236
related O 0 0.013607611879706383
proteins O 0 0.018160581588745117
in O 0 0.0048494949005544186
mouse O 1 0.9769969582557678
, O 0 0.00688506243750453
yeast O 0 0.14096742868423462
and O 0 0.00787551049143076
Drosophila O 0 0.3262159526348114
. O 0 0.016892084851861

The O 0 0.010643996298313141
resulting O 0 0.03996637463569641
amino O 0 0.0470300056040287
- O 0 0.033436935395002365
acid O 0 0.05613710358738899
substitutions O 0 0.016321001574397087
are O 0 0.0018257135525345802
predicted O 0 0.008437312208116055
to O 0 0.00215658126398921
interfere O 0 0.013902686536312103
with O 0 0.0035864743404090405
ATP O 0 0.3366082012653351
binding O 0 0.018688896670937538
or O 0 0.008606625720858574
substrate O 0 0.047423090785741806
recognition O 0 0.027601800858974457
. O 0 0.012820367701351643

Two O 0 0.004241244401782751
of O 0 0.004567858763039112
seventeen O 0 0.09368660300970078
mutated O 1 0.9997479319572449
T B-Disease 1 0.9992332458496094
- I-Disease 0 0.18206974864006042
PLL I-Disease 1 0.9982057809829712
samples O 0 0.018439261242747307
had O 0 0.003675783984363079
a O 0 0.004656712058931589
previously O 0 0.0051811677403748035
reported O 0 0.013921577483415604
A B-Disease 0 0.06341534852981567
- I-Disease 1 0.91721510887146
T I-Disease 1 0.999478280544281
allele O 1 0.9905692338943481
. O 0 0.01954101026058197

In O 0 0.007265607360750437
contrast O 0 0.011950891464948654
, O 0 0.0028750174678862095
no O 0 0.005284563638269901
mutations O 1 0.9972591400146484
were O 0 0.0027424527797847986
detected O 0 0.02948542684316635
in O 0 0.0024068935308605433
the O 0 0.005965299904346466
p53 O 1 0.9997574687004089
gene O 1 0.9933833479881287
, O 0 0.0025263449642807245
suggesting O 0 0.008382880128920078
that O 0 0.0019250829936936498
this O 0 0.006172568537294865
tumour B-Disease 1 0.9999994039535522
suppressor O 1 0.9999409914016724
is O 0 0.0039969622157514095
not O 0 0.0023168076295405626
frequently O 0 0.008953820914030075
altered O 0 0.01911059580743313
in O 0 0.0029195717070251703
this O 0 0.007007732521742582
leukaemia B-Disease 1 0.9999809265136719
. O 0 0.016217108815908432

Occasional O 1 0.7359653115272522
missense O 1 0.9995126724243164
mutations O 1 0.9985066056251526
in O 0 0.004899037070572376
ATM O 0 0.04203095659613609
were O 0 0.0015082159079611301
also O 0 0.0016494578449055552
found O 0 0.0038434783928096294
in O 0 0.005301333963871002
tumour B-Disease 1 0.9999988079071045
DNA O 0 0.143633633852005
from O 0 0.007217932026833296
patients O 1 0.9995531439781189
with O 0 0.004086832981556654
B B-Disease 1 0.8278962969779968
- I-Disease 0 0.04828384891152382
cell I-Disease 0 0.2777784466743469
non I-Disease 0 0.043000247329473495
- I-Disease 1 0.9967334270477295
Hodgkins I-Disease 1 0.9999996423721313
lymphomas I-Disease 1 0.9999772310256958
( O 0 0.020759863778948784
B B-Disease 1 0.7526146769523621
- I-Disease 0 0.033682048320770264
NHL I-Disease 0 0.039568766951560974
) O 0 0.004634578712284565
and O 0 0.0021535493433475494
a O 0 0.011036712676286697
B B-Disease 0 0.21787938475608826
- I-Disease 0 0.03836216777563095
NHL I-Disease 0 0.08986906707286835
cell O 0 0.05955066531896591
line O 0 0.02246364951133728
. O 0 0.013236155733466148

The O 0 0.005455472506582737
evidence O 0 0.0035671433433890343
of O 0 0.001472716685384512
a O 0 0.00401839567348361
significant O 0 0.005522184073925018
proportion O 0 0.00819870550185442
of O 0 0.002442453522235155
loss O 0 0.41754353046417236
- O 0 0.012313329614698887
of O 0 0.0028485222719609737
- O 0 0.027391595765948296
function O 0 0.021201279014348984
mutations O 1 0.9982213377952576
and O 0 0.001546825165860355
a O 0 0.0030726459808647633
complete O 0 0.004974382929503918
absence O 0 0.006207339931279421
of O 0 0.0010682293213903904
the O 0 0.0020015628542751074
normal O 0 0.010072692297399044
copy O 0 0.007090987171977758
of O 0 0.0018816913943737745
ATM O 0 0.0302173662930727
in O 0 0.0017541483975946903
the O 0 0.002006768248975277
majority O 0 0.007819280959665775
of O 0 0.007032073102891445
mutated O 1 0.9999713897705078
tumours B-Disease 1 0.9999977350234985
establishes O 1 0.9674038887023926
somatic O 1 0.9980574250221252
inactivation O 1 0.9952292442321777
of O 0 0.0029377311002463102
this O 0 0.0038929900620132685
gene O 1 0.6070899963378906
in O 0 0.0023990818299353123
the O 0 0.004234811756759882
pathogenesis O 1 0.9995046854019165
of O 0 0.00616459408774972
sporadic B-Disease 1 0.9970129728317261
T I-Disease 1 0.9997348189353943
- I-Disease 1 0.8525979518890381
PLL I-Disease 1 0.9996997117996216
and O 0 0.0037655711639672518
suggests O 0 0.011390400119125843
that O 0 0.002495482098311186
ATM O 0 0.04637797549366951
acts O 0 0.008295693434774876
as O 0 0.004305135924369097
a O 0 0.02305489219725132
tumour B-Disease 1 0.9999983310699463
suppressor O 1 0.9999171495437622
. O 0 0.02585661970078945

As O 0 0.007680587004870176
constitutional O 0 0.014608247205615044
DNA O 0 0.025982830673456192
was O 0 0.002888328395783901
not O 0 0.001346310251392424
available O 0 0.0018405768787488341
, O 0 0.001485126675106585
a O 0 0.0058343904092907906
putative O 1 0.9867374300956726
hereditary O 1 0.99996018409729
predisposition O 1 0.9999653100967407
to O 0 0.008889380842447281
T B-Disease 1 0.9997884631156921
- I-Disease 1 0.5247728824615479
PLL I-Disease 1 0.9993270635604858
will O 0 0.004533685743808746
require O 0 0.009106780402362347
further O 0 0.00585259310901165
investigation O 0 0.01397225446999073
. O 0 0.004730956628918648
. O 0 0.008005645126104355

Myotonic B-Disease 1 0.9999984502792358
dystrophy I-Disease 1 0.9999996423721313
protein O 1 0.954782247543335
kinase O 1 0.992099940776825
is O 0 0.005032769870012999
involved O 0 0.0047589074820280075
in O 0 0.0019644631538540125
the O 0 0.0032459325157105923
modulation O 0 0.03911281004548073
of O 0 0.003258161712437868
the O 0 0.009703590534627438
Ca2 O 1 0.9982825517654419
+ O 1 0.57228684425354
homeostasis O 1 0.9919289350509644
in O 0 0.015153033658862114
skeletal O 1 0.9999217987060547
muscle O 1 0.9999607801437378
cells O 1 0.9694715142250061
. O 0 0.016827013343572617

Myotonic B-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.4089175760746002
DM B-Disease 1 0.9999920129776001
) O 0 0.00737879890948534
, O 0 0.0021374698262661695
the O 0 0.0026918535586446524
most O 0 0.0065709627233445644
prevalent O 1 0.9997830986976624
muscular B-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999997615814209
in O 0 0.006481667049229145
adults O 1 0.9842082858085632
, O 0 0.0031435515265911818
is O 0 0.004385616630315781
caused O 1 0.8461439609527588
by O 0 0.004784259479492903
( O 0 0.0104494234547019
CTG O 1 0.9886205196380615
) O 0 0.007562131620943546
n O 0 0.02308950386941433
- O 0 0.020979052409529686
repeat O 0 0.025026626884937286
expansion O 0 0.008542368188500404
in O 0 0.0025336886756122112
a O 0 0.008173691108822823
gene O 0 0.08490170538425446
encoding O 0 0.029300631955266
a O 0 0.013386172242462635
protein O 0 0.07209044694900513
kinase O 1 0.9801162481307983
( O 0 0.025799084454774857
DM B-Disease 1 0.9996782541275024
protein O 0 0.25961580872535706
kinase O 1 0.9822124242782593
; O 0 0.013557832688093185
DMPK O 1 0.9850895404815674
) O 0 0.005302574019879103
and O 0 0.001769594382494688
involves O 0 0.012145766988396645
changes O 0 0.007653163745999336
in O 0 0.0036881733685731888
cytoarchitecture O 1 0.9787428379058838
and O 0 0.006691062822937965
ion O 0 0.10226892679929733
homeostasis O 1 0.9640974402427673
. O 0 0.015565397217869759

To O 0 0.005109739489853382
obtain O 0 0.00773863447830081
clues O 0 0.01206393726170063
to O 0 0.0019615916535258293
the O 0 0.003241326194256544
normal O 0 0.017155960202217102
biological O 0 0.010198291391134262
role O 0 0.007450805511325598
of O 0 0.003933592699468136
DMPK O 1 0.9934446811676025
in O 0 0.005606496706604958
cellular O 0 0.13290096819400787
ion O 0 0.23869170248508453
homeostasis O 1 0.9956003427505493
, O 0 0.0026364880613982677
we O 0 0.0017045041313394904
have O 0 0.0020875371992588043
compared O 0 0.007394140586256981
the O 0 0.0049369847401976585
resting O 1 0.9241372346878052
[ O 0 0.17090851068496704
Ca2 O 1 0.9965105652809143
+ O 0 0.2498474419116974
] O 0 0.03193969652056694
i O 0 0.005570999812334776
, O 0 0.0017748575191944838
the O 0 0.002731375629082322
amplitude O 0 0.029028108343482018
and O 0 0.0027609996031969786
shape O 0 0.017668986693024635
of O 0 0.006414023693650961
depolarization O 1 0.9998020529747009
- O 1 0.933923602104187
induced O 1 0.9995187520980835
Ca2 O 1 0.9982024431228638
+ O 1 0.7164844274520874
transients O 1 0.9352861642837524
, O 0 0.002693117130547762
and O 0 0.001184114022180438
the O 0 0.0020432197488844395
content O 0 0.004407346248626709
of O 0 0.002354666357859969
ATP O 0 0.2738111615180969
- O 0 0.02516421675682068
driven O 0 0.027828367426991463
ion O 0 0.04901318997144699
pumps O 0 0.03817689046263695
in O 0 0.006196113303303719
cultured O 1 0.9874300360679626
skeletal O 1 0.9999755620956421
muscle O 1 0.9999675750732422
cells O 0 0.24920448660850525
of O 0 0.00300078303553164
wild O 0 0.036637626588344574
- O 0 0.023497501388192177
type O 0 0.02516327239573002
and O 0 0.004525733180344105
DMPK O 1 0.9985520243644714
[ O 0 0.06504450738430023
- O 0 0.06993507593870163
/ O 0 0.310400128364563
- O 0 0.0536101870238781
] O 0 0.07686620950698853
knockout O 1 0.8985874056816101
mice O 1 0.987589955329895
. O 0 0.016120629385113716

In O 0 0.014747841283679008
vitro O 0 0.1312524974346161
- O 0 0.06188637763261795
differentiated O 1 0.94619220495224
DMPK O 1 0.9980148077011108
[ O 0 0.08006937056779861
- O 0 0.08546861261129379
/ O 1 0.6554754376411438
- O 0 0.0481400266289711
] O 0 0.056561391800642014
myotubes O 1 0.8446745276451111
exhibit O 0 0.02045263908803463
a O 0 0.008258816786110401
higher O 0 0.013554757460951805
resting O 0 0.3242602050304413
[ O 0 0.16548678278923035
Ca2 O 1 0.9972851276397705
+ O 0 0.23804794251918793
] O 0 0.03204099461436272
i O 0 0.0051134428940713406
than O 0 0.0028863511979579926
do O 0 0.004442774225026369
wild O 0 0.019909029826521873
- O 0 0.03312843665480614
type O 0 0.1275280863046646
myotubes O 1 0.9719671010971069
because O 0 0.0037146182730793953
of O 0 0.0013443538919091225
an O 0 0.0025561274960637093
altered O 0 0.016052749007940292
open O 0 0.0059596337378025055
probability O 0 0.007431600242853165
of O 0 0.002310302807018161
voltage O 0 0.02816731669008732
- O 0 0.031365860253572464
dependent O 0 0.04428767040371895
l O 0 0.27568766474723816
- O 0 0.05292923375964165
type O 0 0.1476682424545288
Ca2 O 1 0.9773228168487549
+ O 0 0.05964750051498413
and O 0 0.006732711102813482
Na O 1 0.9798979163169861
+ O 0 0.06395553052425385
channels O 0 0.024997076019644737
. O 0 0.011485205963253975

The O 0 0.017626289278268814
mutant O 1 0.9960383176803589
myotubes O 1 0.9841967225074768
exhibit O 0 0.028196312487125397
smaller O 0 0.011020979844033718
and O 0 0.004181137774139643
slower O 0 0.04265940934419632
Ca2 O 1 0.9924410581588745
+ O 0 0.06973113119602203
responses O 0 0.029769638553261757
upon O 0 0.010532911866903305
triggering O 1 0.7655171155929565
by O 0 0.008434154093265533
acetylcholine O 1 0.8272315263748169
or O 0 0.006220909301191568
high O 0 0.00884140282869339
external O 0 0.019574401900172234
K O 0 0.08831872791051865
+ O 0 0.0701424777507782
. O 0 0.014133504591882229

In O 0 0.005525827873498201
addition O 0 0.005022657569497824
, O 0 0.0020669212099164724
we O 0 0.001659044879488647
observed O 0 0.007400848437100649
that O 0 0.0020032168831676245
these O 0 0.004758645314723253
Ca2 O 1 0.9972860813140869
+ O 1 0.8166613578796387
transients O 1 0.995466947555542
partially O 0 0.041717227548360825
result O 0 0.008516390807926655
from O 0 0.0026444129180163145
an O 0 0.00289803184568882
influx O 0 0.02931988425552845
of O 0 0.004608051851391792
extracellular O 0 0.2144598513841629
Ca2 O 1 0.9920819997787476
+ O 0 0.04463762789964676
through O 0 0.006468321196734905
the O 0 0.007683464791625738
l O 0 0.24012765288352966
- O 0 0.057328980416059494
type O 0 0.10006613284349442
Ca2 O 1 0.9781430959701538
+ O 0 0.08938611298799515
channel O 0 0.03950418904423714
. O 0 0.015023806132376194

Neither O 0 0.014965349808335304
the O 0 0.0030516604892909527
content O 0 0.005866341758519411
nor O 0 0.005548485089093447
the O 0 0.0021812880877405405
activity O 0 0.007223090156912804
of O 0 0.005238148383796215
Na O 1 0.9826543927192688
+ O 0 0.16852234303951263
/ O 0 0.12362919002771378
K O 0 0.09128592908382416
+ O 0 0.10049857199192047
ATPase O 1 0.8837870359420776
and O 0 0.01867128536105156
sarcoplasmic O 1 0.9998134970664978
reticulum O 1 0.9990330934524536
Ca2 O 1 0.9953497648239136
+ O 0 0.30750879645347595
- O 0 0.06652626395225525
ATPase O 1 0.9521202445030212
are O 0 0.005167966242879629
affected O 0 0.030752798542380333
by O 0 0.009176760911941528
DMPK O 1 0.9964929223060608
absence O 0 0.04672601819038391
. O 0 0.012721952982246876

In O 0 0.005307984072715044
conclusion O 0 0.008367695845663548
, O 0 0.0016893631545826793
our O 0 0.002438027411699295
data O 0 0.002898239530622959
suggest O 0 0.007363945711404085
that O 0 0.0031732888892292976
DMPK O 1 0.9961168766021729
is O 0 0.0038658692501485348
involved O 0 0.005096833687275648
in O 0 0.0030652463901787996
modulating O 1 0.9508469700813293
the O 0 0.0029752913396805525
initial O 0 0.00918386410921812
events O 0 0.0039667063392698765
of O 0 0.0030473072547465563
excitation O 1 0.9357821941375732
- O 0 0.09596730768680573
contraction O 1 0.9940168857574463
coupling O 0 0.1214701235294342
in O 0 0.0121541079133749
skeletal O 1 0.9998459815979004
muscle O 1 0.9998983144760132
. O 0 0.00698894402012229
. O 0 0.009848822839558125

Constitutional O 0 0.08089631795883179
RB1 O 1 0.9998900890350342
- O 1 0.9120661616325378
gene O 1 0.9979841709136963
mutations O 1 0.9995887875556946
in O 0 0.009230979718267918
patients O 1 0.9994065761566162
with O 0 0.008630149066448212
isolated O 1 0.6830621957778931
unilateral B-Disease 1 0.9821589589118958
retinoblastoma I-Disease 1 0.9997403025627136
. O 0 0.023478886112570763

In O 0 0.007491974625736475
most O 0 0.00951320305466652
patients O 1 0.9994274377822876
with O 0 0.005683901719748974
isolated O 1 0.9324520230293274
unilateral B-Disease 1 0.9968504309654236
retinoblastoma I-Disease 1 0.999991774559021
, O 0 0.010841988027095795
tumor B-Disease 1 0.9999873638153076
development O 0 0.006041583139449358
is O 0 0.0038975023198872805
initiated O 0 0.02008248306810856
by O 0 0.006235589738935232
somatic O 1 0.9588540196418762
inactivation O 1 0.9830034971237183
of O 0 0.003281503915786743
both O 0 0.0042633553966879845
alleles O 1 0.9677664041519165
of O 0 0.003609540406614542
the O 0 0.01161352451890707
RB1 O 1 0.999936580657959
gene O 1 0.985204815864563
. O 0 0.018277399241924286

However O 0 0.007113469298928976
, O 0 0.002181540010496974
some O 0 0.0018370600882917643
of O 0 0.0018794959178194404
these O 0 0.003207460045814514
patients O 1 0.999940037727356
can O 0 0.008020211011171341
transmit O 1 0.9840518236160278
retinoblastoma B-Disease 1 0.9999938011169434
predisposition O 1 0.9998636245727539
to O 0 0.003799354424700141
their O 0 0.007154257968068123
offspring O 1 0.8905572295188904
. O 0 0.014710412360727787

To O 0 0.004708001855760813
determine O 0 0.006084372289478779
the O 0 0.0029156499076634645
frequency O 0 0.015235365368425846
and O 0 0.0012868850026279688
nature O 0 0.0038022769149392843
of O 0 0.002830798039212823
constitutional O 0 0.029008636251091957
RB1 O 1 0.9999595880508423
- O 1 0.9401729106903076
gene O 1 0.998916745185852
mutations O 1 0.9997134804725647
in O 0 0.007436512969434261
patients O 1 0.999907374382019
with O 0 0.0059127784334123135
isolated O 1 0.8844215869903564
unilateral B-Disease 1 0.9887405037879944
retinoblastoma I-Disease 1 0.9999481439590454
, O 0 0.0028527865651994944
we O 0 0.0019260304979979992
analyzed O 0 0.012937061488628387
DNA O 0 0.02464442141354084
from O 0 0.0057832314632833
peripheral O 1 0.9993667006492615
blood O 1 0.98131263256073
and O 0 0.004263836890459061
from O 0 0.013193878345191479
tumor B-Disease 1 0.9999979734420776
tissue O 1 0.999821126461029
. O 0 0.013740426860749722

The O 0 0.006781428121030331
analysis O 0 0.009861117228865623
of O 0 0.006773250177502632
tumors B-Disease 1 0.999969482421875
from O 0 0.006208199542015791
54 O 0 0.018122538924217224
( O 0 0.007115490268915892
71 O 0 0.0197902824729681
% O 0 0.0066298977471888065
) O 0 0.0030493433587253094
of O 0 0.002560884226113558
76 O 0 0.03696323558688164
informative O 0 0.05773606896400452
patients O 1 0.999525785446167
showed O 0 0.013538852334022522
loss O 0 0.01947103440761566
of O 0 0.003508299356326461
constitutional O 0 0.023748798295855522
heterozygosity O 1 0.9990046620368958
( O 0 0.02605387754738331
LOH O 1 0.9998055100440979
) O 0 0.010627150535583496
at O 0 0.011061384342610836
intragenic O 1 0.9918815493583679
loci O 1 0.9865060448646545
. O 0 0.02012971043586731

Three O 0 0.006481977179646492
of O 0 0.005155571736395359
13 O 0 0.022139137610793114
uninformative O 1 0.9984968900680542
patients O 1 0.9997422099113464
had O 0 0.008048211224377155
constitutional O 0 0.020855773240327835
deletions O 1 0.616191565990448
. O 0 0.015516398474574089

For O 0 0.009436472319066525
39 O 0 0.026665188372135162
randomly O 0 0.03509869799017906
selected O 0 0.01955289952456951
tumors B-Disease 1 0.9999829530715942
, O 0 0.006563913077116013
SSCP O 1 0.9989674091339111
, O 0 0.00879089254885912
hetero O 1 0.99872225522995
- O 0 0.047945018857717514
duplex O 1 0.8540351986885071
analysis O 0 0.008618202991783619
, O 0 0.0027944138273596764
sequencing O 0 0.02394733764231205
, O 0 0.002005647635087371
and O 0 0.0020432565361261368
Southern O 0 0.011644781567156315
blot O 1 0.7313036918640137
analysis O 0 0.006469350773841143
were O 0 0.0013258801773190498
used O 0 0.0017936109798029065
to O 0 0.002746472368016839
identify O 0 0.02375551126897335
mutations O 1 0.995311439037323
. O 0 0.011184336617588997

Mutations O 1 0.9945006370544434
were O 0 0.006855653133243322
detected O 0 0.04046531766653061
in O 0 0.003228674875572324
21 O 0 0.011116565205156803
( O 0 0.00657516298815608
91 O 0 0.02270902507007122
% O 0 0.006422321777790785
) O 0 0.003720768028870225
of O 0 0.003146727103739977
23 O 0 0.03758777305483818
tumors B-Disease 1 0.9999821186065674
with O 0 0.011217406950891018
LOH O 1 0.9998785257339478
. O 0 0.01592746190726757

In O 0 0.008886780589818954
6 O 0 0.014342967420816422
( O 0 0.006865321192890406
38 O 0 0.012820489704608917
% O 0 0.005380888935178518
) O 0 0.0028335871174931526
of O 0 0.0022861515171825886
16 O 0 0.01921934261918068
tumors B-Disease 1 0.9999926090240479
without O 0 0.014967727474868298
LOH O 1 0.9999493360519409
, O 0 0.0036905640736222267
one O 0 0.006574767641723156
mutation O 1 0.999055802822113
was O 0 0.007257285062223673
detected O 0 0.15868164598941803
, O 0 0.001361063332296908
and O 0 0.0008725928491912782
in O 0 0.0016098038759082556
9 O 0 0.006577637046575546
( O 0 0.004509129095822573
56 O 0 0.009310255758464336
% O 0 0.0036284264642745256
) O 0 0.0017585206078365445
of O 0 0.0012938508298248053
the O 0 0.0053327917121350765
tumors B-Disease 1 0.9999988079071045
without O 0 0.028566690161824226
LOH O 1 0.9999935626983643
, O 0 0.003439760534092784
both O 0 0.004524793941527605
mutations O 1 0.9993389248847961
were O 0 0.002248625038191676
found O 0 0.008268390782177448
. O 0 0.009244718588888645

Thus O 0 0.0117093650624156
, O 0 0.0025540334172546864
a O 0 0.0039208116941154
total O 0 0.0038021455984562635
of O 0 0.002329783281311393
45 O 0 0.014599217101931572
mutations O 1 0.9968358874320984
were O 0 0.002749331295490265
identified O 0 0.011557789519429207
in O 0 0.005804744083434343
tumors B-Disease 1 0.9999798536300659
of O 0 0.005513701122254133
36 O 0 0.11532068252563477
patients O 1 0.9997046589851379
. O 0 0.015178995206952095

Thirty O 0 0.03763273358345032
- O 0 0.017945077270269394
nine O 0 0.004954495932906866
of O 0 0.002509983954951167
the O 0 0.005501295905560255
mutations O 1 0.9994831085205078
- O 0 0.017185693606734276
including O 0 0.003914732486009598
34 O 0 0.01534831803292036
small O 0 0.010990777052938938
mutations O 1 0.997860848903656
, O 0 0.0022700801491737366
2 O 0 0.004937814082950354
large O 0 0.004396490287035704
structural O 0 0.025048375129699707
alterations O 0 0.056282803416252136
, O 0 0.002133606467396021
and O 0 0.002817984903231263
hypermethylation O 1 0.9993201494216919
in O 0 0.0043723867274820805
3 O 0 0.024685334414243698
tumors O 1 0.9999972581863403
- O 0 0.015310408547520638
were O 0 0.0017303184140473604
not O 0 0.0020292422268539667
detected O 0 0.021978123113512993
in O 0 0.0014923879643902183
the O 0 0.0029016246553510427
corresponding O 0 0.020097510889172554
peripheral O 1 0.9992806315422058
blood O 1 0.9930160045623779
DNA O 0 0.07025932520627975
. O 0 0.012391507625579834

In O 0 0.006586679257452488
6 O 0 0.01416635699570179
( O 0 0.005233298521488905
17 O 0 0.006608906667679548
% O 0 0.003888803767040372
) O 0 0.0020458807703107595
of O 0 0.0011375995818525553
the O 0 0.002780610229820013
36 O 0 0.021792806684970856
patients O 1 0.999569833278656
, O 0 0.0029695606790483
a O 0 0.00845400895923376
mutation O 1 0.9998683929443359
was O 0 0.006192168686538935
detected O 0 0.03425013646483421
in O 0 0.001965942094102502
constitutional O 0 0.007855650037527084
DNA O 0 0.01844736374914646
, O 0 0.0013411241816356778
and O 0 0.0010740876896306872
1 O 0 0.0036268546245992184
of O 0 0.0014246749924495816
these O 0 0.0031283532734960318
mutations O 1 0.9991505146026611
is O 0 0.0028980288188904524
known O 0 0.0036663515493273735
to O 0 0.0014726381050422788
be O 0 0.001395772211253643
associated O 0 0.005736174993216991
with O 0 0.0035849015694111586
reduced O 0 0.038816388696432114
expressivity O 1 0.9982559084892273
. O 0 0.018159708008170128

The O 0 0.005342839751392603
presence O 0 0.008806001394987106
of O 0 0.0020858433563262224
a O 0 0.006717402953654528
constitutional O 0 0.018276851624250412
mutation O 1 0.9996515512466431
was O 0 0.0037977914325892925
not O 0 0.0015875756507739425
associated O 0 0.004484851378947496
with O 0 0.0013735702959820628
an O 0 0.0021717213094234467
early O 0 0.0069760726764798164
age O 0 0.012175886891782284
at O 0 0.007328187581151724
treatment O 1 0.9661898612976074
. O 0 0.010775663889944553

In O 0 0.009108385071158409
1 O 0 0.02030644193291664
patient O 1 0.9971822500228882
, O 0 0.008242890238761902
somatic O 1 0.9958874583244324
mosaicism O 1 0.9995885491371155
was O 0 0.006429470144212246
demonstrated O 0 0.010723967105150223
by O 0 0.0037681336980313063
molecular O 0 0.015437490306794643
analysis O 0 0.004013075027614832
of O 0 0.002305982867255807
DNA O 0 0.021678807213902473
and O 0 0.003194224089384079
RNA O 0 0.04813093692064285
from O 0 0.010052444413304329
peripheral O 1 0.9990876913070679
blood O 1 0.9942514896392822
. O 0 0.014780060388147831

In O 0 0.008906424976885319
2 O 0 0.019957374781370163
patients O 1 0.9992645382881165
without O 0 0.007407391909509897
a O 0 0.011307925917208195
detectable O 1 0.9945724606513977
mutation O 1 0.9988306164741516
in O 0 0.007484515197575092
peripheral O 1 0.9999349117279053
blood O 1 0.9996813535690308
, O 0 0.005968835204839706
mosaicism O 1 0.9999197721481323
was O 0 0.004965380299836397
suggested O 0 0.005270493216812611
because O 0 0.0033644374925643206
1 O 0 0.0032444207463413477
of O 0 0.001466965302824974
the O 0 0.004994441755115986
patients O 1 0.9999748468399048
showed O 1 0.9680997133255005
multifocal O 1 0.9999997615814209
tumors B-Disease 1 0.999998927116394
and O 0 0.002381347818300128
the O 0 0.002019627019762993
other O 0 0.0015420698327943683
later O 0 0.004271487705409527
developed O 0 0.01466040313243866
bilateral B-Disease 0 0.02215266041457653
retinoblastoma I-Disease 1 0.9997645020484924
. O 0 0.016188375651836395

In O 0 0.005538733210414648
conclusion O 0 0.008755802176892757
, O 0 0.0018181559862568974
our O 0 0.0030934277456253767
results O 0 0.0056776124984025955
emphasize O 0 0.009387444704771042
that O 0 0.0013924402883276343
the O 0 0.002667374210432172
manifestation O 1 0.9438258409500122
and O 0 0.003025049576535821
transmissibility O 1 0.9993399977684021
of O 0 0.005118874367326498
retinoblastoma B-Disease 1 0.9999071359634399
depend O 0 0.006488082464784384
on O 0 0.0012179288314655423
the O 0 0.0014529360923916101
nature O 0 0.0034853762481361628
of O 0 0.0011619741562753916
the O 0 0.0021149979438632727
first O 0 0.004988428670912981
mutation O 1 0.9997406601905823
, O 0 0.0017426784615963697
its O 0 0.0018425225280225277
time O 0 0.0019021780462935567
in O 0 0.0012051291996613145
development O 0 0.0023419922217726707
, O 0 0.0011540321866050363
and O 0 0.0007421438931487501
the O 0 0.0012100990861654282
number O 0 0.0018596629379317164
and O 0 0.0011815520701929927
types O 0 0.004570641554892063
of O 0 0.0017864156980067492
cells O 1 0.783644437789917
that O 0 0.0015800850233063102
are O 0 0.0018576716538518667
affected O 0 0.14087775349617004
. O 0 0.004077795427292585
. O 0 0.008190794847905636

Hereditary B-Disease 1 0.9999737739562988
deficiency I-Disease 1 0.9999887943267822
of I-Disease 0 0.002942451508715749
the I-Disease 0 0.003728952258825302
fifth I-Disease 0 0.013484053313732147
component I-Disease 0 0.01276860386133194
of I-Disease 0 0.002720180433243513
complement I-Disease 0 0.01520630531013012
in O 0 0.003706580027937889
man O 0 0.023015961050987244
. O 0 0.011541861109435558

I O 0 0.03753674775362015
. O 0 0.017537107691168785

Clinical O 1 0.9556050896644592
, O 0 0.0081728370860219
immunochemical O 1 0.9922522902488708
, O 0 0.003223714418709278
and O 0 0.0028044080827385187
family O 0 0.012449712492525578
studies O 0 0.013532034121453762
. O 0 0.010562457144260406

The O 0 0.005161231383681297
first O 0 0.005468825809657574
recognized O 0 0.012051853351294994
human O 0 0.016786441206932068
kindred O 1 0.9987586736679077
with O 0 0.008599556982517242
hereditary B-Disease 1 0.9999933242797852
deficiency I-Disease 1 0.9999986886978149
of I-Disease 0 0.001960089895874262
the I-Disease 0 0.002360297366976738
fifth I-Disease 0 0.01152064185589552
component I-Disease 0 0.014121065847575665
of I-Disease 0 0.003499358892440796
complement I-Disease 0 0.026165097951889038
( O 0 0.014612880535423756
C5 O 1 0.9947953820228577
) O 0 0.007367128971964121
is O 0 0.0058134873397648335
described O 0 0.014732233248651028
. O 0 0.010468018241226673

The O 0 0.013689755462110043
proband O 1 0.9002323150634766
, O 0 0.0031962075736373663
a O 0 0.005504878703504801
20 O 0 0.007338475901633501
- O 0 0.01522207260131836
year O 0 0.0060132467187941074
- O 0 0.017709925770759583
old O 0 0.01453178096562624
black O 0 0.026248296722769737
female O 0 0.16250737011432648
with O 0 0.10911355912685394
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.04768950864672661
age O 0 0.022429466247558594
11 O 0 0.01044047437608242
, O 0 0.004472390748560429
lacked O 0 0.3270949125289917
serum O 1 0.9997289776802063
hemolytic O 1 0.9999971389770508
complement O 0 0.03754695504903793
activity O 0 0.014478222467005253
, O 0 0.002869567135348916
even O 0 0.005148676689714193
during O 0 0.015958447009325027
remission O 1 0.9996505975723267
. O 0 0.013351384550333023

C5 O 1 0.9823905229568481
was O 0 0.016245881095528603
undetectable O 1 0.800037145614624
in O 0 0.0038704476319253445
her O 0 0.00931538362056017
serum O 1 0.6492201089859009
by O 0 0.004956752993166447
both O 0 0.005568057764321566
immunodiffusion O 1 0.9984875917434692
and O 0 0.014062603004276752
hemolytic O 1 0.9999939203262329
assays O 0 0.16457274556159973
. O 0 0.016677312552928925

Other O 0 0.004463565535843372
complement O 0 0.015139107592403889
components O 0 0.005773506127297878
were O 0 0.0023347947280853987
normal O 0 0.017486531287431717
during O 0 0.011857137084007263
remission O 1 0.9999279975891113
of O 0 0.011870340444147587
lupus O 1 1.0
, O 0 0.0050892517901957035
but O 0 0.006796141620725393
C1 O 1 0.999796450138092
, O 0 0.006391483824700117
C4 O 1 0.7864342331886292
, O 0 0.006449712906032801
C2 O 1 0.9988296627998352
, O 0 0.00357949105091393
and O 0 0.004459670279175043
C3 O 1 0.9965337514877319
levels O 0 0.023976128548383713
fell O 0 0.030696699395775795
during O 0 0.026640400290489197
exacerbations O 1 0.9996349811553955
. O 0 0.02058868110179901

A O 0 0.023772036656737328
younger O 0 0.03965223953127861
half O 0 0.012944333255290985
- O 0 0.03134068101644516
sister O 0 0.04079551249742508
, O 0 0.0020011363085359335
who O 0 0.0029300565365701914
had O 0 0.0032225886825472116
no O 0 0.004893059376627207
underlying O 1 0.9926740527153015
disease O 1 0.9999995231628418
, O 0 0.0027043852023780346
was O 0 0.0025800608564168215
also O 0 0.0014864454278722405
found O 0 0.003063758835196495
to O 0 0.0022823407780379057
lack O 0 0.020537469536066055
immunochemically O 1 0.9976987242698669
detectable O 1 0.9982351064682007
C5 O 1 0.9966345429420471
. O 0 0.01712791435420513

By O 0 0.030973346903920174
hemolytic O 1 0.9999958276748657
assay O 0 0.4965847134590149
, O 0 0.005172508303076029
she O 0 0.005982113070785999
exhibited O 0 0.015269843861460686
1 O 0 0.00932914949953556
- O 0 0.012633250094950199
2 O 0 0.005487267859280109
% O 0 0.002738465089350939
of O 0 0.0013742368901148438
the O 0 0.003448805073276162
normal O 0 0.02922905422747135
serum O 1 0.9867318272590637
C5 O 1 0.9893488883972168
level O 0 0.007018664386123419
and O 0 0.0022875734139233828
normal O 0 0.012856360524892807
concentrations O 0 0.013522210530936718
of O 0 0.0013825510395690799
other O 0 0.0016135397600010037
complement O 0 0.014349110424518585
components O 0 0.010430346243083477
. O 0 0.0076063512824475765

C5 O 1 0.9934846758842468
levels O 0 0.015418064780533314
of O 0 0.0019353126408532262
other O 0 0.0016328215133398771
family O 0 0.006316827144473791
members O 0 0.002042603213340044
were O 0 0.0012101277243345976
either O 0 0.003939918242394924
normal O 0 0.010429179295897484
or O 0 0.0026424189563840628
approximately O 0 0.0044761039316654205
half O 0 0.006429722998291254
- O 0 0.01848084107041359
normal O 0 0.013676445931196213
, O 0 0.002475056331604719
consistent O 0 0.010973578318953514
with O 0 0.008323512971401215
autosomal O 1 0.9999949932098389
codominant O 1 0.9985873699188232
inheritance O 0 0.25061294436454773
of O 0 0.003564308164641261
the O 0 0.007229415699839592
gene O 1 0.9959259033203125
determining O 0 0.2456374317407608
C5 B-Disease 1 0.9999772310256958
deficiency I-Disease 1 0.9999985694885254
. O 0 0.020061660557985306

Normal O 1 0.9818652272224426
hemolytic O 1 0.9999946355819702
titers O 1 0.986952543258667
were O 0 0.004285218194127083
restored O 0 0.010552800260484219
to O 0 0.0024474544916301966
both O 0 0.006533805746585131
homozygous O 1 0.9979467988014221
C5 B-Disease 1 0.9998266100883484
- I-Disease 1 0.8032211065292358
deficient I-Disease 1 0.9995837807655334
( O 0 0.016689203679561615
C5D B-Disease 1 0.9993040561676025
) O 0 0.0075378711335361
sera O 0 0.03156241402029991
by O 0 0.0025459500029683113
addition O 0 0.0032698570284992456
of O 0 0.0025492191780358553
highly O 0 0.016071151942014694
purified O 0 0.3666312098503113
human O 0 0.038449302315711975
C5 O 1 0.9951744675636292
. O 0 0.014577056281268597

In O 0 0.009644963778555393
specific O 0 0.018843062222003937
C5 O 1 0.9994304776191711
titrations O 1 0.9989145994186401
, O 0 0.0036304371897131205
however O 0 0.0026917189825326204
, O 0 0.0011952535714954138
it O 0 0.0012246561236679554
was O 0 0.002055841963738203
noted O 0 0.002705987077206373
that O 0 0.0013811745448037982
when O 0 0.0033699837513267994
limited O 0 0.005210383795201778
amounts O 0 0.0075956047512590885
of O 0 0.004073301330208778
C5 O 1 0.9765326976776123
were O 0 0.002766790334135294
assayed O 0 0.038030609488487244
in O 0 0.0019021588377654552
the O 0 0.001785488915629685
presence O 0 0.0054892925545573235
of O 0 0.0021850918419659138
low O 0 0.017584607005119324
dilutions O 1 0.8461899757385254
of O 0 0.003412798047065735
either O 0 0.012012369930744171
C5D B-Disease 1 0.999848484992981
serum O 1 0.9936543703079224
, O 0 0.004457118455320597
curving O 0 0.03307722136378288
rather O 0 0.005646265111863613
than O 0 0.005774946883320808
linear O 0 0.04131466895341873
dose O 1 0.9976129531860352
- O 0 0.02546815201640129
response O 0 0.015404613688588142
plots O 0 0.0097527876496315
were O 0 0.0019624701235443354
consistently O 0 0.007302283309400082
obtained O 0 0.003847073297947645
, O 0 0.002354414202272892
suggesting O 0 0.013864208944141865
some O 0 0.005295445676892996
inhibitory O 0 0.27739399671554565
effect O 0 0.02867971733212471
. O 0 0.011741065420210361

Further O 0 0.011793782003223896
studies O 0 0.008425408974289894
suggested O 0 0.006788385100662708
that O 0 0.002558642765507102
low O 0 0.018514398485422134
dilutions O 1 0.9612109661102295
of O 0 0.00754369143396616
C5D B-Disease 1 0.9998800754547119
serum O 1 0.989069402217865
contain O 0 0.011579850688576698
a O 0 0.00773824006319046
factor O 0 0.02504880540072918
( O 0 0.005391106009483337
or O 0 0.0037071926053613424
factors O 0 0.008185157552361488
) O 0 0.003497192868962884
interfering O 0 0.014121146872639656
at O 0 0.002357619581744075
some O 0 0.001752228825353086
step O 0 0.006448926869779825
in O 0 0.0021885272581130266
the O 0 0.00892055593430996
hemolytic O 1 0.9999969005584717
assay O 0 0.16764061152935028
of O 0 0.006303782574832439
C5 O 1 0.9991803765296936
, O 0 0.0030123647302389145
rather O 0 0.004017041064798832
than O 0 0.00340131763368845
a O 0 0.006397855468094349
true O 0 0.018646206706762314
C5 O 1 0.9983469247817993
inhibitor O 1 0.9933285713195801
or O 0 0.01860228180885315
inactivator O 1 0.973347008228302
. O 0 0.015474804677069187

Of O 0 0.006726715713739395
clinical O 0 0.4007253646850586
interest O 0 0.003979027736932039
are O 0 0.0015798850217834115
( O 0 0.0031283320859074593
a O 0 0.003122256137430668
) O 0 0.002052929485216737
the O 0 0.0016786794876679778
documentation O 0 0.007138573564589024
of O 0 0.005607882048934698
membranous O 1 0.9999649524688721
glomerulonephritis B-Disease 1 0.9999991655349731
, O 0 0.030392805114388466
vasculitis B-Disease 1 0.9999995231628418
, O 0 0.004890355281531811
and O 0 0.009276865981519222
arthritis B-Disease 1 1.0
in O 0 0.002964685671031475
an O 0 0.0030217436142265797
individual O 0 0.00812937505543232
lacking O 0 0.33867108821868896
C5 O 1 0.9989909529685974
( O 0 0.0055118766613304615
and O 0 0.0015291731106117368
its O 0 0.004284617956727743
biologic O 1 0.7993113398551941
functions O 0 0.006572267040610313
) O 0 0.0029046612326055765
, O 0 0.001328623271547258
and O 0 0.0016267194878309965
( O 0 0.005794334691017866
b O 0 0.01672009378671646
) O 0 0.0028998511843383312
a O 0 0.0045722839422523975
remarkable O 0 0.014726328663527966
propensity O 1 0.9825261831283569
to O 0 0.010377105325460434
bacterial B-Disease 1 0.999997615814209
infections I-Disease 1 0.9999991655349731
in O 0 0.0031101463828235865
the O 0 0.0045619565062224865
proband O 1 0.9987183809280396
, O 0 0.00226506101898849
even O 0 0.002967249369248748
during O 0 0.004811531398445368
periods O 0 0.008380722254514694
of O 0 0.0026938575319945812
low O 0 0.020941780880093575
- O 0 0.05017026886343956
dose O 1 0.9435135126113892
or O 0 0.006766920443624258
alternate O 0 0.013374381698668003
- O 0 0.032172009348869324
day O 0 0.025556983426213264
corticosteroid O 1 0.9990295171737671
therapy O 1 0.996931791305542
. O 0 0.019005754962563515

Other O 0 0.005148864816874266
observations O 0 0.009171279147267342
indicate O 0 0.007828864268958569
that O 0 0.0015547461807727814
the O 0 0.003704664297401905
C5D B-Disease 1 0.9988870024681091
state O 0 0.0034052457194775343
is O 0 0.0032816349994391203
compatible O 0 0.010974761098623276
with O 0 0.0034245357383042574
normal O 0 0.02938467264175415
coagulation O 1 0.9992244243621826
function O 0 0.010556867346167564
and O 0 0.0012827761238440871
the O 0 0.001858424162492156
capacity O 0 0.00373181258328259
to O 0 0.0021404637955129147
mount O 0 0.018321119248867035
a O 0 0.019996309652924538
neutrophilic O 1 0.9999631643295288
leukocytosis O 1 0.9997265934944153
during O 1 0.578546404838562
pyogenic B-Disease 1 0.9999938011169434
infection I-Disease 1 0.9999980926513672
. O 0 0.009375927969813347
. O 0 0.009621030651032925

Susceptibility O 1 0.9991870522499084
to O 0 0.029110940173268318
ankylosing B-Disease 1 0.9999986886978149
spondylitis I-Disease 1 0.9999994039535522
in O 0 0.010402766056358814
twins O 1 0.9556845426559448
: O 0 0.003975017927587032
the O 0 0.002201356925070286
role O 0 0.00598094193264842
of O 0 0.0031593944877386093
genes O 1 0.9877069592475891
, O 0 0.005477835424244404
HLA O 1 0.999936580657959
, O 0 0.002311054849997163
and O 0 0.0016217668307945132
the O 0 0.0035505162086337805
environment O 0 0.012595114298164845
. O 0 0.009088408201932907

OBJECTIVE O 0 0.018379366025328636
To O 0 0.002778438851237297
determine O 0 0.005201528314501047
the O 0 0.003019757568836212
relative O 0 0.011884291656315327
effects O 0 0.022241519764065742
of O 0 0.0028796070255339146
genetic O 1 0.8435037136077881
and O 0 0.0021450305357575417
environmental O 0 0.00869772769510746
factors O 0 0.010148544795811176
in O 0 0.005057492759078741
susceptibility O 1 0.999948263168335
to O 0 0.02245396561920643
ankylosing B-Disease 1 0.9999997615814209
spondylitis I-Disease 1 0.9999997615814209
( O 0 0.020220322534441948
AS B-Disease 0 0.010599272325634956
) O 0 0.008154821582138538
. O 0 0.009143518283963203

METHODS O 0 0.028873512521386147
Twins O 0 0.4512181580066681
with O 0 0.003235126845538616
AS B-Disease 0 0.0034256423823535442
were O 0 0.001505020190961659
identified O 0 0.006042353808879852
from O 0 0.0016247929306700826
the O 0 0.0021484545432031155
Royal O 0 0.012028684839606285
National O 0 0.012612312100827694
Hospital O 1 0.9997654557228088
for O 0 0.024255899712443352
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999985694885254
database O 0 0.12977327406406403
. O 0 0.015215161256492138

Clinical O 1 0.902137815952301
and O 0 0.006617201026529074
radiographic O 1 0.9860280752182007
examinations O 0 0.02330700494349003
were O 0 0.002086312510073185
performed O 0 0.0057359919883310795
to O 0 0.0021555330604314804
establish O 0 0.012466712854802608
diagnoses O 1 0.9998764991760254
, O 0 0.0036066945176571608
and O 0 0.006319575477391481
disease O 1 0.9999998807907104
severity O 1 0.9999085664749146
was O 0 0.004868191201239824
assessed O 0 0.011490034870803356
using O 0 0.002874246798455715
a O 0 0.004823397845029831
combination O 0 0.013057044707238674
of O 0 0.0025244983844459057
validated O 0 0.021734606474637985
scoring O 0 0.012951335869729519
systems O 0 0.016661694273352623
. O 0 0.010353204794228077

HLA O 1 0.998126208782196
typing O 0 0.36793625354766846
for O 0 0.013498898595571518
HLA O 1 0.9998182654380798
- O 0 0.1305648535490036
B27 O 1 0.9923896193504333
, O 0 0.009994227439165115
HLA O 1 0.9999386072158813
- O 0 0.24619196355342865
B60 O 1 0.9765018820762634
, O 0 0.004075984936207533
and O 0 0.006102144252508879
HLA O 1 0.9999151229858398
- O 0 0.3921215832233429
DR1 O 1 0.9971047043800354
was O 0 0.010526665486395359
performed O 0 0.011822275817394257
by O 0 0.008416973054409027
polymerase O 0 0.17158430814743042
chain O 0 0.0760265588760376
reaction O 0 0.02000434324145317
with O 0 0.003360574832186103
sequence O 0 0.018813084810972214
- O 0 0.016348430886864662
specific O 0 0.00798439048230648
primers O 0 0.03679193556308746
, O 0 0.002940559294074774
and O 0 0.0029312509577721357
zygosity O 1 0.8236749768257141
was O 0 0.006188120227307081
assessed O 0 0.01837761700153351
using O 0 0.009964458644390106
microsatellite O 1 0.9664226174354553
markers O 0 0.0565573126077652
. O 0 0.013680106028914452

Genetic O 0 0.33998438715934753
and O 0 0.005684103816747665
environmental O 0 0.01403308566659689
variance O 0 0.021168019622564316
components O 0 0.005616440437734127
were O 0 0.0015434831148013473
assessed O 0 0.008735724724829197
with O 0 0.0016004170756787062
the O 0 0.0022309485357254744
program O 0 0.009801044128835201
Mx O 1 0.9533607363700867
, O 0 0.0020023181568831205
using O 0 0.0025324178859591484
data O 0 0.002280439017340541
from O 0 0.0017584185115993023
this O 0 0.001320666284300387
and O 0 0.001158021274022758
previous O 0 0.003867020597681403
studies O 0 0.0053160665556788445
of O 0 0.0032982761040329933
twins O 1 0.6305018067359924
with O 0 0.003958545625209808
AS B-Disease 0 0.00886226911097765
. O 0 0.010245390236377716

RESULTS O 0 0.02640533074736595
Six O 0 0.006904602982103825
of O 0 0.0037086461670696735
8 O 0 0.021316159516572952
monozygotic O 1 0.9936933517456055
( O 0 0.025149201974272728
MZ O 1 0.9992864727973938
) O 0 0.012223778292536736
twin O 0 0.13534288108348846
pairs O 0 0.021540796384215355
were O 0 0.006475525442510843
disease O 1 0.9999957084655762
concordant O 1 0.9952166080474854
, O 0 0.0031601754017174244
compared O 0 0.007093573454767466
with O 0 0.0017507033189758658
4 O 0 0.004686491098254919
of O 0 0.002086031949147582
15 O 0 0.00906434841454029
B27 O 1 0.9876576662063599
- O 0 0.03316722810268402
positive O 0 0.029672596603631973
dizygotic O 1 0.9963212013244629
( O 0 0.015011686831712723
DZ O 1 0.9969698786735535
) O 0 0.009433607570827007
twin O 0 0.08046959340572357
pairs O 0 0.016922177746891975
( O 0 0.0058036320842802525
27 O 0 0.007605297025293112
% O 0 0.004554158542305231
) O 0 0.0023588836193084717
and O 0 0.0010703696170821786
4 O 0 0.003923039883375168
of O 0 0.002079722471535206
32 O 0 0.01865243725478649
DZ O 1 0.9990814924240112
twin O 0 0.44702625274658203
pairs O 0 0.016656851395964622
overall O 0 0.013064541853964329
( O 0 0.005549496039748192
12 O 0 0.006097659934312105
. O 0 0.002705199643969536
5 O 0 0.006918333005160093
% O 0 0.006462926045060158
) O 0 0.005586390383541584
. O 0 0.007800532504916191

Nonsignificant O 1 0.9981953501701355
increases O 0 0.026286784559488297
in O 0 0.0033007869496941566
similarity O 0 0.014468162320554256
with O 0 0.001881333184428513
regard O 0 0.005375754088163376
to O 0 0.001946329022757709
age O 0 0.0163688026368618
at O 0 0.02194845676422119
disease O 1 0.9999998807907104
onset O 1 0.9999949932098389
and O 0 0.001719498191960156
all O 0 0.0010201192926615477
of O 0 0.0016459483886137605
the O 0 0.008564263582229614
disease O 1 0.9999997615814209
severity O 1 0.9998645782470703
scores O 0 0.01466299220919609
assessed O 0 0.013213965110480785
were O 0 0.0018445925088599324
noted O 0 0.004729223903268576
in O 0 0.006738156545907259
disease O 1 0.9999994039535522
- O 1 0.8988704681396484
concordant O 1 0.9992411136627197
MZ O 1 0.9999364614486694
twins O 1 0.9782226085662842
compared O 0 0.02777348831295967
with O 0 0.013467414304614067
concordant O 1 0.9906626343727112
DZ O 1 0.9996345043182373
twins O 1 0.8872503638267517
. O 0 0.01965075358748436

HLA O 1 0.9998996257781982
- O 0 0.3755110800266266
B27 O 1 0.977338969707489
and O 0 0.005230501294136047
B60 O 1 0.940604031085968
were O 0 0.0023526507429778576
associated O 0 0.006299276370555162
with O 0 0.002228453289717436
the O 0 0.0054473597556352615
disease O 1 0.9999992847442627
in O 0 0.004690560512244701
probands O 1 0.9989499449729919
, O 0 0.0016830171225592494
and O 0 0.0009845251915976405
the O 0 0.0015049994690343738
rate O 0 0.0067780823446810246
of O 0 0.0045300936326384544
disease O 1 0.999998927116394
concordance O 1 0.7773460149765015
was O 0 0.007048310711979866
significantly O 0 0.02499396540224552
increased O 0 0.01280257198959589
among O 0 0.01037311926484108
DZ O 1 0.9994799494743347
twin O 0 0.46277591586112976
pairs O 0 0.013506926596164703
in O 0 0.0016852738335728645
which O 0 0.0015062181046232581
the O 0 0.0025665494613349438
co O 0 0.03571662679314613
- O 0 0.03841019794344902
twin O 0 0.22083386778831482
was O 0 0.004156721290200949
positive O 0 0.008225362747907639
for O 0 0.0019167690770700574
both O 0 0.0047009349800646305
B27 O 1 0.944711446762085
and O 0 0.008695044554769993
DR1 O 1 0.9968411922454834
. O 0 0.018033498898148537

Additive O 1 0.503615140914917
genetic O 1 0.8664220571517944
effects O 0 0.0861690416932106
were O 0 0.0019061521161347628
estimated O 0 0.0064500425942242146
to O 0 0.001869086641818285
contribute O 0 0.012369155883789062
97 O 0 0.019032184034585953
% O 0 0.004591598641127348
of O 0 0.0015970402164384723
the O 0 0.003436834318563342
population O 0 0.013649078086018562
variance O 0 0.03942172974348068
. O 0 0.010397829115390778

CONCLUSION O 0 0.059045787900686264
Susceptibility O 1 0.9989727735519409
to O 0 0.0037560078781098127
AS B-Disease 0 0.004582725930958986
is O 0 0.0028374199755489826
largely O 0 0.0086467694491148
genetically O 0 0.048544615507125854
determined O 0 0.006943788379430771
, O 0 0.0011661896714940667
and O 0 0.0010497096227481961
the O 0 0.0023491682950407267
environmental O 0 0.01162786316126585
trigger O 1 0.9682027101516724
for O 0 0.0027973612304776907
the O 0 0.0088769206777215
disease O 1 0.9999990463256836
is O 0 0.007265473250299692
probably O 0 0.017293522134423256
ubiquitous O 0 0.4110141694545746
. O 0 0.012926178053021431

HLA O 1 0.9997711777687073
- O 0 0.0779210701584816
B27 O 1 0.8100938200950623
accounts O 0 0.005721879657357931
for O 0 0.0016800247831270099
a O 0 0.0036461027339100838
minority O 0 0.008565264753997326
of O 0 0.0015071564121171832
the O 0 0.0034085987135767937
overall O 0 0.09250271320343018
genetic O 1 0.998862624168396
susceptibility O 1 0.9997530579566956
to O 0 0.003966717515140772
AS B-Disease 0 0.007786435540765524
. O 0 0.009283686988055706

Cell O 0 0.20361512899398804
cycle O 0 0.08571024984121323
- O 0 0.04168242588639259
dependent O 0 0.03620901703834534
colocalization O 1 0.8827595710754395
of O 0 0.005624685902148485
BARD1 O 1 0.9994871616363525
and O 0 0.007821382023394108
BRCA1 O 1 0.9999724626541138
proteins O 0 0.021405698731541634
in O 0 0.0031402241438627243
discrete O 0 0.02300066314637661
nuclear O 0 0.011397908441722393
domains O 0 0.03775588423013687
. O 0 0.0119070028886199

Germ O 1 0.9733380675315857
- O 0 0.04446709528565407
line O 0 0.0174952894449234
mutations O 1 0.9733182787895203
of O 0 0.003249069210141897
the O 0 0.009113730862736702
BRCA1 O 1 0.9999980926513672
gene O 1 0.9996273517608643
predispose O 1 0.998970627784729
women O 0 0.010134429670870304
to O 0 0.003359719179570675
early O 0 0.016138790175318718
- O 1 0.9833934903144836
onset O 1 0.999996542930603
breast B-Disease 1 0.9999996423721313
and I-Disease 1 0.8186160326004028
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
by O 0 0.006230329163372517
compromising O 0 0.03242688626050949
the O 0 0.005580361932516098
genes O 1 0.9925661087036133
presumptive O 1 0.9991884827613831
function O 0 0.01675705797970295
as O 0 0.004484602250158787
a O 0 0.025691011920571327
tumor B-Disease 1 0.9999963045120239
suppressor O 1 0.999882698059082
. O 0 0.017378196120262146

Although O 0 0.007843277417123318
the O 0 0.003917193505913019
biochemical O 0 0.03364111855626106
properties O 0 0.01047101616859436
of O 0 0.006362099200487137
BRCA1 O 1 0.9999929666519165
polypeptides O 1 0.9258784651756287
are O 0 0.0016878278693184257
not O 0 0.0016275831731036305
understood O 0 0.006920905318111181
, O 0 0.0014768546679988503
their O 0 0.0021755227353423834
expression O 0 0.01901589334011078
pattern O 0 0.017608696594834328
and O 0 0.002395331161096692
subcellular O 0 0.11192364245653152
localization O 0 0.04356221854686737
suggest O 0 0.006631474941968918
a O 0 0.0040560695342719555
role O 0 0.00598094193264842
in O 0 0.003914753440767527
cell O 0 0.2793046534061432
- O 0 0.03784876689314842
cycle O 0 0.05765341594815254
regulation O 0 0.03234732896089554
. O 0 0.012071195058524609

When O 0 0.025545889511704445
resting O 1 0.8848040103912354
cells O 1 0.7021048069000244
are O 0 0.0048260996118187904
induced O 1 0.9986681938171387
to O 0 0.0034560151398181915
proliferate O 0 0.04067118093371391
, O 0 0.0020279884338378906
the O 0 0.0025771616492420435
steady O 0 0.015048246830701828
- O 0 0.011064180172979832
state O 0 0.0028015649877488613
levels O 0 0.008626950904726982
of O 0 0.004592579323798418
BRCA1 O 1 0.9999755620956421
increase O 0 0.00886661559343338
in O 0 0.002654556417837739
late O 0 0.013116726651787758
G1 O 1 0.9957582354545593
and O 0 0.002076263539493084
reach O 0 0.005439389031380415
a O 0 0.005161679815500975
maximum O 0 0.012457317672669888
during O 0 0.013986919075250626
S O 0 0.37354835867881775
phase O 0 0.042717985808849335
. O 0 0.014630723744630814

Moreover O 0 0.029590673744678497
, O 0 0.004198829177767038
in O 0 0.004902808926999569
S O 0 0.3431941568851471
phase O 0 0.051946915686130524
cells O 0 0.35049474239349365
, O 0 0.011263921856880188
BRCA1 O 1 0.9999555349349976
polypeptides O 0 0.4560776650905609
are O 0 0.005329219624400139
hyperphosphorylated O 1 0.8265637755393982
and O 0 0.003947247285395861
accumulate O 0 0.034605223685503006
into O 0 0.008644325658679008
discrete O 0 0.04293299838900566
subnuclear O 1 0.9807572364807129
foci O 1 0.9556281566619873
termed O 0 0.12067120522260666
" O 0 0.024360259994864464
BRCA1 O 1 0.9997461438179016
nuclear O 0 0.021345416083931923
dots O 0 0.07462256401777267
. O 0 0.011657229624688625

" O 0 0.046848002821207047
BRCA1 O 1 0.9999196529388428
associates O 0 0.03333140164613724
in O 0 0.00472591258585453
vivo O 0 0.05071110278367996
with O 0 0.0032768333330750465
a O 0 0.009395962581038475
structurally O 0 0.06502548605203629
related O 0 0.021904872730374336
protein O 0 0.0744742602109909
termed O 0 0.22979426383972168
BARD1 O 1 0.9949924349784851
. O 0 0.018508167937397957

Here O 0 0.005569600034505129
we O 0 0.0020410525612533092
show O 0 0.003830092027783394
that O 0 0.0011734124273061752
the O 0 0.002340170321986079
steady O 0 0.015296540223062038
- O 0 0.011741645634174347
state O 0 0.0025711823254823685
levels O 0 0.0077932472340762615
of O 0 0.0030416196677833796
BARD1 O 1 0.9993578791618347
, O 0 0.0023364960215985775
unlike O 0 0.005485704634338617
those O 0 0.0018672263249754906
of O 0 0.00396948866546154
BRCA1 O 1 0.9999948740005493
, O 0 0.0033055911771953106
remain O 0 0.006278319284319878
relatively O 0 0.010573416016995907
constant O 0 0.02081659622490406
during O 0 0.015247647650539875
cell O 0 0.12061875313520432
cycle O 1 0.5578616261482239
progression O 1 0.9919586181640625
. O 0 0.018731411546468735

However O 0 0.009509649127721786
, O 0 0.0054906075820326805
immunostaining O 1 0.9928334951400757
revealed O 0 0.019855905324220657
that O 0 0.004761258605867624
BARD1 O 1 0.9976438879966736
resides O 0 0.030086291953921318
within O 0 0.012399871833622456
BRCA1 O 1 0.9999790191650391
nuclear O 0 0.015009233728051186
dots O 0 0.044239580631256104
during O 0 0.011027207598090172
S O 0 0.04322308301925659
phase O 0 0.012427863664925098
of O 0 0.0016483755316585302
the O 0 0.0033374098129570484
cell O 0 0.28217923641204834
cycle O 0 0.03507068753242493
, O 0 0.002138761570677161
but O 0 0.001552943023853004
not O 0 0.001812431961297989
during O 0 0.005503049120306969
the O 0 0.00659557431936264
G1 O 1 0.9935577511787415
phase O 0 0.054216109216213226
. O 0 0.013142331503331661

Nevertheless O 0 0.030955368652939796
, O 0 0.008603406138718128
BARD1 O 1 0.9990459084510803
polypeptides O 0 0.22506865859031677
are O 0 0.002117582829669118
found O 0 0.0031233513727784157
exclusively O 0 0.0032204706221818924
in O 0 0.0010962511878460646
the O 0 0.001633145846426487
nuclear O 0 0.0037848209030926228
fractions O 0 0.009514905512332916
of O 0 0.0017566109308972955
both O 0 0.003887599566951394
G1 O 1 0.9983401298522949
- O 0 0.02133576199412346
and O 0 0.005564990919083357
S O 1 0.790456235408783
- O 0 0.04702359065413475
phase O 0 0.05945615842938423
cells O 0 0.08831632137298584
. O 0 0.015044917352497578

Therefore O 0 0.014346669428050518
, O 0 0.005429972894489765
progression O 1 0.9938667416572571
to O 0 0.004743823781609535
S O 0 0.18337935209274292
phase O 0 0.020361749455332756
is O 0 0.003660206450149417
accompanied O 0 0.0095276590436697
by O 0 0.0025963305961340666
the O 0 0.003164782887324691
aggregation O 0 0.029969725757837296
of O 0 0.003490225411951542
nuclear O 0 0.012559803202748299
BARD1 O 1 0.994524359703064
polypeptides O 0 0.10826897621154785
into O 0 0.02254345826804638
BRCA1 O 1 0.9998162388801575
nuclear O 0 0.029149843379855156
dots O 0 0.08549865335226059
. O 0 0.01622825488448143

This O 0 0.012233903631567955
cell O 0 0.05716380849480629
cycle O 0 0.06466208398342133
- O 0 0.037745919078588486
dependent O 0 0.03713826462626457
colocalization O 1 0.8319941759109497
of O 0 0.0057694921270012856
BARD1 O 1 0.9992770552635193
and O 0 0.008706691674888134
BRCA1 O 1 0.9999790191650391
indicates O 0 0.018560104072093964
a O 0 0.0053819711320102215
role O 0 0.007154810708016157
for O 0 0.004103485960513353
BARD1 O 1 0.9938055276870728
in O 0 0.011279030703008175
BRCA1 O 1 0.9999880790710449
- O 1 0.9743614196777344
mediated O 1 0.9985686540603638
tumor B-Disease 1 0.9999896287918091
suppression O 1 0.9744212031364441
. O 0 0.014925007708370686

Ethnic O 0 0.022387849166989326
differences O 0 0.012467282824218273
in O 0 0.0034823170863091946
the O 0 0.008654501289129257
HFE O 1 0.9990007281303406
codon O 1 0.8881977796554565
282 O 0 0.17271684110164642
( O 0 0.026961907744407654
Cys O 1 0.9992557168006897
/ O 1 0.9630447626113892
Tyr O 1 0.9965400695800781
) O 0 0.026003967970609665
polymorphism O 0 0.1386631280183792
. O 0 0.016426922753453255

Recent O 0 0.017995063215494156
studies O 0 0.008115414530038834
have O 0 0.0027242139913141727
shown O 0 0.008267901837825775
that O 0 0.005180172622203827
hereditary B-Disease 1 0.9999970197677612
hemochromatosis I-Disease 1 1.0
( O 0 0.3196337819099426
HH B-Disease 1 0.9999899864196777
) O 0 0.0064173308201134205
is O 0 0.0027629253454506397
likely O 0 0.005243356339633465
to O 0 0.0017479280941188335
be O 0 0.0026460031513124704
caused O 0 0.08128617703914642
by O 0 0.0044387225061655045
homozygosity O 1 0.8749237656593323
for O 0 0.0031300114933401346
a O 0 0.010348751209676266
Cys282Tyr O 1 0.9991359114646912
mutation O 1 0.9989525079727173
in O 0 0.0044191437773406506
the O 0 0.008934538811445236
HFE O 1 0.9998400211334229
gene O 1 0.9864833950996399
located O 0 0.01625002548098564
4 O 0 0.01634952984750271
. O 0 0.00980027113109827

5 O 0 0.05144573003053665
Mb O 1 0.9692699909210205
telomeric O 1 0.9816282391548157
to O 0 0.017782265320420265
HLA O 1 0.9990670084953308
- O 0 0.04650139436125755
A O 0 0.023626480251550674
. O 0 0.014902890659868717

Population O 0 0.021238407120108604
studies O 0 0.008020764216780663
of O 0 0.002246057614684105
this O 0 0.003551381640136242
polymorphism O 0 0.11696606874465942
are O 0 0.001685188151896
facilitated O 0 0.011708961799740791
by O 0 0.0018155790166929364
the O 0 0.0016274654772132635
fact O 0 0.002987171523272991
that O 0 0.0017305812798440456
the O 0 0.005189737305045128
Cys282Tyr O 1 0.9989250302314758
mutation O 1 0.9995788931846619
creates O 0 0.03814266622066498
a O 0 0.016358470544219017
Rsal O 1 0.9898592829704285
restriction O 0 0.04315220192074776
site O 0 0.018281804397702217
. O 0 0.013571873307228088

We O 0 0.004377998877316713
have O 0 0.0025359021965414286
studied O 0 0.0051478436216712
the O 0 0.004890046548098326
codon O 0 0.17097531259059906
282 O 0 0.07544317841529846
( O 0 0.026934370398521423
Cys O 1 0.9981597065925598
/ O 1 0.9427821636199951
Tyr O 1 0.9967417120933533
) O 0 0.01264281664043665
polymorphism O 0 0.06734709441661835
in O 0 0.0023558728862553835
different O 0 0.0025228431914001703
ethnic O 0 0.0074015348218381405
groups O 0 0.008481865748763084
. O 0 0.00945369340479374

In O 0 0.003948788624256849
agreement O 0 0.0035539744421839714
with O 0 0.001903891796246171
previous O 0 0.004857019055634737
observations O 0 0.00745104206725955
the O 0 0.007486349903047085
Tyr O 1 0.9996901750564575
allele O 1 0.9983695149421692
appeared O 0 0.009179678745567799
to O 0 0.002132874447852373
be O 0 0.0022685665171593428
rare O 0 0.014696652069687843
or O 0 0.005820524878799915
absent O 0 0.02476523630321026
in O 0 0.004663502331823111
Asiatic O 1 0.9830894470214844
( O 0 0.006709120236337185
Indian O 0 0.006439609918743372
, O 0 0.002698297845199704
Chinese O 0 0.006160668563097715
) O 0 0.007570882327854633
populations O 0 0.03679875284433365
. O 0 0.01009304914623499

The O 0 0.009405442513525486
highest O 0 0.02419004589319229
allele O 1 0.99565190076828
frequency O 0 0.036918122321367264
( O 0 0.006852400489151478
7 O 0 0.007520013488829136
. O 0 0.0022847806103527546
5 O 0 0.005863914731889963
% O 0 0.0044763158075511456
) O 0 0.0028074525762349367
was O 0 0.003425045171752572
found O 0 0.0041840337216854095
in O 0 0.003381013637408614
Swedes O 0 0.050375618040561676
. O 0 0.01152708474546671

Saamis O 1 0.9696478843688965
( O 0 0.013293636031448841
2 O 0 0.010171366855502129
% O 0 0.0060649593360722065
) O 0 0.0031530694104731083
and O 0 0.0022659976966679096
Mordvinians O 1 0.9976227879524231
( O 0 0.006210228893905878
1 O 0 0.007210572715848684
. O 0 0.002454885048791766
8 O 0 0.0074131605215370655
% O 0 0.004732353612780571
) O 0 0.0033628419041633606
had O 0 0.003579230746254325
significantly O 0 0.018431968986988068
lower O 0 0.011414125561714172
frequencies O 0 0.012973054312169552
of O 0 0.002874273806810379
the O 0 0.008346696384251118
Tyr O 1 0.9982537627220154
allele O 1 0.9947407841682434
. O 0 0.0195599514991045

Comparisons O 0 0.03098592348396778
with O 0 0.009832399897277355
allele O 1 0.9834240078926086
frequencies O 0 0.018847258761525154
based O 0 0.00448824604973197
on O 0 0.0037416131235659122
prevalence O 1 0.9914264678955078
estimates O 0 0.010915257036685944
of O 0 0.004810369107872248
HH B-Disease 1 0.9999479055404663
showed O 0 0.01370550412684679
some O 0 0.002923160558566451
disagreements O 0 0.011489992961287498
with O 0 0.002812564605847001
the O 0 0.004379541613161564
RFLP O 1 0.9741227030754089
data O 0 0.006061602849513292
, O 0 0.0027916247490793467
particularly O 0 0.007036739028990269
in O 0 0.004280096385627985
Finns O 0 0.061857108026742935
. O 0 0.016248516738414764

The O 0 0.0116433659568429
newly O 0 0.023993857204914093
described O 0 0.031088154762983322
HFE O 1 0.9995651841163635
marker O 0 0.05097102001309395
provides O 0 0.006637819577008486
a O 0 0.003876854432746768
new O 0 0.002386585809290409
approach O 0 0.004944599699229002
to O 0 0.0015159191098064184
the O 0 0.002743212040513754
screening O 0 0.028508882969617844
of O 0 0.004044287838041782
HH B-Disease 1 0.999937891960144
as O 0 0.0019627430010586977
well O 0 0.0014008918078616261
as O 0 0.0012530324747785926
studies O 0 0.0024745487608015537
of O 0 0.0008516710950061679
the O 0 0.0015587162924930453
relationship O 0 0.006310907192528248
between O 0 0.003040013834834099
the O 0 0.0070909843780100346
HFE O 1 0.9999822378158569
Tyr O 1 0.9999452829360962
allele O 1 0.9994437098503113
and O 0 0.00459368247538805
different O 0 0.008329557254910469
disorders O 1 0.9999978542327881
including O 0 0.02608952857553959
cancer B-Disease 1 0.9999942779541016

Autosomal B-Disease 1 0.9999878406524658
dominant I-Disease 1 0.9990744590759277
neurohypophyseal I-Disease 1 0.9999825954437256
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999969005584717
associated O 0 0.01623784378170967
with O 0 0.003654682310298085
a O 0 0.01281353272497654
missense O 1 0.9964228272438049
mutation O 1 0.9990604519844055
encoding O 0 0.08700835704803467
Gly23 O 1 0.997220516204834
- O 0 0.15115857124328613
- O 0 0.20302627980709076
> O 1 0.9305579662322998
Val O 1 0.9907441735267639
in O 0 0.00934072956442833
neurophysin O 1 0.9940280914306641
II O 1 0.5388853549957275
. O 0 0.015152358449995518

Autosomal B-Disease 1 0.9999356269836426
dominant I-Disease 1 0.9978983402252197
neurohypophyseal I-Disease 1 0.9999812841415405
diabetes I-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.9999940395355225
( O 0 0.02808123268187046
ADNDI B-Disease 1 0.9992559552192688
) O 0 0.006212960928678513
is O 0 0.003410816891118884
an O 0 0.006831585429608822
inherited B-Disease 1 0.9999983310699463
disease I-Disease 1 1.0
caused O 1 0.9991820454597473
by O 0 0.008220127783715725
progressive O 1 0.9997624754905701
degeneration O 1 0.9999974966049194
of O 0 0.004560800269246101
the O 0 0.006836200598627329
magnocellular O 1 0.9995208978652954
neurons O 1 0.8624593019485474
of O 0 0.0026540691033005714
the O 0 0.005577756091952324
hypothalamus O 1 0.999196469783783
leading O 0 0.009401645511388779
to O 0 0.0040631587617099285
decreased O 0 0.2619740664958954
ability O 0 0.008019273169338703
to O 0 0.0020585849415510893
produce O 0 0.007461720146238804
the O 0 0.008023856207728386
hormone O 1 0.9820354580879211
arginine O 1 0.7133035063743591
vasopressin O 1 0.9933722019195557
( O 0 0.027826007455587387
AVP O 1 0.9858782291412354
) O 0 0.01454149466007948
. O 0 0.013695066794753075

Affected O 0 0.3027510941028595
individuals O 0 0.00794555339962244
are O 0 0.001947480719536543
not O 0 0.0036314583849161863
symptomatic O 1 0.9998995065689087
at O 0 0.00576375424861908
birth O 1 0.6893483400344849
, O 0 0.002183838514611125
but O 0 0.002905405592173338
usually O 0 0.012777971103787422
develop O 1 0.9145072102546692
diabetes B-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999868869781494
at O 0 0.011470986530184746
1 O 0 0.015139519236981869
- O 0 0.02999125048518181
6 O 0 0.027227090671658516
yr O 1 0.9557239413261414
of O 0 0.006212009582668543
age O 0 0.019175177440047264
. O 0 0.010195082053542137

The O 0 0.01301294844597578
genetic O 0 0.3257652819156647
locus O 1 0.9839343428611755
of O 0 0.004317761864513159
the O 0 0.0074247452430427074
disease O 1 0.9999958276748657
is O 0 0.00501703517511487
the O 0 0.006090494804084301
AVP O 1 0.9994481205940247
- O 0 0.1649360954761505
neurophysin O 1 0.998573899269104
II O 1 0.8406053781509399
( O 0 0.01479106955230236
NPII O 1 0.9983115196228027
) O 0 0.01003924198448658
gene O 1 0.7202179431915283
, O 0 0.002943495288491249
and O 0 0.003194620367139578
mutations O 1 0.9997121691703796
that O 0 0.0038164800498634577
cause O 1 0.9983175992965698
ADNDI B-Disease 1 0.9998466968536377
have O 0 0.002522523980587721
been O 0 0.0025093811564147472
found O 0 0.002825862728059292
in O 0 0.00114338262937963
both O 0 0.0015304462285712361
the O 0 0.0021170068066567183
signal O 0 0.01708049885928631
peptide O 0 0.03714798018336296
of O 0 0.0019617502111941576
the O 0 0.004530119709670544
prepro O 1 0.9985131621360779
- O 0 0.17347584664821625
AVP O 1 0.9965236783027649
- O 0 0.12563039362430573
NPII O 1 0.9962687492370605
precursor O 0 0.045932792127132416
and O 0 0.003782958723604679
within O 0 0.01028466410934925
NPII O 1 0.995549201965332
itself O 0 0.024980777874588966
. O 0 0.012255397625267506

An O 0 0.011160030029714108
affected O 0 0.30197954177856445
girl O 1 0.7166347503662109
who O 0 0.004893955774605274
presented O 0 0.004495280794799328
at O 0 0.003568787593394518
9 O 0 0.006571504753082991
months O 0 0.005458652973175049
of O 0 0.001875084824860096
age O 0 0.00850388128310442
and O 0 0.0022297820542007685
her O 0 0.007598936557769775
similarly O 0 0.029994411394000053
affected O 1 0.6474949717521667
younger O 1 0.548811674118042
brother O 0 0.022329270839691162
and O 0 0.0019050464034080505
father O 0 0.006808327045291662
were O 0 0.0010199231328442693
all O 0 0.001010214677080512
found O 0 0.0023158753756433725
to O 0 0.0012460130965337157
have O 0 0.0015946690691635013
a O 0 0.005170153453946114
novel O 0 0.02658485248684883
missense O 1 0.9985881447792053
mutation O 1 0.9997467398643494
( O 0 0.01744949072599411
G1758 O 1 0.9954851865768433
- O 0 0.20649169385433197
- O 0 0.19333723187446594
> O 1 0.9856364727020264
T O 1 0.9706969857215881
) O 0 0.006872009485960007
encoding O 0 0.02061905711889267
the O 0 0.0052368296310305595
amino O 0 0.03795965388417244
acid O 0 0.06877840310335159
substitution O 0 0.05300905555486679
Gly23 O 1 0.9897429347038269
- O 0 0.10040688514709473
- O 0 0.08353108167648315
> O 1 0.8614984154701233
Val O 1 0.9760649800300598
within O 0 0.023041773587465286
NPII O 1 0.9826221466064453
. O 0 0.018476156517863274

The O 0 0.02003556117415428
mutation O 1 0.9972538352012634
was O 0 0.010717620141804218
confirmed O 0 0.018365468829870224
by O 0 0.0075800493359565735
restriction O 0 0.051292140036821365
endonuclease O 1 0.9511404633522034
analysis O 0 0.023495664820075035
. O 0 0.014119499363005161

A O 0 0.0415603406727314
T1 O 1 0.978478193283081
- O 0 0.0423714816570282
weighted O 0 0.03362169861793518
magnetic O 0 0.028728416189551353
resonance O 0 0.04074905440211296
imaging O 0 0.0347478985786438
of O 0 0.0025967464316636324
the O 0 0.005559148732572794
fathers O 1 0.9072374701499939
pituitary O 1 0.999970555305481
gland O 1 0.9996912479400635
demonstrates O 0 0.039801497012376785
an O 0 0.012209335342049599
attenuated O 1 0.9992709755897522
posterior O 1 0.999839186668396
pituitary O 1 0.99994957447052
bright O 0 0.3206425905227661
spot O 0 0.04529199376702309
. O 0 0.014448178000748158

This O 0 0.013232704252004623
mutation O 1 0.9995169639587402
may O 0 0.007961668074131012
be O 0 0.0014940545661374927
valuable O 0 0.0042237346060574055
for O 0 0.0018641381757333875
developing O 0 0.010209000669419765
models O 0 0.008667783811688423
of O 0 0.005453905090689659
dominantly B-Disease 1 0.9997802376747131
inherited I-Disease 1 0.999984622001648
neurodegeneration I-Disease 1 0.999996542930603
, O 0 0.003175271674990654
as O 0 0.0017770662670955062
the O 0 0.0018897185800597072
early O 0 0.0054150838404893875
age O 0 0.008240371942520142
of O 0 0.004692112561315298
onset O 1 0.9999865293502808
of O 0 0.009272835217416286
symptoms O 1 0.9999997615814209
suggests O 0 0.03456192836165428
that O 0 0.0020502635743469
this O 0 0.003958934918045998
mutation O 1 0.999977707862854
may O 0 0.006537821609526873
be O 0 0.0018625895027071238
particularly O 0 0.00820524524897337
deleterious O 1 0.9959797859191895
to O 0 0.0029323447961360216
the O 0 0.006172997877001762
magnocellular O 1 0.9992030262947083
neuron O 1 0.9979737401008606
. O 0 0.008724934421479702
. O 0 0.011369151063263416

Frequent O 0 0.10306934267282486
inactivation O 1 0.9910308122634888
of O 0 0.013234822079539299
PTEN O 1 0.9999667406082153
/ O 1 0.9913386106491089
MMAC1 O 1 0.9987751841545105
in O 0 0.010173176415264606
primary O 1 0.9969828724861145
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.02370501682162285

Sporadic B-Disease 1 0.9994468092918396
prostate I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 0.9999998807907104
is O 0 0.005663086660206318
the O 0 0.002726086648181081
most O 0 0.0036539097782224417
common O 0 0.22514867782592773
male B-Disease 1 0.9994858503341675
cancer I-Disease 1 0.9999974966049194
in O 0 0.0024154121056199074
the O 0 0.0022945187520235777
Western O 0 0.005002554971724749
world O 0 0.0032506086863577366
, O 0 0.001549845444969833
yet O 0 0.0022122312802821398
many O 0 0.0009749634191393852
of O 0 0.0008682750049047172
the O 0 0.0018321918323636055
major O 0 0.008197282440960407
genetic O 1 0.6716136932373047
events O 0 0.004209467209875584
involved O 0 0.0039955745451152325
in O 0 0.0017082373378798366
the O 0 0.0034333625808358192
progression O 1 0.99577796459198
of O 0 0.002300271997228265
this O 0 0.0036158673465251923
often O 0 0.09897682070732117
fatal O 1 0.9999996423721313
cancer B-Disease 1 0.9999994039535522
remain O 0 0.007358145900070667
to O 0 0.002411400666460395
be O 0 0.00408321525901556
elucidated O 0 0.356411874294281
. O 0 0.012663059867918491

Numerous O 0 0.03295089304447174
cytogenetic O 1 0.9909645318984985
and O 0 0.005878114141523838
allelotype O 1 0.9951397180557251
studies O 0 0.00830348301678896
have O 0 0.002838888205587864
reported O 0 0.013957671821117401
frequent O 0 0.027109544724225998
loss O 0 0.021056074649095535
of O 0 0.004488433711230755
heterozygosity O 1 0.9966762065887451
on O 0 0.00842843297868967
chromosomal O 1 0.9998016953468323
arm O 1 0.9932847023010254
10q O 1 0.9969475865364075
in O 0 0.01147907692939043
sporadic B-Disease 1 0.9998804330825806
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.02020411007106304

Deletion O 1 0.9746623635292053
mapping O 0 0.034503161907196045
studies O 0 0.009478895924985409
have O 0 0.00326762767508626
unambiguously O 0 0.024405525997281075
identified O 0 0.009070059284567833
a O 0 0.00446929270401597
region O 0 0.00896696001291275
of O 0 0.005537771619856358
chromosome O 1 0.9998329877853394
10q23 O 1 0.9869945645332336
to O 0 0.002156245056539774
be O 0 0.0016275234520435333
the O 0 0.002844648202881217
minimal O 0 0.018077339977025986
area O 0 0.007622973527759314
of O 0 0.004248150158673525
loss O 0 0.3178342878818512
. O 0 0.011683883145451546

A O 0 0.023731593042612076
new O 0 0.02134656347334385
tumor B-Disease 1 0.9999895095825195
suppressor O 1 0.9999496936798096
gene O 1 0.9969695210456848
, O 0 0.01571091264486313
PTEN O 1 0.9999741315841675
/ O 1 0.995451033115387
MMAC1 O 1 0.9995676875114441
, O 0 0.004329240415245295
was O 0 0.005625133868306875
isolated O 0 0.032198887318372726
recently O 0 0.007836971431970596
at O 0 0.0024484721943736076
this O 0 0.0016540784854441881
region O 0 0.006885880138725042
of O 0 0.004168923944234848
chromosome O 1 0.9998875856399536
10q23 O 1 0.9826942086219788
and O 0 0.0020766369998455048
found O 0 0.003040002193301916
to O 0 0.0015134802088141441
be O 0 0.0024920697323977947
inactivated O 0 0.4840066134929657
by O 0 0.005352625623345375
mutation O 1 0.996895432472229
in O 0 0.004665753338485956
three O 0 0.023519227281212807
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cell O 1 0.9753691554069519
lines O 0 0.02484712190926075
. O 0 0.01306242123246193

We O 0 0.010381590574979782
screened O 0 0.44274044036865234
80 O 1 0.7443346977233887
prostate B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999945163726807
by O 0 0.008979982696473598
microsatellite O 1 0.9651959538459778
analysis O 0 0.0073736668564379215
and O 0 0.002132537541911006
found O 0 0.00937085784971714
chromosome O 1 0.9998241066932678
10q23 O 1 0.9911194443702698
to O 0 0.0023501450195908546
be O 0 0.0020930604077875614
deleted O 0 0.01950494758784771
in O 0 0.0030161449685692787
23 O 0 0.012593661434948444
cases O 0 0.016827302053570747
. O 0 0.010664154775440693

We O 0 0.0053542605601251125
then O 0 0.004239027854055166
proceeded O 0 0.008142679929733276
with O 0 0.002485782140865922
sequence O 0 0.01059956755489111
analysis O 0 0.004407231230288744
of O 0 0.0015459646238014102
the O 0 0.004280589520931244
entire O 0 0.04196959733963013
PTEN O 1 0.9998787641525269
/ O 1 0.9587723612785339
MMAC1 O 1 0.9976467490196228
coding O 0 0.07891666144132614
region O 0 0.009823012165725231
and O 0 0.002457610797137022
tested O 0 0.018396154046058655
for O 0 0.004412681329995394
homozygous O 1 0.9985759258270264
deletion O 1 0.9933544397354126
with O 0 0.003524454776197672
new O 0 0.004785521421581507
intragenic O 1 0.9972822666168213
markers O 0 0.018269605934619904
in O 0 0.0015865754103288054
these O 0 0.001831232919357717
23 O 0 0.00765960942953825
cases O 0 0.009159109555184841
with O 0 0.005230307579040527
10q23 O 1 0.99631667137146
loss O 0 0.055283453315496445
of O 0 0.007502343039959669
heterozygosity O 1 0.9965131878852844
. O 0 0.017379509285092354

The O 0 0.005409836769104004
identification O 0 0.010195836424827576
of O 0 0.0019037512829527259
the O 0 0.0034315010998398066
second O 0 0.010263204574584961
mutational O 1 0.9942041039466858
event O 0 0.010386898182332516
in O 0 0.002758729038760066
10 O 0 0.005022014956921339
( O 0 0.005054721608757973
43 O 0 0.014755445532500744
% O 0 0.00918775424361229
) O 0 0.014930960722267628
tumors B-Disease 1 0.9999909400939941
establishes O 1 0.9479318261146545
PTEN O 1 0.9999521970748901
/ O 1 0.9788379669189453
MMAC1 O 1 0.998173713684082
as O 0 0.002984912833198905
a O 0 0.0054654814302921295
main O 0 0.0100185452029109
inactivation O 1 0.9819075465202332
target O 0 0.01096972357481718
of O 0 0.0036043960135430098
10q O 1 0.9944053888320923
loss O 0 0.2539011240005493
in O 0 0.009612983092665672
sporadic B-Disease 1 0.9999098777770996
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.00929082091897726
. O 0 0.010568195022642612

Risk O 1 0.9790118336677551
reversals O 0 0.3668668866157532
in O 0 0.00671231746673584
predictive O 0 0.2870154082775116
testing O 0 0.0338616818189621
for O 0 0.012053596787154675
Huntington B-Disease 1 0.9999978542327881
disease I-Disease 1 0.9999992847442627
. O 0 0.01883973926305771

The O 0 0.008421160280704498
first O 0 0.009751416742801666
predictive O 0 0.09107225388288498
testing O 0 0.034675806760787964
for O 0 0.015060117468237877
Huntington B-Disease 1 0.999995231628418
disease I-Disease 1 0.9999998807907104
( O 0 0.020459244027733803
HD B-Disease 1 0.9811515212059021
) O 0 0.003503513289615512
was O 0 0.002016287064179778
based O 0 0.001666921772994101
on O 0 0.0012376202503219247
analysis O 0 0.0036685261875391006
of O 0 0.0026066924910992384
linked O 0 0.3788376450538635
polymorphic O 1 0.9996498823165894
DNA O 0 0.07098192721605301
markers O 0 0.018543126061558723
to O 0 0.00200660596601665
estimate O 0 0.00668416079133749
the O 0 0.0024590420071035624
likelihood O 0 0.01760762184858322
of O 0 0.0032841109205037355
inheriting O 1 0.9122396111488342
the O 0 0.009786843322217464
mutation O 1 0.9988611936569214
for O 0 0.007419795263558626
HD B-Disease 1 0.7307379245758057
. O 0 0.014001401141285896

Limits O 0 0.01090308278799057
to O 0 0.002511373721063137
accuracy O 0 0.006276367697864771
included O 0 0.004122660029679537
recombination O 0 0.04708265885710716
between O 0 0.0028510410338640213
the O 0 0.0036852469202131033
DNA O 0 0.02738262340426445
markers O 0 0.01615673117339611
and O 0 0.002209558617323637
the O 0 0.005227256566286087
mutation O 1 0.9998345375061035
, O 0 0.004521575290709734
pedigree O 1 0.6023606657981873
structure O 0 0.005560756660997868
, O 0 0.001409093732945621
and O 0 0.0010907129617407918
whether O 0 0.0035438116174191236
DNA O 0 0.01943713054060936
samples O 0 0.008188912644982338
were O 0 0.0013255889061838388
available O 0 0.002295279875397682
from O 0 0.0031224091071635485
family O 0 0.011424832046031952
members O 0 0.007206573151051998
. O 0 0.010253149084746838

With O 0 0.005215309094637632
direct O 0 0.009515332989394665
tests O 0 0.008846581913530827
for O 0 0.002065724926069379
the O 0 0.006068188697099686
HD B-Disease 1 0.9944721460342407
mutation O 1 0.9992989301681519
, O 0 0.002376287244260311
we O 0 0.001404913840815425
have O 0 0.0014443272957578301
assessed O 0 0.007498384919017553
the O 0 0.0015181987546384335
accuracy O 0 0.0037063208874315023
of O 0 0.0013453112915158272
results O 0 0.004536631517112255
obtained O 0 0.0036973028909415007
by O 0 0.0031869341619312763
linkage O 0 0.04742897301912308
approaches O 0 0.016170553863048553
when O 0 0.00410779844969511
requested O 0 0.0050900583155453205
to O 0 0.0014474623603746295
do O 0 0.002210998209193349
so O 0 0.0019475168082863092
by O 0 0.0019194275373592973
the O 0 0.0025724798906594515
test O 0 0.010081203654408455
individuals O 0 0.009180772118270397
. O 0 0.009682274423539639

For O 0 0.003967633005231619
six O 0 0.0038837480824440718
such O 0 0.0019594901241362095
individuals O 0 0.004279141314327717
, O 0 0.0014929083408787847
there O 0 0.0016204116400331259
was O 0 0.0026037946809083223
significant O 0 0.006825609132647514
disparity O 0 0.031553715467453
between O 0 0.0038294391706585884
the O 0 0.004202383570373058
tests O 0 0.018067970871925354
. O 0 0.010370270349085331

Three O 0 0.006226170342415571
went O 0 0.007767974864691496
from O 0 0.0038968734443187714
a O 0 0.008854031562805176
decreased O 1 0.9881640672683716
risk O 1 0.8057401776313782
to O 0 0.0016570906154811382
an O 0 0.0027025649324059486
increased O 0 0.013945445418357849
risk O 1 0.9310408234596252
, O 0 0.0016602836549282074
while O 0 0.0014091600896790624
in O 0 0.0012734265765175223
another O 0 0.0032849416602402925
three O 0 0.001884806901216507
the O 0 0.003416233230382204
risk O 1 0.9354491829872131
was O 0 0.009060421958565712
decreased O 1 0.607143223285675
. O 0 0.011758959852159023

Knowledge O 0 0.008059551008045673
of O 0 0.0018844016594812274
the O 0 0.0027334559708833694
potential O 0 0.008717382326722145
reasons O 0 0.004737837240099907
for O 0 0.001266034203581512
these O 0 0.0012664111563935876
changes O 0 0.00405203178524971
in O 0 0.001431914628483355
results O 0 0.004265890456736088
and O 0 0.0012957332655787468
impact O 0 0.0071360087022185326
of O 0 0.0013613844057545066
these O 0 0.002171450527384877
risk O 1 0.995858371257782
reversals O 1 0.9362019300460815
on O 0 0.00213614571839571
both O 0 0.00345287355594337
patients O 1 0.999945878982544
and O 0 0.0014066254952922463
the O 0 0.002833631355315447
counseling O 1 0.9585272669792175
team O 0 0.004749592859297991
can O 0 0.0026995185762643814
assist O 0 0.006112569943070412
in O 0 0.001471683382987976
the O 0 0.0016744998283684254
development O 0 0.002512609353289008
of O 0 0.0016212480841204524
strategies O 0 0.009906282648444176
for O 0 0.001699600601568818
the O 0 0.0029910693410784006
prevention O 1 0.9964820146560669
and O 0 0.001735782832838595
, O 0 0.0014324792427942157
where O 0 0.001919203670695424
necessary O 0 0.0024688260164111853
, O 0 0.001203802414238453
management O 0 0.0047924756072461605
of O 0 0.0015518736327067018
a O 0 0.007150872144848108
risk O 1 0.9848136305809021
reversal O 0 0.1022469773888588
in O 0 0.0021041487343609333
any O 0 0.0038328494410961866
predictive O 0 0.3209909200668335
testing O 0 0.017000043764710426
program O 0 0.008613267913460732
. O 0 0.004985315725207329
. O 0 0.007575904484838247

A O 0 0.024880889803171158
novel O 0 0.03390544652938843
common O 0 0.03637295588850975
missense O 1 0.9987263083457947
mutation O 1 0.9995607733726501
G301C O 1 0.8920539021492004
in O 0 0.003671450074762106
the O 0 0.0044330726377666
N O 0 0.04444023594260216
- O 0 0.04197325184941292
acetylgalactosamine O 1 0.9315487742424011
- O 0 0.04501842334866524
6 O 0 0.027866605669260025
- O 0 0.07291148602962494
sulfate O 1 0.9819204211235046
sulfatase O 1 0.9979760050773621
gene O 1 0.9479983448982239
in O 0 0.01394512876868248
mucopolysaccharidosis B-Disease 1 0.9938403367996216
IVA I-Disease 1 0.9989053010940552
. O 0 0.02070624753832817

Mucopolysaccharidosis B-Disease 1 0.9971510767936707
IVA I-Disease 1 0.9986763596534729
( O 0 0.02465216815471649
MPS B-Disease 1 0.8302328586578369
IVA I-Disease 1 0.9996702671051025
) O 0 0.007162642665207386
is O 0 0.004939813166856766
an O 0 0.010175943374633789
autosomal B-Disease 1 0.9999985694885254
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 0.999976634979248
storage I-Disease 1 0.9936588406562805
disorder I-Disease 1 0.9999997615814209
caused O 1 0.9984605312347412
by O 0 0.004185720346868038
a O 0 0.011951044201850891
genetic B-Disease 1 0.9988166093826294
defect I-Disease 1 0.9994439482688904
in O 0 0.005754105281084776
N O 0 0.0889299139380455
- O 0 0.049243271350860596
acetylgalactosamine O 1 0.9907256960868835
- O 0 0.04328636825084686
6 O 0 0.028811819851398468
- O 0 0.07950892299413681
sulfate O 1 0.9578585624694824
sulfatase O 1 0.999121367931366
( O 0 0.029797233641147614
GALNS O 1 0.9938775897026062
) O 0 0.013986524194478989
. O 0 0.01158930268138647

In O 0 0.0069451043382287025
previous O 0 0.008376958779990673
studies O 0 0.006156675983220339
, O 0 0.0018120091408491135
we O 0 0.0011261061299592257
have O 0 0.001103561487980187
found O 0 0.00245983200147748
two O 0 0.001841562450863421
common O 0 0.011860467493534088
mutations O 1 0.9993625283241272
in O 0 0.0037518152967095375
Caucasians O 1 0.9768527746200562
and O 0 0.002337900223210454
Japanese O 0 0.007299829740077257
, O 0 0.002910131122916937
respectively O 0 0.008553994819521904
. O 0 0.007479688618332148

To O 0 0.00753014488145709
characterize O 0 0.03818634897470474
the O 0 0.009494224563241005
mutational O 1 0.9984618425369263
spectrum O 0 0.029152562841773033
in O 0 0.001943372655659914
various O 0 0.0016793162794783711
ethnic O 0 0.00648440420627594
groups O 0 0.004522646777331829
, O 0 0.0031784684397280216
mutations O 1 0.9992735981941223
in O 0 0.0022617336362600327
the O 0 0.0049897548742592335
GALNS O 1 0.9993191957473755
gene O 1 0.8564557433128357
in O 0 0.005841137375682592
Colombian O 0 0.10246807336807251
MPS B-Disease 1 0.9966368675231934
IVA I-Disease 1 0.999995231628418
patients O 1 0.999922513961792
were O 0 0.0037239461671561003
investigated O 0 0.01520545594394207
, O 0 0.0023541096597909927
and O 0 0.002044867491349578
genetic O 1 0.6626294851303101
backgrounds O 0 0.009172815829515457
were O 0 0.0013488091062754393
extensively O 0 0.006040584295988083
analyzed O 0 0.008900710381567478
to O 0 0.0020870782900601625
identify O 0 0.008913266472518444
racial O 0 0.011985733173787594
origin O 0 0.006385866552591324
, O 0 0.0016125099500641227
based O 0 0.0026125358417630196
on O 0 0.003913009539246559
mitochondrial O 1 0.5147166848182678
DNA O 0 0.04769132658839226
( O 0 0.01328098401427269
mtDNA O 0 0.09737243503332138
) O 0 0.011855109594762325
lineages O 0 0.0746125802397728
. O 0 0.013088289648294449

Three O 0 0.01139710284769535
novel O 0 0.04713765159249306
missense O 1 0.9992637038230896
mutations O 1 0.9994644522666931
never O 0 0.00962891336530447
identified O 0 0.008295118808746338
previously O 0 0.003150771139189601
in O 0 0.0012104219058528543
other O 0 0.0013719414127990603
populations O 0 0.015206512995064259
and O 0 0.0012231726432219148
found O 0 0.003221070859581232
in O 0 0.0013739732094109058
16 O 0 0.0037539189215749502
out O 0 0.0017178889829665422
of O 0 0.001975820166990161
19 O 0 0.013262655586004257
Colombian O 0 0.045636095106601715
MPS B-Disease 1 0.8607348203659058
IVA I-Disease 1 0.9998500347137451
unrelated O 0 0.3319498598575592
alleles O 1 0.986522376537323
account O 0 0.009096850641071796
for O 0 0.0042985063046216965
84 O 0 0.031467556953430176
. O 0 0.011204224079847336

2 O 0 0.015643062070012093
% O 0 0.00607256917282939
of O 0 0.001939794048666954
the O 0 0.0047284518368542194
alleles O 1 0.9829382300376892
in O 0 0.00312810018658638
this O 0 0.0028456617146730423
study O 0 0.009307225234806538
. O 0 0.008447435684502125

The O 0 0.01334657333791256
G301C O 1 0.9811111092567444
and O 0 0.00837833434343338
S162F O 1 0.997212827205658
mutations O 1 0.9965506792068481
account O 0 0.010522008873522282
for O 0 0.004671128932386637
68 O 0 0.02890433557331562
. O 0 0.011097293347120285

4 O 0 0.022113971412181854
% O 0 0.00962190330028534
and O 0 0.0033097288105636835
10 O 0 0.01048190239816904
. O 0 0.011372195556759834

5 O 0 0.015473080798983574
% O 0 0.006579210516065359
of O 0 0.003691036021336913
mutations O 1 0.9996891021728516
, O 0 0.0021756296046078205
respectively O 0 0.0045438483357429504
, O 0 0.0017265822971239686
whereas O 0 0.006847329903393984
the O 0 0.0025140221696347
remaining O 0 0.008307477459311485
F69V O 1 0.994174063205719
is O 0 0.0038234805688261986
limited O 0 0.004557467065751553
to O 0 0.002060927450656891
a O 0 0.007940168492496014
single O 0 0.023044509813189507
allele O 1 0.9866340160369873
. O 0 0.015847347676753998

The O 0 0.013551328331232071
skewed O 0 0.3899663984775543
prevalence O 1 0.9848795533180237
of O 0 0.0053083342500030994
G301C O 1 0.9601162672042847
in O 0 0.0037046473007649183
only O 0 0.004390716552734375
Colombian O 0 0.48337501287460327
patients O 1 0.9996868371963501
and O 0 0.004636852070689201
haplotype O 1 0.989025890827179
analysis O 0 0.007066691759973764
by O 0 0.003782804124057293
restriction O 0 0.023989316076040268
fragment O 0 0.053036801517009735
length O 0 0.016777386888861656
polymorphisms O 0 0.21607574820518494
in O 0 0.002634286182001233
the O 0 0.005403674673289061
GALNS O 1 0.9993999004364014
gene O 1 0.9870677590370178
suggest O 0 0.011447769589722157
that O 0 0.003125395392999053
G301C O 1 0.8458657264709473
originated O 0 0.012707492336630821
from O 0 0.002884507644921541
a O 0 0.00593675347045064
common O 0 0.013136289082467556
ancestor O 1 0.5431082844734192
. O 0 0.010288354940712452

Investigation O 0 0.01834794692695141
of O 0 0.002719143172726035
the O 0 0.003863242454826832
genetic O 0 0.18234524130821228
background O 0 0.007615802343934774
by O 0 0.0026548856403678656
means O 0 0.003984538372606039
of O 0 0.003030800260603428
mtDNA O 1 0.8096121549606323
lineages O 1 0.8079467415809631
indicate O 0 0.007472096011042595
that O 0 0.0011990959756076336
all O 0 0.0012881106231361628
our O 0 0.005360363982617855
patients O 1 0.9998034834861755
are O 0 0.0019847825169563293
probably O 0 0.005599204450845718
of O 0 0.0024333002511411905
native O 0 0.011022383347153664
American O 0 0.018053213134407997
descent O 0 0.10131016373634338

Low O 0 0.04429122433066368
frequency O 0 0.03786955773830414
of O 0 0.01163480244576931
BRCA1 O 1 0.999987006187439
germline O 1 0.9997949004173279
mutations O 1 0.9985637068748474
in O 0 0.004111988935619593
45 O 0 0.012883787043392658
German O 1 0.7822123765945435
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999831914901733
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.034453414380550385
. O 0 0.013366544619202614

In O 0 0.004532790742814541
this O 0 0.002550991252064705
study O 0 0.005367140751332045
we O 0 0.0025147839915007353
investigated O 0 0.018442431464791298
45 O 0 0.01652223989367485
German O 0 0.4687075614929199
breast B-Disease 1 0.9999990463256836
/ I-Disease 1 0.99994957447052
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.02507796324789524
for O 0 0.011228996329009533
germline O 1 0.9996896982192993
mutations O 1 0.9984238147735596
in O 0 0.0054932693019509315
the O 0 0.011929565109312534
BRCA1 O 1 0.9999929666519165
gene O 1 0.9911982417106628
. O 0 0.016187777742743492

We O 0 0.006717202719300985
identified O 0 0.014563596807420254
four O 0 0.0100333197042346
germline O 1 0.9996498823165894
mutations O 1 0.9971480965614319
in O 0 0.0048264069482684135
three O 0 0.016413666307926178
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
families O 0 0.008914138190448284
and O 0 0.0015627227257937193
in O 0 0.002391874324530363
one O 0 0.02099752239882946
breast B-Disease 1 1.0
- I-Disease 1 0.9999923706054688
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.056796249002218246
. O 0 0.0019321899162605405
among O 0 0.0023519042879343033
these O 0 0.001207473804242909
were O 0 0.0011783555382862687
one O 0 0.005244746804237366
frameshift O 1 0.999947190284729
mutation O 1 0.9996132254600525
, O 0 0.0031206358689814806
one O 0 0.005133660975843668
nonsense O 0 0.17411911487579346
mutation O 1 0.9993987083435059
, O 0 0.0023539133835583925
one O 0 0.003725539892911911
novel O 0 0.019315075129270554
splice O 1 0.9566336870193481
site O 0 0.018288396298885345
mutation O 1 0.9988613128662109
, O 0 0.0026167796459048986
and O 0 0.0023630082141608
one O 0 0.007683891337364912
missense O 1 0.9989804625511169
mutation O 1 0.9983651041984558
. O 0 0.01612854190170765

The O 0 0.01627715677022934
missense O 1 0.9991703033447266
mutation O 1 0.9997376799583435
was O 0 0.006098203826695681
also O 0 0.002397686243057251
found O 0 0.004361262079328299
in O 0 0.00236566667445004
2 O 0 0.011269398964941502
. O 0 0.01059599220752716

8 O 0 0.01867331936955452
% O 0 0.0052004228346049786
of O 0 0.0018664444796741009
the O 0 0.0023103468120098114
general O 0 0.004013814497739077
population O 0 0.007077992893755436
, O 0 0.001759507111273706
suggesting O 0 0.007851609028875828
that O 0 0.0012181834317743778
it O 0 0.0013026257511228323
is O 0 0.0030171647667884827
not O 0 0.005620729178190231
disease O 1 0.9999982118606567
associated O 0 0.019796129316091537
. O 0 0.010355213657021523

The O 0 0.0073187691159546375
average O 0 0.016022318974137306
age O 0 0.015922939404845238
of O 0 0.00953318178653717
disease O 1 0.9999998807907104
onset O 1 0.9999945163726807
in O 0 0.0034511773847043514
those O 0 0.003282414749264717
families O 0 0.017839763313531876
harbouring O 1 0.9997066855430603
causative O 1 0.9998980760574341
mutations O 1 0.9998495578765869
was O 0 0.006774488370865583
between O 0 0.006069447845220566
32 O 0 0.020112786442041397
. O 0 0.01021379604935646

3 O 0 0.019264454022049904
and O 0 0.004569849465042353
37 O 0 0.023133348673582077
. O 0 0.011618457734584808

4 O 0 0.017420286312699318
years O 0 0.005960585083812475
, O 0 0.00261297426186502
whereas O 0 0.009515651501715183
the O 0 0.003490470815449953
family O 0 0.01320713385939598
harbouring O 1 0.9457635879516602
the O 0 0.009136820212006569
missense O 1 0.9997949004173279
mutation O 1 0.9997150301933289
had O 0 0.0046485792845487595
an O 0 0.0031150884460657835
average O 0 0.00952200498431921
age O 0 0.011269325390458107
of O 0 0.005696211941540241
onset O 1 0.9999217987060547
of O 0 0.00640728697180748
51 O 0 0.03302871063351631
. O 0 0.014197049662470818

2 O 0 0.025535056367516518
years O 0 0.012040725909173489
. O 0 0.011112377978861332

These O 0 0.005917048081755638
findings O 0 0.014179868623614311
show O 0 0.010150589980185032
that O 0 0.006178336683660746
BRCA1 O 1 0.9999674558639526
is O 0 0.007011383771896362
implicated O 0 0.17562517523765564
in O 0 0.0022670114412903786
a O 0 0.004897856153547764
small O 0 0.0058774142526090145
fraction O 0 0.019917597994208336
of O 0 0.011333602480590343
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999785423278809
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.016518129035830498
suggesting O 0 0.01261083409190178
the O 0 0.0028287526220083237
involvement O 0 0.011996702291071415
of O 0 0.003098773304373026
another O 0 0.026885420083999634
susceptibility O 1 0.9998906850814819
gene O 1 0.9977141618728638
( O 0 0.01879703626036644
s O 0 0.06973344087600708
) O 0 0.019047120586037636

Paternal O 1 0.991479218006134
transmission O 1 0.9604445099830627
of O 0 0.04112720862030983
congenital B-Disease 1 1.0
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
. O 0 0.0383555106818676

We O 0 0.004779554903507233
report O 0 0.006225515156984329
a O 0 0.006698074284940958
rare O 0 0.015382368117570877
case O 0 0.007585227023810148
of O 0 0.007220253814011812
paternally O 1 0.999848484992981
transmitted O 1 0.9999619722366333
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8607190847396851
DM B-Disease 1 0.9999915361404419
) O 0 0.017311975359916687
. O 0 0.011922423727810383

The O 0 0.010897468775510788
proband O 1 0.9092385768890381
is O 0 0.0038708136416971684
a O 0 0.005245336797088385
23 O 0 0.008155854418873787
year O 0 0.004413277842104435
old O 0 0.008822664618492126
, O 0 0.00543034914880991
mentally B-Disease 1 0.9997914433479309
retarded I-Disease 1 0.999575674533844
male O 1 0.92120361328125
who O 0 0.2465604990720749
suffers O 1 0.9999991655349731
severe O 1 0.9999996423721313
muscular B-Disease 1 0.9999994039535522
weakness I-Disease 1 0.9998760223388672
. O 0 0.016398847103118896

He O 0 0.005634062457829714
presented O 0 0.0075080301612615585
with O 0 0.008116325363516808
respiratory O 1 0.9999996423721313
and O 0 0.004218278918415308
feeding O 1 0.9318837523460388
difficulties O 0 0.21808424592018127
at O 0 0.00876156147569418
birth O 1 0.6623395085334778
. O 0 0.012394795194268227

His O 0 0.01248219609260559
two O 0 0.01116409245878458
sibs O 1 0.999581515789032
suffer O 1 0.9994487166404724
from O 0 0.01785692386329174
childhood O 1 0.9996088147163391
onset O 1 0.9999963045120239
DM B-Disease 1 0.9999926090240479
. O 0 0.026473958045244217

Their O 0 0.007894190959632397
late O 0 0.011751714162528515
father O 0 0.0115326764062047
had O 0 0.0031711661722511053
the O 0 0.003593789879232645
adult O 0 0.028989197686314583
type O 0 0.02164645865559578
of O 0 0.005637662019580603
DM B-Disease 1 0.9999969005584717
, O 0 0.0045636845752596855
with O 0 0.006277200300246477
onset O 1 0.9999620914459229
around O 0 0.00931054912507534
30 O 0 0.011405679397284985
years O 0 0.00796256773173809
. O 0 0.009744792245328426

Only O 0 0.005446739494800568
six O 0 0.0036438724491745234
other O 0 0.0016035792650654912
cases O 0 0.007199927698820829
of O 0 0.0034749694168567657
paternal O 1 0.9990527033805847
transmission O 1 0.9704464673995972
of O 0 0.016777032986283302
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999997615814209
have O 0 0.005411551333963871
been O 0 0.0052359942346811295
reported O 0 0.016827786341309547
recently O 0 0.01913290098309517
. O 0 0.011796105653047562

We O 0 0.005714979488402605
review O 0 0.008549672551453114
the O 0 0.004406536929309368
sex O 0 0.01983443647623062
related O 0 0.011957508511841297
effects O 0 0.027776775881648064
on O 0 0.003938247449696064
transmission O 1 0.5375189781188965
of O 0 0.017354028299450874
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999884366989136
. O 0 0.03053825907409191

Decreased O 1 0.9190301895141602
fertility O 1 0.6707147359848022
of O 0 0.005624131299555302
males O 0 0.1206439882516861
with O 0 0.008150037378072739
adult O 1 0.9940694570541382
onset O 1 0.9999973773956299
DM B-Disease 1 0.9999949932098389
and O 0 0.006726066116243601
contraction O 1 0.7696764469146729
of O 0 0.0021479669958353043
the O 0 0.003702715039253235
repeat O 0 0.05386528745293617
upon O 0 0.008364159613847733
male O 0 0.0483555942773819
transmission O 0 0.11164090037345886
contribute O 0 0.00895028468221426
to O 0 0.0015041192527860403
the O 0 0.002289846073836088
almost O 0 0.007307220716029406
absent O 0 0.03927008435130119
occurrence O 0 0.05359039455652237
of O 0 0.00467658368870616
paternal O 1 0.9963095784187317
transmission O 1 0.961316704750061
of O 0 0.016066478565335274
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999980926513672
. O 0 0.022428708150982857

Also O 0 0.004893725737929344
the O 0 0.00332952500320971
fathers O 0 0.012682730332016945
of O 0 0.0018096681451424956
the O 0 0.0036822049878537655
reported O 0 0.07170575857162476
congenitally O 1 0.9999431371688843
affected O 1 0.9301407337188721
children O 0 0.02091212011873722
showed O 0 0.009351326152682304
, O 0 0.0015333009650930762
on O 0 0.0019306743051856756
average O 0 0.008066629990935326
, O 0 0.0035521816462278366
shorter O 0 0.032906122505664825
CTG O 1 0.9913296699523926
repeat O 0 0.09911850839853287
lengths O 0 0.016949353739619255
and O 0 0.002049910370260477
hence O 0 0.011865676380693913
less O 0 0.017346175387501717
severe O 1 0.9999978542327881
clinical O 1 0.9999755620956421
symptoms O 1 0.9999996423721313
than O 0 0.003032711101695895
the O 0 0.002729533240199089
mothers O 1 0.8739551901817322
of O 0 0.0025613189209252596
children O 0 0.14052264392375946
with O 0 0.0246110949665308
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999943971633911
. O 0 0.024302609264850616

We O 0 0.006644901353865862
conclude O 0 0.016982976347208023
that O 0 0.003842233447358012
paternal O 1 0.9483654499053955
transmission O 1 0.6106991767883301
of O 0 0.014158622361719608
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999995231628418
is O 0 0.009211684577167034
rare O 0 0.07342632859945297
and O 0 0.0036331324372440577
preferentially O 1 0.6274910569190979
occurs O 0 0.030590010806918144
with O 0 0.007243388798087835
onset O 1 0.999885082244873
of O 0 0.00881949532777071
DM B-Disease 1 0.9999933242797852
past O 0 0.010698319412767887
30 O 0 0.0060721090994775295
years O 0 0.002724505728110671
in O 0 0.0013959674397483468
the O 0 0.0029729765374213457
father O 0 0.01656343601644039
. O 0 0.00495415274053812
. O 0 0.009252181276679039

The O 0 0.030303217470645905
RB1 O 1 0.9998438358306885
gene O 1 0.99835604429245
mutation O 1 0.9988221526145935
in O 0 0.0038468700367957354
a O 0 0.008214928209781647
child O 0 0.12205066531896591
with O 0 0.013856400735676289
ectopic B-Disease 1 0.9999871253967285
intracranial I-Disease 1 0.9999918937683105
retinoblastoma I-Disease 1 0.9998975992202759
. O 0 0.023453472182154655

The O 0 0.0314178466796875
RB1 O 1 0.9999179840087891
gene O 1 0.9981315732002258
mutation O 1 0.9997552037239075
was O 0 0.006593065336346626
investigated O 0 0.011569785885512829
in O 0 0.001979061169549823
a O 0 0.006611817982047796
child O 0 0.11230926215648651
with O 0 0.011617941781878471
ectopic B-Disease 1 0.9999837875366211
intracranial I-Disease 1 0.999985933303833
retinoblastoma I-Disease 1 0.9997327923774719
using O 0 0.008648894727230072
DNA O 0 0.022687487304210663
obtained O 0 0.0035751366522163153
from O 0 0.001986756455153227
both O 0 0.0016087312251329422
the O 0 0.004388486035168171
pineal B-Disease 1 0.9997014403343201
and I-Disease 0 0.009789643809199333
retinal I-Disease 1 0.9999963045120239
tumours I-Disease 1 0.9999805688858032
of O 0 0.00425880728289485
the O 0 0.0074745407328009605
patient O 1 0.9996838569641113
. O 0 0.012176833115518093

A O 0 0.029568102210760117
nonsense O 0 0.144111767411232
mutation O 1 0.9975103139877319
in O 0 0.008181051351130009
exon O 0 0.3156036138534546
17 O 0 0.02036743424832821
( O 0 0.011141408234834671
codon O 0 0.1292809098958969
556 O 0 0.06985113769769669
) O 0 0.004491329658776522
of O 0 0.002405177801847458
the O 0 0.008744330145418644
RB1 O 1 0.9999312162399292
gene O 1 0.91331547498703
was O 0 0.004826766438782215
found O 0 0.0034844388719648123
to O 0 0.0012132127303630114
be O 0 0.0013448295649141073
present O 0 0.0037000670563429594
homozygously O 1 0.8128397464752197
in O 0 0.0016892600106075406
both O 0 0.0018801178084686399
the O 0 0.004736125934869051
retinal B-Disease 1 0.9998968839645386
and I-Disease 0 0.003936717286705971
the I-Disease 0 0.012194800190627575
pineal I-Disease 1 0.9999178647994995
tumours I-Disease 1 0.9999794960021973
. O 0 0.02368774451315403

The O 0 0.006947959773242474
same O 0 0.010084463283419609
mutation O 1 0.9987788796424866
was O 0 0.005243090447038412
present O 0 0.005199677776545286
heterozygously O 1 0.8817636966705322
in O 0 0.002020234474912286
the O 0 0.0029981648549437523
DNA O 0 0.017409533262252808
from O 0 0.002559137996286154
the O 0 0.002298906911164522
constitutional O 0 0.007536180783063173
cells O 0 0.021580368280410767
of O 0 0.0017448796425014734
the O 0 0.003970445599406958
patient O 1 0.9998641014099121
, O 0 0.002453496912494302
proving O 0 0.013177603483200073
it O 0 0.0014308963436633348
to O 0 0.001238255761563778
be O 0 0.0016847973456606269
of O 0 0.0038254898972809315
germline O 1 0.9935757517814636
origin O 0 0.023395100608468056
. O 0 0.01312973815947771

The O 0 0.011747590266168118
initial O 0 0.03483952581882477
mutation O 1 0.999647855758667
was O 0 0.006245039869099855
shown O 0 0.005350077524781227
to O 0 0.0017200229922309518
have O 0 0.002214600797742605
occurred O 0 0.009726404212415218
in O 0 0.0023933881893754005
the O 0 0.005425391253083944
paternally O 1 0.9872482419013977
derived O 0 0.0661541000008583
RB1 O 1 0.999908447265625
allele O 1 0.9951011538505554
. O 0 0.016774900257587433

The O 0 0.01540110632777214
mutation O 1 0.998978853225708
is O 0 0.0033517659176141024
in O 0 0.0015370065812021494
an O 0 0.00164826400578022
area O 0 0.0032283698674291372
of O 0 0.0014678583247587085
the O 0 0.003686801763251424
gene O 1 0.6464797854423523
that O 0 0.0028647631406784058
encodes O 0 0.03360048308968544
the O 0 0.005688485223799944
protein O 0 0.040606576949357986
- O 0 0.019906731322407722
binding O 0 0.012954078614711761
region O 0 0.00909343734383583
known O 0 0.004925480578094721
as O 0 0.0016433954006060958
the O 0 0.003081480972468853
pocket O 0 0.23534071445465088
region O 0 0.009398444555699825
and O 0 0.0016703096916899085
has O 0 0.0024186396040022373
been O 0 0.0037298151291906834
detected O 0 0.06288383156061172
in O 0 0.0015521817840635777
other O 0 0.0013642774429172277
cases O 0 0.007818484678864479
of O 0 0.004478785675019026
retinoblastoma B-Disease 1 0.9998811483383179
. O 0 0.006802822928875685
. O 0 0.008947286754846573

Low O 0 0.0372154526412487
levels O 0 0.015741948038339615
of O 0 0.00422245729714632
beta O 0 0.06317362934350967
hexosaminidase O 1 0.9486503601074219
A O 0 0.007924392819404602
in O 0 0.003189108334481716
healthy O 1 0.9185178875923157
individuals O 0 0.007268369663506746
with O 0 0.005109223537147045
apparent O 1 0.9987257122993469
deficiency O 1 0.9999973773956299
of O 0 0.004173933528363705
this O 0 0.00587884709239006
enzyme O 0 0.34276434779167175
. O 0 0.011140093207359314

Appreciable O 0 0.3266226351261139
beta O 0 0.1122845709323883
hexosaminidase O 1 0.875271201133728
A O 0 0.014453813433647156
( O 0 0.008253498934209347
hex O 0 0.04574250802397728
A O 0 0.008799177594482899
) O 0 0.004100529011338949
activity O 0 0.006578702013939619
has O 0 0.002820940688252449
been O 0 0.0036156747955828905
detected O 0 0.03356308117508888
in O 0 0.004744879901409149
cultured O 1 0.9979575872421265
skin O 1 0.999998927116394
fibroblasts O 1 0.999937891960144
and O 0 0.0602547824382782
melanoma B-Disease 1 0.9999998807907104
tissue O 1 0.9999557733535767
from O 0 0.007730584125965834
healthy O 1 0.9738315939903259
individuals O 0 0.007444214075803757
previously O 0 0.006462962832301855
reported O 0 0.009466646239161491
as O 0 0.003218198660761118
having O 0 0.015666162595152855
deficiency B-Disease 1 0.9999836683273315
of I-Disease 0 0.004330089781433344
hex I-Disease 0 0.2533283233642578
A I-Disease 0 0.01131079439073801
activity O 0 0.014740200713276863
indistinguishable O 0 0.02839832752943039
from O 0 0.002707134932279587
that O 0 0.0013899813639000058
of O 0 0.003134044585749507
patients O 1 0.9999098777770996
with O 0 0.01804867386817932
Tay B-Disease 1 0.9999995231628418
- I-Disease 1 0.9995461106300354
Sachs I-Disease 1 0.999991774559021
disease I-Disease 1 0.9999997615814209
( O 0 0.06940986216068268
TSD B-Disease 1 0.9998995065689087
) O 0 0.015146111138164997
. O 0 0.009177923202514648

Identification O 0 0.024720074608922005
and O 0 0.0037959085311740637
quantitation O 1 0.6928312182426453
of O 0 0.004353824537247419
hex O 0 0.07260101288557053
A O 0 0.008218499831855297
, O 0 0.002535499632358551
amounting O 0 0.017948132008314133
to O 0 0.003845885628834367
3 O 0 0.012531029060482979
. O 0 0.009077209047973156

5 O 0 0.025906670838594437
% O 0 0.01614014059305191
- O 0 0.03486843407154083
6 O 0 0.018544714897871017
. O 0 0.012401123531162739

9 O 0 0.018677838146686554
% O 0 0.0056297387927770615
of O 0 0.0023826381657272577
total O 0 0.008285703137516975
beta O 0 0.06976969540119171
hexosaminidase O 1 0.9771956205368042
activity O 0 0.014148229733109474
, O 0 0.002189034828916192
has O 0 0.002854566788300872
been O 0 0.0026487703435122967
obtained O 0 0.003953091334551573
by O 0 0.005460742395371199
cellulose O 0 0.07807348668575287
acetate O 0 0.21584735810756683
gel O 1 0.8922706246376038
electrophoresis O 0 0.16206590831279755
, O 0 0.011094748042523861
DEAE O 1 0.9891464710235596
- O 0 0.05168053135275841
cellulose O 0 0.09252464026212692
ion O 0 0.07596300542354584
- O 0 0.028948631137609482
exchange O 0 0.014108511619269848
chromatography O 0 0.06330999732017517
, O 0 0.009399878792464733
radial O 1 0.8485867977142334
immunodiffusion O 1 0.9686946272850037
, O 0 0.005033619701862335
and O 0 0.005951398517936468
radioimmunoassay O 1 0.9421597719192505
. O 0 0.014500690624117851

Previous O 0 0.018250510096549988
family O 0 0.014277966693043709
studies O 0 0.0072210426442325115
suggested O 0 0.005516960285604
that O 0 0.0011396853951737285
these O 0 0.0010964031098410487
individuals O 0 0.003592404304072261
may O 0 0.004397458862513304
be O 0 0.002024796325713396
compound O 0 0.01747683249413967
heterozygotes O 1 0.9820315837860107
for O 0 0.0031271425541490316
the O 0 0.004768777173012495
common O 0 0.02058211714029312
mutant O 1 0.9996199607849121
TSD B-Disease 1 0.99991774559021
gene O 1 0.9849238395690918
and O 0 0.0038902058731764555
a O 0 0.008137330412864685
rare O 0 0.02907189354300499
( O 0 0.01476565096527338
allelic O 1 0.9821687340736389
) O 0 0.01710343174636364
mutant O 1 0.9965012073516846
gene O 1 0.9556463360786438
. O 0 0.014376314356923103

Thus O 0 0.012942194938659668
, O 0 0.0026726347859948874
the O 0 0.0039384677074849606
postulated O 0 0.04399982467293739
rate O 0 0.027462627738714218
mutant O 1 0.9991005659103394
gene O 1 0.9901537299156189
appears O 0 0.013254047371447086
to O 0 0.0017811123980209231
code O 0 0.00476410798728466
for O 0 0.0011699104215949774
the O 0 0.0021727702114731073
expression O 0 0.010979298502206802
of O 0 0.001999512081965804
low O 0 0.010175453498959541
amounts O 0 0.007137738633900881
of O 0 0.0027798647060990334
hex O 0 0.07670953124761581
A O 0 0.017943894490599632
. O 0 0.011616978794336319

Heterozygotes O 1 0.9904506802558899
for O 0 0.004352524410933256
the O 0 0.0049724881537258625
rare O 0 0.2269023358821869
mutant O 1 0.9995478987693787
may O 0 0.008124454878270626
be O 0 0.0026982270646840334
indistinguishable O 0 0.03008064068853855
from O 0 0.006253618746995926
heterozygotes O 1 0.9074459075927734
for O 0 0.0027698706835508347
the O 0 0.004479712340980768
common O 0 0.056953370571136475
TSD B-Disease 1 0.999924898147583
mutant O 1 0.9982545971870422
. O 0 0.0199406910687685

However O 0 0.009063572622835636
, O 0 0.003014211542904377
direct O 0 0.007637347560375929
visualization O 0 0.02426135167479515
and O 0 0.00352157698944211
quantitation O 1 0.564265787601471
of O 0 0.003188694827258587
hex O 0 0.033993612974882126
A O 0 0.005629237275570631
by O 0 0.0022910707630217075
the O 0 0.0024209264665842056
methods O 0 0.005445074290037155
described O 0 0.008694086223840714
may O 0 0.006295621395111084
prevent O 0 0.020531460642814636
false O 0 0.010300500318408012
- O 0 0.03912028297781944
positive O 0 0.04433318227529526
prenatal O 1 0.9998840093612671
diagnosis O 1 0.9998655319213867
of O 0 0.008209220133721828
TSD B-Disease 1 0.9998741149902344
in O 0 0.006556479725986719
fetuses O 1 0.9977242350578308
having O 0 0.005669133737683296
the O 0 0.0023636827245354652
incomplete O 0 0.013443101197481155
hex B-Disease 1 0.7585821747779846
A I-Disease 0 0.0806422308087349
deficiency I-Disease 1 0.9999887943267822
of O 0 0.002538384636864066
the O 0 0.0037837966810911894
type O 0 0.023394567891955376
described O 0 0.006066793575882912
in O 0 0.0018200307385995984
the O 0 0.0023892202880233526
four O 0 0.0055405511520802975
healthy O 1 0.5996600985527039
individuals O 0 0.02446761727333069

The O 0 0.03183671459555626
tumor B-Disease 1 0.99998939037323
suppressor O 1 0.9999662637710571
gene O 1 0.9981437921524048
Smad4 O 1 0.9991127848625183
/ O 1 0.9164862632751465
Dpc4 O 1 0.9896368384361267
is O 0 0.005018678028136492
required O 0 0.0048912763595581055
for O 0 0.0032462163362652063
gastrulation O 1 0.9863362312316895
and O 0 0.002020803513005376
later O 0 0.0028480710461735725
for O 0 0.0032101536635309458
anterior O 1 0.9988746047019958
development O 0 0.0041617718525230885
of O 0 0.0021694574970752
the O 0 0.006371121387928724
mouse O 1 0.9992870688438416
embryo O 1 0.9781322479248047
. O 0 0.014748888090252876

Mutations O 1 0.9906520843505859
in O 0 0.0054258909076452255
the O 0 0.008655544370412827
SMAD4 O 1 0.9997482895851135
/ O 1 0.9980074763298035
DPC4 O 1 0.9999696016311646
tumor B-Disease 1 0.9999988079071045
suppressor O 1 0.9999837875366211
gene O 1 0.9690178036689758
, O 0 0.003140880726277828
a O 0 0.004688150715082884
key O 0 0.007009644526988268
signal O 0 0.01828252524137497
transducer O 0 0.1518237292766571
in O 0 0.002956904238089919
most O 0 0.005478822626173496
TGFbeta O 1 0.9984911680221558
- O 0 0.03310586139559746
related O 0 0.014437745325267315
pathways O 0 0.4629189372062683
, O 0 0.0016279673436656594
are O 0 0.0010761439334601164
involved O 0 0.004609777592122555
in O 0 0.0018899471033364534
50 O 0 0.006097417324781418
% O 0 0.0072953044436872005
of O 0 0.0077177993953228
pancreatic B-Disease 1 0.9999992847442627
cancers I-Disease 1 0.9999953508377075
. O 0 0.020256394520401955

Homozygous O 1 0.9971824884414673
Smad4 O 1 0.9989013671875
mutant O 1 0.9992138147354126
mice O 1 0.9994126558303833
die O 1 0.96871018409729
before O 0 0.009025165811181068
day O 0 0.010441114194691181
7 O 0 0.01563282310962677
. O 0 0.00930381752550602

5 O 0 0.023585541173815727
of O 0 0.00984903797507286
embryogenesis O 1 0.7629368901252747
. O 0 0.026078784838318825

Mutant O 1 0.996019184589386
embryos O 0 0.04463673382997513
have O 0 0.005208707880228758
reduced O 0 0.015789849683642387
size O 0 0.00978801678866148
, O 0 0.002719312673434615
fail O 0 0.020247654989361763
to O 0 0.004502519965171814
gastrulate O 1 0.7767987847328186
or O 0 0.006600589957088232
express O 0 0.01649792119860649
a O 0 0.011329466477036476
mesodermal O 1 0.9939998388290405
marker O 0 0.1097690612077713
, O 0 0.002835014369338751
and O 0 0.002709596650674939
show O 0 0.01467092428356409
abnormal O 1 0.999099850654602
visceral O 1 0.9975929856300354
endoderm O 1 0.9708263874053955
development O 0 0.018543163314461708
. O 0 0.01383584551513195

Growth B-Disease 0 0.17115522921085358
retardation I-Disease 1 0.9996107220649719
of O 0 0.0038996911607682705
the O 0 0.007254935801029205
Smad4 O 1 0.9994841814041138
- O 1 0.8243061900138855
deficient O 1 0.9987853169441223
embryos O 0 0.029293173924088478
results O 0 0.008292939513921738
from O 0 0.0043542105704545975
reduced O 0 0.026419851928949356
cell O 0 0.08121345937252045
proliferation O 0 0.02911589853465557
rather O 0 0.006569111254066229
than O 0 0.005489167757332325
increased O 0 0.023104090243577957
apoptosis O 1 0.9814319610595703
. O 0 0.014668022282421589

Aggregation O 0 0.091520294547081
of O 0 0.009091829881072044
mutant O 1 0.9983108043670654
Smad4 O 1 0.9985074400901794
ES O 1 0.9959803819656372
cells O 0 0.11567337810993195
with O 0 0.005235177930444479
wild O 0 0.03212544322013855
- O 0 0.04394792020320892
type O 0 0.07735972106456757
tetraploid O 1 0.9882451295852661
morulae O 1 0.9895815849304199
rescues O 1 0.5517317056655884
the O 0 0.016908997669816017
gastrulation B-Disease 1 0.9979206919670105
defect I-Disease 1 0.9930301308631897
. O 0 0.022992083802819252

These O 0 0.00491041224449873
results O 0 0.01014516782015562
indicate O 0 0.009698075242340565
that O 0 0.0033076463732868433
Smad4 O 1 0.9952735304832458
is O 0 0.003665937576442957
initially O 0 0.005947622936218977
required O 0 0.0025061604101210833
for O 0 0.001237825257703662
the O 0 0.0025811446830630302
differentiation O 0 0.027168085798621178
of O 0 0.0022126713301986456
the O 0 0.004979691002517939
visceral O 1 0.999245285987854
endoderm O 1 0.992016077041626
and O 0 0.0021450312342494726
that O 0 0.0020636124536395073
the O 0 0.004795581102371216
gastrulation B-Disease 1 0.9993048906326294
defect I-Disease 1 0.9970406889915466
in O 0 0.0035780000034719706
the O 0 0.00646584527567029
epiblast O 1 0.9988441467285156
is O 0 0.005821463651955128
secondary O 0 0.01395291369408369
and O 0 0.0022400591988116503
non O 0 0.013953963294625282
- O 0 0.032202836126089096
cell O 0 0.04405176639556885
autonomous O 0 0.02686251327395439
. O 0 0.011828415095806122

Rescued O 1 0.6378922462463379
embryos O 0 0.08714579045772552
show O 0 0.047914836555719376
severe O 1 0.9999688863754272
anterior O 1 0.9999390840530396
truncations O 1 0.9957537651062012
, O 0 0.0041741374880075455
indicating O 0 0.010173723101615906
a O 0 0.0034655833151191473
second O 0 0.003635497996583581
important O 0 0.0026026975829154253
role O 0 0.005629122257232666
for O 0 0.003955055959522724
Smad4 O 1 0.9957613348960876
in O 0 0.010177834890782833
anterior O 1 0.9998576641082764
patterning O 1 0.9913341403007507
during O 0 0.029727987945079803
embryogenesis O 1 0.9714464545249939
. O 0 0.016048366203904152

Prevalence O 1 0.9931814074516296
of O 0 0.013258002698421478
p16 O 1 0.998324453830719
and O 0 0.01115215104073286
CDK4 O 1 0.9998658895492554
germline O 1 0.9997096657752991
mutations O 1 0.9992533326148987
in O 0 0.007951658219099045
48 O 1 0.6368857622146606
melanoma B-Disease 1 0.9999994039535522
- O 1 0.9520572423934937
prone O 1 0.9871149063110352
families O 0 0.010818944312632084
in O 0 0.003663597395643592
France O 0 0.0203553419560194
. O 0 0.010787746869027615

The O 0 0.015127260237932205
French O 1 0.8544821739196777
Familial B-Disease 1 0.9999986886978149
Melanoma I-Disease 1 0.9999997615814209
Study O 0 0.0252830870449543
Group O 0 0.021282026544213295
. O 0 0.013050341047346592

Germline O 1 0.9993539452552795
mutations O 1 0.9967203736305237
in O 0 0.005337263457477093
the O 0 0.006553690880537033
p16 O 1 0.9973292350769043
and O 0 0.006328838411718607
CDK4 O 1 0.9998589754104614
genes O 1 0.9673393368721008
have O 0 0.0029256020206958055
been O 0 0.002990397857502103
reported O 0 0.006043232977390289
in O 0 0.0017424620455130935
a O 0 0.005059016402810812
subset O 0 0.030151288956403732
of O 0 0.006708147935569286
melanoma B-Disease 1 0.9999997615814209
pedigrees O 1 0.9861935973167419
, O 0 0.0034160646609961987
but O 0 0.002803333569318056
their O 0 0.005178005434572697
prevalence O 1 0.9987680315971375
is O 0 0.0037326407618820667
not O 0 0.0018875746754929423
well O 0 0.003318890929222107
known O 0 0.011072448454797268
. O 0 0.008997988887131214

We O 0 0.0060506477020680904
searched O 0 0.015429767780005932
for O 0 0.0033669406548142433
such O 0 0.005771396216005087
germline O 1 0.9994613528251648
mutations O 1 0.9974004030227661
in O 0 0.004163113422691822
48 O 0 0.02307547815144062
French O 1 0.9812260866165161
melanoma B-Disease 1 0.9999996423721313
- O 1 0.7527624368667603
prone O 1 0.9778380990028381
families O 0 0.009246107190847397
selected O 0 0.0042617544531822205
according O 0 0.00204678438603878
to O 0 0.00127674569375813
two O 0 0.001647310913540423
major O 0 0.005490138661116362
criteria O 0 0.006698460318148136
families O 0 0.004724988713860512
with O 0 0.0014585853787139058
at O 0 0.0022887722589075565
least O 0 0.00443574832752347
three O 0 0.0036633398849517107
affected O 0 0.02512427791953087
members O 0 0.004298510029911995
( O 0 0.007430152036249638
n O 0 0.024861764162778854
= O 0 0.02694452553987503
20 O 0 0.006308909505605698
) O 0 0.003141626249998808
or O 0 0.002556468825787306
families O 0 0.003981035202741623
with O 0 0.0017321191262453794
two O 0 0.00202959100715816
affected O 0 0.01600419171154499
members O 0 0.002204430988058448
, O 0 0.0009639807976782322
one O 0 0.0012660076608881354
of O 0 0.0009438539273105562
them O 0 0.001561950077302754
affected O 0 0.014234638772904873
before O 0 0.0023732122499495745
the O 0 0.0019398467848077416
age O 0 0.005749878473579884
of O 0 0.0019478079630061984
50 O 0 0.0077524916268885136
( O 0 0.007544998545199633
n O 0 0.0276544988155365
= O 0 0.03139480948448181
28 O 0 0.00927974097430706
) O 0 0.0030551825184375048
, O 0 0.0011914173373952508
and O 0 0.0010568631114438176
one O 0 0.0024072749074548483
additional O 0 0.006909859366714954
minor O 0 0.03531031310558319
criterion O 0 0.03452063351869583
. O 0 0.010443361476063728

Sixteen O 0 0.04120302572846413
different O 0 0.01541569922119379
p16 O 1 0.9991782307624817
germline O 1 0.9998708963394165
mutations O 1 0.9994521737098694
were O 0 0.0024949563667178154
found O 0 0.0034271974582225084
in O 0 0.0014889806043356657
21 O 0 0.00647651357576251
families O 0 0.004883204586803913
, O 0 0.001499235862866044
while O 0 0.0027476625982671976
one O 0 0.006580157671123743
germline O 1 0.9998154044151306
mutation O 1 0.9999117851257324
, O 0 0.006211506202816963
Arg24His O 1 0.9989262223243713
, O 0 0.002855477621778846
was O 0 0.004507096484303474
detected O 0 0.028992367908358574
in O 0 0.0026905047707259655
the O 0 0.007375272456556559
CDK4 O 1 0.9992706179618835
gene O 1 0.9686158895492554
. O 0 0.017058009281754494

The O 0 0.009252959862351418
frequency O 0 0.03234238922595978
of O 0 0.009235616773366928
p16 O 1 0.9982855916023254
gene O 1 0.9942755103111267
mutation O 1 0.9975026249885559
in O 0 0.003216296434402466
our O 0 0.00402198126539588
sample O 0 0.011829257011413574
( O 0 0.004878576844930649
44 O 0 0.00955002661794424
% O 0 0.005085795186460018
) O 0 0.0026395742315799
is O 0 0.0016218686942011118
among O 0 0.002157514216378331
the O 0 0.0019453817512840033
highest O 0 0.007639663759618998
rates O 0 0.010256551206111908
yet O 0 0.005069592501968145
reported O 0 0.007227095775306225
and O 0 0.0014541237615048885
the O 0 0.004953919909894466
CDK4 O 1 0.9997594952583313
mutation O 1 0.9991835951805115
is O 0 0.0034771268256008625
the O 0 0.002670791232958436
second O 0 0.012229293584823608
mutation O 1 0.9998375177383423
detected O 0 0.15241007506847382
in O 0 0.002827952615916729
this O 0 0.005736025050282478
gene O 1 0.9752242565155029
worldwide O 0 0.03347063809633255
. O 0 0.011160467751324177

In O 0 0.0075585427694022655
summary O 0 0.017210356891155243
, O 0 0.0026429484132677317
our O 0 0.0034712431952357292
results O 0 0.008574777282774448
show O 0 0.0084900027140975
frequent O 0 0.02170347422361374
involvement O 0 0.01674993336200714
of O 0 0.0027735375333577394
the O 0 0.007249498274177313
p16 O 1 0.9992503523826599
gene O 1 0.9926015734672546
in O 0 0.013169711455702782
familial B-Disease 1 0.9999982118606567
melanoma I-Disease 1 0.9999997615814209
and O 0 0.0039237625896930695
confirm O 0 0.007593480404466391
the O 0 0.0019820488523691893
role O 0 0.004322175867855549
of O 0 0.0018396397354081273
the O 0 0.005292568355798721
CDK4 O 1 0.998772919178009
gene O 1 0.9274672269821167
as O 0 0.004312579054385424
a O 0 0.05020079016685486
melanoma B-Disease 1 0.9999995231628418
- O 1 0.9748681783676147
predisposing O 1 0.9993307590484619
gene O 1 0.9829147458076477
. O 0 0.007358824368566275
. O 0 0.011038122698664665

Progression O 1 0.9497069120407104
of O 0 0.01242989394813776
somatic O 1 0.9950847029685974
CTG O 1 0.9883431792259216
repeat O 0 0.12357741594314575
length O 0 0.019299086183309555
heterogeneity O 0 0.15459275245666504
in O 0 0.002888070186600089
the O 0 0.005810162052512169
blood O 1 0.9973123073577881
cells O 1 0.9720478653907776
of O 0 0.025578830391168594
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.999966025352478
. O 0 0.023488344624638557

The O 0 0.01134233083575964
genetic O 0 0.07984648644924164
basis O 0 0.007462034467607737
of O 0 0.014843560755252838
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.5287182331085205
DM B-Disease 1 0.9999890327453613
) O 0 0.006391753908246756
is O 0 0.002501401584595442
the O 0 0.001979510299861431
expansion O 0 0.006122703198343515
of O 0 0.0022183088585734367
an O 0 0.005467860959470272
unstable O 1 0.9759795665740967
CTG O 1 0.9976873397827148
repeat O 0 0.036879636347293854
in O 0 0.002755320630967617
the O 0 0.003168755443766713
34 O 0 0.016101235523819923
UTR O 0 0.09954795986413956
of O 0 0.0035627931356430054
the O 0 0.010483995079994202
DM B-Disease 1 0.9999709129333496
protein O 0 0.2768382430076599
kinase O 1 0.9902487397193909
gene O 0 0.49122121930122375
on O 0 0.009306886233389378
chromosome O 1 0.9955079555511475
19 O 0 0.024570684880018234
. O 0 0.010431949980556965

One O 0 0.004489371553063393
of O 0 0.0016799792647361755
the O 0 0.0021299608051776886
principal O 0 0.006188434083014727
features O 0 0.004448757506906986
of O 0 0.0028794361278414726
the O 0 0.010898672975599766
DM B-Disease 1 0.9999973773956299
mutation O 1 0.999794065952301
is O 0 0.004265715833753347
an O 0 0.0033828860614448786
extraordinarily O 0 0.027720391750335693
high O 0 0.005812068469822407
level O 0 0.004388007335364819
of O 0 0.004147953353822231
somatic O 1 0.9989026784896851
mosaicism O 1 0.9999140501022339
, O 0 0.0038057321216911077
due O 0 0.006157899275422096
to O 0 0.0014563036384060979
an O 0 0.0023568826727569103
extremely O 0 0.010078591294586658
high O 0 0.0052771419286727905
degree O 0 0.005262603983283043
of O 0 0.0032660968136042356
somatic O 1 0.9944409728050232
instability O 1 0.8937013745307922
both O 0 0.00286677828989923
within O 0 0.0029843165539205074
and O 0 0.0017870764713734388
between O 0 0.004302745219320059
different O 0 0.006635074969381094
tissues O 1 0.9958024621009827
. O 0 0.013420335948467255

This O 0 0.009894140064716339
instability O 1 0.8867446780204773
appears O 0 0.01756114698946476
to O 0 0.0019078572513535619
be O 0 0.002210355596616864
biased O 0 0.011156904511153698
towards O 0 0.004802349954843521
further O 0 0.0039355698972940445
expansion O 0 0.007138569839298725
and O 0 0.00183364178519696
continuous O 0 0.012483013793826103
throughout O 0 0.0039026017766445875
the O 0 0.0016815419076010585
life O 0 0.003223234787583351
of O 0 0.0012312487233430147
an O 0 0.0018099370645359159
individual O 0 0.003231939161196351
, O 0 0.0015858625993132591
features O 0 0.0034528570249676704
that O 0 0.0011602102313190699
could O 0 0.0021444549784064293
be O 0 0.0013205487048253417
associated O 0 0.004043078515678644
with O 0 0.001401783898472786
the O 0 0.002595344092696905
progressive O 0 0.3129523992538452
nature O 0 0.005189206451177597
of O 0 0.002173766028136015
the O 0 0.009167591109871864
disease O 1 0.999998927116394
. O 0 0.011915258131921291

Although O 0 0.014634457416832447
increasing O 0 0.021777452901005745
measured O 0 0.027626177296042442
allele O 1 0.9959524869918823
size O 0 0.013942527584731579
between O 0 0.009327961131930351
patients O 1 0.9997578263282776
clearly O 0 0.011746554635465145
correlates O 0 0.06334925442934036
with O 0 0.0024286359548568726
an O 0 0.002850946271792054
increased O 0 0.017453765496611595
severity O 1 0.9991772770881653
of O 0 0.006263603921979666
symptoms O 1 0.9999995231628418
and O 0 0.0017965440638363361
an O 0 0.001973488600924611
earlier O 0 0.004231440369039774
age O 0 0.007298862561583519
of O 0 0.0033561557065695524
onset O 1 0.9999964237213135
, O 0 0.0019410054665058851
this O 0 0.0020376997999846935
correlation O 0 0.01364472508430481
is O 0 0.0017888016300275922
not O 0 0.0011517489328980446
precise O 0 0.005015614442527294
and O 0 0.0015861508436501026
measured O 0 0.015529578551650047
allele O 1 0.9963192939758301
length O 0 0.012197833508253098
cannot O 0 0.003287848550826311
be O 0 0.0007731082150712609
used O 0 0.0011262466432526708
as O 0 0.001117522711865604
an O 0 0.001868645427748561
accurate O 0 0.00805933028459549
predictor O 1 0.7723386287689209
of O 0 0.003130498109385371
age O 0 0.012717443518340588
of O 0 0.007492134813219309
onset O 1 0.9998888969421387
. O 0 0.016771582886576653

In O 0 0.0054496233351528645
order O 0 0.0045106615871191025
to O 0 0.001927883131429553
further O 0 0.004947403445839882
characterize O 0 0.02229952998459339
the O 0 0.004007692448794842
dynamics O 0 0.021959956735372543
of O 0 0.008753211237490177
DM B-Disease 1 0.9999854564666748
CTG O 1 0.9989625215530396
repeat O 1 0.9817764163017273
somatic O 1 0.9965307116508484
instability O 1 0.967578113079071
, O 0 0.0021517055574804544
we O 0 0.0013502725632861257
have O 0 0.0015002855798229575
studied O 0 0.005565006751567125
repeat O 0 0.03347814455628395
length O 0 0.00939725898206234
changes O 0 0.004804010968655348
over O 0 0.0025397504214197397
time O 0 0.003658332396298647
in O 0 0.005938188638538122
111 O 1 0.9966339468955994
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.9999685287475586
with O 0 0.006854763254523277
varying O 0 0.025593236088752747
clinical O 1 0.9991329312324524
severity O 1 0.9994822144508362
and O 0 0.006069036200642586
CTG O 1 0.9994117021560669
repeat O 0 0.08995459228754044
size O 0 0.008669066242873669
over O 0 0.0024895318783819675
time O 0 0.0032602360006421804
intervals O 0 0.009409971535205841
of O 0 0.002561734290793538
1 O 0 0.01079483237117529
- O 0 0.019850432872772217
7 O 0 0.011975161731243134
years O 0 0.008031835779547691
. O 0 0.009619641117751598

We O 0 0.004951414652168751
have O 0 0.0028807916678488255
found O 0 0.004256908781826496
a O 0 0.005155329126864672
direct O 0 0.010359148494899273
progression O 1 0.7531907558441162
of O 0 0.0019999011419713497
the O 0 0.002848294796422124
size O 0 0.009358550421893597
heterogeneity O 0 0.16438329219818115
over O 0 0.003189678303897381
time O 0 0.003851580433547497
related O 0 0.007224342320114374
to O 0 0.00349755329079926
initial O 0 0.021996302530169487
CTG O 1 0.9818246960639954
repeat O 0 0.04981633648276329
size O 0 0.0087980842217803
and O 0 0.0015412699431180954
the O 0 0.0019921048078686
time O 0 0.003990536089986563
interval O 0 0.018017400056123734
and O 0 0.0021688216365873814
always O 0 0.0056800865568220615
biased O 0 0.015403160825371742
towards O 0 0.0073198783211410046
further O 0 0.0069052474573254585
expansion O 0 0.02233656868338585
. O 0 0.011845694854855537

Attempts O 0 0.019805744290351868
to O 0 0.0038206486497074366
mathematically O 0 0.017089450731873512
model O 0 0.0066917953081429005
the O 0 0.0032194468658417463
dynamics O 0 0.015820404514670372
have O 0 0.00248331343755126
proved O 0 0.007348458748310804
only O 0 0.0025952502619475126
partially O 0 0.024138692766427994
successful O 0 0.008542226627469063
suggesting O 0 0.00840894877910614
that O 0 0.0011929708998650312
individual O 0 0.0033854241482913494
specific O 0 0.005525762680917978
genetic O 1 0.6983638405799866
and O 0 0.00295031419955194
/ O 0 0.18993031978607178
or O 0 0.003997611813247204
environmental O 0 0.008945811539888382
factors O 0 0.00788661278784275
also O 0 0.0016248100437223911
play O 0 0.00250389170832932
a O 0 0.0038469138089567423
role O 0 0.007703220937401056
in O 0 0.005954931490123272
somatic O 1 0.9985899329185486
mosaicism O 1 0.9995723366737366
. O 0 0.00840477179735899
. O 0 0.009546996094286442

Aspartylglucosaminuria B-Disease 1 0.9902583360671997
among O 0 0.01639648713171482
Palestinian O 0 0.030445531010627747
Arabs O 0 0.038534365594387054
. O 0 0.016732672229409218

Aspartylglucosaminuria B-Disease 1 0.9971627593040466
( O 0 0.04553457349538803
AGU B-Disease 1 0.9997932314872742
) O 0 0.007054079789668322
is O 0 0.0037044237833470106
a O 0 0.00847094226628542
rare O 1 0.8212942481040955
disorder B-Disease 1 0.999992847442627
of I-Disease 0 0.009460540488362312
glycoprotein I-Disease 1 0.9993022680282593
metabolism I-Disease 1 0.998842716217041
caused O 1 0.937214195728302
by O 0 0.00405861297622323
the O 0 0.0061661070212721825
deficiency B-Disease 1 0.9999866485595703
of I-Disease 0 0.0034628312569111586
the I-Disease 0 0.008051653392612934
lysosomal I-Disease 1 0.9995946288108826
enzyme I-Disease 1 0.9802415370941162
aspartylglucosaminidase I-Disease 1 0.9965850114822388
( O 0 0.01994241401553154
AGA O 1 0.9231653809547424
) O 0 0.011111769825220108
. O 0 0.010638026520609856

AGU B-Disease 1 0.9999004602432251
is O 0 0.01565615087747574
inherited O 1 0.9964854717254639
as O 0 0.006854581646621227
an O 0 0.015438455156981945
autosomal O 1 0.9999997615814209
recessive O 1 0.9999997615814209
trait O 1 0.9998602867126465
and O 0 0.004035784397274256
occurs O 0 0.048627085983753204
with O 0 0.001954935723915696
a O 0 0.004373757168650627
high O 0 0.005556950345635414
frequency O 0 0.012839139439165592
in O 0 0.0019117984920740128
Finland O 0 0.009669668041169643
because O 0 0.0037332328502088785
of O 0 0.0018506336491554976
a O 0 0.007661211304366589
founder O 0 0.03102537803351879
effect O 0 0.02368144318461418
. O 0 0.010289597325026989

While O 0 0.009634939953684807
very O 0 0.007963482290506363
few O 0 0.008594281040132046
patients O 1 0.9996262788772583
with O 0 0.007691584527492523
AGU B-Disease 1 0.9999932050704956
have O 0 0.0040671080350875854
been O 0 0.0037875708658248186
reported O 0 0.007812543772161007
from O 0 0.003000968135893345
non O 0 0.010473142378032207
- O 0 0.016961975023150444
Finnish O 0 0.01988600194454193
origin O 0 0.007354154717177153
, O 0 0.0025827742647379637
we O 0 0.005694283172488213
diagnosed O 1 0.9999991655349731
the O 0 0.010803806595504284
disorder O 1 0.9999959468841553
in O 0 0.004915429279208183
8 O 0 0.06292817741632462
patients O 1 0.9998737573623657
originating O 0 0.020595315843820572
from O 0 0.0046556624583899975
3 O 0 0.008738466538488865
unrelated O 0 0.02296406961977482
families O 0 0.006145546678453684
, O 0 0.0018175350269302726
all O 0 0.0015570748364552855
Palestinian O 0 0.00867660902440548
Arabs O 0 0.009807432070374489
from O 0 0.0018207593820989132
the O 0 0.001852621790021658
region O 0 0.006324640475213528
of O 0 0.002684537321329117
Jerusalem O 0 0.017968252301216125
. O 0 0.011418246664106846

The O 0 0.01585462875664234
clinical O 1 0.9985633492469788
diagnosis O 1 0.9999639987945557
of O 0 0.008356742560863495
AGU B-Disease 1 0.9999920129776001
is O 0 0.005375970620661974
often O 0 0.004519889131188393
difficult O 0 0.00469954963773489
, O 0 0.0011425529373809695
in O 0 0.001424742047674954
particular O 0 0.003648346522822976
early O 0 0.002942921593785286
in O 0 0.0011207620846107602
the O 0 0.001479326980188489
course O 0 0.004139100667089224
of O 0 0.0016981532098725438
the O 0 0.0058606998063623905
disease O 1 0.9999998807907104
, O 0 0.001452797674573958
and O 0 0.0008696552831679583
most O 0 0.0013728850753977895
of O 0 0.0013568706344813108
the O 0 0.0043730949983000755
patients O 1 0.9999814033508301
are O 0 0.005780062172561884
diagnosed O 1 0.9999998807907104
after O 0 0.006766991224139929
the O 0 0.002569349715486169
age O 0 0.00696725444868207
of O 0 0.0020543476566672325
5 O 0 0.008006708696484566
years O 0 0.006765484809875488
. O 0 0.008615976199507713

However O 0 0.009102610871195793
, O 0 0.003515369724482298
since O 0 0.007916334085166454
these O 0 0.005491666961461306
patients O 1 0.9996625185012817
excrete O 1 0.9958064556121826
early O 0 0.009658509865403175
large O 0 0.004639031365513802
amounts O 0 0.00714260246604681
of O 0 0.0037753325887024403
aspartylglucosamine O 1 0.9851314425468445
in O 0 0.004753115586936474
urine O 1 0.595779538154602
, O 0 0.004132104106247425
biochemical O 0 0.08903835713863373
screening O 0 0.04584827646613121
is O 0 0.004273086320608854
easy O 0 0.009653699584305286
by O 0 0.006914540193974972
urine O 0 0.3258601129055023
chromatography O 0 0.06348205357789993
. O 0 0.007476828992366791
. O 0 0.010605431161820889

Detection O 0 0.05685719847679138
of O 0 0.0069397264160215855
heterozygous O 1 0.995880126953125
carriers O 0 0.03475864604115486
of O 0 0.003249203320592642
the O 0 0.009441567584872246
ataxia B-Disease 1 0.999998927116394
- I-Disease 1 0.9971563816070557
telangiectasia I-Disease 1 0.9999912977218628
( O 0 0.015099168755114079
ATM O 0 0.2324431985616684
) O 0 0.010003252886235714
gene O 0 0.3702433407306671
by O 0 0.009012286551296711
G2 O 1 0.9974411725997925
phase O 0 0.09028475731611252
chromosomal O 1 0.9983013868331909
radiosensitivity O 1 0.9704443216323853
of O 0 0.012600619345903397
peripheral O 1 0.9999285936355591
blood O 1 0.9998562335968018
lymphocytes O 1 0.9998387098312378
. O 0 0.017380956560373306

In O 0 0.02319112792611122
ataxia B-Disease 1 0.999994158744812
- I-Disease 1 0.9881553649902344
telangiectasia I-Disease 1 0.9999895095825195
( O 0 0.016196129843592644
A B-Disease 1 0.860592246055603
- I-Disease 1 0.9958192110061646
T I-Disease 1 0.9999439716339111
) O 0 0.015232319943606853
patients O 1 0.9998737573623657
, O 0 0.004722153302282095
mutations O 1 0.9974531531333923
in O 0 0.002095700241625309
a O 0 0.005963086150586605
single O 0 0.014154555276036263
gene O 1 0.8616712093353271
, O 0 0.003977867774665356
ATM O 0 0.044125113636255264
, O 0 0.0022869978565722704
result O 0 0.006160697899758816
in O 0 0.0033608288504183292
an O 0 0.019103234633803368
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.005278103053569794
embraces O 0 0.19694091379642487
a O 0 0.005130670964717865
variety O 0 0.0057755266316235065
of O 0 0.0025554709136486053
clinical O 1 0.8047696948051453
features O 0 0.005465239752084017
and O 0 0.002317381789907813
manifests O 1 0.9931437969207764
extreme O 1 0.8215012550354004
radiosensitivity O 1 0.9954470992088318
and O 0 0.0023875022307038307
a O 0 0.00574153708294034
strong O 0 0.009517796337604523
pre O 0 0.0395185612142086
- O 0 0.031435973942279816
disposition O 0 0.07501216232776642
to O 0 0.008412126451730728
malignancy B-Disease 1 0.9999374151229858
. O 0 0.013371656648814678

Heterozygotes O 1 0.9777920246124268
for O 0 0.005561287049204111
the O 0 0.007396617904305458
ATM O 1 0.8770921230316162
gene O 1 0.9238122701644897
have O 0 0.004175758920609951
no O 0 0.0047732084058225155
clinical O 0 0.16732585430145264
expression O 0 0.012791301123797894
of O 0 0.002380266087129712
A B-Disease 1 0.7268728017807007
- I-Disease 1 0.982962429523468
T I-Disease 1 0.9999338388442993
but O 0 0.004104072693735361
may O 0 0.007649018429219723
be O 0 0.005861066747456789
cancer B-Disease 1 0.9999970197677612
prone O 1 0.9940605759620667
with O 0 0.002443421632051468
a O 0 0.006291064899414778
moderate O 0 0.0242229662835598
increase O 0 0.005994883365929127
in O 0 0.0019583117682486773
in O 0 0.0040696910582482815
vitro O 1 0.8723437190055847
radiosensitivity O 1 0.9863091707229614
. O 0 0.01506838109344244

We O 0 0.006498260423541069
performed O 0 0.01163207832723856
a O 0 0.011258856393396854
blind O 1 0.9699857234954834
chromosomal O 1 0.9953219294548035
analysis O 0 0.01318733487278223
on O 0 0.006627009715884924
G2 O 1 0.9978173971176147
- O 0 0.05451541766524315
phase O 0 0.055777765810489655
lymphocytes O 1 0.9946622252464294
from O 0 0.006088713183999062
7 O 0 0.012510477565228939
unrelated O 0 0.03537825867533684
A B-Disease 1 0.746986985206604
- I-Disease 1 0.9982621073722839
T I-Disease 1 0.9999827146530151
patients O 1 0.9998061060905457
, O 0 0.0037316724192351103
13 O 0 0.011555975303053856
obligate O 1 0.738166332244873
A B-Disease 1 0.6261130571365356
- I-Disease 1 0.9723702669143677
T I-Disease 1 0.9998088479042053
heterozygotes O 1 0.9979707598686218
( O 0 0.008384880609810352
parents O 0 0.0082227298989892
of O 0 0.0021658828482031822
the O 0 0.005670786835253239
patients O 1 0.9999521970748901
) O 0 0.003133164718747139
, O 0 0.0013978711795061827
and O 0 0.0014708720846101642
14 O 0 0.007029699627310038
normal O 0 0.015284995548427105
controls O 0 0.017576010897755623
following O 0 0.012596448883414268
X O 0 0.21789103746414185
- O 0 0.033800460398197174
irradiation O 0 0.07088231295347214
with O 0 0.004526327829807997
1 O 0 0.0114066693931818
Gy O 1 0.9062807559967041
in O 0 0.0028720595873892307
order O 0 0.002815843094140291
to O 0 0.001889804843813181
evaluate O 0 0.013999281451106071
this O 0 0.004024580121040344
cytogenetic O 1 0.9133865833282471
method O 0 0.007889696396887302
as O 0 0.0019176597706973553
a O 0 0.0037102638743817806
tool O 0 0.009256386198103428
for O 0 0.0027594377752393484
detection O 0 0.025309117510914803
of O 0 0.005397970788180828
ATM O 1 0.8512808084487915
carriers O 0 0.23306605219841003
. O 0 0.013781318441033363

Both O 0 0.010385912843048573
A B-Disease 0 0.19794252514839172
- I-Disease 1 0.9031146168708801
T I-Disease 1 0.9996615648269653
homozygotes O 1 0.9993619322776794
and O 0 0.008721272461116314
heterozygotes O 1 0.9989020824432373
showed O 0 0.017701417207717896
significantly O 0 0.020737215876579285
increased O 0 0.011138496920466423
levels O 0 0.010330199263989925
of O 0 0.005475401412695646
radiation O 1 0.9972066283226013
- O 1 0.8561851978302002
induced O 1 0.9997612833976746
chromatid O 1 0.9998006224632263
damage O 1 0.942703902721405
relative O 0 0.010622801259160042
to O 0 0.0015252562006935477
that O 0 0.0012398184044286609
of O 0 0.002213692758232355
normal O 0 0.02109992504119873
controls O 0 0.02767680585384369
. O 0 0.01218835636973381

These O 0 0.004702340811491013
results O 0 0.007330053951591253
show O 0 0.0048266383819282055
that O 0 0.001498510129749775
the O 0 0.004811796359717846
G2 O 1 0.9988852143287659
- O 0 0.04332226887345314
phase O 0 0.0984615609049797
chromosomal O 1 0.9996592998504639
radiosensitivity O 1 0.9971932768821716
assay O 0 0.060509465634822845
can O 0 0.0034548542462289333
be O 0 0.0010854469146579504
used O 0 0.001305215060710907
for O 0 0.0009063631878234446
the O 0 0.002100481651723385
detection O 0 0.017793718725442886
of O 0 0.0032383787911385298
A B-Disease 0 0.3423062562942505
- I-Disease 1 0.9521487951278687
T I-Disease 1 0.9997362494468689
heterozygotes O 1 0.9969769716262817
. O 0 0.017025122418999672

In O 0 0.007997802458703518
combination O 0 0.026147225871682167
with O 0 0.0039315903559327126
molecular O 0 0.03094504401087761
genetic O 1 0.6836846470832825
analyses O 0 0.008334611542522907
, O 0 0.0013168236473575234
this O 0 0.001317330519668758
test O 0 0.0049487934447824955
may O 0 0.0027126080822199583
be O 0 0.0006549100507982075
of O 0 0.0007650826591998339
value O 0 0.001647191820666194
in O 0 0.0012211801949888468
studies O 0 0.003796296427026391
of O 0 0.0032217446714639664
familial B-Disease 1 0.999984622001648
and I-Disease 0 0.005670333281159401
sporadic I-Disease 1 0.9992489218711853
cancers I-Disease 1 0.999996542930603
aimed O 0 0.012132696807384491
at O 0 0.0038632128853350878
determination O 0 0.007349217776209116
of O 0 0.001471565687097609
the O 0 0.0024650206323713064
potential O 0 0.009590116329491138
involvement O 0 0.014658603817224503
of O 0 0.003943505231291056
ATM O 1 0.991359531879425
mutations O 1 0.9998008608818054
in O 0 0.013546247966587543
tumor B-Disease 1 0.9999986886978149
risk O 1 0.9973280429840088
or O 0 0.006108848378062248
development O 0 0.00522712292149663
. O 0 0.00418282812461257
. O 0 0.007033142261207104

Ataxia B-Disease 1 0.9999833106994629
- I-Disease 1 0.9836909174919128
telangiectasia I-Disease 1 0.9999524354934692
: O 0 0.010688062757253647
identification O 0 0.011372876353561878
and O 0 0.0018750936724245548
detection O 0 0.016724325716495514
of O 0 0.00295333843678236
founder O 0 0.053023118525743484
- O 0 0.053231000900268555
effect O 0 0.0316547229886055
mutations O 1 0.9975441098213196
in O 0 0.0025827852077782154
the O 0 0.004219581373035908
ATM O 1 0.8371865749359131
gene O 1 0.7713189721107483
in O 0 0.0048819901421666145
ethnic O 0 0.017363080754876137
populations O 0 0.058343589305877686
. O 0 0.013462364673614502

To O 0 0.0051223947666585445
facilitate O 0 0.01150441262871027
the O 0 0.0033956102561205626
evaluation O 0 0.012900839559733868
of O 0 0.004252075217664242
ATM O 1 0.9323014616966248
heterozygotes O 1 0.9978905320167542
for O 0 0.005155067425221205
susceptibility O 1 0.9996980428695679
to O 0 0.0025788156781345606
other O 0 0.0029511605389416218
diseases O 1 0.9999947547912598
, O 0 0.002019359730184078
such O 0 0.002422124147415161
as O 0 0.03553150221705437
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.0020697875879704952
we O 0 0.0011718430323526263
have O 0 0.0012060748413205147
attempted O 0 0.005307334009557962
to O 0 0.0012780906399711967
define O 0 0.0046201734803617
the O 0 0.001698673702776432
most O 0 0.0030942896846681833
common O 0 0.010931385681033134
mutations O 1 0.9988580942153931
and O 0 0.0014571857172995806
their O 0 0.0022418226581066847
frequencies O 0 0.014444994740188122
in O 0 0.0076233199797570705
ataxia B-Disease 1 0.9999961853027344
- I-Disease 1 0.9936301112174988
telangiectasia I-Disease 1 0.9999823570251465
( O 0 0.015624106861650944
A B-Disease 0 0.46227598190307617
- I-Disease 1 0.9382907152175903
T I-Disease 1 0.9987712502479553
) O 0 0.011801932007074356
homozygotes O 1 0.9731513261795044
from O 0 0.006258771289139986
10 O 0 0.00767449801787734
ethnic O 0 0.01734328083693981
populations O 0 0.05287060886621475
. O 0 0.013382190838456154

Both O 0 0.014616260305047035
genomic O 1 0.9607442617416382
mutations O 1 0.9991681575775146
and O 0 0.0018422637367621064
their O 0 0.002367479493841529
effects O 0 0.022230032831430435
on O 0 0.0029759914614260197
cDNA O 0 0.05125731974840164
were O 0 0.004253888037055731
characterized O 0 0.04749396815896034
. O 0 0.010763395577669144

Protein O 0 0.11371264606714249
- O 0 0.04933434724807739
truncation O 0 0.3511398434638977
testing O 0 0.014660457149147987
of O 0 0.002218326786532998
the O 0 0.003408275078982115
entire O 0 0.020534271374344826
ATM O 0 0.08572904765605927
cDNA O 0 0.11972352117300034
detected O 0 0.07461167871952057
92 O 0 0.036725226789712906
( O 0 0.009335030801594257
66 O 0 0.020888136699795723
% O 0 0.010104379616677761
) O 0 0.009713222272694111
truncating O 1 0.9916480779647827
mutations O 1 0.9974946975708008
in O 0 0.006207657977938652
140 O 0 0.04063224047422409
mutant O 1 0.9979098439216614
alleles O 1 0.9989857077598572
screened O 0 0.08918824046850204
. O 0 0.014407705515623093

The O 0 0.01159545499831438
haplotyping O 1 0.8832231760025024
of O 0 0.006625744514167309
patients O 1 0.9997997879981995
with O 0 0.004191739019006491
identical O 0 0.057019736617803574
mutations O 1 0.9998358488082886
indicates O 0 0.01176024042069912
that O 0 0.0012900074943900108
almost O 0 0.002511486178264022
all O 0 0.0007348918006755412
of O 0 0.000926590000744909
these O 0 0.0010884703369811177
represent O 0 0.0036197793669998646
common O 0 0.007385833188891411
ancestry O 0 0.017758559435606003
and O 0 0.0012599941110238433
that O 0 0.001477228244766593
very O 0 0.003636841895058751
few O 0 0.007156862877309322
spontaneously O 1 0.9641006588935852
recurring O 1 0.9995212554931641
ATM O 1 0.9929794669151306
mutations O 1 0.9990261793136597
exist O 0 0.014948784373700619
. O 0 0.012324654497206211

Assays O 0 0.11462414264678955
requiring O 0 0.03388165310025215
minimal O 0 0.023592716082930565
amounts O 0 0.008549107238650322
of O 0 0.003287689061835408
genomic O 1 0.8360254764556885
DNA O 0 0.023730289191007614
were O 0 0.0016209256136789918
designed O 0 0.003614383051171899
to O 0 0.001606022473424673
allow O 0 0.00636792927980423
rapid O 0 0.031604886054992676
screening O 0 0.02688124030828476
for O 0 0.0029034654144197702
common O 0 0.011492895893752575
ethnic O 0 0.023244895040988922
mutations O 1 0.9997645020484924
. O 0 0.013290684670209885

These O 0 0.010076949372887611
rapid O 0 0.04939327389001846
assays O 0 0.12447355687618256
detected O 1 0.9016026854515076
mutations O 1 0.9915812611579895
in O 0 0.004058217629790306
76 O 0 0.022646712139248848
% O 0 0.005637126974761486
of O 0 0.0033538835123181343
Costa O 0 0.030849838629364967
Rican O 1 0.7850500345230103
patients O 1 0.9997984766960144
( O 0 0.007582653313875198
3 O 0 0.007541125174611807
) O 0 0.002875643316656351
, O 0 0.0016013728454709053
50 O 0 0.004494642373174429
% O 0 0.0030378829687833786
of O 0 0.002420824719592929
Norwegian O 0 0.0256830882281065
patients O 1 0.9996942281723022
( O 0 0.006502608768641949
1 O 0 0.007421516347676516
) O 0 0.0029377981554716825
, O 0 0.0016148024005815387
25 O 0 0.0043818168342113495
% O 0 0.003660995978862047
of O 0 0.0025128875859081745
Polish O 1 0.6665576696395874
patients O 1 0.9998204112052917
( O 0 0.007601997349411249
4 O 0 0.008367927744984627
) O 0 0.00280864629894495
, O 0 0.0013939992059022188
and O 0 0.0011668119113892317
14 O 0 0.004782794509083033
% O 0 0.0036861433181911707
of O 0 0.002580371219664812
Italian O 0 0.39733362197875977
patients O 1 0.9999333620071411
( O 0 0.00775819830596447
1 O 0 0.006698143668472767
) O 0 0.00248656515032053
, O 0 0.0010838990565389395
as O 0 0.0013366335770115256
well O 0 0.0013911174610257149
as O 0 0.0017777819884940982
in O 0 0.003395924810320139
patients O 1 0.9985998272895813
of O 0 0.004240477457642555
Amish O 1 0.786396861076355
/ O 0 0.17749367654323578
Mennonite O 0 0.04497614875435829
and O 0 0.0039931656792759895
Irish O 0 0.02247040532529354
English O 0 0.011331363581120968
backgrounds O 0 0.018876435235142708
. O 0 0.01028737798333168

Additional O 0 0.03079316020011902
mutations O 1 0.9987697005271912
were O 0 0.0029084004927426577
observed O 0 0.009297468699514866
in O 0 0.0021127788349986076
Japanese O 0 0.006566180381923914
, O 0 0.0022798271384090185
Utah O 0 0.01185690239071846
Mormon O 0 0.016520218923687935
, O 0 0.0018215759191662073
and O 0 0.0018666968680918217
African O 0 0.017051739618182182
American O 0 0.023505205288529396
patients O 1 0.9996325969696045
. O 0 0.013286402449011803

These O 0 0.007713992148637772
assays O 0 0.03203054144978523
should O 0 0.004056734032928944
facilitate O 0 0.011439075693488121
screening O 0 0.023822776973247528
for O 0 0.0033741870429366827
A B-Disease 0 0.11594907939434052
- I-Disease 1 0.9466951489448547
T I-Disease 1 0.9999116659164429
heterozygotes O 1 0.9908185601234436
in O 0 0.0034860072191804647
the O 0 0.0038878859486430883
populations O 0 0.029117003083229065
studied O 0 0.008492824621498585
. O 0 0.00452082185074687
. O 0 0.00922825001180172

The O 0 0.017608795315027237
von B-Disease 1 0.9524096250534058
Hippel I-Disease 1 0.999727189540863
- I-Disease 1 0.9903649687767029
Lindau I-Disease 1 0.9999567270278931
tumor I-Disease 1 0.9999978542327881
suppressor O 1 0.9999738931655884
gene O 1 0.9930469393730164
is O 0 0.004340462852269411
required O 0 0.004097338765859604
for O 0 0.003723818575963378
cell O 0 0.04778846353292465
cycle O 0 0.0500810369849205
exit O 0 0.040442969650030136
upon O 0 0.016197210177779198
serum O 1 0.963615357875824
withdrawal O 0 0.06229124963283539
. O 0 0.01542134303599596

The O 0 0.016114776954054832
inactivation O 1 0.9103391766548157
of O 0 0.004200765863060951
the O 0 0.007000012788921595
von B-Disease 1 0.8355309367179871
Hippel I-Disease 1 0.9988368153572083
- I-Disease 1 0.58219975233078
Lindau I-Disease 1 0.9984036087989807
( I-Disease 0 0.03604744002223015
VHL I-Disease 1 0.999944806098938
) I-Disease 0 0.03758399561047554
tumor I-Disease 1 0.9999959468841553
suppressor O 1 0.9999855756759644
gene O 1 0.999599277973175
predisposes O 1 0.9998784065246582
affected O 0 0.34675097465515137
individuals O 0 0.007596229203045368
to O 0 0.0026029860600829124
the O 0 0.006197687238454819
human O 1 0.9877563714981079
VHL B-Disease 1 0.9999997615814209
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.0041854665614664555
is O 0 0.0046052467077970505
associated O 0 0.008014070801436901
with O 0 0.0049238610081374645
sporadic B-Disease 1 0.999065101146698
renal I-Disease 1 1.0
cell I-Disease 1 0.9997385144233704
carcinomas I-Disease 1 0.9999977350234985
( O 0 0.02456931583583355
RCC B-Disease 1 0.99896240234375
) O 0 0.010163520462810993
and O 0 0.007168087176978588
brain B-Disease 1 0.999870777130127
hemangioblastomas I-Disease 1 0.9907055497169495
. O 0 0.02051306702196598

VHL O 1 0.9986892342567444
- O 0 0.11525361239910126
negative O 0 0.09721667319536209
786 O 1 0.9941678047180176
- O 0 0.09036377817392349
0 O 0 0.05532490089535713
RCC B-Disease 1 0.9977080821990967
cells O 0 0.1417980194091797
are O 0 0.004124360159039497
tumorigenic O 1 0.9308766722679138
in O 0 0.005630812142044306
nude O 1 0.9594785571098328
mice O 1 0.995537281036377
which O 0 0.0030014244839549065
is O 0 0.0038043931126594543
suppressed O 0 0.03654055297374725
by O 0 0.003242418635636568
the O 0 0.004441163502633572
reintroduction O 1 0.7425268292427063
of O 0 0.011363760568201542
VHL B-Disease 1 0.9998555183410645
. O 0 0.019035622477531433

Remarkably O 0 0.061439938843250275
, O 0 0.004230420105159283
this O 0 0.004063916392624378
occurs O 0 0.022091906517744064
without O 0 0.005261760670691729
affecting O 0 0.12119615823030472
the O 0 0.0028684306889772415
growth O 0 0.0102279307320714
rate O 0 0.009844197891652584
and O 0 0.00311849731951952
cell O 0 0.03922908753156662
cycle O 0 0.03474557772278786
profile O 0 0.020172812044620514
of O 0 0.002281569642946124
these O 0 0.0036153020337224007
cells O 0 0.049289751797914505
in O 0 0.003653734689578414
culture O 0 0.016770733520388603
. O 0 0.009298496879637241

The O 0 0.018711047247052193
786 O 1 0.9843912124633789
- O 0 0.052057113498449326
0 O 0 0.028251955285668373
cell O 0 0.02988370694220066
line O 0 0.006499126087874174
, O 0 0.0023215538822114468
like O 0 0.004796159453690052
many O 0 0.007639078423380852
cancer B-Disease 1 0.9999994039535522
cells O 1 0.9839760065078735
, O 0 0.0036101285368204117
fails O 0 0.020046686753630638
to O 0 0.0023685439955443144
exit O 0 0.017128372564911842
the O 0 0.005036479327827692
cell O 0 0.04709448665380478
cycle O 0 0.049743782728910446
upon O 0 0.01800423301756382
serum O 1 0.9165305495262146
withdrawal O 0 0.06304395198822021
. O 0 0.014562651515007019

Here O 0 0.007186826318502426
, O 0 0.0026819088961929083
it O 0 0.0017981284763664007
is O 0 0.0022396689746528864
shown O 0 0.004443202633410692
that O 0 0.0017572924261912704
reintroduction O 0 0.045606642961502075
of O 0 0.0018359964014962316
the O 0 0.0033428333699703217
wild O 0 0.032699212431907654
- O 0 0.11666277050971985
type O 1 0.5410908460617065
VHL B-Disease 1 0.9998062252998352
gene O 1 0.9804304242134094
restores O 0 0.056409358978271484
the O 0 0.0037173472810536623
ability O 0 0.011178484186530113
of O 0 0.0053437575697898865
VHL O 1 0.9999698400497437
- O 1 0.849385678768158
negative O 1 0.9861581325531006
RCC B-Disease 1 0.9999899864196777
cancer I-Disease 1 0.999998927116394
cells O 1 0.8606926798820496
to O 0 0.003215540898963809
exit O 0 0.017800454050302505
the O 0 0.004528683610260487
cell O 0 0.04417029395699501
cycle O 0 0.029644588008522987
and O 0 0.003779096994549036
enter O 0 0.03098360262811184
G0 O 1 0.999115526676178
/ O 1 0.7997824549674988
quiescence O 1 0.9830493927001953
in O 0 0.008904097601771355
low O 0 0.04190543293952942
serum O 1 0.7269151210784912
. O 0 0.016816752031445503

Both O 0 0.021967127919197083
VHL O 1 0.9996930360794067
- O 0 0.043985530734062195
positive O 0 0.020616747438907623
and O 0 0.007886993698775768
VHL O 1 0.999954342842102
- O 0 0.4375706911087036
negative O 0 0.4821091592311859
RCC B-Disease 1 0.9995090961456299
cells O 1 0.589163601398468
exit O 0 0.025583844631910324
the O 0 0.0055345166474580765
cell O 0 0.04364265128970146
cycle O 0 0.0372367799282074
by O 0 0.00811394490301609
contact O 0 0.03423941135406494
inhibition O 1 0.862880527973175
. O 0 0.01417976338416338

The O 0 0.021660206839442253
cyclin O 1 0.9852541089057922
- O 0 0.06269510090351105
dependent O 0 0.06815692037343979
kinase O 1 0.9964200258255005
inhibitor O 1 0.9960103034973145
, O 0 0.00827106274664402
p27 O 1 0.9971038699150085
, O 0 0.006419650744646788
accumulates O 1 0.815353512763977
upon O 0 0.01285073533654213
serum O 1 0.9960158467292786
withdrawal O 0 0.031325917690992355
, O 0 0.001894409884698689
only O 0 0.0013784512411803007
in O 0 0.001018258510157466
the O 0 0.0016780635342001915
presence O 0 0.006497408263385296
of O 0 0.0032666076440364122
VHL B-Disease 1 0.9999736547470093
, O 0 0.0021528678480535746
as O 0 0.0012904020259156823
a O 0 0.002975837094709277
result O 0 0.004277560394257307
of O 0 0.0012252709129825234
the O 0 0.002371736103668809
stabilization O 0 0.026242947205901146
of O 0 0.002331094816327095
the O 0 0.0053749713115394115
protein O 0 0.0480206236243248
. O 0 0.010622000321745872

We O 0 0.004917442798614502
propose O 0 0.013196410611271858
that O 0 0.0016290697967633605
the O 0 0.002814481733366847
loss O 0 0.015287033282220364
of O 0 0.0032358847092837095
wild O 0 0.04789673537015915
- O 0 0.30761808156967163
type O 1 0.8747618198394775
VHL B-Disease 1 0.9999222755432129
gene O 1 0.9700475931167603
results O 0 0.00826064869761467
in O 0 0.0017844033427536488
a O 0 0.004423620644956827
specific O 0 0.00795393530279398
cellular O 0 0.4113330543041229
defect O 1 0.9873896837234497
in O 0 0.005882267374545336
serum O 1 0.9962687492370605
- O 0 0.029563765972852707
dependent O 0 0.021256526932120323
growth O 0 0.012880737893283367
control O 0 0.012713642790913582
, O 0 0.002084491541609168
which O 0 0.003022318473085761
may O 0 0.013694783672690392
initiate O 1 0.9665400385856628
tumor B-Disease 1 0.999969482421875
formation O 0 0.05846773087978363
. O 0 0.014864591881632805

This O 0 0.006955830380320549
is O 0 0.006109497044235468
corrected O 0 0.030498862266540527
by O 0 0.003443286521360278
the O 0 0.003275257535278797
reintroduction O 0 0.10509549081325531
of O 0 0.0034769712947309017
wild O 0 0.03312643989920616
- O 0 0.07743950188159943
type O 1 0.7468160390853882
VHL B-Disease 1 0.9998829364776611
, O 0 0.008587239310145378
implicating O 1 0.9748291969299316
VHL B-Disease 1 0.9999383687973022
as O 0 0.0031549495179206133
the O 0 0.003249421250075102
first O 0 0.00983063131570816
tumor B-Disease 1 0.9999980926513672
suppressor O 1 0.9998735189437866
involved O 0 0.008979015983641148
in O 0 0.0019517210312187672
the O 0 0.002400606870651245
regulation O 0 0.009687048383057117
of O 0 0.002779486821964383
cell O 0 0.2655274569988251
cycle O 0 0.21794183552265167
exit O 0 0.025223178789019585
, O 0 0.001876018475741148
which O 0 0.0014308486133813858
is O 0 0.0018538488075137138
consistent O 0 0.005495502147823572
with O 0 0.0018038093112409115
its O 0 0.004845055751502514
gatekeeper O 1 0.9988980293273926
function O 0 0.012750817462801933
in O 0 0.002924082102254033
the O 0 0.007211736869066954
kidney O 1 0.9999971389770508
. O 0 0.007355414796620607
. O 0 0.01084383949637413

Piebaldism B-Disease 1 0.9996592998504639
with O 0 0.0290735624730587
deafness B-Disease 1 0.999992847442627
: O 0 0.011335857212543488
molecular O 0 0.021907368674874306
evidence O 0 0.0034640193916857243
for O 0 0.0023820523638278246
an O 0 0.005356003064662218
expanded O 0 0.08443069458007812
syndrome O 1 0.9999994039535522
. O 0 0.017847493290901184

In O 0 0.00562206981703639
a O 0 0.007555535528808832
South O 0 0.0077446456998586655
African O 0 0.019220881164073944
girl O 0 0.053394727408885956
of O 0 0.004609375260770321
Xhosa O 1 0.9957861304283142
stock O 0 0.02625330165028572
with O 0 0.007808172609657049
severe O 1 0.9999657869338989
piebaldism B-Disease 1 0.9996490478515625
and O 0 0.007860751822590828
profound O 1 0.9999247789382935
congenital O 1 1.0
sensorineural B-Disease 1 0.9999996423721313
deafness I-Disease 1 0.9999998807907104
we O 0 0.004128473345190287
identified O 0 0.010170175693929195
a O 0 0.0064825331792235374
novel O 0 0.026734966784715652
missense O 1 0.9950413107872009
substitution O 0 0.02999209426343441
at O 0 0.005737542640417814
a O 0 0.007920083589851856
highly O 0 0.015081635676324368
conserved O 0 0.02769647352397442
residue O 0 0.029495224356651306
in O 0 0.0029161712154746056
the O 0 0.005805888678878546
intracellular O 0 0.4177408516407013
kinase O 1 0.8466380834579468
domain O 0 0.016303734853863716
of O 0 0.0023960138205438852
the O 0 0.0066077010706067085
KIT O 1 0.9870359301567078
proto O 1 0.9977225661277771
- O 1 0.7494903206825256
oncogene O 1 0.9997242093086243
, O 0 0.015837838873267174
R796G O 1 0.9620091319084167
. O 0 0.0162959024310112

Though O 0 0.03580824285745621
auditory B-Disease 1 0.9966247081756592
anomalies I-Disease 1 0.9062613844871521
have O 0 0.0033350519370287657
been O 0 0.0032334511633962393
observed O 0 0.009219731204211712
in O 0 0.0033423842396587133
mice O 1 0.9972648620605469
with O 0 0.005271222908049822
dominant O 0 0.1338316649198532
white O 0 0.027669724076986313
spotting O 1 0.989632248878479
( O 0 0.017231250181794167
W O 1 0.86435866355896
) O 0 0.004944770131260157
due O 0 0.006822157651185989
to O 0 0.004259300418198109
KIT O 1 0.9964002370834351
mutations O 1 0.999868631362915
, O 0 0.009542962536215782
deafness B-Disease 1 0.9999992847442627
is O 0 0.003913741558790207
not O 0 0.0019844945054501295
typical O 0 0.013077041134238243
in O 0 0.0036067254841327667
human O 0 0.02052975259721279
piebaldism B-Disease 1 0.9874876737594604
. O 0 0.013795740902423859

Thus O 0 0.013272264041006565
, O 0 0.002892485586926341
the O 0 0.003992507234215736
occurrence O 0 0.1973821222782135
of O 0 0.009109977632761002
sensorineural B-Disease 1 0.9999955892562866
deafness I-Disease 1 0.9999995231628418
in O 0 0.00505303917452693
this O 0 0.005682115443050861
patient O 1 0.9986122846603394
extends O 0 0.04204735532402992
considerably O 0 0.02398621290922165
the O 0 0.0053819022141397
phenotypic O 1 0.9638782143592834
range O 0 0.006664393935352564
of O 0 0.0039045880548655987
piebaldism B-Disease 1 0.9906505346298218
due O 0 0.012804662808775902
to O 0 0.004834378603845835
KIT O 1 0.9812195897102356
gene O 1 0.9987974166870117
mutation O 1 0.9991638660430908
in O 0 0.0053339251317083836
humans O 0 0.030405141413211823
and O 0 0.0038833548314869404
tightens O 1 0.9963881969451904
the O 0 0.005984660238027573
clinical O 1 0.8106585741043091
similarity O 0 0.023859146982431412
between O 0 0.006168889347463846
piebaldism B-Disease 1 0.9861727356910706
and O 0 0.0015957943396642804
the O 0 0.0016134224133566022
various O 0 0.0022413011174649
forms O 0 0.009503642097115517
of O 0 0.012039534747600555
Waardenburg B-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
. O 0 0.010927964001893997
. O 0 0.011410567909479141

Cycloheximide O 1 0.9568248391151428
facilitates O 0 0.041174646466970444
the O 0 0.0044192783534526825
identification O 0 0.010307909920811653
of O 0 0.0038674853276461363
aberrant O 1 0.6249061822891235
transcripts O 0 0.016657881438732147
resulting O 0 0.019035188481211662
from O 0 0.002943272702395916
a O 0 0.006341204512864351
novel O 0 0.021640945225954056
splice O 1 0.9690060615539551
- O 0 0.032782766968011856
site O 0 0.018203582614660263
mutation O 1 0.9962047934532166
in O 0 0.005308812949806452
COL17A1 O 1 0.9923641681671143
in O 0 0.0036994656547904015
a O 0 0.011143614538013935
patient O 1 0.9980104565620422
with O 0 0.010680337436497211
generalized O 1 0.9999068975448608
atrophic B-Disease 1 0.9999969005584717
benign I-Disease 1 0.9999873638153076
epidermolysis I-Disease 1 0.9999932050704956
bullosa I-Disease 1 0.9999033212661743
. O 0 0.03401058167219162

Patients O 1 0.9995263814926147
with O 0 0.020015867426991463
generalized O 1 0.9999250173568726
atrophic B-Disease 1 0.9999982118606567
benign I-Disease 1 0.9999861717224121
epidermolysis I-Disease 1 0.9999963045120239
bullosa I-Disease 1 0.9999780654907227
often O 0 0.02017408423125744
show O 0 0.014526136219501495
decreased O 0 0.3099750280380249
expression O 0 0.023307837545871735
of O 0 0.004933446645736694
type O 1 0.975059449672699
XVII O 1 0.9999638795852661
collagen O 1 0.9997988343238831
, O 0 0.005226644687354565
a O 0 0.010915868915617466
transmembrane O 1 0.9533153772354126
hemidesmosomal O 1 0.9711685180664062
protein O 0 0.05948317423462868
encoded O 0 0.03228370472788811
by O 0 0.010485256090760231
COL17A1 O 1 0.9822244048118591
. O 0 0.016426866874098778

This O 0 0.004240030888468027
report O 0 0.004177523776888847
documents O 0 0.0033183612395077944
a O 0 0.006978889927268028
novel O 0 0.026278039440512657
splice O 1 0.9009625315666199
- O 0 0.030708763748407364
site O 0 0.01794220507144928
mutation O 1 0.9978352189064026
in O 0 0.004983421415090561
COL17A1 O 1 0.9937082529067993
in O 0 0.003941166214644909
a O 0 0.011034543626010418
patient O 1 0.9990082383155823
with O 0 0.012665457092225552
generalized O 1 0.9998639822006226
atrophic B-Disease 1 0.9999979734420776
benign I-Disease 1 0.9999850988388062
epidermolysis I-Disease 1 0.9999978542327881
bullosa I-Disease 1 0.999976634979248
, O 0 0.005468916147947311
and O 0 0.0024080423172563314
applies O 0 0.0077263424172997475
a O 0 0.0038161540869623423
new O 0 0.002262979280203581
methodology O 0 0.007460364606231451
to O 0 0.0018218454206362367
define O 0 0.0067202127538621426
and O 0 0.002131942193955183
characterize O 0 0.029499877244234085
the O 0 0.0068197716027498245
resulting O 0 0.04448574036359787
mRNA O 0 0.08370319753885269
splice O 1 0.800066351890564
variants O 0 0.06846775114536285
. O 0 0.0120473587885499

Mutational O 1 0.9726313352584839
analysis O 0 0.013204902410507202
of O 0 0.005732009653002024
COL17A1 O 1 0.995391845703125
identified O 0 0.020930824801325798
a O 0 0.014554928056895733
maternally O 1 0.9986600875854492
inherited O 1 0.9995893836021423
G O 1 0.9922330379486084
- O 0 0.023595398291945457
to O 0 0.005953351967036724
- O 0 0.2093932032585144
T O 1 0.9969552755355835
transversion O 1 0.8449340462684631
at O 0 0.004765390884131193
the O 0 0.0036446049343794584
- O 0 0.013650071807205677
1 O 0 0.0073781670071184635
position O 0 0.004904490429908037
of O 0 0.005103751085698605
exon O 0 0.3544583320617676
32 O 0 0.033046554774045944
. O 0 0.014477158896625042

This O 0 0.014417201280593872
acceptor O 0 0.38984429836273193
splice O 1 0.9496021866798401
- O 0 0.038689106702804565
site O 0 0.017333192750811577
mutation O 1 0.9980851411819458
led O 0 0.008088093250989914
to O 0 0.0019876589067280293
the O 0 0.0027931025251746178
formation O 0 0.016420381143689156
of O 0 0.004169038031250238
aberrant O 0 0.3853111267089844
transcripts O 0 0.013661671429872513
present O 0 0.005701815243810415
at O 0 0.005605303216725588
extremely O 0 0.019326675683259964
low O 0 0.021993421018123627
levels O 0 0.02135922573506832
. O 0 0.010412332601845264

Based O 0 0.0054343040101230145
on O 0 0.0025436044670641422
our O 0 0.003376106731593609
recent O 0 0.006442554295063019
finding O 0 0.009090615436434746
that O 0 0.005119564477354288
cycloheximide O 1 0.9976403713226318
stabilized O 1 0.9931395649909973
mutant O 1 0.9966006875038147
COL17A1 O 1 0.9840582013130188
transcripts O 0 0.017449218779802322
in O 0 0.005295023787766695
keratinocytes O 1 0.99793940782547
homozygous O 1 0.9841541051864624
for O 0 0.003476457903161645
a O 0 0.015389363281428814
frameshift O 1 0.9998757839202881
mutation O 1 0.9996035695075989
, O 0 0.0024025021120905876
the O 0 0.0023333204444497824
effects O 0 0.014113334938883781
of O 0 0.0016757381381466985
the O 0 0.0035672022495418787
splice O 1 0.9747902154922485
- O 0 0.026821332052350044
site O 0 0.014563712291419506
mutation O 1 0.9972346425056458
on O 0 0.004019544925540686
splicing O 0 0.04883437976241112
of O 0 0.004972509108483791
COL17A1 O 1 0.9920585751533508
transcripts O 0 0.015635045245289803
were O 0 0.0025280946865677834
determined O 0 0.00985632836818695
using O 0 0.007707446347922087
reverse O 0 0.05806252360343933
transcriptase O 1 0.9682633876800537
polymerase O 1 0.5769764184951782
chain O 0 0.050122447311878204
reaction O 0 0.01780814304947853
of O 0 0.003001971635967493
total O 0 0.008595670573413372
RNA O 0 0.053745467215776443
from O 0 0.008521050214767456
keratinocytes O 1 0.9684420228004456
incubated O 0 0.049334995448589325
for O 0 0.004183671902865171
2 O 0 0.010040843859314919
. O 0 0.007946650497615337

5 O 0 0.026721294969320297
h O 0 0.0368538498878479
in O 0 0.0026132913772016764
the O 0 0.002949320012703538
presence O 0 0.009205285459756851
or O 0 0.0036716503091156483
absence O 0 0.010048938915133476
of O 0 0.002760490169748664
10 O 0 0.01260718796402216
microg O 1 0.9888822436332703
cycloheximide O 1 0.9596516489982605
per O 0 0.02329293079674244
ml O 1 0.8492721319198608
. O 0 0.01822136528789997

Using O 0 0.00909425038844347
this O 0 0.003256889060139656
approach O 0 0.008071111515164375
, O 0 0.0026867277920246124
an O 0 0.0047576287761330605
abnormally O 1 0.9870577454566956
spliced O 0 0.16621960699558258
transcript O 0 0.02494782581925392
was O 0 0.005149661097675562
identified O 0 0.00758412154391408
that O 0 0.0014767373213544488
contains O 0 0.003155340673401952
an O 0 0.0020846943370997906
extra O 0 0.009185883216559887
264 O 0 0.026791397482156754
bases O 0 0.010431846603751183
upstream O 0 0.020715733990073204
from O 0 0.006444621365517378
exon O 0 0.31537288427352905
32 O 0 0.01252217497676611
, O 0 0.0025512520223855972
resulting O 0 0.01400130894035101
in O 0 0.002792044309899211
a O 0 0.011446965858340263
premature O 1 0.9970306158065796
termination O 1 0.9587442874908447
codon O 0 0.4443744122982025
27 O 0 0.024306070059537888
bp O 0 0.03824872523546219
downstream O 0 0.02545912377536297
from O 0 0.004109542351216078
the O 0 0.006828512996435165
cryptic O 1 0.6038888692855835
splice O 1 0.9061570763587952
site O 0 0.01886643096804619
. O 0 0.012180785648524761

Three O 0 0.006586291827261448
other O 0 0.0048994687385857105
splice O 1 0.850992739200592
variants O 0 0.030717749148607254
, O 0 0.001791228074580431
including O 0 0.0016062204958871007
one O 0 0.0024350639432668686
derived O 0 0.005853280890733004
from O 0 0.0021466128528118134
the O 0 0.002785037737339735
skipping O 0 0.023742331191897392
of O 0 0.0037531752604991198
exon O 1 0.7595392465591431
32 O 0 0.012228419072926044
, O 0 0.00175717961974442
were O 0 0.0013562821550294757
also O 0 0.002698930213227868
identified O 0 0.01468947995454073
. O 0 0.011088283732533455

These O 0 0.005454583093523979
results O 0 0.009637560695409775
indicate O 0 0.008814478293061256
the O 0 0.003197968704625964
usefulness O 0 0.029716355726122856
of O 0 0.004699692130088806
cycloheximide O 1 0.9997437596321106
treatment O 1 0.9661422967910767
in O 0 0.002936199540272355
evaluating O 0 0.014108072966337204
the O 0 0.004365759436041117
abnormal O 1 0.7444201111793518
processing O 0 0.006049529183655977
of O 0 0.002039338229224086
mRNA O 0 0.023987719789147377
due O 0 0.006737310905009508
to O 0 0.003506406443193555
splice O 1 0.9080025553703308
- O 0 0.03138044476509094
site O 0 0.018405983224511147
mutations O 1 0.995621383190155
, O 0 0.0035169972106814384
because O 0 0.005723323207348585
( O 0 0.0054763806983828545
i O 0 0.005892012268304825
) O 0 0.006581663154065609
aberrant O 1 0.7296556830406189
splicing O 0 0.07205720990896225
often O 0 0.006921498570591211
generates O 0 0.028724635019898415
a O 0 0.014586567878723145
premature O 1 0.9973824620246887
termination O 1 0.9690236449241638
codon O 0 0.36707618832588196
, O 0 0.0042689088732004166
( O 0 0.006367458496242762
ii O 0 0.021759221330285072
) O 0 0.003986972384154797
transcripts O 0 0.011950974352657795
with O 0 0.0066010314039886
premature O 1 0.9979415535926819
termination O 1 0.9935592412948608
codons O 1 0.7794455289840698
can O 0 0.00566226476803422
occur O 0 0.013071990571916103
at O 0 0.0037790792994201183
low O 0 0.015407400205731392
or O 0 0.006619065534323454
undetectable O 1 0.966052770614624
levels O 0 0.012449940666556358
due O 0 0.006701732520014048
to O 0 0.0026795847807079554
nonsense O 0 0.03668311610817909
- O 0 0.03743096441030502
mediated O 0 0.12690232694149017
mRNA O 0 0.062262654304504395
decay O 0 0.04758857935667038
, O 0 0.0035104425624012947
and O 0 0.0027116225101053715
( O 0 0.006627738010138273
iii O 0 0.022871607914566994
) O 0 0.0026098941452801228
the O 0 0.0019644417334347963
levels O 0 0.005785205867141485
of O 0 0.0015178148169070482
these O 0 0.001375573338009417
transcripts O 0 0.006133686285465956
can O 0 0.002649571979418397
be O 0 0.001501087797805667
increased O 0 0.007842238992452621
by O 0 0.0055867028422653675
cycloheximide O 1 0.9831485748291016
. O 0 0.012741186656057835

A O 0 0.04546113312244415
deletion O 1 0.9972297549247742
mutation O 1 0.9994989633560181
in O 0 0.006318210624158382
COL17A1 O 1 0.9892617464065552
in O 0 0.002973933471366763
five O 0 0.004816621076315641
Austrian O 0 0.02641218714416027
families O 0 0.010160766541957855
with O 0 0.008393218740820885
generalized O 1 0.9998503923416138
atrophic B-Disease 1 0.9999982118606567
benign I-Disease 1 0.9999879598617554
epidermolysis I-Disease 1 0.9999954700469971
bullosa I-Disease 1 0.9999573230743408
represents O 0 0.038385409861803055
propagation O 0 0.03551357984542847
of O 0 0.004035784397274256
an O 0 0.006897048093378544
ancestral O 0 0.22775287926197052
allele O 1 0.9965924620628357
. O 0 0.018802007660269737

Patients O 1 0.9992621541023254
with O 0 0.021453766152262688
generalized O 1 0.9995962977409363
atrophic B-Disease 1 0.9999932050704956
benign I-Disease 1 0.9999879598617554
epidermolysis I-Disease 1 0.9999948740005493
bullosa I-Disease 1 0.9999829530715942
, O 0 0.007646105717867613
a O 0 0.008324851281940937
usually O 0 0.009299885481595993
nonlethal O 0 0.04341203346848488
form O 0 0.011933477595448494
of O 0 0.009509528987109661
junctional B-Disease 1 0.9998998641967773
epidermolysis I-Disease 1 0.999994158744812
bullosa I-Disease 1 0.9999865293502808
, O 0 0.008483140729367733
have O 0 0.006620910484343767
generalized O 1 0.995934247970581
blistering B-Disease 1 0.9980800151824951
, O 0 0.012545179575681686
nail B-Disease 1 0.9999865293502808
dystrophy I-Disease 1 0.9999995231628418
, O 0 0.016584288328886032
patchy B-Disease 1 0.999795138835907
alopecia I-Disease 1 0.9999982118606567
, O 0 0.0067854514345526695
and O 0 0.007004040293395519
dental B-Disease 1 0.9999427795410156
abnormalities I-Disease 1 0.9999512434005737
. O 0 0.015924477949738503

Skin B-Disease 1 0.9999935626983643
fragility I-Disease 1 0.9990560412406921
in O 0 0.004205859731882811
most O 0 0.003979152534157038
cases O 0 0.009433353319764137
is O 0 0.0029694736003875732
due O 0 0.006167971529066563
to O 0 0.0032441741786897182
mutations O 1 0.9986139535903931
in O 0 0.0025606052950024605
the O 0 0.004954077303409576
gene O 1 0.8591175675392151
encoding O 0 0.07871019840240479
type O 1 0.9536677002906799
XVII O 1 0.9999648332595825
collagen O 1 0.9999489784240723
( O 0 0.021370824426412582
COL17A1 O 1 0.9956374764442444
) O 0 0.011473279446363449
. O 0 0.010151184163987637

Recently O 0 0.02189319021999836
, O 0 0.0031967759132385254
we O 0 0.002158148679882288
reported O 0 0.008992568589746952
five O 0 0.003955489490181208
Austrian O 0 0.023180538788437843
families O 0 0.010536173358559608
with O 0 0.008542622439563274
generalized O 1 0.9998353719711304
atrophic B-Disease 1 0.9999986886978149
benign I-Disease 1 0.9999960660934448
epidermolysis I-Disease 1 0.9999959468841553
bullosa I-Disease 1 0.9999804496765137
who O 0 0.009338581003248692
share O 0 0.007900008000433445
the O 0 0.004473439883440733
same O 0 0.013285502791404724
COL17A1 O 1 0.9996852874755859
mutation O 1 0.9996026158332825
. O 0 0.018330076709389687

Affected O 0 0.3571738600730896
individuals O 0 0.0075200991705060005
in O 0 0.0019995986949652433
three O 0 0.0023362936917692423
families O 0 0.0062221502885222435
are O 0 0.0027264587115496397
homozygous O 1 0.9959434866905212
for O 0 0.0042919195257127285
4003delTC O 1 0.9979506134986877
, O 0 0.00294400192797184
whereas O 0 0.007628852501511574
those O 0 0.0013620826648548245
in O 0 0.0013311355141922832
two O 0 0.0013072434812784195
others O 0 0.0035775171127170324
are O 0 0.002896600402891636
compound O 0 0.03727981075644493
heterozygotes O 1 0.9932043552398682
. O 0 0.01397626381367445

To O 0 0.004513356368988752
determine O 0 0.00721767358481884
if O 0 0.0031110914424061775
the O 0 0.0036857330705970526
occurrence O 0 0.0713355764746666
of O 0 0.003940661437809467
4003delTC O 1 0.975536048412323
in O 0 0.0026145929004997015
these O 0 0.0021424517035484314
unrelated O 0 0.02239714004099369
families O 0 0.010056477971374989
signifies O 0 0.04724209010601044
propagation O 0 0.01902039535343647
of O 0 0.0018363711424171925
an O 0 0.004163566045463085
ancestral O 0 0.126097172498703
allele O 1 0.9951876401901245
or O 0 0.006533823907375336
a O 0 0.012235615402460098
mutational O 1 0.9984732270240784
hot O 0 0.05630626156926155
spot O 0 0.024920383468270302
, O 0 0.005116515327244997
haplotypes O 1 0.9085531830787659
were O 0 0.002232265193015337
determined O 0 0.007195865735411644
for O 0 0.0032215288374572992
polymorphisms O 0 0.4432820975780487
both O 0 0.0026452909223735332
within O 0 0.003767983056604862
and O 0 0.0034989763516932726
flanking O 1 0.9417539238929749
COL17A1 O 1 0.9933072924613953
. O 0 0.02126024104654789

Five O 0 0.024889687076210976
intragenic O 1 0.985383927822113
polymorphisms O 1 0.8223164677619934
were O 0 0.002368604764342308
chosen O 0 0.003884212812408805
based O 0 0.0024192272685468197
on O 0 0.0019823622424155474
their O 0 0.004670184571295977
informativeness O 1 0.959345281124115
. O 0 0.012039665132761002

One O 0 0.0058614881709218025
of O 0 0.001958343666046858
these O 0 0.001551141613163054
, O 0 0.0016192340990528464
not O 0 0.0014292335836216807
previously O 0 0.004931707866489887
reported O 0 0.008380635641515255
, O 0 0.0021580676548182964
was O 0 0.005209891591221094
2988 O 1 0.8598236441612244
A O 0 0.009672111831605434
or O 0 0.0053458488546311855
C O 0 0.019977374002337456
that O 0 0.0021360707469284534
introduces O 0 0.015761975198984146
a O 0 0.004175967536866665
new O 0 0.0035282885655760765
restriction O 0 0.016180844977498055
site O 0 0.007074669934809208
for O 0 0.00446252292022109
Eco0109 O 1 0.9742311835289001
I O 0 0.01989305205643177
. O 0 0.0112604396417737

All O 0 0.0045894430950284
the O 0 0.007131749764084816
4003delTC O 1 0.9982581734657288
alleles O 1 0.9992828965187073
showed O 0 0.012079763226211071
the O 0 0.0033090992365032434
same O 0 0.00593192595988512
haplotype O 1 0.9672825336456299
for O 0 0.002153840148821473
these O 0 0.0020363677758723497
five O 0 0.007828349247574806
polymorphic O 1 0.9990922212600708
markers O 0 0.0571269728243351
. O 0 0.01211924385279417

Fourteen O 0 0.06470394134521484
microsatellite O 1 0.9925409555435181
polymorphisms O 1 0.9696881175041199
were O 0 0.0024643430951982737
selected O 0 0.003342839889228344
based O 0 0.002156518865376711
on O 0 0.001532366732135415
their O 0 0.0023185559548437595
high O 0 0.008959989063441753
heterozygosity O 1 0.9675938487052917
and O 0 0.0018840502016246319
their O 0 0.0021508019417524338
location O 0 0.005486422684043646
within O 0 0.00669748755171895
10q23 O 1 0.99407958984375
- O 0 0.07443094998598099
q25 O 1 0.9875675439834595
near O 0 0.04357963427901268
COL17A1 O 1 0.9961147308349609
. O 0 0.019969943910837173

Three O 0 0.008894359692931175
families O 0 0.01374486181885004
shared O 0 0.021788761019706726
microsatellite O 1 0.9889612793922424
polymorphisms O 1 0.9845970273017883
covering O 0 0.016371898353099823
at O 0 0.0037119886837899685
most O 0 0.0035355149302631617
19 O 0 0.011799524538218975
cM O 0 0.03819745406508446
, O 0 0.0019697779789566994
whereas O 0 0.0066063799895346165
the O 0 0.0018021754221990705
others O 0 0.0034041618928313255
shared O 0 0.005711442790925503
smaller O 0 0.007524812128394842
regions O 0 0.008747595362365246
consistent O 0 0.006777966860681772
with O 0 0.0021161192562431097
cross O 0 0.009946969337761402
- O 0 0.013033811934292316
over O 0 0.0029160380363464355
events O 0 0.004019285086542368
during O 0 0.004263229668140411
passage O 0 0.005700353533029556
of O 0 0.0016373518155887723
this O 0 0.0031895239371806383
mutation O 1 0.9988512992858887
through O 0 0.004519307520240545
several O 0 0.0039024774450808764
generations O 0 0.02643584832549095
. O 0 0.010807855054736137

These O 0 0.005203263368457556
results O 0 0.009746615774929523
indicate O 0 0.009301066398620605
that O 0 0.003336486639454961
4003delTC O 1 0.988564133644104
occurs O 0 0.0206584595143795
on O 0 0.0020882999524474144
a O 0 0.005165583919733763
single O 0 0.015029075555503368
ancestral O 0 0.07307533174753189
allele O 1 0.9957789182662964
. O 0 0.007691321428865194
. O 0 0.01149722933769226

The O 0 0.02593512274324894
haptoglobin O 1 0.9796028733253479
- O 0 0.27940526604652405
gene O 1 0.9772912859916687
deletion O 1 0.9655154943466187
responsible O 0 0.019142717123031616
for O 0 0.007325350772589445
anhaptoglobinemia B-Disease 1 0.980499804019928
. O 0 0.015521002002060413

We O 0 0.004639907740056515
have O 0 0.0025545815005898476
found O 0 0.004774739500135183
an O 0 0.004740193951874971
allelic O 1 0.9638767838478088
deletion O 1 0.646245539188385
of O 0 0.003058056579902768
the O 0 0.006108711939305067
haptoglobin O 1 0.9949806332588196
( O 0 0.01157293375581503
Hp O 0 0.05222059041261673
) O 0 0.0078018722124397755
gene O 0 0.13649272918701172
from O 0 0.002541251014918089
an O 0 0.00235566683113575
individual O 0 0.005056343507021666
with O 0 0.006693948060274124
anhaptoglobinemia B-Disease 1 0.9504613876342773
. O 0 0.018059732392430305

The O 0 0.015050911344587803
Hp O 0 0.2596959173679352
gene O 1 0.9632083177566528
cluster O 0 0.03636344149708748
consists O 0 0.006503656506538391
of O 0 0.002669994719326496
coding O 0 0.035739168524742126
regions O 0 0.006235013250261545
of O 0 0.0013701531570404768
the O 0 0.002660014433786273
alpha O 0 0.03917211666703224
chain O 0 0.0353894978761673
and O 0 0.002673589624464512
beta O 0 0.036872413009405136
chain O 0 0.023104049265384674
of O 0 0.002430508378893137
the O 0 0.005405912175774574
haptoglobin O 1 0.9986811280250549
gene O 1 0.9937984347343445
( O 0 0.008971677161753178
Hp O 0 0.02324811741709709
) O 0 0.002345896093174815
and O 0 0.0007529889699071646
of O 0 0.0009597527678124607
the O 0 0.003014221088960767
alpha O 0 0.04118151590228081
chain O 0 0.03440496325492859
and O 0 0.003049949649721384
beta O 0 0.03403784707188606
chain O 0 0.02103361487388611
of O 0 0.0021861691493541002
the O 0 0.005296603310853243
haptoglobin O 1 0.99490886926651
- O 0 0.045720424503088
related O 0 0.030196338891983032
gene O 1 0.9868226051330566
( O 0 0.016933461651206017
Hpr O 1 0.9988420605659485
) O 0 0.005954266060143709
, O 0 0.0018355805659666657
in O 0 0.0021902411244809628
tandem O 0 0.02137846127152443
from O 0 0.0028849958907812834
the O 0 0.003525272011756897
5 O 0 0.0105660455301404
side O 0 0.01280896831303835
. O 0 0.011759359389543533

Southern O 0 0.037237558513879776
blot O 1 0.8709903955459595
and O 0 0.006070780102163553
PCR O 1 0.5910782814025879
analyses O 0 0.00983255635946989
have O 0 0.0018581640906631947
indicated O 0 0.00448251236230135
that O 0 0.000859904452227056
the O 0 0.00125531991943717
individual O 0 0.002653558971360326
with O 0 0.002955096773803234
anhaptoglobinemia B-Disease 1 0.9952580332756042
was O 0 0.006033768877387047
homozygous O 1 0.9866422414779663
for O 0 0.002175885485485196
the O 0 0.004652686882764101
gene O 1 0.9952254295349121
deletion O 1 0.9733510613441467
and O 0 0.0017375843599438667
that O 0 0.00163973867893219
the O 0 0.004374994896352291
gene O 1 0.9666236042976379
deletion O 1 0.9840294718742371
was O 0 0.003045282792299986
included O 0 0.0019667905289679766
at O 0 0.0024507970083504915
least O 0 0.0037169873248785734
from O 0 0.002552590798586607
the O 0 0.0033748603891581297
promoter O 0 0.18541057407855988
region O 0 0.009242932312190533
of O 0 0.002917892299592495
Hp O 0 0.0439702570438385
to O 0 0.006761910393834114
Hpr O 1 0.9948546886444092
alpha O 0 0.046847447752952576
but O 0 0.002789074555039406
not O 0 0.002222201321274042
to O 0 0.005278491880744696
Hpr O 1 0.9875756502151489
beta O 0 0.08328510820865631
( O 0 0.018201202154159546
Hpdel O 1 0.9768769145011902
) O 0 0.01204998604953289
. O 0 0.011463187634944916

In O 0 0.005086924880743027
addition O 0 0.005538491066545248
, O 0 0.0019618491642177105
we O 0 0.0013760835863649845
found O 0 0.003062213771045208
seven O 0 0.003266603220254183
individuals O 0 0.0041790795512497425
with O 0 0.00249777571298182
hypohaptoglobinemia B-Disease 1 0.9755423665046692
in O 0 0.0017324944492429495
three O 0 0.002026272239163518
families O 0 0.004331240896135569
, O 0 0.0012714638141915202
and O 0 0.0013400529278442264
the O 0 0.002859011059626937
genotypes O 1 0.9939725995063782
of O 0 0.0013909749686717987
six O 0 0.0023925628047436476
of O 0 0.0013007598463445902
the O 0 0.001607573707588017
seven O 0 0.003041713498532772
individuals O 0 0.004032278433442116
were O 0 0.0011977849062532187
found O 0 0.0033059034030884504
to O 0 0.0019364660838618875
be O 0 0.004203088115900755
Hp2 O 1 0.9956046342849731
/ O 1 0.6085202097892761
Hpdel O 1 0.9717202186584473
. O 0 0.018212852999567986

The O 0 0.013450426049530506
phenotypes O 1 0.9956658482551575
and O 0 0.00507726613432169
genotypes O 1 0.9986328482627869
in O 0 0.001650667516514659
one O 0 0.001370113343000412
of O 0 0.0009409066988155246
these O 0 0.0008972820360213518
three O 0 0.0015345184365287423
families O 0 0.005130082368850708
showed O 0 0.006279247347265482
the O 0 0.003042390337213874
father O 0 0.008238416165113449
to O 0 0.002216493943706155
be O 0 0.004244427662342787
hypohaptoglobinemic B-Disease 1 0.9791855216026306
( O 0 0.014894211664795876
Hp2 O 1 0.9383673071861267
) O 0 0.008583602495491505
and O 0 0.0052665118128061295
Hp2 O 1 0.9980779886245728
/ O 1 0.9125905632972717
Hpdel O 1 0.9639642834663391
, O 0 0.0037293964996933937
the O 0 0.0032832094002515078
mother O 0 0.013461085967719555
to O 0 0.002109014429152012
be O 0 0.0031362813897430897
Hp2 O 1 0.9670034646987915
- O 0 0.01955173909664154
1 O 0 0.008417708799242973
and O 0 0.004261171445250511
Hp1 O 1 0.9994022846221924
/ O 1 0.8829032182693481
Hp2 O 1 0.9945342540740967
, O 0 0.0017466912977397442
one O 0 0.0010999474907293916
of O 0 0.0007876553572714329
the O 0 0.001221731654368341
two O 0 0.001158441649749875
children O 0 0.0055282581597566605
to O 0 0.0020254289265722036
be O 0 0.003506748005747795
hypohaptoglobinemic B-Disease 1 0.9916029572486877
( O 0 0.011528524570167065
Hp2 O 1 0.9755107164382935
) O 0 0.006112929433584213
and O 0 0.004014248959720135
Hp2 O 1 0.999268114566803
/ O 1 0.95084547996521
Hpdel O 1 0.9957161545753479
, O 0 0.001986259361729026
and O 0 0.0009744795970618725
the O 0 0.0014580782735720277
other O 0 0.0010374271078035235
child O 0 0.0128746023401618
to O 0 0.0018853920046240091
be O 0 0.003119096392765641
Hp1 O 1 0.9710111618041992
and O 0 0.005534004885703325
Hp1 O 1 0.9986385703086853
/ O 1 0.9660869240760803
Hpdel O 1 0.9892504215240479
, O 0 0.003804038977250457
showing O 0 0.011081384494900703
an O 0 0.004622208885848522
anomalous O 0 0.27705857157707214
inheritance O 0 0.3113430440425873
of O 0 0.003963316325098276
Hp O 1 0.9673193693161011
phenotypes O 1 0.9983224272727966
in O 0 0.0020952518098056316
the O 0 0.0032670360524207354
child O 0 0.08175450563430786
with O 0 0.007461914326995611
Hp1 O 1 0.9979721903800964
. O 0 0.01353918295353651

The O 0 0.01925184391438961
Hp2 O 1 0.9989232420921326
/ O 1 0.9774951338768005
Hpdel O 1 0.9943546056747437
individuals O 0 0.008186697028577328
had O 0 0.0037729479372501373
an O 0 0.002736221067607403
extremely O 0 0.013284701853990555
low O 0 0.010091976262629032
level O 0 0.004278180189430714
of O 0 0.0029537093359977007
Hp O 0 0.053827349096536636
( O 0 0.00858564767986536
mean O 0 0.02047884836792946
+ O 0 0.10061214864253998
/ O 0 0.09823500365018845
- O 0 0.060381826013326645
SD O 1 0.9805474281311035
= O 0 0.06168624386191368
0 O 0 0.027087843045592308
. O 0 0.010059203952550888
049 O 1 0.9947696328163147
+ O 0 0.1315404176712036
/ O 0 0.0790640264749527
- O 0 0.032522667199373245
0 O 0 0.025668218731880188
. O 0 0.009272409602999687
043 O 1 0.9921981692314148
mg O 1 0.9963104128837585
/ O 0 0.22492098808288574
ml O 1 0.820667028427124
; O 0 0.011312325485050678
n O 0 0.03339115157723427
= O 0 0.03748451545834541
6 O 0 0.01103795226663351
) O 0 0.003855491988360882
, O 0 0.0017815076280385256
compared O 0 0.005134922452270985
with O 0 0.0012477824930101633
the O 0 0.0020688744261860847
level O 0 0.0050387210212647915
( O 0 0.004142795689404011
1 O 0 0.005263783037662506
. O 0 0.002567501738667488
64 O 0 0.01799616776406765
+ O 0 0.06136702746152878
/ O 0 0.05215277895331383
- O 0 0.020774144679307938
1 O 0 0.010583952069282532
. O 0 0.005504024680703878
07 O 1 0.7880143523216248
mg O 1 0.9955793023109436
/ O 0 0.4273168742656708
ml O 1 0.8747460246086121
) O 0 0.005538002587854862
obtained O 0 0.005061016418039799
from O 0 0.004089838359504938
52 O 0 0.024573171511292458
healthy O 1 0.5046945214271545
volunteers O 0 0.03702716529369354
having O 0 0.02887691557407379
phenotype O 1 0.999927282333374
Hp2 O 1 0.9972802400588989
, O 0 0.003988285083323717
whereas O 0 0.011484906077384949
the O 0 0.004660086240619421
serum O 1 0.9901461005210876
Hp O 0 0.032320015132427216
level O 0 0.004482107702642679
of O 0 0.0016582095995545387
an O 0 0.0026541005354374647
individual O 0 0.005061469506472349
with O 0 0.005357992369681597
Hp1 O 1 0.9994164705276489
/ O 1 0.9611886739730835
Hpdel O 1 0.9962034821510315
was O 0 0.012986035086214542
0 O 0 0.03194092586636543
. O 0 0.010814662091434002

50 O 0 0.04121857136487961
mg O 1 0.9982006549835205
/ O 1 0.8145170211791992
ml O 1 0.9704264402389526
, O 0 0.003039759350940585
which O 0 0.0018684898968786001
was O 0 0.002371926559135318
approximately O 0 0.00385579583235085
half O 0 0.0028731769416481256
the O 0 0.0016034288564696908
level O 0 0.0028745951130986214
of O 0 0.0018234294839203358
Hp O 0 0.022293252870440483
in O 0 0.0028937014285475016
control O 0 0.014277886599302292
sera O 0 0.143281489610672
from O 0 0.0042545124888420105
the O 0 0.00644659623503685
Hp1 O 1 0.9997346997261047
phenotype O 1 0.9999101161956787
( O 0 0.009248964488506317
1 O 0 0.008034194819629192
. O 0 0.003303156467154622
26 O 0 0.015408295206725597
+ O 0 0.06019655987620354
/ O 0 0.053721632808446884
- O 0 0.027922386303544044
0 O 0 0.0206511951982975
. O 0 0.004384153056889772
33 O 0 0.025913890451192856
mg O 1 0.9724598526954651
/ O 0 0.29217204451560974
ml O 1 0.9228575229644775
; O 0 0.009244081564247608
n O 0 0.02804381214082241
= O 0 0.030850928276777267
9 O 0 0.00955205224454403
) O 0 0.0031524612568318844
, O 0 0.001993793761357665
showing O 0 0.010968449525535107
a O 0 0.015219936147332191
gene O 1 0.9892318844795227
- O 0 0.08445190638303757
dosage O 1 0.9799486994743347
effect O 0 0.03543059527873993
. O 0 0.011737866327166557

The O 0 0.007646036334335804
other O 0 0.006089487578719854
allele O 1 0.9943460822105408
( O 0 0.014763079583644867
Hp2 O 1 0.9940504431724548
) O 0 0.003910619765520096
of O 0 0.0019108614651486278
individuals O 0 0.006232328247278929
with O 0 0.005712845362722874
Hp2 O 1 0.9991733431816101
/ O 1 0.9204500317573547
Hpdel O 1 0.9914388656616211
was O 0 0.004473191220313311
found O 0 0.002988284919410944
to O 0 0.0009753601625561714
have O 0 0.0011445218697190285
, O 0 0.0009813589276745915
in O 0 0.0009816914098337293
all O 0 0.001706522423774004
exons O 0 0.1550646722316742
, O 0 0.002658408135175705
no O 0 0.005604663398116827
mutation O 1 0.998615026473999
, O 0 0.002703035483136773
by O 0 0.004499539732933044
DNA O 0 0.04316207021474838
sequencing O 0 0.05783737823367119
. O 0 0.011611707508563995

On O 0 0.0036779374349862337
the O 0 0.0018827645108103752
basis O 0 0.001578310038894415
of O 0 0.0009981285547837615
the O 0 0.00156679330393672
present O 0 0.002368517918512225
study O 0 0.003615562804043293
, O 0 0.0012565586948767304
the O 0 0.0017652055248618126
mechanism O 0 0.009379701688885689
of O 0 0.0026559983380138874
anhaptoglobinemia B-Disease 1 0.9800373315811157
and O 0 0.0016813866095617414
the O 0 0.0024058278650045395
mechanism O 0 0.01233967300504446
of O 0 0.0031047770753502846
anomalous O 1 0.7742390632629395
inheritance O 1 0.6236498355865479
of O 0 0.004504688084125519
Hp O 1 0.9629995226860046
phenotypes O 1 0.9994675517082214
were O 0 0.002465667901560664
well O 0 0.003986394964158535
explained O 0 0.01353645883500576
. O 0 0.00924740917980671

However O 0 0.008632221259176731
, O 0 0.0023067519068717957
the O 0 0.002447066828608513
mechanism O 0 0.014973408542573452
of O 0 0.004983894061297178
hypohaptoglobinemia B-Disease 1 0.9786204099655151
remains O 0 0.03143687546253204
unknown O 0 0.06567242741584778

ATM O 1 0.9669445753097534
mutations O 1 0.9983410835266113
and O 0 0.007913151755928993
phenotypes O 1 0.9961521029472351
in O 0 0.014553473331034184
ataxia B-Disease 1 0.9999974966049194
- I-Disease 1 0.9978652596473694
telangiectasia I-Disease 1 0.9999845027923584
families O 0 0.013197597116231918
in O 0 0.0026199454441666603
the O 0 0.003550013294443488
British O 0 0.01601562462747097
Isles O 0 0.2618812322616577
: O 0 0.006520407740026712
expression O 0 0.016169803217053413
of O 0 0.004021133296191692
mutant O 1 0.9965938925743103
ATM O 0 0.04155851900577545
and O 0 0.001747740781866014
the O 0 0.003589876927435398
risk O 1 0.9893407225608826
of O 0 0.008247455582022667
leukemia B-Disease 1 1.0
, O 1 0.5953361392021179
lymphoma B-Disease 1 1.0
, O 0 0.009287675842642784
and O 0 0.11075378209352493
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
. O 0 0.01402684673666954

We O 0 0.00442139757797122
report O 0 0.004337947349995375
the O 0 0.003415179904550314
spectrum O 0 0.020896896719932556
of O 0 0.003875517984852195
59 O 0 0.035899605602025986
ATM O 1 0.5564880967140198
mutations O 1 0.9932304620742798
observed O 0 0.02077588066458702
in O 0 0.007657662965357304
ataxia B-Disease 1 0.9999960660934448
- I-Disease 1 0.9971490502357483
telangiectasia I-Disease 1 0.9999970197677612
( O 0 0.015633627772331238
A B-Disease 1 0.9351192712783813
- I-Disease 1 0.9866743683815002
T I-Disease 1 0.999866247177124
) O 0 0.011641627177596092
patients O 1 0.9947878122329712
in O 0 0.002227326389402151
the O 0 0.0035133324563503265
British O 0 0.018919846042990685
Isles O 1 0.9164831638336182
. O 0 0.015102203004062176

Of O 0 0.00831920001655817
51 O 0 0.04171302914619446
ATM O 1 0.9729527831077576
mutations O 1 0.9983665347099304
identified O 0 0.011927677318453789
in O 0 0.0024311323650181293
families O 0 0.005862441845238209
native O 0 0.00429571932181716
to O 0 0.0014493085909634829
the O 0 0.0028413161635398865
British O 0 0.010442636907100677
Isles O 0 0.22601734101772308
, O 0 0.0025544564705342054
11 O 0 0.005596093367785215
were O 0 0.002275274135172367
founder O 0 0.09183397889137268
mutations O 1 0.9994671940803528
, O 0 0.0015464570606127381
and O 0 0.0010883481008931994
2 O 0 0.002921665320172906
of O 0 0.0009501069434918463
these O 0 0.0013021425111219287
11 O 0 0.005797242280095816
conferred O 0 0.016758425161242485
a O 0 0.010792536661028862
milder O 1 0.9997469782829285
clinical O 1 0.9995245933532715
phenotype O 1 0.9999735355377197
with O 0 0.0024645505473017693
respect O 0 0.003502386622130871
to O 0 0.0022132601588964462
both O 0 0.006543566007167101
cerebellar B-Disease 1 0.9999932050704956
degeneration I-Disease 1 0.9999991655349731
and O 0 0.0057892827317118645
cellular O 0 0.1277037113904953
features O 0 0.013454470783472061
. O 0 0.00994446687400341

We O 0 0.004383610561490059
report O 0 0.004158670082688332
, O 0 0.0016701704589650035
in O 0 0.0013210424222052097
two O 0 0.002381005557253957
A B-Disease 0 0.035907384008169174
- I-Disease 1 0.5937735438346863
T I-Disease 1 0.9992114305496216
families O 0 0.008396890014410019
, O 0 0.002238539047539234
an O 0 0.004104649648070335
ATM O 1 0.7307658791542053
mutation O 1 0.9985194802284241
( O 0 0.01505168154835701
7271T O 1 0.9958223104476929
- O 0 0.15435436367988586
- O 0 0.14650973677635193
> O 1 0.9950708150863647
G O 1 0.868943989276886
) O 0 0.003840649500489235
that O 0 0.0016439830651506782
may O 0 0.0037512965500354767
be O 0 0.0013667208841070533
associated O 0 0.004139962140470743
with O 0 0.0012294456828385592
an O 0 0.002261931775137782
increased O 0 0.01397574320435524
risk O 1 0.9646696448326111
of O 0 0.010718160308897495
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999955892562866
in O 0 0.004004846327006817
both O 0 0.005679645575582981
homozygotes O 1 0.999653697013855
and O 0 0.005887988954782486
heterozygotes O 1 0.9988517761230469
( O 0 0.009102055802941322
relative O 0 0.017060142010450363
risk O 1 0.5740676522254944
12 O 0 0.008108071982860565
. O 0 0.00318079418502748
7 O 0 0.010589111596345901
; O 0 0.007355199661105871
P O 0 0.2512921690940857
= O 0 0.04070495814085007
. O 0 0.008617877960205078
0025 O 1 0.9971290230751038
) O 0 0.005206638015806675
, O 0 0.0019033071584999561
although O 0 0.0023071274627000093
there O 0 0.001678738510236144
is O 0 0.0019541457295417786
a O 0 0.005406784825026989
less O 0 0.011508121155202389
severe O 1 0.9999758005142212
A B-Disease 1 0.9745569229125977
- I-Disease 1 0.9970000386238098
T I-Disease 1 0.9999780654907227
phenotype O 1 0.9998268485069275
in O 0 0.002045135013759136
terms O 0 0.001836039125919342
of O 0 0.0010065257083624601
the O 0 0.002036351477727294
degree O 0 0.005782030522823334
of O 0 0.007162720430642366
cerebellar B-Disease 1 0.9999922513961792
degeneration I-Disease 1 0.999997615814209
. O 0 0.021311206743121147

This O 0 0.015210704877972603
mutation O 1 0.998784601688385
( O 0 0.020648611709475517
7271T O 1 0.9891830682754517
- O 0 0.09154651314020157
- O 0 0.10430692136287689
> O 1 0.9846693873405457
G O 0 0.332295686006546
) O 0 0.0037961502093821764
also O 0 0.0017006712732836604
allows O 0 0.005713471211493015
expression O 0 0.011388934217393398
of O 0 0.0020067128352820873
full O 0 0.006777267437428236
- O 0 0.02173726260662079
length O 0 0.015607058070600033
ATM O 0 0.05224005877971649
protein O 0 0.024796823039650917
at O 0 0.002803840208798647
a O 0 0.0036773940082639456
level O 0 0.003855722723528743
comparable O 0 0.006509035360068083
with O 0 0.0015439416747540236
that O 0 0.0016293413937091827
in O 0 0.0034288018941879272
unaffected O 1 0.9452530741691589
individuals O 0 0.013203217647969723
. O 0 0.009839867241680622

In O 0 0.005193618591874838
addition O 0 0.0042822398245334625
, O 0 0.0014343527145683765
we O 0 0.001121988520026207
have O 0 0.0013855642173439264
studied O 0 0.003813799936324358
18 O 0 0.00798020325601101
A B-Disease 0 0.485369473695755
- I-Disease 1 0.996171772480011
T I-Disease 1 0.999987006187439
patients O 1 0.9997664093971252
, O 0 0.0021583132911473513
in O 0 0.0018140795873478055
15 O 0 0.0044789668172597885
families O 0 0.005357537884265184
, O 0 0.0019657425582408905
who O 0 0.006311062723398209
developed O 1 0.9834091663360596
leukemia B-Disease 1 0.9999998807907104
, O 0 0.4637830853462219
lymphoma B-Disease 1 1.0
, O 0 0.01057372521609068
preleukemic O 1 0.9999004602432251
T O 1 0.9998165965080261
- O 0 0.3809645175933838
cell O 0 0.24604150652885437
proliferation O 0 0.05144233629107475
, O 0 0.0049261413514614105
or O 1 0.624626636505127
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.005128373391926289
mostly O 0 0.006286934483796358
in O 0 0.005124871619045734
childhood O 1 0.9873449206352234
. O 0 0.01633823662996292

A O 0 0.016953347250819206
wide O 0 0.014043633826076984
variety O 0 0.00621376745402813
of O 0 0.0038655956741422415
ATM O 1 0.9889259934425354
mutation O 1 0.9998364448547363
types O 0 0.010013829916715622
, O 0 0.002259370870888233
including O 0 0.00513717345893383
missense O 1 0.9992409944534302
mutations O 1 0.9982002973556519
and O 0 0.002234179526567459
in O 0 0.002633919008076191
- O 0 0.017465969547629356
frame O 0 0.021472599357366562
deletions O 0 0.22618624567985535
, O 0 0.0021929542999714613
were O 0 0.0015301840612664819
seen O 0 0.006244155112653971
in O 0 0.0026130550540983677
these O 0 0.0048784660175442696
patients O 1 0.9992479681968689
. O 0 0.015215225517749786

We O 0 0.004264889284968376
also O 0 0.0022682093549519777
show O 0 0.004225080367177725
that O 0 0.0011776844039559364
25 O 0 0.0029423623345792294
% O 0 0.002247639698907733
of O 0 0.001067961798980832
all O 0 0.0018782734405249357
A B-Disease 0 0.23706179857254028
- I-Disease 1 0.991075873374939
T I-Disease 1 0.9999692440032959
patients O 1 0.9997411370277405
carried O 0 0.006834271363914013
in O 0 0.0028166358824819326
- O 0 0.018596982583403587
frame O 0 0.021277131512761116
deletions O 1 0.8484288454055786
or O 0 0.01214977353811264
missense O 1 0.9998268485069275
mutations O 1 0.9994540810585022
, O 0 0.0018922151066362858
many O 0 0.0012644550297409296
of O 0 0.0010351407108828425
which O 0 0.0012067799689248204
were O 0 0.0009590210393071175
also O 0 0.0014661686727777123
associated O 0 0.004956674762070179
with O 0 0.002026683883741498
expression O 0 0.013767160475254059
of O 0 0.004462561570107937
mutant O 1 0.9978448152542114
ATM O 0 0.43258869647979736
protein O 0 0.06584466993808746
. O 0 0.01175964716821909

The O 0 0.018164759501814842
DMPK O 1 0.9974374771118164
gene O 1 0.9832882285118103
of O 0 0.009984338656067848
severely O 1 0.9997504353523254
affected O 1 0.9997019171714783
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.9999942779541016
is O 0 0.018146788701415062
hypermethylated O 1 0.9997450709342957
proximal O 1 0.9998666048049927
to O 0 0.00267884717322886
the O 0 0.0029377019964158535
largely O 0 0.012327400036156178
expanded O 0 0.022292768582701683
CTG O 1 0.9885772466659546
repeat O 0 0.09033529460430145
. O 0 0.015324411913752556

Using O 0 0.02298854850232601
methylation O 0 0.08873958885669708
- O 0 0.0327780656516552
sensitive O 0 0.025098826736211777
restriction O 0 0.028280680999159813
enzymes O 0 0.029442595317959785
, O 0 0.0023784833028912544
we O 0 0.0023485515266656876
characterized O 0 0.01900298520922661
the O 0 0.0037774655502289534
methylation O 0 0.04285161942243576
pattern O 0 0.014298980124294758
on O 0 0.0018074475228786469
the O 0 0.002074869116768241
5 O 0 0.005754323676228523
side O 0 0.003921301569789648
of O 0 0.001585575519129634
the O 0 0.004707291256636381
CTG O 1 0.9971293807029724
repeat O 0 0.03471533954143524
in O 0 0.003067215671762824
the O 0 0.005238563288003206
DMPK O 1 0.998034656047821
gene O 1 0.6296864151954651
of O 0 0.0031568859703838825
normal O 0 0.01353184413164854
individuals O 0 0.0037270132452249527
and O 0 0.0013498590560629964
of O 0 0.0036372877657413483
patients O 1 0.9999792575836182
affected O 1 0.9811903238296509
with O 0 0.049716804176568985
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.007241629995405674
showing O 0 0.014517305418848991
expansions O 0 0.01816374622285366
of O 0 0.0030262982472777367
the O 0 0.006612006109207869
repetitive O 1 0.9965329170227051
sequence O 0 0.03437907248735428
. O 0 0.01099296472966671

The O 0 0.017592888325452805
gene O 0 0.4318300783634186
segment O 0 0.041814785450696945
analyzed O 0 0.020805135369300842
corresponds O 0 0.01506521925330162
to O 0 0.0022890432737767696
the O 0 0.005234536714851856
genomic O 1 0.6714679002761841
SacI O 1 0.9921815395355225
- O 0 0.05735411494970322
HindIII O 1 0.9651435613632202
fragment O 0 0.05915064737200737
carrying O 0 0.016898950561881065
exons O 0 0.17908446490764618
11 O 0 0.01416967436671257
- O 0 0.025559954345226288
15 O 0 0.012390073388814926
. O 0 0.010710432194173336

There O 0 0.007424935232847929
is O 0 0.0071053276769816875
constitutive O 0 0.13039182126522064
methylation O 0 0.06516962498426437
in O 0 0.005917000584304333
intron O 1 0.9549130201339722
12 O 0 0.009545715525746346
at O 0 0.004725631792098284
restriction O 0 0.013788541778922081
sites O 0 0.004659302998334169
of O 0 0.0031929065007716417
SacII O 1 0.9839782118797302
and O 0 0.004360560327768326
HhaI O 1 0.9960590600967407
, O 0 0.006141053978353739
localized O 1 0.8721635937690735
1 O 0 0.009814676828682423
, O 0 0.0037227182183414698
159 O 0 0.028701068833470345
- O 0 0.01782277785241604
1 O 0 0.008578620851039886
, O 0 0.0033187740482389927
232 O 0 0.03498082235455513
bp O 0 0.03228001669049263
upstream O 0 0.018327081575989723
of O 0 0.0030043257866054773
the O 0 0.006296414416283369
CTG O 1 0.9966118931770325
repeat O 0 0.29521065950393677
, O 0 0.0029623256996273994
whereas O 0 0.008289183489978313
most O 0 0.001841831486672163
, O 0 0.0011269178939983249
if O 0 0.0015091224340721965
not O 0 0.0007337108836509287
all O 0 0.0006658111233264208
, O 0 0.0006742380210198462
of O 0 0.0007047023973427713
the O 0 0.001183386193588376
other O 0 0.0012583378702402115
sites O 0 0.0032459942158311605
of O 0 0.0025563521776348352
SacII O 1 0.9964235424995422
, O 0 0.00511902803555131
HhaI O 1 0.9948775768280029
, O 0 0.0025630444288253784
and O 0 0.0025500121992081404
HpaII O 1 0.9507574439048767
in O 0 0.0025927098467946053
this O 0 0.0019879171159118414
region O 0 0.0074166287668049335
are O 0 0.0027509192004799843
unmethylated O 1 0.9855179786682129
, O 0 0.0021954223047941923
in O 0 0.0022035627625882626
normal O 0 0.013772760517895222
individuals O 0 0.0035077109932899475
and O 0 0.0010488498955965042
most O 0 0.001671963487751782
of O 0 0.0019917190074920654
the O 0 0.0064399209804832935
patients O 1 0.9997561573982239
. O 0 0.011292731389403343

In O 0 0.004401125945150852
a O 0 0.004693324211984873
number O 0 0.0025751988869160414
of O 0 0.002073002513498068
young O 0 0.012598377652466297
and O 0 0.005542473867535591
severely O 1 0.9999268054962158
affected O 1 0.9992121458053589
patients O 1 0.9999608993530273
, O 0 0.0023253574036061764
however O 0 0.0028484584763646126
, O 0 0.0015530007658526301
complete O 0 0.004555802326649427
methylation O 0 0.022366518154740334
of O 0 0.0014685540227219462
these O 0 0.001676185755059123
restriction O 0 0.011040003038942814
sites O 0 0.003327204380184412
was O 0 0.002571347402408719
found O 0 0.0034291979391127825
in O 0 0.00236879987642169
the O 0 0.007163985166698694
mutated O 1 0.9994025230407715
allele O 1 0.9943577647209167
. O 0 0.01737910881638527

In O 0 0.004093779716640711
most O 0 0.0024744230322539806
of O 0 0.0018344511045143008
these O 0 0.0032125043217092752
patients O 1 0.9998831748962402
, O 0 0.0022895289584994316
the O 0 0.00409343745559454
onset O 1 0.9998860359191895
of O 0 0.0036130251828581095
the O 0 0.013345908373594284
disease O 1 0.9999998807907104
was O 1 0.8009487986564636
congenital O 1 0.9999998807907104
. O 0 0.01609962061047554

Preliminary O 0 0.0203830748796463
in O 0 0.008181503973901272
vivo O 1 0.8327848315238953
footprinting O 1 0.9878722429275513
data O 0 0.005242851562798023
gave O 0 0.004837102722376585
evidence O 0 0.0030384662095457315
for O 0 0.002666901331394911
protein O 0 0.042561642825603485
- O 0 0.02503780461847782
DNA O 0 0.033190906047821045
contact O 0 0.015308057889342308
in O 0 0.003297586692497134
normal O 0 0.02266651764512062
genes O 0 0.05338336154818535
at O 0 0.004327371250838041
an O 0 0.0048821154050529
Sp1 O 1 0.9871206879615784
consensus O 0 0.01213131844997406
binding O 0 0.012748057022690773
site O 0 0.006646248046308756
upstream O 0 0.0137983039021492
of O 0 0.0017494696658104658
the O 0 0.005611577071249485
CTG O 1 0.9963787198066711
repeat O 0 0.06430908292531967
and O 0 0.001554441754706204
for O 0 0.0012905106414109468
a O 0 0.004261861089617014
significant O 0 0.006252495106309652
reduction O 0 0.009600888006389141
of O 0 0.0013581713428720832
this O 0 0.0019800502341240644
interaction O 0 0.0086109833791852
in O 0 0.002557752188295126
cells O 0 0.023005690425634384
with O 0 0.0030734960455447435
a O 0 0.013124500401318073
hypermethylated O 1 0.998856782913208
DMPK O 1 0.9997580647468567
gene O 1 0.9929333925247192
. O 0 0.006280621513724327
. O 0 0.010574833489954472

The O 0 0.03127365559339523
hemochromatosis B-Disease 1 0.9999960660934448
gene O 1 0.9950820207595825
product O 0 0.016589179635047913
complexes O 0 0.017400266602635384
with O 0 0.0027483981102705
the O 0 0.00565308565273881
transferrin O 1 0.9984890222549438
receptor O 1 0.970207929611206
and O 0 0.004286282230168581
lowers O 1 0.7397114038467407
its O 0 0.005757248494774103
affinity O 0 0.02871883288025856
for O 0 0.0041262563318014145
ligand O 0 0.060471657663583755
binding O 0 0.02496025152504444
. O 0 0.011121740564703941

We O 0 0.006260603666305542
recently O 0 0.013442810624837875
reported O 0 0.010896657593548298
the O 0 0.0035358662717044353
positional O 0 0.038721852004528046
cloning O 0 0.025727931410074234
of O 0 0.0021403783466666937
a O 0 0.005823958665132523
candidate O 0 0.020652875304222107
gene O 1 0.9763134121894836
for O 0 0.009460273198783398
hereditary B-Disease 1 0.999991774559021
hemochromatosis I-Disease 1 0.9999997615814209
called O 0 0.1598576009273529
HFE O 1 0.9995649456977844
. O 0 0.023805582895874977

The O 0 0.013222653418779373
gene O 1 0.5966187715530396
product O 0 0.009417249821126461
, O 0 0.001748887705616653
a O 0 0.00296605471521616
member O 0 0.0028206820134073496
of O 0 0.0013617362128570676
the O 0 0.003511222777888179
major O 0 0.019581789150834084
histocompatibility O 1 0.9998186230659485
complex O 0 0.019041728228330612
class O 0 0.01760452799499035
I O 0 0.011833985336124897
- O 0 0.016057519242167473
like O 0 0.005115735810250044
family O 0 0.0074701132252812386
, O 0 0.0014849153812974691
was O 0 0.0021193702705204487
found O 0 0.0024821090046316385
to O 0 0.001194866024889052
have O 0 0.0019045595545321703
a O 0 0.0071244738064706326
mutation O 1 0.9963663816452026
, O 0 0.006750732660293579
Cys O 1 0.9967310428619385
- O 0 0.04757428169250488
282 O 0 0.20125481486320496
- O 0 0.08608359098434448
- O 0 0.2057458609342575
> O 1 0.9874445199966431
Tyr O 1 0.9990447163581848
( O 0 0.01516661886125803
C282Y O 1 0.9818249344825745
) O 0 0.0040215919725596905
, O 0 0.001292256754823029
in O 0 0.001840494223870337
85 O 0 0.01297980360686779
% O 0 0.0052608298137784
of O 0 0.0051073310896754265
patient O 1 0.9990960359573364
chromosomes O 0 0.47464731335639954
. O 0 0.013128052465617657

This O 0 0.01985885575413704
mutation O 1 0.9949870109558105
eliminates O 0 0.06314133107662201
the O 0 0.004498759750276804
ability O 0 0.009837953373789787
of O 0 0.004222619812935591
HFE O 1 0.9996446371078491
to O 0 0.0029480878729373217
associate O 0 0.009679563343524933
with O 0 0.004809955600649118
beta2 O 1 0.9974908828735352
- O 0 0.0910172089934349
microglobulin O 1 0.9923944473266602
( O 0 0.013434144668281078
beta2m O 1 0.9478209614753723
) O 0 0.004991490393877029
and O 0 0.003018415765836835
prevents O 1 0.713107168674469
cell O 0 0.25308334827423096
- O 0 0.03338572010397911
surface O 0 0.022798987105488777
expression O 0 0.03742043673992157
. O 0 0.009899845346808434

A O 0 0.019939497113227844
second O 0 0.02002134546637535
mutation O 1 0.9995802044868469
that O 0 0.0022446957882493734
has O 0 0.002617989666759968
no O 0 0.002444513374939561
effect O 0 0.009120757691562176
on O 0 0.0036323899403214455
beta2m O 1 0.9954611659049988
association O 0 0.011899357661604881
, O 0 0.004128012340515852
H63D O 1 0.9992082715034485
, O 0 0.0023781191557645798
was O 0 0.0026523920241743326
found O 0 0.0029322332702577114
in O 0 0.0010715547250583768
eight O 0 0.0017937800148501992
out O 0 0.001697996398434043
of O 0 0.0018454495584592223
nine O 0 0.01117541640996933
patients O 1 0.9999076128005981
heterozygous O 1 0.991038978099823
for O 0 0.003152197226881981
the O 0 0.007127837277948856
C282Y O 1 0.9970746040344238
mutant O 1 0.9930641055107117
. O 0 0.015944411978125572

In O 0 0.0044815996661782265
this O 0 0.0023487324360758066
report O 0 0.0033973208628594875
, O 0 0.0014665058115497231
we O 0 0.0013173555489629507
demonstrate O 0 0.005406843964010477
in O 0 0.0035503420513123274
cultured O 0 0.30389007925987244
293 O 1 0.9261521100997925
cells O 1 0.9766156673431396
overexpressing O 1 0.998596727848053
wild O 0 0.05008922517299652
- O 0 0.03414013236761093
type O 0 0.035043105483055115
or O 0 0.010680301114916801
mutant O 1 0.9988841414451599
HFE O 1 0.9998350143432617
proteins O 0 0.019392862915992737
that O 0 0.001472744857892394
both O 0 0.001649786252528429
the O 0 0.002796018263325095
wild O 0 0.025410296395421028
- O 0 0.026619793847203255
type O 0 0.027336256578564644
and O 0 0.007302324753254652
H63D O 1 0.9997270703315735
HFE O 1 0.999896764755249
proteins O 0 0.037719786167144775
form O 0 0.01218524482101202
stable O 0 0.02913268655538559
complexes O 0 0.020020082592964172
with O 0 0.0033823398407548666
the O 0 0.008029533550143242
transferrin O 1 0.9923747181892395
receptor O 1 0.985016942024231
( O 0 0.022653965279459953
TfR O 1 0.9929500818252563
) O 0 0.0123796621337533
. O 0 0.012332046404480934

The O 0 0.01761874556541443
C282Y O 1 0.996374785900116
mutation O 1 0.9993332028388977
nearly O 0 0.025689151138067245
completely O 0 0.016764774918556213
prevents O 0 0.03810060769319534
the O 0 0.0029544818680733442
association O 0 0.0071416087448596954
of O 0 0.0021029075141996145
the O 0 0.00616193562746048
mutant O 1 0.9988862872123718
HFE O 1 0.9996215105056763
protein O 0 0.044356513768434525
with O 0 0.003626018762588501
the O 0 0.006893485318869352
TfR O 1 0.9939354062080383
. O 0 0.01906658336520195

Studies O 0 0.01682157814502716
on O 0 0.004974461160600185
cell O 0 0.045943208038806915
- O 0 0.02688630484044552
associated O 0 0.016938749700784683
transferrin O 0 0.3906196057796478
at O 0 0.004638709127902985
37 O 0 0.012202044017612934
degrees O 0 0.008754188194870949
C O 0 0.021967077627778053
suggest O 0 0.0063608488999307156
that O 0 0.0018652421422302723
the O 0 0.004602554254233837
overexpressed O 1 0.9864637851715088
wild O 0 0.04457804933190346
- O 0 0.06375377625226974
type O 0 0.1343497782945633
HFE O 1 0.9992621541023254
protein O 0 0.07237052917480469
decreases O 0 0.037884414196014404
the O 0 0.003773191710934043
affinity O 0 0.01965153031051159
of O 0 0.0025648162700235844
the O 0 0.005605523474514484
TfR O 1 0.9952272176742554
for O 0 0.010385936126112938
transferrin O 1 0.9050155282020569
. O 0 0.017449703067541122

The O 0 0.019648490473628044
overexpressed O 1 0.9982566237449646
H63D O 1 0.999357283115387
protein O 0 0.05515581741929054
does O 0 0.004252295009791851
not O 0 0.001291917054913938
have O 0 0.0012792946072295308
this O 0 0.001540529541671276
effect O 0 0.005625379271805286
, O 0 0.001072871731594205
providing O 0 0.0021867810282856226
the O 0 0.0011388383572921157
first O 0 0.0016601249808445573
direct O 0 0.003117557615041733
evidence O 0 0.0018763401312753558
for O 0 0.0014577110996469855
a O 0 0.0053026918321847916
functional O 0 0.019458580762147903
consequence O 0 0.01711701601743698
of O 0 0.002616479992866516
the O 0 0.007492074742913246
H63D O 1 0.999883770942688
mutation O 1 0.9997231364250183
. O 0 0.016428841277956963

Addition O 0 0.014052524231374264
of O 0 0.005930177867412567
soluble O 0 0.08438434451818466
wild O 0 0.038940005004405975
- O 0 0.0600876659154892
type O 0 0.37550538778305054
HFE O 1 0.99981290102005
/ O 1 0.9842616319656372
beta2m O 1 0.9931421279907227
heterodimers O 1 0.9864708781242371
to O 0 0.0073031168431043625
cultured O 1 0.7650769948959351
cells O 1 0.6836578845977783
also O 0 0.00391744077205658
decreased O 0 0.058140650391578674
the O 0 0.0036109231878072023
apparent O 0 0.0345437191426754
affinity O 0 0.02020854689180851
of O 0 0.001814617426134646
the O 0 0.0040734983049333096
TfR O 1 0.994314968585968
for O 0 0.002174260327592492
its O 0 0.0041770003736019135
ligand O 0 0.03108554147183895
under O 0 0.004194188397377729
steady O 0 0.019972942769527435
- O 0 0.01244007796049118
state O 0 0.002796572633087635
conditions O 0 0.005122086498886347
, O 0 0.0013684422010555863
both O 0 0.0016370814992114902
in O 0 0.0028970229905098677
293 O 1 0.5899279713630676
cells O 0 0.1546834111213684
and O 0 0.0025748535990715027
in O 0 0.005331049673259258
HeLa O 1 0.9996929168701172
cells O 1 0.6278030872344971
. O 0 0.015139222145080566

Furthermore O 0 0.02717755176126957
, O 0 0.0032553523778915405
at O 0 0.004125678446143866
4 O 0 0.008758083917200565
degrees O 0 0.009005160070955753
C O 0 0.019418885931372643
, O 0 0.0018362001283094287
the O 0 0.00206124410033226
added O 0 0.0051711248233914375
soluble O 0 0.03366506099700928
complex O 0 0.011071642860770226
of O 0 0.0060458313673734665
HFE O 1 0.9999568462371826
/ O 1 0.9828265905380249
beta2m O 1 0.9939648509025574
inhibited O 0 0.4707097113132477
binding O 0 0.016673840582370758
of O 0 0.0046082595363259315
transferrin O 1 0.9361640810966492
to O 0 0.007226630114018917
HeLa O 1 0.9993898868560791
cell O 1 0.6300745010375977
TfR O 1 0.9774332642555237
in O 0 0.0035918953362852335
a O 0 0.009702752344310284
concentration O 0 0.04158804193139076
- O 0 0.030225249007344246
dependent O 0 0.02802998758852482
manner O 0 0.018513817340135574
. O 0 0.009032892994582653

Scatchard O 0 0.11296983808279037
plots O 0 0.016402332112193108
of O 0 0.0019144535763189197
these O 0 0.0012416236568242311
data O 0 0.002497990382835269
indicate O 0 0.00508076511323452
that O 0 0.0012693727621808648
the O 0 0.002288759918883443
added O 0 0.00665252236649394
heterodimer O 1 0.9943022727966309
substantially O 0 0.02981685847043991
reduced O 0 0.01447643805295229
the O 0 0.003468428272753954
affinity O 0 0.026019161567091942
of O 0 0.005508336238563061
TfR O 1 0.9959190487861633
for O 0 0.008001692593097687
transferrin O 1 0.984569251537323
. O 0 0.015090038068592548

These O 0 0.005189254879951477
results O 0 0.007624780293554068
establish O 0 0.008534007705748081
a O 0 0.006980301812291145
molecular O 0 0.02636510506272316
link O 0 0.01718735322356224
between O 0 0.007454015780240297
HFE O 1 0.9992372989654541
and O 0 0.002415046561509371
a O 0 0.004545058123767376
key O 0 0.00726573821157217
protein O 0 0.02379310317337513
involved O 0 0.005866088904440403
in O 0 0.001928581390529871
iron O 0 0.018377481028437614
transport O 0 0.0071318200789391994
, O 0 0.00205496558919549
the O 0 0.004187907557934523
TfR O 1 0.9994550347328186
, O 0 0.002147489693015814
and O 0 0.0014084597351029515
raise O 0 0.005840016528964043
the O 0 0.0019855487626045942
possibility O 0 0.00630862545222044
that O 0 0.0020195087417960167
alterations O 0 0.01311586331576109
in O 0 0.001805014442652464
this O 0 0.0021178347524255514
regulatory O 0 0.0199739933013916
mechanism O 0 0.014908738434314728
may O 0 0.003820621408522129
play O 0 0.0015481933951377869
a O 0 0.002406468614935875
role O 0 0.004018315579742193
in O 0 0.0017850070726126432
the O 0 0.004330821335315704
pathogenesis O 1 0.9997877478599548
of O 0 0.010931933298707008
hereditary B-Disease 1 0.9999979734420776
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.009776967577636242
. O 0 0.011472387239336967

Genomic O 0 0.1374964565038681
organization O 0 0.012950402684509754
of O 0 0.0041534919291734695
the O 0 0.01106778159737587
UBE3A O 1 0.9997561573982239
/ O 1 0.9830092787742615
E6 O 1 0.995331346988678
- O 0 0.057679083198308945
AP O 0 0.07703995704650879
gene O 1 0.7202684283256531
and O 0 0.004410911351442337
related O 0 0.02115023322403431
pseudogenes O 1 0.9843518137931824
. O 0 0.013944126665592194

The O 0 0.03114045038819313
UBE3A O 1 0.9991632699966431
gene O 1 0.953605055809021
encodes O 0 0.07816498726606369
the O 0 0.008718029595911503
E6 O 1 0.9441436529159546
- O 0 0.04498790577054024
AP O 0 0.056075651198625565
ubiquitin O 0 0.0908244326710701
- O 0 0.036968495696783066
protein O 0 0.042257074266672134
ligase O 0 0.02838493511080742
and O 0 0.0019270895281806588
has O 0 0.002846925752237439
recently O 0 0.006261202972382307
been O 0 0.0021987862419337034
shown O 0 0.003582407720386982
to O 0 0.0015000577550381422
be O 0 0.003796514356508851
mutated O 1 0.9998459815979004
in O 0 0.05470220372080803
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999979734420776
who O 0 0.011869635432958603
lack O 0 0.17157676815986633
15q11 O 1 0.9994934797286987
- O 1 0.6057982444763184
q13 O 1 0.9948171973228455
deletions O 1 0.948553204536438
or O 0 0.016173504292964935
chromosome O 1 0.9968187808990479
15 O 0 0.02838071435689926
paternal O 1 0.9951568245887756
uniparental B-Disease 1 0.9998953342437744
disomy I-Disease 1 0.9958388805389404
. O 0 0.021456215530633926

Previous O 0 0.052810750901699066
UBE3A O 1 0.997062623500824
cDNA O 0 0.10029108077287674
analysis O 0 0.010779659263789654
has O 0 0.004599427338689566
shown O 0 0.007778821047395468
a O 0 0.006718297488987446
coding O 0 0.039784982800483704
region O 0 0.007522319909185171
of O 0 0.0022681690752506256
approximately O 0 0.010213835164904594
2 O 0 0.013144117780029774
. O 0 0.009520717896521091

6 O 0 0.027686867862939835
kb O 0 0.06956396251916885
and O 0 0.002664842177182436
a O 0 0.00620032474398613
3 O 0 0.011528991162776947
- O 0 0.029630983248353004
untranslated O 0 0.11017449200153351
region O 0 0.019582334905862808
( O 0 0.011509212665259838
UTR O 0 0.4900452792644501
) O 0 0.006449128966778517
of O 0 0.0045726788230240345
< O 0 0.27976855635643005
50 O 0 0.011260461062192917
bp O 0 0.03065757267177105
, O 0 0.004124881234019995
whereas O 0 0.010248360224068165
Northern O 0 0.007492609787732363
analysis O 0 0.006122470833361149
has O 0 0.0038875958416610956
indicated O 0 0.011868663132190704
mRNA O 0 0.02731773816049099
sizes O 0 0.00990565586835146
of O 0 0.0022270320914685726
5 O 0 0.00974323321133852
- O 0 0.02330115996301174
8 O 0 0.019605137407779694
kb O 0 0.11105752736330032
. O 0 0.016624003648757935

We O 0 0.005566809792071581
have O 0 0.0038362881168723106
analyzed O 0 0.014856097288429737
additional O 0 0.009766493923962116
cDNA O 0 0.08051735162734985
clones O 0 0.12020799517631531
and O 0 0.002352159470319748
provide O 0 0.003214182797819376
evidence O 0 0.002836443716660142
for O 0 0.0014090267941355705
an O 0 0.002382818842306733
additional O 0 0.006241277325898409
0 O 0 0.02269388549029827
. O 0 0.00942265149205923

5 O 0 0.027172105386853218
kb O 0 0.0619971938431263
of O 0 0.004245981574058533
5 O 0 0.012810753658413887
- O 0 0.02850765362381935
UTR O 1 0.5011391639709473
and O 0 0.006096489727497101
> O 0 0.2037283182144165
2 O 0 0.01142092328518629
kb O 0 0.0426713302731514
of O 0 0.0037457160651683807
3 O 0 0.015524395741522312
- O 0 0.046809837222099304
UTR O 1 0.7503369450569153
. O 0 0.01750447228550911

We O 0 0.0037702678237110376
have O 0 0.002381268423050642
established O 0 0.00414804182946682
the O 0 0.0032497053034603596
genomic O 0 0.13491852581501007
organization O 0 0.007819972932338715
of O 0 0.0041608563624322414
UBE3A O 1 0.9991764426231384
and O 0 0.0020323542412370443
the O 0 0.0022938030306249857
sequence O 0 0.01304600015282631
of O 0 0.005057828035205603
intron O 1 0.9965768456459045
- O 0 0.11108624190092087
exon O 1 0.5912476181983948
borders O 0 0.0338808037340641
. O 0 0.013399542309343815

We O 0 0.004732679575681686
have O 0 0.002254694700241089
also O 0 0.0019223325653001666
mapped O 0 0.015146552585065365
two O 0 0.0028730863705277443
highly O 0 0.016500698402523994
homologous O 0 0.1714577078819275
processed O 0 0.026589814573526382
pseudogenes O 1 0.9860345125198364
, O 0 0.006673004478216171
UBE3AP1 O 1 0.9973939657211304
and O 0 0.005227834917604923
UBE3AP2 O 1 0.9960261583328247
, O 0 0.002793061314150691
to O 0 0.002564363880082965
chromosomes O 0 0.04552185907959938
2 O 0 0.005013380199670792
and O 0 0.0014655718114227057
21 O 0 0.006271230522543192
, O 0 0.0016263516154140234
respectively O 0 0.003993582911789417
, O 0 0.001363191520795226
and O 0 0.0013987654820084572
determined O 0 0.007817575708031654
their O 0 0.004654650576412678
genomic O 0 0.32080569863319397
organization O 0 0.015405525453388691
. O 0 0.011936969123780727

These O 0 0.004036382306367159
results O 0 0.005893528461456299
will O 0 0.0016619254602119327
form O 0 0.003143094712868333
the O 0 0.001248711021617055
basis O 0 0.0015108536463230848
for O 0 0.0015529593219980597
studies O 0 0.0049876198172569275
of O 0 0.00426105409860611
mutation O 1 0.998076319694519
and O 0 0.005208377260714769
imprinting O 1 0.9805268049240112
of O 0 0.013432721607387066
UBE3A O 1 0.999538779258728
. O 0 0.02020815759897232

Mutation O 1 0.9976971745491028
spectrum O 0 0.07757635414600372
and O 0 0.009924080222845078
genotype O 1 0.9995647072792053
- O 1 0.7401866912841797
phenotype O 1 0.9998396635055542
analyses O 0 0.020715048536658287
in O 0 0.007792126387357712
Cowden B-Disease 1 0.9999951124191284
disease I-Disease 1 0.9999995231628418
and O 0 0.00797777995467186
Bannayan B-Disease 1 0.9999724626541138
- I-Disease 1 0.9996238946914673
Zonana I-Disease 1 0.9999943971633911
syndrome I-Disease 1 0.9999998807907104
, O 0 0.007240896578878164
two O 0 0.012231390923261642
hamartoma B-Disease 1 0.9999822378158569
syndromes I-Disease 1 0.9999955892562866
with O 0 0.03584590554237366
germline O 1 0.9999682903289795
PTEN O 1 0.9999735355377197
mutation O 1 0.9997350573539734
. O 0 0.02437494322657585

The O 0 0.037262290716171265
tumour B-Disease 1 0.9999986886978149
suppressor O 1 0.9999828338623047
gene O 1 0.9996602535247803
PTEN O 1 0.9999086856842041
, O 0 0.0035537697840481997
which O 0 0.0022214390337467194
maps O 0 0.005367375444620848
to O 0 0.004210974555462599
10q23 O 1 0.9050694108009338
. O 0 0.014527009800076485

3 O 0 0.016052404418587685
and O 0 0.003592299995943904
encodes O 0 0.04149961471557617
a O 0 0.009752470999956131
403 O 0 0.04283894598484039
amino O 0 0.0414130873978138
acid O 0 0.06365792453289032
dual O 0 0.031443629413843155
specificity O 0 0.06164206191897392
phosphatase O 1 0.9777066707611084
( O 0 0.019248314201831818
protein O 0 0.06786957383155823
tyrosine O 1 0.8653419017791748
phosphatase O 1 0.9976327419281006
; O 0 0.012567486613988876
PTPase O 1 0.9942499399185181
) O 0 0.0041258372366428375
, O 0 0.0016834050184115767
was O 0 0.0025274264626204967
shown O 0 0.0053208391182124615
recently O 0 0.0052243745885789394
to O 0 0.001255685812793672
play O 0 0.0023998920805752277
a O 0 0.005267806351184845
broad O 0 0.013523074798285961
role O 0 0.00814992468804121
in O 0 0.0049069542437791824
human O 0 0.057912830263376236
malignancy B-Disease 1 0.9999635219573975
. O 0 0.01792815327644348

Somatic O 1 0.9917352199554443
PTEN O 1 0.9995890259742737
deletions O 1 0.9597294926643372
and O 0 0.006913665682077408
mutations O 1 0.9991814494132996
were O 0 0.0025522459764033556
observed O 0 0.009981407783925533
in O 0 0.004048127681016922
sporadic B-Disease 1 0.9986035227775574
breast I-Disease 1 0.9999991655349731
, I-Disease 0 0.01763741299510002
brain I-Disease 1 0.9999983310699463
, I-Disease 0 0.08226899057626724
prostate I-Disease 1 1.0
and I-Disease 1 0.8168986439704895
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9801418781280518
lines O 0 0.008414183743298054
and O 0 0.0011592122027650476
in O 0 0.001563730649650097
several O 0 0.0032501285895705223
primary O 0 0.0973975658416748
tumours B-Disease 1 0.9999819993972778
such O 0 0.00418921047821641
as O 0 0.010522148571908474
endometrial B-Disease 1 0.9999996423721313
carcinomas I-Disease 1 0.9999997615814209
, O 1 0.9857679009437561
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8769264221191406
thyroid B-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999986886978149
. O 0 0.024165615439414978

In O 0 0.005585815757513046
addition O 0 0.007702769245952368
, O 0 0.005135487765073776
PTEN O 1 0.9999431371688843
was O 0 0.004751883447170258
identified O 0 0.007167843170464039
as O 0 0.00196241051889956
the O 0 0.004557874519377947
susceptibility O 1 0.9995818734169006
gene O 1 0.9122136235237122
for O 0 0.003930638078600168
two O 0 0.010550210252404213
hamartoma B-Disease 1 0.9999985694885254
syndromes I-Disease 1 0.9999997615814209
Cowden B-Disease 1 0.999998927116394
disease I-Disease 1 0.9999994039535522
( O 0 0.017867958173155785
CD B-Disease 0 0.0895373672246933
; O 0 0.01265215314924717
MIM O 1 0.9997666478157043
158350 O 1 0.9862501621246338
) O 0 0.00714781554415822
and O 0 0.004412515088915825
Bannayan B-Disease 1 0.9972679615020752
- I-Disease 0 0.3730221688747406
Zonana I-Disease 1 0.9976840019226074
( I-Disease 0 0.020802456885576248
BZS I-Disease 1 0.9853099584579468
) I-Disease 0 0.009320094250142574
or I-Disease 0 0.0113011309877038
Ruvalcaba I-Disease 1 0.9986118078231812
- I-Disease 0 0.25183215737342834
Riley I-Disease 1 0.961764395236969
- I-Disease 1 0.8582653999328613
Smith I-Disease 1 0.9825043082237244
syndrome I-Disease 1 0.9999997615814209
( O 0 0.034453216940164566
MIM O 1 0.9996888637542725
153480 O 1 0.9955368041992188
) O 0 0.015884505584836006
. O 0 0.011681889183819294

Constitutive O 0 0.17218370735645294
DNA O 0 0.05080166831612587
from O 0 0.006841725669801235
37 O 0 0.018256550654768944
CD B-Disease 0 0.02074076607823372
families O 0 0.007172941695898771
and O 0 0.0018526589265093207
seven O 0 0.007019495125859976
BZS B-Disease 1 0.9924113750457764
families O 0 0.01103940885514021
was O 0 0.00721343420445919
screened O 0 0.047864895313978195
for O 0 0.01605592854321003
germline O 1 0.9994670748710632
PTEN O 1 0.9998512268066406
mutations O 1 0.9990193843841553
. O 0 0.01867673732340336

PTEN O 1 0.9998424053192139
mutations O 1 0.9970607161521912
were O 0 0.0035957167856395245
identified O 0 0.007697879336774349
in O 0 0.0020158342085778713
30 O 0 0.004479972645640373
of O 0 0.0022973588202148676
37 O 0 0.01579749397933483
( O 0 0.006720248609781265
81 O 0 0.01920873112976551
% O 0 0.005660858936607838
) O 0 0.0033517645206302404
CD B-Disease 0 0.012486258521676064
families O 0 0.004568808246403933
, O 0 0.0018108641961589456
including O 0 0.0035519860684871674
missense O 1 0.9967677593231201
and O 0 0.0036906676832586527
nonsense O 0 0.032663293182849884
point O 0 0.010755793191492558
mutations O 1 0.9980536699295044
, O 0 0.004268621560186148
deletions O 0 0.3070559501647949
, O 0 0.003708998439833522
insertions O 0 0.1343841254711151
, O 0 0.0026617569383233786
a O 0 0.009585651569068432
deletion O 1 0.9963876008987427
/ O 0 0.45167675614356995
insertion O 0 0.42686283588409424
and O 0 0.004609386436641216
splice O 1 0.8534486889839172
site O 0 0.031671226024627686
mutations O 1 0.9828451871871948
. O 0 0.014516781084239483

These O 0 0.009075683541595936
mutations O 1 0.9965479969978333
were O 0 0.002004432724788785
scattered O 0 0.006402410566806793
over O 0 0.0018608813406899571
the O 0 0.0017760093323886395
entire O 0 0.008340248838067055
length O 0 0.00845605880022049
of O 0 0.004593594931066036
PTEN O 1 0.9999622106552124
, O 0 0.0025009566452354193
with O 0 0.0013689968036487699
the O 0 0.0014772892463952303
exception O 0 0.004746319260448217
of O 0 0.001066127559170127
the O 0 0.001401441521011293
first O 0 0.002353231655433774
, O 0 0.0019082550425082445
fourth O 0 0.008299396373331547
and O 0 0.003159797051921487
last O 0 0.01189044676721096
exons O 0 0.1238018199801445
. O 0 0.015386464074254036

A O 0 0.02127855084836483
hot O 0 0.03152043744921684
spot O 0 0.021643122658133507
for O 0 0.008106345310807228
PTEN O 1 0.9999809265136719
mutation O 1 0.9992786049842834
in O 0 0.003492281073704362
CD B-Disease 0 0.014558013528585434
was O 0 0.003691297024488449
identified O 0 0.007511391770094633
in O 0 0.002915611257776618
exon O 0 0.371970534324646
5 O 0 0.005480116233229637
that O 0 0.001406136667355895
contains O 0 0.0035130970645695925
the O 0 0.0031669740565121174
PTPase O 1 0.9882381558418274
core O 0 0.018378788605332375
motif O 0 0.044969044625759125
, O 0 0.0017177775735035539
with O 0 0.0015564225614070892
13 O 0 0.00452152406796813
of O 0 0.001819936907850206
30 O 0 0.006760955322533846
( O 0 0.0054506342858076096
43 O 0 0.011951938271522522
% O 0 0.00680014630779624
) O 0 0.005906142294406891
CD B-Disease 0 0.034177254885435104
mutations O 1 0.9822433590888977
identified O 0 0.012694844976067543
in O 0 0.003083419520407915
this O 0 0.00462621683254838
exon O 0 0.25403720140457153
. O 0 0.013904241845011711

Seven O 0 0.007083119358867407
of O 0 0.0028319319244474173
30 O 0 0.007692436221987009
( O 0 0.004941892810165882
23 O 0 0.007300929166376591
% O 0 0.0038629123009741306
) O 0 0.0018211551941931248
were O 0 0.0008751682471483946
within O 0 0.0021526662167161703
the O 0 0.002175688510760665
core O 0 0.010348975658416748
motif O 0 0.026255041360855103
, O 0 0.001650218153372407
the O 0 0.0019420672906562686
majority O 0 0.006225032266229391
( O 0 0.0027318447828292847
five O 0 0.0013948811683803797
of O 0 0.0010146120330318809
seven O 0 0.002662279875949025
) O 0 0.0018834987422451377
of O 0 0.0012440573191270232
which O 0 0.001853646943345666
were O 0 0.0038758479058742523
missense O 1 0.9995667338371277
mutations O 1 0.9997499585151672
, O 0 0.0034237967338413
possibly O 0 0.00962100364267826
pointing O 0 0.009007450193166733
to O 0 0.0017330278642475605
the O 0 0.0024042914155870676
functional O 0 0.012504098936915398
significance O 0 0.005134977865964174
of O 0 0.0018562909681349993
this O 0 0.003109670476987958
region O 0 0.01324611809104681
. O 0 0.008733632043004036

Germline O 1 0.9998013377189636
PTEN O 1 0.9999692440032959
mutations O 1 0.9994100332260132
were O 0 0.0029956018552184105
identified O 0 0.006616466678678989
in O 0 0.0012155052972957492
four O 0 0.0012727868743240833
of O 0 0.0011850285809487104
seven O 0 0.003664140123873949
( O 0 0.005807980895042419
57 O 0 0.015652934089303017
% O 0 0.008989755995571613
) O 0 0.00970012228935957
BZS B-Disease 1 0.8978389501571655
families O 0 0.01630479469895363
studied O 0 0.01625923626124859
. O 0 0.013703545555472374

Interestingly O 0 0.10795093327760696
, O 0 0.004233202897012234
none O 0 0.005427411291748285
of O 0 0.0019504589727148414
these O 0 0.0034283981658518314
mutations O 1 0.9991616010665894
was O 0 0.004514877684414387
observed O 0 0.007762144319713116
in O 0 0.0015674192691221833
the O 0 0.004030877258628607
PTPase O 1 0.9833832383155823
core O 0 0.03040711022913456
motif O 0 0.0941830575466156
. O 0 0.01360014546662569

It O 0 0.004664695356041193
is O 0 0.0029696247074753046
also O 0 0.0018329822923988104
worthy O 0 0.009978999383747578
of O 0 0.0017796491738408804
note O 0 0.006232186686247587
that O 0 0.0013639252865687013
a O 0 0.003931345418095589
single O 0 0.007687320467084646
nonsense O 0 0.025429194793105125
point O 0 0.01069866307079792
mutation O 1 0.9988254904747009
, O 0 0.004868004005402327
R233X O 1 0.9824763536453247
, O 0 0.002419837284833193
was O 0 0.003259500255808234
observed O 0 0.007418637163937092
in O 0 0.0015555322170257568
the O 0 0.0047928872518241405
germline O 1 0.9995625615119934
DNA O 0 0.029070857912302017
from O 0 0.00321510573849082
two O 0 0.002739167073741555
unrelated O 0 0.020199228078126907
CD B-Disease 0 0.018929872661828995
families O 0 0.006468004547059536
and O 0 0.002436778973788023
one O 0 0.008208644576370716
BZS B-Disease 1 0.9895854592323303
family O 0 0.02659355103969574
. O 0 0.011939342133700848

Genotype O 1 0.9996728897094727
- O 1 0.9267069697380066
phenotype O 1 0.9998375177383423
studies O 0 0.008319346234202385
were O 0 0.0016303639858961105
not O 0 0.001535972231067717
performed O 0 0.004896898753941059
on O 0 0.001364468247629702
this O 0 0.0017520488472655416
small O 0 0.004089174792170525
group O 0 0.006186156067997217
of O 0 0.006862698122859001
BZS B-Disease 1 0.9829846024513245
families O 0 0.024919865652918816
. O 0 0.013225255534052849

However O 0 0.011618648655712605
, O 0 0.009952718392014503
genotype O 1 0.9991742968559265
- O 1 0.5424329042434692
phenotype O 1 0.9994342923164368
analysis O 0 0.022678440436720848
inthe O 1 0.9064545631408691
group O 0 0.007197501137852669
of O 0 0.0025906660594046116
CD B-Disease 0 0.020959952846169472
families O 0 0.0094460379332304
revealed O 0 0.011907648295164108
two O 0 0.0020204209722578526
possible O 0 0.005713519640266895
associations O 0 0.008383164182305336
worthy O 0 0.011519942432641983
of O 0 0.0017645210027694702
follow O 0 0.005893398076295853
- O 0 0.010417980141937733
up O 0 0.0032512503676116467
in O 0 0.002593908691778779
independent O 0 0.008038649335503578
analyses O 0 0.018964918330311775
. O 0 0.01043832115828991

The O 0 0.005654199980199337
first O 0 0.004214003216475248
was O 0 0.0031897027511149645
an O 0 0.002350706374272704
association O 0 0.006494198460131884
noted O 0 0.00292018661275506
in O 0 0.0010439138859510422
the O 0 0.0013895033625885844
group O 0 0.0032228827476501465
of O 0 0.0018849802436307073
CD B-Disease 0 0.02137203887104988
families O 0 0.013967913575470448
with O 0 0.04037293791770935
breast B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999996423721313
. O 0 0.016786813735961914

A O 0 0.022830704227089882
correlation O 0 0.03756435215473175
was O 0 0.006239315960556269
observed O 0 0.008822009898722172
between O 0 0.002606380032375455
the O 0 0.0028005195781588554
presence O 0 0.013844775035977364
/ O 0 0.07697757333517075
absence O 0 0.012459470890462399
of O 0 0.003041233401745558
a O 0 0.015750840306282043
PTEN O 1 0.9999822378158569
mutation O 1 0.9996709823608398
and O 0 0.0023202267475426197
the O 0 0.0034208367578685284
type O 0 0.02103468030691147
of O 0 0.005378630943596363
breast O 1 0.9999971389770508
involvement O 0 0.34458258748054504
( O 0 0.014358068816363811
unaffected O 1 0.9982461929321289
versus O 1 0.9780840277671814
benign O 1 0.999940037727356
versus O 1 0.9981069564819336
malignant O 1 0.9999961853027344
) O 0 0.013366908766329288
. O 0 0.010202704928815365

Specifically O 0 0.012250740081071854
and O 0 0.0019568779971450567
more O 0 0.0019469730323180556
directly O 0 0.003623940283432603
, O 0 0.0016426672227680683
an O 0 0.002258973428979516
association O 0 0.006677278317511082
was O 0 0.0029346225783228874
also O 0 0.0019125938415527344
observed O 0 0.005714974366128445
between O 0 0.001709650387056172
the O 0 0.0013757095439359546
presence O 0 0.004890099633485079
of O 0 0.0019058206817135215
a O 0 0.016679510474205017
PTEN O 1 0.9999967813491821
mutation O 1 0.9999849796295166
and O 1 0.5072020292282104
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999990463256836
. O 0 0.020801961421966553

Secondly O 0 0.11784151196479797
, O 0 0.0031639032531529665
there O 0 0.0024679675698280334
appeared O 0 0.004722996149212122
to O 0 0.001484833424910903
be O 0 0.001617943518795073
an O 0 0.0032919354271143675
interdependent O 0 0.15644685924053192
association O 0 0.014825547114014626
between O 0 0.008270991034805775
mutations O 1 0.99517822265625
upstream O 0 0.019275210797786713
and O 0 0.0016269820043817163
within O 0 0.003175395308062434
the O 0 0.004384403117001057
PTPase O 1 0.9935798645019531
core O 0 0.019114941358566284
motif O 0 0.03253946453332901
, O 0 0.001981256762519479
the O 0 0.0021199327893555164
core O 0 0.009773516096174717
motif O 0 0.025769798085093498
containing O 0 0.004973979666829109
the O 0 0.0021904567256569862
majority O 0 0.006366082467138767
of O 0 0.004606630187481642
missense O 1 0.9999699592590332
mutations O 1 0.9999421834945679
, O 0 0.001870359992608428
and O 0 0.0009312455076724291
the O 0 0.00155198376160115
involvement O 0 0.007339785806834698
of O 0 0.0011763524962589145
all O 0 0.001475545926950872
major O 0 0.007822173647582531
organ O 1 0.6115254759788513
systems O 0 0.010380257852375507
( O 0 0.0050132181495428085
central O 0 0.006613788194954395
nervous O 1 0.9982420206069946
system O 0 0.012852726504206657
, O 0 0.008781520649790764
thyroid O 1 0.9999996423721313
, O 0 0.07419651001691818
breast O 1 0.9999998807907104
, O 0 0.13532030582427979
skin O 1 0.9999997615814209
and O 0 0.17694520950317383
gastrointestinal O 1 0.9999998807907104
tract O 1 0.9999904632568359
) O 0 0.013242964632809162
. O 0 0.011488544754683971

However O 0 0.006982672028243542
, O 0 0.0016336907865479589
these O 0 0.0012489038053900003
observations O 0 0.004263864830136299
would O 0 0.001347176730632782
need O 0 0.0025644528213888407
to O 0 0.001130476244725287
be O 0 0.0015780620742589235
confirmed O 0 0.0059562078677117825
by O 0 0.0020921053364872932
studying O 0 0.00370543054305017
a O 0 0.0035145662259310484
larger O 0 0.005198715720325708
number O 0 0.002365193096920848
of O 0 0.002328817965462804
CD B-Disease 0 0.023467570543289185
families O 0 0.01325933076441288
. O 0 0.01077960804104805

Molecular O 1 0.5174647569656372
defects O 1 0.9991745352745056
leading O 0 0.00933083426207304
to O 0 0.0025196487549692392
human O 0 0.011568357236683369
complement B-Disease 0 0.03740789741277695
component I-Disease 1 0.9368878602981567
C6 I-Disease 1 0.999992847442627
deficiency I-Disease 1 0.9999980926513672
in O 0 0.003742136061191559
an O 0 0.00438104011118412
African O 0 0.02169959433376789
- O 0 0.032863445580005646
American O 0 0.014017095789313316
family O 0 0.021929211914539337
. O 0 0.012395781464874744

Complement B-Disease 0 0.09120345860719681
component I-Disease 1 0.8947014212608337
C6 I-Disease 1 0.9999887943267822
deficiency I-Disease 1 0.9999995231628418
( O 0 0.021685071289539337
C6D B-Disease 1 0.9990811347961426
) O 0 0.007935740984976292
was O 0 0.012156305834650993
diagnosed O 1 0.9999988079071045
in O 0 0.002440626733005047
a O 0 0.004930706229060888
16 O 0 0.008034965954720974
- O 0 0.014856256544589996
year O 0 0.007715864572674036
- O 0 0.01867740973830223
old O 0 0.01274824794381857
African O 0 0.01918831281363964
- O 0 0.024412065744400024
American O 0 0.01464181486517191
male O 0 0.17966137826442719
with O 0 0.021310172975063324
meningococcal B-Disease 1 0.9999997615814209
meningitis I-Disease 1 0.9999994039535522
. O 0 0.024421419948339462

The O 0 0.01963542401790619
patients O 1 0.9996426105499268
father O 0 0.016022806987166405
and O 0 0.002030544448643923
two O 0 0.0027376841753721237
brothers O 0 0.013656475581228733
also O 0 0.002839052816852927
had O 0 0.00636999262496829
C6D B-Disease 1 0.9991874098777771
, O 0 0.0029750976245850325
but O 0 0.002455665497109294
gave O 0 0.00431407755240798
no O 0 0.002842957153916359
history O 0 0.006007116753607988
of O 0 0.006919459905475378
meningitis B-Disease 1 0.9999994039535522
or O 0 0.01097157970070839
other O 0 0.008240352384746075
neisserial B-Disease 1 0.9998302459716797
infection I-Disease 1 0.9999961853027344
. O 0 0.02291122078895569

By O 0 0.009894185699522495
using O 0 0.011972175911068916
exon O 0 0.3454747796058655
- O 0 0.03135035187005997
specific O 0 0.016325173899531364
polymerase O 1 0.6429654359817505
chain O 0 0.31159302592277527
reaction O 0 0.0372006893157959
( O 0 0.011480933986604214
PCR O 0 0.12110288441181183
) O 0 0.009565528482198715
/ O 0 0.03590056300163269
single O 0 0.01702616736292839
- O 0 0.03650817275047302
strand O 0 0.07692787796258926
conformation O 0 0.18351802229881287
polymorphism O 0 0.09919135272502899
as O 0 0.003329520346596837
a O 0 0.007160872686654329
screening O 0 0.028884345665574074
step O 0 0.010278050787746906
and O 0 0.002978859469294548
nucleotide O 0 0.043614596128463745
sequencing O 0 0.025593310594558716
of O 0 0.00312039558775723
target O 0 0.01216905191540718
exons O 0 0.14408166706562042
, O 0 0.002019651932641864
we O 0 0.0014792283764109015
determined O 0 0.00552360899746418
that O 0 0.0013700363924726844
the O 0 0.0031242009717971087
proband O 1 0.8599488139152527
was O 0 0.004007585812360048
a O 0 0.006886303890496492
compound O 0 0.020880481228232384
heterozygote O 1 0.9142048954963684
for O 0 0.0053555103950202465
two O 0 0.011125821620225906
C6 O 1 0.9996886253356934
gene O 1 0.9961287975311279
mutations O 1 0.9952487349510193
. O 0 0.016406770795583725

The O 0 0.005951596423983574
first O 0 0.005298872943967581
, O 0 0.004540370777249336
1195delC O 1 0.7764297723770142
located O 0 0.008030316792428493
in O 0 0.0038292098324745893
exon O 0 0.4171988368034363
7 O 0 0.00916669424623251
, O 0 0.0018102972535416484
is O 0 0.002176030073314905
a O 0 0.005675995256751776
novel O 0 0.029312649741768837
mutation O 1 0.999649167060852
, O 0 0.001822976628318429
while O 0 0.0016365773044526577
the O 0 0.001672622049227357
second O 0 0.004193971399217844
, O 0 0.002909514121711254
1936delG O 1 0.9660779237747192
in O 0 0.003811736823990941
exon O 1 0.5505182147026062
12 O 0 0.006548967678099871
, O 0 0.0021091296803206205
has O 0 0.0025543896481394768
been O 0 0.002596777630969882
described O 0 0.006281598005443811
before O 0 0.0026397774927318096
to O 0 0.0028713413048535585
cause O 1 0.989696741104126
C6D B-Disease 1 0.9967179894447327
in O 0 0.003904351033270359
an O 0 0.004562504589557648
unrelated O 0 0.030075494199991226
African O 0 0.020973069593310356
- O 0 0.02504623867571354
American O 0 0.010732109658420086
individual O 0 0.01027000229805708
. O 0 0.011202300898730755

Both O 0 0.018258703872561455
mutations O 1 0.9966394901275635
result O 0 0.02029740810394287
in O 0 0.008787943050265312
premature O 1 0.9986405968666077
termination O 1 0.9789851903915405
codons O 0 0.4072768986225128
and O 0 0.009898335672914982
C6 O 1 0.9993839263916016
null O 1 0.5715082883834839
alleles O 1 0.9935454726219177
. O 0 0.0185229629278183

Allele O 1 0.9938312768936157
- O 0 0.048713214695453644
specific O 0 0.015718944370746613
PCR O 0 0.12203333526849747
indicated O 0 0.01086517795920372
that O 0 0.0015458205016329885
the O 0 0.003069339320063591
probands O 1 0.8684619665145874
two O 0 0.0030759433284401894
brothers O 0 0.016124911606311798
also O 0 0.0036750014405697584
inherited O 1 0.9819113612174988
the O 0 0.0077739981934428215
1195delC O 1 0.9996141195297241
mutation O 1 0.9997506737709045
from O 0 0.004360336344689131
their O 0 0.0043472833931446075
heterozygous O 1 0.9942147135734558
mother O 0 0.022231068462133408
and O 0 0.0023858766071498394
the O 0 0.005443801172077656
1936delG O 1 0.9988172650337219
mutation O 1 0.9994101524353027
from O 0 0.005146603565663099
their O 0 0.005796672310680151
homozygous O 1 0.9988221526145935
father O 0 0.022645890712738037
. O 0 0.005444279406219721
. O 0 0.009524027816951275

PAX6 O 1 0.9996201992034912
mutations O 1 0.9972055554389954
reviewed O 0 0.04372919723391533
. O 0 0.016395533457398415

Mutations O 1 0.998348593711853
in O 0 0.012205083854496479
PAX6 O 1 0.999862790107727
are O 0 0.0024468854535371065
responsible O 0 0.009199013002216816
for O 0 0.002710177795961499
human O 0 0.017886945977807045
aniridia B-Disease 1 0.9997527003288269
and O 0 0.0017073642229661345
have O 0 0.0014033420011401176
also O 0 0.0011091865599155426
been O 0 0.00218714727088809
found O 0 0.004436270333826542
in O 0 0.004397412296384573
patients O 1 0.9998169541358948
with O 0 0.005428075324743986
Peters B-Disease 1 0.999346911907196
anomaly I-Disease 1 0.9988549947738647
, O 0 0.004389528650790453
with O 0 0.016474222764372826
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.0060260402970016
with O 0 0.011839412152767181
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.9999277591705322
keratitis I-Disease 1 0.9999996423721313
, O 0 0.004152422770857811
and O 0 0.00224541244097054
with O 0 0.005772267002612352
isolated B-Disease 1 0.9782773852348328
foveal I-Disease 1 0.9996302127838135
hypoplasia I-Disease 1 0.9998917579650879
. O 0 0.024850254878401756

No O 0 0.014517647214233875
locus O 1 0.9760170578956604
other O 0 0.005174044519662857
than O 0 0.012245392426848412
chromosome O 1 0.9995030164718628
11p13 O 1 0.9912406802177429
has O 0 0.0057207620702683926
been O 0 0.005608012434095144
implicated O 0 0.14759477972984314
in O 0 0.005794035270810127
aniridia B-Disease 1 0.999022364616394
, O 0 0.0035071761813014746
and O 0 0.0038021202199161053
PAX6 O 1 0.9999040365219116
is O 0 0.0035257593262940645
clearly O 0 0.0046683670952916145
the O 0 0.002125329105183482
major O 0 0.004885859787464142
, O 0 0.0014680071035400033
if O 0 0.0018950430676341057
not O 0 0.0010533769382163882
only O 0 0.0022571287117898464
, O 0 0.0040527768433094025
gene O 1 0.7260001301765442
responsible O 0 0.026176253333687782
. O 0 0.012950914911925793

Twenty O 0 0.027716999873518944
- O 0 0.01816767454147339
eight O 0 0.005555291194468737
percent O 0 0.006970221642404795
of O 0 0.0036118736024945974
identified O 0 0.026461824774742126
PAX6 O 1 0.9999256134033203
mutations O 1 0.9995548129081726
are O 0 0.005378567148000002
C O 1 0.5770425796508789
- O 0 0.24815692007541656
T O 1 0.9601921439170837
changes O 0 0.012367292307317257
at O 0 0.008865680545568466
CpG O 1 0.9891363382339478
dinucleotides O 1 0.9834206700325012
, O 0 0.0035527402069419622
20 O 0 0.0048390584997832775
% O 0 0.003948614001274109
are O 0 0.0018720991211012006
splicing O 0 0.051409829407930374
errors O 0 0.012358620762825012
, O 0 0.0017815381288528442
and O 0 0.0010942869121208787
more O 0 0.0014294286957010627
than O 0 0.0025571694131940603
30 O 0 0.005295732524245977
% O 0 0.00522536039352417
are O 0 0.002981324680149555
deletion O 1 0.9572795033454895
or O 0 0.00868693832308054
insertion O 0 0.14524881541728973
events O 0 0.014929739758372307
. O 0 0.01037861779332161

There O 0 0.006224796175956726
is O 0 0.0048432485200464725
a O 0 0.009821194224059582
noticeably O 1 0.7240521907806396
elevated O 0 0.23494122922420502
level O 0 0.006389156449586153
of O 0 0.0030742387752979994
mutation O 1 0.9994182586669922
in O 0 0.0019685302395373583
the O 0 0.0028833227697759867
paired O 0 0.032994817942380905
domain O 0 0.013273781165480614
compared O 0 0.005580229684710503
with O 0 0.0013315366813912988
the O 0 0.0016954560996964574
rest O 0 0.004737850744277239
of O 0 0.0019958948250859976
the O 0 0.005878442898392677
gene O 1 0.9690551161766052
. O 0 0.009385489858686924

Increased O 0 0.06256227195262909
mutation O 1 0.9972317814826965
in O 0 0.004018117673695087
the O 0 0.004264642484486103
homeodomain O 1 0.9155288338661194
is O 0 0.003978545777499676
accounted O 0 0.008934499695897102
for O 0 0.0017045041313394904
by O 0 0.002176976529881358
the O 0 0.00511174788698554
hypermutable O 1 0.9937153458595276
CpG O 1 0.9910138249397278
dinucleotide O 1 0.8387833833694458
in O 0 0.008297756314277649
codon O 0 0.14107626676559448
240 O 0 0.038183458149433136
. O 0 0.012845225632190704

Very O 0 0.013695145957171917
nearly O 0 0.015563205815851688
all O 0 0.004444073885679245
mutations O 1 0.9992496371269226
appear O 0 0.012011419050395489
to O 0 0.0035311784595251083
cause O 1 0.7784804701805115
loss O 0 0.019567813724279404
of O 0 0.002031205454841256
function O 0 0.006637037266045809
of O 0 0.0017876082565635443
the O 0 0.0056346445344388485
mutant O 1 0.9996053576469421
allele O 1 0.9992390871047974
, O 0 0.0022497037425637245
and O 0 0.0011286856606602669
more O 0 0.0016235390212386847
than O 0 0.0026608530897647142
80 O 0 0.007437565363943577
% O 0 0.00420070206746459
of O 0 0.003150663571432233
exonic O 1 0.9895483255386353
substitutions O 0 0.02574150077998638
result O 0 0.011558844707906246
in O 0 0.0048601385205984116
nonsense O 0 0.050013378262519836
codons O 0 0.2298213243484497
. O 0 0.01502179354429245

In O 0 0.006470005959272385
a O 0 0.0139124421402812
gene O 1 0.7780970335006714
with O 0 0.0028175360057502985
such O 0 0.0024286936968564987
extraordinarily O 0 0.04643953964114189
high O 0 0.008326229639351368
sequence O 0 0.019861586391925812
conservation O 0 0.010684278793632984
throughout O 0 0.005937567446380854
evolution O 0 0.010580322705209255
, O 0 0.0017303414642810822
there O 0 0.0014887289144098759
are O 0 0.0018702137749642134
presumed O 0 0.12970495223999023
undiscovered O 1 0.981212317943573
missense O 1 0.9994305968284607
mutations O 1 0.9996843338012695
, O 0 0.002361238468438387
these O 0 0.0012017824919894338
are O 0 0.001196108991280198
hypothesized O 0 0.04595646634697914
to O 0 0.0014016003115102649
exist O 0 0.0023065973073244095
in O 0 0.0012625938979908824
as O 0 0.00236496701836586
- O 0 0.015158030204474926
yet O 0 0.010800781659781933
unidentified O 0 0.037487320601940155
phenotypes O 1 0.995147168636322
. O 0 0.005587081890553236
. O 0 0.008913733996450901

Genetic O 1 0.9203059673309326
heterogeneity O 0 0.40258994698524475
and O 0 0.006467232946306467
penetrance O 1 0.9718291759490967
analysis O 0 0.007036715745925903
of O 0 0.002675511408597231
the O 0 0.0073310015723109245
BRCA1 O 1 0.9999878406524658
and O 0 0.011187189258635044
BRCA2 O 1 0.9999951124191284
genes O 1 0.9959995746612549
in O 0 0.02582666464149952
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999985694885254
families O 0 0.02884841151535511
. O 0 0.012685023248195648

The O 0 0.2131945788860321
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999994039535522
Linkage O 1 0.972685694694519
Consortium O 0 0.06634007394313812
. O 0 0.016281485557556152

The O 0 0.006987558212131262
contribution O 0 0.014619872905313969
of O 0 0.007615045178681612
BRCA1 O 1 0.9999698400497437
and O 0 0.009740915149450302
BRCA2 O 1 0.9999988079071045
to O 0 0.019553933292627335
inherited B-Disease 1 0.9999995231628418
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
was O 0 0.007903184741735458
assessed O 0 0.017164533957839012
by O 0 0.004367283079773188
linkage O 0 0.10100970417261124
and O 0 0.004524518735706806
mutation O 1 0.9993744492530823
analysis O 0 0.007364412769675255
in O 0 0.0029763721395283937
237 O 0 0.03402381017804146
families O 0 0.006391014903783798
, O 0 0.001735829864628613
each O 0 0.0016903759678825736
with O 0 0.0015148967504501343
at O 0 0.002609350485727191
least O 0 0.004234276711940765
four O 0 0.0033272262662649155
cases O 0 0.010618055239319801
of O 0 0.009290151298046112
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
, O 0 0.002511689206585288
collected O 0 0.0038136548828333616
by O 0 0.0041417614556849
the O 0 0.021986743435263634
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999997615814209
Linkage O 1 0.9661856293678284
Consortium O 0 0.07062563300132751
. O 0 0.01720239780843258

Families O 0 0.013814774341881275
were O 0 0.0019524029921740294
included O 0 0.002466316567733884
without O 0 0.002889042254537344
regard O 0 0.00454775569960475
to O 0 0.0014895846834406257
the O 0 0.0036448126193135977
occurrence O 0 0.10440763831138611
of O 0 0.008574249222874641
ovarian B-Disease 1 0.9999996423721313
or I-Disease 0 0.009672216139733791
other I-Disease 0 0.006944663356989622
cancers I-Disease 1 0.9999808073043823
. O 0 0.011138449423015118

Overall O 0 0.04333285242319107
, O 0 0.01143078412860632
disease O 1 0.9999973773956299
was O 0 0.006990790832787752
linked O 0 0.23963993787765503
to O 0 0.006057318300008774
BRCA1 O 1 0.9999595880508423
in O 0 0.0028452177066355944
an O 0 0.002995138755068183
estimated O 0 0.011577023193240166
52 O 0 0.012223714031279087
% O 0 0.004443291574716568
of O 0 0.0014640542212873697
families O 0 0.0050771525129675865
, O 0 0.002230399753898382
to O 0 0.004186054691672325
BRCA2 O 1 0.9999781847000122
in O 0 0.0032326430082321167
32 O 0 0.009471665136516094
% O 0 0.003038630820810795
of O 0 0.001182243344374001
families O 0 0.0037131328135728836
, O 0 0.0011847182177007198
and O 0 0.000944796425756067
to O 0 0.0014574453234672546
neither O 0 0.009490122087299824
gene O 1 0.7364959120750427
in O 0 0.002383244689553976
16 O 0 0.006332035176455975
% O 0 0.004965533036738634
( O 0 0.0050687026232481
95 O 0 0.009511059150099754
% O 0 0.006497860420495272
confidence O 0 0.014843372628092766
interval O 0 0.03572855517268181
[ O 0 0.04269324615597725
CI O 1 0.997497022151947
] O 0 0.03460726514458656
6 O 0 0.00978537742048502
% O 0 0.007438776083290577
- O 0 0.015995323657989502
28 O 0 0.010277808643877506
% O 0 0.005826134234666824
) O 0 0.0031616210471838713
, O 0 0.0020483892876654863
suggesting O 0 0.013323224149644375
other O 0 0.005053408443927765
predisposition O 1 0.9998273849487305
genes O 1 0.8254741430282593
. O 0 0.013241719454526901

The O 0 0.008527329191565514
majority O 0 0.016558634117245674
( O 0 0.008997644297778606
81 O 0 0.022571656852960587
% O 0 0.004931604955345392
) O 0 0.002363719744607806
of O 0 0.0019527634140104055
the O 0 0.011223607696592808
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999420642852783
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.012332987040281296
were O 0 0.002753225155174732
due O 0 0.009858557023108006
to O 0 0.0045608351938426495
BRCA1 O 1 0.999984860420227
, O 0 0.002477095229551196
with O 0 0.0017744057113304734
most O 0 0.002757120179012418
others O 0 0.004046312998980284
( O 0 0.004143344238400459
14 O 0 0.006838920526206493
% O 0 0.005785002838820219
) O 0 0.0038482851814478636
due O 0 0.009069669991731644
to O 0 0.007516287267208099
BRCA2 O 1 0.9999405145645142
. O 0 0.01946101523935795

Conversely O 0 0.06538110971450806
, O 0 0.0023208349011838436
the O 0 0.002466898411512375
majority O 0 0.005648776423186064
of O 0 0.0017889324808493257
families O 0 0.005268596578389406
with O 0 0.002862365450710058
male B-Disease 0 0.06720605492591858
and I-Disease 0 0.0049135866574943066
female I-Disease 1 0.9989516735076904
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
were O 0 0.0032985666766762733
due O 0 0.009598910808563232
to O 0 0.006272089667618275
BRCA2 O 1 0.999993085861206
( O 0 0.013038690201938152
76 O 0 0.037920188158750534
% O 0 0.009286240674555302
) O 0 0.00808730535209179
. O 0 0.010182169266045094

The O 0 0.009706340730190277
largest O 0 0.020020248368382454
proportion O 0 0.02367909625172615
( O 0 0.007162496447563171
67 O 0 0.01664859987795353
% O 0 0.00521747674793005
) O 0 0.0022082626819610596
of O 0 0.0012146980734542012
families O 0 0.0051679592579603195
due O 0 0.004763995762914419
to O 0 0.0012721708044409752
other O 0 0.00173967145383358
genes O 0 0.15895670652389526
was O 0 0.003126414492726326
found O 0 0.0032495742198079824
in O 0 0.001416490995325148
families O 0 0.0033442333806306124
with O 0 0.0010903239017352462
four O 0 0.0014928763266652822
or O 0 0.0020501797553151846
five O 0 0.0024045142345130444
cases O 0 0.007589090149849653
of O 0 0.004507468082010746
female O 1 0.9992390871047974
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
only O 0 0.007883699610829353
. O 0 0.009537078440189362

These O 0 0.004679795820266008
estimates O 0 0.007249955087900162
were O 0 0.001584670040756464
not O 0 0.002430200343951583
substantially O 0 0.02741527557373047
affected O 0 0.023089006543159485
either O 0 0.004493669606745243
by O 0 0.0029416263569146395
changing O 0 0.007408734876662493
the O 0 0.0035901861265301704
assumed O 0 0.026074234396219254
penetrance O 1 0.9954317808151245
model O 0 0.015221422538161278
for O 0 0.005622768308967352
BRCA1 O 1 0.9999806880950928
or O 0 0.004236516542732716
by O 0 0.0024023535661399364
including O 0 0.0024703883100301027
or O 0 0.004938811995089054
excluding O 0 0.030748434364795685
BRCA1 O 1 0.9999871253967285
mutation O 1 0.9992905855178833
data O 0 0.01536168996244669
. O 0 0.013107175938785076

Among O 0 0.010077091865241528
those O 0 0.003459834260866046
families O 0 0.00837764423340559
with O 0 0.007080648560076952
disease O 1 0.9999997615814209
due O 0 0.01769855059683323
to O 0 0.004416278563439846
BRCA1 O 1 0.9999943971633911
that O 0 0.0018364081624895334
were O 0 0.0015266219852492213
tested O 0 0.010289301164448261
by O 0 0.0015525268390774727
one O 0 0.001188162830658257
of O 0 0.0010155728086829185
the O 0 0.0021601086482405663
standard O 0 0.007358741480857134
screening O 0 0.025811824947595596
methods O 0 0.006572392303496599
, O 0 0.0038239930290728807
mutations O 1 0.9975695013999939
were O 0 0.0028008869849145412
detected O 0 0.025384021922945976
in O 0 0.001784584135748446
the O 0 0.0034432588145136833
coding O 0 0.046320706605911255
sequence O 0 0.02021159417927265
or O 0 0.006226268131285906
splice O 0 0.1547919064760208
sites O 0 0.004587383475154638
in O 0 0.0018909248756244779
an O 0 0.0028015635907649994
estimated O 0 0.011814712546765804
63 O 0 0.01853276789188385
% O 0 0.0070456210523843765
( O 0 0.006281440146267414
95 O 0 0.0136977918446064
% O 0 0.011273782700300217
CI O 1 0.9773597121238708
51 O 0 0.024160107597708702
% O 0 0.009715686552226543
- O 0 0.023021455854177475
77 O 0 0.02421925589442253
% O 0 0.00832758005708456
) O 0 0.008076685480773449
. O 0 0.008492563851177692

The O 0 0.009833235293626785
estimated O 0 0.019472720101475716
sensitivity O 0 0.027475889772176743
was O 0 0.0039033046923577785
identical O 0 0.0071251243352890015
for O 0 0.0016143518732860684
direct O 0 0.006536476779729128
sequencing O 0 0.024650447070598602
and O 0 0.0016847365768626332
other O 0 0.001963926712051034
techniques O 0 0.010784103535115719
. O 0 0.009392062202095985

The O 0 0.013883069157600403
penetrance O 1 0.9917795062065125
of O 0 0.010836619883775711
BRCA2 O 1 0.9999765157699585
was O 0 0.006450039334595203
estimated O 0 0.009197256527841091
by O 0 0.003115128492936492
maximizing O 0 0.021428119391202927
the O 0 0.005096195265650749
LOD O 1 0.9436894059181213
score O 0 0.009493974037468433
in O 0 0.008328607305884361
BRCA2 O 1 0.9999953508377075
- O 1 0.9023077487945557
mutation O 1 0.9998125433921814
families O 0 0.009051447734236717
, O 0 0.0015650488203391433
over O 0 0.002252129139378667
all O 0 0.002087510423734784
possible O 0 0.010507860220968723
penetrance O 1 0.9932737350463867
functions O 0 0.015730582177639008
. O 0 0.010813489556312561

The O 0 0.009390633553266525
estimated O 0 0.023213697597384453
cumulative O 1 0.7513822317123413
risk O 1 0.992780864238739
of O 0 0.015369454398751259
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
reached O 0 0.012284373864531517
28 O 0 0.011073957197368145
% O 0 0.006622575223445892
( O 0 0.005485355854034424
95 O 0 0.012213100679218769
% O 0 0.010480610653758049
CI O 1 0.9802951216697693
9 O 0 0.014021314680576324
% O 0 0.007058426272124052
- O 0 0.016198130324482918
44 O 0 0.012321061454713345
% O 0 0.005886800587177277
) O 0 0.003139324253425002
by O 0 0.0026907953433692455
age O 0 0.00869233999401331
50 O 0 0.005765549838542938
years O 0 0.004456473048776388
and O 0 0.0022693315986543894
84 O 0 0.017826959490776062
% O 0 0.006066476926207542
( O 0 0.005045261234045029
95 O 0 0.013928288593888283
% O 0 0.009358568117022514
CI O 1 0.9587293863296509
43 O 0 0.016545897349715233
% O 0 0.006841350346803665
- O 0 0.015138881281018257
95 O 0 0.012350905686616898
% O 0 0.005989438388496637
) O 0 0.0032084451522678137
by O 0 0.003146194852888584
age O 0 0.011635970324277878
70 O 0 0.012540154159069061
years O 0 0.007769415155053139
. O 0 0.009846188127994537

The O 0 0.017013700678944588
corresponding O 1 0.8963130116462708
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risks O 1 0.9759371280670166
were O 0 0.0049255057238042355
0 O 0 0.02505776286125183
. O 0 0.009200229309499264

4 O 0 0.02026832289993763
% O 0 0.009647328406572342
( O 0 0.006367138586938381
95 O 0 0.015818050131201744
% O 0 0.011253577657043934
CI O 1 0.9612377882003784
0 O 0 0.024001216515898705
% O 0 0.008101604878902435
- O 0 0.013630025088787079
1 O 0 0.007273598574101925
% O 0 0.0048146010376513
) O 0 0.002673956798389554
by O 0 0.0024653819855302572
age O 0 0.007441233843564987
50 O 0 0.004702836275100708
years O 0 0.0028733897488564253
and O 0 0.0015196327585726976
27 O 0 0.008203355595469475
% O 0 0.004878273233771324
( O 0 0.004721532110124826
95 O 0 0.01151907816529274
% O 0 0.009314821101725101
CI O 1 0.9574874639511108
0 O 0 0.022364262491464615
% O 0 0.009127047844231129
- O 0 0.01979564130306244
47 O 0 0.01814412511885166
% O 0 0.0055514113046228886
) O 0 0.0032728344667702913
by O 0 0.003201629500836134
age O 0 0.012049231678247452
70 O 0 0.014939716085791588
years O 0 0.008867012336850166
. O 0 0.01014203391969204

The O 0 0.01427520252764225
lifetime O 0 0.46397197246551514
risk O 1 0.9928056597709656
of O 0 0.022328117862343788
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
appears O 0 0.09473591297864914
similar O 0 0.005408302415162325
to O 0 0.001749710412696004
the O 0 0.004303390625864267
risk O 1 0.9754692316055298
in O 0 0.008787186816334724
BRCA1 O 1 0.9999988079071045
carriers O 1 0.9285804033279419
, O 0 0.002329649170860648
but O 0 0.0017222235910594463
there O 0 0.0013160838279873133
was O 0 0.0018972557736560702
some O 0 0.0013914466835558414
suggestion O 0 0.005811498034745455
of O 0 0.0013214185601100326
a O 0 0.0052957371808588505
lower O 0 0.017154328525066376
risk O 1 0.854269802570343
in O 0 0.009111054241657257
BRCA2 O 1 0.9999966621398926
carriers O 1 0.99513840675354
< O 1 0.9838864207267761
50 O 0 0.007949902676045895
years O 0 0.003887300845235586
of O 0 0.0027815212961286306
age O 0 0.01763193868100643
. O 0 0.010130430571734905

Eye B-Disease 1 0.9993189573287964
movement I-Disease 0 0.1941155195236206
abnormalities I-Disease 1 0.9999310970306396
correlate O 0 0.05352695658802986
with O 0 0.008102214895188808
genotype O 1 0.9990195035934448
in O 0 0.011149116791784763
autosomal O 1 0.9999966621398926
dominant O 1 0.9993512034416199
cerebellar B-Disease 1 0.9999909400939941
ataxia I-Disease 1 0.9999982118606567
type I-Disease 1 0.9927120208740234
I I-Disease 0 0.02239062637090683
. O 0 0.009894652292132378

We O 0 0.008703729137778282
compared O 0 0.023886671289801598
horizontal O 0 0.44510579109191895
eye O 1 0.9963878393173218
movements O 0 0.021213684231042862
( O 0 0.012001830153167248
visually O 0 0.04795067757368088
guided O 0 0.034604061394929886
saccades O 1 0.9994251728057861
, O 0 0.006949778646230698
antisaccades O 1 0.9789395928382874
, O 0 0.0024589544627815485
and O 0 0.002212990541011095
smooth O 0 0.028931375592947006
pursuit O 0 0.020077219232916832
) O 0 0.003522897604852915
in O 0 0.002153692999854684
control O 0 0.01180837769061327
subjects O 0 0.011644908227026463
( O 0 0.006922672502696514
n O 0 0.02471235953271389
= O 0 0.02716047130525112
14 O 0 0.007896668277680874
) O 0 0.0039449417963624
and O 0 0.003009313251823187
patients O 1 0.9982576966285706
with O 0 0.0018650769488885999
three O 0 0.001999570056796074
forms O 0 0.006029951851814985
of O 0 0.005192785523831844
autosomal O 1 0.9999929666519165
dominant O 1 0.9964302182197571
cerebellar B-Disease 1 0.9999618530273438
ataxias I-Disease 1 0.9998748302459717
type I-Disease 1 0.9157032370567322
I I-Disease 0 0.3271927237510681
spinocerebellar B-Disease 1 0.9999600648880005
ataxias I-Disease 1 0.9927478432655334
1 I-Disease 0 0.009680565446615219
and I-Disease 0 0.0025104389060288668
2 I-Disease 0 0.008042543195188046
( O 0 0.008695940487086773
SCA1 B-Disease 1 0.9795677661895752
, O 0 0.005703192204236984
n O 0 0.03080662712454796
= O 0 0.03200912848114967
11 O 0 0.012219523079693317
; O 0 0.00917373038828373
SCA2 B-Disease 1 0.984293520450592
, O 0 0.005577729549258947
n O 0 0.029532188549637794
= O 0 0.027766425162553787
10 O 0 0.0062858895398676395
) O 0 0.004335785284638405
and O 0 0.003968613222241402
SCA3 B-Disease 1 0.9998538494110107
/ O 1 0.979688823223114
Machado B-Disease 1 0.992962658405304
- I-Disease 1 0.5717720985412598
Joseph I-Disease 1 0.9411262273788452
disease I-Disease 1 0.9999948740005493
( O 0 0.0234827920794487
MJD B-Disease 1 0.9990599751472473
) O 0 0.011167853139340878
( O 0 0.010885418392717838
n O 0 0.031681254506111145
= O 0 0.03676100820302963
16 O 0 0.013639779761433601
) O 0 0.007784825749695301
. O 0 0.010739665478467941

In O 0 0.013121201656758785
SCA1 B-Disease 1 0.9916438460350037
, O 0 0.009976494126021862
saccade O 1 0.988787829875946
amplitude O 0 0.06985072791576385
was O 0 0.007793408818542957
significantly O 0 0.02306952513754368
increased O 0 0.01199759729206562
, O 0 0.0035169285256415606
resulting O 0 0.023964695632457733
in O 0 0.006611081305891275
hypermetria B-Disease 1 0.9905722737312317
. O 0 0.014243915677070618

The O 0 0.009798629209399223
smooth O 0 0.0347629152238369
pursuit O 0 0.0327480174601078
gain O 0 0.01822228543460369
was O 0 0.010290729813277721
decreased O 1 0.5757578611373901
. O 0 0.012238756753504276

In O 0 0.013099795207381248
SCA2 B-Disease 1 0.9944494962692261
, O 0 0.010589481331408024
saccade O 1 0.9798105955123901
velocity O 0 0.05353992432355881
was O 0 0.015956314280629158
markedly O 1 0.5880072712898254
decreased O 0 0.2355872392654419
. O 0 0.015433142893016338

The O 0 0.005880739539861679
percentage O 0 0.010247308760881424
of O 0 0.002455017063766718
errors O 0 0.012997481971979141
in O 0 0.0036468617618083954
antisaccades O 1 0.9924693703651428
was O 0 0.006142308935523033
greatly O 0 0.016101114451885223
increased O 0 0.006885625887662172
and O 0 0.0015994110144674778
was O 0 0.00381508469581604
significantly O 0 0.021015556529164314
correlated O 0 0.031392041593790054
with O 0 0.003366126213222742
age O 0 0.020678449422121048
at O 0 0.02840716950595379
disease O 1 0.9999996423721313
onset O 1 0.9999790191650391
. O 0 0.019830672070384026

In O 0 0.005461178254336119
addition O 0 0.005183699540793896
, O 0 0.0023610349744558334
a O 0 0.00562108913436532
correlation O 0 0.019909309223294258
between O 0 0.004671015776693821
smooth O 0 0.02336568385362625
pursuit O 0 0.017918646335601807
gain O 0 0.007293167524039745
and O 0 0.001220932463183999
the O 0 0.0015527700306847692
number O 0 0.002530675381422043
of O 0 0.003899891162291169
trinucleotide O 1 0.999518871307373
repeats O 0 0.07084456831216812
was O 0 0.007002514787018299
found O 0 0.009298566728830338
. O 0 0.007952430285513401

In O 0 0.01524584461003542
SCA3 B-Disease 1 0.9995228052139282
, O 0 0.009628649801015854
gaze B-Disease 1 0.9606578946113586
- I-Disease 0 0.14432883262634277
evoked I-Disease 1 0.9823473691940308
nystagmus I-Disease 1 0.9998759031295776
was O 0 0.006885332055389881
often O 0 0.004441507160663605
present O 0 0.002977553987875581
as O 0 0.002631286159157753
was O 0 0.007234099321067333
saccade O 1 0.9924103021621704
hypometria O 1 0.9547670483589172
and O 0 0.004070097114890814
smooth O 0 0.02514626644551754
pursuit O 0 0.025318212807178497
gain O 0 0.017937911674380302
was O 0 0.009115088731050491
markedly O 1 0.7957868576049805
decreased O 0 0.3520069718360901
. O 0 0.0135254031047225

Three O 0 0.00846612174063921
major O 0 0.011623567901551723
criteria O 0 0.010897721163928509
, O 0 0.006523558869957924
saccade O 1 0.986388623714447
amplitude O 0 0.08033599704504013
, O 0 0.00718182697892189
saccade O 1 0.9690398573875427
velocity O 0 0.02679576724767685
, O 0 0.002087856875732541
and O 0 0.0015688295243307948
presence O 0 0.006607118993997574
of O 0 0.003574949689209461
gaze B-Disease 1 0.9952331185340881
- I-Disease 0 0.42588353157043457
evoked I-Disease 1 0.9979941844940186
nystagmus I-Disease 1 0.9999297857284546
, O 0 0.002617226680740714
permitted O 0 0.003890747670084238
the O 0 0.0022959865164011717
correct O 0 0.013524424284696579
assignment O 0 0.012856695801019669
of O 0 0.0018594656139612198
90 O 0 0.007167972158640623
% O 0 0.0029679464641958475
of O 0 0.0013027398381382227
the O 0 0.003970681689679623
SCA1 B-Disease 1 0.9970604777336121
, O 0 0.002817493164911866
90 O 0 0.0070607890374958515
% O 0 0.003330858889967203
of O 0 0.0014547330792993307
the O 0 0.0037683555856347084
SCA2 B-Disease 1 0.9990358352661133
, O 0 0.002308039925992489
and O 0 0.0017061422113329172
93 O 0 0.011339566670358181
% O 0 0.003231386188417673
of O 0 0.001297604525461793
the O 0 0.004042494110763073
patients O 1 0.9998924732208252
with O 0 0.0051586925983428955
SCA3 B-Disease 1 0.9996646642684937
to O 0 0.003015304682776332
their O 0 0.004562690854072571
genetically O 1 0.5051720142364502
confirmed O 0 0.0572240874171257
patient O 1 0.9993576407432556
group O 0 0.004904646892100573
and O 0 0.0013120438670739532
, O 0 0.0015474564861506224
therefore O 0 0.0031296382658183575
, O 0 0.0016353033715859056
may O 0 0.004752127919346094
help O 0 0.007188340649008751
orient O 0 0.03797708824276924
diagnoses O 1 0.9986370205879211
of O 0 0.005564393941313028
SCA1 B-Disease 1 0.9995064735412598
, O 0 0.006098160054534674
SCA2 B-Disease 1 0.9983008503913879
, O 0 0.0037725036963820457
and O 0 0.003371670376509428
SCA3 B-Disease 1 0.9997105002403259
at O 0 0.005701194051653147
early O 0 0.009843435138463974
clinical O 0 0.4115566313266754
stages O 0 0.013146425597369671
of O 0 0.0022049429826438427
the O 0 0.006603426765650511
diseases O 1 0.9999978542327881
. O 0 0.004940092097967863
. O 0 0.007961135357618332

Genetic O 0 0.11926376819610596
basis O 0 0.005767734255641699
and O 0 0.003194700926542282
molecular O 0 0.02357805334031582
mechanism O 0 0.02524697780609131
for O 0 0.013857939280569553
idiopathic B-Disease 1 0.9999997615814209
ventricular I-Disease 1 0.9999996423721313
fibrillation I-Disease 1 0.9999992847442627
. O 0 0.030110402032732964

Ventricular B-Disease 1 0.9999951124191284
fibrillation I-Disease 1 0.9999957084655762
causes O 1 0.9976826906204224
more O 0 0.00530441477894783
than O 0 0.0048072449862957
300 O 0 0.010678454302251339
, O 0 0.004455468151718378
000 O 0 0.04685737192630768
sudden O 1 0.9993023872375488
deaths O 1 0.5608056783676147
each O 0 0.003256743773818016
year O 0 0.0037521289195865393
in O 0 0.001910113962367177
the O 0 0.0037419649306684732
USA O 0 0.027668161317706108
alone O 0 0.018466154113411903
. O 0 0.01054180134087801

In O 0 0.006640841718763113
approximately O 0 0.012494081631302834
5 O 0 0.010566653683781624
- O 0 0.012964203022420406
12 O 0 0.00544644333422184
% O 0 0.0033032384235411882
of O 0 0.0011845090193673968
these O 0 0.0015372525667771697
cases O 0 0.005890185944736004
, O 0 0.001285311533138156
there O 0 0.0012030790094286203
are O 0 0.001156254787929356
no O 0 0.00423103291541338
demonstrable O 1 0.9996225833892822
cardiac O 1 0.9999959468841553
or O 0 0.007862499915063381
non O 0 0.03605165332555771
- O 1 0.9953845143318176
cardiac O 1 0.9999990463256836
causes O 1 0.9984329342842102
to O 0 0.0020529255270957947
account O 0 0.002864750800654292
for O 0 0.0012457750272005796
the O 0 0.0023097796365618706
episode O 0 0.017233828082680702
, O 0 0.0017394486349076033
which O 0 0.0015325512504205108
is O 0 0.0019831350073218346
therefore O 0 0.003974404186010361
classified O 0 0.010933304205536842
as O 0 0.010553564876317978
idiopathic B-Disease 1 0.9999997615814209
ventricular I-Disease 1 0.9999996423721313
fibrillation I-Disease 1 0.9999997615814209
( O 0 0.10246408730745316
IVF B-Disease 1 0.9993447661399841
) O 0 0.013708709739148617
. O 0 0.010937481187283993

A O 0 0.02109728567302227
distinct O 0 0.02032780461013317
group O 0 0.009062412194907665
of O 0 0.006613158620893955
IVF B-Disease 1 0.9999892711639404
patients O 1 0.9999527931213379
has O 0 0.004105058498680592
been O 0 0.0026828220579773188
found O 0 0.0030844430439174175
to O 0 0.0011217027204111218
present O 0 0.0019932007417082787
with O 0 0.001971988473087549
a O 0 0.008319392800331116
characteristic O 1 0.8154038190841675
electrocardiographic O 1 0.998893678188324
pattern O 0 0.13385917246341705
. O 0 0.0139689976349473

Because O 0 0.008029164746403694
of O 0 0.0018211352871730924
the O 0 0.002028582850471139
small O 0 0.0036186459474265575
size O 0 0.0042476109229028225
of O 0 0.0013936255127191544
most O 0 0.003195409895852208
pedigrees O 0 0.20082230865955353
and O 0 0.0013696469832211733
the O 0 0.0030504369642585516
high O 0 0.010055742226541042
incidence O 1 0.999321699142456
of O 0 0.005306863691657782
sudden B-Disease 1 0.9997231364250183
death I-Disease 1 0.8259512782096863
, O 0 0.0021628630347549915
however O 0 0.003192775882780552
, O 0 0.0032350157853215933
molecular O 0 0.023999689146876335
genetic O 0 0.3299708962440491
studies O 0 0.00733440276235342
of O 0 0.004076989833265543
IVF B-Disease 1 0.9994584918022156
have O 0 0.003218932542949915
not O 0 0.0020655773114413023
yet O 0 0.004246401134878397
been O 0 0.003760687541216612
done O 0 0.008748290129005909
. O 0 0.010030180215835571

Because O 0 0.051187604665756226
IVF B-Disease 1 0.999944806098938
causes O 1 0.9999208450317383
cardiac O 1 0.9999974966049194
rhythm O 1 0.9980828762054443
disturbance O 1 0.992921769618988
, O 0 0.003245861502364278
we O 0 0.0024007270112633705
investigated O 0 0.013558671809732914
whether O 0 0.0061835357919335365
malfunction O 1 0.9814189672470093
of O 0 0.003539622761309147
ion O 0 0.0428941585123539
channels O 0 0.01315956562757492
could O 0 0.005880438722670078
cause O 1 0.6465189456939697
the O 0 0.006535173859447241
disorder O 1 0.9999781847000122
by O 0 0.005076659377664328
studying O 0 0.011880177073180676
mutations O 1 0.9978765249252319
in O 0 0.0032665131147950888
the O 0 0.00823027640581131
cardiac O 1 0.9999842643737793
sodium O 1 0.8872392177581787
channel O 0 0.06623385846614838
gene O 1 0.9806817770004272
SCN5A O 1 0.9906870722770691
. O 0 0.017784086987376213

We O 0 0.004667941946536303
have O 0 0.0025674612261354923
now O 0 0.003772308584302664
identified O 0 0.008871090598404408
a O 0 0.011996018700301647
missense O 1 0.9985721111297607
mutation O 1 0.9994494318962097
, O 0 0.004048061557114124
a O 0 0.009584732353687286
splice O 1 0.9862675666809082
- O 0 0.14687316119670868
donor O 1 0.9677615165710449
mutation O 1 0.9994899034500122
, O 0 0.0027803140692412853
and O 0 0.0019851403776556253
a O 0 0.012630073353648186
frameshift O 1 0.9998822212219238
mutation O 1 0.9994667172431946
in O 0 0.0028971293941140175
the O 0 0.0037057807203382254
coding O 0 0.040824707597494125
region O 0 0.00959825050085783
of O 0 0.003664909629151225
SCN5A O 1 0.9975433945655823
in O 0 0.004337634425610304
three O 0 0.006984150968492031
IVF B-Disease 1 0.9991409778594971
families O 0 0.022651495411992073
. O 0 0.014608289115130901

We O 0 0.005312011577188969
show O 0 0.00856694020330906
that O 0 0.0034776802640408278
sodium O 0 0.04556795582175255
channels O 0 0.010513583198189735
with O 0 0.002424142323434353
the O 0 0.007409526966512203
missense O 1 0.9988324046134949
mutation O 1 0.999848484992981
recover O 1 0.8007768988609314
from O 0 0.0091325044631958
inactivation O 1 0.9961972236633301
more O 0 0.004426087252795696
rapidly O 0 0.01562928408384323
than O 0 0.002943305065855384
normal O 0 0.00823693536221981
and O 0 0.000973795133177191
that O 0 0.001271857414394617
the O 0 0.00541584100574255
frameshift O 1 0.9999856948852539
mutation O 1 0.9999779462814331
causes O 1 0.9954653382301331
the O 0 0.00652350066229701
sodium O 0 0.0885874330997467
channel O 0 0.012418643571436405
to O 0 0.0021312362514436245
be O 0 0.0027759389486163855
non O 0 0.013615017756819725
- O 0 0.030928675085306168
functional O 0 0.03433188423514366
. O 0 0.012065539136528969

Our O 0 0.011993488296866417
results O 0 0.012580967508256435
indicate O 0 0.01157491747289896
that O 0 0.003448065835982561
mutations O 1 0.9988468885421753
in O 0 0.007248736452311277
cardiac O 1 0.9999885559082031
ion O 1 0.6142476797103882
- O 0 0.0332304984331131
channel O 0 0.028564536944031715
genes O 0 0.14323417842388153
contribute O 0 0.008904816582798958
to O 0 0.0015318269142881036
the O 0 0.0029390486888587475
risk O 1 0.538444459438324
of O 0 0.004198683425784111
developing O 0 0.03655092790722847
IVF B-Disease 1 0.9991409778594971
. O 0 0.008350699208676815
. O 0 0.011232400313019753

Molecular O 0 0.08772574365139008
heterogeneity O 0 0.19357964396476746
in O 0 0.010027633979916573
mucopolysaccharidosis B-Disease 1 0.9981290698051453
IVA I-Disease 1 0.9992073178291321
in O 0 0.002899349434301257
Australia O 0 0.004232459701597691
and O 0 0.0016942829824984074
Northern O 0 0.006563864182680845
Ireland O 0 0.008506177924573421
: O 0 0.004930463153868914
nine O 0 0.007362762000411749
novel O 0 0.028355078771710396
mutations O 1 0.9986893534660339
including O 0 0.004292540717869997
T312S O 1 0.9668831825256348
, O 0 0.0025796315167099237
a O 0 0.005436922423541546
common O 0 0.012043324299156666
allele O 1 0.9991992115974426
that O 0 0.004474278539419174
confers O 1 0.9951635599136353
a O 0 0.03424603119492531
mild O 1 0.9998788833618164
phenotype O 1 0.9999381303787231
. O 0 0.015879983082413673

Mucopolysaccharidosis B-Disease 1 0.9966152310371399
IVA I-Disease 1 0.9989994168281555
( O 0 0.02500167116522789
MPS B-Disease 1 0.9335079789161682
IVA I-Disease 1 0.9997923970222473
) O 0 0.006823346950113773
is O 0 0.004673364106565714
an O 0 0.010871058329939842
autosomal B-Disease 1 0.9999979734420776
recessive I-Disease 1 0.9999985694885254
lysosomal I-Disease 1 0.9999517202377319
storage I-Disease 1 0.95356285572052
disorder I-Disease 1 0.9999990463256836
caused O 1 0.9967256784439087
by O 0 0.0046602096408605576
a O 0 0.013189812190830708
genetic B-Disease 1 0.9995872378349304
defect I-Disease 1 0.9994568228721619
in O 0 0.0064667025581002235
N O 0 0.11259878426790237
- O 0 0.04646878316998482
acetylgalactosamine O 1 0.9803515076637268
- O 0 0.04086436331272125
6 O 0 0.025878019630908966
- O 0 0.06941857933998108
sulfate O 1 0.984434187412262
sulfatase O 1 0.9989270567893982
( O 0 0.02559293992817402
GALNS O 1 0.9979283809661865
) O 0 0.009984003379940987
. O 0 0.010263723321259022

Previous O 0 0.014806989580392838
studies O 0 0.008128059096634388
of O 0 0.004573586396872997
patients O 1 0.9988676309585571
from O 0 0.003862468060106039
a O 0 0.005729461554437876
British O 0 0.010763883590698242
- O 0 0.01830667443573475
Irish O 0 0.019674040377140045
population O 0 0.009502596221864223
showed O 0 0.006732647772878408
that O 0 0.0016634227940812707
the O 0 0.004305115435272455
I113F O 1 0.9993788003921509
mutation O 1 0.9997221827507019
is O 0 0.002576747676357627
the O 0 0.0016404726775363088
most O 0 0.0023486183490604162
common O 0 0.006767135113477707
single O 0 0.014930575154721737
mutation O 1 0.9996163845062256
among O 0 0.013014149852097034
MPS B-Disease 1 0.9987902045249939
IVA I-Disease 1 0.9999923706054688
patients O 1 0.9998216032981873
and O 0 0.0037436187267303467
produces O 0 0.04887966066598892
a O 0 0.03939097374677658
severe O 1 0.9999942779541016
clinical O 1 0.9997619986534119
phenotype O 1 0.9999804496765137
. O 0 0.017895063385367393

We O 0 0.00692678103223443
studied O 0 0.012838654220104218
mutations O 1 0.9965417981147766
in O 0 0.002971949055790901
the O 0 0.005308748688548803
GALNS O 1 0.9985718727111816
gene O 1 0.7811904549598694
from O 0 0.004815759602934122
23 O 0 0.009074474684894085
additional O 0 0.009208474308252335
MPS B-Disease 1 0.9794710278511047
IVA I-Disease 1 0.9999772310256958
patients O 1 0.9998489618301392
( O 0 0.007999300956726074
15 O 0 0.006396634969860315
from O 0 0.00260770320892334
Australia O 0 0.003910292871296406
, O 0 0.0018043707823380828
8 O 0 0.0048593333922326565
from O 0 0.002380046295002103
Northern O 0 0.006726211868226528
Ireland O 0 0.008890935219824314
) O 0 0.003016986884176731
, O 0 0.001282252254895866
with O 0 0.0019671840127557516
various O 0 0.003821993712335825
clinical O 1 0.9984904527664185
phenotypes O 1 0.999931812286377
( O 0 0.04063735529780388
severe O 1 0.9999872446060181
, O 0 0.003436214057728648
16 O 0 0.007357473485171795
cases O 0 0.011481832712888718
; O 0 0.0038435659371316433
intermediate O 0 0.011320946738123894
, O 0 0.002281532622873783
4 O 0 0.008556407876312733
cases O 0 0.012904821895062923
; O 0 0.005986378528177738
mild O 1 0.998968243598938
, O 0 0.003198199439793825
3 O 0 0.009184256196022034
cases O 0 0.011712538078427315
) O 0 0.007060862146317959
. O 0 0.008288665674626827

We O 0 0.004919384140521288
found O 0 0.004914263729006052
two O 0 0.0022555445320904255
common O 0 0.012040856294333935
mutations O 1 0.9992572665214539
that O 0 0.0016504805535078049
together O 0 0.0023016822524368763
accounted O 0 0.008562037721276283
for O 0 0.0016940288478508592
32 O 0 0.007838655263185501
% O 0 0.0033695977181196213
of O 0 0.0013515545288100839
the O 0 0.0029726135544478893
44 O 0 0.01635333150625229
unrelated O 0 0.10719016194343567
alleles O 1 0.9976727366447449
in O 0 0.004477967042475939
these O 0 0.005748651921749115
patients O 1 0.9997017979621887
. O 0 0.011800418607890606

One O 0 0.0065470412373542786
is O 0 0.004310441203415394
the O 0 0.0064544351771473885
T312S O 1 0.9986403584480286
mutation O 1 0.9996059536933899
, O 0 0.0031090660486370325
a O 0 0.007639284711331129
novel O 0 0.026115553453564644
mutation O 1 0.9994271993637085
found O 0 0.008441570214927197
exclusively O 0 0.00989503227174282
in O 0 0.0070156012661755085
milder O 1 0.9996873140335083
patients O 1 0.9997453093528748
. O 0 0.013797725550830364

The O 0 0.004582802299410105
other O 0 0.0015414929948747158
is O 0 0.002063001738861203
the O 0 0.0020739517640322447
previously O 0 0.00573433144018054
described O 0 0.013822403736412525
I113F O 1 0.9481497406959534
that O 0 0.003965824842453003
produces O 0 0.026974035426974297
a O 0 0.027239784598350525
severe O 1 0.9999593496322632
phenotype O 1 0.999859094619751
. O 0 0.0202261283993721

The O 0 0.014909612014889717
I113F O 1 0.9686306715011597
and O 0 0.007748604752123356
T312S O 1 0.9983797073364258
mutations O 1 0.9977245926856995
accounted O 0 0.019516596570611
for O 0 0.0032303265761584044
8 O 0 0.009720833972096443
( O 0 0.005066015757620335
18 O 0 0.006453842390328646
% O 0 0.005735388956964016
) O 0 0.003192296251654625
and O 0 0.0017992653883993626
6 O 0 0.008604871109127998
( O 0 0.004498894326388836
14 O 0 0.006813029758632183
% O 0 0.004416231065988541
) O 0 0.0024296550545841455
of O 0 0.0024676250759512186
44 O 0 0.019515611231327057
unrelated O 0 0.06496579945087433
alleles O 1 0.9950687885284424
, O 0 0.005758248269557953
respectively O 0 0.013494200073182583
. O 0 0.010016141459345818

The O 0 0.009875518269836903
relatively O 0 0.01552744209766388
high O 0 0.014463809318840504
residual O 1 0.6491274237632751
GALNS O 1 0.9980423450469971
activity O 0 0.01842699944972992
seen O 0 0.010481808334589005
when O 0 0.005140481982380152
the O 0 0.005265490151941776
T312S O 1 0.9750103950500488
mutant O 1 0.9703865051269531
cDNA O 0 0.08836667984724045
is O 0 0.00977074634283781
overexpressed O 1 0.9553136229515076
in O 0 0.00665007159113884
mutant O 1 0.9922629594802856
cells O 0 0.053052376955747604
provides O 0 0.005883380305022001
an O 0 0.001960525056347251
explanation O 0 0.006102523300796747
for O 0 0.0017349990084767342
the O 0 0.005745788104832172
mild O 1 0.9999222755432129
phenotype O 1 0.9999765157699585
in O 0 0.007960217073559761
patients O 1 0.9998241066932678
with O 0 0.0042143757455050945
this O 0 0.006358295679092407
mutation O 1 0.9996703863143921
. O 0 0.01337669137865305

The O 0 0.005655374377965927
distribution O 0 0.008012402802705765
and O 0 0.0019108132692053914
relative O 0 0.009516622871160507
frequencies O 0 0.010289402678608894
of O 0 0.0018428515177220106
the O 0 0.004209605511277914
I113F O 1 0.9720004796981812
and O 0 0.005243080668151379
T312S O 1 0.9995657801628113
mutations O 1 0.9993415474891663
in O 0 0.002668178640305996
Australia O 0 0.004579886328428984
corresponded O 0 0.011897692456841469
to O 0 0.0017337043536826968
those O 0 0.00202531972900033
observed O 0 0.007918760180473328
in O 0 0.0016901901690289378
Northern O 0 0.005705349612981081
Ireland O 0 0.006012964528053999
and O 0 0.0012155581498518586
are O 0 0.0008861927199177444
unique O 0 0.002460374729707837
to O 0 0.0008721394697204232
these O 0 0.0010209651663899422
two O 0 0.002042288426309824
populations O 0 0.019552908837795258
, O 0 0.0021967305801808834
suggesting O 0 0.007683785166591406
that O 0 0.0016828919760882854
both O 0 0.0033405974972993135
mutations O 1 0.9988688826560974
were O 0 0.0015573567943647504
probably O 0 0.005656393710523844
introduced O 0 0.004083096981048584
to O 0 0.0011497280793264508
Australia O 0 0.003858037991449237
by O 0 0.003160460852086544
Irish O 0 0.016180388629436493
migrants O 0 0.015531707555055618
during O 0 0.007296223193407059
the O 0 0.0037237333599478006
19th O 0 0.011646317318081856
century O 0 0.010927819646894932
. O 0 0.011630093678832054

Haplotype O 1 0.9529228210449219
analysis O 0 0.01517203263938427
using O 0 0.007367663085460663
6 O 0 0.015666618943214417
RFLPs O 1 0.8465268611907959
provides O 0 0.006187305320054293
additional O 0 0.003371925326064229
data O 0 0.002502485876902938
that O 0 0.0015957874711602926
the O 0 0.005236635450273752
I113F O 1 0.9961821436882019
mutation O 1 0.9989919066429138
originated O 0 0.017144007608294487
from O 0 0.004029268864542246
a O 0 0.007134009152650833
common O 0 0.013794325292110443
ancestor O 0 0.30477088689804077
. O 0 0.011207683943212032

The O 0 0.00517383124679327
other O 0 0.003356603905558586
9 O 0 0.012472374364733696
novel O 0 0.02734774351119995
mutations O 1 0.9985859394073486
identified O 0 0.010723535902798176
in O 0 0.0017730251420289278
these O 0 0.002352059818804264
23 O 0 0.01540403626859188
patients O 1 0.9993201494216919
were O 0 0.0012130880495533347
each O 0 0.0017593931406736374
limited O 0 0.003983414266258478
to O 0 0.0016281395219266415
a O 0 0.00555709283798933
single O 0 0.014712727628648281
family O 0 0.023880556225776672
. O 0 0.012182438746094704

These O 0 0.0032869766000658274
data O 0 0.0034235839266330004
provide O 0 0.00374270835891366
further O 0 0.0037862739991396666
evidence O 0 0.0038506053388118744
for O 0 0.0031811378430575132
extensive O 0 0.026081740856170654
allelic O 1 0.9855332970619202
heterogeneity O 1 0.5234623551368713
in O 0 0.005890041124075651
MPS B-Disease 1 0.7093591094017029
IVA I-Disease 1 0.9997101426124573
in O 0 0.0041679381392896175
British O 0 0.017154810950160027
- O 0 0.41446757316589355
Irish O 1 0.8068246841430664
patients O 1 0.9997654557228088
and O 0 0.0016402510227635503
provide O 0 0.002012948039919138
evidence O 0 0.002233814913779497
for O 0 0.0014750233385711908
their O 0 0.0025349589996039867
transmission O 0 0.027882331982254982
to O 0 0.0014804825186729431
Australia O 0 0.0033543154131621122
by O 0 0.0032267787028104067
British O 0 0.012523485347628593
- O 0 0.022487830370664597
Irish O 0 0.02374647930264473
migrants O 0 0.01933368295431137
. O 0 0.005266554653644562
. O 0 0.010582289658486843

Identification O 0 0.02044212631881237
of O 0 0.0047584595158696175
constitutional O 0 0.04184899479150772
WT1 O 1 0.9999802112579346
mutations O 1 0.9997768998146057
, O 0 0.00293215224519372
in O 0 0.003939302638173103
patients O 1 0.9997835755348206
with O 0 0.0061805350705981255
isolated O 1 0.9989150762557983
diffuse B-Disease 1 0.9999935626983643
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
, O 0 0.004092990420758724
and O 0 0.00187282997649163
analysis O 0 0.006899347063153982
of O 0 0.0060064648278057575
genotype O 1 0.9998571872711182
/ O 1 0.9962856769561768
phenotype O 1 0.9998929500579834
correlations O 0 0.031689420342445374
by O 0 0.002215941436588764
use O 0 0.0016067904653027654
of O 0 0.001634644577279687
a O 0 0.009218232706189156
computerized O 1 0.8690552711486816
mutation O 1 0.9978492259979248
database O 0 0.03749578818678856
. O 0 0.013250038959085941

Constitutional O 0 0.043051961809396744
mutations O 1 0.9938926696777344
of O 0 0.004420241340994835
the O 0 0.009645327925682068
WT1 O 1 0.9999234676361084
gene O 1 0.9808452129364014
, O 0 0.004417889751493931
encoding O 0 0.026282377541065216
a O 0 0.011008855886757374
zinc O 1 0.5153768062591553
- O 0 0.036973681300878525
finger O 1 0.8777368068695068
transcription O 0 0.12536022067070007
factor O 0 0.02768232859671116
involved O 0 0.009764025919139385
in O 0 0.0075295777060091496
renal O 1 0.9999992847442627
and O 0 0.008116059005260468
gonadal O 1 0.9997214674949646
development O 0 0.0053080846555531025
, O 0 0.001802112557925284
are O 0 0.0009551393450237811
found O 0 0.0029994077049195766
in O 0 0.0015201002825051546
most O 0 0.0043509770184755325
patients O 1 0.9997426867485046
with O 0 0.0073109096847474575
Denys B-Disease 1 0.9999395608901978
- I-Disease 1 0.9985089898109436
Drash I-Disease 1 0.9999814033508301
syndrome I-Disease 1 1.0
( O 0 0.05976242944598198
DDS B-Disease 1 0.9998723268508911
) O 0 0.007321257144212723
, O 0 0.003389403223991394
or O 0 0.011459960602223873
diffuse B-Disease 1 0.9999891519546509
mesangial I-Disease 1 0.9999994039535522
sclerosis I-Disease 1 1.0
( O 0 0.06453006714582443
DMS B-Disease 1 0.9996836185455322
) O 0 0.007877307012677193
associated O 0 0.0084178876131773
with O 0 0.005017759278416634
pseudohermaphroditism B-Disease 1 0.9994322657585144
and O 0 0.006533966865390539
/ O 1 0.9086812138557434
or O 0 0.02611156553030014
Wilms B-Disease 1 0.9999974966049194
tumor I-Disease 1 0.9999903440475464
( O 0 0.0347541980445385
WT B-Disease 1 0.9990389347076416
) O 0 0.01275696512311697
. O 0 0.010947983711957932

Most O 0 0.02400486171245575
mutations O 1 0.9973205924034119
in O 0 0.01649637334048748
DDS B-Disease 1 0.9999710321426392
patients O 1 0.9999011754989624
lie O 0 0.015598883852362633
in O 0 0.004327136557549238
exon O 1 0.6301150321960449
8 O 0 0.01033219788223505
or O 0 0.005754350684583187
exon O 0 0.3801485300064087
9 O 0 0.01193754281848669
, O 0 0.004202565643936396
encoding O 0 0.039273545145988464
zinc O 1 0.8825727701187134
finger O 0 0.37511536478996277
2 O 0 0.01155970711261034
or O 0 0.007508914452046156
zinc O 1 0.7940382957458496
finger O 1 0.7163220047950745
3 O 0 0.008162593469023705
, O 0 0.001842305064201355
respectively O 0 0.0041297851130366325
, O 0 0.001607690006494522
with O 0 0.001952023827470839
a O 0 0.005873874761164188
hot O 0 0.025068137794733047
spot O 0 0.022904638200998306
( O 0 0.009451321326196194
R394W O 1 0.8865377306938171
) O 0 0.005871781148016453
in O 0 0.004235242027789354
exon O 0 0.2738993167877197
9 O 0 0.020388705655932426
. O 0 0.009566141292452812

We O 0 0.006474252324551344
analyzed O 0 0.015394565649330616
a O 0 0.005769470240920782
series O 0 0.006624259985983372
of O 0 0.002976721618324518
24 O 0 0.017226438969373703
patients O 1 0.9995836615562439
, O 0 0.002189208287745714
10 O 0 0.003892479231581092
with O 0 0.004001130815595388
isolated B-Disease 1 0.9132568836212158
DMS I-Disease 1 0.9998748302459717
( O 0 0.0234035924077034
IDMS B-Disease 1 0.9996980428695679
) O 0 0.006027063354849815
, O 0 0.002269570017233491
10 O 0 0.004596463870257139
with O 0 0.004307998809963465
DDS B-Disease 1 0.9999167919158936
, O 0 0.002572329482063651
and O 0 0.0016445097280666232
4 O 0 0.006584395654499531
with O 0 0.006194164045155048
urogenital B-Disease 1 0.9999914169311523
abnormalities I-Disease 1 0.9999905824661255
and O 0 0.0077707902528345585
/ O 1 0.8965696692466736
or O 0 0.01684056967496872
WT B-Disease 1 0.9991236329078674
. O 0 0.017121607437729836

We O 0 0.00835762731730938
report O 0 0.02001924067735672
WT1 O 1 0.9998243451118469
heterozygous O 1 0.9990154504776001
mutations O 1 0.9991298317909241
in O 0 0.005650547333061695
16 O 0 0.015633460134267807
patients O 1 0.9998708963394165
, O 0 0.002094941446557641
4 O 0 0.004933369345963001
of O 0 0.0018316436326131225
whom O 0 0.00821002759039402
presented O 0 0.0069311377592384815
with O 0 0.009137053042650223
IDMS B-Disease 1 0.999907374382019
. O 0 0.016817210242152214

One O 0 0.009582841768860817
male O 0 0.019652238115668297
and O 0 0.0020770856644958258
two O 0 0.004510837607085705
female O 1 0.7394266724586487
IDMS B-Disease 1 0.9999963045120239
patients O 1 0.9999630451202393
with O 0 0.02166331559419632
WT1 O 1 0.9999911785125732
mutations O 1 0.9999774694442749
underwent O 1 0.9998844861984253
normal O 1 0.5808361172676086
puberty O 1 0.9957755208015442
. O 0 0.019413365051150322

Two O 0 0.011746620759367943
mutations O 1 0.9985633492469788
associated O 0 0.01465955562889576
with O 0 0.006255310960114002
IDMS B-Disease 1 0.9998538494110107
are O 0 0.001928565907292068
different O 0 0.0014035439817234874
from O 0 0.0017242298927158117
those O 0 0.002346582477912307
described O 0 0.010846566408872604
in O 0 0.00881895050406456
DDS B-Disease 1 0.9999887943267822
patients O 1 0.9999263286590576
. O 0 0.015570162795484066

No O 0 0.02987646497786045
WT1 O 1 0.9997548460960388
mutations O 1 0.9980777502059937
were O 0 0.004129363223910332
detected O 0 0.026132358238101006
in O 0 0.001421405584551394
the O 0 0.002014442812651396
six O 0 0.004266844596713781
other O 0 0.005831199232488871
IDMS B-Disease 1 0.9999967813491821
patients O 1 0.999955415725708
, O 0 0.00450908625498414
suggesting O 0 0.026396825909614563
genetic O 1 0.9522096514701843
heterogeneity O 1 0.7103606462478638
of O 0 0.004446031525731087
this O 0 0.009405536577105522
disease O 1 0.9999964237213135
. O 0 0.01454178337007761

We O 0 0.010976905934512615
analyzed O 0 0.05359968543052673
genotype O 1 0.9990997314453125
/ O 1 0.9927264451980591
phenotype O 1 0.999879002571106
correlations O 0 0.03794046863913536
, O 0 0.0017284966306760907
on O 0 0.0009373864741064608
the O 0 0.0009232633165083826
basis O 0 0.001178902224637568
of O 0 0.0008180403965525329
the O 0 0.001560279168188572
constitution O 0 0.003258535172790289
of O 0 0.00218506483361125
a O 0 0.014028767123818398
WT1 O 1 0.9999020099639893
mutation O 1 0.9991617202758789
database O 0 0.01682739332318306
of O 0 0.0035960243549197912
84 O 0 0.044299010187387466
germ O 1 0.9880800843238831
- O 0 0.03762245923280716
line O 0 0.01699422299861908
mutations O 1 0.9988754391670227
, O 0 0.0019401080207899213
to O 0 0.001373978448100388
compare O 0 0.007632361724972725
the O 0 0.0017452227184548974
distribution O 0 0.004201411735266447
and O 0 0.001718121231533587
type O 0 0.01218807976692915
of O 0 0.0028264285065233707
mutations O 1 0.999792754650116
, O 0 0.00157430418767035
according O 0 0.0014921181136742234
to O 0 0.0011413280153647065
the O 0 0.002536847023293376
different O 0 0.00666395528241992
symptoms O 1 0.9999946355819702
. O 0 0.0110374316573143

This O 0 0.008942457847297192
demonstrated O 0 0.01689896546304226
( O 0 0.007049097679555416
1 O 0 0.00681797880679369
) O 0 0.002727475482970476
the O 0 0.002277371706441045
association O 0 0.008294629864394665
between O 0 0.005807061213999987
mutations O 1 0.9965401887893677
in O 0 0.003989556338638067
exons O 0 0.2712426483631134
8 O 0 0.007984987460076809
and O 0 0.002098362660035491
9 O 0 0.007329017389565706
and O 0 0.003577479626983404
DMS B-Disease 1 0.9996809959411621
; O 0 0.005589456297457218
( O 0 0.0049630082212388515
2 O 0 0.006100478116422892
) O 0 0.00329623487778008
among O 0 0.00699441647157073
patients O 1 0.9997537732124329
with O 0 0.004926155786961317
DMS B-Disease 1 0.9995192289352417
, O 0 0.0023216786794364452
a O 0 0.004170868080109358
higher O 0 0.006295892875641584
frequency O 0 0.014359533786773682
of O 0 0.003728838637471199
exon O 1 0.9118675589561462
8 O 0 0.018175434321165085
mutations O 1 0.9973635077476501
among O 0 0.008215142413973808
46 O 0 0.018096156418323517
, O 0 0.0073074838146567345
XY O 1 0.9999544620513916
patients O 1 0.9998088479042053
with O 0 0.005197680555284023
female O 0 0.32563790678977966
phenotype O 1 0.9999011754989624
than O 0 0.0046482989564538
among O 0 0.0068441047333180904
46 O 0 0.02075524814426899
, O 0 0.010361768305301666
XY O 1 0.9999361038208008
patients O 1 0.9993559718132019
with O 0 0.004446901846677065
sexual O 0 0.02082167938351631
ambiguity O 0 0.022052519023418427
or O 0 0.008243345655500889
male O 1 0.9843722581863403
phenotype O 1 0.9999643564224243
; O 0 0.005353821441531181
and O 0 0.002137488918378949
( O 0 0.004905420355498791
3 O 0 0.006154651753604412
) O 0 0.0035453778691589832
statistically O 0 0.011927248910069466
significant O 0 0.005036098882555962
evidence O 0 0.003210959490388632
that O 0 0.0023686420172452927
mutations O 1 0.9857836961746216
in O 0 0.004111286252737045
exons O 0 0.16047516465187073
8 O 0 0.008599589578807354
and O 0 0.0018808668246492743
9 O 0 0.011491963639855385
preferentially O 0 0.08452030271291733
affect O 0 0.028630321845412254
amino O 0 0.030416293069720268
acids O 0 0.016806449741125107
with O 0 0.0017558750696480274
different O 0 0.0021033769007772207
functions O 0 0.0055290814489126205
. O 0 0.003949910402297974
. O 0 0.008203545585274696

The O 0 0.025286588817834854
185delAG O 1 0.9994389414787292
BRCA1 O 1 0.9999886751174927
mutation O 1 0.9997155070304871
originated O 0 0.020476000383496284
before O 0 0.0038624645676463842
the O 0 0.00307841831818223
dispersion O 0 0.024326851591467857
of O 0 0.0016135075129568577
Jews O 0 0.004116705618798733
in O 0 0.0015738154761493206
the O 0 0.0025815670378506184
diaspora O 0 0.012978392653167248
and O 0 0.0018170417752116919
is O 0 0.0020744374487549067
not O 0 0.0014579235576093197
limited O 0 0.00526531133800745
to O 0 0.004597678780555725
Ashkenazim O 1 0.9564624428749084
. O 0 0.012088307179510593

The O 0 0.019639648497104645
185delAG O 1 0.9972133040428162
mutation O 1 0.9991023540496826
in O 0 0.013141253963112831
BRCA1 O 1 0.9999843835830688
is O 0 0.008710239082574844
detected O 0 0.050143543630838394
in O 0 0.003013908863067627
Ashkenazi O 0 0.3475651443004608
Jews O 0 0.005407940596342087
both O 0 0.002509098034352064
in O 0 0.005663728807121515
familial B-Disease 1 0.9999995231628418
breast I-Disease 1 1.0
and I-Disease 1 0.9864229559898376
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.0022534227464348078
in O 0 0.0017132163047790527
the O 0 0.00270985160022974
general O 0 0.007004905957728624
population O 0 0.013742933981120586
. O 0 0.009195970371365547

All O 0 0.011455661617219448
tested O 0 0.251608282327652
Ashkenazi O 1 0.9967104196548462
mutation O 1 0.9998340606689453
carriers O 0 0.137913778424263
share O 0 0.009300663135945797
the O 0 0.0036908446345478296
same O 0 0.00814076792448759
allelic O 1 0.9684247970581055
pattern O 0 0.030017882585525513
at O 0 0.005251467693597078
the O 0 0.011520321480929852
BRCA1 O 1 0.9999845027923584
locus O 1 0.9987131357192993
. O 0 0.01957888901233673

Our O 0 0.009618409909307957
previous O 0 0.007813681848347187
study O 0 0.0068949437700212
showed O 0 0.007228867616504431
that O 0 0.001702394220046699
this O 0 0.0035841932985931635
Ashkenazi O 1 0.9986671209335327
mutation O 1 0.9999048709869385
also O 0 0.003860017517581582
occurs O 0 0.01268637366592884
in O 0 0.0016946217510849237
Iraqi O 0 0.006170421373099089
Jews O 0 0.004855790175497532
with O 0 0.002050254726782441
a O 0 0.006324977148324251
similar O 0 0.013707426376640797
allelic O 1 0.9886027574539185
pattern O 0 0.06417250633239746
. O 0 0.014894451014697552

We O 0 0.005624082870781422
extended O 0 0.007575380150228739
our O 0 0.003667403943836689
analysis O 0 0.004673406481742859
to O 0 0.0012455838732421398
other O 0 0.001799313467927277
non O 0 0.01123754307627678
- O 0 0.02749595046043396
Ashkenazi O 0 0.4295036792755127
subsets O 0 0.027077892795205116
354 O 0 0.027212154120206833
of O 0 0.0027414069045335054
Moroccan O 0 0.02331051230430603
origin O 0 0.008117729797959328
, O 0 0.002766193123534322
200 O 0 0.009126956574618816
Yemenites O 1 0.920200526714325
and O 0 0.002614834113046527
150 O 0 0.0085976617410779
Iranian O 0 0.008176354691386223
Jews O 0 0.013975159265100956
. O 0 0.010481586679816246

Heteroduplex O 1 0.7234304547309875
analysis O 0 0.018492896109819412
complemented O 0 0.019856426864862442
by O 0 0.003921929281204939
direct O 0 0.010450243018567562
DNA O 0 0.03262612968683243
sequencing O 0 0.03509236499667168
of O 0 0.006106170825660229
abnormally O 1 0.9965595602989197
migrating O 0 0.1091996431350708
bands O 0 0.01694621331989765
were O 0 0.002753602107986808
employed O 0 0.0142996059730649
. O 0 0.009370401501655579

Four O 0 0.007882283069193363
of O 0 0.003759772749617696
Moroccan O 0 0.028743861243128777
origin O 0 0.01099124364554882
( O 0 0.005584790837019682
1 O 0 0.0054479436948895454
. O 0 0.0017823312664404511
1 O 0 0.004690013360232115
% O 0 0.003729414427652955
) O 0 0.0021487080957740545
and O 0 0.0010077913757413626
none O 0 0.003053981577977538
of O 0 0.0014931001933291554
the O 0 0.003670573001727462
Yemenites O 1 0.9899970293045044
or O 0 0.004289714619517326
Iranians O 0 0.005488475318998098
was O 0 0.003196168225258589
a O 0 0.005372453946620226
carrier O 0 0.02393963746726513
of O 0 0.0026044307742267847
the O 0 0.007341057062149048
185delAG O 1 0.9986944794654846
mutation O 1 0.9992891550064087
. O 0 0.01648854650557041

BRCA1 O 1 0.9999183416366577
allelic O 1 0.9927905797958374
patterns O 0 0.026832062751054764
were O 0 0.0021640686318278313
determined O 0 0.005020118784159422
for O 0 0.0009876281255856156
four O 0 0.0012755380012094975
of O 0 0.0009229453280568123
these O 0 0.0010398508748039603
individuals O 0 0.002850389340892434
and O 0 0.0010366454953327775
for O 0 0.001283089048229158
12 O 0 0.004015152808278799
additional O 0 0.0047358134761452675
non O 0 0.011238079518079758
- O 0 0.03431476280093193
Ashkenazi O 1 0.9818810224533081
185delAG O 1 0.9991132616996765
mutation O 1 0.9998824596405029
carriers O 1 0.9153052568435669
who O 0 0.010680850595235825
had O 0 0.4537769556045532
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.99998939037323
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.020737994462251663

Six O 0 0.01893647015094757
non O 0 0.023601071909070015
- O 0 0.03296557068824768
Ashkenazi O 1 0.6335940361022949
individuals O 0 0.006029688287526369
shared O 0 0.005266197491437197
the O 0 0.003268687054514885
common O 0 0.020533641800284386
Ashkenazi O 1 0.9988793730735779
haplotype O 1 0.9989120960235596
, O 0 0.0018528971122577786
four O 0 0.002105343621224165
had O 0 0.002412602072581649
a O 0 0.0034842153545469046
closely O 0 0.006070028990507126
related O 0 0.008250724524259567
pattern O 0 0.01620193012058735
, O 0 0.0012448811903595924
and O 0 0.0009322685655206442
the O 0 0.002360503887757659
rest O 0 0.008272903971374035
( O 0 0.007237897254526615
n O 0 0.02808278426527977
= O 0 0.02649744041264057
6 O 0 0.008616349659860134
) O 0 0.003085306379944086
displayed O 0 0.006409390829503536
a O 0 0.008686338551342487
distinct O 0 0.046656232327222824
BRCA1 O 1 0.9999715089797974
allelic O 1 0.9980273842811584
pattern O 0 0.24577774107456207
. O 0 0.016149863600730896

We O 0 0.006872148718684912
conclude O 0 0.013369116932153702
that O 0 0.0026418273337185383
the O 0 0.007756796199828386
185delAG O 1 0.9993991851806641
BRCA1 O 1 0.999993085861206
mutation O 1 0.9998189806938171
occurs O 0 0.040417853742837906
in O 0 0.0025717203970998526
some O 0 0.0037357995752245188
non O 0 0.014793675392866135
- O 0 0.039956290274858475
Ashkenazi O 1 0.9843624830245972
populations O 0 0.03561728820204735
at O 0 0.004353028256446123
rates O 0 0.010596686974167824
comparable O 0 0.009700325317680836
with O 0 0.0018078861758112907
that O 0 0.0016427751397714019
of O 0 0.004515917506068945
Ashkenazim O 1 0.994273841381073
. O 0 0.015417984686791897

The O 0 0.00661978404968977
majority O 0 0.00984424352645874
of O 0 0.0033382964320480824
Jewish O 0 0.025544211268424988
185delAG O 1 0.9996892213821411
mutation O 1 0.9999579191207886
carriers O 1 0.8572625517845154
have O 0 0.0025360481813549995
a O 0 0.00562008423730731
common O 0 0.014691113494336605
allelic O 1 0.9986391663551331
pattern O 0 0.044853098690509796
, O 0 0.0023202276788651943
supporting O 0 0.006254083942621946
the O 0 0.0029652314260601997
founder O 0 0.021297335624694824
effect O 0 0.012740003876388073
notion O 0 0.008337059989571571
, O 0 0.0018790961476042867
but O 0 0.0018862680299207568
dating O 0 0.007830208167433739
the O 0 0.004153049550950527
mutations O 1 0.996533989906311
origin O 0 0.0043363021686673164
to O 0 0.0009858598932623863
an O 0 0.0015105457277968526
earlier O 0 0.0033679793123155832
date O 0 0.003865942358970642
than O 0 0.002476586028933525
currently O 0 0.004488810431212187
estimated O 0 0.01622036285698414
. O 0 0.010774149559438229

However O 0 0.007253480143845081
, O 0 0.0016304804012179375
the O 0 0.002196492161601782
different O 0 0.003452148288488388
allelic O 1 0.9932042360305786
pattern O 0 0.023282714188098907
at O 0 0.004768389742821455
the O 0 0.008184700272977352
BRCA1 O 1 0.999996542930603
locus O 1 0.998659610748291
even O 0 0.00398813933134079
in O 0 0.001813377602957189
some O 0 0.0026480904780328274
Jewish O 0 0.020510591566562653
mutation O 1 0.9999566078186035
carriers O 1 0.966389536857605
, O 0 0.0029684389010071754
might O 0 0.006984176579862833
suggest O 0 0.007194196339696646
that O 0 0.0020012788008898497
the O 0 0.005616850219666958
mutation O 1 0.9989513158798218
arose O 0 0.028266331180930138
independently O 0 0.013680539093911648
. O 0 0.00546356663107872
. O 0 0.009425335563719273

Crystal O 0 0.03898007050156593
structure O 0 0.008284245617687702
of O 0 0.0032098114024847746
the O 0 0.010347157716751099
hemochromatosis B-Disease 1 0.9999986886978149
protein O 1 0.9799805283546448
HFE O 1 0.9998804330825806
and O 0 0.003545342478901148
characterization O 0 0.014934180304408073
of O 0 0.0018050693906843662
its O 0 0.003430293407291174
interaction O 0 0.0146265784278512
with O 0 0.0068542310036718845
transferrin O 1 0.9951574206352234
receptor O 1 0.9328445196151733
. O 0 0.01723632961511612

HFE O 1 0.9966145157814026
is O 0 0.010630146600306034
an O 0 0.010778902098536491
MHC O 1 0.9989000558853149
- O 0 0.03053026832640171
related O 0 0.012519958429038525
protein O 0 0.023129211738705635
that O 0 0.0018843325087800622
is O 0 0.003803223604336381
mutated O 1 0.994762122631073
in O 0 0.0025443315971642733
the O 0 0.0043889740481972694
iron B-Disease 1 0.8238106966018677
- I-Disease 1 0.9874715209007263
overload I-Disease 1 0.9999531507492065
disease I-Disease 1 0.9999997615814209
hereditary B-Disease 1 0.9999984502792358
hemochromatosis I-Disease 1 0.9999996423721313
. O 0 0.03310982882976532

HFE O 1 0.9978093504905701
binds O 0 0.10650728642940521
to O 0 0.011136902496218681
transferrin O 1 0.9844279885292053
receptor O 1 0.9696878790855408
( O 0 0.01906798966228962
TfR O 1 0.9944918155670166
) O 0 0.006397083401679993
and O 0 0.002822362817823887
reduces O 0 0.03805889934301376
its O 0 0.004341380205005407
affinity O 0 0.024627860635519028
for O 0 0.003524618921801448
iron O 0 0.032040152698755264
- O 0 0.02844822034239769
loaded O 0 0.023478630930185318
transferrin O 1 0.8685104250907898
, O 0 0.006628444418311119
implicating O 1 0.7199029922485352
HFE O 1 0.9994943141937256
in O 0 0.008743940852582455
iron O 1 0.5403420329093933
metabolism O 1 0.9724593162536621
. O 0 0.016518639400601387

The O 0 0.012020952068269253
2 O 0 0.019114665687084198
. O 0 0.012893256731331348

6 O 0 0.02434377558529377
A O 0 0.013989443890750408
crystal O 0 0.020147476345300674
structure O 0 0.007136140018701553
of O 0 0.004422810859978199
HFE O 1 0.9997676014900208
reveals O 0 0.02360936999320984
the O 0 0.002270736265927553
locations O 0 0.005041551776230335
of O 0 0.005030193366110325
hemochromatosis B-Disease 1 0.9999997615814209
mutations O 1 0.9999160766601562
and O 0 0.0033191090915352106
a O 0 0.008307576179504395
patch O 1 0.997962236404419
of O 0 0.004006836097687483
histidines O 1 0.9981071949005127
that O 0 0.0017077901866286993
could O 0 0.002172071486711502
be O 0 0.001403285190463066
involved O 0 0.004942225757986307
in O 0 0.004590537399053574
pH O 1 0.9910058975219727
- O 0 0.04104328528046608
dependent O 0 0.04162336513400078
interactions O 0 0.03466461971402168
. O 0 0.012616179883480072

We O 0 0.0036549167707562447
also O 0 0.002468788530677557
demonstrate O 0 0.0076401554979383945
that O 0 0.003612594213336706
soluble O 1 0.6408913135528564
TfR O 1 0.9990876913070679
and O 0 0.007209416013211012
HFE O 1 0.9999326467514038
bind O 0 0.06311909109354019
tightly O 0 0.01646140217781067
at O 0 0.0024241507053375244
the O 0 0.0020201459992676973
basic O 0 0.00730906194075942
pH O 0 0.34113121032714844
of O 0 0.0015334163326770067
the O 0 0.0031063933856785297
cell O 0 0.3007802367210388
surface O 0 0.008812062442302704
, O 0 0.0014334344305098057
but O 0 0.0016186367720365524
not O 0 0.0012326891301199794
at O 0 0.002610842464491725
the O 0 0.004932756070047617
acidic O 1 0.9292246699333191
pH O 1 0.8180004954338074
of O 0 0.008801036514341831
intracellular O 1 0.9389581680297852
vesicles O 1 0.5589873790740967
. O 0 0.015570936724543571

TfR O 1 0.9924089908599854
HFE O 1 0.9987751841545105
stoichiometry O 1 0.8016035556793213
( O 0 0.012827347032725811
2 O 0 0.010288864374160767
1 O 0 0.007960398681461811
) O 0 0.004344493616372347
differs O 0 0.017017705366015434
from O 0 0.008295324631035328
TfR O 1 0.9980990290641785
transferrin O 1 0.9887005686759949
stoichiometry O 0 0.3080986440181732
( O 0 0.009557927958667278
2 O 0 0.008622311055660248
2 O 0 0.007087483070790768
) O 0 0.002928640227764845
, O 0 0.001659471308812499
implying O 0 0.013338243588805199
a O 0 0.0033595114946365356
different O 0 0.0019306945614516735
mode O 0 0.01280948705971241
of O 0 0.0019496072782203555
binding O 0 0.011081647127866745
for O 0 0.004315085709095001
HFE O 1 0.9998703002929688
and O 0 0.004591831471771002
transferrin O 1 0.9883308410644531
to O 0 0.004748448263853788
TfR O 1 0.9962823987007141
, O 0 0.002481686184182763
consistent O 0 0.0064401342533528805
with O 0 0.0018918422283604741
our O 0 0.0032444673124700785
demonstration O 0 0.012325355783104897
that O 0 0.004664245992898941
HFE O 1 0.9998267292976379
, O 0 0.006153613328933716
transferrin O 1 0.9819839596748352
, O 0 0.0032360076438635588
and O 0 0.0027826442383229733
TfR O 1 0.997471809387207
form O 0 0.0109202666208148
a O 0 0.012051280587911606
ternary O 0 0.0884530320763588
complex O 0 0.021059971302747726
. O 0 0.012644479051232338

Identification O 0 0.01789817400276661
of O 0 0.002647609217092395
three O 0 0.003935272805392742
novel O 0 0.026335647329688072
mutations O 1 0.9979409575462341
and O 0 0.0017485995776951313
a O 0 0.0035877677146345377
high O 0 0.005723260343074799
frequency O 0 0.012400947511196136
of O 0 0.0017954695504158735
the O 0 0.005130631849169731
Arg778Leu O 1 0.9993659853935242
mutation O 1 0.9998583793640137
in O 0 0.005770156625658274
Korean O 0 0.0687071830034256
patients O 1 0.9999308586120605
with O 0 0.010765344835817814
Wilson B-Disease 1 0.9993075132369995
disease I-Disease 1 0.9999992847442627
. O 0 0.01619774103164673

Four O 0 0.022752759978175163
mutations O 1 0.9990569949150085
- O 0 0.060849979519844055
- O 0 0.05254093185067177
R778L O 1 0.9639500975608826
, O 0 0.006934558041393757
A874V O 1 0.9933218359947205
, O 0 0.005816373508423567
L1083F O 1 0.9886685013771057
, O 0 0.0032036115881055593
and O 0 0.0035294487606734037
2304delC O 1 0.9841896891593933
- O 0 0.025406895205378532
- O 0 0.01292615570127964
in O 0 0.002271214034408331
the O 0 0.0031019325833767653
copper O 0 0.020292138680815697
- O 0 0.019806819036602974
transporting O 0 0.02436172217130661
enzyme O 0 0.06830915063619614
, O 0 0.0058922297321259975
P O 0 0.23093511164188385
- O 0 0.04708324372768402
type O 0 0.1145765632390976
ATPase O 1 0.9935128092765808
( O 0 0.015436173416674137
ATP7B O 1 0.9966381788253784
) O 0 0.004191073123365641
, O 0 0.0012028556084260345
were O 0 0.001245003892108798
identified O 0 0.007173912599682808
in O 0 0.0030737370252609253
Korean O 0 0.04206046834588051
Patients O 1 0.9998602867126465
with O 0 0.009523771703243256
Wilson B-Disease 1 0.9985931515693665
disease I-Disease 1 0.9999964237213135
. O 0 0.015319936908781528

Arg778Leu O 1 0.9870622754096985
, O 0 0.003017732873558998
the O 0 0.0024149338714778423
most O 0 0.003202509367838502
frequently O 0 0.009249917231500149
reported O 0 0.015894737094640732
mutation O 1 0.9964640736579895
of O 0 0.0025582958478480577
this O 0 0.0036301608197391033
enzyme O 0 0.04176798090338707
, O 0 0.0018508160719648004
was O 0 0.002335701370611787
found O 0 0.0029244311153888702
in O 0 0.0011979452101513743
six O 0 0.00185954081825912
of O 0 0.0015398624818772078
eight O 0 0.007631252519786358
unrelated O 1 0.8493494391441345
patients O 1 0.9997760653495789
studied O 0 0.006979300640523434
, O 0 0.0020758970640599728
an O 0 0.004467453341931105
allele O 1 0.9961125254631042
frequency O 0 0.022684892639517784
of O 0 0.004107065498828888
37 O 0 0.021140115335583687
. O 0 0.010584122501313686

5 O 0 0.01885535567998886
% O 0 0.007303120102733374
, O 0 0.002090783789753914
which O 0 0.0020402546506375074
is O 0 0.0032024423126131296
considerably O 0 0.018068501725792885
higher O 0 0.0049984934739768505
than O 0 0.0022138033527880907
those O 0 0.0014252428663894534
in O 0 0.0014052618062123656
other O 0 0.002155897906050086
Asian O 0 0.021771429106593132
populations O 0 0.04437285289168358
. O 0 0.012448616325855255

The O 0 0.007817641831934452
novel O 0 0.021149668842554092
single O 0 0.02020794153213501
nucleotide O 0 0.0875016376376152
deletion O 1 0.9607751965522766
, O 0 0.005614299327135086
2304delC O 1 0.9639276266098022
, O 0 0.0022866432555019855
was O 0 0.0026664419565349817
found O 0 0.003205304965376854
in O 0 0.0019956794567406178
one O 0 0.005821887869387865
patient O 1 0.9967823028564453
. O 0 0.01210568193346262

Since O 0 0.020816484466195107
a O 0 0.018944626674056053
mutation O 1 0.9868022799491882
at O 0 0.012436452321708202
cDNA O 0 0.131445050239563
nucleotide O 0 0.18817520141601562
2302 O 1 0.9968390464782715
( O 0 0.01931513100862503
2302insC O 1 0.9505451917648315
) O 0 0.0055513037368655205
had O 0 0.003535760333761573
been O 0 0.003019328461959958
previously O 0 0.0037780865095555782
described O 0 0.005357408430427313
, O 0 0.001145133632235229
this O 0 0.0010759829310700297
region O 0 0.0038630517665296793
of O 0 0.0013594201300293207
the O 0 0.004602506291121244
ATP7B O 1 0.9999172687530518
gene O 1 0.9991180300712585
may O 0 0.008292877115309238
be O 0 0.00292186695151031
susceptible O 1 0.9979015588760376
to O 0 0.005729575641453266
gene O 1 0.9980564713478088
rearrangements O 1 0.9990947246551514
causing O 1 0.9998323917388916
Wilson B-Disease 1 0.9986506104469299
disease I-Disease 1 0.9999978542327881
. O 0 0.018282506614923477

Disruption O 0 0.09443654119968414
of O 0 0.00725529296323657
splicing O 0 0.08512921631336212
regulated O 0 0.02242407016456127
by O 0 0.005004729609936476
a O 0 0.013810742646455765
CUG O 1 0.9946873188018799
- O 0 0.04973886162042618
binding O 0 0.03617743402719498
protein O 0 0.058511581271886826
in O 0 0.016888068988919258
myotonic B-Disease 1 0.9999964237213135
dystrophy I-Disease 1 0.999998927116394
. O 0 0.028020257130265236

Myotonic B-Disease 1 0.9999967813491821
dystrophy I-Disease 1 0.9999995231628418
( O 0 0.17964598536491394
DM B-Disease 1 0.9999730587005615
) O 0 0.009964796714484692
is O 0 0.005518818274140358
caused O 0 0.24015478789806366
by O 0 0.003729627002030611
a O 0 0.008778117597103119
CTG O 1 0.9870560169219971
expansion O 0 0.009612076915800571
in O 0 0.001600446179509163
the O 0 0.002747372491285205
3 O 0 0.009349063970148563
untranslated O 0 0.10792597383260727
region O 0 0.008468247018754482
of O 0 0.0029730459209531546
the O 0 0.010722832754254341
DM B-Disease 1 0.9999879598617554
gene O 1 0.9894630312919617
. O 0 0.017266809940338135

One O 0 0.01019732840359211
model O 0 0.01669277250766754
of O 0 0.011631535366177559
DM B-Disease 1 0.9999898672103882
pathogenesis O 1 0.9998469352722168
suggests O 0 0.025798305869102478
that O 0 0.004696942865848541
RNAs O 0 0.04380107298493385
from O 0 0.003447861410677433
the O 0 0.002944651758298278
expanded O 0 0.010414524003863335
allele O 1 0.9835373759269714
create O 0 0.007509273011237383
a O 0 0.0050898767076432705
gain O 0 0.01108371652662754
- O 0 0.013033266179263592
of O 0 0.0034019495360553265
- O 0 0.027288325130939484
function O 0 0.02673155628144741
mutation O 1 0.996292769908905
by O 0 0.003352009691298008
the O 0 0.0031678981613367796
inappropriate O 0 0.013610754162073135
binding O 0 0.008003399707376957
of O 0 0.0018358634551987052
proteins O 0 0.010466141626238823
to O 0 0.002185727236792445
the O 0 0.0054287682287395
CUG O 1 0.9976434111595154
repeats O 0 0.10624037683010101
. O 0 0.012525183148682117

Data O 0 0.008590654470026493
presented O 0 0.005472351796925068
here O 0 0.002479720627889037
indicate O 0 0.005685440730303526
that O 0 0.0015833096113055944
the O 0 0.0031250983010977507
conserved O 0 0.028696617111563683
heterogeneous O 0 0.04952152818441391
nuclear O 0 0.0153227923437953
ribonucleoprotein O 1 0.7985447645187378
, O 0 0.006137179210782051
CUG O 1 0.9958381652832031
- O 0 0.03163906931877136
binding O 0 0.024732792750000954
protein O 0 0.039700184017419815
( O 0 0.010572523809969425
CUG O 1 0.9975308775901794
- O 0 0.03588875010609627
BP O 0 0.05575531721115112
) O 0 0.004601564723998308
, O 0 0.0019696042872965336
may O 0 0.005698272492736578
mediate O 0 0.020619338378310204
the O 0 0.005019343923777342
trans O 1 0.6273205876350403
- O 0 0.02954407036304474
dominant O 0 0.036639995872974396
effect O 0 0.009723084047436714
of O 0 0.0024897227995097637
the O 0 0.005100924056023359
RNA O 0 0.06432954221963882
. O 0 0.009777059778571129

CUG O 1 0.9991662502288818
- O 0 0.06722638010978699
BP O 0 0.07098978012800217
was O 0 0.00703391432762146
found O 0 0.004961376078426838
to O 0 0.002476128051057458
bind O 0 0.018825814127922058
to O 0 0.0024714404717087746
the O 0 0.004529919009655714
human O 0 0.1706191897392273
cardiac O 1 0.9999959468841553
troponin O 1 0.9999631643295288
T O 1 0.997870922088623
( O 0 0.0171990767121315
cTNT O 1 0.976007878780365
) O 0 0.00798597652465105
pre O 0 0.030412977561354637
- O 0 0.030051248148083687
messenger O 0 0.05674207955598831
RNA O 0 0.04547068849205971
and O 0 0.003213658696040511
regulate O 0 0.024913493543863297
its O 0 0.005909062922000885
alternative O 0 0.02141985110938549
splicing O 0 0.09611091017723083
. O 0 0.013667842373251915

Splicing O 0 0.11037398129701614
of O 0 0.008875079452991486
cTNT O 1 0.873091459274292
was O 0 0.012347242794930935
disrupted O 1 0.5017260909080505
in O 0 0.016704892739653587
DM B-Disease 1 0.9999967813491821
striated O 1 0.9999886751174927
muscle O 1 0.9999246597290039
and O 0 0.0029274190310388803
in O 0 0.004207616671919823
normal O 0 0.0546015165746212
cells O 0 0.25220149755477905
expressing O 0 0.01649590954184532
transcripts O 0 0.013730556704103947
that O 0 0.0034209038130939007
contain O 0 0.02145933173596859
CUG O 1 0.9923272728919983
repeats O 0 0.09165176749229431
. O 0 0.01642642915248871

Altered O 0 0.06702544540166855
expression O 0 0.028391951695084572
of O 0 0.00576339615508914
genes O 1 0.6020978689193726
regulated O 0 0.037224628031253815
posttranscriptionally O 1 0.9506757855415344
by O 0 0.010889541357755661
CUG O 1 0.9992604851722717
- O 0 0.04588286578655243
BP O 0 0.059913184493780136
therefore O 0 0.007273477967828512
may O 0 0.007026428356766701
contribute O 0 0.01576739177107811
to O 0 0.0096755875274539
DM B-Disease 1 0.999984860420227
pathogenesis O 1 0.9997267127037048
. O 0 0.010817413218319416
. O 0 0.01142040640115738

Identification O 0 0.016865180805325508
of O 0 0.0024317940697073936
a O 0 0.006634515710175037
novel O 0 0.021297188475728035
nonsense O 0 0.3434825837612152
mutation O 1 0.9995135068893433
and O 0 0.003304343903437257
a O 0 0.008402744308114052
missense O 1 0.979672908782959
substitution O 0 0.022376006469130516
in O 0 0.0027503648307174444
the O 0 0.0065672569908201694
vasopressin O 1 0.9989690780639648
- O 0 0.48160111904144287
neurophysin O 1 0.9984702467918396
II O 1 0.8199347257614136
gene O 0 0.20735931396484375
in O 0 0.002634217031300068
two O 0 0.0025804329197853804
Spanish O 0 0.022860359400510788
kindreds O 1 0.9734832048416138
with O 0 0.016408802941441536
familial B-Disease 1 0.9999942779541016
neurohypophyseal I-Disease 1 0.999990701675415
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999682903289795
. O 0 0.02469565160572529

Familial B-Disease 1 0.9999920129776001
neurohypophyseal I-Disease 1 0.999971866607666
diabetes I-Disease 1 0.9999996423721313
insipidus I-Disease 1 0.9999880790710449
( O 0 0.03431455418467522
FNDI B-Disease 1 0.9997730851173401
) O 0 0.006888189353048801
is O 0 0.0036865125875920057
an O 0 0.006985026877373457
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 0.9998807907104492
disease I-Disease 1 1.0
caused O 1 0.9998855590820312
by O 0 0.018380258232355118
deficiency O 1 0.9999977350234985
in O 0 0.0052726734429597855
the O 0 0.010998699814081192
antidiuretic O 1 0.9994100332260132
hormone O 1 0.9973908066749573
arginine O 1 0.9124668836593628
vasopressin O 1 0.9794639348983765
( O 0 0.02437254972755909
AVP O 1 0.9128317832946777
) O 0 0.0076182205229997635
encoded O 0 0.016165243461728096
by O 0 0.0034909469541162252
the O 0 0.006501992233097553
AVP O 1 0.9939519762992859
- O 0 0.06120290979743004
neurophysin O 1 0.9884061813354492
II O 0 0.29386964440345764
( O 0 0.017585597932338715
AVP O 1 0.9990479350090027
- O 0 0.1312589943408966
NPII O 1 0.9925935864448547
) O 0 0.011339148506522179
gene O 1 0.636174738407135
on O 0 0.009971944615244865
chromosome O 1 0.9973908066749573
20p13 O 1 0.9668342471122742
. O 0 0.01697223260998726

In O 0 0.004219082649797201
this O 0 0.003075934248045087
study O 0 0.0049871536903083324
, O 0 0.001643682480789721
we O 0 0.0017346561653539538
analyzed O 0 0.008009761571884155
two O 0 0.002147154649719596
families O 0 0.006614596117287874
with O 0 0.004309170413762331
FNDI B-Disease 1 0.992483913898468
using O 0 0.007162659894675016
direct O 0 0.010125720873475075
automated O 0 0.027260160073637962
fluorescent O 0 0.04774067550897598
, O 0 0.003567054867744446
solid O 0 0.008963956497609615
phase O 0 0.01750967465341091
, O 0 0.0025984388776123524
single O 0 0.012800276279449463
- O 0 0.025623269379138947
stranded O 0 0.0697406753897667
DNA O 0 0.036374323070049286
sequencing O 0 0.03736605495214462
of O 0 0.006635109893977642
PCR O 0 0.14351695775985718
- O 0 0.048229340463876724
amplified O 0 0.44592246413230896
AVP O 1 0.9975404739379883
- O 0 0.17821426689624786
NPII O 1 0.9878026843070984
DNA O 0 0.07889123260974884
. O 0 0.017451370134949684

In O 0 0.0047269850037992
one O 0 0.0023519715759903193
of O 0 0.0013381202006712556
the O 0 0.0022108973935246468
families O 0 0.005719262175261974
, O 0 0.0026712599210441113
affected O 0 0.032646648585796356
individuals O 0 0.004732825327664614
presented O 0 0.004374213516712189
a O 0 0.0059305401518940926
novel O 0 0.02241586707532406
nonsense O 0 0.23953869938850403
mutation O 1 0.9963608384132385
in O 0 0.004535582382231951
exon O 0 0.24119126796722412
3 O 0 0.005746905226260424
of O 0 0.0016908772522583604
the O 0 0.003964338451623917
gene O 1 0.7508935928344727
, O 0 0.0023089698515832424
consisting O 0 0.004477012902498245
in O 0 0.002019075443968177
a O 0 0.007408608216792345
G O 0 0.32412609457969666
to O 0 0.00496688112616539
T O 1 0.9354056119918823
transition O 0 0.02051609568297863
at O 0 0.007216630969196558
nucleotide O 0 0.07713356614112854
2101 O 1 0.9507259726524353
, O 0 0.0036729939747601748
which O 0 0.0028826782945543528
produces O 0 0.013734910637140274
a O 0 0.006089299451559782
stop O 0 0.014352049678564072
signal O 0 0.017229320481419563
in O 0 0.004812668077647686
codon O 0 0.14507128298282623
82 O 0 0.04130632057785988
( O 0 0.01663423515856266
Glu O 1 0.995639443397522
) O 0 0.006575664505362511
of O 0 0.005217835772782564
NPII O 1 0.9964730143547058
. O 0 0.015986621379852295

The O 0 0.023908115923404694
premature O 1 0.9981141090393066
termination O 1 0.9730089902877808
eliminates O 0 0.05676984041929245
part O 0 0.00449857022613287
of O 0 0.0019345490727573633
the O 0 0.0050383335910737514
C O 0 0.08271908015012741
- O 0 0.030338779091835022
terminal O 0 0.05398779362440109
domain O 0 0.01586429588496685
of O 0 0.0032560687977820635
NPII O 1 0.9972374439239502
, O 0 0.0025728861801326275
including O 0 0.0019342933082953095
a O 0 0.006483101285994053
cysteine O 0 0.0436166487634182
residue O 0 0.028135770931839943
in O 0 0.002237162087112665
position O 0 0.0052548847161233425
85 O 0 0.012392178177833557
, O 0 0.0016551793087273836
which O 0 0.0014574418310075998
could O 0 0.0020617670379579067
be O 0 0.0012536817230284214
involved O 0 0.0034683409612625837
in O 0 0.0013373733963817358
the O 0 0.0028654152993112803
correct O 0 0.01380435936152935
folding O 0 0.02785300649702549
of O 0 0.0031218838412314653
the O 0 0.007464708760380745
prohormone O 1 0.9982713460922241
. O 0 0.014026992954313755

In O 0 0.006354540586471558
the O 0 0.0037798043340444565
second O 0 0.007132908329367638
family O 0 0.009944752790033817
, O 0 0.0027623665519058704
a O 0 0.008680962026119232
G279A O 1 0.79604572057724
substitution O 0 0.029047615826129913
at O 0 0.005791215226054192
position O 0 0.005957568995654583
- O 0 0.011862333863973618
1 O 0 0.004282803740352392
of O 0 0.0013487577671185136
the O 0 0.0027550163213163614
signal O 0 0.020562896504998207
peptide O 0 0.056579940021038055
was O 0 0.004603596869856119
observed O 0 0.007896136492490768
in O 0 0.001751170726493001
all O 0 0.0028286653105169535
affected O 0 0.04704359546303749
individuals O 0 0.010492639616131783
. O 0 0.009180216118693352

This O 0 0.02048644982278347
missense O 1 0.9981344938278198
mutation O 1 0.9993031024932861
, O 0 0.004029917996376753
which O 0 0.004039849620312452
replaces O 1 0.7162661552429199
Ala O 1 0.9973458647727966
with O 0 0.007089580874890089
Thr O 1 0.9998505115509033
, O 0 0.003065151860937476
is O 0 0.004458330571651459
frequent O 0 0.05975518375635147
among O 0 0.02007070928812027
FNDI B-Disease 1 0.9999973773956299
patients O 1 0.9999818801879883
and O 0 0.0019258115207776427
is O 0 0.002434409921988845
thought O 0 0.004845073912292719
to O 0 0.00176171213388443
reduce O 0 0.009429066441953182
the O 0 0.0024691158905625343
efficiency O 0 0.009414718486368656
of O 0 0.004163234494626522
cleavage O 1 0.8926111459732056
by O 0 0.00882632564753294
signal O 0 0.03370233625173569
peptidases O 1 0.6252515316009521
. O 0 0.00757178571075201
. O 0 0.010633888654410839

Genetic O 1 0.5685702562332153
heterogeneity O 0 0.27234092354774475
of O 0 0.010259808972477913
Saethre B-Disease 1 0.9998099207878113
- I-Disease 1 0.9979813694953918
Chotzen I-Disease 1 0.9999809265136719
syndrome I-Disease 1 1.0
, O 0 0.004883899353444576
due O 0 0.008265587501227856
to O 0 0.002993897534906864
TWIST O 1 0.6202821731567383
and O 0 0.007460650987923145
FGFR O 1 0.9994112253189087
mutations O 1 0.9991112351417542
. O 0 0.015923846513032913

Thirty O 0 0.04482025280594826
- O 0 0.024006551131606102
two O 0 0.005798324476927519
unrelated O 0 0.14339512586593628
patients O 1 0.9988663196563721
with O 0 0.002710078377276659
features O 0 0.005507991183549166
of O 0 0.00422883965075016
Saethre B-Disease 1 0.9998810291290283
- I-Disease 1 0.9964534044265747
Chotzen I-Disease 1 0.9999861717224121
syndrome I-Disease 1 0.9999998807907104
, O 0 0.004358080681413412
a O 0 0.008525091223418713
common O 0 0.3443754315376282
autosomal B-Disease 1 0.9999963045120239
dominant I-Disease 1 0.9970394968986511
condition I-Disease 1 0.9310364723205566
of O 0 0.005821841768920422
craniosynostosis B-Disease 1 0.9999990463256836
and O 0 0.01666574366390705
limb B-Disease 1 0.9999991655349731
anomalies I-Disease 1 0.9981465339660645
, O 0 0.0021178799215704203
were O 0 0.001763528329320252
screened O 0 0.024107513949275017
for O 0 0.003716570558026433
mutations O 1 0.9987694621086121
in O 0 0.0038225639145821333
TWIST O 1 0.9568042159080505
, O 0 0.005324120633304119
FGFR2 O 1 0.9989701509475708
, O 0 0.003614614950492978
and O 0 0.003998665139079094
FGFR3 O 1 0.9983400106430054
. O 0 0.012548252940177917

Nine O 0 0.010396200232207775
novel O 0 0.0128323407843709
and O 0 0.0019747852347791195
three O 0 0.0050013018772006035
recurrent O 1 0.9999315738677979
TWIST O 1 0.9985806941986084
mutations O 1 0.9995163679122925
were O 0 0.0021971683017909527
found O 0 0.003858503419905901
in O 0 0.001910506864078343
12 O 0 0.006918516010046005
families O 0 0.010556160472333431
. O 0 0.008597955107688904

Seven O 0 0.009540771134197712
families O 0 0.007046240847557783
were O 0 0.0016318269772455096
found O 0 0.0028030320536345243
to O 0 0.0010548734571784735
have O 0 0.001595949404872954
the O 0 0.005026393570005894
FGFR3 O 1 0.9998830556869507
P250R O 1 0.9998078942298889
mutation O 1 0.9997383952140808
, O 0 0.0025599696673452854
and O 0 0.001175959245301783
one O 0 0.0016931761056184769
individual O 0 0.0022584982216358185
was O 0 0.0023720350582152605
found O 0 0.002774351043626666
to O 0 0.0009615343296900392
have O 0 0.001683355076238513
an O 0 0.0043105087243020535
FGFR2 O 1 0.9984388947486877
VV269 O 1 0.9934912323951721
- O 0 0.05441077798604965
270 O 0 0.06974741071462631
deletion O 1 0.9622071981430054
. O 0 0.01665904000401497

To O 0 0.005135906394571066
date O 0 0.006151105277240276
, O 0 0.00209288508631289
our O 0 0.004302920773625374
detection O 0 0.024116069078445435
rate O 0 0.007861168123781681
for O 0 0.0031390271615236998
TWIST O 0 0.4069114625453949
or O 0 0.01162186823785305
FGFR O 1 0.9995970129966736
mutations O 1 0.9995785355567932
is O 0 0.004734524060040712
68 O 0 0.013276142068207264
% O 0 0.0038903371896594763
in O 0 0.002061808481812477
our O 0 0.007800341118127108
Saethre B-Disease 1 0.9997039437294006
- I-Disease 1 0.9988648891448975
Chotzen I-Disease 1 0.9999945163726807
syndrome I-Disease 1 1.0
patients O 1 0.9999737739562988
, O 0 0.0026237170677632093
including O 0 0.0023054596967995167
our O 0 0.0038290824741125107
five O 0 0.006994631607085466
patients O 1 0.9995952248573303
elsewhere O 0 0.011726919561624527
reported O 0 0.012632310390472412
with O 0 0.006746555212885141
TWIST O 1 0.9888764023780823
mutations O 1 0.9995843768119812
. O 0 0.013106174767017365

More O 0 0.007135927677154541
than O 0 0.004767666105180979
35 O 0 0.01012504380196333
different O 0 0.0049256132915616035
TWIST O 1 0.9867298603057861
mutations O 1 0.998863697052002
are O 0 0.0018815035000443459
now O 0 0.002928847447037697
known O 0 0.003885399317368865
in O 0 0.0013173893094062805
the O 0 0.0026721542235463858
literature O 0 0.008543037809431553
. O 0 0.00823295209556818

The O 0 0.006553580053150654
most O 0 0.005350102670490742
common O 0 0.01586110331118107
phenotypic O 1 0.999461829662323
features O 0 0.007265765685588121
, O 0 0.0016206306172534823
present O 0 0.002060020575299859
in O 0 0.0011059105163440108
more O 0 0.001278357463888824
than O 0 0.0014184665633365512
a O 0 0.002528382232412696
third O 0 0.0036930665373802185
of O 0 0.001805769745260477
our O 0 0.006580289453268051
patients O 1 0.9997239708900452
with O 0 0.004947187844663858
TWIST O 1 0.9981259703636169
mutations O 1 0.9998353719711304
, O 0 0.002134431852027774
are O 0 0.0020662201568484306
coronal B-Disease 1 0.9691734313964844
synostosis I-Disease 1 0.9978519678115845
, O 0 0.004884608555585146
brachycephaly B-Disease 1 0.9963434338569641
, O 0 0.005260447971522808
low B-Disease 0 0.21884480118751526
frontal I-Disease 1 0.9999873638153076
hairline I-Disease 1 0.9999983310699463
, O 0 0.014171645976603031
facial B-Disease 1 0.999985933303833
asymmetry I-Disease 1 0.9988340735435486
, O 0 0.010124264284968376
ptosis B-Disease 1 0.9999980926513672
, O 0 0.00805603340268135
hypertelorism B-Disease 1 0.999880313873291
, O 0 0.004096782300621271
broad B-Disease 0 0.029328718781471252
great I-Disease 0 0.013976368121802807
toes I-Disease 1 0.9994726777076721
, O 0 0.0037364389281719923
and O 0 0.004156018141657114
clinodactyly B-Disease 1 0.9824944138526917
. O 0 0.01667606085538864

Significant O 0 0.02959592081606388
intra O 0 0.2537134289741516
- O 0 0.026838164776563644
and O 0 0.006522937677800655
interfamilial O 1 0.9961366057395935
phenotypic O 1 0.9980385899543762
variability O 0 0.32552990317344666
is O 0 0.002811468206346035
present O 0 0.0025010814424604177
for O 0 0.0018436986720189452
either O 0 0.008252691477537155
TWIST O 1 0.9932471513748169
mutations O 1 0.9993815422058105
or O 0 0.016140026971697807
FGFR O 1 0.9997907280921936
mutations O 1 0.9986573457717896
. O 0 0.016003837808966637

The O 0 0.009382989257574081
overlap O 0 0.024228887632489204
in O 0 0.0038273585960268974
clinical O 1 0.8589515686035156
features O 0 0.004186565522104502
and O 0 0.0009195287129841745
the O 0 0.001621365430764854
presence O 0 0.005218167323619127
, O 0 0.0010263073490932584
in O 0 0.0009563089115545154
the O 0 0.0015264017274603248
same O 0 0.003738097380846739
genes O 0 0.04575682431459427
, O 0 0.0017250018427148461
of O 0 0.0022213326301425695
mutations O 1 0.9970600008964539
for O 0 0.0014786369865760207
more O 0 0.001583087258040905
than O 0 0.0023306566290557384
one O 0 0.0037545720115303993
craniosynostotic B-Disease 1 0.9993798732757568
condition I-Disease 1 0.9119018316268921
- O 0 0.011359727010130882
such O 0 0.001930705620907247
as O 0 0.004167007748037577
Saethre B-Disease 1 0.9993077516555786
- I-Disease 0 0.2871272563934326
Chotzen I-Disease 1 0.9978631138801575
, I-Disease 0 0.006455578841269016
Crouzon I-Disease 1 0.9969756603240967
, I-Disease 0 0.003344915574416518
and I-Disease 0 0.004774376284331083
Pfeiffer I-Disease 1 0.999845027923584
syndromes I-Disease 1 0.9999970197677612
- O 0 0.017452670261263847
support O 0 0.004537641070783138
the O 0 0.0032600192353129387
hypothesis O 0 0.019322989508509636
that O 0 0.002930499380454421
TWIST O 1 0.7178594470024109
and O 0 0.0031681449618190527
FGFRs O 1 0.9816272854804993
are O 0 0.0014677764847874641
components O 0 0.003058119211345911
of O 0 0.0011326762614771724
the O 0 0.0020478470250964165
same O 0 0.004547868389636278
molecular O 0 0.025608094409108162
pathway O 0 0.09561480581760406
involved O 0 0.004583102650940418
in O 0 0.0017224251059815288
the O 0 0.0033061769790947437
modulation O 0 0.14862334728240967
of O 0 0.0059998780488967896
craniofacial O 1 0.9999903440475464
and O 0 0.007304458413273096
limb O 1 0.9999669790267944
development O 0 0.00647797342389822
in O 0 0.004100404214113951
humans O 0 0.03054369054734707
. O 0 0.004298651125282049
. O 0 0.00803140178322792

Mutation O 1 0.995267927646637
analysis O 0 0.01589103788137436
of O 0 0.009636946953833103
UBE3A O 1 0.9999723434448242
in O 1 0.5718100070953369
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999890327453613
. O 0 0.02027539163827896

Angelman B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 0.01815776154398918
AS B-Disease 0 0.007012124173343182
) O 0 0.003740216139703989
is O 0 0.0036575656849890947
caused O 1 0.5923712849617004
by O 0 0.008466913364827633
chromosome O 1 0.9997679591178894
15q11 O 1 0.996669590473175
- O 0 0.09116917103528976
q13 O 1 0.9828901886940002
deletions O 0 0.4132438898086548
of O 0 0.004516067449003458
maternal O 1 0.9192622303962708
origin O 0 0.00910144578665495
, O 0 0.002715524984523654
by O 0 0.008134671486914158
paternal O 1 0.9981467723846436
uniparental B-Disease 1 0.9999521970748901
disomy I-Disease 1 0.9982592463493347
( O 0 0.02445009909570217
UPD B-Disease 1 0.99956876039505
) O 0 0.007727760821580887
15 O 0 0.006655567325651646
, O 0 0.00250424537807703
by O 0 0.0059333378449082375
imprinting O 1 0.9998868703842163
defects O 1 0.9999008178710938
, O 0 0.0022059755865484476
and O 0 0.0013373836409300566
by O 0 0.004324556328356266
mutations O 1 0.9986973404884338
in O 0 0.003704206785187125
the O 0 0.009453625418245792
UBE3A O 1 0.9997962117195129
gene O 1 0.9796344637870789
. O 0 0.015798121690750122

UBE3A O 1 0.9975797533988953
encodes O 0 0.13590486347675323
a O 0 0.018757212907075882
ubiquitin O 0 0.09827741980552673
- O 0 0.04242665320634842
protein O 0 0.05166875198483467
ligase O 0 0.042118098586797714
and O 0 0.003912016749382019
shows O 0 0.01575205847620964
brain O 1 0.9998996257781982
- O 0 0.03518848121166229
specific O 0 0.016842924058437347
imprinting O 1 0.9964109063148499
. O 0 0.01452679093927145

Here O 0 0.008264744654297829
we O 0 0.005952166859060526
describe O 0 0.037887636572122574
UBE3A O 1 0.9983844757080078
coding O 1 0.5500916242599487
- O 0 0.046596307307481766
region O 0 0.03673391044139862
mutations O 1 0.9994066953659058
detected O 0 0.18008889257907867
by O 0 0.00893476139754057
SSCP O 1 0.9878271222114563
analysis O 0 0.009794631972908974
in O 0 0.002696393057703972
13 O 0 0.0071017020381987095
AS B-Disease 0 0.005329782608896494
individuals O 0 0.006649198476225138
or O 0 0.005131486337631941
families O 0 0.012445311062037945
. O 0 0.010387755930423737

Two O 0 0.006895460654050112
identical O 0 0.022178437560796738
de O 0 0.03518930822610855
novo O 0 0.05976099520921707
5 O 0 0.017849255353212357
- O 0 0.029486462473869324
bp O 0 0.046928729861974716
duplications O 0 0.16311563551425934
in O 0 0.006106585264205933
exon O 0 0.31092262268066406
16 O 0 0.008974400348961353
were O 0 0.0022835310082882643
found O 0 0.00818623322993517
. O 0 0.007544361986219883

Among O 0 0.006744599435478449
the O 0 0.0021899568382650614
other O 0 0.001622233190573752
11 O 0 0.006482766941189766
unique O 0 0.011578927747905254
mutations O 1 0.9989112615585327
, O 0 0.0023446879349648952
8 O 0 0.004835409112274647
were O 0 0.0012698172358796
small O 0 0.005094217602163553
deletions O 0 0.494499146938324
or O 0 0.006217838265001774
insertions O 1 0.5137065649032593
predicted O 0 0.015380607917904854
to O 0 0.003790915012359619
cause O 1 0.9010142683982849
frameshifts O 1 0.9881407022476196
, O 0 0.003428463125601411
1 O 0 0.005597718525677919
was O 0 0.003014370333403349
a O 0 0.006703855935484171
mutation O 1 0.9984242916107178
to O 0 0.0017102892743423581
a O 0 0.004601458087563515
stop O 0 0.0139485327526927
codon O 0 0.06710367649793625
, O 0 0.002245801268145442
1 O 0 0.005084883887320757
was O 0 0.0035367379896342754
a O 0 0.010901134461164474
missense O 1 0.9995080232620239
mutation O 1 0.9996762275695801
, O 0 0.0026445840485394
and O 0 0.0014435144839808345
1 O 0 0.00485477689653635
was O 0 0.002957109594717622
predicted O 0 0.00941197108477354
to O 0 0.002902320120483637
cause O 0 0.19713737070560455
insertion O 0 0.06735967099666595
of O 0 0.0018595053115859628
an O 0 0.003389668883755803
isoleucine O 1 0.8169142603874207
in O 0 0.0028307561296969652
the O 0 0.0034275981597602367
hect O 1 0.9105649590492249
domain O 0 0.013699009083211422
of O 0 0.00234361388720572
the O 0 0.007012585643678904
UBE3A O 1 0.9998513460159302
protein O 0 0.04073259234428406
, O 0 0.0022269843611866236
which O 0 0.0018816913943737745
functions O 0 0.0036536147817969322
in O 0 0.0030405207071453333
E2 O 1 0.8873342871665955
binding O 0 0.015088954009115696
and O 0 0.0033339839428663254
ubiquitin O 0 0.056780800223350525
transfer O 0 0.013152512721717358
. O 0 0.009506914764642715

Eight O 0 0.008079605177044868
of O 0 0.0021472731605172157
the O 0 0.002990063978359103
cases O 0 0.011519067920744419
were O 0 0.003006577491760254
familial O 1 0.9999798536300659
, O 0 0.0017922616098076105
and O 0 0.0010852200211957097
five O 0 0.002560568507760763
were O 0 0.0028676073998212814
sporadic O 0 0.0733318105340004
. O 0 0.012107004411518574

In O 0 0.0063561489805579185
two O 0 0.007186027243733406
familial O 1 0.9999188184738159
cases O 0 0.020592398941516876
and O 0 0.001660217298194766
one O 0 0.003406896721571684
sporadic O 0 0.4362751245498657
case O 0 0.00818783137947321
, O 0 0.004217654932290316
mosaicism O 1 0.9994974136352539
for O 0 0.010936806909739971
UBE3A O 1 0.9999821186065674
mutations O 1 0.9997614026069641
was O 0 0.007345670368522406
detected O 0 0.03525903448462486
in O 0 0.001550680841319263
the O 0 0.001830540131777525
mother O 0 0.009407460689544678
of O 0 0.0014698599698022008
three O 0 0.0020146018359810114
AS B-Disease 0 0.004757157061249018
sons O 0 0.02921166643500328
, O 0 0.0015226389514282346
in O 0 0.0012933113612234592
the O 0 0.002844862174242735
maternal O 1 0.9967203736305237
grandfather O 0 0.024199029430747032
of O 0 0.0015552997356280684
two O 0 0.0017533402424305677
AS B-Disease 0 0.004144306294620037
first O 0 0.0035175317898392677
cousins O 0 0.06652606278657913
, O 0 0.0015910001238808036
and O 0 0.0009988296078518033
in O 0 0.0013979909708723426
the O 0 0.002447386970743537
mother O 0 0.010264396667480469
of O 0 0.0015328074805438519
an O 0 0.0029170240741223097
AS B-Disease 0 0.008162380196154118
daughter O 0 0.4594764709472656
. O 0 0.010600527748465538

The O 0 0.007542206905782223
frequencies O 0 0.016146758571267128
with O 0 0.0020868289284408092
which O 0 0.0024967514909803867
we O 0 0.00402741739526391
detected O 1 0.5584526658058167
mutations O 1 0.9974302649497986
were O 0 0.0026747453957796097
5 O 0 0.00683396402746439
( O 0 0.004604507703334093
14 O 0 0.0058726719580590725
% O 0 0.004141731653362513
) O 0 0.0023428851272910833
of O 0 0.0014624957693740726
35 O 0 0.006524857133626938
in O 0 0.0026075392961502075
sporadic O 0 0.20183433592319489
cases O 0 0.009638120420277119
and O 0 0.0023782593198120594
8 O 0 0.008324619382619858
( O 0 0.005048425868153572
80 O 0 0.007903493009507656
% O 0 0.004278563894331455
) O 0 0.0018799763638526201
of O 0 0.0015124904457479715
10 O 0 0.004666683729737997
in O 0 0.005380884278565645
familial O 1 0.9999290704727173
cases O 0 0.031138047575950623
. O 0 0.0052591608837246895
. O 0 0.008778445422649384

The O 0 0.02978699468076229
hemochromatosis B-Disease 1 0.9999880790710449
845 O 1 0.9979478716850281
G O 1 0.9843506813049316
- O 0 0.05878191068768501
- O 0 0.04344949126243591
> O 0 0.0969424694776535
A O 0 0.009266274981200695
and O 0 0.003706041257828474
187 O 0 0.04307783022522926
C O 0 0.057680558413267136
- O 0 0.04602418839931488
- O 0 0.0820687934756279
> O 1 0.9674429893493652
G O 1 0.981141209602356
mutations O 1 0.9978286623954773
: O 0 0.011307844892144203
prevalence O 1 0.9943389296531677
in O 0 0.003849220694974065
non O 0 0.018630318343639374
- O 0 0.17496994137763977
Caucasian O 1 0.994966447353363
populations O 0 0.12272246181964874
. O 0 0.012788033112883568

Hemochromatosis B-Disease 1 0.9999454021453857
, O 0 0.008706691674888134
the O 0 0.011176644824445248
inherited B-Disease 1 0.9999899864196777
disorder I-Disease 1 0.9999990463256836
of I-Disease 0 0.00733889639377594
iron I-Disease 1 0.9563864469528198
metabolism I-Disease 1 0.9976934790611267
, O 0 0.0033228364773094654
leads O 0 0.01833658292889595
, O 0 0.0027559404261410236
if O 0 0.005481702275574207
untreated O 1 0.9998593330383301
, O 0 0.002404916798695922
to O 0 0.00332908658310771
progressive O 1 0.9736262559890747
iron B-Disease 1 0.8216875195503235
overload I-Disease 1 0.9990979433059692
and O 0 0.0072410027496516705
premature B-Disease 1 0.9994255304336548
death I-Disease 0 0.47960367798805237
. O 0 0.011086653918027878

The O 0 0.03552968055009842
hemochromatosis B-Disease 1 0.9999955892562866
gene O 1 0.9983657002449036
, O 0 0.010661821812391281
HFE O 1 0.9997819066047668
, O 0 0.004470648244023323
recently O 0 0.010092939250171185
has O 0 0.0033688771072775126
been O 0 0.003309177700430155
identified O 0 0.0067756823264062405
, O 0 0.0013526445254683495
and O 0 0.001497125718742609
characterization O 0 0.011134165339171886
of O 0 0.0015892505180090666
this O 0 0.0031852484680712223
gene O 1 0.9905338287353516
has O 0 0.0032939075026661158
shown O 0 0.004314630292356014
that O 0 0.000998498173430562
it O 0 0.0013804723275825381
contains O 0 0.003434976562857628
two O 0 0.0025867633521556854
mutations O 1 0.9966112971305847
that O 0 0.0020565991289913654
result O 0 0.006319128908216953
in O 0 0.0031235001515597105
amino O 0 0.034146882593631744
acid O 0 0.05455140769481659
substitutions O 0 0.032429564744234085
- O 0 0.037794604897499084
cDNA O 0 0.1090792864561081
nucleotides O 0 0.08369885385036469
845 O 1 0.9443937540054321
G O 1 0.808394193649292
- O 0 0.04607411473989487
- O 0 0.04620848223567009
> O 0 0.4194755554199219
A O 0 0.014051161706447601
( O 0 0.010561292059719563
C282Y O 0 0.3228036165237427
) O 0 0.004764619283378124
and O 0 0.0027994331903755665
187 O 0 0.03992003574967384
C O 0 0.0580136738717556
- O 0 0.05159895867109299
- O 0 0.07906422019004822
> O 1 0.8770956993103027
G O 0 0.25658175349235535
( O 0 0.017725428566336632
H63D O 1 0.9869711399078369
) O 0 0.012660782784223557
. O 0 0.01256705354899168

Although O 0 0.03556885942816734
hemochromatosis B-Disease 1 0.9999808073043823
is O 0 0.0068250796757638454
common O 0 0.009160906076431274
in O 0 0.004003685899078846
Caucasians O 1 0.9926145076751709
, O 0 0.006244868505746126
affecting O 1 0.9798990488052368
> O 1 0.9962045550346375
= O 0 0.046483997255563736
1 O 0 0.013195064850151539
/ O 0 0.029954198747873306
300 O 0 0.00755592854693532
individuals O 0 0.003396437969058752
of O 0 0.0016418570885434747
northern O 0 0.005158590152859688
European O 0 0.00427532522007823
origin O 0 0.005258796736598015
, O 0 0.0013005423825234175
it O 0 0.0010988442227244377
has O 0 0.0017586647300049663
not O 0 0.0011858834186568856
been O 0 0.0023644203320145607
recognized O 0 0.005513068754225969
in O 0 0.0018059065332636237
other O 0 0.0027514502871781588
populations O 0 0.03888804093003273
. O 0 0.011556324549019337

The O 0 0.006399644538760185
present O 0 0.005916459485888481
study O 0 0.006942063104361296
used O 0 0.004638181533664465
PCR O 0 0.055237285792827606
and O 0 0.0031863702461123466
restriction O 0 0.030887143686413765
- O 0 0.040481455624103546
enzyme O 0 0.1925625056028366
digestion O 0 0.39279597997665405
to O 0 0.003046013880521059
analyze O 0 0.009930734522640705
the O 0 0.0023983377031981945
frequency O 0 0.013045687228441238
of O 0 0.001753179938532412
the O 0 0.005161287263035774
845 O 1 0.9972835779190063
G O 1 0.9785153865814209
- O 0 0.04418209567666054
- O 0 0.038815345615148544
> O 0 0.10826194286346436
A O 0 0.009061719290912151
and O 0 0.003121571848168969
187 O 0 0.03989950194954872
C O 0 0.05460658669471741
- O 0 0.04903470352292061
- O 0 0.06603936105966568
> O 1 0.9150198101997375
G O 1 0.923500120639801
mutations O 1 0.9880461692810059
in O 0 0.009684501215815544
HLA O 1 0.9992004036903381
- O 0 0.031255245208740234
typed O 0 0.030960047617554665
samples O 0 0.011498410254716873
from O 0 0.0039022332057356834
non O 0 0.01477846410125494
- O 0 0.03459414467215538
Caucasian O 1 0.9675004482269287
populations O 0 0.028085073456168175
, O 0 0.0023747379891574383
comprising O 0 0.0073264772072434425
Australian O 0 0.011617465876042843
Aboriginal O 0 0.018425654619932175
, O 0 0.001978257903829217
Chinese O 0 0.003238495672121644
, O 0 0.0019356311531737447
and O 0 0.0024211714044213295
Pacific O 0 0.023983780294656754
Islanders O 0 0.1874091476202011
. O 0 0.012728692032396793

Results O 0 0.019232872873544693
showed O 0 0.011080732569098473
that O 0 0.0018753544427454472
the O 0 0.004592270124703646
845 O 1 0.9962576627731323
G O 1 0.9833514094352722
- O 0 0.05925178527832031
- O 0 0.09027952700853348
> O 1 0.8877758383750916
A O 0 0.018756801262497902
mutation O 1 0.9992244243621826
was O 0 0.0035878990311175585
present O 0 0.0021975310519337654
in O 0 0.0013926253886893392
these O 0 0.0017672172980383039
populations O 0 0.02617807127535343
( O 0 0.008979159407317638
allele O 1 0.9961997866630554
frequency O 0 0.03164474293589592
0 O 0 0.01305775623768568
. O 0 0.0022234334610402584
32 O 0 0.00855371542274952
% O 0 0.0050150505267083645
) O 0 0.0024949233047664165
, O 0 0.0012108547380194068
and O 0 0.0010486390674486756
, O 0 0.0015764815034344792
furthermore O 0 0.007972980849444866
, O 0 0.0014952159253880382
it O 0 0.001447500311769545
was O 0 0.002474796259775758
always O 0 0.003363102674484253
seen O 0 0.005052703432738781
in O 0 0.0019192190375179052
conjunction O 0 0.014974623918533325
with O 0 0.008002358488738537
HLA O 1 0.9999725818634033
haplotypes O 1 0.9980108141899109
common O 0 0.012010157108306885
in O 0 0.003765964647755027
Caucasians O 1 0.9908334612846375
, O 0 0.0027087435591965914
suggesting O 0 0.012394491583108902
that O 0 0.0040686530992388725
845 O 1 0.9978442192077637
G O 1 0.9960880279541016
- O 0 0.09955695271492004
- O 0 0.07550546526908875
> O 1 0.8578115105628967
A O 0 0.009142139926552773
may O 0 0.0055078500881791115
have O 0 0.0016632666811347008
been O 0 0.0018696949118748307
introduced O 0 0.0037079746834933758
into O 0 0.0024402670096606016
these O 0 0.0025337792467325926
populations O 0 0.02528153546154499
by O 0 0.010153005830943584
Caucasian O 1 0.944905698299408
admixture O 1 0.9689764976501465
. O 0 0.02001817338168621

187 O 0 0.10813280194997787
C O 0 0.09898927807807922
- O 0 0.0650094673037529
- O 0 0.08403191715478897
> O 1 0.9401534795761108
G O 0 0.1692848801612854
was O 0 0.0034858463332057
present O 0 0.0029784301295876503
at O 0 0.002988559426739812
an O 0 0.004263737704604864
allele O 1 0.9715340733528137
frequency O 0 0.021569648757576942
of O 0 0.0034602864179760218
2 O 0 0.01251123659312725
. O 0 0.010775825940072536

68 O 0 0.03025437705218792
% O 0 0.00548828300088644
in O 0 0.0016745905159041286
the O 0 0.0017335773445665836
two O 0 0.0028666050639003515
populations O 0 0.025652557611465454
analyzed O 0 0.017880698665976524
( O 0 0.005745409522205591
Australian O 0 0.01152985543012619
Aboriginal O 0 0.018294302746653557
and O 0 0.0029510478489100933
Chinese O 0 0.008212334476411343
) O 0 0.0074199289083480835
. O 0 0.00889794621616602

In O 0 0.004720656201243401
the O 0 0.004518548492342234
Australian O 0 0.015095042064785957
Aboriginal O 0 0.02662293240427971
samples O 0 0.01651890203356743
, O 0 0.004347691778093576
187 O 0 0.04335232824087143
C O 0 0.062390923500061035
- O 0 0.04360184818506241
- O 0 0.058577388525009155
> O 1 0.975691020488739
G O 0 0.177305206656456
was O 0 0.0036474301014095545
found O 0 0.003030841937288642
to O 0 0.001313807675614953
be O 0 0.0017296990845352411
associated O 0 0.007044580765068531
with O 0 0.00630991393700242
HLA O 1 0.9999456405639648
haplotypes O 1 0.9983689188957214
common O 0 0.011780967935919762
in O 0 0.004005310591310263
Caucasians O 1 0.9975831508636475
, O 0 0.0025621771346777678
suggesting O 0 0.008202877826988697
that O 0 0.001328909769654274
it O 0 0.001489149872213602
was O 0 0.0028571179136633873
introduced O 0 0.005554450675845146
by O 0 0.003702340414747596
recent O 0 0.015486138872802258
admixture O 1 0.9419825673103333
. O 0 0.015255331993103027

In O 0 0.004055870696902275
the O 0 0.0027113445103168488
Chinese O 0 0.00466674380004406
samples O 0 0.012210534885525703
analyzed O 0 0.013799802400171757
, O 0 0.004157754126936197
187 O 0 0.043349966406822205
C O 0 0.07397144287824631
- O 0 0.04993695020675659
- O 0 0.08245242387056351
> O 1 0.9610318541526794
G O 0 0.12702858448028564
was O 0 0.0037335273809731007
present O 0 0.003408012678846717
in O 0 0.0018941008020192385
association O 0 0.005260178353637457
with O 0 0.0017089132452383637
a O 0 0.0040323915891349316
wide O 0 0.008260142058134079
variety O 0 0.005560701712965965
of O 0 0.004447550047188997
HLA O 1 0.9999853372573853
haplotypes O 1 0.9991577863693237
, O 0 0.003040460404008627
showing O 0 0.010342619381844997
this O 0 0.003430695738643408
mutation O 1 0.9998592138290405
to O 0 0.0015132767148315907
be O 0 0.0015860112616792321
widespread O 0 0.021668046712875366
and O 0 0.0017243217444047332
likely O 0 0.005156048573553562
to O 0 0.0021613766439259052
predate O 0 0.031155258417129517
the O 0 0.0026215557008981705
more O 0 0.003933786880224943
genetically O 0 0.04424683377146721
restricted O 0 0.02903539314866066
845 O 1 0.9950878024101257
G O 1 0.9447792172431946
- O 0 0.07424895465373993
- O 0 0.05982716754078865
> O 1 0.9071220755577087
A O 0 0.02746463380753994
mutation O 1 0.9982251524925232
. O 0 0.015381459146738052

Genotype O 1 0.9981905817985535
- O 1 0.8090543746948242
phenotype O 1 0.9991405010223389
correlations O 0 0.0927916094660759
in O 0 0.018406027927994728
attenuated B-Disease 1 0.9998413324356079
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999927282333374
. O 0 0.0374833308160305

Germ O 1 0.9791038036346436
- O 0 0.0491369254887104
line O 0 0.02055875025689602
mutations O 1 0.9889729619026184
of O 0 0.004198500420898199
the O 0 0.012126725167036057
tumor B-Disease 1 0.9999986886978149
suppressor O 1 0.9999809265136719
APC O 1 0.9992235898971558
are O 0 0.006226902361959219
implicated O 1 0.8418987989425659
in O 0 0.015643224120140076
attenuated B-Disease 1 0.9999698400497437
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999995231628418
( O 0 0.18263231217861176
AAPC B-Disease 1 0.9999589920043945
) O 0 0.007407153956592083
, O 0 0.002602808643132448
a O 0 0.008237368427217007
variant O 1 0.9199991226196289
of O 0 0.014495212584733963
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.6737048625946045
FAP B-Disease 1 0.9999809265136719
) O 0 0.01741805113852024
. O 0 0.010711049661040306

AAPC B-Disease 1 0.9982303977012634
is O 0 0.0073373932391405106
recognized O 0 0.00902463123202324
by O 0 0.0023802900686860085
the O 0 0.0035294690169394016
occurrence O 0 0.048188865184783936
of O 0 0.005775597877800465
< O 1 0.899965226650238
100 O 0 0.01919960416853428
colonic B-Disease 1 0.9997381567955017
adenomas I-Disease 1 0.9996737241744995
and O 0 0.0027915160171687603
a O 0 0.005982118658721447
later O 0 0.011200695298612118
onset O 1 0.9999704360961914
of O 0 0.2531982362270355
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.017660945653915405
age O 0 0.03159217908978462
> O 1 0.9855679273605347
40 O 0 0.010380556806921959
years O 0 0.0068266564048826694
) O 0 0.007274920120835304
. O 0 0.008784198202192783

The O 0 0.0055624740198254585
aim O 0 0.009165780618786812
of O 0 0.0014383092056959867
this O 0 0.0015450402861461043
study O 0 0.003801496932283044
was O 0 0.002332465723156929
to O 0 0.0025958342012017965
assess O 0 0.05160395801067352
genotype O 1 0.9994890689849854
- O 1 0.7084618806838989
phenotype O 1 0.9995730519294739
correlations O 0 0.06627154350280762
in O 0 0.009650655090808868
AAPC B-Disease 1 0.9998940229415894
families O 0 0.025326350703835487
. O 0 0.0151947271078825

By O 0 0.015542327426373959
protein O 0 0.07394374907016754
- O 0 0.0443512499332428
truncation O 1 0.657130777835846
test O 0 0.021568451076745987
( O 0 0.01051376573741436
PTT O 0 0.12365728616714478
) O 0 0.005808123853057623
assay O 0 0.025231046602129936
, O 0 0.0016252710483968258
the O 0 0.0023061037063598633
entire O 0 0.011717882007360458
coding O 0 0.03392859920859337
region O 0 0.007371455430984497
of O 0 0.0023012638557702303
the O 0 0.006498448085039854
APC B-Disease 1 0.9997926354408264
gene O 1 0.9878838658332825
was O 0 0.008157252334058285
screened O 0 0.025774575769901276
in O 0 0.0032814026344567537
affected O 0 0.024410957470536232
individuals O 0 0.005481881555169821
from O 0 0.0043645636178553104
11 O 0 0.020762672647833824
AAPC B-Disease 1 0.9999592304229736
kindreds O 1 0.9972499012947083
, O 0 0.00321057322435081
and O 0 0.0018862311262637377
their O 0 0.00431892229244113
phenotypic O 1 0.9931491017341614
differences O 0 0.013004628010094166
were O 0 0.004150116350501776
examined O 0 0.039531733840703964
. O 0 0.012247064150869846

Five O 0 0.011290734633803368
novel O 0 0.03459368273615837
germ O 1 0.9945566654205322
- O 0 0.04710870981216431
line O 0 0.02733992040157318
APC B-Disease 1 0.9993441700935364
mutations O 1 0.9987820982933044
were O 0 0.0032666546758264303
identified O 0 0.009931925684213638
in O 0 0.0030524416361004114
seven O 0 0.009645720012485981
kindreds O 1 0.9797977209091187
. O 0 0.013079878874123096

Mutations O 1 0.99367755651474
were O 0 0.003181110369041562
located O 0 0.004730835556983948
in O 0 0.0012178625911474228
three O 0 0.0014786917017772794
different O 0 0.0015012763906270266
regions O 0 0.005347639787942171
of O 0 0.0018583923811092973
the O 0 0.0062589459121227264
APC B-Disease 1 0.9995792508125305
gene O 1 0.9882102012634277
( O 0 0.007338805589824915
1 O 0 0.006872877944260836
) O 0 0.002601929707452655
at O 0 0.001989135053008795
the O 0 0.002351442351937294
5 O 0 0.006952859461307526
end O 0 0.008656706660985947
spanning O 0 0.027188848704099655
exons O 0 0.11826523393392563
4 O 0 0.009136591106653214
and O 0 0.002273174934089184
5 O 0 0.005846972111612558
, O 0 0.002079249359667301
( O 0 0.0034096892923116684
2 O 0 0.004679462872445583
) O 0 0.0027651027776300907
within O 0 0.004861281719058752
exon O 0 0.3694693446159363
9 O 0 0.00810882356017828
, O 0 0.001919997506774962
and O 0 0.0015539296437054873
( O 0 0.004187076352536678
3 O 0 0.006032163742929697
) O 0 0.002529122866690159
at O 0 0.0020265551283955574
the O 0 0.0029349280521273613
3 O 0 0.012504353187978268
distal O 1 0.9970325231552124
end O 0 0.007238367106765509
of O 0 0.0020965242292732
the O 0 0.006081377621740103
gene O 1 0.9474075436592102
. O 0 0.010406339541077614

Variability O 0 0.09210297465324402
in O 0 0.0031294715590775013
the O 0 0.0030876202508807182
number O 0 0.004916660953313112
of O 0 0.009731784462928772
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999994158744812
was O 0 0.00678240554407239
most O 0 0.003968802280724049
apparent O 0 0.12217625230550766
in O 0 0.0019489475525915623
individuals O 0 0.004040909465402365
with O 0 0.003052624175325036
mutations O 1 0.9993075132369995
in O 0 0.0021258064080029726
region O 0 0.0068786186166107655
1 O 0 0.004876632243394852
, O 0 0.001650955993682146
and O 0 0.0025189355947077274
upper O 1 0.9942101240158081
- O 1 0.9981344938278198
gastrointestinal O 1 0.9999995231628418
manifestations O 1 0.9877086877822876
were O 0 0.0029656754340976477
more O 0 0.004861833527684212
severe O 1 0.9998540878295898
in O 0 0.003038864815607667
them O 0 0.0030355947092175484
. O 0 0.009051606059074402

In O 0 0.0053618899546563625
individuals O 0 0.008330742828547955
with O 0 0.006011354736983776
mutations O 1 0.9972261786460876
in O 0 0.002821670612320304
either O 0 0.004304416477680206
region O 0 0.008002093993127346
2 O 0 0.005241792183369398
or O 0 0.003797117155045271
region O 0 0.007412719074636698
3 O 0 0.004812858533114195
, O 0 0.0013654563808813691
the O 0 0.0019306669710204005
average O 0 0.005860624834895134
number O 0 0.002886819187551737
of O 0 0.004038146696984768
adenomas B-Disease 1 0.9999563694000244
tended O 0 0.018769284710288048
to O 0 0.001785126980394125
be O 0 0.0018223117804154754
lower O 0 0.006268883589655161
than O 0 0.0017575750825926661
those O 0 0.001194751006551087
in O 0 0.0012492986861616373
individuals O 0 0.0045952876098454
with O 0 0.003902229480445385
mutations O 1 0.999502420425415
in O 0 0.002531372243538499
region O 0 0.008715206757187843
1 O 0 0.006076309829950333
, O 0 0.0017297255108132958
although O 0 0.003469557734206319
age O 0 0.009386389516294003
at O 0 0.007682971656322479
diagnosis O 1 0.9999202489852905
was O 0 0.006462721154093742
similar O 0 0.00963645987212658
. O 0 0.01019267551600933

In O 0 0.007219596765935421
all O 0 0.008930539712309837
AAPC B-Disease 1 0.9997593760490417
kindreds O 1 0.992179274559021
, O 0 0.003687413176521659
a O 0 0.006865036208182573
predominance O 0 0.33741486072540283
of O 0 0.0042975302785634995
right O 0 0.23615770041942596
- O 1 0.92147296667099
sided O 1 0.9991835951805115
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999940395355225
and O 0 0.03223592787981033
rectal B-Disease 1 0.9999988079071045
polyp I-Disease 1 0.9999980926513672
sparing O 1 0.996023416519165
was O 0 0.012975344434380531
observed O 0 0.026303118094801903
. O 0 0.011360486969351768

No O 0 0.03489598259329796
desmoid B-Disease 1 0.9997594952583313
tumors I-Disease 1 0.9999713897705078
were O 0 0.003045246936380863
found O 0 0.004236786626279354
in O 0 0.002217113273218274
these O 0 0.003652110230177641
kindreds O 1 0.9588647484779358
. O 0 0.011876718141138554

Our O 0 0.007458430249243975
data O 0 0.005363431293517351
suggest O 0 0.007748743519186974
that O 0 0.0016769269714131951
, O 0 0.002054499229416251
in O 0 0.004923736676573753
AAPC B-Disease 1 0.9999502897262573
families O 0 0.009748083539307117
, O 0 0.0019234528299421072
the O 0 0.001917583984322846
location O 0 0.00340378494001925
of O 0 0.0018350475002080202
the O 0 0.005481338128447533
APC B-Disease 1 0.9998574256896973
mutation O 1 0.9999465942382812
may O 0 0.014902422204613686
partially O 0 0.052752796560525894
predict O 0 0.02850385196506977
specific O 0 0.015644095838069916
phenotypic O 1 0.9957935810089111
expression O 0 0.045955270528793335
. O 0 0.011819634586572647

This O 0 0.00421857787296176
should O 0 0.002846818882972002
help O 0 0.0039302390068769455
in O 0 0.0012197236064821482
the O 0 0.00175532849971205
design O 0 0.0035078078508377075
of O 0 0.003039292525500059
tailored O 0 0.17658483982086182
clinical O 1 0.986214816570282
- O 0 0.029527194797992706
management O 0 0.013693708926439285
protocols O 0 0.011943859979510307
in O 0 0.002462307922542095
this O 0 0.003317053895443678
subset O 0 0.03346710652112961
of O 0 0.009903897531330585
FAP B-Disease 1 0.9999972581863403
patients O 1 0.9999125003814697
. O 0 0.007653124164789915
. O 0 0.011067869141697884

Wilms B-Disease 1 0.9999642372131348
' I-Disease 1 0.8242229223251343
tumor I-Disease 1 0.9998217225074768
1 O 0 0.01564476452767849
and O 0 0.005390180740505457
Dax O 1 0.9054790735244751
- O 0 0.03447560593485832
1 O 0 0.019382046535611153
modulate O 0 0.21421891450881958
the O 0 0.008562871254980564
orphan O 1 0.9893574118614197
nuclear O 0 0.030638476833701134
receptor O 1 0.97654128074646
SF O 1 0.9947217702865601
- O 0 0.027874864637851715
1 O 0 0.00938212126493454
in O 0 0.004125488921999931
sex O 0 0.02499384805560112
- O 0 0.028460435569286346
specific O 0 0.015272475779056549
gene O 1 0.9335855841636658
expression O 0 0.04013075679540634
. O 0 0.01189582608640194

Products O 0 0.017323791980743408
of O 0 0.00991272833198309
steroidogenic O 1 0.9992620348930359
factor O 0 0.050464995205402374
1 O 0 0.014919856563210487
( O 0 0.012880937196314335
SF O 1 0.9951764345169067
- O 0 0.026442306116223335
1 O 0 0.010694201104342937
) O 0 0.005601005163043737
and O 0 0.007445612922310829
Wilms B-Disease 1 0.9999871253967285
tumor I-Disease 1 0.999964714050293
1 O 0 0.02038823813199997
( O 0 0.015336711890995502
WT1 O 1 0.9991618394851685
) O 0 0.007965016178786755
genes O 0 0.0407743938267231
are O 0 0.0016513607697561383
essential O 0 0.004891000222414732
for O 0 0.0032067985739558935
mammalian O 1 0.989909291267395
gonadogenesis O 1 0.9923204779624939
prior O 0 0.008599020540714264
to O 0 0.003923660609871149
sexual O 0 0.02660921961069107
differentiation O 0 0.09065894037485123
. O 0 0.013308048248291016

In O 0 0.011715148575603962
males O 0 0.29187241196632385
, O 0 0.007872351445257664
SF O 1 0.9988647699356079
- O 0 0.026330089196562767
1 O 0 0.012782729230821133
participates O 0 0.025239363312721252
in O 0 0.003279620548710227
sexual O 0 0.015226224437355995
development O 0 0.0052378131076693535
by O 0 0.004381583537906408
regulating O 0 0.0256694033741951
expression O 0 0.014794676564633846
of O 0 0.0023348627146333456
the O 0 0.0077993921004235744
polypeptide O 1 0.9974367022514343
hormone O 1 0.9978362917900085
Mullerian O 1 0.9966375827789307
inhibiting O 1 0.9858322143554688
substance O 0 0.10846628993749619
( O 0 0.025662114843726158
MIS O 1 0.9954706430435181
) O 0 0.013026067055761814
. O 0 0.01049134787172079

Here O 0 0.006137891672551632
, O 0 0.0024228536058217287
we O 0 0.002272020559757948
show O 0 0.006987207103520632
that O 0 0.0055452026426792145
WT1 O 1 0.9998354911804199
- O 0 0.3713141977787018
KTS O 1 0.9987308382987976
isoforms O 0 0.12791980803012848
associate O 0 0.01222113985568285
and O 0 0.0034870312083512545
synergize O 1 0.9928843975067139
with O 0 0.00864200945943594
SF O 1 0.9996070265769958
- O 0 0.023036833852529526
1 O 0 0.008269364945590496
to O 0 0.0033485975582152605
promote O 0 0.021200107410550117
MIS O 1 0.997198224067688
expression O 0 0.058606524020433426
. O 0 0.016479579731822014

In O 0 0.008647046983242035
contrast O 0 0.020894329994916916
, O 0 0.010312436148524284
WT1 O 1 0.9998927116394043
missense O 1 0.9996706247329712
mutations O 1 0.999672532081604
, O 0 0.003891420317813754
associated O 0 0.0074153863824903965
with O 0 0.003467835020273924
male B-Disease 0 0.16425226628780365
pseudohermaphroditism I-Disease 1 0.9981352090835571
in O 0 0.00935372430831194
Denys B-Disease 1 0.9999176263809204
- I-Disease 1 0.9990166425704956
Drash I-Disease 1 0.99997878074646
syndrome I-Disease 1 1.0
, O 0 0.0061079366132617
fail O 0 0.028874769806861877
to O 0 0.0057794381864368916
synergize O 1 0.9906436800956726
with O 0 0.01108520943671465
SF O 1 0.9992087483406067
- O 0 0.037499986588954926
1 O 0 0.017500173300504684
. O 0 0.011188924312591553

Additionally O 0 0.02216985449194908
, O 0 0.0029648463241755962
the O 0 0.004295417573302984
X O 0 0.35218918323516846
- O 0 0.022962862625718117
linked O 0 0.028998898342251778
, O 0 0.0034727558959275484
candidate O 0 0.018336595967411995
dosage O 1 0.9823352694511414
- O 0 0.028713859617710114
sensitive O 0 0.024259939789772034
sex O 0 0.031560588628053665
- O 0 0.039625320583581924
reversal O 1 0.6570849418640137
gene O 1 0.9493772387504578
, O 0 0.007137241307646036
Dax O 1 0.9276445508003235
- O 0 0.02586098574101925
1 O 0 0.01015264168381691
, O 0 0.004805917385965586
antagonizes O 1 0.9807822704315186
synergy O 0 0.06452803313732147
between O 0 0.010130010545253754
SF O 1 0.9981023669242859
- O 0 0.02375953644514084
1 O 0 0.009095449931919575
and O 0 0.003878749907016754
WT1 O 1 0.999937891960144
, O 0 0.0022906307131052017
most O 0 0.002147905295714736
likely O 0 0.004553657025098801
through O 0 0.002428076695650816
a O 0 0.003527505788952112
direct O 0 0.007028108462691307
interaction O 0 0.012628307566046715
with O 0 0.0066406275145709515
SF O 1 0.9992735981941223
- O 0 0.03391984850168228
1 O 0 0.017049264162778854
. O 0 0.010851411148905754

We O 0 0.00783912930637598
propose O 0 0.024083571508526802
that O 0 0.0056584724225103855
WT1 O 1 0.9984937906265259
and O 0 0.005605156999081373
Dax O 1 0.9892144799232483
- O 0 0.02839939296245575
1 O 0 0.013935147784650326
functionally O 0 0.22030998766422272
oppose O 0 0.011427078396081924
each O 0 0.0017641378799453378
other O 0 0.0014009170699864626
in O 0 0.003357631154358387
testis O 1 0.9966321587562561
development O 0 0.008427022956311703
by O 0 0.00876843836158514
modulating O 1 0.9976477026939392
SF O 1 0.9988701939582825
- O 0 0.04325981065630913
1 O 0 0.022799843922257423
- O 0 0.05334297940135002
mediated O 0 0.4452947676181793
transactivation O 1 0.9833245277404785
. O 0 0.010557211935520172
. O 0 0.012698364444077015

A O 0 0.03637966513633728
mouse O 1 0.808752715587616
model O 0 0.019201859831809998
for O 0 0.010202132165431976
Prader B-Disease 1 0.9999871253967285
- I-Disease 1 0.9993137121200562
Willi I-Disease 1 0.9999990463256836
syndrome I-Disease 1 1.0
imprinting O 1 0.9999256134033203
- O 1 0.8028008341789246
centre O 0 0.09791157394647598
mutations O 1 0.999565064907074
. O 0 0.014058939181268215

Imprinting O 1 0.7916698455810547
in O 0 0.005708769895136356
the O 0 0.008602776564657688
15q11 O 1 0.9961256384849548
- O 0 0.06290578842163086
q13 O 1 0.9262109994888306
region O 0 0.017389973625540733
involves O 0 0.020986203104257584
an O 0 0.007137779612094164
imprinting O 1 0.990754246711731
centre O 0 0.024830905720591545
( O 0 0.012135817669332027
IC O 1 0.8591821789741516
) O 0 0.004515836015343666
, O 0 0.0019498029723763466
mapping O 0 0.010084058158099651
in O 0 0.0016264583682641387
part O 0 0.002845323644578457
to O 0 0.001303801080211997
the O 0 0.002748332917690277
promoter O 0 0.06665226072072983
and O 0 0.00214498583227396
first O 0 0.005296967923641205
exon O 0 0.09739327430725098
of O 0 0.007738982792943716
SNRPN O 1 0.9976416826248169
. O 0 0.018303601071238518

Deletion O 1 0.7049360275268555
of O 0 0.004517272114753723
this O 0 0.00722701707854867
IC O 1 0.973987340927124
abolishes O 1 0.976443886756897
local O 0 0.01653745025396347
paternally O 1 0.9827189445495605
derived O 0 0.02716146968305111
gene O 1 0.9739583730697632
expression O 0 0.020502347499132156
and O 0 0.002305504633113742
results O 0 0.00858595222234726
in O 0 0.008214439265429974
Prader B-Disease 1 0.9999939203262329
- I-Disease 1 0.9997265934944153
Willi I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 1 0.5577631592750549
PWS B-Disease 1 0.9999765157699585
) O 0 0.017946874722838402
. O 0 0.012906511314213276

We O 0 0.004894259851425886
have O 0 0.0032849996350705624
created O 0 0.007462176028639078
two O 0 0.0051094223745167255
deletion O 1 0.9974104762077332
mutations O 1 0.9992495179176331
in O 0 0.00620241230353713
mice O 1 0.9975157976150513
to O 0 0.004439059644937515
understand O 0 0.02168617770075798
PWS B-Disease 1 0.9999397993087769
and O 0 0.0023152451030910015
the O 0 0.0027176528237760067
mechanism O 0 0.011259084567427635
of O 0 0.002622871194034815
this O 0 0.005380718037486076
IC O 1 0.9071843028068542
. O 0 0.013127267360687256

Mice O 1 0.9992808699607849
harbouring O 1 0.9891995191574097
an O 0 0.010021023452281952
intragenic O 1 0.9954925775527954
deletion O 1 0.9899880290031433
in O 0 0.005812870338559151
Snrpn O 1 0.9972679615020752
are O 0 0.0039004511199891567
phenotypically O 1 0.9985053539276123
normal O 0 0.01823270507156849
, O 0 0.0025415110867470503
suggesting O 0 0.012765922583639622
that O 0 0.003715553553774953
mutations O 1 0.9964175224304199
of O 0 0.004038772080093622
SNRPN O 1 0.998684823513031
are O 0 0.0015377384843304753
not O 0 0.001407583593390882
sufficient O 0 0.006648127920925617
to O 0 0.005358089227229357
induce O 1 0.9884710311889648
PWS B-Disease 1 0.9996800422668457
. O 0 0.020540859550237656

Mice O 1 0.9866018891334534
with O 0 0.005495760124176741
a O 0 0.008848466910421848
larger O 0 0.01576210744678974
deletion O 1 0.9440032243728638
involving O 0 0.014825128018856049
both O 0 0.0042837453074753284
Snrpn O 1 0.9942606687545776
and O 0 0.0026731074322015047
the O 0 0.007419584784656763
putative O 1 0.9974155426025391
PWS O 1 0.9999653100967407
- O 0 0.43329569697380066
IC O 1 0.9498506784439087
lack O 0 0.020522773265838623
expression O 0 0.018704736605286598
of O 0 0.0026791186537593603
the O 0 0.006070103496313095
imprinted O 1 0.9965773224830627
genes O 1 0.9744485020637512
Zfp127 O 1 0.9945544004440308
( O 0 0.018835976719856262
mouse O 1 0.9905799031257629
homologue O 1 0.9857826232910156
of O 0 0.009502326138317585
ZNF127 O 1 0.998004138469696
) O 0 0.007952447980642319
, O 0 0.00552641786634922
Ndn O 1 0.9955653548240662
and O 0 0.005185192450881004
Ipw O 1 0.829447865486145
, O 0 0.0026263289619237185
and O 0 0.002505960175767541
manifest O 0 0.028684265911579132
several O 0 0.006463412661105394
phenotypes O 1 0.9952788352966309
common O 0 0.017857098951935768
to O 0 0.010991591960191727
PWS B-Disease 1 0.99998939037323
infants O 1 0.9998612403869629
. O 0 0.017624467611312866

These O 0 0.0036229798570275307
data O 0 0.0044320919550955296
demonstrate O 0 0.005449492018669844
that O 0 0.0010242766002193093
both O 0 0.001062681432813406
the O 0 0.001233347924426198
position O 0 0.0021362993866205215
of O 0 0.001354409847408533
the O 0 0.0030044999439269304
IC O 1 0.9309840798377991
and O 0 0.0014857094502076507
its O 0 0.0021048409398645163
role O 0 0.003774711862206459
in O 0 0.0014445397537201643
the O 0 0.002069722395390272
coordinate O 0 0.011964068748056889
expression O 0 0.01455001812428236
of O 0 0.0030247028917074203
genes O 0 0.4622926712036133
is O 0 0.0033570986706763506
conserved O 0 0.01757780648767948
between O 0 0.0044245426543056965
mouse O 1 0.9929593801498413
and O 0 0.0021511015947908163
human O 0 0.006815800443291664
, O 0 0.001403805217705667
and O 0 0.0014196186093613505
indicate O 0 0.005480553023517132
that O 0 0.0013992845779284835
the O 0 0.0033549435902386904
mouse O 1 0.9807093143463135
is O 0 0.003504699096083641
a O 0 0.004682695493102074
suitable O 0 0.009532722644507885
model O 0 0.008220824413001537
system O 0 0.00416808994486928
in O 0 0.001348280580714345
which O 0 0.001224067062139511
to O 0 0.001298864372074604
investigate O 0 0.007663713302463293
the O 0 0.002985897473990917
molecular O 0 0.017596879974007607
mechanisms O 0 0.011648183688521385
of O 0 0.0027645849622786045
imprinting O 1 0.995375394821167
in O 0 0.0017931609181687236
this O 0 0.001484984066337347
region O 0 0.0045274109579622746
of O 0 0.0015696259215474129
the O 0 0.004221088252961636
genome O 0 0.4947938323020935
. O 0 0.005060518626123667
. O 0 0.00792565755546093

Mutations O 1 0.9764251112937927
of O 0 0.004953386262059212
the O 0 0.007476868107914925
ATM O 1 0.6886114478111267
gene O 1 0.9744511842727661
detected O 0 0.04889295622706413
in O 0 0.004698209464550018
Japanese O 0 0.11990214139223099
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9994850158691406
telangiectasia I-Disease 1 0.9999997615814209
patients O 1 0.9999791383743286
: O 0 0.005901138763874769
possible O 0 0.005988237913697958
preponderance O 0 0.07769005745649338
of O 0 0.0015978059964254498
the O 0 0.001996808685362339
two O 0 0.0032151774503290653
founder O 0 0.2506653368473053
mutations O 1 0.9996440410614014
4612del165 O 1 0.9918896555900574
and O 0 0.008954807184636593
7883del5 O 1 0.9801501035690308
. O 0 0.018005354329943657

The O 0 0.011444042436778545
ATM O 0 0.07451443374156952
( O 0 0.013032793067395687
A O 0 0.04202105104923248
- O 1 0.7330918908119202
T O 1 0.9990274906158447
, O 0 0.011357981711626053
mutated O 1 0.998035728931427
) O 0 0.013610128313302994
gene O 0 0.16258367896080017
on O 0 0.005883625242859125
human O 0 0.036157362163066864
chromosome O 1 0.9991660118103027
11q22 O 1 0.9761331081390381
. O 0 0.015530161559581757

3 O 0 0.01539780292659998
has O 0 0.005175380036234856
recently O 0 0.009401436895132065
been O 0 0.003635203931480646
identified O 0 0.006755491718649864
as O 0 0.0018640529597178102
the O 0 0.0032004883978515863
gene O 1 0.659489095211029
responsible O 0 0.007232907693833113
for O 0 0.0018216095631942153
the O 0 0.005612483713775873
human O 1 0.9862675666809082
recessive B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9992066025733948
telangiectasia I-Disease 1 0.9999963045120239
( O 0 0.02414809726178646
A B-Disease 1 0.9540715217590332
- I-Disease 1 0.987163245677948
T I-Disease 1 0.9993857145309448
) O 0 0.012294688262045383
. O 0 0.010405200533568859

In O 0 0.004446239210665226
order O 0 0.003119270084425807
to O 0 0.001795730204321444
define O 0 0.007104475982487202
the O 0 0.0026915310882031918
types O 0 0.008272115141153336
of O 0 0.005019666161388159
disease O 1 0.9999997615814209
- O 1 0.9815455079078674
causing O 1 0.9992879033088684
ATM O 1 0.9920744895935059
mutations O 1 0.9988110065460205
in O 0 0.003403260838240385
Japanese O 0 0.012810922227799892
A B-Disease 1 0.7414427399635315
- I-Disease 1 0.9977976083755493
T I-Disease 1 0.9999878406524658
patients O 1 0.9996351003646851
as O 0 0.0021278192289173603
well O 0 0.0014283382333815098
as O 0 0.0010113827884197235
to O 0 0.0010404756758362055
look O 0 0.0032477115746587515
for O 0 0.0017842274392023683
possible O 0 0.009465699084103107
mutational O 1 0.9987247586250305
hotspots O 1 0.9350276589393616
, O 0 0.0045095994137227535
reverse O 0 0.030155910179018974
- O 0 0.027001207694411278
transcribed O 0 0.04433678090572357
RNA O 0 0.04888519272208214
derived O 0 0.012513777241110802
from O 0 0.004421439953148365
ten O 0 0.010916770435869694
patients O 1 0.9955279231071472
belonging O 0 0.010916481725871563
to O 0 0.0020696979481726885
eight O 0 0.005050278268754482
unrelated O 0 0.024019435048103333
Japanese O 0 0.01171674020588398
A B-Disease 0 0.36112648248672485
- I-Disease 1 0.9173433780670166
T I-Disease 1 0.9987205862998962
families O 0 0.009404251351952553
was O 0 0.00456661032512784
analyzed O 0 0.014274860732257366
for O 0 0.004122660029679537
mutations O 1 0.9943775534629822
by O 0 0.003538780380040407
the O 0 0.00487089715898037
restriction O 0 0.04233899340033531
endonuclease O 1 0.9881184697151184
fingerprinting O 0 0.04371597245335579
method O 0 0.01719450019299984
. O 0 0.012061316519975662

As O 0 0.005456999409943819
has O 0 0.003824707120656967
been O 0 0.003529777517542243
reported O 0 0.007874027825891972
by O 0 0.0023364494554698467
others O 0 0.004621212836354971
, O 0 0.003627695608884096
mutations O 1 0.9987426400184631
that O 0 0.002098947996273637
lead O 0 0.006315093953162432
to O 0 0.0035014746244996786
exon O 1 0.7450405955314636
skipping O 0 0.07479884475469589
or O 0 0.0137264309450984
premature O 1 0.9917904138565063
protein O 0 0.0546419695019722
truncation O 0 0.43614462018013
were O 0 0.0022397669963538647
also O 0 0.0021838797256350517
predominant O 0 0.0160073209553957
in O 0 0.0026736059226095676
our O 0 0.007118003908544779
mutants O 1 0.9453186392784119
. O 0 0.012844597920775414

Six O 0 0.010775348171591759
different O 0 0.005600133445113897
mutations O 1 0.9825555086135864
were O 0 0.0019707658793777227
identified O 0 0.005643111653625965
on O 0 0.001251347130164504
12 O 0 0.00276757450774312
of O 0 0.0012481271987780929
the O 0 0.002732004737481475
16 O 0 0.013199361972510815
alleles O 1 0.9974699020385742
examined O 0 0.0802185907959938
. O 0 0.014135858044028282

Four O 0 0.007109489291906357
were O 0 0.0035335132852196693
deletions O 0 0.2495509535074234
involving O 0 0.01206443551927805
a O 0 0.005582182668149471
loss O 0 0.013337860815227032
of O 0 0.0017982139252126217
a O 0 0.006062544882297516
single O 0 0.014764146879315376
exon O 1 0.7809051275253296
exon O 1 0.5384533405303955
7 O 0 0.011907573789358139
, O 0 0.0038593171630054712
exon O 0 0.10745218396186829
16 O 0 0.010053539648652077
, O 0 0.003851452376693487
exon O 0 0.3434183895587921
33 O 0 0.021913088858127594
or O 0 0.010746551677584648
exon O 0 0.13058991730213165
35 O 0 0.03311847150325775
. O 0 0.01494026929140091

The O 0 0.007292880676686764
others O 0 0.0061578163877129555
were O 0 0.0023044783156365156
minute O 0 0.01545664481818676
deletions O 0 0.2235948145389557
, O 0 0.004697419703006744
4649delA O 1 0.8399916887283325
in O 0 0.0051675415597856045
exon O 1 0.6096775531768799
33 O 0 0.016183599829673767
and O 0 0.004279622808098793
7883del5 O 1 0.7819706201553345
in O 0 0.006563272792845964
exon O 1 0.7252950668334961
55 O 0 0.03380260244011879
. O 0 0.011794405058026314

The O 0 0.021211156621575356
mutations O 1 0.9986987113952637
4612del165 O 1 0.9870529770851135
and O 0 0.004890406504273415
7883del5 O 1 0.9610662460327148
were O 0 0.0022279657423496246
found O 0 0.0033882567659020424
in O 0 0.0013689252082258463
more O 0 0.001508141285739839
than O 0 0.0017488209996372461
two O 0 0.002040393417701125
unrelated O 0 0.02169373445212841
families O 0 0.00810638815164566
; O 0 0.00442226929590106
44 O 0 0.011024929583072662
% O 0 0.005624514538794756
( O 0 0.0036063161678612232
7 O 0 0.0046349819749593735
of O 0 0.0016591688618063927
16 O 0 0.005075526889413595
) O 0 0.0021753718610852957
of O 0 0.0013232567580416799
the O 0 0.004119321703910828
mutant O 1 0.998752236366272
alleles O 1 0.9974201917648315
had O 0 0.0033942079171538353
one O 0 0.0014315738808363676
of O 0 0.0014436913188546896
the O 0 0.0024174877908080816
two O 0 0.005756345111876726
mutations O 1 0.9966006875038147
. O 0 0.013399542309343815

The O 0 0.02141442522406578
4612del165 O 1 0.9963923096656799
mutations O 1 0.9971433281898499
in O 0 0.001937179476954043
three O 0 0.001639718422666192
different O 0 0.0016116764163598418
families O 0 0.0036778149660676718
were O 0 0.0011005328269675374
all O 0 0.0013208661694079638
ascribed O 0 0.016126710921525955
to O 0 0.0017589409835636616
the O 0 0.002921686042100191
same O 0 0.007462992332875729
T O 1 0.9925388693809509
- O 0 0.046383947134017944
- O 0 0.04589403048157692
> O 1 0.590928316116333
A O 0 0.009907680563628674
substitution O 0 0.018848370760679245
at O 0 0.003911706618964672
the O 0 0.004608443938195705
splice O 1 0.7606987953186035
donor O 0 0.05661437660455704
site O 0 0.013035302981734276
in O 0 0.00796250719577074
intron O 1 0.9759175777435303
33 O 0 0.037261076271533966
. O 0 0.014624201692640781

Microsatellite O 1 0.9896448850631714
genotyping O 1 0.6363351941108704
around O 0 0.009791797026991844
the O 0 0.007099816109985113
ATM O 1 0.5364614725112915
locus O 1 0.9939199686050415
also O 0 0.00385487824678421
indicated O 0 0.008354241028428078
that O 0 0.0016720249550417066
a O 0 0.005460892803966999
common O 0 0.012228880077600479
haplotype O 1 0.9966092109680176
was O 0 0.004010384902358055
shared O 0 0.004356661811470985
by O 0 0.002263432601466775
the O 0 0.004337123595178127
mutant O 1 0.9995208978652954
alleles O 1 0.9986227750778198
in O 0 0.0038116828072816133
both O 0 0.006306259427219629
mutations O 1 0.9991238713264465
. O 0 0.011393977329134941

This O 0 0.006120404694229364
suggests O 0 0.0101019237190485
that O 0 0.001235908130183816
these O 0 0.001193353207781911
two O 0 0.0022075872402638197
founder O 0 0.4402357041835785
mutations O 1 0.999927282333374
may O 0 0.005185537040233612
be O 0 0.001815610215999186
predominant O 0 0.016415484249591827
among O 0 0.004787431564182043
Japanese O 0 0.01460226345807314
ATM O 1 0.9266970157623291
mutant O 1 0.9992265701293945
alleles O 1 0.9979604482650757
. O 0 0.019243530929088593

W474C O 1 0.913266658782959
amino O 0 0.0952029749751091
acid O 0 0.14349046349525452
substitution O 0 0.05063547194004059
affects O 0 0.4662942886352539
early O 0 0.006758183240890503
processing O 0 0.005248903296887875
of O 0 0.0014710578834638
the O 0 0.0029945182614028454
alpha O 0 0.03617537394165993
- O 0 0.022365354001522064
subunit O 0 0.04503944516181946
of O 0 0.004304694477468729
beta O 0 0.05768127366900444
- O 0 0.03136913850903511
hexosaminidase O 1 0.8576161861419678
A O 0 0.007999039255082607
and O 0 0.0024095671251416206
is O 0 0.0034006289206445217
associated O 0 0.009570272639393806
with O 0 0.008404294028878212
subacute O 1 0.9999794960021973
G B-Disease 1 0.9835426807403564
( I-Disease 0 0.015387699007987976
M2 I-Disease 1 0.886277973651886
) I-Disease 0 0.01418986450880766
gangliosidosis I-Disease 1 0.9205129742622375
. O 0 0.014773577451705933

Mutations O 1 0.9930093288421631
in O 0 0.006480831652879715
the O 0 0.010718357749283314
HEXA O 1 0.9998779296875
gene O 1 0.9579282402992249
, O 0 0.0042253173887729645
encoding O 0 0.022142725065350533
the O 0 0.005329439416527748
alpha O 0 0.035934675484895706
- O 0 0.022724786773324013
subunit O 0 0.049521107226610184
of O 0 0.005190338008105755
beta O 0 0.04679041728377342
- O 0 0.03495386987924576
hexosaminidase O 1 0.961024820804596
A O 0 0.013219879008829594
( O 0 0.008246831595897675
Hex O 0 0.0677521601319313
A O 0 0.00923314318060875
) O 0 0.0031048923265188932
, O 0 0.0013312076916918159
that O 0 0.0016839393647387624
abolish O 0 0.02994367852807045
Hex O 0 0.05090760812163353
A O 0 0.01407287921756506
enzyme O 0 0.10449250787496567
activity O 0 0.03190704435110092
cause O 1 0.998347282409668
Tay B-Disease 1 0.9999977350234985
- I-Disease 1 0.9993405938148499
Sachs I-Disease 1 0.9999606609344482
disease I-Disease 1 0.9999991655349731
( O 0 0.03626800701022148
TSD B-Disease 1 0.9998132586479187
) O 0 0.006638227961957455
, O 0 0.0028643026016652584
the O 0 0.007768147625029087
fatal O 1 0.9999940395355225
infantile B-Disease 1 0.999994158744812
form I-Disease 0 0.014743788167834282
of I-Disease 0 0.006162405479699373
G I-Disease 1 0.983540952205658
( I-Disease 0 0.01186671108007431
M2 I-Disease 0 0.32741662859916687
) I-Disease 0 0.009188114665448666
gangliosidosis I-Disease 1 0.9133113026618958
, I-Disease 0 0.004964981693774462
Type I-Disease 0 0.034637633711099625
1 I-Disease 0 0.012937061488628387
. O 0 0.008809343911707401

Less O 0 0.050041984766721725
severe O 1 0.9998536109924316
, O 0 0.013223922811448574
subacute O 1 0.9999840259552002
( O 0 0.03243791311979294
juvenile O 1 0.9997679591178894
- O 1 0.9519729018211365
onset O 1 0.9999853372573853
) O 0 0.00890116486698389
and O 0 0.006035739090293646
chronic O 1 0.9999992847442627
( O 0 0.01793837361037731
adult O 1 0.9514201879501343
- O 1 0.8585604429244995
onset O 1 0.9999758005142212
) O 0 0.007073761895298958
variants O 0 0.02891034260392189
are O 0 0.001741808489896357
characterized O 0 0.01610562391579151
by O 0 0.002478774869814515
a O 0 0.005234403070062399
broad O 0 0.0176740363240242
spectrum O 0 0.026295877993106842
of O 0 0.0032108158338814974
clinical O 1 0.9949548840522766
manifestations O 1 0.9337635636329651
and O 0 0.0015100776217877865
are O 0 0.0011007613502442837
associated O 0 0.0047390940599143505
with O 0 0.0022070209961384535
residual O 0 0.21740077435970306
levels O 0 0.007721368223428726
of O 0 0.0023367772810161114
Hex O 0 0.22367258369922638
A O 0 0.01538048405200243
enzyme O 0 0.07527461647987366
activity O 0 0.01928270421922207
. O 0 0.009776833467185497

We O 0 0.006712819915264845
identified O 0 0.013770591467618942
a O 0 0.013661384582519531
1422 O 1 0.9985137581825256
G O 1 0.9704353213310242
- O 0 0.05066467449069023
- O 0 0.07088065892457962
> O 1 0.8156277537345886
C O 0 0.049159128218889236
( O 0 0.010976459830999374
amino O 0 0.04648829624056816
acid O 0 0.2349267154932022
W474C O 1 0.8121340870857239
) O 0 0.005967174656689167
substitution O 0 0.014662490226328373
in O 0 0.0014160822611302137
the O 0 0.0014847195707261562
first O 0 0.0019909674301743507
position O 0 0.0031563022639602423
of O 0 0.002588357077911496
exon O 0 0.12859302759170532
13 O 0 0.008108988404273987
of O 0 0.0032480652444064617
HEXA O 1 0.9994891881942749
of O 0 0.0028737259563058615
a O 0 0.007002472877502441
non O 0 0.01241928618401289
- O 0 0.020671235397458076
Jewish O 0 0.0169513076543808
proband O 1 0.9909447431564331
who O 0 0.011056351475417614
manifested O 1 0.7069966793060303
a O 0 0.02404041402041912
subacute O 1 0.9999697208404541
variant O 1 0.9693255424499512
of O 0 0.007008376531302929
G B-Disease 1 0.9831759929656982
( I-Disease 0 0.014745598658919334
M2 I-Disease 1 0.8906959891319275
) I-Disease 0 0.014601022005081177
gangliosidosis I-Disease 1 0.9206973314285278
. O 0 0.012725031934678555

On O 0 0.00458845729008317
the O 0 0.004598918370902538
second O 0 0.015603884123265743
maternally O 1 0.9966855645179749
inherited O 1 0.9997199177742004
allele O 1 0.9994561076164246
, O 0 0.0027002834249287844
we O 0 0.002032993594184518
identified O 0 0.0074971746653318405
the O 0 0.0039588953368365765
common O 1 0.7331293225288391
infantile O 1 0.9999997615814209
disease O 1 0.9999998807907104
- O 1 0.9894885420799255
causing O 1 0.9992662072181702
4 O 0 0.018269075080752373
- O 0 0.03353201970458031
bp O 0 0.060088641941547394
insertion O 0 0.27098697423934937
, O 0 0.008730660192668438
+ O 0 0.20645934343338013
TATC O 1 0.9959695339202881
1278 O 1 0.9921302199363708
, O 0 0.005511259660124779
in O 0 0.006020907312631607
exon O 0 0.22695420682430267
11 O 0 0.019230877980589867
. O 0 0.01317979209125042

Pulse O 1 0.7024358510971069
- O 0 0.062678761780262
chase O 0 0.06014115363359451
analysis O 0 0.014400530606508255
using O 0 0.01377931796014309
proband O 1 0.990845263004303
fibroblasts O 1 0.9929552674293518
revealed O 0 0.016991442069411278
that O 0 0.0025400016456842422
the O 0 0.0041477978229522705
W474C O 1 0.8732133507728577
- O 0 0.024453673511743546
containing O 0 0.015544576570391655
alpha O 0 0.05739828944206238
- O 0 0.03896516561508179
subunit O 0 0.08288232982158661
precursor O 0 0.03840917348861694
was O 0 0.006300563458353281
normally O 0 0.011142406612634659
synthesized O 0 0.021663494408130646
, O 0 0.002176715759560466
but O 0 0.001953222556039691
not O 0 0.002343123545870185
phosphorylated O 0 0.43327242136001587
or O 0 0.007169454824179411
secreted O 0 0.057772714644670486
, O 0 0.0026356582529842854
and O 0 0.0014962870627641678
the O 0 0.00424678809940815
mature O 0 0.17389440536499023
lysosomal O 1 0.996625542640686
alpha O 0 0.10057317465543747
- O 0 0.03757195919752121
subunit O 0 0.06375068426132202
was O 0 0.006050108000636101
not O 0 0.003996840678155422
detected O 0 0.054357659071683884
. O 0 0.010180545039474964

When O 0 0.0128557700663805
the O 0 0.007757937535643578
W474C O 1 0.6219087243080139
- O 0 0.029761824756860733
containing O 0 0.01724645309150219
alpha O 0 0.055010270327329636
- O 0 0.03289981558918953
subunit O 0 0.07470716536045074
was O 0 0.010579698719084263
transiently O 1 0.9694157242774963
co O 0 0.03184075653553009
- O 0 0.01778993383049965
expressed O 0 0.007023475132882595
with O 0 0.0021913605742156506
the O 0 0.004137413110584021
beta O 0 0.04110303521156311
- O 0 0.026581473648548126
subunit O 0 0.04805025830864906
to O 0 0.0028698397800326347
produce O 0 0.00936825480312109
Hex O 0 0.05263339355587959
A O 0 0.016162635758519173
( O 0 0.010874498635530472
alphabeta O 1 0.6784088015556335
) O 0 0.006978407967835665
in O 0 0.005428158212453127
COS O 1 0.9964686632156372
- O 0 0.03483327478170395
7 O 0 0.020387329161167145
cells O 0 0.03426795452833176
, O 0 0.0028014343697577715
the O 0 0.005037432536482811
mature O 0 0.04921606555581093
alpha O 0 0.06141611933708191
- O 0 0.03237538784742355
subunit O 0 0.06000018119812012
was O 0 0.004222537856549025
present O 0 0.0029217847622931004
, O 0 0.0014018533984199166
but O 0 0.001264061313122511
its O 0 0.0017710371175780892
level O 0 0.0031093673314899206
was O 0 0.0024315440095961094
much O 0 0.0032810422126203775
lower O 0 0.006157738156616688
than O 0 0.002346007851883769
that O 0 0.0014962544664740562
from O 0 0.003981209825724363
normal O 0 0.02430832013487816
alpha O 0 0.05076143890619278
- O 0 0.04156918078660965
subunit O 0 0.11870212852954865
transfections O 1 0.9076886773109436
, O 0 0.003146946895867586
although O 0 0.0029751667752861977
higher O 0 0.004622575361281633
than O 0 0.0020871676970273256
in O 0 0.001858505536802113
those O 0 0.004087761510163546
cells O 1 0.5754744410514832
transfected O 1 0.9792752861976624
with O 0 0.004281667061150074
an O 0 0.0050416667945683
alpha O 0 0.04897194728255272
- O 0 0.03387606516480446
subunit O 0 0.08899317681789398
associated O 0 0.019444193691015244
with O 0 0.012427986599504948
infantile O 1 0.9999723434448242
TSD B-Disease 1 0.9993840456008911
. O 0 0.02621218003332615

Furthermore O 0 0.024163564667105675
, O 0 0.002874051220715046
the O 0 0.0032102814875543118
precursor O 0 0.02069712243974209
level O 0 0.004054343793541193
of O 0 0.0016724930610507727
the O 0 0.004158808384090662
W474C O 1 0.9846566319465637
alpha O 0 0.059575412422418594
- O 0 0.026954540982842445
subunit O 0 0.05142390355467796
was O 0 0.004440697841346264
found O 0 0.003786347573623061
to O 0 0.0021922625601291656
accumulate O 0 0.020631862804293633
in O 0 0.00235064048320055
comparison O 0 0.006764750927686691
to O 0 0.0018634959124028683
the O 0 0.0038395116571336985
normal O 0 0.026256665587425232
alpha O 0 0.05856456235051155
- O 0 0.04327196255326271
subunit O 0 0.110819011926651
precursor O 0 0.061757445335388184
levels O 0 0.035007067024707794
. O 0 0.013747802935540676

We O 0 0.006521257571876049
conclude O 0 0.015119384042918682
that O 0 0.0028803027234971523
the O 0 0.0077771982178092
1422 O 1 0.9982628226280212
G O 1 0.9569923281669617
- O 0 0.05867718905210495
- O 0 0.07760803401470184
> O 1 0.9691835045814514
C O 0 0.10967738181352615
mutation O 1 0.9942160248756409
is O 0 0.0034049982205033302
the O 0 0.0028834983240813017
cause O 0 0.024826714769005775
of O 0 0.003275386756286025
Hex B-Disease 1 0.8363841772079468
A I-Disease 0 0.07037129253149033
enzyme I-Disease 1 0.9974601864814758
deficiency I-Disease 1 0.9999967813491821
in O 0 0.004371446557343006
the O 0 0.008310668170452118
proband O 1 0.994892954826355
. O 0 0.014552507549524307

The O 0 0.011762517504394054
resulting O 0 0.05608939751982689
W474C O 1 0.9813628196716309
substitution O 0 0.040636952966451645
clearly O 0 0.0144821060821414
interferes O 1 0.5106126070022583
with O 0 0.005312958732247353
alpha O 0 0.045493192970752716
- O 0 0.028123119845986366
subunit O 0 0.05623418092727661
processing O 0 0.00874030590057373
, O 0 0.0018488492351025343
but O 0 0.0018939214060083032
because O 0 0.003040649462491274
the O 0 0.0023924135603010654
base O 0 0.010370686650276184
substitution O 0 0.027678707614541054
falls O 0 0.024449370801448822
at O 0 0.0029796285089105368
the O 0 0.0019767426420003176
first O 0 0.002084683394059539
position O 0 0.003073312109336257
of O 0 0.0025403182953596115
exon O 0 0.4227217435836792
13 O 0 0.009544254280626774
, O 0 0.004336098674684763
aberrant O 1 0.9920720458030701
splicing O 0 0.4951664209365845
may O 0 0.005714405793696642
also O 0 0.0017401386285200715
contribute O 0 0.007663110736757517
to O 0 0.002746674930676818
Hex B-Disease 0 0.4277821183204651
A I-Disease 0 0.10707522928714752
deficiency I-Disease 1 0.9999904632568359
in O 0 0.004633043892681599
this O 0 0.005327942781150341
proband O 1 0.9785531759262085
. O 0 0.006491423584520817
. O 0 0.009645123966038227

Two O 0 0.018490910530090332
frequent O 0 0.09665277600288391
missense O 1 0.9975433349609375
mutations O 1 0.9989871382713318
in O 0 0.023427067324519157
Pendred B-Disease 1 0.9999852180480957
syndrome I-Disease 1 1.0
. O 0 0.02488596923649311

Pendred B-Disease 1 0.9999520778656006
syndrome I-Disease 1 1.0
is O 0 0.0157002005726099
an O 0 0.07887975126504898
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9986860156059265
by O 0 0.008462926372885704
early O 0 0.03495435044169426
childhood O 1 0.999975323677063
deafness B-Disease 1 0.9999997615814209
and O 0 0.03305644541978836
goiter B-Disease 1 0.9999983310699463
. O 0 0.017842119559645653

A O 0 0.014916827902197838
century O 0 0.006531624123454094
after O 0 0.006335347890853882
its O 0 0.0033844555728137493
recognition O 0 0.011283359490334988
as O 0 0.003546040039509535
a O 0 0.049139708280563354
syndrome O 1 0.9999997615814209
by O 0 0.01002167072147131
Vaughan O 1 0.9827484488487244
Pendred O 1 0.9970569610595703
, O 0 0.005611318629235029
the O 0 0.009952197782695293
disease O 1 0.9999992847442627
gene O 1 0.9990004897117615
( O 0 0.01534267608076334
PDS O 1 0.9992515444755554
) O 0 0.0062508247792720795
was O 0 0.004931190516799688
mapped O 0 0.02344456873834133
to O 0 0.007665236480534077
chromosome O 1 0.9953773021697998
7q22 O 1 0.9865260720252991
- O 0 0.09121618419885635
q31 O 1 0.8687625527381897
. O 0 0.02127525582909584

1 O 0 0.012767010368406773
and O 0 0.002052105264738202
, O 0 0.0025115162134170532
recently O 0 0.007017434109002352
, O 0 0.0016886097146198153
found O 0 0.0030651327688246965
to O 0 0.002080304082483053
encode O 0 0.018731944262981415
a O 0 0.01356967817991972
putative O 1 0.9628676772117615
sulfate O 1 0.9929882884025574
transporter O 1 0.9779272079467773
. O 0 0.017118806019425392

We O 0 0.00911604892462492
performed O 0 0.02050565741956234
mutation O 1 0.9822090268135071
analysis O 0 0.006048057693988085
of O 0 0.0017356903990730643
the O 0 0.004915247205644846
PDS B-Disease 1 0.999890923500061
gene O 1 0.9951973557472229
in O 0 0.006633670534938574
patients O 1 0.9993798732757568
from O 0 0.004565114621073008
14 O 0 0.013120727613568306
Pendred B-Disease 1 0.9960057139396667
families O 0 0.010021908208727837
originating O 0 0.01323582511395216
from O 0 0.002646826207637787
seven O 0 0.0027325605042278767
countries O 0 0.0018446706235408783
and O 0 0.0016041899798437953
identified O 0 0.010144774802029133
all O 0 0.004524518735706806
mutations O 1 0.9967229962348938
. O 0 0.013211310841143131

The O 0 0.01581154763698578
mutations O 1 0.9771820902824402
include O 0 0.004627479240298271
three O 0 0.00247559929266572
single O 0 0.008540873415768147
base O 0 0.012309537269175053
deletions O 0 0.04578608274459839
, O 0 0.0025780382566154003
one O 0 0.005369284655898809
splice O 0 0.3903343379497528
site O 0 0.01962675154209137
mutation O 1 0.9980015158653259
and O 0 0.004237236920744181
10 O 0 0.01372996810823679
missense O 1 0.9990241527557373
mutations O 1 0.9982269406318665
. O 0 0.01835062727332115

One O 0 0.026759393513202667
missense O 1 0.9971753358840942
mutation O 1 0.9992460012435913
( O 0 0.018601691350340843
L236P O 1 0.9820984601974487
) O 0 0.00487750256434083
was O 0 0.0027240924537181854
found O 0 0.00299680233001709
in O 0 0.0016313523519784212
a O 0 0.0059957075864076614
homozygous O 1 0.9673818349838257
state O 0 0.0022926824167370796
in O 0 0.0017179952701553702
two O 0 0.003307564649730921
consanguineous O 1 0.99284428358078
families O 0 0.007626394275575876
and O 0 0.0016346104675903916
in O 0 0.0018023716984316707
a O 0 0.005900330375880003
heterozygous O 1 0.9631924629211426
state O 0 0.0020207189954817295
in O 0 0.001207399065606296
five O 0 0.0022770899813622236
additional O 0 0.005705163814127445
non O 0 0.018701354041695595
- O 0 0.06684916466474533
consanguineous O 1 0.9955405592918396
families O 0 0.02354697324335575
. O 0 0.013812098652124405

Another O 0 0.053245771676301956
missense O 1 0.9964309930801392
mutation O 1 0.9987486600875854
( O 0 0.01954331435263157
T416P O 1 0.8867296576499939
) O 0 0.0055452692322432995
was O 0 0.0027255723252892494
found O 0 0.0030087423510849476
in O 0 0.0017028310103341937
a O 0 0.006802017334848642
homozygous O 1 0.992419421672821
state O 0 0.00207185884937644
in O 0 0.0014048430602997541
one O 0 0.002020892221480608
family O 0 0.0055978079326450825
and O 0 0.001187184825539589
in O 0 0.0015887385234236717
a O 0 0.0063238684087991714
heterozygous O 1 0.9447224140167236
state O 0 0.002642963081598282
in O 0 0.0019736522808670998
four O 0 0.003446691669523716
families O 0 0.010718069039285183
. O 0 0.009817137382924557

Pendred B-Disease 1 0.999630331993103
patients O 1 0.9994990825653076
in O 0 0.003626912832260132
three O 0 0.0032557379454374313
non O 0 0.01514548808336258
- O 0 0.050739746540784836
consanguineous O 1 0.9933835864067078
families O 0 0.009972909465432167
were O 0 0.00188825570512563
shown O 0 0.004953510593622923
to O 0 0.0015432158252224326
be O 0 0.002610134892165661
compound O 0 0.02125716023147106
heterozygotes O 1 0.9868627786636353
for O 0 0.005293773487210274
L236P O 1 0.9844470024108887
and O 0 0.007425118237733841
T416P O 1 0.9814193248748779
. O 0 0.015397063456475735

In O 0 0.004893698263913393
total O 0 0.004169764928519726
, O 0 0.0014025162672623992
one O 0 0.0015480245929211378
or O 0 0.0019157679053023458
both O 0 0.0010382314212620258
of O 0 0.0010538538917899132
these O 0 0.002155674621462822
mutations O 1 0.9995288848876953
were O 0 0.0013258801773190498
found O 0 0.0023358536418527365
in O 0 0.000995380338281393
nine O 0 0.0023032703902572393
of O 0 0.0011122014839202166
the O 0 0.00251755490899086
14 O 0 0.009431164711713791
families O 0 0.01100996695458889
analyzed O 0 0.027731239795684814
. O 0 0.010736275464296341

The O 0 0.0055595943704247475
identification O 0 0.009219570085406303
of O 0 0.001969587290659547
two O 0 0.0031093349680304527
frequent O 1 0.7197269201278687
PDS B-Disease 1 0.9999645948410034
mutations O 1 0.9997299313545227
will O 0 0.0021869377233088017
facilitate O 0 0.00778141338378191
the O 0 0.003783963155001402
molecular O 0 0.10247666388750076
diagnosis O 1 0.9998993873596191
of O 0 0.016207503154873848
Pendred B-Disease 1 0.9999949932098389
syndrome I-Disease 1 1.0
. O 0 0.0260537751019001

Insertional O 1 0.9941918253898621
mutation O 1 0.9973015189170837
by O 0 0.013001244515180588
transposable O 1 0.8894727826118469
element O 0 0.022518090903759003
, O 0 0.005714798346161842
L1 O 1 0.8830702304840088
, O 0 0.00267872610129416
in O 0 0.003072594990953803
the O 0 0.00973432045429945
DMD B-Disease 1 0.9999969005584717
gene O 1 0.9964518547058105
results O 0 0.010427088476717472
in O 0 0.004565442446619272
X B-Disease 1 0.903786838054657
- I-Disease 0 0.18393585085868835
linked I-Disease 1 0.9730706810951233
dilated I-Disease 1 0.9999005794525146
cardiomyopathy I-Disease 1 0.9999963045120239
. O 0 0.025079209357500076

X B-Disease 1 0.8978883624076843
- I-Disease 0 0.28016844391822815
linked I-Disease 1 0.9500077366828918
dilated I-Disease 1 0.9999741315841675
cardiomyopathy I-Disease 1 0.9999996423721313
( O 0 0.027299031615257263
XLDCM B-Disease 1 0.9988538026809692
) O 0 0.005626261699944735
is O 0 0.0034728366881608963
a O 0 0.008685645647346973
clinical O 1 0.9749317169189453
phenotype O 1 0.9995057582855225
of O 0 0.006669906899333
dystrophinopathy B-Disease 1 0.9962893724441528
which O 0 0.0026456054765731096
is O 0 0.003198519116267562
characterized O 0 0.14857074618339539
by O 0 0.0049093132838606834
preferential O 1 0.9892300963401794
myocardial B-Disease 1 0.9999980926513672
involvement I-Disease 0 0.0356881357729435
without O 0 0.005815665237605572
any O 0 0.004689332097768784
overt O 0 0.32509124279022217
clinical O 1 0.910599946975708
signs O 0 0.05879496410489082
of O 0 0.013779887929558754
skeletal B-Disease 1 0.9999945163726807
myopathy I-Disease 1 0.9999992847442627
. O 0 0.02256026677787304

To O 0 0.00394962914288044
date O 0 0.005198343191295862
, O 0 0.002250694902613759
several O 0 0.004227904137223959
mutations O 1 0.995526134967804
in O 0 0.003579081268981099
the O 0 0.013583631254732609
Duchenne B-Disease 1 0.9999998807907104
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
gene O 1 0.9999686479568481
, O 0 0.026048850268125534
DMD O 1 0.9999986886978149
, O 0 0.0030203263740986586
have O 0 0.001680408837273717
been O 0 0.002939982106909156
identified O 0 0.008473171852529049
in O 0 0.003317783819511533
patients O 1 0.9997393488883972
with O 0 0.005526124499738216
XLDCM B-Disease 1 0.9998550415039062
, O 0 0.002558472566306591
but O 0 0.0021764258854091167
a O 0 0.008114674128592014
pathogenic O 1 0.9863209128379822
correlation O 0 0.019792605191469193
of O 0 0.0024500556755810976
these O 0 0.0036923389416188
cardiospecific O 1 0.9991425275802612
mutations O 1 0.9993008375167847
in O 0 0.008308482356369495
DMD O 1 0.9999793767929077
with O 0 0.004957356955856085
the O 0 0.008641171269118786
XLDCM B-Disease 1 0.9999535083770752
phenotype O 1 0.9999886751174927
has O 0 0.005529945716261864
remained O 0 0.006524872966110706
to O 0 0.002339388942345977
be O 0 0.003675504121929407
elucidated O 0 0.34412166476249695
. O 0 0.013165827840566635

We O 0 0.00415562791749835
report O 0 0.0037275548093020916
here O 0 0.0017664326587691903
the O 0 0.0016494767041876912
identification O 0 0.006221687886863947
of O 0 0.0013618109514936805
a O 0 0.0042593814432621
unique O 0 0.007920428179204464
de O 0 0.030774524435400963
novo O 0 0.1880864053964615
L1 O 1 0.9614818692207336
insertion O 0 0.08539316058158875
in O 0 0.0037662885151803493
the O 0 0.008055435493588448
muscle O 1 0.998875081539154
exon O 1 0.9195301532745361
1 O 0 0.014273183420300484
in O 0 0.008422681130468845
DMD O 1 0.9999332427978516
in O 0 0.00582488626241684
three O 0 0.008805801160633564
XLDCM B-Disease 1 0.9998006224632263
patients O 1 0.9990761280059814
from O 0 0.004307231865823269
two O 0 0.003258294891566038
unrelated O 0 0.03014851175248623
Japanese O 0 0.01517170388251543
families O 0 0.016279982402920723
. O 0 0.013365204446017742

The O 0 0.013016153126955032
insertion O 0 0.08856187760829926
was O 0 0.006544908042997122
a O 0 0.009128272533416748
5 O 0 0.012285142205655575
- O 0 0.024905873462557793
truncated O 0 0.04510556533932686
form O 0 0.007748340722173452
of O 0 0.003434339538216591
human O 0 0.02048364467918873
L1 O 1 0.972873330116272
inversely O 0 0.058163296431303024
integrated O 0 0.01483679935336113
in O 0 0.0020822235383093357
the O 0 0.002647720044478774
5 O 0 0.00932756345719099
- O 0 0.022335683926939964
untranslated O 0 0.17713873088359833
region O 0 0.010039165616035461
in O 0 0.002721168799325824
the O 0 0.007210484705865383
muscle O 1 0.9998282194137573
exon O 1 0.955268144607544
1 O 0 0.008414863608777523
, O 0 0.001873153611086309
which O 0 0.002284906804561615
affected O 0 0.014180735684931278
the O 0 0.002836786210536957
transcription O 0 0.02650441601872444
or O 0 0.0020451867021620274
the O 0 0.001249189954251051
stability O 0 0.005074790678918362
of O 0 0.0017568232724443078
the O 0 0.004587701056152582
muscle O 1 0.999932050704956
form O 0 0.0062419455498456955
of O 0 0.003580896183848381
dystrophin O 1 0.9999288320541382
transcripts O 0 0.010507399216294289
but O 0 0.0016196033684536815
not O 0 0.0008222570177167654
that O 0 0.0006778191891498864
of O 0 0.0011004856787621975
the O 0 0.004126809071749449
brain O 1 0.9999872446060181
or O 0 0.009270137175917625
Purkinje O 1 0.9993389248847961
cell O 0 0.43719813227653503
form O 0 0.006915565114468336
, O 0 0.002029937691986561
probably O 0 0.005927274934947491
due O 0 0.004527582786977291
to O 0 0.0010745646432042122
its O 0 0.0018840492703020573
unique O 0 0.0045221056789159775
site O 0 0.004560919012874365
of O 0 0.002508503617718816
integration O 0 0.017927827313542366
. O 0 0.01039181649684906

We O 0 0.00572274811565876
speculate O 0 0.017216352745890617
that O 0 0.0015459086280316114
this O 0 0.00218252744525671
insertion O 0 0.03200644999742508
of O 0 0.0023909343872219324
an O 0 0.0050019617192447186
L1 O 1 0.9619864225387573
sequence O 0 0.026991115882992744
in O 0 0.007920792326331139
DMD O 1 0.9999958276748657
is O 0 0.003887725295498967
responsible O 0 0.007596013136208057
for O 0 0.001260707271285355
some O 0 0.0011618210701271892
of O 0 0.0008297658641822636
the O 0 0.0015028240159153938
population O 0 0.005289479158818722
of O 0 0.0024178053718060255
Japanese O 0 0.03124256618320942
patients O 1 0.999760091304779
with O 0 0.007434855215251446
XLDCM B-Disease 1 0.9989802241325378
. O 0 0.007210617884993553
. O 0 0.008513903245329857

Severe O 1 0.9998760223388672
early O 0 0.04691600427031517
- O 1 0.995830237865448
onset O 1 0.9999972581863403
obesity B-Disease 1 0.9999990463256836
, O 0 0.02583630010485649
adrenal B-Disease 1 0.9999990463256836
insufficiency I-Disease 1 0.9999988079071045
and O 0 0.007634966634213924
red O 1 0.9989244341850281
hair O 1 0.9999371767044067
pigmentation O 1 0.9999985694885254
caused O 1 0.998343825340271
by O 0 0.017019307240843773
POMC O 1 0.9999699592590332
mutations O 1 0.9997755885124207
in O 0 0.008994723670184612
humans O 0 0.05871514603495598
. O 0 0.01539976242929697

Sequential O 0 0.0895032212138176
cleavage O 0 0.16385787725448608
of O 0 0.002644551219418645
the O 0 0.004017338622361422
precursor O 0 0.04424825683236122
protein O 0 0.043053802102804184
pre O 0 0.0377604179084301
- O 0 0.034357912838459015
pro O 0 0.040543630719184875
- O 0 0.05467478558421135
opiomelanocortin O 1 0.9819977879524231
( O 0 0.022152822464704514
POMC O 1 0.9990317821502686
) O 0 0.008205982856452465
generates O 0 0.02739124745130539
the O 0 0.01085081696510315
melanocortin O 1 0.9959120750427246
peptides O 0 0.21997381746768951
adrenocorticotrophin O 1 0.9917154908180237
( O 0 0.021871553733944893
ACTH O 1 0.9944009184837341
) O 0 0.00901719368994236
, O 0 0.007735659368336201
melanocyte O 1 0.9989377856254578
- O 0 0.11764141917228699
stimulating O 1 0.9925393462181091
hormones O 1 0.9979733824729919
( O 0 0.02690069004893303
MSH O 1 0.9993477463722229
) O 0 0.012611409649252892
alpha O 0 0.03716052323579788
, O 0 0.00450899638235569
beta O 0 0.02834765799343586
and O 0 0.003006658749654889
gamma O 0 0.035440221428871155
as O 0 0.0021464170422405005
well O 0 0.0021902595181018114
as O 0 0.0024259292986243963
the O 0 0.006174382288008928
opioid O 1 0.9886437058448792
- O 0 0.06200500950217247
receptor O 1 0.6020780801773071
ligand O 0 0.09493419528007507
beta O 0 0.09226375818252563
- O 0 0.1030149906873703
endorphin O 1 0.9842841625213623
. O 0 0.023238006979227066

While O 0 0.006038414314389229
a O 0 0.005780851934105158
few O 0 0.00429766159504652
cases O 0 0.007926398888230324
of O 0 0.004524365998804569
isolated O 1 0.9986792206764221
ACTH B-Disease 1 0.999993085861206
deficiency I-Disease 1 0.9999990463256836
have O 0 0.006999097298830748
been O 0 0.006386347580701113
reported O 0 0.019030064344406128
( O 0 0.020226560533046722
OMIM O 1 0.9997755885124207
201400 O 1 0.9933657050132751
) O 0 0.006790674291551113
, O 0 0.003342323936522007
an O 0 0.006902592722326517
inherited O 1 0.9998971223831177
POMC O 1 0.999993085861206
defect O 1 0.9997991919517517
has O 0 0.005500346887856722
not O 0 0.002149432897567749
been O 0 0.0033997080754488707
described O 0 0.008657239377498627
so O 0 0.004850348457694054
far O 0 0.008532023057341576
. O 0 0.008675502613186836

Recent O 0 0.018705066293478012
studies O 0 0.009827600792050362
in O 0 0.003566182218492031
animal O 0 0.02517816238105297
models O 0 0.012600145302712917
elucidated O 0 0.06521231681108475
a O 0 0.004102490376681089
central O 0 0.0030963921453803778
role O 0 0.004875609651207924
of O 0 0.003335261018946767
alpha O 0 0.13312791287899017
- O 0 0.12050820142030716
MSH O 1 0.999148964881897
in O 0 0.003542641643434763
the O 0 0.002687619999051094
regulation O 0 0.008816374465823174
of O 0 0.0021856531966477633
food O 0 0.012996882200241089
intake O 0 0.0544721856713295
by O 0 0.004630326759070158
activation O 0 0.038115762174129486
of O 0 0.0030985360499471426
the O 0 0.008441414684057236
brain O 1 0.9998993873596191
melanocortin O 1 0.9995119571685791
- O 0 0.04887160658836365
4 O 0 0.02260352298617363
- O 0 0.05947152152657509
receptor O 1 0.9191610217094421
( O 0 0.020069630816578865
MC4 O 1 0.9990453124046326
- O 0 0.07973440736532211
R O 0 0.06523659080266953
; O 0 0.009776783175766468
refs O 0 0.0642169937491417
3 O 0 0.01345567312091589
- O 0 0.017859017476439476
5 O 0 0.008297988213598728
) O 0 0.0023103973362594843
and O 0 0.0011171035002917051
the O 0 0.0022575592156499624
linkage O 0 0.026051873341202736
of O 0 0.0033509312197566032
human O 0 0.11359205096960068
obesity B-Disease 1 0.9999969005584717
to O 0 0.006727117113769054
chromosome O 1 0.9993461966514587
2 O 0 0.005511160474270582
in O 0 0.0015406161546707153
close O 0 0.0046532610431313515
proximity O 0 0.009749436751008034
to O 0 0.0021120894234627485
the O 0 0.007391082122921944
POMC O 1 0.9999620914459229
locus O 1 0.9995833039283752
, O 0 0.0030457680113613605
led O 0 0.005257983226329088
to O 0 0.001391522935591638
the O 0 0.0016391113167628646
proposal O 0 0.003978589083999395
of O 0 0.0013791135279461741
an O 0 0.0021239614579826593
association O 0 0.008582749404013157
of O 0 0.004972802009433508
POMC O 1 0.999945878982544
with O 0 0.009492870420217514
human O 1 0.6424533724784851
obesity B-Disease 1 0.9999929666519165
. O 0 0.01589992828667164

The O 0 0.00815090723335743
dual O 0 0.020199105143547058
role O 0 0.009485112503170967
of O 0 0.0060257092118263245
alpha O 0 0.07130386680364609
- O 0 0.08349587023258209
MSH O 1 0.9987610578536987
in O 0 0.006334153935313225
regulating O 0 0.0379166342318058
food O 0 0.017743969336152077
intake O 0 0.17017322778701782
and O 0 0.004110733512789011
influencing O 1 0.6233749985694885
hair O 1 0.9998756647109985
pigmentation O 1 0.9999967813491821
predicts O 0 0.3641374707221985
that O 0 0.0022986046969890594
the O 0 0.004407149273902178
phenotype O 1 0.9998863935470581
associated O 0 0.0074624731205403805
with O 0 0.002252445090562105
a O 0 0.008745160885155201
defect O 1 0.9976473450660706
in O 0 0.008953998796641827
POMC O 1 0.9997565150260925
function O 0 0.017170341685414314
would O 0 0.003968076314777136
include O 0 0.009678530506789684
obesity B-Disease 1 0.9999887943267822
, O 0 0.005340395029634237
alteration O 1 0.9618093967437744
in O 0 0.008841322734951973
pigmentation O 1 0.9999780654907227
and O 0 0.01860497146844864
ACTH B-Disease 1 0.9999724626541138
deficiency I-Disease 1 0.9999984502792358
. O 0 0.021541347727179527

The O 0 0.007361751049757004
observation O 0 0.014851581305265427
of O 0 0.00330385216511786
these O 0 0.0054633100517094135
symptoms O 1 0.9999940395355225
in O 0 0.002528832061216235
two O 0 0.00311853620223701
probands O 1 0.9990392923355103
prompted O 0 0.09041494131088257
us O 0 0.005284894723445177
to O 0 0.0020826514810323715
search O 0 0.008674702607095242
for O 0 0.004033929668366909
mutations O 1 0.9872847199440002
within O 0 0.0069650644436478615
their O 0 0.009646891616284847
POMC O 1 0.9996230602264404
genes O 1 0.8106386065483093
. O 0 0.016978273168206215

Patient O 1 0.9991865754127502
1 O 0 0.010746810585260391
was O 0 0.0032637256663292646
found O 0 0.0027867043390870094
to O 0 0.0011021432001143694
be O 0 0.00138770358171314
a O 0 0.005209333263337612
compound O 0 0.018526749685406685
heterozygote O 1 0.9242975115776062
for O 0 0.0024400127585977316
two O 0 0.0037945439107716084
mutations O 1 0.993016242980957
in O 0 0.005147926975041628
exon O 0 0.434651643037796
3 O 0 0.012350994162261486
( O 0 0.00872717797756195
G7013T O 1 0.9878520965576172
, O 0 0.005334486719220877
C7133delta O 1 0.9790167212486267
) O 0 0.004387778230011463
which O 0 0.002230295678600669
interfere O 0 0.012099645100533962
with O 0 0.002216850407421589
appropriate O 0 0.006763055920600891
synthesis O 0 0.017061464488506317
of O 0 0.004349905531853437
ACTH O 1 0.9955820441246033
and O 0 0.006188944447785616
alpha O 0 0.13110920786857605
- O 0 0.36926180124282837
MSH O 1 0.9991342425346375
. O 0 0.018569642677903175

Patient O 1 0.9969677329063416
2 O 0 0.01396390050649643
was O 0 0.007239844184368849
homozygous O 1 0.7425234913825989
for O 0 0.002823117421939969
a O 0 0.011258798651397228
mutation O 1 0.9978657364845276
in O 0 0.005752986762672663
exon O 0 0.4995101988315582
2 O 0 0.012058946304023266
( O 0 0.00993918627500534
C3804A O 1 0.7459324598312378
) O 0 0.0070496187545359135
which O 0 0.008796379901468754
abolishes O 1 0.9914630055427551
POMC O 1 0.9988186955451965
translation O 0 0.03564649075269699
. O 0 0.014121239073574543

These O 0 0.004105503670871258
findings O 0 0.008446337655186653
represent O 0 0.003132679034024477
the O 0 0.0015354531351476908
first O 0 0.001763130770996213
examples O 0 0.002803877228870988
of O 0 0.001645058742724359
a O 0 0.00811724178493023
genetic B-Disease 1 0.9987443685531616
defect I-Disease 1 0.999632716178894
within O 0 0.006885345093905926
the O 0 0.008974269032478333
POMC O 1 0.9998742341995239
gene O 1 0.9685437679290771
and O 0 0.00264876801520586
define O 0 0.00935337133705616
a O 0 0.006484274752438068
new O 0 0.014375044964253902
monogenic B-Disease 1 0.9999727010726929
endocrine I-Disease 1 0.9999983310699463
disorder I-Disease 1 0.9999990463256836
resulting O 0 0.143363818526268
in O 0 0.003851106623187661
early O 0 0.018794452771544456
- O 1 0.9953776597976685
onset O 1 0.9999972581863403
obesity B-Disease 1 0.9999994039535522
, O 0 0.02630801498889923
adrenal B-Disease 1 0.9999990463256836
insufficiency I-Disease 1 0.9999951124191284
and O 0 0.0094892717897892
red O 1 0.9986681938171387
hair O 1 0.9999586343765259
pigmentation O 1 0.9999938011169434
. O 0 0.006476894486695528
. O 0 0.009805107489228249

A O 0 0.02468634396791458
European O 0 0.017765948548913002
multicenter O 1 0.9708319902420044
study O 0 0.012629746459424496
of O 0 0.0063736517913639545
phenylalanine B-Disease 1 0.999663233757019
hydroxylase I-Disease 1 0.9997554421424866
deficiency I-Disease 1 0.9999985694885254
: O 0 0.008311482146382332
classification O 0 0.015397412702441216
of O 0 0.002842171583324671
105 O 0 0.03079676255583763
mutations O 1 0.9992790818214417
and O 0 0.0018022859003394842
a O 0 0.004365670494735241
general O 0 0.004511762876063585
system O 0 0.005844400264322758
for O 0 0.0032626292668282986
genotype O 1 0.9992426633834839
- O 0 0.018086429685354233
based O 0 0.005116255488246679
prediction O 0 0.023940598592162132
of O 0 0.008357576094567776
metabolic O 1 0.9998792409896851
phenotype O 1 0.999830961227417
. O 0 0.021402016282081604

Phenylketonuria B-Disease 1 0.9999208450317383
( O 0 0.05844888091087341
PKU B-Disease 1 0.9999507665634155
) O 0 0.012535884976387024
and O 0 0.008538459427654743
mild B-Disease 1 0.9992713332176208
hyperphenylalaninemia I-Disease 1 0.9998158812522888
( O 0 0.03350381925702095
MHP B-Disease 1 0.9999634027481079
) O 0 0.009364011697471142
are O 0 0.006009452044963837
allelic B-Disease 1 0.9996433258056641
disorders I-Disease 1 0.9999992847442627
caused O 1 0.9989339709281921
by O 0 0.007321174256503582
mutations O 1 0.9994522929191589
in O 0 0.002506652846932411
the O 0 0.005141864530742168
gene O 1 0.9111244678497314
encoding O 0 0.06640070676803589
phenylalanine O 1 0.9940138459205627
hydroxylase O 1 0.9934130311012268
( O 0 0.030070822685956955
PAH O 1 0.9997026324272156
) O 0 0.012776744551956654
. O 0 0.01069862674921751

Previous O 0 0.013832515105605125
studies O 0 0.008401123806834221
have O 0 0.0020826037507504225
suggested O 0 0.004226128105074167
that O 0 0.001158247352577746
the O 0 0.0024779685772955418
highly O 0 0.01337397936731577
variable O 0 0.4180755913257599
metabolic O 1 0.9994325041770935
phenotypes O 1 0.9992682337760925
of O 0 0.016748156398534775
PAH B-Disease 1 0.9999980926513672
deficiency I-Disease 1 0.9999982118606567
correlate O 1 0.9095405340194702
with O 0 0.022768935188651085
PAH O 1 0.9999828338623047
genotypes O 1 0.999180257320404
. O 0 0.024033579975366592

We O 0 0.006581851281225681
identified O 0 0.013439838774502277
both O 0 0.006187915802001953
causative O 1 0.9968997240066528
mutations O 1 0.9996110796928406
in O 0 0.007753188256174326
686 O 1 0.9998038411140442
patients O 1 0.9998257756233215
from O 0 0.0031172495801001787
seven O 0 0.003767002373933792
European O 0 0.007491330150514841
centers O 0 0.017321689054369926
. O 0 0.010797247290611267

On O 0 0.0033293652813881636
the O 0 0.0020065228454768658
basis O 0 0.002126573584973812
of O 0 0.0015411657514050603
the O 0 0.0036995778791606426
phenotypic O 1 0.9927156567573547
characteristics O 0 0.01217248197644949
of O 0 0.0035849495325237513
297 O 1 0.9924830794334412
functionally O 1 0.999714195728302
hemizygous O 1 0.9999469518661499
patients O 1 0.9999103546142578
, O 0 0.002515506697818637
105 O 0 0.007431596517562866
of O 0 0.0013359470758587122
the O 0 0.0031158127821981907
mutations O 1 0.9991281628608704
were O 0 0.0015391960041597486
assigned O 0 0.004303599242120981
to O 0 0.0009572136914357543
one O 0 0.0013016979210078716
of O 0 0.0014374656602740288
four O 0 0.0038406166713684797
arbitrary O 0 0.01967846415936947
phenotype O 1 0.9996013045310974
categories O 0 0.021960286423563957
. O 0 0.01095817144960165

We O 0 0.00573550583794713
proposed O 0 0.006917851511389017
and O 0 0.0023792313877493143
tested O 0 0.014407123439013958
a O 0 0.004437610507011414
simple O 0 0.005420898087322712
model O 0 0.0062054842710494995
for O 0 0.002278801053762436
correlation O 0 0.020986055955290794
between O 0 0.008913048543035984
genotype O 1 0.9976391792297363
and O 0 0.007060404401272535
phenotypic O 1 0.9930102229118347
outcome O 0 0.0263555608689785
. O 0 0.013782985508441925

The O 0 0.011099055409431458
observed O 0 0.040245454758405685
phenotype O 1 0.9998205304145813
matched O 0 0.02859470248222351
the O 0 0.007252800744026899
predicted O 0 0.03919830173254013
phenotype O 1 0.999512791633606
in O 0 0.0048166299238801
79 O 0 0.018634183332324028
% O 0 0.003507907735183835
of O 0 0.0013678681571036577
the O 0 0.0020738195162266493
cases O 0 0.006537369452416897
, O 0 0.001113944104872644
and O 0 0.0007256423123180866
in O 0 0.0009709509904496372
only O 0 0.0014291292754933238
5 O 0 0.004099847283214331
of O 0 0.0024926364421844482
184 O 1 0.932626485824585
patients O 1 0.999775230884552
was O 0 0.004280947148799896
the O 0 0.003602045588195324
observed O 0 0.025191951543092728
phenotype O 1 0.999813973903656
more O 0 0.002679445780813694
than O 0 0.0023057996295392513
one O 0 0.0030862540006637573
category O 0 0.010306710377335548
away O 0 0.004951052833348513
from O 0 0.002675144700333476
that O 0 0.002330980496481061
expected O 0 0.007985067553818226
. O 0 0.008886297233402729

Among O 0 0.00809190422296524
the O 0 0.002860285108909011
seven O 0 0.005764109548181295
contributing O 0 0.015509777702391148
centers O 0 0.009078617207705975
, O 0 0.001889270730316639
the O 0 0.0022622181568294764
proportion O 0 0.009763164445757866
of O 0 0.002822808688506484
patients O 1 0.9999076128005981
for O 0 0.0016934305895119905
whom O 0 0.006436260417103767
the O 0 0.003177332691848278
observed O 0 0.326468825340271
phenotype O 1 0.999964714050293
did O 0 0.0033152573741972446
not O 0 0.00148618349339813
match O 0 0.0038536626379936934
the O 0 0.0033556115813553333
predicted O 0 0.03303561732172966
phenotype O 1 0.999675989151001
was O 0 0.005552439019083977
4 O 0 0.007713021710515022
% O 0 0.005822370760142803
- O 0 0.015870120376348495
23 O 0 0.010370055213570595
% O 0 0.006990413181483746
( O 0 0.011060560122132301
P O 1 0.5258499979972839
< O 1 0.6874475479125977
. O 0 0.007518208585679531
0001 O 1 0.9907744526863098
) O 0 0.004945298656821251
, O 0 0.001834570779465139
suggesting O 0 0.007945830933749676
that O 0 0.0014058680972084403
differences O 0 0.004131740890443325
in O 0 0.001416517305187881
methods O 0 0.0031103508081287146
used O 0 0.0018819234101101756
for O 0 0.002969594905152917
mutation O 1 0.9994148015975952
detection O 0 0.29966190457344055
or O 0 0.011810286901891232
phenotype O 1 0.999980092048645
classification O 0 0.11593198031187057
may O 0 0.005531677510589361
account O 0 0.003060342511162162
for O 0 0.0015232053119689226
a O 0 0.004343228880316019
considerable O 0 0.012948976829648018
proportion O 0 0.017560990527272224
of O 0 0.007190832402557135
genotype O 1 0.9999158382415771
- O 1 0.9488661885261536
phenotype O 1 0.9997226595878601
inconsistencies O 0 0.05258530378341675
. O 0 0.012853494845330715

Our O 0 0.0068397498689591885
data O 0 0.00551021471619606
indicate O 0 0.008306531235575676
that O 0 0.002761855721473694
the O 0 0.009386942721903324
PAH O 1 0.9999626874923706
- O 1 0.9313830733299255
mutation O 1 0.9997599720954895
genotype O 1 0.9971177577972412
is O 0 0.0038277129642665386
the O 0 0.002395756309852004
main O 0 0.00648510130122304
determinant O 0 0.2533682882785797
of O 0 0.005750366020947695
metabolic O 1 0.9999595880508423
phenotype O 1 0.9999048709869385
in O 0 0.004834768828004599
most O 0 0.008167087100446224
patients O 1 0.9999610185623169
with O 0 0.06798586249351501
PAH B-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999983310699463
. O 0 0.024020183831453323

In O 0 0.004580742679536343
the O 0 0.002485371893271804
present O 0 0.0036055021919310093
study O 0 0.0037952361162751913
, O 0 0.0012379674008116126
the O 0 0.002159979660063982
classification O 0 0.014411992393434048
of O 0 0.004380539990961552
105 O 1 0.5765480995178223
PAH O 1 0.9999958276748657
mutations O 1 0.9999336004257202
may O 0 0.006248630117624998
allow O 0 0.0022902272175997496
the O 0 0.001726358663290739
prediction O 0 0.00977633148431778
of O 0 0.0017707537626847625
the O 0 0.004312717821449041
biochemical O 1 0.6626101732254028
phenotype O 1 0.9998397827148438
in O 0 0.005525634158402681
> O 1 0.9024848341941833
10 O 0 0.005809931084513664
, O 0 0.003154768142849207
000 O 0 0.0305009912699461
genotypes O 1 0.9976296424865723
, O 0 0.0028369720093905926
which O 0 0.002083125291392207
may O 0 0.0036337864585220814
be O 0 0.0009947248036041856
useful O 0 0.0026946670841425657
for O 0 0.0009901460725814104
the O 0 0.0020534603390842676
management O 0 0.00770975137129426
of O 0 0.0040345508605241776
hyperphenylalaninemia B-Disease 1 0.9995488524436951
in O 0 0.011268517933785915
newborns O 1 0.999306321144104
. O 0 0.015448465943336487

Somatic O 1 0.973055362701416
instability O 0 0.238959401845932
of O 0 0.004129180684685707
the O 0 0.00787394493818283
CTG O 1 0.9976462721824646
repeat O 0 0.15374219417572021
in O 0 0.006913894787430763
mice O 1 0.9945934414863586
transgenic O 0 0.056248895823955536
for O 0 0.005174844991415739
the O 0 0.015554267913103104
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999997615814209
region O 0 0.02995155192911625
is O 0 0.005285392981022596
age O 0 0.013308257795870304
dependent O 0 0.01691223308444023
but O 0 0.0021438063122332096
not O 0 0.0019989239517599344
correlated O 0 0.01925555244088173
to O 0 0.001635855296626687
the O 0 0.003439602442085743
relative O 0 0.022073304280638695
intertissue O 1 0.9721131920814514
transcription O 0 0.10052766650915146
levels O 0 0.02013823203742504
and O 0 0.007414207328110933
proliferative O 1 0.9993083477020264
capacities O 0 0.04576334357261658
. O 0 0.013664480298757553

A O 0 0.028300199657678604
( O 0 0.017940683290362358
CTG O 1 0.9700447916984558
) O 0 0.010828995145857334
nexpansion O 0 0.168173685669899
in O 0 0.0029235193505883217
the O 0 0.003342433599755168
3 O 0 0.010929824784398079
- O 0 0.02882273495197296
untranslated O 0 0.39717260003089905
region O 0 0.02020137384533882
( O 0 0.010508260689675808
UTR O 0 0.14290401339530945
) O 0 0.004609672352671623
of O 0 0.0027966841589659452
the O 0 0.010166950523853302
DM O 1 0.9999637603759766
protein O 1 0.5902623534202576
kinase O 1 0.9919354915618896
gene O 1 0.9673964381217957
( O 0 0.016794968396425247
DMPK O 1 0.9943742752075195
) O 0 0.004389388952404261
is O 0 0.0028979049529880285
responsible O 0 0.009611657820641994
for O 0 0.007077456917613745
causing O 1 0.9999312162399292
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.7501476407051086
DM B-Disease 1 0.9999899864196777
) O 0 0.015675658360123634
. O 0 0.010853765532374382

Major O 0 0.02962743490934372
instability O 1 0.8531897068023682
, O 0 0.0026784685906022787
with O 0 0.0020483892876654863
very O 0 0.0032592955976724625
large O 0 0.004871149081736803
expansions O 0 0.015490734949707985
between O 0 0.002810484729707241
generations O 0 0.010858077555894852
and O 0 0.0016686056042090058
high O 0 0.0051852986216545105
levels O 0 0.00918132346123457
of O 0 0.005137115251272917
somatic O 1 0.9991888403892517
mosaicism O 1 0.9998438358306885
, O 0 0.0037669434677809477
is O 0 0.004309088923037052
observed O 0 0.015109510160982609
in O 0 0.006083259824663401
patients O 1 0.9997144341468811
. O 0 0.011593536473810673

There O 0 0.0053049661219120026
is O 0 0.003382432507351041
a O 0 0.005124368239194155
good O 0 0.007167843170464039
correlation O 0 0.021280735731124878
between O 0 0.005078272894024849
repeat O 0 0.04747075214982033
size O 0 0.00941306073218584
( O 0 0.00426684832200408
at O 0 0.00296966964378953
least O 0 0.004654969088733196
in O 0 0.003179834457114339
leucocytes O 1 0.9943916201591492
) O 0 0.00569569319486618
, O 0 0.004374954849481583
clinical O 1 0.9872905611991882
severity O 1 0.999525785446167
and O 0 0.0028274094220250845
age O 0 0.0111806346103549
of O 0 0.006629209965467453
onset O 1 0.9999740123748779
. O 0 0.016210313886404037

The O 0 0.021199844777584076
trinucleotide O 1 0.9959717392921448
repeat O 1 0.7245098352432251
instability O 1 0.9478205442428589
mechanisms O 0 0.0290976669639349
involved O 0 0.010761476121842861
in O 0 0.006210049614310265
DM B-Disease 1 0.9999603033065796
and O 0 0.002914736745879054
other O 0 0.002982723992317915
human O 0 0.4763043522834778
genetic B-Disease 1 0.9999881982803345
diseases I-Disease 1 0.9999992847442627
are O 0 0.0040860651060938835
unknown O 0 0.019419748336076736
. O 0 0.008936269208788872

We O 0 0.008603919297456741
studied O 0 0.017760781571269035
somatic O 1 0.8990302681922913
instability O 0 0.41416749358177185
by O 0 0.004453434143215418
measuring O 0 0.015438714995980263
the O 0 0.007241790648549795
CTG O 1 0.993617057800293
repeat O 0 0.10377057641744614
length O 0 0.010433549992740154
at O 0 0.0031374997925013304
several O 0 0.0021348237060010433
ages O 0 0.009455340914428234
in O 0 0.0017629796639084816
various O 0 0.0030647392850369215
tissues O 1 0.9461020231246948
of O 0 0.004275615327060223
transgenic O 1 0.9844472408294678
mice O 1 0.9985499978065491
carrying O 0 0.012233534827828407
a O 0 0.008108647540211678
( O 0 0.010727113112807274
CTG O 1 0.9766777753829956
) O 0 0.009434453211724758
55expansion O 1 0.9322241544723511
surrounded O 0 0.014757871627807617
by O 0 0.0038307381328195333
45 O 0 0.009640638716518879
kb O 0 0.03877623751759529
of O 0 0.0026083355769515038
the O 0 0.005013730376958847
human O 0 0.044242724776268005
DM B-Disease 1 0.9999771118164062
region O 0 0.014338863082230091
, O 0 0.0030143805779516697
using O 0 0.004186516162008047
small O 0 0.00928772334009409
- O 0 0.035902731120586395
pool O 0 0.05262765660881996
PCR O 0 0.13831257820129395
. O 0 0.016911907121539116

These O 0 0.009917685762047768
mice O 1 0.9935756325721741
have O 0 0.0029671506490558386
been O 0 0.002835906809195876
shown O 0 0.004389109555631876
to O 0 0.0018987138755619526
reproduce O 0 0.01947285607457161
the O 0 0.0040458147414028645
intergenerational O 0 0.3588741421699524
and O 0 0.004136499483138323
somatic O 1 0.9711238741874695
instability O 0 0.2332460731267929
of O 0 0.0025625377893447876
the O 0 0.0041048345156013966
55 O 0 0.0257557462900877
CTG O 1 0.9976750016212463
repeat O 0 0.19416551291942596
suggesting O 0 0.01643211767077446
that O 0 0.002491304185241461
surrounding O 0 0.009235712699592113
sequences O 0 0.014232168905436993
and O 0 0.0017040108796209097
the O 0 0.0035625125747174025
chromatin O 0 0.053189393132925034
environment O 0 0.007570122834295034
are O 0 0.0018002883298322558
involved O 0 0.006655226927250624
in O 0 0.004025727044790983
instability O 1 0.8539987802505493
mechanisms O 0 0.04919020086526871
. O 0 0.01360881607979536

As O 0 0.006259862799197435
observed O 0 0.009031330235302448
in O 0 0.001343308831565082
some O 0 0.0011208854848518968
of O 0 0.0012518508592620492
the O 0 0.003434098092839122
tissues O 1 0.9997521042823792
of O 0 0.013628126122057438
DM B-Disease 1 0.9999998807907104
patients O 1 0.9999816417694092
, O 0 0.0026802895590662956
there O 0 0.0022255522198975086
is O 0 0.002137671923264861
a O 0 0.0048774052411317825
tendency O 0 0.023748788982629776
for O 0 0.002423641039058566
repeat O 0 0.09883356094360352
length O 0 0.009138508699834347
and O 0 0.0033781160600483418
somatic O 1 0.9978873133659363
mosaicism O 1 0.9993857145309448
to O 0 0.0023620191495865583
increase O 0 0.004712304566055536
with O 0 0.0013704905286431313
the O 0 0.0018491256050765514
age O 0 0.005235937424004078
of O 0 0.0021806496661156416
the O 0 0.0069490643218159676
mouse O 1 0.9944329857826233
. O 0 0.012782488949596882

Furthermore O 0 0.022217165678739548
, O 0 0.002703307894989848
we O 0 0.0020242242608219385
observed O 0 0.007783341687172651
no O 0 0.00237002270296216
correlation O 0 0.013985282741487026
between O 0 0.002502264454960823
the O 0 0.004760684445500374
somatic O 1 0.99755859375
mutation O 1 0.9994694590568542
rate O 0 0.017507212236523628
and O 0 0.006194287911057472
tissue O 1 0.9995794892311096
proliferation O 0 0.04686853289604187
capacity O 0 0.013608437031507492
. O 0 0.010229519568383694

The O 0 0.01617061346769333
somatic O 1 0.99896240234375
mutation O 1 0.9998314380645752
rates O 0 0.013664172030985355
in O 0 0.0019810693338513374
different O 0 0.002940552309155464
tissues O 1 0.9959931373596191
were O 0 0.0011566255707293749
also O 0 0.0013159490190446377
not O 0 0.0014859311049804091
correlated O 0 0.016580071300268173
to O 0 0.001354897627606988
the O 0 0.0021867873147130013
relative O 0 0.012392226606607437
inter O 0 0.02440488524734974
- O 0 0.11114087700843811
tissue O 1 0.9985122084617615
difference O 0 0.009461116045713425
in O 0 0.003055642591789365
transcriptional O 0 0.057654205709695816
levels O 0 0.007257574237883091
of O 0 0.001646907883696258
the O 0 0.0021429748740047216
three O 0 0.003914236091077328
genes O 0 0.4220086932182312
( O 0 0.010256271809339523
DMAHP O 1 0.9990715980529785
, O 0 0.00619095703586936
DMPK O 1 0.9977009892463684
and O 0 0.003559977514669299
59 O 0 0.01630357839167118
) O 0 0.003930622711777687
surrounding O 0 0.00786276813596487
the O 0 0.004370618145912886
repeat O 0 0.046386875212192535
. O 0 0.005801462568342686
. O 0 0.008771509863436222

A O 0 0.02788427658379078
novel O 0 0.05231041461229324
missense O 1 0.9991204142570496
mutation O 1 0.9998239874839783
in O 0 0.006761765573173761
patients O 1 0.9991835951805115
from O 0 0.0045799077488482
a O 0 0.015331053175032139
retinoblastoma B-Disease 1 0.9998910427093506
pedigree O 1 0.9645736813545227
showing O 0 0.015666184946894646
only O 0 0.005051040090620518
mild O 1 0.9984645843505859
expression O 0 0.017277663573622704
of O 0 0.002706280443817377
the O 0 0.012110386975109577
tumor B-Disease 1 0.9999990463256836
phenotype O 1 0.9999277591705322
. O 0 0.015639090910553932

We O 0 0.005112759303301573
have O 0 0.002740708412602544
used O 0 0.0032847807742655277
single O 0 0.012042252346873283
strand O 0 0.06320124864578247
conformation O 0 0.30075913667678833
polymorphism O 0 0.08008194714784622
analysis O 0 0.006322067230939865
to O 0 0.0018460828578099608
study O 0 0.004437037277966738
the O 0 0.0027228568214923143
27 O 0 0.00969666987657547
exons O 0 0.043512336909770966
of O 0 0.0027361612301319838
the O 0 0.007232596632093191
RB1 O 1 0.9999566078186035
gene O 1 0.973471999168396
in O 0 0.0029307573568075895
individuals O 0 0.004535998217761517
from O 0 0.002396744443103671
a O 0 0.005067611113190651
family O 0 0.013384232297539711
showing O 0 0.04566916450858116
mild O 1 0.9993218183517456
expression O 0 0.018450522795319557
of O 0 0.003468327922746539
the O 0 0.012793621979653835
retinoblastoma B-Disease 1 0.9999926090240479
phenotype O 1 0.9999759197235107
. O 0 0.017028938978910446

In O 0 0.004476511385291815
this O 0 0.0034569797571748495
family O 0 0.016432862728834152
affected O 0 0.3773021101951599
individuals O 0 0.011233379133045673
developed O 0 0.22315581142902374
unilateral B-Disease 1 0.9993320107460022
tumors I-Disease 1 0.999997615814209
and O 0 0.0019753349479287863
, O 0 0.0012726450804620981
as O 0 0.0016208976740017533
a O 0 0.003884565085172653
result O 0 0.006107164081186056
of O 0 0.002283625304698944
linkage O 0 0.042749762535095215
analysis O 0 0.007439522072672844
, O 0 0.003817632095888257
unaffected O 1 0.9989995360374451
mutation O 1 0.9999256134033203
carriers O 0 0.47656404972076416
were O 0 0.0018668213160708547
also O 0 0.001688408083282411
identified O 0 0.007420321926474571
within O 0 0.003647551639005542
the O 0 0.004734780173748732
pedigree O 0 0.4943399131298065
. O 0 0.013502206653356552

A O 0 0.020378971472382545
single O 0 0.01679515652358532
band O 0 0.022029245272278786
shift O 0 0.023425452411174774
using O 0 0.009675582870841026
SSCP O 1 0.9887375831604004
was O 0 0.005805918946862221
identified O 0 0.00988761056214571
in O 0 0.0035615377128124237
exon O 0 0.16443036496639252
21 O 0 0.008579764515161514
which O 0 0.002345132874324918
resulted O 0 0.010227124206721783
in O 0 0.0021792431361973286
a O 0 0.009653826244175434
missense O 1 0.9989998936653137
mutation O 1 0.9987863898277283
converting O 0 0.023265188559889793
a O 0 0.01906050741672516
cys O 1 0.9940255880355835
- O 0 0.06950978189706802
- O 0 0.07114957273006439
> O 1 0.8981053829193115
arg O 1 0.8906700015068054
at O 0 0.009274044074118137
nucleotide O 0 0.045886434614658356
position O 0 0.007398471236228943
28 O 0 0.007926590740680695
in O 0 0.002385388594120741
the O 0 0.005665068048983812
exon O 1 0.6577869057655334
. O 0 0.014997845515608788

The O 0 0.014903716742992401
mutation O 1 0.9987332224845886
destroyed O 0 0.024849815294146538
an O 0 0.007159340661019087
NdeI O 1 0.9735890626907349
restriction O 0 0.06050558015704155
enzyme O 0 0.09224274009466171
site O 0 0.017830941826105118
. O 0 0.012349581345915794

Analysis O 0 0.00970977358520031
of O 0 0.0022185789421200752
all O 0 0.0017131565837189555
family O 0 0.007922951132059097
members O 0 0.0037377330008894205
demonstrated O 0 0.007313997019082308
that O 0 0.00162311305757612
the O 0 0.004744451958686113
missense O 1 0.9993056058883667
mutation O 1 0.9999291896820068
co O 0 0.058268602937459946
- O 0 0.04206284135580063
segregated O 0 0.06455309689044952
with O 0 0.008106215856969357
patients O 1 0.9999728202819824
with O 0 0.014502263627946377
tumors B-Disease 1 0.999998927116394
or O 0 0.005547983106225729
who O 0 0.0032893645111471415
, O 0 0.001427250448614359
as O 0 0.0012189651606604457
a O 0 0.0029106484726071358
result O 0 0.005708683282136917
of O 0 0.0020078630186617374
linkage O 0 0.08198872208595276
analysis O 0 0.006388550158590078
had O 0 0.0030962242744863033
been O 0 0.0028160212095826864
predicted O 0 0.008198326453566551
to O 0 0.0014628529315814376
carry O 0 0.005000516772270203
the O 0 0.005942342337220907
predisposing O 1 0.9975225329399109
mutation O 1 0.999535322189331
. O 0 0.017937131226062775

These O 0 0.004517583176493645
observations O 0 0.007342728320509195
point O 0 0.0032579887192696333
to O 0 0.0014238544972613454
another O 0 0.004381452687084675
region O 0 0.006574780214577913
of O 0 0.0021839712280780077
the O 0 0.008242512121796608
RB1 O 1 0.999950647354126
gene O 1 0.9939349293708801
where O 0 0.010805463418364525
mutations O 1 0.9980085492134094
only O 0 0.002991922665387392
modify O 0 0.01330787967890501
the O 0 0.002050785580649972
function O 0 0.005323871038854122
of O 0 0.0012844292214140296
the O 0 0.0030580100137740374
gene O 1 0.9304360747337341
and O 0 0.0014771507121622562
raise O 0 0.005960181821137667
important O 0 0.0021650728303939104
questions O 0 0.0036497514229267836
for O 0 0.0030124206095933914
genetic O 1 0.9906643629074097
counseling O 1 0.7395102381706238
in O 0 0.0021451294887810946
families O 0 0.004678796976804733
with O 0 0.0018752544419839978
these O 0 0.002660238416865468
distinctive O 1 0.7208459973335266
phenotypes O 1 0.9994995594024658
. O 0 0.005609209183603525
. O 0 0.007766706869006157

Maternal B-Disease 1 0.9964091181755066
disomy I-Disease 1 0.9977364540100098
and O 0 0.015694860368967056
Prader B-Disease 1 0.9999927282333374
- I-Disease 1 0.9995242357254028
Willi I-Disease 1 0.999998927116394
syndrome I-Disease 1 1.0
consistent O 0 0.03601149097084999
with O 0 0.009383175522089005
gamete O 1 0.9987517595291138
complementation O 1 0.999419093132019
in O 0 0.0035133857745677233
a O 0 0.005051953252404928
case O 0 0.006982817780226469
of O 0 0.00500203762203455
familial O 1 0.9999790191650391
translocation O 1 0.9981572031974792
( O 0 0.009766370058059692
3 O 0 0.008807741105556488
; O 0 0.004498849622905254
15 O 0 0.006023239344358444
) O 0 0.005163492169231176
( O 0 0.008724790066480637
p25 O 1 0.9899438619613647
; O 0 0.011071988381445408
q11 O 1 0.8924663662910461
. O 0 0.004822723101824522
2 O 0 0.011374039575457573
) O 0 0.006820607464760542
. O 0 0.009457042440772057

Maternal B-Disease 1 0.9993736147880554
uniparental I-Disease 1 0.999788224697113
disomy I-Disease 1 0.9985866546630859
( I-Disease 0 0.037316009402275085
UPD I-Disease 1 0.9993040561676025
) I-Disease 0 0.008798112161457539
for I-Disease 0 0.005877634510397911
chromosome I-Disease 1 0.9981620907783508
15 I-Disease 0 0.0072252764366567135
is O 0 0.0027681852225214243
responsible O 0 0.005894392728805542
for O 0 0.0013973468448966742
an O 0 0.0022203889675438404
estimated O 0 0.007926159538328648
30 O 0 0.004572281613945961
% O 0 0.0029431565199047327
of O 0 0.0017941257683560252
cases O 0 0.009210005402565002
of O 0 0.006893733516335487
Prader B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999135732650757
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.6439499258995056
PWS B-Disease 1 0.9999878406524658
) O 0 0.017668060958385468
. O 0 0.01261710561811924

We O 0 0.004462450742721558
report O 0 0.003693181090056896
on O 0 0.00199110503308475
an O 0 0.002546918811276555
unusual O 0 0.007747820112854242
case O 0 0.005064760334789753
of O 0 0.0032034118194133043
maternal B-Disease 1 0.9995893836021423
disomy I-Disease 1 0.996178388595581
15 I-Disease 0 0.011763215996325016
in O 0 0.005468618590384722
PWS B-Disease 1 0.9999833106994629
that O 0 0.002164170378819108
is O 0 0.002105859573930502
most O 0 0.001816247939132154
consistent O 0 0.005915388464927673
with O 0 0.0021522699389606714
adjacent O 0 0.010294070467352867
- O 0 0.018848687410354614
1 O 0 0.008325141854584217
segregation O 0 0.020069818943738937
of O 0 0.0024535227566957474
a O 0 0.011594405397772789
paternal O 1 0.9996048808097839
t O 1 0.9913243055343628
( O 0 0.007934540510177612
3 O 0 0.009118624962866306
; O 0 0.004438608884811401
15 O 0 0.007487725466489792
) O 0 0.005756666883826256
( O 0 0.009091503918170929
p25 O 1 0.986359179019928
; O 0 0.010003573261201382
q11 O 1 0.6444066762924194
. O 0 0.0030111719388514757
2 O 0 0.00485227070748806
) O 0 0.0025390353985130787
with O 0 0.002686446765437722
simultaneous O 0 0.0332806371152401
maternal O 1 0.9962549209594727
meiotic O 1 0.9990693926811218
nondisjunction O 1 0.992782473564148
for O 0 0.01304316334426403
chromosome O 1 0.9953279495239258
15 O 0 0.02026033028960228
. O 0 0.013744764029979706

The O 0 0.01688561588525772
patient O 1 0.9993027448654175
( O 0 0.017342738807201385
J O 1 0.9987977743148804
. O 0 0.005754498299211264
B O 0 0.03397196903824806
. O 0 0.0023810011334717274
) O 0 0.0024041023571044207
, O 0 0.0013202230911701918
a O 0 0.003571801818907261
17 O 0 0.00836437288671732
- O 0 0.013581203296780586
year O 0 0.007414729800075293
- O 0 0.01967947743833065
old O 0 0.013530060648918152
white O 0 0.01649590954184532
male O 0 0.03600545972585678
with O 0 0.006675371900200844
PWS B-Disease 1 0.9999923706054688
, O 0 0.0030552372336387634
was O 0 0.0029807593673467636
found O 0 0.003296667244285345
to O 0 0.0013101926306262612
have O 0 0.0023709170054644346
47 O 0 0.015526446513831615
chromosomes O 0 0.04171568155288696
with O 0 0.002381160855293274
a O 0 0.008451891131699085
supernumerary O 1 0.9924947023391724
, O 0 0.007819957099854946
paternal O 1 0.9958916902542114
der O 0 0.4538290202617645
( O 0 0.007556064985692501
15 O 0 0.005793977528810501
) O 0 0.00242876959964633
consisting O 0 0.0026244111359119415
of O 0 0.0011432796018198133
the O 0 0.002417796291410923
short O 0 0.009334109723567963
arm O 0 0.05832619220018387
and O 0 0.002423883182927966
the O 0 0.006676813121885061
proximal O 1 0.9998610019683838
long O 0 0.01766141690313816
arm O 0 0.1480945348739624
of O 0 0.006272403988987207
chromosome O 1 0.9997279047966003
15 O 0 0.008594183251261711
, O 0 0.0033420443069189787
and O 0 0.007070782594382763
distal O 1 0.9998606443405151
chromosome O 1 0.9995887875556946
arm O 1 0.9815850257873535
3p O 1 0.9423386454582214
. O 0 0.02131570130586624

The O 0 0.015848929062485695
t O 1 0.9299759268760681
( O 0 0.008662174455821514
3 O 0 0.009220995008945465
; O 0 0.004085533320903778
15 O 0 0.0050146267749369144
) O 0 0.0024742267560213804
was O 0 0.0018372217891737819
present O 0 0.001791569055058062
in O 0 0.0011330114211887121
the O 0 0.00156197149772197
balanced O 0 0.0057103075087070465
state O 0 0.0015332222683355212
in O 0 0.0017186906188726425
the O 0 0.004383949562907219
patients O 1 0.9999713897705078
father O 0 0.016582855954766273
and O 0 0.0022286931052803993
a O 0 0.008034233003854752
sister O 0 0.043911222368478775
. O 0 0.01182871125638485

Fluorescent O 0 0.13986054062843323
in O 0 0.00934536848217249
situ O 0 0.39218953251838684
hybridization O 0 0.05356486886739731
analysis O 0 0.009798707440495491
demonstrated O 0 0.010291029699146748
that O 0 0.0026939401868730783
the O 0 0.00675577949732542
PWS B-Disease 1 0.9998859167098999
critical O 0 0.022930795326828957
region O 0 0.012099210172891617
resided O 0 0.02200419083237648
on O 0 0.0026719344314187765
the O 0 0.005027285777032375
derivative O 0 0.3151876628398895
chromosome O 1 0.999229907989502
3 O 0 0.006209793500602245
and O 0 0.001174089964479208
that O 0 0.0010583240073174238
there O 0 0.0014397262129932642
was O 0 0.002614131662994623
no O 0 0.0032458940986543894
deletion O 0 0.2561485767364502
of O 0 0.0025524208322167397
the O 0 0.006226681638509035
PWS B-Disease 1 0.9999297857284546
region O 0 0.009907077997922897
on O 0 0.001842865371145308
the O 0 0.0026616493705660105
normal O 0 0.013262542895972729
pair O 0 0.007306128274649382
of O 0 0.0029263992328196764
15s O 1 0.988962709903717
present O 0 0.007687982637435198
in O 0 0.007159123197197914
J O 1 0.9979617595672607
. O 0 0.013581434264779091

B O 0 0.16419033706188202
. O 0 0.024654550477862358

Methylation O 0 0.09935494512319565
analysis O 0 0.016974398866295815
at O 0 0.007952893152832985
exon O 0 0.10320567339658737
alpha O 0 0.026341283693909645
of O 0 0.0019304289016872644
the O 0 0.0027555536944419146
small O 0 0.006513806991279125
nuclear O 0 0.013695924542844296
ribonucleoprotein O 1 0.9431639909744263
- O 0 0.038254689425230026
associated O 0 0.027075204998254776
polypeptide O 1 0.8617638945579529
N O 0 0.048481591045856476
( O 0 0.01442326046526432
SNRPN O 1 0.9941422343254089
) O 0 0.011365319602191448
gene O 0 0.49418410658836365
showed O 0 0.011520338244736195
a O 0 0.007099432405084372
pattern O 0 0.023431770503520966
characteristic O 0 0.0149906687438488
of O 0 0.001731005497276783
only O 0 0.002109937835484743
the O 0 0.005345798097550869
maternal O 1 0.9993987083435059
chromosome O 1 0.9994207620620728
15 O 0 0.012883289717137814
in O 0 0.007354969624429941
J O 1 0.9946637153625488
. O 0 0.013853169977664948

B O 0 0.16850276291370392
. O 0 0.025129450485110283

Maternal B-Disease 1 0.997126042842865
disomy I-Disease 1 0.9937723278999329
was O 0 0.009523834101855755
confirmed O 0 0.016711339354515076
by O 0 0.00796087272465229
polymerase O 1 0.5511971116065979
chain O 0 0.059417884796857834
reaction O 0 0.020132947713136673
analysis O 0 0.008605994284152985
of O 0 0.004734762478619814
microsatellite O 1 0.9756293892860413
repeats O 0 0.03972550481557846
at O 0 0.005420481786131859
the O 0 0.006783471442759037
gamma O 0 0.1996423751115799
- O 0 0.06352776288986206
aminobutyric O 1 0.9662883281707764
acid O 1 0.5885286331176758
receptor O 1 0.8978938460350037
beta3 O 1 0.9670295119285583
subunit O 0 0.17233572900295258
( O 0 0.024912670254707336
GABRB3 O 1 0.9832747578620911
) O 0 0.020320065319538116
locus O 1 0.9561417102813721
. O 0 0.016508003696799278

A O 0 0.03813553974032402
niece O 1 0.8852156400680542
( O 0 0.016072863712906837
B O 0 0.05039788782596588
. O 0 0.004780214745551348
B O 0 0.032056473195552826
. O 0 0.002265539485961199
) O 0 0.0026906493585556746
with O 0 0.0017510491888970137
45 O 0 0.007986159063875675
chromosomes O 0 0.032840583473443985
and O 0 0.00134950946085155
the O 0 0.003087014192715287
derivative O 0 0.025463148951530457
3 O 0 0.005221334286034107
but O 0 0.001840307842940092
without O 0 0.0038238130509853363
the O 0 0.004761188291013241
der O 0 0.2167438566684723
( O 0 0.00641900347545743
15 O 0 0.0072860559448599815
) O 0 0.004445362836122513
demonstrated O 0 0.011577515862882137
a O 0 0.011023049242794514
phenotype O 1 0.999754011631012
consistent O 0 0.010389119386672974
with O 0 0.0020008322317153215
that O 0 0.0018267023842781782
reported O 0 0.008176927454769611
for O 0 0.004358579404652119
haploinsufficiency O 1 0.9301449656486511
of O 0 0.008585944771766663
distal O 1 0.9997984766960144
3 O 0 0.028939396142959595
p O 0 0.06892676651477814
. O 0 0.012790929526090622

Uniparental B-Disease 1 0.9997170567512512
disomy I-Disease 1 0.9958454966545105
associated O 0 0.022063830867409706
with O 0 0.00544295459985733
unbalanced O 0 0.09943488985300064
segregation O 0 0.03363015875220299
of O 0 0.004066463094204664
non O 0 0.018793009221553802
- O 0 0.09881160408258438
Robertsonian O 1 0.9986119270324707
translocations O 1 0.9985184073448181
has O 0 0.005036988295614719
been O 0 0.003679970046505332
reported O 0 0.008541363291442394
previously O 0 0.004365701228380203
but O 0 0.0016168716829270124
has O 0 0.0019307862967252731
not O 0 0.001127472030930221
, O 0 0.0009193570585921407
to O 0 0.0010150210000574589
our O 0 0.002064213389530778
knowledge O 0 0.0030203594360500574
, O 0 0.0015062903985381126
been O 0 0.0026267662178725004
observed O 0 0.006996068637818098
in O 0 0.0015777323860675097
a O 0 0.004791798070073128
case O 0 0.008348767645657063
of O 0 0.008443661965429783
PWS B-Disease 1 0.9998904466629028
. O 0 0.020424136891961098

Furthermore O 0 0.019504327327013016
, O 0 0.0024649000260978937
our O 0 0.0031870324164628983
findings O 0 0.006012764759361744
are O 0 0.001005873316898942
best O 0 0.0028961997013539076
interpreted O 0 0.004828759003430605
as O 0 0.0025349208153784275
true O 0 0.01645502820611
gamete O 1 0.9890908598899841
complementation O 1 0.9981787204742432
resulting O 0 0.047213293612003326
in O 0 0.00983904954046011
maternal B-Disease 1 0.9991633892059326
UPD I-Disease 1 0.9998528957366943
15 I-Disease 0 0.02973775379359722
and O 0 0.017794020473957062
PWS B-Disease 1 0.9997894167900085

Schwartz B-Disease 1 0.9870961904525757
- I-Disease 1 0.9610852003097534
Jampel I-Disease 1 0.9998801946640015
syndrome I-Disease 1 0.9999998807907104
type I-Disease 0 0.20507608354091644
2 I-Disease 0 0.009114636108279228
and O 0 0.004023171961307526
Stuve B-Disease 1 0.9998782873153687
- I-Disease 1 0.9989136457443237
Wiedemann I-Disease 1 0.9999737739562988
syndrome I-Disease 1 0.9999998807907104
: O 0 0.005699791479855776
a O 0 0.004628479015082121
case O 0 0.004525125026702881
for O 0 0.0019637809600681067
" O 0 0.00616410281509161
lumping O 0 0.1356392800807953
" O 0 0.009391702711582184
. O 0 0.008608953095972538

Recent O 0 0.019956424832344055
studies O 0 0.009650522843003273
demonstrated O 0 0.00851432140916586
the O 0 0.0016513937152922153
existence O 0 0.0044314987026154995
of O 0 0.0016223544953390956
a O 0 0.005956888664513826
genetically O 0 0.1526084840297699
distinct O 0 0.013993233442306519
, O 0 0.0025218103546649218
usually O 0 0.006745743099600077
lethal O 0 0.1397096812725067
form O 0 0.004202245734632015
of O 0 0.0017230863450095057
the O 0 0.0038658082485198975
Schwartz B-Disease 1 0.9987068176269531
- I-Disease 1 0.9940348267555237
Jampel I-Disease 1 0.9999829530715942
syndrome I-Disease 1 1.0
( O 0 0.10137108713388443
SJS B-Disease 1 0.9999784231185913
) O 0 0.007220140658318996
of O 0 0.005718880798667669
myotonia B-Disease 1 0.9999957084655762
and O 0 0.012744287960231304
skeletal B-Disease 1 0.9999922513961792
dysplasia I-Disease 1 0.9999995231628418
, O 0 0.00350919459015131
which O 0 0.002526587573811412
we O 0 0.002999283606186509
called O 0 0.02143358439207077
SJS B-Disease 1 0.9999480247497559
type I-Disease 0 0.08546289056539536
2 I-Disease 0 0.019047513604164124
. O 0 0.011590815149247646

This O 0 0.02197035402059555
disorder O 1 0.9999879598617554
is O 0 0.006120350211858749
reminiscent O 0 0.019107790663838387
of O 0 0.0021870171185582876
another O 0 0.009845485910773277
rare O 1 0.5741921663284302
condition O 1 0.5451202392578125
, O 0 0.0022335548419505358
the O 0 0.006004509050399065
Stuve B-Disease 1 0.9998252987861633
- I-Disease 1 0.9981980919837952
Wiedemann I-Disease 1 0.9999645948410034
syndrome I-Disease 1 1.0
( O 0 0.06392902135848999
SWS B-Disease 1 0.9999586343765259
) O 0 0.006564056966453791
, O 0 0.002138477750122547
which O 0 0.0025247337762266397
comprises O 0 0.011097789742052555
campomelia B-Disease 1 0.8705471754074097
at O 0 0.005484468303620815
birth O 0 0.10582801699638367
with O 0 0.00876410398632288
skeletal B-Disease 1 0.9999945163726807
dysplasia I-Disease 1 1.0
, O 0 0.014401482418179512
contractures B-Disease 1 0.9999831914901733
, O 0 0.0032798105385154486
and O 0 0.0020860021468251944
early B-Disease 0 0.009611504152417183
death I-Disease 0 0.11484203487634659
. O 0 0.01153378002345562

To O 0 0.004556675907224417
test O 0 0.008645865134894848
for O 0 0.002487365622073412
possible O 0 0.009608772583305836
nosologic O 1 0.9487789273262024
identity O 0 0.012669172137975693
between O 0 0.003970555495470762
these O 0 0.004386870190501213
disorders O 1 0.9999973773956299
, O 0 0.0018483555177226663
we O 0 0.0012963579501956701
reviewed O 0 0.004311534576117992
the O 0 0.0013549956493079662
literature O 0 0.0025821637827903032
and O 0 0.0011212133103981614
obtained O 0 0.002565686358138919
a O 0 0.0033177270088344812
follow O 0 0.005124623887240887
- O 0 0.007070992607623339
up O 0 0.0018491579685360193
of O 0 0.0010118569480255246
the O 0 0.0014486449072137475
only O 0 0.0015510375378653407
two O 0 0.002285002265125513
surviving O 1 0.7996780276298523
patients O 1 0.9997743964195251
, O 0 0.002235585357993841
one O 0 0.0028850589878857136
with O 0 0.006222459953278303
SJS B-Disease 1 0.9999929666519165
type I-Disease 0 0.10523536056280136
2 I-Disease 0 0.0076095955446362495
at O 0 0.0034893814008682966
age O 0 0.007541096769273281
10 O 0 0.0038416588213294744
years O 0 0.002813096856698394
and O 0 0.0016113235615193844
another O 0 0.005654865875840187
with O 0 0.0051066214218735695
SWS B-Disease 1 0.9997512698173523
at O 0 0.0075748031958937645
age O 0 0.015851112082600594
7 O 0 0.013757471926510334
years O 0 0.007970567792654037
. O 0 0.011149758473038673

Patients O 1 0.9997121691703796
reported O 0 0.01720864698290825
as O 0 0.003332393243908882
having O 0 0.009179714135825634
either O 0 0.02369585819542408
neonatal O 1 0.9999984502792358
SJS B-Disease 1 0.9999969005584717
or O 0 0.021724460646510124
SWS B-Disease 1 0.9995831847190857
presented O 0 0.00808126013725996
a O 0 0.005174086894840002
combination O 0 0.011927248910069466
of O 0 0.0021294308826327324
a O 0 0.009363707154989243
severe O 1 0.9999722242355347
, O 0 0.008890662342309952
prenatal O 1 0.9999703168869019
- O 1 0.9997546076774597
onset O 1 0.9999998807907104
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.018539872020483017
with O 0 0.026160668581724167
congenital B-Disease 1 1.0
joint I-Disease 1 0.9991558790206909
contractures I-Disease 1 0.999998927116394
, O 0 0.1469755917787552
respiratory O 1 1.0
and O 0 0.005042520817369223
feeding O 1 0.99063640832901
difficulties O 1 0.6117216944694519
, O 0 0.0035215052776038647
tendency O 0 0.480331689119339
to O 0 0.004962607752531767
hyperthermia B-Disease 1 0.9999693632125854
, O 0 0.0032242094166576862
and O 0 0.0024716875050216913
frequent O 0 0.1719033569097519
death O 0 0.27516162395477295
in O 0 0.004239869304001331
infancy O 1 0.9705265164375305
) O 0 0.003305630059912801
with O 0 0.0019328200723975897
a O 0 0.005703167524188757
distinct O 0 0.030528955161571503
campomelic B-Disease 1 0.9996479749679565
- I-Disease 1 0.9564634561538696
metaphyseal I-Disease 1 0.9997194409370422
skeletal I-Disease 1 0.9998683929443359
dysplasia I-Disease 1 0.9999878406524658
. O 0 0.022096816450357437

The O 0 0.006145424209535122
similarity O 0 0.01742796041071415
of O 0 0.002087418921291828
the O 0 0.003814211580902338
clinical O 1 0.8321813941001892
and O 0 0.002977756317704916
radiographic O 1 0.9987713694572449
findings O 0 0.009403889067471027
is O 0 0.0023383675143122673
so O 0 0.0026521547697484493
extensive O 0 0.00745474873110652
that O 0 0.0015566821675747633
these O 0 0.00332841114141047
disorders O 1 0.9999979734420776
appear O 0 0.006406473461538553
to O 0 0.0015243153320625424
be O 0 0.0014616763219237328
a O 0 0.00487036257982254
single O 0 0.010928855277597904
entity O 0 0.027499966323375702
. O 0 0.01155178714543581

The O 0 0.006595340091735125
follow O 0 0.009379450231790543
- O 0 0.01492427010089159
up O 0 0.004529629368335009
observation O 0 0.009326391853392124
of O 0 0.0014351035933941603
an O 0 0.002017180435359478
identical O 0 0.006507302168756723
and O 0 0.0012553349370136857
unique O 0 0.005271385423839092
pattern O 0 0.018935177475214005
of O 0 0.005133110098540783
progressive O 1 0.9999743700027466
bone B-Disease 1 0.9999997615814209
dysplasia I-Disease 1 0.9999997615814209
in O 0 0.002336501609534025
the O 0 0.002247247379273176
two O 0 0.0030850486364215612
patients O 1 0.9998486042022705
( O 0 0.003925432916730642
one O 0 0.002561405533924699
with O 0 0.005950516555458307
SJS B-Disease 1 0.9999966621398926
type I-Disease 0 0.09519079327583313
2 I-Disease 0 0.006166279781609774
, O 0 0.0018484346801415086
one O 0 0.0031546016689389944
with O 0 0.00548371160402894
SWS B-Disease 1 0.9995982050895691
) O 0 0.008102488704025745
surviving O 0 0.02821238525211811
beyond O 0 0.017481982707977295
infancy O 1 0.9887087941169739
adds O 0 0.016808971762657166
to O 0 0.0017311457777395844
the O 0 0.0020673375111073256
evidence O 0 0.0030966438353061676
in O 0 0.0020419368520379066
favor O 0 0.006622506771236658
of O 0 0.0028789364732801914
identity O 0 0.019549928605556488
. O 0 0.009303641505539417

The O 0 0.009237109683454037
hypothesis O 0 0.03206055238842964
that O 0 0.006697452161461115
SWS B-Disease 1 0.9997379183769226
and O 0 0.011317899450659752
SJS B-Disease 1 0.9999911785125732
type I-Disease 0 0.07385559380054474
2 I-Disease 0 0.006021110340952873
are O 0 0.001069869613274932
the O 0 0.0024435671512037516
same O 0 0.008823719806969166
disorder O 1 0.9999957084655762
should O 0 0.003734747413545847
be O 0 0.0023642401210963726
testable O 0 0.023592717945575714
by O 0 0.004405072424560785
molecular O 0 0.022038143128156662
methods O 0 0.007920641452074051
. O 0 0.003879291471093893
. O 0 0.008464183658361435

A O 0 0.03454425558447838
mouse O 1 0.9212863445281982
model O 0 0.015383451245725155
of O 0 0.007626198697835207
severe O 1 0.9999983310699463
von B-Disease 1 0.999994158744812
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.2979902923107147
defects O 1 0.9999818801879883
in O 0 0.009718148969113827
hemostasis O 1 0.999982476234436
and O 0 0.01762840338051319
thrombosis B-Disease 1 0.9999980926513672
. O 0 0.02208671160042286

von B-Disease 1 0.9860383868217468
Willebrand I-Disease 1 0.9999594688415527
factor I-Disease 0 0.46066445112228394
( I-Disease 0 0.02774910442531109
vWf I-Disease 1 0.9961045980453491
) I-Disease 0 0.041508518159389496
deficiency I-Disease 1 0.9999990463256836
causes O 1 0.9999933242797852
severe O 1 0.9999996423721313
von B-Disease 1 0.999993085861206
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.010591150261461735
humans O 1 0.9473183155059814
. O 0 0.0120976148173213

We O 0 0.007451765239238739
generated O 0 0.016780942678451538
a O 0 0.010604850016534328
mouse O 1 0.8908271789550781
model O 0 0.00948272179812193
for O 0 0.0023231878876686096
this O 0 0.005927839316427708
disease O 1 0.9999929666519165
by O 0 0.00496953260153532
using O 0 0.010236120782792568
gene O 1 0.8368430137634277
targeting O 0 0.03378666937351227
. O 0 0.012282706797122955

vWf B-Disease 1 0.9977412223815918
- I-Disease 1 0.7466237545013428
deficient I-Disease 1 0.9965565204620361
mice O 1 0.9968005418777466
appeared O 0 0.017287949100136757
normal O 0 0.021993082016706467
at O 0 0.006083934102207422
birth O 0 0.2834702730178833
; O 0 0.0033694617450237274
they O 0 0.001394946244545281
were O 0 0.0017694983398541808
viable O 0 0.01898346282541752
and O 0 0.004566592629998922
fertile O 0 0.07190948724746704
. O 0 0.011585560627281666

Neither O 0 0.07026246935129166
vWf O 1 0.9926929473876953
nor O 0 0.05166025459766388
vWf O 1 0.997825562953949
propolypeptide O 1 0.9963853359222412
( O 0 0.02407963015139103
von B-Disease 1 0.9934834837913513
Willebrand I-Disease 1 0.999995231628418
antigen O 1 0.9997487664222717
II O 1 0.806425154209137
) O 0 0.00448435777798295
were O 0 0.0021515542175620794
detectable O 0 0.34397509694099426
in O 0 0.003367394907400012
plasma O 0 0.03464536741375923
, O 0 0.004566618707031012
platelets O 1 0.9981845021247864
, O 0 0.0031678425148129463
or O 0 0.006580432411283255
endothelial O 1 0.9998171925544739
cells O 0 0.24513868987560272
of O 0 0.003227551933377981
the O 0 0.008185269311070442
homozygous O 1 0.9979016780853271
mutant O 1 0.997229278087616
mice O 1 0.9944827556610107
. O 0 0.021412812173366547

The O 0 0.01734621822834015
mutant O 1 0.9992478489875793
mice O 1 0.9997212290763855
exhibited O 1 0.869856059551239
defects O 1 0.9998865127563477
in O 0 0.005169594194740057
hemostasis O 1 0.9998056292533875
with O 0 0.003729719202965498
a O 0 0.009945813566446304
highly O 0 0.036055177450180054
prolonged O 1 0.9999215602874756
bleeding O 1 0.9999977350234985
time O 0 0.008273511193692684
and O 0 0.004703931976109743
spontaneous O 1 0.9993730187416077
bleeding O 1 0.9999966621398926
events O 0 0.006769680883735418
in O 0 0.002339483704417944
approximately O 0 0.005699559114873409
10 O 0 0.004339723382145166
% O 0 0.0053357346914708614
of O 0 0.005480706226080656
neonates O 1 0.999515175819397
. O 0 0.01467417273670435

As O 0 0.0052934493869543076
in O 0 0.0025117790792137384
the O 0 0.005086531396955252
human O 1 0.8415595889091492
disease O 1 0.9999985694885254
, O 0 0.0027856763917952776
the O 0 0.003487304551526904
factor O 0 0.34540727734565735
VIII O 1 0.9979978203773499
level O 0 0.00474081514403224
in O 0 0.0017042818944901228
these O 0 0.0024436074309051037
mice O 1 0.998021125793457
was O 0 0.005261340644210577
reduced O 0 0.01431061327457428
strongly O 0 0.0051859160885214806
as O 0 0.0013863316271454096
a O 0 0.0030844470020383596
result O 0 0.004334147088229656
of O 0 0.0013263487489894032
the O 0 0.0017813327722251415
lack O 0 0.006446593441069126
of O 0 0.002434148220345378
protection O 0 0.0118614062666893
provided O 0 0.006437284871935844
by O 0 0.009473593905568123
vWf O 1 0.9908682107925415
. O 0 0.01745431497693062

Defective O 1 0.9998359680175781
thrombosis B-Disease 1 0.9999951124191284
in O 0 0.01855655200779438
mutant O 1 0.9997993111610413
mice O 1 0.9989959597587585
was O 0 0.005263613071292639
also O 0 0.002314414829015732
evident O 0 0.009692530147731304
in O 0 0.001630541868507862
an O 0 0.0019626093562692404
in O 0 0.003361891023814678
vivo O 0 0.16904757916927338
model O 0 0.013097187504172325
of O 0 0.01080843061208725
vascular B-Disease 1 0.9999995231628418
injury I-Disease 1 0.9999040365219116
. O 0 0.016895577311515808

In O 0 0.004272102378308773
this O 0 0.0027885797899216413
model O 0 0.006478971801698208
, O 0 0.0023032482713460922
the O 0 0.004379441495984793
exteriorized O 1 0.9966750144958496
mesentery O 1 0.9965298771858215
was O 0 0.014395000413060188
superfused O 1 0.9683494567871094
with O 0 0.010431683622300625
ferric O 1 0.9951752424240112
chloride O 0 0.06012685224413872
and O 0 0.002131508896127343
the O 0 0.0033825356513261795
accumulation O 0 0.04596175253391266
of O 0 0.006242424715310335
fluorescently O 1 0.9983526468276978
labeled O 1 0.7950984239578247
platelets O 1 0.9956264495849609
was O 0 0.010005580261349678
observed O 0 0.017597133293747902
by O 0 0.009078703820705414
intravital O 1 0.9838295578956604
microscopy O 0 0.07230369746685028
. O 0 0.014777559787034988

We O 0 0.005867112893611193
conclude O 0 0.0123281953856349
that O 0 0.0023757154121994972
these O 0 0.0030158322770148516
mice O 1 0.9933683276176453
very O 0 0.007480003405362368
closely O 0 0.01522092055529356
mimic O 1 0.999538779258728
severe O 1 0.9999843835830688
human O 1 0.9899411797523499
von B-Disease 1 0.9999924898147583
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0024603381752967834
will O 0 0.001472266623750329
be O 0 0.0011676891008391976
very O 0 0.0019248612225055695
useful O 0 0.002805823227390647
for O 0 0.001421033521182835
investigating O 0 0.007771898526698351
the O 0 0.0024667587131261826
role O 0 0.006170573644340038
of O 0 0.003392887534573674
vWf O 1 0.9919232726097107
in O 0 0.003841711673885584
normal O 0 0.03196077048778534
physiology O 1 0.843981921672821
and O 0 0.002513191429898143
in O 0 0.005942815449088812
disease O 1 0.9999985694885254
models O 0 0.015494313091039658
. O 0 0.004714606329798698
. O 0 0.007785404566675425

Oral O 0 0.22590728104114532
contraceptives O 0 0.34285226464271545
and O 0 0.002727270359173417
the O 0 0.00491012167185545
risk O 1 0.9844642281532288
of O 0 0.011683216318488121
hereditary B-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.018895898014307022

Hereditary B-Disease 1 0.9999954700469971
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999991655349731
Clinical O 1 0.9961710572242737
Study O 0 0.02027212642133236
Group O 0 0.016568701714277267
. O 0 0.011234740726649761

BACKGROUND O 0 0.037377532571554184
Women O 0 0.013747582212090492
with O 0 0.0057110413908958435
mutations O 1 0.9992148876190186
in O 0 0.002207504352554679
either O 0 0.00489142257720232
the O 0 0.006815438158810139
BRCA1 O 1 0.9999735355377197
or O 0 0.007014906965196133
the O 0 0.008881825953722
BRCA2 O 1 0.9999964237213135
gene O 1 0.9933585524559021
have O 0 0.002883734181523323
a O 0 0.005417608190327883
high O 0 0.009991873055696487
lifetime O 1 0.710324227809906
risk O 1 0.996206521987915
of O 0 0.0542900487780571
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.017793819308280945

Oral O 1 0.5068838596343994
contraceptives O 1 0.989845871925354
protect O 0 0.49185043573379517
against O 1 0.9425623416900635
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.0031644715927541256
general O 0 0.004094566684216261
, O 0 0.0013550769072026014
but O 0 0.0012262400705367327
it O 0 0.0008840716327540576
is O 0 0.001095427549444139
not O 0 0.0008677205187268555
known O 0 0.0027622852940112352
whether O 0 0.0018005368765443563
they O 0 0.0010016612941399217
also O 0 0.0015639517223462462
protect O 0 0.007939564064145088
against O 0 0.005960159469395876
hereditary B-Disease 1 0.9994885921478271
forms I-Disease 0 0.016798701137304306
of I-Disease 0 0.050788652151823044
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.01922101341187954

METHODS O 0 0.01910623349249363
We O 0 0.00515872985124588
enrolled O 0 0.02324693091213703
207 O 0 0.3191129267215729
women O 0 0.012311798520386219
with O 0 0.010224001482129097
hereditary B-Disease 1 0.9999988079071045
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.003795995144173503
161 O 0 0.01756027527153492
of O 0 0.0017041731625795364
their O 0 0.002109352732077241
sisters O 0 0.01356907282024622
as O 0 0.0016101625515148044
controls O 0 0.009173695929348469
in O 0 0.001665771589614451
a O 0 0.005651396699249744
case O 0 0.007772243116050959
- O 0 0.020607957616448402
control O 0 0.01990056410431862
study O 0 0.01303066685795784
. O 0 0.010762796737253666

All O 0 0.004171957261860371
the O 0 0.006573123391717672
patients O 1 0.9992499947547913
carried O 0 0.009636122733354568
a O 0 0.013260471634566784
pathogenic O 1 0.9990214109420776
mutation O 1 0.9989699125289917
in O 0 0.006219191011041403
either O 0 0.01749970018863678
BRCA1 O 1 0.9999771118164062
( O 0 0.012927298434078693
179 O 0 0.043815430253744125
women O 0 0.012987733818590641
) O 0 0.006701177451759577
or O 0 0.01341204158961773
BRCA2 O 1 0.9999710321426392
( O 0 0.015053137205541134
28 O 0 0.01656421087682247
women O 0 0.011582710780203342
) O 0 0.008155331015586853
. O 0 0.010587828233838081

The O 0 0.0080359922721982
control O 0 0.01705213263630867
women O 0 0.0070634507574141026
were O 0 0.00167650799266994
enrolled O 0 0.013755813241004944
regardless O 0 0.006197247188538313
of O 0 0.0013211084296926856
whether O 0 0.002434679539874196
or O 0 0.0020592499058693647
not O 0 0.000962324847932905
they O 0 0.001222604769282043
had O 0 0.00407077930867672
either O 0 0.010134140960872173
mutation O 1 0.9972022771835327
. O 0 0.014850989915430546

Lifetime O 0 0.06131373345851898
histories O 0 0.029479483142495155
of O 0 0.004564832895994186
oral O 1 0.8166118860244751
- O 1 0.5139967799186707
contraceptive O 1 0.997363269329071
use O 0 0.0028360821306705475
were O 0 0.0011932560009881854
obtained O 0 0.002916600788012147
by O 0 0.0024611656554043293
interview O 0 0.006850480102002621
or O 0 0.002531621605157852
by O 0 0.001993298763409257
written O 0 0.0030516290571540594
questionnaire O 0 0.015868280082941055
and O 0 0.0012262511299923062
were O 0 0.0012161943595856428
compared O 0 0.00795354787260294
between O 0 0.004958475008606911
patients O 1 0.9997435212135315
and O 0 0.001974172657355666
control O 0 0.02524060755968094
women O 0 0.006700583733618259
, O 0 0.0017671054229140282
after O 0 0.005160601809620857
adjustment O 0 0.013903195038437843
for O 0 0.0016116135520860553
year O 0 0.0036199961323291063
of O 0 0.0025381732266396284
birth O 0 0.04470495134592056
and O 0 0.0027884538285434246
parity O 0 0.03842226415872574
. O 0 0.009102430194616318

RESULTS O 0 0.022558311000466347
The O 0 0.0070280092768371105
adjusted O 0 0.02733776532113552
odds O 0 0.04809176176786423
ratio O 0 0.04201081767678261
for O 0 0.02470855601131916
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
associated O 0 0.010129536502063274
with O 0 0.0013981455704197288
any O 0 0.0014821590157225728
past O 0 0.0028763888403773308
use O 0 0.002158181741833687
of O 0 0.0024815695360302925
oral O 0 0.3877207636833191
contraceptives O 1 0.9887097477912903
was O 0 0.008811554871499538
0 O 0 0.02395130880177021
. O 0 0.009870870970189571

5 O 0 0.02246173284947872
( O 0 0.008818075060844421
95 O 0 0.013782317750155926
percent O 0 0.009662342257797718
confidence O 0 0.014674372039735317
interval O 0 0.02533012069761753
, O 0 0.003907237201929092
0 O 0 0.012624550610780716
. O 0 0.0022929846309125423
3 O 0 0.005280086304992437
to O 0 0.002349152462556958
0 O 0 0.01401063334196806
. O 0 0.0032022411469370127
8 O 0 0.010017693042755127
) O 0 0.006090243346989155
. O 0 0.007747758645564318

The O 0 0.01134699396789074
risk O 1 0.9879931211471558
decreased O 1 0.5116363763809204
with O 0 0.003064963733777404
increasing O 0 0.01087468396872282
duration O 0 0.01806648075580597
of O 0 0.0016782463062554598
use O 0 0.0030341160017997026
( O 0 0.0057939887046813965
P O 0 0.04764688387513161
for O 0 0.002926829271018505
trend O 0 0.023513371124863625
, O 0 0.006157026160508394
< O 1 0.5904121994972229
0 O 0 0.020414941012859344
. O 0 0.005053984001278877
001 O 1 0.5047881603240967
) O 0 0.004155122675001621
; O 0 0.0023423703387379646
use O 0 0.001520980498753488
for O 0 0.0009446217445656657
six O 0 0.002249297918751836
or O 0 0.002229194389656186
more O 0 0.001608438091352582
years O 0 0.002350358758121729
was O 0 0.0032457474153488874
associated O 0 0.005109037272632122
with O 0 0.0019859473686665297
a O 0 0.004434370901435614
60 O 0 0.008624686859548092
percent O 0 0.008526821620762348
reduction O 0 0.01996087096631527
in O 0 0.005076551344245672
risk O 1 0.896609365940094
. O 0 0.01067876536399126

Oral O 0 0.32912638783454895
- O 0 0.0809786468744278
contraceptive O 1 0.9093720316886902
use O 0 0.01049690879881382
protected O 0 0.049640148878097534
against O 0 0.26712512969970703
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
both O 0 0.0038235171232372522
for O 0 0.0025772489607334137
carriers O 0 0.02182777039706707
of O 0 0.002589276758953929
the O 0 0.010653887875378132
BRCA1 O 1 0.9999970197677612
mutation O 1 0.999947190284729
( O 0 0.01345735788345337
odds O 0 0.04031069204211235
ratio O 0 0.02122195065021515
, O 0 0.0028786244802176952
0 O 0 0.010350103490054607
. O 0 0.002039885614067316
5 O 0 0.005063933786004782
; O 0 0.0030323434621095657
95 O 0 0.009103694930672646
percent O 0 0.006984028033912182
confidence O 0 0.01272336021065712
interval O 0 0.021006453782320023
, O 0 0.002923285821452737
0 O 0 0.01017997320741415
. O 0 0.0018914047395810485
3 O 0 0.004965960048139095
to O 0 0.002538441214710474
0 O 0 0.011701432056725025
. O 0 0.002380446530878544
9 O 0 0.005791511386632919
) O 0 0.002214224776253104
and O 0 0.0009860735153779387
for O 0 0.0017961029661819339
carriers O 0 0.018866335973143578
of O 0 0.002644557738676667
the O 0 0.010192189365625381
BRCA2 O 1 0.9999984502792358
mutation O 1 0.999945878982544
( O 0 0.013816035352647305
odds O 0 0.05820532515645027
ratio O 0 0.02291720360517502
, O 0 0.0036392337642610073
0 O 0 0.012672601267695427
. O 0 0.0026060380041599274
4 O 0 0.006429643835872412
; O 0 0.0036611384712159634
95 O 0 0.009785442613065243
percent O 0 0.008077102713286877
confidence O 0 0.014176503755152225
interval O 0 0.022921118885278702
, O 0 0.003084458876401186
0 O 0 0.0110630476847291
. O 0 0.0018792821792885661
2 O 0 0.004139173775911331
to O 0 0.0019320648862048984
1 O 0 0.005835324991494417
. O 0 0.0025982672814279795
1 O 0 0.008261875249445438
) O 0 0.0049047209322452545
. O 0 0.007092257030308247

CONCLUSIONS O 0 0.04686621204018593
Oral O 0 0.17289893329143524
- O 0 0.08904451876878738
contraceptive O 1 0.9963108897209167
use O 0 0.006009989883750677
may O 0 0.007010003086179495
reduce O 0 0.012901706621050835
the O 0 0.0044188168831169605
risk O 1 0.9760814309120178
of O 0 0.025503115728497505
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.004708240740001202
women O 0 0.010128914378583431
with O 0 0.006115928292274475
pathogenic O 1 0.9996423721313477
mutations O 1 0.9992984533309937
in O 0 0.003975489642471075
the O 0 0.008886964991688728
BRCA1 O 1 0.9999915361404419
or O 0 0.07624571025371552
BRCA2 O 1 0.9999924898147583
gene O 1 0.9957120418548584

A O 0 0.020198866724967957
Japanese O 0 0.016360295936465263
family O 0 0.015937741845846176
with O 0 0.007904564961791039
adrenoleukodystrophy B-Disease 1 0.9999669790267944
with O 0 0.006062059663236141
a O 0 0.01455493550747633
codon O 1 0.6229947209358215
291 O 1 0.5194023847579956
deletion O 1 0.9788605570793152
: O 0 0.007192698307335377
a O 0 0.009148700162768364
clinical O 1 0.6812653541564941
, O 0 0.0037453442346304655
biochemical O 0 0.1462271809577942
, O 0 0.003612199332565069
pathological O 1 0.9811730980873108
, O 0 0.002602779073640704
and O 0 0.0027044201269745827
genetic O 1 0.66664057970047
report O 0 0.009251329116523266
. O 0 0.008755450136959553

We O 0 0.0055747684091329575
report O 0 0.004420474637299776
a O 0 0.005989884026348591
Japanese O 0 0.010326447896659374
family O 0 0.01836285926401615
with O 0 0.012741155922412872
adrenoleukodystrophy B-Disease 1 0.9999980926513672
( O 0 0.06873977929353714
ALD B-Disease 1 0.9999963045120239
) O 0 0.00555439805611968
with O 0 0.001708768424578011
a O 0 0.003258500946685672
three O 0 0.0028531840071082115
base O 0 0.010731496848165989
pair O 0 0.018444078043103218
deletion O 1 0.9917885661125183
( O 0 0.015245520509779453
delGAG O 1 0.9828521609306335
291 O 0 0.07201141119003296
) O 0 0.0064689419232308865
in O 0 0.003982194233685732
the O 0 0.014259067364037037
ALD B-Disease 1 0.9999871253967285
gene O 1 0.993690013885498
. O 0 0.016909204423427582

A O 0 0.018794381991028786
variety O 0 0.00932098738849163
of O 0 0.004725143313407898
phenotypes O 1 0.9981653094291687
were O 0 0.00317520834505558
observed O 0 0.009182507172226906
within O 0 0.0032376847229897976
this O 0 0.0030790898017585278
family O 0 0.016890238970518112
. O 0 0.010929939337074757

While O 0 0.008607991971075535
the O 0 0.007036573253571987
proband O 1 0.9968369007110596
( O 0 0.015342107973992825
patient O 1 0.9987834095954895
1 O 0 0.010230841115117073
) O 0 0.0032386945094913244
was O 0 0.0027392490301281214
classified O 0 0.005953326355665922
as O 0 0.001745517598465085
having O 0 0.004832254722714424
a O 0 0.00571737764403224
rare O 0 0.016922255977988243
intermediate O 0 0.017908014357089996
type O 0 0.01709599606692791
of O 0 0.003641708754003048
adult O 1 0.8979517817497253
cerebral O 1 0.9999713897705078
and O 0 0.006423782557249069
cerebello O 1 0.9998632669448853
- O 1 0.9976674914360046
brain O 1 0.9999898672103882
stem O 1 0.9813636541366577
forms O 0 0.00941554643213749
, O 0 0.002314527053385973
his O 0 0.004659406840801239
younger O 1 0.5546833872795105
brother O 0 0.35243791341781616
( O 0 0.011910289525985718
patient O 1 0.9976728558540344
2 O 0 0.00781622901558876
) O 0 0.003411069978028536
and O 0 0.002366140717640519
nephew O 1 0.8351944088935852
( O 0 0.010502386838197708
patient O 1 0.9987030029296875
3 O 0 0.0084924828261137
) O 0 0.003570638131350279
had O 0 0.0043526277877390385
a O 0 0.012955781072378159
childhood O 1 0.9995569586753845
ALD B-Disease 1 0.999997615814209
type O 1 0.6638844013214111
. O 0 0.016692059114575386

Another O 0 0.034675680100917816
nephew O 1 0.9310188889503479
( O 0 0.015078618191182613
patient O 1 0.9950944185256958
4 O 0 0.00998543668538332
) O 0 0.0031363307498395443
of O 0 0.002953606890514493
patient O 1 0.9966057538986206
1 O 0 0.00673894165083766
was O 0 0.0036286332178860903
classified O 0 0.006696066353470087
as O 0 0.0020537544041872025
having O 0 0.0060951984487473965
an O 0 0.0049917553551495075
adolescent O 1 0.99899822473526
form O 0 0.01687723584473133
. O 0 0.010803023353219032

The O 0 0.010900872759521008
tau O 0 0.39430248737335205
level O 0 0.007478067651391029
in O 0 0.0031524982769042253
the O 0 0.006820149254053831
cerebrospinal O 1 0.999930739402771
fluid O 1 0.9919581413269043
( O 0 0.01588660106062889
CSF O 1 0.9987504482269287
) O 0 0.0052808974869549274
in O 0 0.0038173305802047253
patient O 1 0.9973573088645935
1 O 0 0.005752405617386103
was O 0 0.0023959316313266754
as O 0 0.0013155625201761723
high O 0 0.0028964392840862274
as O 0 0.0011522070271894336
that O 0 0.00100564060267061
of O 0 0.003063282696530223
patients O 1 0.9999613761901855
with O 0 0.17012335360050201
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
( O 0 0.023582445457577705
AD B-Disease 0 0.13777120411396027
) O 0 0.011017612181603909
. O 0 0.010240388102829456

His O 0 0.028447138145565987
brain O 1 0.9992278814315796
magnetic O 0 0.041163332760334015
resonance O 0 0.06426294147968292
image O 0 0.047150980681180954
( O 0 0.015901213511824608
MRI O 1 0.9973288774490356
) O 0 0.007746079470962286
showed O 0 0.016981137916445732
abnormalities B-Disease 1 0.9994615912437439
in I-Disease 0 0.002117669442668557
the I-Disease 0 0.0036872797645628452
bilateral I-Disease 0 0.01680920086801052
cerebellar I-Disease 1 0.9999281167984009
hemispheres I-Disease 1 0.9983060359954834
and O 0 0.011177192442119122
brain O 1 0.9999985694885254
stem O 1 0.9974518418312073
, O 0 0.0018989985110238194
but O 0 0.0014026165008544922
not O 0 0.0010530529543757439
in O 0 0.001539576449431479
the O 0 0.005805415101349354
cerebral O 1 0.9999974966049194
white O 0 0.01568591222167015
matter O 0 0.004280384164303541
, O 0 0.00157346879132092
where O 0 0.002584761241450906
marked O 0 0.01006865780800581
reductions O 0 0.010832776315510273
of O 0 0.0021502093877643347
the O 0 0.006529157515615225
cerebral O 1 0.9999972581863403
blood O 1 0.9991426467895508
flow O 0 0.017308950424194336
and O 0 0.0038249415811151266
oxygen O 1 0.6925714015960693
metabolism O 1 0.9806296229362488
were O 0 0.002531458158046007
clearly O 0 0.008100091479718685
demonstrated O 0 0.01523695420473814
by O 0 0.007901801727712154
positron O 1 0.9852761626243591
emission O 0 0.10833355039358139
tomography O 1 0.8681329488754272
( O 0 0.021013231948018074
PET O 1 0.9917728304862976
) O 0 0.010876841843128204
. O 0 0.009004948660731316

In O 0 0.015395266003906727
patients O 1 0.9989527463912964
2 O 0 0.008944639936089516
and O 0 0.002004055306315422
3 O 0 0.005017791874706745
, O 0 0.0016399768646806479
the O 0 0.0028935198206454515
autopsy O 0 0.22509394586086273
findings O 0 0.014462227001786232
showed O 0 0.017393160611391068
massive O 1 0.7910910248756409
demyelination B-Disease 1 0.9999486207962036
of I-Disease 0 0.004461618606001139
the I-Disease 0 0.01014567632228136
cerebral I-Disease 1 0.9999940395355225
white I-Disease 0 0.01573982648551464
matter I-Disease 0 0.004554189275950193
with O 0 0.0025849826633930206
sparing O 0 0.10356604307889938
of O 0 0.0021587014198303223
the O 0 0.005328112281858921
U O 1 0.8571965098381042
- O 0 0.1514226347208023
fibers O 0 0.40107735991477966
, O 0 0.0027383139822632074
compatible O 0 0.008789671584963799
with O 0 0.0016112177399918437
the O 0 0.0023717270232737064
findings O 0 0.010939886793494225
of O 0 0.0063699656166136265
childhood O 1 0.9997605681419373
ALD B-Disease 1 0.9999935626983643
. O 0 0.02402416430413723

Oleic O 1 0.8433791399002075
and O 0 0.01500951498746872
erucic O 1 0.9880552887916565
acids O 0 0.06985286623239517
( O 0 0.013330653309822083
Lorenzos O 1 0.6680833101272583
Oil O 0 0.013831129297614098
) O 0 0.003996406216174364
were O 0 0.0017969992477446795
administered O 0 0.016917839646339417
to O 0 0.00405089883133769
patients O 1 0.9993663430213928
1 O 0 0.006093153730034828
and O 0 0.001524668768979609
4 O 0 0.004739078227430582
, O 0 0.001353123807348311
but O 0 0.0020043211989104748
sufficient O 0 0.007581290323287249
effectiveness O 0 0.024377992376685143
was O 0 0.00441755773499608
not O 0 0.0028739667031913996
obtained O 0 0.008203809149563313
. O 0 0.010546288453042507

The O 0 0.006352616939693689
findings O 0 0.009854651056230068
in O 0 0.0019407811341807246
this O 0 0.001991103170439601
family O 0 0.008453261107206345
suggest O 0 0.007314007263630629
that O 0 0.0023684222251176834
delGAG291 O 1 0.9740296006202698
is O 0 0.002488879719749093
part O 0 0.0022833526600152254
of O 0 0.0012811718042939901
the O 0 0.0028546710964292288
cause O 0 0.2550296485424042
of O 0 0.0032415895257145166
Japanese O 0 0.13734543323516846
ALD B-Disease 1 0.9999974966049194
with O 0 0.011304114945232868
phenotypic O 1 0.9943295121192932
variations O 0 0.032239045947790146
. O 0 0.009569322690367699

Moreover O 0 0.025958608835935593
, O 0 0.003115507774055004
although O 0 0.0027585297357290983
the O 0 0.0017430277075618505
scale O 0 0.005719718523323536
of O 0 0.001215111231431365
the O 0 0.0017656080890446901
study O 0 0.004402626305818558
is O 0 0.0024868668988347054
limited O 0 0.0038879725616425276
, O 0 0.0010915725724771619
there O 0 0.001235390780493617
is O 0 0.00149429717566818
a O 0 0.003318596165627241
possibility O 0 0.008202669210731983
that O 0 0.0027351086027920246
PET O 1 0.9978664517402649
can O 0 0.005251485854387283
detect O 0 0.07276200503110886
an O 0 0.0070462943986058235
insidious B-Disease 1 0.999897837638855
lesion I-Disease 1 0.9999687671661377
which O 0 0.0036631689872592688
is O 0 0.0040159327909350395
undetectable O 1 0.970808744430542
by O 0 0.006268578115850687
computed O 0 0.08265545219182968
tomogram O 1 0.9961467981338501
( O 0 0.01589115709066391
CT O 1 0.9994126558303833
) O 0 0.006097735371440649
or O 0 0.0058138868771493435
MRI O 1 0.991134524345398
analysis O 0 0.005366825498640537
, O 0 0.0014300006441771984
and O 0 0.0008198930299840868
that O 0 0.0009456844418309629
the O 0 0.0016545627731829882
higher O 0 0.003970534540712833
level O 0 0.0035928545985370874
of O 0 0.0025731066707521677
tau O 1 0.7686825394630432
reflects O 0 0.009839379228651524
the O 0 0.00239940476603806
process O 0 0.004581249784678221
of O 0 0.005624375771731138
neuronal B-Disease 1 0.999316930770874
degeneration I-Disease 1 0.9999977350234985
in O 0 0.020111745223402977
ALD B-Disease 1 0.9999932050704956
. O 0 0.02035779133439064

Lorenzos O 1 0.9690620303153992
Oil O 0 0.013559565879404545
should O 0 0.0030340421944856644
be O 0 0.0013469632249325514
given O 0 0.002127378946170211
in O 0 0.0012963111512362957
the O 0 0.0024447771720588207
early O 0 0.007801436353474855
stage O 0 0.015492996200919151
. O 0 0.0044551026076078415
. O 0 0.008048636838793755

Nonsense O 0 0.48146921396255493
mutation O 1 0.996560275554657
in O 0 0.006971215363591909
exon O 0 0.17556039988994598
4 O 0 0.009068508632481098
of O 0 0.002947799162939191
human O 0 0.01730930618941784
complement O 0 0.05055903270840645
C9 O 1 0.9997431635856628
gene O 1 0.9901780486106873
is O 0 0.0031316441018134356
the O 0 0.002517460146918893
major O 0 0.008261132054030895
cause O 0 0.08175040781497955
of O 0 0.002756864530965686
Japanese O 0 0.015281125903129578
complement B-Disease 1 0.6999682188034058
C9 I-Disease 1 0.9999786615371704
deficiency I-Disease 1 0.999996542930603
. O 0 0.018700551241636276

Deficiency B-Disease 1 0.9998799562454224
of I-Disease 0 0.004158833529800177
the I-Disease 0 0.004100970923900604
ninth I-Disease 0 0.01691955141723156
component I-Disease 0 0.01441638171672821
of I-Disease 0 0.0026221368461847305
human I-Disease 0 0.011605875566601753
complement I-Disease 0 0.022660749033093452
( O 0 0.010408108122646809
C9 O 1 0.9996035695075989
) O 0 0.004167892504483461
is O 0 0.0018527992069721222
the O 0 0.0014303213683888316
most O 0 0.003046493511646986
common O 0 0.02063053846359253
complement B-Disease 1 0.9973695278167725
deficiency I-Disease 1 0.9999995231628418
in O 0 0.003295924048870802
Japan O 0 0.004307532217353582
but O 0 0.0021437632385641336
is O 0 0.002971232868731022
rare O 0 0.009816508740186691
in O 0 0.001645707176066935
other O 0 0.0016291573410853744
countries O 0 0.0036611435934901237
. O 0 0.008361417800188065

We O 0 0.005141252186149359
studied O 0 0.006241767667233944
the O 0 0.0029544997960329056
molecular O 0 0.015458743087947369
basis O 0 0.0038617528043687344
of O 0 0.005610536318272352
C9 B-Disease 1 0.999981164932251
deficiency I-Disease 1 0.9999954700469971
in O 0 0.0031378697603940964
four O 0 0.004117174539715052
Japanese O 0 0.0208682119846344
C9 B-Disease 1 0.9999223947525024
- I-Disease 1 0.9979779124259949
deficient I-Disease 1 0.9999690055847168
patients O 1 0.9999662637710571
who O 0 0.009681584313511848
had O 0 0.015312077477574348
suffered O 1 0.9999761581420898
from O 0 0.09173599630594254
meningococcal B-Disease 1 0.9999997615814209
meningitis I-Disease 1 0.9999990463256836
. O 0 0.026604022830724716

Direct O 0 0.030017506331205368
sequencing O 0 0.04928668588399887
of O 0 0.007912698201835155
amplified O 0 0.17000122368335724
C9 O 1 0.9980359673500061
cDNA O 0 0.07894735783338547
and O 0 0.0046403477899730206
DNA O 0 0.02936631627380848
revealed O 0 0.012500789947807789
a O 0 0.007587790489196777
nonsense O 0 0.03164824843406677
substitution O 0 0.03255851939320564
( O 0 0.010112782008945942
CGA O 0 0.2244846671819687
- O 0 0.050714198499917984
- O 0 0.07816040515899658
> O 1 0.9726731777191162
TGA O 1 0.9963100552558899
) O 0 0.00748580414801836
at O 0 0.006454068701714277
codon O 0 0.08050650358200073
95 O 0 0.01593519002199173
in O 0 0.004716269206255674
exon O 0 0.0872705951333046
4 O 0 0.0066929771564900875
in O 0 0.0015415503876283765
the O 0 0.0028073699213564396
four O 0 0.00920922588557005
C9 B-Disease 1 0.9995032548904419
- I-Disease 1 0.7522632479667664
deficient I-Disease 1 0.9889842867851257
individuals O 0 0.017263175919651985
. O 0 0.012718820944428444

An O 0 0.021562160924077034
allele O 1 0.986693799495697
- O 0 0.0390297956764698
specific O 0 0.01703357882797718
polymerase O 1 0.6424968838691711
chain O 0 0.12805703282356262
reaction O 0 0.02521428093314171
system O 0 0.008021055720746517
designed O 0 0.005757587030529976
to O 0 0.0023896724451333284
detect O 0 0.026092451065778732
exclusively O 0 0.005104397889226675
only O 0 0.0013431942788884044
one O 0 0.0013100097421556711
of O 0 0.0009055677219294012
the O 0 0.002031743060797453
normal O 0 0.01127731241285801
and O 0 0.0028581861406564713
mutant O 1 0.9994675517082214
alleles O 1 0.9992101192474365
indicated O 0 0.008857512846589088
that O 0 0.001098130946047604
all O 0 0.0008169093634933233
the O 0 0.002097325399518013
four O 0 0.005000746808946133
patients O 1 0.99969482421875
were O 0 0.0026286044158041477
homozygous O 1 0.9413203001022339
for O 0 0.0028655764181166887
the O 0 0.004902736749500036
mutation O 1 0.997626006603241
in O 0 0.004765329882502556
exon O 1 0.710739016532898
4 O 0 0.00654763076454401
and O 0 0.0010345184709876776
that O 0 0.0009373530629090965
the O 0 0.0020062203984707594
parents O 0 0.009610859677195549
of O 0 0.00332777202129364
patient O 1 0.9985100626945496
2 O 0 0.01018237043172121
were O 0 0.004301921930164099
heterozygous O 1 0.9716339111328125
. O 0 0.014958582818508148

The O 0 0.010187403298914433
common O 0 0.023104822263121605
mutation O 1 0.9988279938697815
at O 0 0.011682312935590744
codon O 0 0.10810387134552002
95 O 0 0.018611539155244827
in O 0 0.004874883219599724
exon O 0 0.3736637830734253
4 O 0 0.01041148230433464
might O 0 0.005890252534300089
be O 0 0.0015042994637042284
responsible O 0 0.007206781301647425
for O 0 0.0022595205809921026
most O 0 0.005566579755395651
Japanese O 0 0.08808550983667374
C9 B-Disease 1 0.9999663829803467
deficiency I-Disease 1 0.9999924898147583
. O 0 0.008298163302242756
. O 0 0.010661917738616467

BRCA1 O 1 0.9995782971382141
required O 0 0.012035361491143703
for O 0 0.005042838864028454
transcription O 0 0.073903888463974
- O 0 0.033481355756521225
coupled O 0 0.047677651047706604
repair O 1 0.842986524105072
of O 0 0.007446374278515577
oxidative O 1 0.999523401260376
DNA O 1 0.6623165011405945
damage O 1 0.898501455783844
. O 0 0.012282648123800755

The O 0 0.025675345212221146
breast B-Disease 1 0.9999979734420776
and I-Disease 1 0.7057096362113953
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999948740005493
gene O 1 0.9998267292976379
BRCA1 O 1 0.9999775886535645
encodes O 1 0.5224564671516418
a O 0 0.017563005909323692
zinc O 1 0.9356107115745544
finger O 1 0.9264624714851379
protein O 0 0.03602558746933937
of O 0 0.003331006271764636
unknown O 0 0.018658297136425972
function O 0 0.019658569246530533
. O 0 0.00881167035549879

Association O 0 0.01651942729949951
of O 0 0.003511498449370265
the O 0 0.008046958595514297
BRCA1 O 1 0.9999802112579346
protein O 0 0.03091445006430149
with O 0 0.0024048711638897657
the O 0 0.003901876974850893
DNA O 0 0.18955159187316895
repair O 1 0.9862825274467468
protein O 0 0.2816413342952728
Rad51 O 1 0.9989593029022217
and O 0 0.0030941024888306856
changes O 0 0.005002863705158234
in O 0 0.0015631492715328932
the O 0 0.002551851561293006
phosphorylation O 0 0.02641168422996998
and O 0 0.0028919093310832977
cellular O 0 0.02692590095102787
localization O 0 0.021033626049757004
of O 0 0.0018490789225324988
the O 0 0.003767790040001273
protein O 0 0.029027121141552925
after O 0 0.009991246275603771
exposure O 0 0.15884338319301605
to O 0 0.003976016771048307
DNA O 0 0.045855969190597534
- O 0 0.03416358679533005
damaging O 0 0.08258408308029175
agents O 0 0.007539661601185799
are O 0 0.0014908177545294166
consistent O 0 0.005678113084286451
with O 0 0.001672366401180625
a O 0 0.00398654118180275
role O 0 0.0077545540407299995
for O 0 0.0057983193546533585
BRCA1 O 1 0.9999715089797974
in O 0 0.0067578949965536594
DNA O 0 0.10672954469919205
repair O 1 0.9285314083099365
. O 0 0.01296817697584629

Here O 0 0.006284268572926521
, O 0 0.0024470787029713392
it O 0 0.0018996475264430046
is O 0 0.0025199123192578554
shown O 0 0.006108842324465513
that O 0 0.004042414017021656
mouse O 1 0.9986972212791443
embryonic O 1 0.9957212209701538
stem O 1 0.997626006603241
cells O 1 0.9969421029090881
deficient B-Disease 1 0.9987939596176147
in I-Disease 0 0.009764031507074833
BRCA1 I-Disease 1 0.9999946355819702
are O 0 0.003811686532571912
defective O 1 0.9937626719474792
in O 0 0.0016120878281071782
the O 0 0.0017971803899854422
ability O 0 0.005398116540163755
to O 0 0.0014734257711097598
carry O 0 0.004838849417865276
out O 0 0.004946302156895399
transcription O 0 0.05412553250789642
- O 0 0.029945284128189087
coupled O 0 0.040405239909887314
repair O 0 0.49163344502449036
of O 0 0.006562078837305307
oxidative O 1 0.9990026354789734
DNA O 0 0.45911192893981934
damage O 1 0.9174266457557678
, O 0 0.0019806299824267626
and O 0 0.0014804212842136621
are O 0 0.0022212741896510124
hypersensitive O 1 0.9986053109169006
to O 0 0.0064341905526816845
ionizing O 1 0.9934176206588745
radiation O 1 0.9332241415977478
and O 0 0.004637358244508505
hydrogen O 0 0.033402733504772186
peroxide O 0 0.1128372848033905
. O 0 0.012809372507035732

These O 0 0.005164682399481535
results O 0 0.011381039395928383
suggest O 0 0.012418484315276146
that O 0 0.006593081634491682
BRCA1 O 1 0.9999681711196899
participates O 0 0.03267559036612511
, O 0 0.0025306609459221363
directly O 0 0.00469126645475626
or O 0 0.0037208462599664927
indirectly O 0 0.016769539564847946
, O 0 0.0020194826647639275
in O 0 0.0025801577139645815
transcription O 0 0.07545649260282516
- O 0 0.025682002305984497
coupled O 0 0.037230126559734344
repair O 0 0.4943452775478363
of O 0 0.005918347276747227
oxidative O 1 0.9997712969779968
DNA O 1 0.8611769080162048
damage O 1 0.8994415998458862
. O 0 0.006263512186706066
. O 0 0.00837614294141531

Truncation O 1 0.9907814860343933
mutations O 1 0.9925710558891296
in O 0 0.0039053817745298147
the O 0 0.005655068904161453
transactivation O 1 0.9856511950492859
region O 0 0.014955716207623482
of O 0 0.006798522546887398
PAX6 O 1 0.9999209642410278
result O 0 0.016113778576254845
in O 0 0.00442034425213933
dominant O 1 0.5961785912513733
- O 0 0.11739494651556015
negative O 0 0.16479098796844482
mutants O 1 0.9408084750175476
. O 0 0.014653131365776062

PAX6 O 1 0.9977303147315979
is O 0 0.009738503955304623
a O 0 0.010093201883137226
transcription O 0 0.05411888659000397
factor O 0 0.01897566206753254
with O 0 0.002049356000497937
two O 0 0.0027059626299887896
DNA O 0 0.03140711039304733
- O 0 0.02344314195215702
binding O 0 0.022203536704182625
domains O 0 0.03189178556203842
( O 0 0.008438952267169952
paired O 0 0.02619866095483303
box O 0 0.019002670422196388
and O 0 0.004406331572681665
homeobox O 1 0.998896598815918
) O 0 0.004715243820101023
and O 0 0.0020193406380712986
a O 0 0.009081161580979824
proline O 1 0.5799984931945801
- O 0 0.046491798013448715
serine O 0 0.20555582642555237
- O 0 0.047294747084379196
threonine O 0 0.33014824986457825
( O 0 0.01703280210494995
PST O 1 0.9512545466423035
) O 0 0.00995673332363367
- O 0 0.031195640563964844
rich O 0 0.03983341529965401
transactivation O 1 0.9630129337310791
domain O 0 0.05925203114748001
. O 0 0.019621005281805992

PAX6 O 1 0.9994893074035645
regulates O 1 0.9874193072319031
eye O 1 0.996417760848999
development O 0 0.006747795268893242
in O 0 0.0029525200370699167
animals O 0 0.01246363203972578
ranging O 0 0.010170551016926765
from O 0 0.005383096635341644
jellyfish O 1 0.8961113691329956
to O 0 0.005228204652667046
Drosophila O 0 0.16267581284046173
to O 0 0.005488219670951366
humans O 0 0.03738021105527878
. O 0 0.009775149635970592

Heterozygous O 1 0.9931255578994751
mutations O 1 0.9907528162002563
in O 0 0.004101309925317764
the O 0 0.005545726511627436
human O 0 0.04894556477665901
PAX6 O 1 0.9999808073043823
gene O 1 0.9985389709472656
result O 0 0.009363207034766674
in O 0 0.0022713502403348684
various O 0 0.0034622158855199814
phenotypes O 1 0.9983980059623718
, O 0 0.0030227869283407927
including O 0 0.0047583626583218575
aniridia B-Disease 1 0.9996535778045654
, O 0 0.006560888607054949
Peters B-Disease 1 0.9983021020889282
anomaly I-Disease 1 0.9996034502983093
, O 0 0.011669564060866833
autosomal B-Disease 1 0.9999970197677612
dominant I-Disease 1 0.9996740818023682
keratitis I-Disease 1 0.9999973773956299
, O 0 0.006472127512097359
and O 0 0.008569848723709583
familial B-Disease 1 0.9999945163726807
foveal I-Disease 1 0.9999655485153198
dysplasia I-Disease 1 0.9999949932098389
. O 0 0.025915242731571198

It O 0 0.00529220188036561
is O 0 0.0032350681722164154
believed O 0 0.006034454796463251
that O 0 0.0022988696582615376
the O 0 0.005893875379115343
mutated O 1 0.998658299446106
allele O 1 0.9885729551315308
of O 0 0.010051081888377666
PAX6 O 1 0.9999089241027832
produces O 0 0.0357419028878212
an O 0 0.0062055401504039764
inactive O 0 0.23870837688446045
protein O 0 0.042901087552309036
and O 0 0.005218954756855965
aniridia B-Disease 1 0.9994066953659058
is O 0 0.008027785457670689
caused O 1 0.8632751107215881
due O 0 0.009819242171943188
to O 0 0.003973681014031172
genetic O 1 0.9913285374641418
haploinsufficiency O 1 0.9963275790214539
. O 0 0.014358832500874996

However O 0 0.0070728277787566185
, O 0 0.0029176208190619946
several O 0 0.005306730046868324
truncation O 1 0.9986538887023926
mutations O 1 0.999723494052887
have O 0 0.0027020780835300684
been O 0 0.0023188807535916567
found O 0 0.002965745981782675
to O 0 0.0016521865036338568
occur O 0 0.007664539851248264
in O 0 0.0014681511092931032
the O 0 0.003419504500925541
C O 0 0.0579836368560791
- O 0 0.024553753435611725
terminal O 0 0.03582340106368065
half O 0 0.007543169893324375
of O 0 0.005510355811566114
PAX6 O 1 0.9997578263282776
in O 0 0.00840276014059782
patients O 1 0.9997400641441345
with O 0 0.006446135230362415
Aniridia B-Disease 1 0.99950110912323
resulting O 0 0.05125490948557854
in O 0 0.0047795092687010765
mutant O 1 0.9978214502334595
proteins O 0 0.013207624666392803
that O 0 0.0016916178865358233
retain O 0 0.007996080443263054
the O 0 0.003245864761993289
DNA O 0 0.041524093598127365
- O 0 0.017163744196295738
binding O 0 0.012676157988607883
domains O 0 0.013656712137162685
but O 0 0.0016138384817168117
have O 0 0.0016531572910025716
lost O 0 0.00626023393124342
most O 0 0.00202548666857183
of O 0 0.001715886639431119
the O 0 0.005779811181128025
transactivation O 1 0.9970941543579102
domain O 0 0.042276859283447266
. O 0 0.01275605894625187

It O 0 0.005004257429391146
is O 0 0.003059065667912364
not O 0 0.0016600925009697676
clear O 0 0.00399501109495759
whether O 0 0.003290730994194746
such O 0 0.0028610071167349815
mutants O 1 0.991786539554596
really O 0 0.014401841908693314
behave O 0 0.019468558952212334
as O 0 0.0032778754830360413
loss O 0 0.019815504550933838
- O 0 0.01251488458365202
of O 0 0.0027469219639897346
- O 0 0.025656934827566147
function O 0 0.018936295062303543
mutants O 1 0.6656123995780945
as O 0 0.004194148816168308
predicted O 0 0.015709906816482544
by O 0 0.007194802165031433
haploinsufficiency O 1 0.9441460967063904
. O 0 0.014329249039292336

Contrary O 0 0.01220069918781519
to O 0 0.0015852540964260697
this O 0 0.0015574493445456028
theory O 0 0.0034696070943027735
, O 0 0.0011307374807074666
our O 0 0.0020595472306013107
data O 0 0.0025131627917289734
showed O 0 0.0049759335815906525
that O 0 0.0011639068834483624
these O 0 0.00175581406801939
mutants O 0 0.2916475534439087
are O 0 0.0027621460612863302
dominant O 0 0.08723601698875427
- O 0 0.022915638983249664
negative O 0 0.021969903260469437
in O 0 0.004706156440079212
transient O 1 0.9915830492973328
transfection O 1 0.995693027973175
assays O 0 0.053889017552137375
when O 0 0.004083232954144478
they O 0 0.0013287389883771539
are O 0 0.0016546013066545129
coexpressed O 1 0.9177231192588806
with O 0 0.0040486278012394905
wild O 0 0.035976771265268326
- O 0 0.062016602605581284
type O 0 0.3869813084602356
PAX6 O 1 0.9990518689155579
. O 0 0.022067995741963387

We O 0 0.0041508967988193035
found O 0 0.0043053897097706795
that O 0 0.0013166831340640783
the O 0 0.0027390564791858196
dominant O 0 0.18205758929252625
- O 0 0.03910180926322937
negative O 0 0.049557119607925415
effects O 0 0.04889397323131561
result O 0 0.007666992023587227
from O 0 0.0022755165118724108
the O 0 0.0028057575691491365
enhanced O 0 0.027506651356816292
DNA O 0 0.03287329524755478
binding O 0 0.012789887376129627
ability O 0 0.007992991246283054
of O 0 0.0019028824754059315
these O 0 0.0038060506340116262
mutants O 1 0.7504343390464783
. O 0 0.012380041182041168

Kinetic O 0 0.04437362775206566
studies O 0 0.009235572069883347
of O 0 0.00286858226172626
binding O 0 0.012275888584554195
and O 0 0.003059353679418564
dissociation O 1 0.620147168636322
revealed O 0 0.010641389526426792
that O 0 0.0015143940690904856
various O 0 0.003119796048849821
truncation O 1 0.9953728318214417
mutants O 1 0.9835975766181946
have O 0 0.004035646561533213
3 O 0 0.010040119290351868
- O 0 0.019799431785941124
5 O 0 0.011882442981004715
- O 0 0.022984927520155907
fold O 0 0.029718240723013878
higher O 0 0.007776400074362755
affinity O 0 0.017735103145241737
to O 0 0.002075738972052932
various O 0 0.0024345116689801216
DNA O 0 0.029014328494668007
- O 0 0.01788289286196232
binding O 0 0.012228552252054214
sites O 0 0.004312836565077305
when O 0 0.004477034322917461
compared O 0 0.006801733747124672
with O 0 0.0020540407858788967
the O 0 0.004575566854327917
wild O 0 0.03394840657711029
- O 0 0.05781472474336624
type O 0 0.17562991380691528
PAX6 O 1 0.9986936450004578
. O 0 0.022217683494091034

These O 0 0.0037862632889300585
results O 0 0.0060090902261435986
provide O 0 0.0033323492389172316
a O 0 0.004116920754313469
new O 0 0.0027371032629162073
insight O 0 0.013205300085246563
into O 0 0.0027590489480644464
the O 0 0.0022160469088703394
role O 0 0.007597276009619236
of O 0 0.005163050722330809
mutant O 1 0.9979349374771118
PAX6 O 1 0.99972003698349
in O 0 0.013670715503394604
causing O 1 0.9964627623558044
aniridia B-Disease 1 0.9993409514427185
. O 0 0.009666353464126587
. O 0 0.010528326034545898

Reversal O 0 0.39907193183898926
of O 0 0.02156635746359825
severe O 1 0.9999974966049194
hypertrophic B-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 0.9999997615814209
and O 0 0.007032536435872316
excellent O 0 0.02264435775578022
neuropsychologic O 1 0.9942640662193298
outcome O 0 0.014249398373067379
in O 0 0.003071546321734786
very B-Disease 0 0.005728717427700758
- I-Disease 0 0.023898106068372726
long I-Disease 0 0.017819838598370552
- I-Disease 0 0.053514908999204636
chain I-Disease 1 0.6597915291786194
acyl I-Disease 1 0.9678189158439636
- I-Disease 0 0.06323187798261642
coenzyme I-Disease 1 0.9882424473762512
A I-Disease 0 0.2887245714664459
dehydrogenase I-Disease 1 0.9998154044151306
deficiency I-Disease 1 0.9999922513961792
. O 0 0.019394394010305405

Very B-Disease 0 0.021169008687138557
- I-Disease 0 0.04080282524228096
long I-Disease 0 0.025875572115182877
- I-Disease 0 0.0589611642062664
chain I-Disease 0 0.2396831214427948
acyl I-Disease 1 0.9595769047737122
- I-Disease 0 0.055711131542921066
coenzyme I-Disease 1 0.7399287819862366
A I-Disease 0 0.03520462289452553
dehydrogenase I-Disease 1 0.9942048192024231
( I-Disease 0 0.020913459360599518
VLCAD I-Disease 1 0.999284565448761
) I-Disease 0 0.015606001950800419
deficiency I-Disease 1 0.999993085861206
is O 0 0.005246274173259735
a O 0 0.014965827576816082
disorder O 1 0.9999899864196777
of O 0 0.007530543487519026
fatty O 1 0.999523401260376
acid O 1 0.9866958856582642
beta O 0 0.2699171304702759
oxidation O 0 0.03550950065255165
that O 0 0.002286818576976657
reportedly O 0 0.009538437239825726
has O 0 0.0030183896888047457
high O 0 0.005131829530000687
rates O 0 0.010156533680856228
of O 0 0.004512593615800142
morbidity O 1 0.9995930790901184
and O 0 0.00796438381075859
mortality O 1 0.9975278973579407
. O 0 0.015799805521965027

We O 0 0.006168392952531576
describe O 0 0.01094058807939291
the O 0 0.002363205887377262
outcome O 0 0.007373506668955088
of O 0 0.0019870090764015913
a O 0 0.005323517601937056
5 O 0 0.008432618342339993
- O 0 0.014929411001503468
year O 0 0.006912452168762684
- O 0 0.021069876849651337
old O 0 0.016202270984649658
girl O 1 0.504501223564148
with O 0 0.013639715500175953
VLCAD B-Disease 1 0.9999949932098389
deficiency I-Disease 1 0.9999996423721313
who O 0 0.005686810240149498
was O 0 0.003499054815620184
first O 0 0.002923777559772134
seen O 0 0.00622120127081871
at O 0 0.002929423935711384
5 O 0 0.005198020488023758
months O 0 0.004785190336406231
of O 0 0.002180651528760791
age O 0 0.013969195075333118
with O 0 0.010825094766914845
severe O 1 0.9999985694885254
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.3993645906448364
hepatomegaly B-Disease 1 0.9999994039535522
, O 0 0.2461351901292801
encephalopathy B-Disease 1 0.9999997615814209
, O 0 0.007126582320779562
and O 0 0.007078750524669886
hypotonia B-Disease 1 0.9997065663337708
. O 0 0.016072336584329605

Biochemical O 0 0.0931849554181099
studies O 0 0.02176307514309883
indicated O 0 0.18402817845344543
VLCAD B-Disease 1 0.9999897480010986
deficiency I-Disease 1 0.9999997615814209
caused O 1 0.9883018136024475
by O 0 0.0050111450254917145
a O 0 0.00923176109790802
stable O 0 0.11153924465179443
yet O 0 0.0158921480178833
inactive O 0 0.1566610187292099
enzyme O 0 0.10223276168107986
. O 0 0.01423732191324234

Molecular O 0 0.07099133729934692
genetic O 0 0.0619758740067482
analysis O 0 0.00849915947765112
of O 0 0.0031931886915117502
her O 0 0.018862085416913033
VLCAD O 1 0.9995962977409363
gene O 1 0.9915193915367126
revealed O 0 0.027416447177529335
a O 0 0.015481647104024887
T1372C O 1 0.970969021320343
( O 0 0.017251133918762207
F458L O 1 0.8543996214866638
) O 0 0.016142137348651886
missense O 1 0.9963657855987549
mutation O 1 0.9981783628463745
and O 0 0.005308656487613916
a O 0 0.018462682142853737
1668 O 1 0.9965433478355408
ACAG O 1 0.9985981583595276
1669 O 1 0.9929904937744141
splice O 1 0.976758599281311
site O 0 0.04237876087427139
mutation O 1 0.9969747066497803
. O 0 0.013798913918435574

After O 0 0.02412012219429016
initial O 0 0.033086925745010376
treatment O 1 0.939045786857605
with O 0 0.007423789240419865
intravenous O 1 0.998977780342102
glucose O 1 0.9893966317176819
and O 0 0.007436114829033613
carnitine O 1 0.9986714124679565
, O 0 0.004015679471194744
the O 0 0.005489638540893793
patient O 1 0.9995003938674927
has O 0 0.005603990517556667
thrived O 0 0.03516218438744545
on O 0 0.0025285626761615276
a O 0 0.0067863245494663715
low O 0 0.02382735349237919
- O 0 0.05177292600274086
fat O 0 0.43973982334136963
diet O 0 0.07146567106246948
supplemented O 0 0.02051534689962864
with O 0 0.004466403741389513
medium O 0 0.015492072328925133
- O 0 0.03445235639810562
chain O 0 0.12073693424463272
triglyceride O 0 0.3447921574115753
oil O 0 0.011579282581806183
and O 0 0.006025603506714106
carnitine O 1 0.9968107342720032
and O 0 0.005459005478769541
avoidance O 1 0.730714738368988
of O 0 0.006601986940950155
fasting O 1 0.8388186693191528
. O 0 0.01451736781746149

Her O 1 0.6666894555091858
ventricular O 1 0.9999932050704956
hypertrophy O 1 0.9999912977218628
resolved O 0 0.04378601536154747
significantly O 0 0.024556368589401245
over O 0 0.004234222695231438
1 O 0 0.005796345882117748
year O 0 0.00351746310479939
, O 0 0.0017126804450526834
and O 0 0.002344073262065649
cognitively O 1 0.9992735981941223
, O 0 0.0022360074799507856
she O 0 0.0030285906977951527
is O 0 0.001637617009691894
in O 0 0.001425572787411511
the O 0 0.002379407873377204
superior O 0 0.011052899993956089
range O 0 0.004862103145569563
for O 0 0.0023843934759497643
age O 0 0.014913920313119888
. O 0 0.008243334479629993

Clinical O 1 0.6549975872039795
recognition O 0 0.02972332388162613
of O 0 0.010434308089315891
VLCAD B-Disease 1 0.999995231628418
deficiency I-Disease 1 0.9999998807907104
is O 0 0.005791149102151394
important O 0 0.00338690890930593
because O 0 0.002934771589934826
it O 0 0.0010336023988202214
is O 0 0.001200445694848895
one O 0 0.000983550096862018
of O 0 0.000788854609709233
the O 0 0.0017487728036940098
few O 0 0.004166911356151104
directly O 0 0.015610272996127605
treatable O 1 0.9999978542327881
causes O 1 0.9998352527618408
of O 0 0.009311653673648834
cardiomyopathy B-Disease 1 0.9999998807907104
in O 0 0.005146679002791643
children O 0 0.016315175220370293
. O 0 0.004295925609767437
. O 0 0.008262520655989647

Cloning O 0 0.046376876533031464
of O 0 0.003021597396582365
a O 0 0.005129115656018257
novel O 0 0.008253584615886211
member O 0 0.0026729574892669916
of O 0 0.0012530478416010737
the O 0 0.0027766465209424496
low O 0 0.02102855034172535
- O 0 0.03997929394245148
density O 0 0.0386984646320343
lipoprotein O 1 0.9991790652275085
receptor O 1 0.986823320388794
family O 0 0.029573701322078705
. O 0 0.01432254258543253

A O 0 0.0402819961309433
gene O 0 0.1750461608171463
encoding O 0 0.03743402659893036
a O 0 0.010759669356048107
novel O 0 0.02503860741853714
transmembrane O 1 0.6609536409378052
protein O 0 0.03854185342788696
was O 0 0.004768935963511467
identified O 0 0.009926047176122665
by O 0 0.004021821077913046
DNA O 0 0.024681683629751205
sequence O 0 0.013223612681031227
analysis O 0 0.0049624149687588215
within O 0 0.003832031972706318
the O 0 0.006284742150455713
insulin B-Disease 1 0.9995889067649841
- I-Disease 1 0.7043940424919128
dependent I-Disease 1 0.9920656085014343
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999955892562866
( O 0 0.02797171287238598
IDDM B-Disease 1 0.9986003041267395
) O 0 0.02015819028019905
locus O 1 0.9966530203819275
IDDM4 O 1 0.9944406151771545
on O 0 0.015647444874048233
chromosome O 1 0.99852055311203
11q13 O 1 0.9719880819320679
. O 0 0.018335405737161636

Based O 0 0.00647991755977273
on O 0 0.00256809638813138
its O 0 0.005033203866332769
chromosomal O 1 0.9986590147018433
position O 0 0.004899227060377598
, O 0 0.001966556767001748
this O 0 0.003387028118595481
gene O 1 0.5756910443305969
is O 0 0.0026839696802198887
a O 0 0.004136199131608009
candidate O 0 0.008171353489160538
for O 0 0.004128820262849331
conferring O 1 0.6974684596061707
susceptibility O 1 0.9999305009841919
to O 0 0.017646975815296173
diabetes B-Disease 1 0.9999986886978149
. O 0 0.018672725185751915

The O 0 0.015588835813105106
gene O 1 0.8060346841812134
, O 0 0.004170597065240145
termed O 0 0.03520980849862099
low O 0 0.023417212069034576
- O 0 0.035037219524383545
density O 0 0.03489111363887787
lipoprotein O 1 0.9960248470306396
receptor O 1 0.9316902160644531
related O 0 0.022334549576044083
protein O 0 0.049446772783994675
5 O 0 0.013172742910683155
( O 0 0.00903069507330656
LRP5 O 1 0.9941306710243225
) O 0 0.005893408786505461
, O 0 0.003177299164235592
encodes O 0 0.03373529389500618
a O 0 0.007269599009305239
protein O 0 0.02769504301249981
of O 0 0.004081472754478455
1615 O 0 0.2852294445037842
amino O 0 0.03273220360279083
acids O 0 0.01791614480316639
that O 0 0.00164375442545861
contains O 0 0.004178456496447325
conserved O 0 0.014772397466003895
modules O 0 0.006823980715125799
which O 0 0.0014464461710304022
are O 0 0.0010257657850161195
characteristic O 0 0.008091973140835762
of O 0 0.0012783232377842069
the O 0 0.002747232560068369
low O 0 0.01828351616859436
- O 0 0.03536282479763031
density O 0 0.033713120967149734
lipoprotein O 1 0.9973881840705872
( O 0 0.02699960209429264
LDL O 1 0.9995309114456177
) O 0 0.02098497934639454
receptor O 1 0.8878897428512573
family O 0 0.024733077734708786
. O 0 0.011840353719890118

These O 0 0.00552411237731576
modules O 0 0.01677759177982807
include O 0 0.007137840148061514
a O 0 0.010549632832407951
putative O 0 0.41208574175834656
signal O 0 0.040487341582775116
peptide O 0 0.06553930789232254
for O 0 0.004092383664101362
protein O 0 0.02622244879603386
export O 0 0.006688535213470459
, O 0 0.0025768124032765627
four O 0 0.0050404854118824005
epidermal O 1 0.9939426779747009
growth O 0 0.028685571625828743
factor O 0 0.05125214532017708
( O 0 0.018276672810316086
EGF O 1 0.9983330368995667
) O 0 0.008181496523320675
repeats O 0 0.02887166477739811
with O 0 0.004263347014784813
associated O 0 0.013414629735052586
spacer O 0 0.3045390248298645
domains O 0 0.028324583545327187
, O 0 0.0035880524665117264
three O 0 0.00847113411873579
LDL O 1 0.999885082244873
- O 0 0.3338426351547241
receptor O 1 0.98276686668396
( O 0 0.015530097298324108
LDLR O 1 0.995560884475708
) O 0 0.006554349325597286
repeats O 0 0.02356136217713356
, O 0 0.0020811022259294987
a O 0 0.004817548673599958
single O 0 0.011608047410845757
transmembrane O 0 0.3799687922000885
spanning O 0 0.02156958542764187
domain O 0 0.01483514066785574
, O 0 0.0016759525751695037
and O 0 0.001486735651269555
a O 0 0.007997939363121986
cytoplasmic O 0 0.3694891333580017
domain O 0 0.03400064632296562
. O 0 0.01094846986234188

The O 0 0.009026501327753067
encoded O 0 0.027800170704722404
protein O 0 0.027052707970142365
has O 0 0.0025113464798778296
a O 0 0.003801847342401743
unique O 0 0.004582091234624386
organization O 0 0.005503570660948753
of O 0 0.003608451224863529
EGF O 1 0.9996523857116699
and O 0 0.007930675521492958
LDLR O 1 0.9997138381004333
repeats O 0 0.2673534154891968
; O 0 0.004704316612333059
therefore O 0 0.00462031364440918
, O 0 0.003505944972857833
LRP5 O 1 0.998690664768219
likely O 0 0.012830141931772232
represents O 0 0.00904909148812294
a O 0 0.0037449225783348083
new O 0 0.0027002040296792984
category O 0 0.007319635711610317
of O 0 0.0019893688149750233
the O 0 0.006610093172639608
LDLR O 1 0.9983382225036621
family O 0 0.027200208976864815
. O 0 0.014366627670824528

Both O 0 0.007311241701245308
human O 0 0.013537744991481304
and O 0 0.005893565248697996
mouse O 1 0.9992509484291077
LRP5 O 1 0.9998469352722168
cDNAs O 1 0.9982123374938965
have O 0 0.003389824880287051
been O 0 0.003363399999216199
isolated O 0 0.017243698239326477
and O 0 0.0014719441533088684
the O 0 0.003047006204724312
encoded O 0 0.025787033140659332
mature O 0 0.04417191073298454
proteins O 0 0.01579439640045166
are O 0 0.0016621483955532312
95 O 0 0.00896611250936985
% O 0 0.005608865525573492
identical O 0 0.009355232119560242
, O 0 0.0024361310061067343
indicating O 0 0.010287946090102196
a O 0 0.004130759742110968
high O 0 0.0047073825262486935
degree O 0 0.0050981249660253525
of O 0 0.0022554693277925253
evolutionary O 0 0.02313281036913395
conservation O 0 0.015438231639564037
. O 0 0.004686139523983002
. O 0 0.008296811021864414

The O 0 0.016766337677836418
APC B-Disease 1 0.9954517483711243
variants O 0 0.1373249888420105
I1307K O 1 0.9751357436180115
and O 0 0.003776886034756899
E1317Q O 1 0.9814815521240234
are O 0 0.002401112811639905
associated O 0 0.011713502928614616
with O 0 0.03098808415234089
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0031650520395487547
but O 0 0.0016235312214121222
not O 0 0.0011426209239289165
always O 0 0.0026344601064920425
with O 0 0.0016288085607811809
a O 0 0.005830380599945784
family O 0 0.01243915781378746
history O 0 0.008806463330984116
. O 0 0.008493415080010891

Classical O 0 0.07786961644887924
familial B-Disease 1 0.9999982118606567
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 0 0.38678625226020813
FAP B-Disease 1 0.9999724626541138
) O 0 0.007075909525156021
is O 0 0.003052190411835909
a O 0 0.005673427600413561
high O 0 0.011995579116046429
- O 1 0.6398563981056213
penetrance O 1 0.9999136924743652
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9999257326126099
disease I-Disease 1 0.9999996423721313
that O 0 0.005851142108440399
predisposes O 1 0.999824583530426
to O 0 0.003049315884709358
hundreds O 0 0.006852092687040567
or O 0 0.004111760761588812
thousands O 0 0.009213517419993877
of O 0 0.012614171020686626
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999995231628418
and I-Disease 0 0.051036685705184937
carcinoma I-Disease 1 0.9999998807907104
and O 0 0.002295084297657013
that O 0 0.0016066572861745954
results O 0 0.00626083230599761
from O 0 0.00613178638741374
truncating O 1 0.9988982677459717
mutations O 1 0.9983693957328796
in O 0 0.00436281505972147
the O 0 0.008935248479247093
APC B-Disease 1 0.9970058798789978
gene O 1 0.966528058052063
. O 0 0.01360164862126112

A O 0 0.031718626618385315
variant O 0 0.2421184629201889
of O 0 0.013635501265525818
FAP B-Disease 1 0.9999463558197021
is O 0 0.07891680300235748
attenuated B-Disease 1 0.9999709129333496
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999994039535522
, O 0 0.005426440853625536
which O 0 0.002676521660760045
results O 0 0.006072022952139378
from O 0 0.004728860687464476
germ O 1 0.9953746199607849
- O 0 0.027028027921915054
line O 0 0.015137601643800735
mutations O 1 0.9938439130783081
in O 0 0.0020839523058384657
the O 0 0.0021547393407672644
5 O 0 0.0049889786168932915
and O 0 0.0013444640208035707
3 O 0 0.0050947838462889194
regions O 0 0.006974212825298309
of O 0 0.0025576534681022167
the O 0 0.007598839234560728
APC B-Disease 1 0.9991470575332642
gene O 1 0.9841692447662354
. O 0 0.016197193413972855

Attenuated B-Disease 1 0.9999542236328125
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
patients O 1 0.9999922513961792
have O 0 0.004263298586010933
" O 0 0.006480693351477385
multiple O 0 0.06681470572948456
" O 0 0.3084944784641266
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999980926513672
( O 0 0.009959707967936993
typically O 0 0.0082839485257864
fewer O 0 0.007036936469376087
than O 0 0.0024526487104594707
100 O 0 0.004154793452471495
) O 0 0.0026017494965344667
without O 0 0.0030089968349784613
the O 0 0.005072243977338076
florid O 1 0.9967494010925293
phenotype O 1 0.9993376135826111
of O 0 0.005903094075620174
classical O 0 0.022200116887688637
FAP B-Disease 1 0.9999083280563354
. O 0 0.015597105957567692

Another O 0 0.01725771836936474
group O 0 0.008752253837883472
of O 0 0.004260788671672344
patients O 1 0.9997208714485168
with O 0 0.004697386175394058
multiple O 1 0.7118109464645386
adenomas B-Disease 1 0.9999899864196777
has O 0 0.005889267660677433
no O 0 0.005176403559744358
mutations O 1 0.9954649806022644
in O 0 0.002409227890893817
the O 0 0.005306224338710308
APC B-Disease 1 0.9998470544815063
gene O 1 0.989477813243866
, O 0 0.0022728624753654003
and O 0 0.0015937876887619495
their O 0 0.004288232419639826
phenotype O 1 0.9999216794967651
probably O 0 0.011327485553920269
results O 0 0.006052000913769007
from O 0 0.0028781562577933073
variation O 0 0.014001189731061459
at O 0 0.003031124360859394
a O 0 0.008311665616929531
locus O 1 0.9985519051551819
, O 0 0.004292341414839029
or O 0 0.0072298813611269
loci O 1 0.9887845516204834
, O 0 0.002732229419052601
elsewhere O 0 0.006145884282886982
in O 0 0.002326610963791609
the O 0 0.004856129176914692
genome O 0 0.3744364380836487
. O 0 0.013669751584529877

Recently O 0 0.02397702820599079
, O 0 0.0038185350131243467
however O 0 0.0029377606697380543
, O 0 0.0023941670078784227
a O 0 0.010613604448735714
missense O 1 0.9920340180397034
variant O 1 0.5768258571624756
of O 0 0.008145139552652836
APC B-Disease 1 0.9991771578788757
( O 0 0.01641680859029293
I1307K O 1 0.9927539229393005
) O 0 0.005341788753867149
was O 0 0.0033257310278713703
described O 0 0.006636496167629957
that O 0 0.0021744973491877317
confers O 0 0.3705419898033142
an O 0 0.0032750475220382214
increased O 0 0.026024775579571724
risk O 1 0.9977020621299744
of O 0 0.039383791387081146
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.004124027211219072
including O 0 0.00442948192358017
multiple O 0 0.4566120207309723
adenomas B-Disease 1 0.999974250793457
, O 0 0.004672013223171234
in O 0 0.004856439772993326
Ashkenazim O 1 0.9966738224029541
. O 0 0.01381969265639782

We O 0 0.004213504958897829
have O 0 0.002254535909742117
studied O 0 0.0039644087664783
a O 0 0.0032195723615586758
set O 0 0.0027993798721581697
of O 0 0.0034693991765379906
164 O 0 0.23196524381637573
patients O 1 0.9995135068893433
with O 0 0.008742164820432663
multiple O 1 0.9948452711105347
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999973773956299
and I-Disease 0 0.008373182266950607
/ I-Disease 1 0.9913068413734436
or I-Disease 0 0.01821541227400303
carcinoma I-Disease 1 0.9999992847442627
and O 0 0.005692912265658379
analyzed O 0 0.03632418066263199
codons O 1 0.5763553380966187
1263 O 1 0.9901828169822693
- O 0 0.08424080163240433
1377 O 1 0.9415869116783142
( O 0 0.023658666759729385
exon O 1 0.9064828753471375
15G O 1 0.9378177523612976
) O 0 0.00554472953081131
of O 0 0.002238048007711768
the O 0 0.005885129328817129
APC B-Disease 1 0.9986690282821655
gene O 1 0.8088167309761047
for O 0 0.0061098444275557995
germ O 1 0.979945182800293
- O 0 0.03018895909190178
line O 0 0.0158695001155138
variants O 0 0.04435877501964569
. O 0 0.010840821079909801

Three O 0 0.01455903984606266
patients O 1 0.9990112781524658
with O 0 0.002938752295449376
the O 0 0.005547990556806326
I1307K O 1 0.9997197985649109
allele O 1 0.9989707469940186
were O 0 0.004074622876942158
detected O 0 0.043679628521203995
, O 0 0.0019522247603163123
each O 0 0.0022423998452723026
of O 0 0.0040267156437039375
Ashkenazi O 1 0.9497865438461304
descent O 0 0.056825488805770874
. O 0 0.014012062922120094

Four O 0 0.016987036913633347
patients O 1 0.9985976815223694
had O 0 0.005061253439635038
a O 0 0.009195401333272457
germ O 1 0.9754790663719177
- O 0 0.036393534392118454
line O 0 0.02003639005124569
E1317Q O 1 0.9905665516853333
missense O 1 0.9936780333518982
variant O 1 0.6308978199958801
of O 0 0.005539479199796915
APC O 1 0.9996628761291504
that O 0 0.0023690795060247183
was O 0 0.0023264673072844744
not O 0 0.0012327736476436257
present O 0 0.0022555519826710224
in O 0 0.0019414369016885757
controls O 0 0.011742924340069294
; O 0 0.0024306282866746187
one O 0 0.0012430482311174273
of O 0 0.0009047820349223912
these O 0 0.0011468501761555672
individuals O 0 0.0037414212711155415
had O 0 0.0025260180700570345
an O 0 0.002560786437243223
unusually O 0 0.02063215896487236
large O 0 0.004638670478016138
number O 0 0.0031216656789183617
of O 0 0.0042363316752016544
metaplastic B-Disease 1 0.9993403553962708
polyps I-Disease 1 0.9997667670249939
of I-Disease 0 0.004630230367183685
the I-Disease 0 0.008518610149621964
colorectum I-Disease 1 0.9886893630027771
. O 0 0.016249265521764755

There O 0 0.005098328460007906
is O 0 0.003019166411831975
increasing O 0 0.007703636772930622
evidence O 0 0.002580551663413644
that O 0 0.0014529263135045767
there O 0 0.0021021333523094654
exist O 0 0.007114042527973652
germ O 1 0.8268709778785706
- O 0 0.018029028549790382
line O 0 0.008684983476996422
variants O 0 0.016574233770370483
of O 0 0.0022932421416044235
the O 0 0.006245043128728867
APC B-Disease 1 0.9996542930603027
gene O 1 0.9796776175498962
that O 0 0.003712726989760995
predispose O 1 0.9920108914375305
to O 0 0.0015368822496384382
the O 0 0.0015487299533560872
development O 0 0.0030166078358888626
of O 0 0.0036838918458670378
multiple O 1 0.9965900182723999
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999992847442627
and I-Disease 0 0.14765289425849915
carcinoma I-Disease 1 1.0
, O 0 0.00297380518168211
but O 0 0.0020633493550121784
without O 0 0.003418264677748084
the O 0 0.004926837980747223
florid O 1 0.9987226128578186
phenotype O 1 0.9997448325157166
of O 0 0.005059815477579832
classical O 0 0.014058119617402554
FAP B-Disease 1 0.9999696016311646
, O 0 0.0026862435042858124
and O 0 0.0015495030675083399
possibly O 0 0.006869023200124502
with O 0 0.0020339959301054478
importance O 0 0.007704318035393953
for O 0 0.06974343210458755
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9982479810714722
in O 0 0.0024121408350765705
the O 0 0.00233893608674407
general O 0 0.006243933457881212
population O 0 0.010211261920630932
. O 0 0.004017863422632217
. O 0 0.007091665640473366

Genomic O 0 0.11955097317695618
structure O 0 0.011483851820230484
of O 0 0.002553432248532772
the O 0 0.0058540767058730125
human O 1 0.9674359560012817
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999547004699707
diarrhea I-Disease 1 1.0
( O 0 0.38482117652893066
CLD B-Disease 1 0.9999675750732422
) O 0 0.023359186947345734
gene O 1 0.9485949277877808
. O 0 0.014465332962572575

Congenital B-Disease 1 0.9999997615814209
chloride I-Disease 1 0.9996652603149414
diarrhea I-Disease 1 0.9999998807907104
( O 0 0.07626847177743912
CLD B-Disease 1 0.9999903440475464
) O 0 0.0071723572909832
is O 0 0.0044494252651929855
caused O 1 0.7845953702926636
by O 0 0.006173106841742992
mutations O 1 0.9983863830566406
in O 0 0.003010307438671589
a O 0 0.008230242878198624
gene O 1 0.8992183208465576
which O 0 0.004675149917602539
encodes O 0 0.19891183078289032
an O 0 0.013328596018254757
intestinal O 1 0.9999990463256836
anion O 1 0.9969448447227478
transporter O 1 0.9884096384048462
. O 0 0.01847076043486595

We O 0 0.00529227452352643
report O 0 0.00412820465862751
here O 0 0.0024275686591863632
the O 0 0.0023722087498754263
complete O 0 0.008222430013120174
genomic O 0 0.06259945034980774
organization O 0 0.005470773670822382
of O 0 0.001686079427599907
the O 0 0.004685979802161455
human O 0 0.05187962204217911
CLD B-Disease 1 0.9999418258666992
gene O 1 0.9822515249252319
which O 0 0.005879128817468882
spans O 0 0.037090856581926346
approximately O 0 0.014031462371349335
39kb O 1 0.8395763635635376
, O 0 0.003272375790402293
and O 0 0.0023069351445883512
comprises O 0 0.011691371910274029
21 O 0 0.02056889794766903
exons O 0 0.2562423646450043
. O 0 0.015260138548910618

All O 0 0.014767213724553585
exon O 1 0.8571541905403137
/ O 0 0.3686824440956116
intron O 1 0.7654874920845032
boundaries O 0 0.008797235786914825
conform O 0 0.011442018672823906
to O 0 0.002494394313544035
the O 0 0.005948987789452076
GT O 1 0.9975225329399109
/ O 1 0.9844797253608704
AG O 1 0.9926949739456177
rule O 0 0.02995789796113968
. O 0 0.013561689294874668

An O 0 0.005529414396733046
analysis O 0 0.006617736537009478
of O 0 0.0018849667394533753
the O 0 0.004547445103526115
putative O 1 0.6291206479072571
promoter O 1 0.7589433193206787
region O 0 0.011969746090471745
sequence O 0 0.01574879325926304
shows O 0 0.0059312996454536915
a O 0 0.00803449098020792
putative O 1 0.9833088517189026
TATA O 1 0.9958133101463318
box O 0 0.02058389224112034
and O 0 0.0032354032155126333
predicts O 0 0.03525703400373459
multiple O 0 0.024455420672893524
transcription O 0 0.07422510534524918
factor O 0 0.027899596840143204
binding O 0 0.017459645867347717
sites O 0 0.009790216572582722
. O 0 0.009089270606637001

The O 0 0.0111459419131279
genomic O 0 0.1736842542886734
structure O 0 0.009071653708815575
was O 0 0.004322354216128588
determined O 0 0.007471470162272453
using O 0 0.004138866905122995
DNA O 0 0.015022196806967258
from O 0 0.0020508128218352795
several O 0 0.0014911651378497481
sources O 0 0.0026408901903778315
including O 0 0.001967565855011344
multiple O 0 0.010419449768960476
large O 0 0.00820954144001007
- O 0 0.03167111799120903
insert O 1 0.5512224435806274
libaries O 1 0.8321138620376587
and O 0 0.004460155498236418
genomic O 0 0.1070990189909935
DNA O 0 0.03130669519305229
from O 0 0.007421551272273064
Finnish O 1 0.8283102512359619
CLD B-Disease 1 0.9999910593032837
patients O 1 0.9999539852142334
and O 0 0.004860036540776491
controls O 0 0.026516133919358253
. O 0 0.010867267847061157

Exon O 1 0.7283770442008972
- O 0 0.041821278631687164
specific O 0 0.013154296204447746
primers O 0 0.04606245085597038
developed O 0 0.0077818613499403
in O 0 0.001434685429558158
this O 0 0.0016399620799347758
study O 0 0.004167081322520971
will O 0 0.0022097027394920588
facilitate O 0 0.02058926783502102
mutation O 1 0.9992343187332153
screening O 0 0.04042629152536392
studies O 0 0.007423975504934788
of O 0 0.0033198297023773193
patients O 1 0.9997560381889343
with O 0 0.003976086154580116
the O 0 0.010999578051269054
disease O 1 0.9999988079071045
. O 0 0.012210829183459282

Genomic O 0 0.1375567764043808
sequencing O 0 0.04076014459133148
of O 0 0.004528558813035488
a O 0 0.01918148249387741
BAC O 1 0.9997074007987976
clone O 1 0.9994986057281494
H O 1 0.9976840019226074
_ O 0 0.02131222002208233
RG364P16 O 1 0.882472574710846
revealed O 0 0.015100189484655857
the O 0 0.0029097546357661486
presence O 0 0.0071287150494754314
of O 0 0.0016117809573188424
another O 0 0.005320644937455654
, O 0 0.002577489009127021
highly O 0 0.014636760577559471
homologous O 1 0.7251284718513489
gene O 0 0.3330100178718567
3 O 0 0.008053408935666084
of O 0 0.0022582223173230886
the O 0 0.008052726276218891
CLD B-Disease 1 0.9999618530273438
gene O 1 0.9806954264640808
, O 0 0.0021182065829634666
with O 0 0.0017485297285020351
a O 0 0.004372537601739168
similar O 0 0.0086064413189888
genomic O 1 0.6107271313667297
structure O 0 0.007422015070915222
, O 0 0.001959131332114339
recently O 0 0.008391945622861385
identified O 0 0.008769180625677109
as O 0 0.003129712538793683
the O 0 0.010083729401230812
Pendred B-Disease 1 0.9999921321868896
syndrome I-Disease 1 1.0
gene O 1 0.9997554421424866
( O 0 0.022357206791639328
PDS B-Disease 1 0.9997170567512512
) O 0 0.00842433050274849
. O 0 0.004622492473572493
. O 0 0.009282464161515236

The O 0 0.020966099575161934
APCI1307K O 1 0.9995599389076233
allele O 1 0.9997290968894958
and O 0 0.019967611879110336
cancer B-Disease 1 0.999998927116394
risk O 1 0.9792613387107849
in O 0 0.0025849677622318268
a O 0 0.0048980931751430035
community O 0 0.005980403628200293
- O 0 0.010578121989965439
based O 0 0.003389977850019932
study O 0 0.005056120455265045
of O 0 0.0038345339708030224
Ashkenazi O 1 0.961536705493927
Jews O 0 0.01758071966469288
. O 0 0.01107022911310196

Mutations O 1 0.9971600770950317
in O 0 0.010697734542191029
APC O 1 0.9966680407524109
are O 0 0.006046429742127657
classically O 1 0.9935826659202576
associated O 0 0.018559196963906288
with O 0 0.014737799763679504
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.5742794871330261
FAP B-Disease 1 0.9999892711639404
) O 0 0.007311088964343071
, O 0 0.002958455355837941
a O 0 0.009687342680990696
highly O 0 0.091267429292202
penetrant O 1 0.999983549118042
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.999901533126831
disorder I-Disease 1 0.9999997615814209
characterized O 1 0.9900334477424622
by O 0 0.012362237088382244
multiple O 1 0.9989333748817444
intestinal O 1 1.0
polyps B-Disease 1 0.9999990463256836
and O 0 0.003918803296983242
, O 0 0.003013573819771409
without O 0 0.007592819165438414
surgical O 1 0.9997316002845764
intervention O 0 0.027954943478107452
, O 0 0.001771969604305923
the O 0 0.002082861727103591
development O 0 0.006474599242210388
of O 0 0.0204522293061018
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.02852575108408928
CRC B-Disease 1 0.9975071549415588
) O 0 0.010992192663252354
. O 0 0.010197211988270283

APC B-Disease 1 0.9876075387001038
is O 0 0.010966097004711628
a O 0 0.02446618489921093
tumour O 1 0.9999973773956299
- O 1 0.9717231392860413
suppressor O 1 0.9999648332595825
gene O 1 0.9915522336959839
, O 0 0.004154128488153219
and O 0 0.00470611872151494
somatic O 1 0.9970898032188416
loss O 1 0.6148106455802917
occurs O 0 0.0587226077914238
in O 0 0.009935451671481133
tumours B-Disease 1 0.9999566078186035
. O 0 0.014750626869499683

The O 0 0.024746829643845558
germline O 1 0.9997832179069519
T O 1 0.9974625110626221
- O 0 0.021784555166959763
to O 0 0.0032884252723306417
- O 0 0.017974471673369408
A O 0 0.014167649671435356
transversion O 1 0.9806610345840454
responsible O 0 0.0115872323513031
for O 0 0.0025712468195706606
the O 0 0.006509717088192701
APC O 1 0.9989026784896851
I1307K O 1 0.997825026512146
allele O 1 0.992463231086731
converts O 0 0.022044092416763306
the O 0 0.005575402639806271
wild O 0 0.026060976088047028
- O 0 0.027676139026880264
type O 0 0.026904424652457237
sequence O 0 0.0140723567456007
to O 0 0.003480439307168126
a O 0 0.012682301923632622
homopolymer O 1 0.9979457259178162
tract O 1 0.9999024868011475
( O 0 0.017751814797520638
A8 O 1 0.9976288676261902
) O 0 0.004221708048135042
that O 0 0.0018426724709570408
is O 0 0.004347608890384436
genetically O 0 0.30122557282447815
unstable O 1 0.9112785458564758
and O 0 0.004516361281275749
prone O 1 0.8725126385688782
to O 0 0.0075919134542346
somatic O 1 0.9967189431190491
mutation O 1 0.99916672706604
. O 0 0.016458693891763687

The O 0 0.0209459587931633
I1307K O 1 0.9915072917938232
allele O 1 0.9909535646438599
was O 0 0.006057944614440203
found O 0 0.005850307177752256
in O 0 0.0036612083204090595
6 O 0 0.012355228886008263
. O 0 0.008533664979040623

1 O 0 0.016550444066524506
% O 0 0.008429892361164093
of O 0 0.0053656622767448425
unselected O 1 0.9500722885131836
Ashkenazi O 1 0.9606794714927673
Jews O 0 0.008455196395516396
and O 0 0.0023702154867351055
higher O 0 0.0076232836581766605
proportions O 0 0.30772021412849426
of O 0 0.00368836079724133
Ashkenazim O 1 0.9963290095329285
with O 0 0.0036084020975977182
family O 0 0.010441991500556469
or O 0 0.00413887482136488
personal O 0 0.00859133992344141
histories O 0 0.021826092153787613
of O 0 0.005555646028369665
CRC B-Disease 1 0.9979592561721802
( O 0 0.016194414347410202
ref O 1 0.9709908962249756
. O 0 0.005516159348189831
2 O 0 0.01073384564369917
) O 0 0.006746577098965645
. O 0 0.008878879249095917

To O 0 0.005473057273775339
evaluate O 0 0.015357104130089283
the O 0 0.0025084109511226416
role O 0 0.005615756381303072
of O 0 0.003222517902031541
I1307K O 1 0.9989223480224609
in O 0 0.007618905510753393
cancer B-Disease 1 0.9999974966049194
, O 0 0.003214650321751833
we O 0 0.004238201305270195
genotyped O 1 0.9724075794219971
5 O 0 0.012211387045681477
, O 0 0.006850100588053465
081 O 1 0.9964852333068848
Ashkenazi O 1 0.979176938533783
volunteers O 0 0.018358824774622917
in O 0 0.0024800249375402927
a O 0 0.005558497738093138
community O 0 0.009769353084266186
survey O 0 0.016088351607322693
. O 0 0.009642308577895164

Risk O 1 0.508129358291626
of O 0 0.008668581955134869
developing O 1 0.8999341130256653
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.019859081134200096
breast I-Disease 1 0.9999967813491821
and I-Disease 0 0.0028896385338157415
other I-Disease 0 0.004130559973418713
cancers I-Disease 1 0.9999957084655762
were O 0 0.0022173812612891197
compared O 0 0.00861017219722271
between O 0 0.006132815033197403
genotyped O 1 0.9992895126342773
I1307K O 1 0.9993706345558167
carriers O 0 0.3749998211860657
and O 0 0.0029375592712312937
non O 0 0.012455535121262074
- O 0 0.028509225696325302
carriers O 0 0.03524152189493179
and O 0 0.0014036454958841205
their O 0 0.0020599293056875467
first O 0 0.004189124796539545
- O 0 0.019034208729863167
degree O 0 0.012917846441268921
relatives O 0 0.027851495891809464
. O 0 0.012229040265083313

Sperm O 0 0.1160309836268425
DNA O 0 0.04150743782520294
analysis O 0 0.007869797758758068
in O 0 0.003908536862581968
a O 0 0.020374005660414696
Friedreich B-Disease 1 0.9999109506607056
ataxia I-Disease 1 0.9999929666519165
premutation O 1 0.9994046688079834
carrier O 1 0.8901989459991455
suggests O 0 0.023515330627560616
both O 0 0.006250090431421995
meiotic O 1 0.9957435727119446
and O 0 0.006077176425606012
mitotic O 0 0.2793419063091278
expansion O 0 0.014565560035407543
in O 0 0.004197144880890846
the O 0 0.008307957090437412
FRDA B-Disease 1 0.9987265467643738
gene O 1 0.979468047618866
. O 0 0.015998316928744316

Friedreich B-Disease 1 0.9997715353965759
ataxia I-Disease 1 0.9999886751174927
is O 0 0.009510938078165054
usually O 0 0.011148953810334206
caused O 0 0.30004212260246277
by O 0 0.002127678832039237
an O 0 0.0018746646819636226
expansion O 0 0.006595393177121878
of O 0 0.00189547601621598
a O 0 0.008165882900357246
GAA O 0 0.42476966977119446
trinucleotide O 1 0.9988787770271301
repeat O 0 0.07469812780618668
in O 0 0.00661454675719142
intron O 1 0.9044874906539917
1 O 0 0.008875792846083641
of O 0 0.0030478481203317642
the O 0 0.00829512719064951
FRDA B-Disease 1 0.9988044500350952
gene O 1 0.890556812286377
. O 0 0.017901811748743057

Occasionally O 0 0.023348398506641388
, O 0 0.0028577703051269054
a O 0 0.005091476254165173
fully O 0 0.010759171098470688
expanded O 0 0.015425963327288628
allele O 1 0.9906495213508606
has O 0 0.004145245533436537
been O 0 0.003047614824026823
found O 0 0.0036348055582493544
to O 0 0.001942985225468874
arise O 0 0.012791434302926064
from O 0 0.0029051213059574366
a O 0 0.006762306671589613
premutation O 1 0.5209229588508606
of O 0 0.00300819450058043
100 O 0 0.0058245607651770115
or O 0 0.005137729458510876
less O 0 0.015026509761810303
triplet O 1 0.9812086820602417
repeats O 0 0.08857718110084534
. O 0 0.016009973362088203

We O 0 0.005489932838827372
have O 0 0.002942827995866537
examined O 0 0.015472150407731533
the O 0 0.0043757157400250435
sperm O 0 0.04286772012710571
DNA O 0 0.026759542524814606
of O 0 0.0038323651533573866
a O 0 0.014407563954591751
premutation O 1 0.9831373691558838
carrier O 0 0.30095207691192627
. O 0 0.016147995367646217

This O 0 0.011813493445515633
mans O 0 0.365919828414917
leucocyte O 1 0.9810865521430969
DNA O 0 0.04583710804581642
showed O 0 0.012938284315168858
one O 0 0.0058761416003108025
normal O 0 0.026116203516721725
allele O 1 0.9883655309677124
and O 0 0.0026198856066912413
one O 0 0.004782772157341242
allele O 1 0.923399806022644
of O 0 0.0028490652330219746
approximately O 0 0.009255971759557724
100 O 0 0.012084662914276123
repeats O 0 0.05338725447654724
. O 0 0.01089844573289156

His O 0 0.015307825990021229
sperm O 0 0.057737238705158234
showed O 0 0.014088052324950695
an O 0 0.004394343122839928
expanded O 0 0.012532851658761501
allele O 1 0.9754618406295776
in O 0 0.0029183626174926758
a O 0 0.006442672573029995
tight O 0 0.017205817624926567
range O 0 0.006823863834142685
centering O 0 0.017494946718215942
on O 0 0.002105980645865202
a O 0 0.004258745815604925
size O 0 0.006402380298823118
of O 0 0.0027055866084992886
approximately O 0 0.013370693661272526
320 O 0 0.07872337102890015
trinucleotide O 1 0.9972593784332275
repeats O 0 0.11927145719528198
. O 0 0.019150901585817337

His O 0 0.016913730651140213
affected O 0 0.30336588621139526
son O 0 0.09631769359111786
has O 0 0.0065180170349776745
repeat O 0 0.03758372366428375
sizes O 0 0.014104831032454967
of O 0 0.0040031541138887405
1040 O 1 0.9820367693901062
and O 0 0.00558230746537447
540 O 0 0.0733226090669632
. O 0 0.01163557730615139

These O 0 0.004771464038640261
data O 0 0.004576163832098246
suggest O 0 0.00771333510056138
that O 0 0.0023887441493570805
expansion O 0 0.011366627179086208
occurs O 0 0.014204699546098709
in O 0 0.0016554789617657661
two O 0 0.0018736413912847638
stages O 0 0.010453596711158752
, O 0 0.0015482973540201783
the O 0 0.0016214433126151562
first O 0 0.0030178693123161793
during O 0 0.008484496735036373
meiosis O 1 0.8214393854141235
followed O 0 0.008688376285135746
by O 0 0.002567414892837405
a O 0 0.00627575209364295
second O 0 0.012375768274068832
mitotic O 0 0.21164073050022125
expansion O 0 0.026864901185035706
. O 0 0.013614569790661335

We O 0 0.0032061932142823935
also O 0 0.0019842421170324087
show O 0 0.003229080233722925
that O 0 0.0010289561469107866
in O 0 0.0011759278131648898
all O 0 0.0015816733939573169
informative O 0 0.020121276378631592
carrier O 0 0.2934786379337311
father O 0 0.01348105352371931
to O 0 0.0038243692833930254
affected O 0 0.2723592221736908
child O 0 0.33398082852363586
transmissions O 0 0.0471402183175087
, O 0 0.0023968664463609457
with O 0 0.0014128608163446188
the O 0 0.0021187500096857548
notable O 0 0.005394897423684597
exception O 0 0.007310307119041681
of O 0 0.0018217795295640826
the O 0 0.004345163702964783
premutation O 1 0.9981902241706848
carrier O 1 0.504226565361023
, O 0 0.0022983886301517487
the O 0 0.003012527944520116
expansion O 0 0.015306038782000542
size O 0 0.016027191653847694
decreases O 0 0.11858293414115906
. O 0 0.006143280770629644
. O 0 0.00968859065324068

The O 0 0.017841752618551254
R496H O 1 0.9888181090354919
mutation O 1 0.9954686164855957
of O 0 0.006060548592358828
arylsulfatase O 1 0.99770587682724
A O 0 0.011212336830794811
does O 0 0.006095473654568195
not O 0 0.004676934331655502
cause O 1 0.99813312292099
metachromatic B-Disease 1 0.9998993873596191
leukodystrophy I-Disease 1 0.9999842643737793
. O 0 0.01974124275147915

Deficiency B-Disease 1 0.999953031539917
of I-Disease 0 0.011733614839613438
arylsulfatase I-Disease 1 0.9892877340316772
A I-Disease 0 0.023246482014656067
( O 0 0.020636113360524178
ARSA O 1 0.9976441264152527
) O 0 0.015550004318356514
enzyme O 0 0.10152243822813034
activity O 0 0.04140744358301163
causes O 1 0.999121367931366
metachromatic B-Disease 1 0.9998989105224609
leukodystrophy I-Disease 1 0.9999743700027466
( O 0 0.04251794517040253
MLD B-Disease 1 0.999330997467041
) O 0 0.013474935665726662
. O 0 0.011880971491336823

A O 0 0.012998808175325394
number O 0 0.005451911129057407
of O 0 0.006883441470563412
ARSA O 1 0.999902606010437
gene O 1 0.999090313911438
mutations O 1 0.9996585845947266
responsible O 0 0.015515575185418129
for O 0 0.005653130356222391
MLD B-Disease 1 0.999907374382019
have O 0 0.004281338304281235
been O 0 0.005739354994148016
identified O 0 0.01699371077120304
. O 0 0.009865637868642807

Recently O 0 0.02197849191725254
, O 0 0.00370048894546926
the O 0 0.005940221715718508
R496H O 1 0.9944615960121155
mutation O 1 0.9991920590400696
of O 0 0.0091804638504982
ARSA O 1 0.9993884563446045
was O 0 0.005172582808881998
proposed O 0 0.0042465864680707455
to O 0 0.0011291945120319724
be O 0 0.001471110386773944
a O 0 0.005018025171011686
cause O 0 0.11210691183805466
of O 0 0.005936660338193178
MLD B-Disease 1 0.9999086856842041
( O 0 0.019961658865213394
Draghia O 1 0.9914564490318298
et O 0 0.05901990458369255
al O 0 0.022477904334664345
. O 0 0.003769920440390706
, O 0 0.0033031946513801813
1997 O 0 0.014204599894583225
) O 0 0.0065378244034945965
. O 0 0.008302243426442146

We O 0 0.0050300052389502525
have O 0 0.0035289220977574587
investigated O 0 0.017171991989016533
the O 0 0.006878322456032038
R496H O 1 0.9994673132896423
mutation O 1 0.9996799230575562
and O 0 0.00222259690053761
found O 0 0.004708651918917894
this O 0 0.003770182142034173
mutation O 1 0.9969509840011597
at O 0 0.003454037243500352
a O 0 0.004876264370977879
relatively O 0 0.007314710412174463
high O 0 0.005594502203166485
frequency O 0 0.012476791627705097
in O 0 0.0017878516810014844
an O 0 0.0024771529715508223
African O 0 0.011471332050859928
American O 0 0.007680135779082775
population O 0 0.012457377277314663
( O 0 0.010067013092339039
f O 0 0.038972172886133194
= O 0 0.035144224762916565
0 O 0 0.01653345674276352
. O 0 0.003771746065467596
09 O 0 0.04542040824890137
, O 0 0.004586092662066221
n O 0 0.027363920584321022
= O 0 0.03788457065820694
61 O 0 0.025528760626912117
subjects O 0 0.012843465432524681
) O 0 0.006978804245591164
. O 0 0.009866654872894287

The O 0 0.025355538353323936
ARSA O 1 0.999134361743927
enzyme O 0 0.20316044986248016
activity O 0 0.01221412606537342
in O 0 0.0022932507563382387
subjects O 0 0.005133354105055332
with O 0 0.001317636459134519
and O 0 0.001270447508431971
without O 0 0.0032573984935879707
the O 0 0.00481639476493001
R496H O 1 0.9996569156646729
mutation O 1 0.999916672706604
was O 0 0.005070350132882595
determined O 0 0.0067496104165911674
and O 0 0.0012777249794453382
found O 0 0.0028242883272469044
to O 0 0.001372386235743761
be O 0 0.002411953406408429
normal O 0 0.021359175443649292
. O 0 0.009794756770133972

It O 0 0.005909365601837635
is O 0 0.003932903055101633
therefore O 0 0.004296553321182728
concluded O 0 0.007125589996576309
that O 0 0.0014554162044078112
the O 0 0.004139295779168606
R496H O 1 0.9991533756256104
mutation O 1 0.9996453523635864
of O 0 0.008836043067276478
ARSA O 1 0.9998288154602051
does O 0 0.008310400880873203
not O 0 0.0032158317044377327
negatively O 0 0.021776903420686722
influence O 0 0.0059900772757828236
the O 0 0.002178394002839923
activity O 0 0.008174809627234936
of O 0 0.0044897934421896935
ARSA O 1 0.99979168176651
and O 0 0.003228803863748908
is O 0 0.0031193899922072887
not O 0 0.002286769449710846
a O 0 0.008781470358371735
cause O 0 0.12276555597782135
of O 0 0.014133099466562271
MLD B-Disease 1 0.9992606043815613

Down O 0 0.03297394886612892
- O 0 0.0309459175914526
regulation O 0 0.01933925971388817
of O 0 0.005209721624851227
transmembrane O 1 0.9829829931259155
carbonic O 1 0.9992806315422058
anhydrases O 1 0.9985490441322327
in O 0 0.0222846120595932
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9998639822006226
carcinoma I-Disease 1 0.9999997615814209
cell O 1 0.8810870051383972
lines O 0 0.010810122825205326
by O 0 0.005226020235568285
wild O 0 0.031175876036286354
- O 0 0.07776718586683273
type O 0 0.3943915367126465
von B-Disease 1 0.9597334861755371
Hippel I-Disease 1 0.9996433258056641
- I-Disease 1 0.8753215074539185
Lindau I-Disease 1 0.999014139175415
transgenes O 1 0.9661151766777039
. O 0 0.019789116457104683

To O 0 0.010924185626208782
discover O 0 0.06088676303625107
genes O 0 0.23255020380020142
involved O 0 0.009725655429065228
in O 0 0.005712712183594704
von B-Disease 1 0.8857471346855164
Hippel I-Disease 1 0.9992026686668396
- I-Disease 1 0.7207447290420532
Lindau I-Disease 1 0.9987891316413879
( O 0 0.027449678629636765
VHL B-Disease 1 0.9998811483383179
) O 0 0.01671716943383217
- O 0 0.04844881594181061
mediated O 1 0.9042233228683472
carcinogenesis O 1 0.996928870677948
, O 0 0.0034695775248110294
we O 0 0.0030033315997570753
used O 0 0.011202634312212467
renal B-Disease 1 0.9999997615814209
cell I-Disease 1 0.9998170733451843
carcinoma I-Disease 1 0.9999998807907104
cell O 1 0.894429087638855
lines O 0 0.028356097638607025
stably O 1 0.9606388807296753
transfected O 1 0.9943980574607849
with O 0 0.0065069845877587795
wild O 0 0.05893056467175484
- O 0 0.1697579026222229
type O 1 0.7567167282104492
VHL O 1 0.9997192025184631
- O 0 0.08064524829387665
expressing O 0 0.08243230730295181
transgenes O 1 0.909746527671814
. O 0 0.022051895037293434

Large O 0 0.020971180871129036
- O 0 0.03165287896990776
scale O 0 0.025465134531259537
RNA O 0 0.06045084819197655
differential O 0 0.02598254568874836
display O 0 0.0069919428788125515
technology O 0 0.0042482344433665276
applied O 0 0.0035292054526507854
to O 0 0.0015456437831744552
these O 0 0.0018091608071699739
cell O 0 0.02736658602952957
lines O 0 0.009325388818979263
identified O 0 0.00969157088547945
several O 0 0.0038570668548345566
differentially O 1 0.7519975900650024
expressed O 0 0.012968383729457855
genes O 0 0.14533190429210663
, O 0 0.002198977628722787
including O 0 0.002240894827991724
an O 0 0.005420928820967674
alpha O 0 0.12126238644123077
carbonic O 1 0.9956446886062622
anhydrase O 1 0.9985081553459167
gene O 1 0.9731061458587646
, O 0 0.010725478641688824
termed O 0 0.11253079026937485
CA12 O 1 0.9946410655975342
. O 0 0.020897159352898598

The O 0 0.010777219198644161
deduced O 0 0.04739830642938614
protein O 0 0.041583940386772156
sequence O 0 0.01380668394267559
was O 0 0.0032014590688049793
classified O 0 0.005890987813472748
as O 0 0.001720478292554617
a O 0 0.0038601974956691265
one O 0 0.004074824042618275
- O 0 0.022906461730599403
pass O 0 0.025847598910331726
transmembrane O 1 0.8914030194282532
CA O 0 0.02964121289551258
possessing O 0 0.013581824488937855
an O 0 0.0048096682876348495
apparently O 0 0.02189326286315918
intact O 0 0.034968189895153046
catalytic O 0 0.06089553236961365
domain O 0 0.019775202497839928
in O 0 0.0028790857177227736
the O 0 0.005527686793357134
extracellular O 0 0.0654543936252594
CA O 0 0.041518211364746094
module O 0 0.045554209500551224
. O 0 0.01402849517762661

Reintroduced O 1 0.7781394124031067
wild O 0 0.068491131067276
- O 0 0.11836501955986023
type O 0 0.49326521158218384
VHL B-Disease 1 0.9997624754905701
strongly O 0 0.027944743633270264
inhibited O 0 0.3034522831439972
the O 0 0.005371470004320145
overexpression O 1 0.8879367113113403
of O 0 0.0023275951389223337
the O 0 0.005310008767992258
CA12 O 1 0.9995014667510986
gene O 1 0.8575766086578369
in O 0 0.0032472165767103434
the O 0 0.006942818406969309
parental O 1 0.9998561143875122
renal B-Disease 1 1.0
cell I-Disease 1 0.9999326467514038
carcinoma I-Disease 1 0.9999998807907104
cell O 1 0.9677812457084656
lines O 0 0.027901312336325645
. O 0 0.011731065809726715

Similar O 0 0.014741912484169006
results O 0 0.008488019928336143
were O 0 0.0019637211225926876
obtained O 0 0.005375837907195091
with O 0 0.00510728545486927
CA9 O 1 0.9992497563362122
, O 0 0.005307284649461508
encoding O 0 0.03436318412423134
another O 0 0.015853697434067726
transmembrane O 1 0.7494432926177979
CA O 0 0.023541556671261787
with O 0 0.0028679806273430586
an O 0 0.004227960482239723
intact O 0 0.04213417321443558
catalytic O 0 0.09448977559804916
domain O 0 0.04349854961037636
. O 0 0.014117952436208725

Although O 0 0.009019427001476288
both O 0 0.003538807388395071
domains O 0 0.0159453134983778
of O 0 0.0028382891323417425
the O 0 0.007780507672578096
VHL B-Disease 1 0.9997965693473816
protein O 0 0.05623128265142441
contribute O 0 0.013656508177518845
to O 0 0.0030592400580644608
regulation O 0 0.012173537164926529
of O 0 0.003935770131647587
CA12 O 1 0.9984102249145508
expression O 0 0.02673465572297573
, O 0 0.0024178053718060255
the O 0 0.004450986161828041
elongin O 1 0.9859490394592285
binding O 0 0.019748838618397713
domain O 0 0.021119631826877594
alone O 0 0.0095345014706254
could O 0 0.006720333825796843
effectively O 0 0.03379169851541519
regulate O 0 0.2885274887084961
CA9 O 1 0.9979872703552246
expression O 0 0.08391985297203064
. O 0 0.0194915309548378

We O 0 0.01101925503462553
mapped O 0 0.05664637312293053
CA12 O 1 0.9891374707221985
and O 0 0.01335492730140686
CA9 O 1 0.9995405673980713
loci O 1 0.9817507863044739
to O 0 0.014716800302267075
chromosome O 1 0.9892241358757019
bands O 0 0.04541505128145218
15q22 O 1 0.9535924792289734
and O 0 0.008572175167500973
17q21 O 1 0.8780211806297302
. O 0 0.017393536865711212

2 O 0 0.01901874877512455
respectively O 0 0.008268824778497219
, O 0 0.0031963165383785963
regions O 0 0.015902698040008545
prone O 1 0.7560203671455383
to O 0 0.004301564302295446
amplification O 0 0.042062148451805115
in O 0 0.004091130569577217
some O 0 0.0064890626817941666
human O 0 0.14739085733890533
cancers B-Disease 1 0.9999667406082153
. O 0 0.014295097440481186

Additional O 0 0.011133977212011814
experiments O 0 0.010888945311307907
are O 0 0.0015870964853093028
needed O 0 0.004393944051116705
to O 0 0.0016585220582783222
define O 0 0.006803841330111027
the O 0 0.0021562541369348764
role O 0 0.006128346547484398
of O 0 0.003340664319694042
CA O 1 0.8895042538642883
IX O 1 0.9991549253463745
and O 0 0.003167969174683094
CA O 1 0.71379554271698
XII O 1 0.996929943561554
enzymes O 0 0.023441743105649948
in O 0 0.0015660563949495554
the O 0 0.0019446801161393523
regulation O 0 0.010174203664064407
of O 0 0.0027781613171100616
pH O 1 0.824696958065033
in O 0 0.0020187573973089457
the O 0 0.004058653023093939
extracellular O 0 0.10076652467250824
microenvironment O 1 0.9977898597717285
and O 0 0.0021544613409787416
its O 0 0.003382705617696047
potential O 0 0.009836764074862003
impact O 0 0.017456579953432083
on O 0 0.00644768076017499
cancer B-Disease 1 0.999997615814209
cell O 1 0.553797721862793
growth O 0 0.02420053444802761
. O 0 0.011524341069161892

A O 0 0.038687024265527725
gene O 0 0.18177126348018646
encoding O 0 0.04663710668683052
a O 0 0.01506092306226492
transmembrane O 0 0.38931143283843994
protein O 0 0.03985871374607086
is O 0 0.00702101131901145
mutated O 1 0.9990339279174805
in O 0 0.0077386461198329926
patients O 1 0.9999634027481079
with O 0 0.13379913568496704
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999996423721313
and O 0 0.19310009479522705
optic B-Disease 1 0.9999978542327881
atrophy I-Disease 1 0.9999996423721313
( O 1 0.9358762502670288
Wolfram B-Disease 1 0.9999972581863403
syndrome I-Disease 1 1.0
) O 0 0.020767899230122566
. O 0 0.012845607474446297

Wolfram B-Disease 1 0.999906063079834
syndrome I-Disease 1 1.0
( O 0 0.0737260952591896
WFS B-Disease 1 0.9997342228889465
; O 0 0.03766929730772972
OMIM O 1 0.999886155128479
222300 O 1 0.9906992316246033
) O 0 0.006645691581070423
is O 0 0.004651187919080257
an O 0 0.01255045086145401
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
defined O 0 0.01586761139333248
by O 0 0.0052520036697387695
young O 0 0.20483732223510742
- O 1 0.9528232216835022
onset O 1 0.9999849796295166
non O 0 0.13697212934494019
- O 1 0.9886530041694641
immune O 1 0.9999943971633911
insulin B-Disease 1 0.9999599456787109
- I-Disease 1 0.9695547223091125
dependent I-Disease 1 0.9934758543968201
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.999997615814209
and O 0 0.0139673026278615
progressive O 1 0.9999141693115234
optic B-Disease 1 0.9999939203262329
atrophy I-Disease 1 0.9999725818634033
. O 0 0.022086238488554955

Linkage O 0 0.07241754978895187
to O 0 0.005944142583757639
markers O 0 0.03158731386065483
on O 0 0.010712680406868458
chromosome O 1 0.9995051622390747
4p O 1 0.995598316192627
was O 0 0.008320705965161324
confirmed O 0 0.010408029891550541
in O 0 0.002334572607651353
five O 0 0.004740506876260042
families O 0 0.013402396813035011
. O 0 0.009947055019438267

On O 0 0.003929021768271923
the O 0 0.0021766619756817818
basis O 0 0.002882144181057811
of O 0 0.004496503621339798
meiotic O 1 0.9998112320899963
recombinants O 1 0.99957674741745
and O 0 0.010930809192359447
disease O 1 0.9999996423721313
- O 0 0.24093107879161835
associated O 0 0.018659867346286774
haplotypes O 1 0.9971802234649658
, O 0 0.0032459308858960867
the O 0 0.0073696584440767765
WFS B-Disease 1 0.9998132586479187
gene O 1 0.9730302095413208
was O 0 0.007312339264899492
localized O 1 0.6477289199829102
to O 0 0.002787189558148384
a O 0 0.013199125416576862
BAC O 1 0.9978129863739014
/ O 1 0.6163870692253113
P1 O 1 0.7659094333648682
contig O 0 0.289731502532959
of O 0 0.004109053406864405
less O 0 0.007582930848002434
than O 0 0.006161311641335487
250 O 0 0.024191608652472496
kb O 0 0.26118332147598267
. O 0 0.01679052785038948

Mutations O 1 0.990212619304657
in O 0 0.005359705537557602
a O 0 0.010917115956544876
novel O 0 0.036699846386909485
gene O 1 0.9535375237464905
( O 0 0.016630709171295166
WFS1 O 1 0.9445308446884155
) O 0 0.008994635194540024
encoding O 0 0.0287057813256979
a O 0 0.013531830161809921
putative O 0 0.32335230708122253
transmembrane O 1 0.8541598320007324
protein O 0 0.031018882989883423
were O 0 0.0014998955884948373
found O 0 0.002644688356667757
in O 0 0.001152170356363058
all O 0 0.0014037195360288024
affected O 0 0.022287048399448395
individuals O 0 0.0034398359712213278
in O 0 0.0019569145515561104
six O 0 0.0071365488693118095
WFS B-Disease 1 0.9998699426651001
families O 0 0.008631458505988121
, O 0 0.0015644625527784228
and O 0 0.0010952228913083673
these O 0 0.0022637175861746073
mutations O 1 0.9985052347183228
were O 0 0.0016308935591951013
associated O 0 0.00500883162021637
with O 0 0.0024071454536169767
the O 0 0.011835368350148201
disease O 1 0.9999997615814209
phenotype O 1 0.999981164932251
. O 0 0.020411882549524307

WFS1 O 1 0.9976282715797424
appears O 0 0.021210888400673866
to O 0 0.003115554805845022
function O 0 0.009621698409318924
in O 0 0.0029818685725331306
survival O 0 0.056562792509794235
of O 0 0.005087831988930702
islet O 1 0.9970082640647888
beta O 1 0.7783116102218628
- O 0 0.15585501492023468
cells O 0 0.3928512632846832
and O 0 0.005907259415835142
neurons O 1 0.8305756449699402
. O 0 0.005728648975491524
. O 0 0.008103067986667156

Stable O 0 0.04937279224395752
interaction O 0 0.014744987711310387
between O 0 0.003050924278795719
the O 0 0.0020231842063367367
products O 0 0.003394233761355281
of O 0 0.001794721931219101
the O 0 0.006461110897362232
BRCA1 O 1 0.9999794960021973
and O 0 0.015519026666879654
BRCA2 O 1 0.9999996423721313
tumor B-Disease 1 0.9999994039535522
suppressor O 1 0.9999711513519287
genes O 1 0.8130669593811035
in O 0 0.006122276186943054
mitotic O 1 0.9098291993141174
and O 0 0.008926881477236748
meiotic O 1 0.9986321330070496
cells O 1 0.8876757621765137
. O 0 0.016705667600035667

BRCA1 O 1 0.9999191761016846
and O 0 0.01340202521532774
BRCA2 O 1 0.9999657869338989
account O 0 0.007268356159329414
for O 0 0.0023371363058686256
most O 0 0.003189860377460718
cases O 0 0.008088239468634129
of O 0 0.0038187250029295683
familial O 1 0.9999809265136719
, O 0 0.004906546324491501
early O 0 0.17828874289989471
onset O 1 0.9999991655349731
breast B-Disease 1 0.9999995231628418
and I-Disease 0 0.007560639642179012
/ I-Disease 1 0.9996260404586792
or I-Disease 1 0.9454745054244995
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 0.0038370154798030853
encode O 0 0.018697407096624374
products O 0 0.005118218716233969
that O 0 0.0012898680288344622
each O 0 0.0025957843754440546
interact O 0 0.0141386603936553
with O 0 0.005352508742362261
hRAD51 O 1 0.9788048267364502
. O 0 0.016065875068306923

Results O 0 0.016334963962435722
presented O 0 0.006189768202602863
here O 0 0.002802024595439434
show O 0 0.007864329032599926
that O 0 0.005579565651714802
BRCA1 O 1 0.9999886751174927
and O 0 0.009876935742795467
BRCA2 O 1 0.9999886751174927
coexist O 0 0.03397576883435249
in O 0 0.0027984774205833673
a O 0 0.00832407083362341
biochemical O 0 0.04078672081232071
complex O 0 0.01003058347851038
and O 0 0.0032506908755749464
colocalize O 1 0.9762614965438843
in O 0 0.005807534791529179
subnuclear O 1 0.9870812296867371
foci O 1 0.9465431571006775
in O 0 0.008087243884801865
somatic O 1 0.9940584897994995
cells O 0 0.13364487886428833
and O 0 0.0014299924951046705
on O 0 0.001494075870141387
the O 0 0.0028268005698919296
axial O 0 0.06970362365245819
elements O 0 0.004808673169463873
of O 0 0.003730115946382284
developing O 0 0.028616618365049362
synaptonemal O 1 0.9888333082199097
complexes O 0 0.05918005108833313
. O 0 0.014560920186340809

Like O 0 0.04475199803709984
BRCA1 O 1 0.9999423027038574
and O 0 0.012323221191763878
RAD51 O 1 0.9997124075889587
, O 0 0.014597413130104542
BRCA2 O 1 0.9999526739120483
relocates O 1 0.9206094741821289
to O 0 0.012871524319052696
PCNA O 1 0.9950555562973022
+ O 0 0.10054735094308853
replication O 0 0.07366691529750824
sites O 0 0.008970113471150398
following O 0 0.0099796736612916
exposure O 0 0.1770225465297699
of O 0 0.00390070048160851
S O 1 0.8731648325920105
phase O 0 0.042332690209150314
cells O 0 0.0773092657327652
to O 0 0.00911162979900837
hydroxyurea O 1 0.9966009855270386
or O 0 0.02819185145199299
UV O 1 0.9979647397994995
irradiation O 1 0.781975507736206
. O 0 0.015857070684432983

Thus O 0 0.018386248499155045
, O 0 0.009812508709728718
BRCA1 O 1 0.9999880790710449
and O 0 0.008349617011845112
BRCA2 O 1 0.9999862909317017
participate O 0 0.007910285145044327
, O 0 0.0015523459296673536
together O 0 0.001653302926570177
, O 0 0.0010965900728479028
in O 0 0.0016977748600766063
a O 0 0.00618504174053669
pathway O 0 0.2106635421514511
( O 0 0.009131801314651966
s O 0 0.03325061872601509
) O 0 0.003691337304189801
associated O 0 0.004639660473912954
with O 0 0.001289648236706853
the O 0 0.00239803409203887
activation O 0 0.039910007268190384
of O 0 0.0023483724799007177
double O 0 0.019020969048142433
- O 0 0.027413079515099525
strand O 0 0.05526483803987503
break O 0 0.03051476925611496
repair O 1 0.7404080033302307
and O 0 0.006415075156837702
/ O 0 0.11964299529790878
or O 0 0.013938122428953648
homologous O 1 0.5488634705543518
recombination O 0 0.2426697015762329
. O 0 0.01951977238059044

Dysfunction O 1 0.9999611377716064
of O 0 0.004242096561938524
this O 0 0.004596108105033636
pathway O 1 0.8983561396598816
may O 0 0.0057665202766656876
be O 0 0.0014416399644687772
a O 0 0.0044664922170341015
general O 0 0.006266272626817226
phenomenon O 0 0.021651018410921097
in O 0 0.001525856088846922
the O 0 0.002126676496118307
majority O 0 0.006279271095991135
of O 0 0.0022565920371562243
cases O 0 0.009309014305472374
of O 0 0.004840342327952385
hereditary B-Disease 1 0.9999972581863403
breast I-Disease 1 0.9999994039535522
and I-Disease 0 0.008866795338690281
/ I-Disease 1 0.9995369911193848
or I-Disease 1 0.9486412405967712
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.008449230343103409
. O 0 0.011134722270071507

A O 0 0.029135674238204956
novel O 0 0.049268729984760284
Arg362Ser O 1 0.9979958534240723
mutation O 1 0.9975579977035522
in O 0 0.003911508247256279
the O 0 0.005825773347169161
sterol O 1 0.9817066788673401
27 O 0 0.024389885365962982
- O 0 0.07644413411617279
hydroxylase O 1 0.9849470853805542
gene O 1 0.9475798606872559
( O 0 0.014173910953104496
CYP27 O 1 0.9825325012207031
) O 0 0.005496870260685682
: O 0 0.0033668875694274902
its O 0 0.0030006386805325747
effects O 0 0.016609083861112595
on O 0 0.0028943922370672226
pre O 0 0.02545159123837948
- O 0 0.02661096677184105
mRNA O 0 0.04875883087515831
splicing O 0 0.07174369692802429
and O 0 0.005946862045675516
enzyme O 0 0.07609006017446518
activity O 0 0.02480063959956169
. O 0 0.01196985226124525

A O 0 0.02471066638827324
novel O 0 0.02919723652303219
C O 0 0.032439302653074265
to O 0 0.0035501637030392885
A O 0 0.014043363742530346
mutation O 1 0.9937505125999451
in O 0 0.003223671345040202
the O 0 0.005303708836436272
sterol O 1 0.7041673064231873
27 O 0 0.02865299955010414
- O 0 0.06125149503350258
hydroxylase O 1 0.965265154838562
gene O 1 0.9654992818832397
( O 0 0.014642653986811638
CYP27 O 1 0.9939992427825928
) O 0 0.004407335538417101
was O 0 0.003406740026548505
identified O 0 0.008303039707243443
by O 0 0.004502858035266399
sequencing O 0 0.05902785062789917
amplified O 0 0.33279964327812195
CYP27 O 1 0.9991641044616699
gene O 1 0.9059700965881348
products O 0 0.010301904752850533
from O 0 0.005063761491328478
a O 0 0.01006085705012083
patient O 1 0.9948207139968872
with O 0 0.010367696173489094
cerebrotendinous B-Disease 1 0.9996904134750366
xanthomatosis I-Disease 1 0.9995753169059753
( O 0 0.03434557467699051
CTX B-Disease 1 0.9986403584480286
) O 0 0.015177270397543907
. O 0 0.011914094910025597

The O 0 0.019814737141132355
mutation O 1 0.9961937665939331
changed O 0 0.0152266975492239
the O 0 0.008028310723602772
adrenodoxin O 1 0.9753620624542236
cofactor O 0 0.46798884868621826
binding O 0 0.03223961591720581
residue O 0 0.0751243531703949
362Arg O 1 0.9454606175422668
to O 0 0.00810382328927517
362Ser O 1 0.983640730381012
( O 0 0.017484325915575027
CGT O 1 0.9940963983535767
362Arg O 1 0.9888517260551453
to O 0 0.013474714010953903
AGT O 1 0.9999463558197021
362Ser O 1 0.9942294359207153
) O 0 0.006716299336403608
, O 0 0.0014675906859338284
and O 0 0.00114861608017236
was O 0 0.0031265215948224068
responsible O 0 0.009787442162632942
for O 0 0.005707563366740942
deficiency O 1 0.9999910593032837
in O 0 0.0030135982669889927
the O 0 0.004181845113635063
sterol O 1 0.9824144244194031
27 O 0 0.02523743361234665
- O 0 0.04368080943822861
hydroxylase O 1 0.5913218855857849
activity O 0 0.013305945321917534
, O 0 0.0024266461841762066
as O 0 0.00230317167006433
confirmed O 0 0.00873333029448986
by O 0 0.003752189688384533
expression O 0 0.016895068809390068
of O 0 0.004152545239776373
mutant O 1 0.9695264101028442
cDNA O 0 0.08557011932134628
into O 0 0.01772351935505867
COS O 1 0.9881142973899841
- O 0 0.0400833785533905
1 O 0 0.021464625373482704
cells O 0 0.07111639529466629
. O 0 0.01246652565896511

Quantitative O 0 0.04304550215601921
analysis O 0 0.010274500586092472
showed O 0 0.007951500825583935
that O 0 0.0014512953348457813
the O 0 0.002466208767145872
expression O 0 0.015588900074362755
of O 0 0.004854530096054077
CYP27 O 1 0.9994495511054993
gene O 1 0.961414098739624
mRNA O 0 0.0327855683863163
in O 0 0.002884600544348359
the O 0 0.005282992497086525
patient O 1 0.9866790175437927
represented O 0 0.012359854765236378
52 O 0 0.028770403936505318
. O 0 0.010511286556720734

5 O 0 0.014811476692557335
% O 0 0.004975508898496628
of O 0 0.001978822983801365
the O 0 0.003934416454285383
normal O 0 0.021611468866467476
level O 0 0.011339053511619568
. O 0 0.01160444226115942

As O 0 0.007013890892267227
the O 0 0.008345156908035278
mutation O 1 0.9984685778617859
occurred O 0 0.020807024091482162
at O 0 0.0037420254666358232
the O 0 0.0034857422579079866
penultimate O 0 0.24764293432235718
nucleotide O 0 0.04649027809500694
of O 0 0.004214491229504347
exon O 0 0.48499220609664917
6 O 0 0.014388284645974636
( O 0 0.006192582193762064
- O 0 0.011586920358240604
2 O 0 0.005108368117362261
position O 0 0.0036871207412332296
of O 0 0.0032781402114778757
exon O 0 0.1938374787569046
6 O 0 0.020253261551260948
- O 0 0.04329024627804756
intron O 1 0.9429038166999817
6 O 0 0.023970305919647217
splice O 0 0.0898653194308281
site O 0 0.009652400389313698
) O 0 0.002690183464437723
of O 0 0.0014928927412256598
the O 0 0.003566744737327099
gene O 1 0.9709826111793518
, O 0 0.0017347182147204876
we O 0 0.0019212643383070827
hypothesized O 0 0.027854325249791145
that O 0 0.0015555700520053506
the O 0 0.004247086588293314
mutation O 1 0.9999412298202515
may O 0 0.010651128366589546
partially O 0 0.03181814029812813
affect O 0 0.012393995188176632
the O 0 0.003333879401907325
normal O 0 0.020902028307318687
splicing O 0 0.058201950043439865
efficiency O 0 0.013806761242449284
in O 0 0.003992293495684862
exon O 0 0.37657681107521057
6 O 0 0.01009286753833294
and O 0 0.003345177508890629
cause O 0 0.1631578952074051
alternative O 0 0.017284438014030457
splicing O 0 0.10131624341011047
elsewhere O 0 0.009677556343376637
, O 0 0.001879529096186161
which O 0 0.0023242624010890722
resulted O 0 0.014413970522582531
in O 0 0.0035093962214887142
decreased O 0 0.15343238413333893
transcript O 0 0.01895073428750038
in O 0 0.003315720474347472
the O 0 0.006663626059889793
patient O 1 0.994647204875946
. O 0 0.013668254017829895

Transfection O 1 0.7524257302284241
of O 0 0.005847143474966288
constructed O 0 0.013324984349310398
minigenes O 1 0.9806170463562012
, O 0 0.0023351137060672045
with O 0 0.0017863159300759435
or O 0 0.003152819350361824
without O 0 0.0036197637673467398
the O 0 0.004981437232345343
mutation O 1 0.9994426369667053
, O 0 0.0027919155545532703
into O 0 0.007715368177741766
COS O 1 0.9967023730278015
- O 0 0.028721945360302925
1 O 0 0.014045151881873608
cells O 0 0.08023460954427719
confirmed O 0 0.008828474208712578
that O 0 0.0017577015096321702
the O 0 0.004525953903794289
mutant O 1 0.9980582594871521
minigene O 1 0.9929186701774597
was O 0 0.0045294566079974174
responsible O 0 0.007017880212515593
for O 0 0.0018810135079547763
a O 0 0.006311713717877865
mRNA O 0 0.040008220821619034
species O 0 0.018147289752960205
alternatively O 0 0.02694672904908657
spliced O 0 0.04359964653849602
at O 0 0.0052832928486168385
an O 0 0.005749180912971497
activated O 1 0.5853192806243896
cryptic O 0 0.30098140239715576
5 O 0 0.018659807741642
splice O 0 0.14528298377990723
site O 0 0.015056014992296696
88 O 0 0.030882490798830986
bp O 0 0.03570627048611641
upstream O 0 0.01703212969005108
from O 0 0.0021994609851390123
the O 0 0.0019384522456675768
3 O 0 0.006345243658870459
end O 0 0.006246511358767748
of O 0 0.003943278454244137
exon O 0 0.4566674828529358
6 O 0 0.018131010234355927
. O 0 0.009485198184847832

Our O 0 0.008744573220610619
data O 0 0.005431755445897579
suggest O 0 0.006275874096900225
that O 0 0.0015716740163043141
the O 0 0.002505516866222024
C O 0 0.018642473965883255
to O 0 0.0021587281953543425
A O 0 0.012768993154168129
mutation O 1 0.991705060005188
at O 0 0.0038895225152373314
the O 0 0.003472833428531885
penultimate O 0 0.2469344586133957
nucleotide O 0 0.04734347015619278
of O 0 0.004758486989885569
exon O 0 0.08719465136528015
6 O 0 0.007413003593683243
of O 0 0.0024021114222705364
the O 0 0.006036768667399883
CYP27 O 1 0.9992913007736206
gene O 1 0.9871527552604675
not O 0 0.003134867176413536
only O 0 0.003882534336298704
causes O 1 0.9639978408813477
the O 0 0.007250751368701458
deficiency B-Disease 1 0.9999902248382568
in I-Disease 0 0.00276186247356236
the I-Disease 0 0.005093966610729694
sterol I-Disease 1 0.9956868290901184
27 I-Disease 0 0.023749299347400665
- I-Disease 0 0.0339181050658226
hydroxylase I-Disease 1 0.9348270893096924
activity I-Disease 0 0.010935868136584759
, O 0 0.0018145724898204207
but O 0 0.0019022603519260883
also O 0 0.002592697273939848
partially O 0 0.023593099787831306
leads O 0 0.011304007843136787
to O 0 0.0022092945873737335
alternative O 0 0.012519273906946182
pre O 0 0.03529944270849228
- O 0 0.0279811043292284
mRNA O 0 0.045062266290187836
splicing O 0 0.043578632175922394
of O 0 0.003269990673288703
the O 0 0.00763015216216445
gene O 1 0.8158632516860962
. O 0 0.013390195555984974

To O 0 0.0035033919848501682
our O 0 0.003506427863612771
knowledge O 0 0.00357733853161335
, O 0 0.0012783403508365154
this O 0 0.0010440298356115818
is O 0 0.0012195614399388433
the O 0 0.0011140004498884082
first O 0 0.0019475966691970825
report O 0 0.003022446297109127
regarding O 0 0.00515325041487813
effects O 0 0.02039114199578762
on O 0 0.0034352571237832308
pre O 0 0.028867485001683235
- O 0 0.0301547609269619
mRNA O 0 0.04538987949490547
splicing O 0 0.045838527381420135
of O 0 0.003100021043792367
a O 0 0.010271253064274788
mutation O 1 0.9959063529968262
at O 0 0.004252627957612276
the O 0 0.0037040580064058304
- O 0 0.014358961023390293
2 O 0 0.005355957429856062
position O 0 0.0029905857518315315
of O 0 0.001635925960727036
a O 0 0.005900603719055653
5 O 0 0.013042328879237175
splice O 1 0.5210330486297607
site O 0 0.014174757525324821
. O 0 0.011908735148608685

ATM O 1 0.860584557056427
germline O 1 0.9987149238586426
mutations O 1 0.9883866906166077
in O 0 0.006569219753146172
classical O 0 0.024955682456493378
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9996542930603027
telangiectasia I-Disease 1 0.9999995231628418
patients O 1 0.9999338388442993
in O 0 0.0032084528356790543
the O 0 0.003990056458860636
Dutch O 0 0.033858101814985275
population O 0 0.02108103781938553
. O 0 0.012651086784899235

Germline O 1 0.9996829032897949
mutations O 1 0.9974599480628967
in O 0 0.0035196933895349503
the O 0 0.004796575754880905
ATM O 1 0.8256363868713379
gene O 1 0.8878668546676636
are O 0 0.0020811804570257664
responsible O 0 0.0068460432812571526
for O 0 0.002654469106346369
the O 0 0.018002726137638092
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999665379524231
telangiectasia I-Disease 1 0.9999988079071045
( O 0 0.02725132182240486
A B-Disease 1 0.8885486125946045
- I-Disease 1 0.9930717349052429
T I-Disease 1 0.9996778964996338
) O 0 0.010316276922821999
. O 0 0.009897381067276001

In O 0 0.004823162220418453
our O 0 0.004747141618281603
study O 0 0.005354090593755245
, O 0 0.001723055844195187
we O 0 0.0013976582558825612
have O 0 0.0018876410322263837
determined O 0 0.006931990850716829
the O 0 0.005149494856595993
ATM O 1 0.8210658431053162
mutation O 1 0.9989390969276428
spectrum O 0 0.02741233818233013
in O 0 0.002438405528664589
19 O 0 0.009739259257912636
classical O 0 0.007253841031342745
A B-Disease 0 0.4492616057395935
- I-Disease 1 0.9951692223548889
T I-Disease 1 0.9999679327011108
patients O 1 0.9997561573982239
, O 0 0.0023437810596078634
including O 0 0.0023872661404311657
some O 0 0.003305851947516203
immigrant O 0 0.038401246070861816
populations O 0 0.028878867626190186
, O 0 0.0017005945555865765
as O 0 0.001259306212887168
well O 0 0.0013471246929839253
as O 0 0.0016635709907859564
12 O 0 0.003279860597103834
of O 0 0.0021112968679517508
Dutch O 0 0.01855115219950676
ethnic O 0 0.013361074030399323
origin O 0 0.015824852511286736
. O 0 0.012249130755662918

Both O 0 0.008290641941130161
the O 0 0.00732234213501215
protein O 0 0.055667489767074585
truncation O 1 0.5965005159378052
test O 0 0.01680685393512249
( O 0 0.00806835014373064
PTT O 0 0.09918710589408875
) O 0 0.0034139128401875496
and O 0 0.0013875385047867894
the O 0 0.0034664298873394728
restriction O 0 0.03400789946317673
endonuclease O 1 0.9952312111854553
fingerprinting O 0 0.05602084472775459
( O 0 0.011470397934317589
REF O 1 0.9736745953559875
) O 0 0.0043541244231164455
method O 0 0.00438837381079793
were O 0 0.0009664102690294385
used O 0 0.0011675123823806643
and O 0 0.0008334859157912433
compared O 0 0.004273021128028631
for O 0 0.0012279078364372253
their O 0 0.002335871336981654
detection O 0 0.02331610396504402
efficiency O 0 0.011064029298722744
, O 0 0.002874160185456276
identifying O 0 0.021632634103298187
76 O 0 0.025699295103549957
% O 0 0.004980719182640314
and O 0 0.0016917436150833964
60 O 0 0.005727508570998907
% O 0 0.0032525716815143824
of O 0 0.0019129908178001642
the O 0 0.004897942300885916
mutations O 1 0.9989331364631653
, O 0 0.0035313039552420378
respectively O 0 0.009505757130682468
. O 0 0.008234594948589802

Most O 0 0.021781569346785545
patients O 1 0.9980581402778625
were O 0 0.002104606479406357
found O 0 0.0034329858608543873
to O 0 0.0017472408944740891
be O 0 0.002878573490306735
compound O 0 0.03314617648720741
heterozygote O 1 0.9696648120880127
. O 0 0.01612059399485588

Seventeen O 0 0.07674303650856018
mutations O 1 0.9892565011978149
were O 0 0.0038726581260561943
distinct O 0 0.01014832966029644
, O 0 0.001483430853113532
of O 0 0.0012646591058000922
which O 0 0.0016743658343330026
10 O 0 0.0031483382917940617
were O 0 0.0012414745287969708
not O 0 0.0020192423835396767
reported O 0 0.010684716515243053
previously O 0 0.008222034201025963
. O 0 0.007538164034485817

Mutations O 1 0.9985764026641846
are O 0 0.004241226240992546
small O 0 0.009112656116485596
deletions O 0 0.19768019020557404
or O 0 0.005841270089149475
point O 0 0.011163382790982723
mutations O 1 0.9969929456710815
frequently O 0 0.02512946166098118
affecting O 1 0.8355464935302734
splice O 1 0.9570454955101013
sites O 0 0.013448902405798435
. O 0 0.010043575428426266

Moreover O 0 0.024689631536602974
, O 0 0.00448607187718153
a O 0 0.0077658770605921745
16 O 0 0.014226209372282028
. O 0 0.010740060359239578

7 O 0 0.040032677352428436
- O 0 0.05812130868434906
kb O 1 0.5301741361618042
genomic O 0 0.4108366072177887
deletion O 0 0.14415067434310913
of O 0 0.0021487008780241013
the O 0 0.0025058207102119923
3 O 0 0.005132950376719236
end O 0 0.003981675952672958
of O 0 0.0013742867158725858
the O 0 0.0032335754949599504
gene O 1 0.9759284853935242
, O 0 0.002001904882490635
most O 0 0.0024292399175465107
likely O 0 0.0054054586216807365
a O 0 0.003961144480854273
result O 0 0.005556147079914808
of O 0 0.0024734679609537125
recombination O 0 0.052850913256406784
between O 0 0.00272878585383296
two O 0 0.0017558843828737736
LINE O 0 0.008227658458054066
elements O 0 0.004240795504301786
, O 0 0.002142519224435091
was O 0 0.005616072565317154
identified O 0 0.01717953570187092
. O 0 0.009353870525956154

The O 0 0.006738779600709677
most O 0 0.0054306937381625175
frequently O 0 0.011359100230038166
found O 0 0.010691476985812187
mutation O 1 0.9996274709701538
, O 0 0.002934342250227928
identified O 0 0.006233550608158112
in O 0 0.0015186931705102324
three O 0 0.0023962317500263453
unrelated O 0 0.020149432122707367
Turkish O 0 0.021926328539848328
A B-Disease 0 0.4302920997142792
- I-Disease 1 0.9898057579994202
T I-Disease 1 0.9997225403785706
individuals O 0 0.006112552713602781
, O 0 0.0019077156903222203
was O 0 0.002648317953571677
previously O 0 0.0034046454820781946
described O 0 0.0046079098246991634
to O 0 0.0011147625045850873
be O 0 0.001070326892659068
a O 0 0.004205327946692705
Turkish O 0 0.013531397096812725
A B-Disease 0 0.03819569572806358
- I-Disease 1 0.7205208539962769
T I-Disease 1 0.9990891218185425
founder O 0 0.2581164538860321
mutation O 1 0.9987998008728027
. O 0 0.017779415473341942

The O 0 0.006440478842705488
presence O 0 0.008295221254229546
of O 0 0.002270985161885619
a O 0 0.0067580705508589745
founder O 0 0.25099003314971924
mutation O 1 0.9994779229164124
among O 0 0.007476577535271645
relatively O 0 0.009823981672525406
small O 0 0.004797632340341806
ethnic O 0 0.007393283303827047
population O 0 0.0074480134062469006
groups O 0 0.003180101979523897
in O 0 0.001781079568900168
Western O 0 0.0047525507397949696
Europe O 0 0.006212389562278986
could O 0 0.0031728544272482395
indicate O 0 0.008380226790904999
a O 0 0.005513996817171574
high O 0 0.009539946913719177
carrier O 0 0.05719052627682686
frequency O 0 0.020026804879307747
in O 0 0.0025061150081455708
such O 0 0.003127315314486623
communities O 0 0.01472536288201809
. O 0 0.011896784417331219

In O 0 0.013078081421554089
patients O 1 0.9863597750663757
of O 0 0.003096997272223234
Dutch O 0 0.0178728885948658
ethnic O 0 0.00796188972890377
origin O 0 0.006304129026830196
, O 0 0.001764353713952005
however O 0 0.002149837091565132
, O 0 0.0011920121032744646
no O 0 0.0023018638603389263
significant O 0 0.0062492964789271355
founder O 0 0.020297270268201828
effect O 0 0.01244284212589264
could O 0 0.0032243228051811457
be O 0 0.0020656087435781956
identified O 0 0.0133989118039608
. O 0 0.008593407459557056

The O 0 0.010216645896434784
observed O 0 0.02685786411166191
genetic O 1 0.5368380546569824
heterogeneity O 0 0.3343365788459778
including O 0 0.002459162613376975
the O 0 0.002286979230120778
relative O 0 0.008365179412066936
high O 0 0.004556239582598209
percentage O 0 0.0073972842656075954
of O 0 0.0030578908044844866
splice O 1 0.9826247096061707
- O 0 0.029968151822686195
site O 0 0.013323781080543995
mutations O 1 0.998197615146637
had O 0 0.003835749113932252
no O 0 0.0028774691745638847
reflection O 0 0.013310817070305347
on O 0 0.003116310341283679
the O 0 0.007971343584358692
phenotype O 1 0.9993626475334167
. O 0 0.014214297756552696

All O 0 0.014214664697647095
patients O 1 0.9983444213867188
manifested O 0 0.37639886140823364
classical O 0 0.008657350204885006
A B-Disease 0 0.3893662989139557
- I-Disease 1 0.9559110403060913
T I-Disease 1 0.9996869564056396
and O 0 0.0029334197752177715
increased O 0 0.016951784491539
cellular O 0 0.4812507927417755
radioresistant O 1 0.9897323250770569
DNA O 0 0.06415611505508423
synthesis O 0 0.0525100976228714
. O 0 0.01557148713618517

Determination O 0 0.022117476910352707
of O 0 0.0027023875154554844
the O 0 0.005111432168632746
genomic O 0 0.06264467537403107
structure O 0 0.005144028924405575
of O 0 0.0017950987676158547
the O 0 0.004461004864424467
COL4A4 O 1 0.9997897744178772
gene O 1 0.9033243656158447
and O 0 0.001552988076582551
of O 0 0.0025218152441084385
novel O 1 0.593166172504425
mutations O 1 0.9999823570251465
causing O 1 0.9999462366104126
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.033819735050201416

Autosomal B-Disease 1 0.999997615814209
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999998807907104
is O 0 0.011293093673884869
a O 0 0.02089458331465721
progressive O 1 0.9990608096122742
hematuric B-Disease 1 0.9998379945755005
glomerulonephritis I-Disease 1 0.9999960660934448
characterized O 1 0.988308310508728
by O 0 0.01639082096517086
glomerular B-Disease 1 0.9999074935913086
basement I-Disease 1 0.9665136933326721
membrane I-Disease 1 0.979042649269104
abnormalities I-Disease 1 0.9999361038208008
and O 0 0.0030899050179868937
associated O 0 0.0073621924966573715
with O 0 0.004159548785537481
mutations O 1 0.9985963702201843
in O 0 0.0030245319940149784
either O 0 0.004608734045177698
the O 0 0.004921198356896639
COL4A3 O 1 0.9915437698364258
or O 0 0.0062429714016616344
the O 0 0.006580004934221506
COL4A4 O 1 0.9997678399085999
gene O 1 0.9368211030960083
, O 0 0.002766141900792718
which O 0 0.002098597353324294
encode O 0 0.015661707147955894
the O 0 0.004616579040884972
alpha3 O 1 0.9141172170639038
and O 0 0.004550837446004152
alpha4 O 1 0.9974949359893799
type O 1 0.956501841545105
IV O 1 0.9995085000991821
collagen O 1 0.999874472618103
chains O 0 0.13452883064746857
, O 0 0.0046029649674892426
respectively O 0 0.012875596061348915
. O 0 0.00966964103281498

To O 0 0.004623088985681534
date O 0 0.008042661473155022
, O 0 0.004697740543633699
mutation O 1 0.9996941089630127
screening O 0 0.0261008832603693
in O 0 0.001522309030406177
the O 0 0.0017614368116483092
two O 0 0.002343738917261362
genes O 0 0.323108434677124
has O 0 0.0035231669899076223
been O 0 0.0042504798620939255
hampered O 0 0.40435755252838135
by O 0 0.0024707771372050047
the O 0 0.0026078096125274897
lack O 0 0.009193981066346169
of O 0 0.0037603587843477726
genomic O 0 0.48031121492385864
structure O 0 0.011690061539411545
information O 0 0.005193985998630524
. O 0 0.009835083037614822

We O 0 0.005067890509963036
report O 0 0.004521983675658703
here O 0 0.0019362494349479675
the O 0 0.0020195182878524065
complete O 0 0.005568157881498337
characterization O 0 0.013047861866652966
of O 0 0.0015545734204351902
the O 0 0.0024761268869042397
48 O 0 0.009921793825924397
exons O 0 0.03845754265785217
of O 0 0.0023578093387186527
the O 0 0.00503642950206995
COL4A4 O 1 0.9996416568756104
gene O 1 0.9857428073883057
, O 0 0.0023978550452739
a O 0 0.005779268220067024
comprehensive O 0 0.022222895175218582
gene O 1 0.9695904850959778
screen O 0 0.01662418432533741
, O 0 0.0015680865617468953
and O 0 0.0010891839629039168
the O 0 0.002111082663759589
subsequent O 0 0.012198211625218391
detection O 0 0.018908383324742317
of O 0 0.0018926174379885197
10 O 0 0.004968948196619749
novel O 0 0.018257969990372658
mutations O 1 0.9956610798835754
in O 0 0.0036738913040608168
eight O 0 0.018286436796188354
patients O 1 0.999998927116394
diagnosed O 1 1.0
with O 1 0.8325764536857605
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.03389832377433777

Furthermore O 0 0.03118382953107357
, O 0 0.0032958886586129665
we O 0 0.0024785823188722134
identified O 0 0.00926934089511633
a O 0 0.006526842247694731
glycine O 0 0.04981029033660889
to O 0 0.004746918100863695
alanine O 0 0.06484004110097885
substitution O 0 0.020852403715252876
in O 0 0.002847957191988826
the O 0 0.004841911140829325
collagenous O 1 0.9988125562667847
domain O 0 0.017273079603910446
that O 0 0.0017975757364183664
is O 0 0.0027462258003652096
apparently O 0 0.012774309143424034
silent O 0 0.022952303290367126
in O 0 0.0016977384220808744
the O 0 0.0039060255512595177
heterozygous O 1 0.9995856881141663
carriers O 0 0.19674403965473175
, O 0 0.00229891249909997
in O 0 0.002885557943955064
11 O 0 0.01204248983412981
. O 0 0.010297239758074284

5 O 0 0.013188384473323822
% O 0 0.003919162321835756
of O 0 0.0012695753248408437
all O 0 0.001467184629291296
control O 0 0.009695053100585938
individuals O 0 0.004445111844688654
, O 0 0.001230802503414452
and O 0 0.0008533854852430522
in O 0 0.0011336563620716333
one O 0 0.0018519209697842598
control O 0 0.008900213986635208
individual O 0 0.006297065410763025
homozygous O 1 0.9849867224693298
for O 0 0.002626609755679965
this O 0 0.003565729595720768
glycine O 0 0.08944419026374817
substitution O 0 0.048099640756845474
. O 0 0.011971132829785347

There O 0 0.005319471471011639
has O 0 0.003748909803107381
been O 0 0.0022978505585342646
no O 0 0.002137807197868824
previous O 0 0.003364304546266794
finding O 0 0.00442406814545393
of O 0 0.0015103272162377834
a O 0 0.006346145644783974
glycine O 0 0.2120431512594223
substitution O 0 0.01665457896888256
that O 0 0.0012969240779057145
is O 0 0.001719834515824914
not O 0 0.001134291640482843
associated O 0 0.004005742259323597
with O 0 0.0016816116403788328
any O 0 0.0033813156187534332
obvious O 0 0.38012099266052246
phenotype O 1 0.9998444318771362
in O 0 0.008536000736057758
homozygous O 1 0.9947039484977722
individuals O 0 0.01662571169435978
. O 0 0.011767762713134289

Founder O 1 0.8004193305969238
BRCA1 O 1 0.9999699592590332
and O 0 0.017437156289815903
BRCA2 O 1 0.9999947547912598
mutations O 1 0.9989619255065918
in O 0 0.004284811206161976
French O 0 0.05062118172645569
Canadian O 1 0.9202782511711121
breast B-Disease 1 0.999998927116394
and I-Disease 1 0.8470335602760315
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.038166578859090805
. O 0 0.014519762247800827

We O 0 0.00485932407900691
have O 0 0.0031656932551413774
identified O 0 0.010509545914828777
four O 0 0.00568746542558074
mutations O 1 0.877971351146698
in O 0 0.0016648902092128992
each O 0 0.001548617146909237
of O 0 0.002095090225338936
the O 0 0.01164046861231327
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999994039535522
- O 1 0.9916688203811646
susceptibility O 1 0.9999498128890991
genes O 1 0.9946170449256897
, O 0 0.008786015212535858
BRCA1 O 1 0.9999910593032837
and O 0 0.007331036496907473
BRCA2 O 1 0.9999898672103882
, O 0 0.0031147198751568794
in O 0 0.00323147838935256
French O 0 0.10568637400865555
Canadian O 1 0.9960399866104126
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.3991008698940277
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999842643737793
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.021720852702856064
from O 0 0.010168596170842648
Quebec O 0 0.11394323408603668
. O 0 0.013455546461045742

To O 0 0.008544785901904106
identify O 0 0.02228548936545849
founder O 0 0.03636310249567032
effects O 0 0.07074636220932007
, O 0 0.002177822170779109
we O 0 0.0022388529032468796
examined O 0 0.01732366904616356
independently O 0 0.012624146416783333
ascertained O 0 0.36329519748687744
French O 0 0.028687912970781326
Canadian O 1 0.9153016805648804
cancer B-Disease 1 0.9999963045120239
families O 0 0.007124359253793955
for O 0 0.0014132753713056445
the O 0 0.0018869205377995968
distribution O 0 0.004104715771973133
of O 0 0.0017094527138397098
these O 0 0.002416027942672372
eight O 0 0.011747533455491066
mutations O 1 0.9982176423072815
. O 0 0.014415479265153408

Mutations O 1 0.9960214495658875
were O 0 0.0037378021515905857
found O 0 0.0051577333360910416
in O 0 0.002419851254671812
41 O 0 0.012225308455526829
of O 0 0.00396242830902338
97 O 0 0.034782759845256805
families O 0 0.01688682846724987
. O 0 0.012218378484249115

Six O 0 0.007678078953176737
of O 0 0.0031537439208477736
eight O 0 0.009326661005616188
mutations O 1 0.9958155751228333
were O 0 0.002229916863143444
observed O 0 0.008529271930456161
at O 0 0.003554808907210827
least O 0 0.007733572274446487
twice O 0 0.014218046329915524
. O 0 0.009961927309632301

The O 0 0.024840814992785454
BRCA1 O 1 0.9999896287918091
C4446T O 1 0.9997714161872864
mutation O 1 0.9996235370635986
was O 0 0.0043238624930381775
the O 0 0.002420241478830576
most O 0 0.004087652545422316
common O 0 0.015191679820418358
mutation O 1 0.9998341798782349
found O 0 0.005055595189332962
, O 0 0.0020313553977757692
followed O 0 0.005632457323372364
by O 0 0.003602217882871628
the O 0 0.010107866488397121
BRCA2 O 1 0.9999918937683105
8765delAG O 1 0.9993383288383484
mutation O 1 0.9991675615310669
. O 0 0.02291029319167137

Together O 0 0.006011266727000475
, O 0 0.003124658251181245
these O 0 0.0028592476155608892
mutations O 1 0.9971829652786255
were O 0 0.001985691487789154
found O 0 0.003480634419247508
in O 0 0.0016001778421923518
28 O 0 0.005013409070670605
of O 0 0.0016899302136152983
41 O 0 0.011920242570340633
families O 0 0.006703532766550779
identified O 0 0.006855653133243322
to O 0 0.0015956006245687604
have O 0 0.002781272865831852
a O 0 0.014133564196527004
mutation O 1 0.9973090887069702
. O 0 0.013289271853864193

The O 0 0.007090399973094463
odds O 0 0.022853946313261986
of O 0 0.0029449088033288717
detection O 0 0.01746196113526821
of O 0 0.001324939075857401
any O 0 0.0012726880377158523
of O 0 0.0010009725810959935
the O 0 0.0025954737793654203
four O 0 0.010028300806879997
BRCA1 O 1 0.9999955892562866
mutations O 1 0.9997422099113464
was O 0 0.006982783786952496
18 O 0 0.012975117191672325
. O 0 0.009233173914253712

7x O 1 0.9893094301223755
greater O 0 0.014761899597942829
if O 0 0.004079089034348726
one O 0 0.0025613748002797365
or O 0 0.003032192587852478
more O 0 0.002972620539367199
cases O 0 0.012036127038300037
of O 0 0.04602433741092682
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
were O 0 0.002660960890352726
also O 0 0.001696993364021182
present O 0 0.002509352285414934
in O 0 0.001571662724018097
the O 0 0.003412889316678047
family O 0 0.016834935173392296
. O 0 0.01076425239443779

The O 0 0.0074938759207725525
odds O 0 0.02040100283920765
of O 0 0.002396209863945842
detection O 0 0.016571367159485817
of O 0 0.001088632270693779
any O 0 0.0011505904840305448
of O 0 0.0012217722833156586
the O 0 0.0027992757968604565
four O 0 0.010081707499921322
BRCA2 O 1 0.9999979734420776
mutations O 1 0.9998325109481812
was O 0 0.009239845909178257
5 O 0 0.014122473075985909
. O 0 0.010855885222554207

3x O 1 0.9722890853881836
greater O 0 0.011021463200449944
if O 0 0.0034015532582998276
there O 0 0.0014682861510664225
were O 0 0.0009061277960427105
at O 0 0.001686688861809671
least O 0 0.0036772158928215504
five O 0 0.003692941041663289
cases O 0 0.014161735773086548
of O 0 0.010967295616865158
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999980926513672
in O 0 0.0036698910407721996
the O 0 0.004259615670889616
family O 0 0.016864176839590073
. O 0 0.009721132926642895

Interestingly O 0 0.07017312198877335
, O 0 0.0035382844507694244
the O 0 0.002557472325861454
presence O 0 0.007481519132852554
of O 0 0.003212040290236473
a O 0 0.2972729802131653
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
case O 0 0.034899838268756866
< O 1 0.9856340289115906
36 O 0 0.01253607589751482
years O 0 0.004032018594443798
of O 0 0.0025180240627378225
age O 0 0.010564102791249752
was O 0 0.005899060517549515
strongly O 0 0.012006619945168495
predictive O 0 0.029058309271931648
of O 0 0.0014576208777725697
the O 0 0.0016004384960979223
presence O 0 0.004263958428055048
of O 0 0.0010075559839606285
any O 0 0.001329137827269733
of O 0 0.0013148236321285367
the O 0 0.0029268614016473293
eight O 0 0.011364210397005081
mutations O 1 0.9988081455230713
screened O 0 0.06778600066900253
. O 0 0.01318170316517353

Carriers O 0 0.04782334342598915
of O 0 0.002818881534039974
the O 0 0.0030580696184188128
same O 0 0.006775059271603823
mutation O 1 0.9998363256454468
, O 0 0.002057124860584736
from O 0 0.001932777464389801
different O 0 0.0017756271408870816
families O 0 0.0045610517263412476
, O 0 0.001819843309931457
shared O 0 0.00612662686035037
similar O 0 0.008739280514419079
haplotypes O 1 0.9979640245437622
, O 0 0.0023602060973644257
indicating O 0 0.007301377598196268
that O 0 0.0012438950361683965
the O 0 0.0031636501662433147
mutant O 1 0.9996501207351685
alleles O 1 0.9990550875663757
were O 0 0.002392442198470235
likely O 0 0.00507722282782197
to O 0 0.0012773344060406089
be O 0 0.00136221491266042
identical O 0 0.0054752095602452755
by O 0 0.002025154884904623
descent O 0 0.014257787726819515
for O 0 0.002157599665224552
a O 0 0.008415189571678638
mutation O 1 0.9985266923904419
in O 0 0.0028937896713614464
the O 0 0.003338363254442811
founder O 0 0.02655027247965336
population O 0 0.016152765601873398
. O 0 0.01075688749551773

The O 0 0.005413193721324205
identification O 0 0.009509963914752007
of O 0 0.002892583142966032
common O 0 0.1268555372953415
BRCA1 O 1 0.999996542930603
and O 0 0.01318273227661848
BRCA2 O 1 0.9999995231628418
mutations O 1 0.9998799562454224
will O 0 0.0032215379178524017
facilitate O 0 0.01332804374396801
carrier O 0 0.12877234816551208
detection O 0 0.0262918621301651
in O 0 0.0031004617922008038
French O 0 0.04897288605570793
Canadian O 1 0.989966630935669
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
and O 1 0.5073384642601013
breast B-Disease 1 1.0
/ I-Disease 1 0.9999927282333374
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.04413287341594696
. O 0 0.015320972539484501

Are O 0 0.009667613543570042
Dp71 O 1 0.9746376872062683
and O 0 0.012228050269186497
Dp140 O 1 0.9992923736572266
brain O 1 0.9999598264694214
dystrophin O 1 0.9992541670799255
isoforms O 1 0.6148772239685059
related O 0 0.014743056148290634
to O 0 0.005553963594138622
cognitive B-Disease 1 0.9955365657806396
impairment I-Disease 1 0.9998605251312256
in O 0 0.034156978130340576
Duchenne B-Disease 1 0.9999996423721313
muscular I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999995231628418
? O 1 0.696449875831604

Molecular O 0 0.06007114425301552
study O 0 0.012533290311694145
and O 0 0.0037284016143530607
neuropsychological O 1 0.8734289407730103
analysis O 0 0.008396700024604797
were O 0 0.0017835218459367752
performed O 0 0.005976986140012741
concurrently O 0 0.007089517079293728
on O 0 0.003612345550209284
49 O 0 0.04692032188177109
patients O 1 0.999853253364563
with O 0 0.028997300192713737
Duchenne B-Disease 1 0.9999998807907104
muscular I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.7463510632514954
DMD B-Disease 1 0.9999994039535522
) O 0 0.005467238835990429
in O 0 0.0015846261521801353
order O 0 0.0018620853079482913
to O 0 0.0012191470013931394
find O 0 0.004189112689346075
a O 0 0.005421070381999016
molecular O 0 0.0153112281113863
explanation O 0 0.00789981335401535
for O 0 0.0018306473502889276
the O 0 0.0046649896539747715
cognitive B-Disease 1 0.9902870655059814
impairment I-Disease 1 0.9997257590293884
observed O 0 0.02196486108005047
in O 0 0.005199698265641928
most O 0 0.022740868851542473
DMD B-Disease 1 0.9999994039535522
patients O 1 0.9999576807022095
. O 0 0.01855088584125042

Complete O 0 0.012169734574854374
analysis O 0 0.006043290253728628
of O 0 0.0022110475692898035
the O 0 0.008000359870493412
dystrophin O 1 0.9997510313987732
gene O 1 0.9733859300613403
was O 0 0.005089468788355589
performed O 0 0.00519181601703167
to O 0 0.0014247380895540118
define O 0 0.005430890712887049
the O 0 0.00227845530025661
localization O 0 0.02366427332162857
of O 0 0.0030324789695441723
deletions O 0 0.4141557216644287
and O 0 0.002735869726166129
duplications O 0 0.23841430246829987
in O 0 0.002508237725123763
relation O 0 0.006300664506852627
to O 0 0.0016694256337359548
the O 0 0.004137835465371609
different O 0 0.011940489523112774
DMD B-Disease 1 0.9999721050262451
promoters O 1 0.8267448544502258
. O 0 0.019388101994991302

Qualitative O 0 0.02774624712765217
analysis O 0 0.007199862506240606
of O 0 0.0020026795100420713
the O 0 0.005101719871163368
Dp71 O 1 0.9926204681396484
transcript O 0 0.019932040944695473
and O 0 0.001639186986722052
testing O 0 0.006609399802982807
for O 0 0.0010390274692326784
the O 0 0.0017967723542824388
specific O 0 0.0038765028584748507
first O 0 0.004347755573689938
exon O 0 0.08566021919250488
of O 0 0.004941386170685291
Dp140 O 1 0.95140141248703
were O 0 0.0018583090277388692
also O 0 0.0018902707379311323
carried O 0 0.006313736084848642
out O 0 0.005570231471210718
. O 0 0.009275971911847591

Neuropsychological O 1 0.811054527759552
analysis O 0 0.02009524777531624
assessed O 0 0.03173837065696716
verbal O 0 0.03326360881328583
and O 0 0.00547378696501255
visuospatial O 1 0.9942704439163208
intelligence O 0 0.014568046666681767
, O 0 0.004282752517610788
verbal O 0 0.03820247948169708
memory O 0 0.03558811545372009
, O 0 0.002284976188093424
and O 0 0.001982757356017828
reading O 0 0.008777192793786526
skills O 0 0.014180035330355167
. O 0 0.010217533446848392

Comparison O 0 0.01968453638255596
of O 0 0.003999605309218168
molecular O 0 0.019009143114089966
and O 0 0.0030933746602386236
psychometric O 1 0.7852609157562256
findings O 0 0.011464991606771946
demonstrated O 0 0.010061235167086124
that O 0 0.002398610580712557
deletions O 0 0.2634531259536743
and O 0 0.0028848873917013407
duplications O 1 0.9022908806800842
that O 0 0.0017685299972072244
were O 0 0.002057152334600687
localized O 1 0.7870673537254333
in O 0 0.0022087672259658575
the O 0 0.004309913143515587
distal O 1 0.9991872906684875
part O 0 0.004434531554579735
of O 0 0.0019503931980580091
the O 0 0.00460305018350482
gene O 1 0.9944872260093689
seemed O 0 0.010177661664783955
to O 0 0.0019090034766122699
be O 0 0.0023019493091851473
preferentially O 0 0.06486236304044724
associated O 0 0.010794256813824177
with O 0 0.0051817623898386955
cognitive B-Disease 1 0.9907913208007812
impairment I-Disease 1 0.9997426867485046
. O 0 0.014484829269349575

Two O 0 0.011027602478861809
altered O 0 0.045722585171461105
Dp71 O 1 0.7926046848297119
transcripts O 0 0.013124622404575348
and O 0 0.001767197041772306
two O 0 0.0031208908185362816
deleted O 0 0.043539077043533325
Dp140 O 1 0.8881002068519592
DNA O 0 0.035298001021146774
sequences O 0 0.015767043456435204
were O 0 0.0013748423662036657
found O 0 0.0027185508515685797
in O 0 0.0016664172289893031
four O 0 0.005296603310853243
patients O 1 0.9999483823776245
with O 0 0.042365316301584244
severe O 1 0.9999991655349731
cerebral B-Disease 1 0.9999997615814209
dysfunction I-Disease 1 0.9999983310699463
. O 0 0.025619978085160255

These O 0 0.005819059908390045
findings O 0 0.01318489108234644
suggest O 0 0.007563860155642033
that O 0 0.0014080842956900597
some O 0 0.00239351112395525
sequences O 0 0.013116776011884212
located O 0 0.004384043160825968
in O 0 0.001953854924067855
the O 0 0.004476239904761314
distal O 1 0.9989149570465088
part O 0 0.0054252962581813335
of O 0 0.0020116197410970926
the O 0 0.004744565114378929
gene O 1 0.9490216970443726
and O 0 0.0017768583493307233
, O 0 0.001316847512498498
in O 0 0.0014601097209379077
particular O 0 0.005071146879345179
, O 0 0.002652103081345558
some O 0 0.007096538320183754
DMD B-Disease 1 0.9999929666519165
isoforms O 1 0.6296804547309875
expressed O 0 0.009819724597036839
in O 0 0.0030345614068210125
the O 0 0.0070594921708106995
brain O 1 0.9999583959579468
may O 0 0.006608244962990284
be O 0 0.0015098685398697853
related O 0 0.004487818107008934
to O 0 0.0016516855685040355
the O 0 0.004416570533066988
cognitive B-Disease 1 0.9968441724777222
impairment I-Disease 1 0.9997815489768982
associated O 0 0.02072741463780403
with O 0 0.010805760510265827
DMD B-Disease 1 0.9999933242797852
. O 0 0.009171780198812485
. O 0 0.010361172258853912

I1307K O 1 0.9951629638671875
APC O 1 0.9948644042015076
and O 0 0.009146180003881454
hMLH1 O 1 0.9971311092376709
mutations O 1 0.9955768585205078
in O 0 0.0033161616884171963
a O 0 0.006568006239831448
non O 0 0.01306131575256586
- O 0 0.018874770030379295
Jewish O 0 0.010998026467859745
family O 0 0.012413246557116508
with O 0 0.006450293585658073
hereditary B-Disease 1 0.999885082244873
non I-Disease 1 0.9737638235092163
- I-Disease 1 0.999796450138092
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.026770150288939476

We O 0 0.006815347354859114
describe O 0 0.015051051042973995
a O 0 0.008059979416429996
French O 0 0.021305985748767853
Canadian O 0 0.029956797137856483
hereditary B-Disease 1 0.9993813037872314
non I-Disease 1 0.935297429561615
- I-Disease 1 0.9998853206634521
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.49153631925582886
HNPCC B-Disease 1 0.9999957084655762
) O 0 0.012742739170789719
kindred O 1 0.9951133131980896
which O 0 0.0035080614034086466
carries O 0 0.011275669559836388
a O 0 0.008380045183002949
novel O 0 0.040951699018478394
truncating O 1 0.995376706123352
mutation O 1 0.9991719722747803
in O 0 0.01111536007374525
hMLH1 O 1 0.9591032862663269
. O 0 0.017674872651696205

Interestingly O 0 0.06276101619005203
, O 0 0.0047839186154305935
the O 0 0.00791668239980936
I1307K O 1 0.9962589740753174
APC O 1 0.9988019466400146
polymorphism O 1 0.6692026853561401
, O 0 0.0034912191331386566
associated O 0 0.006065387278795242
with O 0 0.0016146147390827537
an O 0 0.0026541724801063538
increased O 0 0.015932632610201836
risk O 1 0.9988942742347717
of O 0 0.10498333722352982
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0032799337059259415
is O 0 0.002169248880818486
also O 0 0.0014755339361727238
present O 0 0.0022024831268936396
in O 0 0.0018658406333997846
this O 0 0.0030580100137740374
family O 0 0.015311873517930508
. O 0 0.009553730487823486

The O 0 0.015257559716701508
I1307K O 1 0.9951021671295166
polymorphism O 1 0.7754250764846802
has O 0 0.0042785461992025375
previously O 0 0.004267725627869368
only O 0 0.001731822150759399
been O 0 0.0026238032151013613
identified O 0 0.005349278450012207
in O 0 0.0013894651783630252
individuals O 0 0.0038711153902113438
of O 0 0.0025266080629080534
self O 0 0.05934666097164154
- O 0 0.04089534282684326
reported O 0 0.028626181185245514
Ashkenazi O 1 0.7461132407188416
Jewish O 0 0.020101558417081833
origins O 0 0.034708116203546524
. O 0 0.011887971311807632

In O 0 0.004933976102620363
addition O 0 0.005203146953135729
, O 0 0.0016600512899458408
in O 0 0.001493167132139206
this O 0 0.0019244179129600525
family O 0 0.006689966656267643
, O 0 0.0014389504212886095
there O 0 0.0016738821286708117
appears O 0 0.0067977700382471085
to O 0 0.0010086668189615011
be O 0 0.0010386919602751732
no O 0 0.0021733720786869526
relationship O 0 0.006191974505782127
between O 0 0.002404429716989398
the O 0 0.0036746629048138857
I1307K O 1 0.9981070756912231
polymorphism O 1 0.8336329460144043
and O 0 0.0017020751256495714
the O 0 0.0021109108347445726
presence O 0 0.007766141090542078
or O 0 0.0042236484587192535
absence O 0 0.021071193739771843
of O 0 0.007257058750838041
cancer B-Disease 1 0.9999966621398926
. O 0 0.006103691644966602
. O 0 0.008894486352801323

Identification O 0 0.016591310501098633
of O 0 0.002339630387723446
a O 0 0.006543265655636787
novel O 0 0.023383740335702896
mutation O 1 0.9987542629241943
of O 0 0.002836251864209771
the O 0 0.005362926982343197
CPO O 1 0.960365891456604
gene O 1 0.5490393042564392
in O 0 0.003849994158372283
a O 0 0.008254439570009708
Japanese O 0 0.02099709026515484
hereditary B-Disease 1 0.9993647933006287
coproporphyria I-Disease 1 0.9983711838722229
family O 0 0.03803005442023277
. O 0 0.013562244363129139

Hereditary B-Disease 1 0.9996019005775452
coproporphyria I-Disease 1 0.9988928437232971
( O 0 0.020312702283263206
HCP B-Disease 1 0.9962425231933594
) O 0 0.005440577398985624
is O 0 0.0033305855467915535
an O 0 0.006911132484674454
autosomal B-Disease 1 0.9999986886978149
dominant I-Disease 1 0.9998981952667236
disease I-Disease 1 0.9999998807907104
characterized O 1 0.9526569247245789
by O 0 0.005088066216558218
a O 0 0.021554403007030487
deficiency B-Disease 1 0.9999912977218628
of I-Disease 0 0.007098921574652195
coproporphyrinogen I-Disease 1 0.9994316697120667
oxidase I-Disease 1 0.9983805418014526
( O 0 0.015584312379360199
CPO O 1 0.6180033683776855
) O 0 0.00701787369325757
caused O 0 0.04805834963917732
by O 0 0.0033508087508380413
a O 0 0.008618325926363468
mutation O 1 0.9970530271530151
in O 0 0.0032153178472071886
the O 0 0.007004349492490292
CPO O 1 0.9730980396270752
gene O 1 0.9637936949729919
. O 0 0.016314594075083733

Only O 0 0.009742164984345436
11 O 0 0.018837695941329002
mutations O 1 0.9227941632270813
of O 0 0.0026034896727651358
the O 0 0.004531328100711107
gene O 1 0.968440592288971
have O 0 0.0028833611868321896
been O 0 0.004054883029311895
reported O 0 0.013383792713284492
in O 0 0.00960117019712925
HCP B-Disease 1 0.9998667240142822
patients O 1 0.999789297580719
. O 0 0.016480831429362297

We O 0 0.006115430034697056
report O 0 0.009352668188512325
another O 0 0.016448266804218292
mutation O 1 0.9946042895317078
in O 0 0.0035527690779417753
a O 0 0.007193290628492832
Japanese O 0 0.013305356726050377
family O 0 0.021866340190172195
. O 0 0.012878207489848137

Polymerase O 1 0.8290340304374695
chain O 0 0.21881677210330963
reaction O 0 0.050439298152923584
- O 0 0.03093811124563217
single O 0 0.017628734931349754
strand O 0 0.0811084434390068
conformational O 1 0.902359664440155
polymorphism O 0 0.10777533054351807
and O 0 0.002474564127624035
direct O 0 0.008389350958168507
sequence O 0 0.014789577573537827
analyses O 0 0.011926839128136635
demonstrated O 0 0.012510671280324459
a O 0 0.00826307199895382
C O 0 0.0297817662358284
to O 0 0.0046454379335045815
T O 1 0.6375099420547485
substitution O 0 0.020595256239175797
in O 0 0.004040882457047701
exon O 0 0.06841292232275009
1 O 0 0.005998590029776096
of O 0 0.001672770013101399
the O 0 0.005391738377511501
CPO O 1 0.917866051197052
gene O 1 0.6005253791809082
at O 0 0.007211382035166025
nucleotide O 0 0.04521118104457855
position O 0 0.006964277010411024
85 O 0 0.014746518805623055
, O 0 0.001990337623283267
which O 0 0.0018527559004724026
lies O 0 0.006678489502519369
in O 0 0.0020761550404131413
the O 0 0.00444829324260354
putative O 1 0.9340633153915405
presequence O 1 0.7701013088226318
for O 0 0.003975576721131802
targeting O 0 0.018991520628333092
to O 0 0.0047944230027496815
mitochondria O 0 0.14822961390018463
. O 0 0.012329966761171818

This O 0 0.017748165875673294
mutation O 1 0.992026150226593
changes O 0 0.010782410390675068
the O 0 0.004845106042921543
codon O 0 0.06827370822429657
for O 0 0.0034924435894936323
glutamine O 0 0.049403831362724304
to O 0 0.00300618726760149
a O 0 0.0095634451135993
termination O 1 0.8107428550720215
codon O 0 0.14198604226112366
at O 0 0.009962501935660839
amino O 0 0.04381630942225456
acid O 0 0.057668350636959076
position O 0 0.011516272090375423
29 O 0 0.01958143152296543
. O 0 0.010518252849578857

MaeI O 1 0.9809864163398743
restriction O 0 0.040395982563495636
analysis O 0 0.010178099386394024
showed O 0 0.008513794280588627
two O 0 0.0018587515223771334
other O 0 0.002492311643436551
carriers O 0 0.026131676509976387
in O 0 0.002280360786244273
the O 0 0.004399926867336035
family O 0 0.01739286631345749
. O 0 0.011024603620171547

The O 0 0.017916345968842506
C O 0 0.4062505066394806
- O 1 0.7747918367385864
T O 1 0.9982179999351501
mutation O 1 0.9969574213027954
is O 0 0.00475957989692688
located O 0 0.0054723178036510944
within O 0 0.0030330917797982693
a O 0 0.004811323247849941
recently O 0 0.009985596872866154
proposed O 0 0.011109747923910618
putative O 0 0.06206769123673439
alternative O 0 0.01461135782301426
translation O 0 0.017568502575159073
initiation O 0 0.06058816611766815
codon O 0 0.4337768256664276
( O 0 0.020557232201099396
TIC O 1 0.9984222650527954
- O 0 0.024857377633452415
1 O 0 0.009220009669661522
) O 0 0.0037602318916469812
, O 0 0.0019412735709920526
supporting O 0 0.007418661378324032
that O 0 0.004428821615874767
TIC O 1 0.9993249177932739
- O 0 0.019030315801501274
1 O 0 0.0061010513454675674
is O 0 0.00234534265473485
the O 0 0.0031379845459014177
real O 0 0.017626306042075157
TIC O 1 0.9991292357444763
rather O 0 0.008310828357934952
than O 0 0.01094982773065567
TIC O 1 0.9987093210220337
- O 0 0.03404776379466057
2 O 0 0.012192916125059128
. O 0 0.005100975278764963
. O 0 0.009485655464231968

Human B-Disease 0 0.03838527202606201
complement I-Disease 0 0.05254470556974411
factor I-Disease 1 0.9044984579086304
H I-Disease 1 0.9998538494110107
deficiency I-Disease 1 0.9999971389770508
associated O 0 0.12355948239564896
with O 0 0.43281400203704834
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.039679769426584244

This O 0 0.005504659377038479
study O 0 0.006435034796595573
reports O 0 0.00469954265281558
on O 0 0.0019465247169137
six O 0 0.003951490391045809
cases O 0 0.008688765577971935
of O 0 0.005422366317361593
deficiency B-Disease 1 0.9999958276748657
in I-Disease 0 0.002535454696044326
the I-Disease 0 0.003089508507400751
human I-Disease 0 0.010744478553533554
complement I-Disease 0 0.02194542996585369
regulatory I-Disease 0 0.04384162649512291
protein I-Disease 0 0.06456326693296432
Factor I-Disease 0 0.2139236479997635
H I-Disease 1 0.9941726326942444
( O 0 0.015199058689177036
FH O 1 0.9990052580833435
) O 0 0.004148995503783226
in O 0 0.001436624675989151
the O 0 0.0019274811493232846
context O 0 0.0048656165599823
of O 0 0.0025760342832654715
an O 0 0.0203782320022583
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.028754539787769318

Five O 0 0.005157548002898693
of O 0 0.001830401481129229
the O 0 0.002503900323063135
cases O 0 0.006810120772570372
were O 0 0.001590540399774909
observed O 0 0.006816374137997627
in O 0 0.0019896384328603745
children O 0 0.009057553485035896
presenting O 0 0.02160819247364998
with O 0 0.052118636667728424
idiopathic O 1 0.9999998807907104
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9596088528633118
HUS B-Disease 1 0.9999980926513672
) O 0 0.01777750812470913
. O 0 0.009919724427163601

Two O 0 0.003733626799657941
of O 0 0.0020979803521186113
the O 0 0.0033464194275438786
children O 0 0.011726859025657177
exhibited O 0 0.03228258714079857
a O 0 0.021137738600373268
homozygous O 1 0.9999744892120361
deficiency O 1 0.9999988079071045
characterized O 1 0.537533164024353
by O 0 0.0026525359135121107
the O 0 0.0021221337374299765
absence O 0 0.007049895357340574
of O 0 0.0015978090232238173
the O 0 0.0029469088185578585
150 O 0 0.013394423760473728
- O 0 0.02510388009250164
kD O 0 0.48833519220352173
form O 0 0.008228378370404243
of O 0 0.003788427449762821
Factor O 0 0.27145934104919434
H O 1 0.9700099229812622
and O 0 0.001464454922825098
the O 0 0.0021721955854445696
presence O 0 0.0068838391453027725
, O 0 0.001768199261277914
upon O 0 0.005332950968295336
immunoblotting O 1 0.9507346749305725
, O 0 0.0013844002969563007
of O 0 0.0011696042492985725
the O 0 0.0027997817378491163
42 O 0 0.021447980776429176
- O 0 0.04499594122171402
kD O 1 0.9743813872337341
Factor O 0 0.18126638233661652
H O 1 0.9761234521865845
- O 0 0.02639327198266983
like O 0 0.008742247708141804
protein O 0 0.03323827311396599
1 O 0 0.012659094296395779
( O 0 0.011189294047653675
FHL O 1 0.9933833479881287
- O 0 0.028857465833425522
1 O 0 0.0095854252576828
) O 0 0.0034159328788518906
and O 0 0.0016718825791031122
other O 0 0.004093768075108528
FH O 1 0.9998088479042053
- O 0 0.04038838669657707
related O 0 0.02318587526679039
protein O 0 0.05249066650867462
( O 0 0.012661373242735863
FHR O 1 0.9942434430122375
) O 0 0.009533186443150043
bands O 0 0.022096816450357437
. O 0 0.010141807608306408

Southern O 0 0.03902333229780197
blot O 1 0.7457106113433838
and O 0 0.00529617490246892
PCR O 0 0.06360343098640442
analysis O 0 0.006927173584699631
of O 0 0.002156563801690936
DNA O 0 0.01562781073153019
of O 0 0.0020927456207573414
one O 0 0.005312986206263304
patient O 1 0.9985130429267883
with O 0 0.010102467611432076
homozygous O 1 0.9999744892120361
deficiency O 1 0.9999994039535522
ruled O 0 0.022802891209721565
out O 0 0.0029129688628017902
the O 0 0.0023118022363632917
presence O 0 0.005608999170362949
of O 0 0.0013795712729915977
a O 0 0.0043784212321043015
large O 0 0.00799689069390297
deletion O 1 0.506037712097168
of O 0 0.002985609695315361
the O 0 0.006878071464598179
FH O 1 0.9999518394470215
gene O 1 0.9290911555290222
as O 0 0.0028074367437511683
the O 0 0.0033812271431088448
underlying O 0 0.09745766967535019
defect O 1 0.9980353713035583
for O 0 0.0044148266315460205
the O 0 0.012403862550854683
deficiency O 1 0.9999953508377075
. O 0 0.019570184871554375

The O 0 0.00520828552544117
other O 0 0.002265376038849354
four O 0 0.00261064269579947
children O 0 0.008205011487007141
presented O 0 0.006214303430169821
with O 0 0.007214725017547607
heterozygous O 1 0.9998855590820312
deficiency O 1 0.999998927116394
and O 0 0.0037037848960608244
exhibited O 0 0.019129635766148567
a O 0 0.008808435872197151
normal O 0 0.024364205077290535
immunoblotting O 1 0.9658436179161072
pattern O 0 0.020755238831043243
of O 0 0.0021030809730291367
proteins O 0 0.011153853498399258
of O 0 0.0023686825297772884
the O 0 0.007388829719275236
FH O 1 0.9999039173126221
family O 0 0.03647246211767197
. O 0 0.01386591698974371

Factor B-Disease 1 0.9608099460601807
H I-Disease 1 0.9992958307266235
deficiency I-Disease 1 0.9999808073043823
is O 0 0.005087242927402258
the O 0 0.0030931541696190834
only O 0 0.005091709550470114
complement B-Disease 1 0.9838343858718872
deficiency I-Disease 1 0.999998927116394
associated O 0 0.01956808567047119
with O 0 0.010602938942611217
HUS B-Disease 1 0.9999334812164307
. O 0 0.019234152510762215

These O 0 0.005154730286449194
observations O 0 0.0095526659861207
suggest O 0 0.0077769821509718895
a O 0 0.005079952999949455
role O 0 0.007747042924165726
for O 0 0.004687892738729715
FH O 1 0.9997554421424866
and O 0 0.005371515639126301
/ O 0 0.4948674440383911
or O 0 0.012463396415114403
FH O 1 0.9998668432235718
receptors O 0 0.2548165023326874
in O 0 0.002868643496185541
the O 0 0.005390351638197899
pathogenesis O 1 0.999765932559967
of O 0 0.014130914583802223
idiopathic O 1 0.9999995231628418
HUS B-Disease 1 0.9999958276748657
. O 0 0.009780527092516422
. O 0 0.011790101416409016

Further O 0 0.00875589344650507
evidence O 0 0.003786225337535143
for O 0 0.0015542441979050636
a O 0 0.004573594778776169
major O 0 0.007473581470549107
ancient O 0 0.013824489898979664
mutation O 1 0.9999659061431885
underlying O 1 0.999082088470459
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999997615814209
from O 0 0.016219252720475197
linkage O 1 0.98728346824646
disequilibrium O 1 0.9970154762268066
studies O 0 0.008520526811480522
in O 0 0.0021861379500478506
the O 0 0.0032433494925498962
Japanese O 0 0.010953303426504135
population O 0 0.014914621599018574
. O 0 0.010133089497685432

The O 0 0.050530798733234406
myotonic B-Disease 1 0.9999943971633911
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.29030802845954895
DM B-Disease 1 0.9999910593032837
) O 0 0.01865359954535961
mutation O 1 0.9987542629241943
is O 0 0.006160116754472256
an O 0 0.005865922663360834
unstable O 1 0.747309148311615
( O 0 0.01530459988862276
CTG O 1 0.9840370416641235
) O 0 0.009205564856529236
n O 0 0.021662961691617966
repeat O 0 0.025158226490020752
, O 0 0.002109851688146591
present O 0 0.002699813572689891
at O 0 0.0021026544272899628
a O 0 0.003167710267007351
copy O 0 0.00834321603178978
number O 0 0.002373051829636097
of O 0 0.0021326665300875902
5 O 0 0.009469697251915932
- O 0 0.018604084849357605
37 O 0 0.019117042422294617
repeats O 0 0.025879358872771263
on O 0 0.004025868605822325
normal O 0 0.024247832596302032
chromosomes O 0 0.05388174578547478
but O 0 0.003331264480948448
amplified O 0 0.024687157943844795
to O 0 0.0028255172073841095
50 O 0 0.00925767607986927
- O 0 0.020871514454483986
3000 O 0 0.048499852418899536
copies O 0 0.01325639896094799
on O 0 0.011858277022838593
DM B-Disease 1 0.9998065829277039
chromosomes O 0 0.4908563196659088
. O 0 0.019125690683722496

Previous O 0 0.015184483490884304
findings O 0 0.01315711997449398
in O 0 0.004021545872092247
Caucasian O 1 0.8215534687042236
populations O 0 0.026579588651657104
of O 0 0.0039988234639167786
a O 0 0.023657547309994698
DM B-Disease 1 0.9999939203262329
founder O 1 0.9074554443359375
chromosome O 1 0.9994168281555176
raise O 0 0.014783046208322048
a O 0 0.005996622145175934
question O 0 0.005251661874353886
about O 0 0.0021234701853245497
the O 0 0.0027389756869524717
molecular O 0 0.01682913303375244
events O 0 0.005064342636615038
involved O 0 0.0045096492394804955
in O 0 0.00187870638910681
the O 0 0.004375821445137262
expansion O 0 0.03186781331896782
mutation O 1 0.9988424181938171
. O 0 0.014796039089560509

To O 0 0.0060697696171700954
investigate O 0 0.013932951726019382
whether O 0 0.005347220692783594
a O 0 0.00900043360888958
founder O 0 0.040335655212402344
chromosome O 1 0.9958764314651489
for O 0 0.0033913846127688885
the O 0 0.011314958333969116
DM B-Disease 1 0.9999929666519165
mutation O 1 0.9998093247413635
exists O 0 0.009235323406755924
in O 0 0.0014753843424841762
the O 0 0.002084336243569851
Japanese O 0 0.007195190992206335
population O 0 0.00728974025696516
, O 0 0.002384678227826953
we O 0 0.0033790955785661936
genotyped O 1 0.8544051647186279
families O 0 0.009179111570119858
using O 0 0.008790959604084492
polymorphic O 1 0.995554506778717
markers O 0 0.03175315633416176
near O 0 0.011073841713368893
the O 0 0.005365122575312853
( O 0 0.011787009425461292
CTG O 1 0.9500784873962402
) O 0 0.010862965136766434
n O 0 0.029503578320145607
repeat O 0 0.04166271165013313
region O 0 0.013221783563494682
and O 0 0.003661954076960683
constructed O 0 0.018864046782255173
haplotypes O 1 0.9561752676963806
. O 0 0.01569916121661663

Six O 0 0.011136187240481377
different O 0 0.005817846395075321
haplotypes O 1 0.6182635426521301
were O 0 0.002253958722576499
found O 0 0.0064908177591860294
and O 0 0.006182527635246515
DM B-Disease 1 0.9999969005584717
alleles O 1 0.9989601373672485
were O 0 0.00389652862213552
always O 0 0.012273969128727913
haplotype O 1 0.9957642555236816
A O 0 0.02044958434998989
. O 0 0.011023839935660362

To O 0 0.005450129508972168
find O 0 0.005382021889090538
an O 0 0.0021133627742528915
origin O 0 0.004164592828601599
of O 0 0.0015019243583083153
the O 0 0.0032556187361478806
( O 0 0.008202715776860714
CTG O 1 0.9946255087852478
) O 0 0.011054515838623047
n O 0 0.031389910727739334
repeat O 0 0.2572636008262634
mutation O 1 0.9979111552238464
and O 0 0.0017339817713946104
to O 0 0.0017025304259732366
investigate O 0 0.0073910546489059925
the O 0 0.002414451679214835
mechanism O 0 0.008867050521075726
of O 0 0.0016407975926995277
the O 0 0.002991177374497056
expansion O 0 0.01670491322875023
mutation O 1 0.9981656670570374
in O 0 0.0019800313748419285
the O 0 0.002244564238935709
Japanese O 0 0.006007091142237186
population O 0 0.005756583530455828
we O 0 0.0014655187260359526
have O 0 0.0018141951877623796
studied O 0 0.005463154520839453
90 O 0 0.012397030368447304
Japanese O 0 0.02333102934062481
DM B-Disease 1 0.9999266862869263
families O 0 0.015963546931743622
comprising O 0 0.013288716785609722
190 O 0 0.02747625857591629
affected O 0 0.05277622491121292
and O 0 0.003250366309657693
130 O 0 0.027172615751624107
unaffected O 1 0.8068680167198181
members O 0 0.009854135103523731
. O 0 0.011552833020687103

The O 0 0.006123658269643784
results O 0 0.008770249783992767
suggest O 0 0.006213585380464792
that O 0 0.0014972250210121274
a O 0 0.003258440876379609
few O 0 0.004011512268334627
common O 0 0.008625964634120464
ancestral O 1 0.721229076385498
mutations O 1 0.9996316432952881
in O 0 0.0025151586160063744
both O 0 0.003498421050608158
Caucasian O 1 0.9596200585365295
and O 0 0.0023839659988880157
Japanese O 0 0.009466060437262058
populations O 0 0.02450697496533394
have O 0 0.00230944762006402
originated O 0 0.008587239310145378
by O 0 0.002007740782573819
expansion O 0 0.005820078309625387
of O 0 0.0016379265580326319
an O 0 0.002877996303141117
ancestral O 0 0.03522336483001709
n O 0 0.027639375999569893
= O 0 0.028349988162517548
5 O 0 0.00938351172953844
repeat O 0 0.026661738753318787
to O 0 0.004799497313797474
n O 0 0.02905038185417652
= O 0 0.03678324818611145
19 O 0 0.017346233129501343
- O 0 0.02630421705543995
37 O 0 0.024958210065960884
copies O 0 0.018925393000245094
. O 0 0.011775657534599304

These O 0 0.004140864126384258
data O 0 0.004859231878072023
support O 0 0.006642351858317852
multistep O 0 0.07563260942697525
models O 0 0.008678163401782513
of O 0 0.0037896225694566965
triplet O 1 0.997502863407135
repeat O 0 0.36947518587112427
expansion O 0 0.008180678822100163
that O 0 0.0013657879317179322
have O 0 0.0013831951655447483
been O 0 0.001791444607079029
proposed O 0 0.003514511277899146
for O 0 0.0019267189782112837
both O 0 0.0060615683905780315
DM B-Disease 1 0.9999608993530273
and O 0 0.009987370111048222
Friedreichs B-Disease 1 0.9995007514953613
ataxia I-Disease 1 0.9999860525131226
. O 0 0.008404076099395752
. O 0 0.010234564542770386

The O 0 0.008098118007183075
molecular O 0 0.02030942589044571
basis O 0 0.005053719971328974
of O 0 0.009275555610656738
C6 B-Disease 1 0.9999970197677612
deficiency I-Disease 1 0.9999986886978149
in O 0 0.0035625596065074205
the O 0 0.0033240574412047863
western O 0 0.007608165964484215
Cape O 0 0.12780795991420746
, O 0 0.003321322612464428
South O 0 0.007747232913970947
Africa O 0 0.018976669758558273
. O 0 0.010384628549218178

Deficiency B-Disease 1 0.9999344348907471
of I-Disease 0 0.0034346533939242363
the I-Disease 0 0.0033304253593087196
sixth I-Disease 0 0.015721961855888367
component I-Disease 0 0.013208916410803795
of I-Disease 0 0.0024916655384004116
human I-Disease 0 0.011664383113384247
complement I-Disease 0 0.022074541077017784
( O 0 0.011966307647526264
C6 O 1 0.9997519850730896
) O 0 0.004164697602391243
has O 0 0.002420094097033143
been O 0 0.0022408319637179375
reported O 0 0.005003473721444607
in O 0 0.0012110446114093065
a O 0 0.0025032940320670605
number O 0 0.001664086477831006
of O 0 0.0011312912683933973
families O 0 0.004278235137462616
from O 0 0.002154738176614046
the O 0 0.0021609559189528227
western O 0 0.0066932025365531445
Cape O 0 0.1442122757434845
, O 0 0.0032026676926761866
South O 0 0.007448411080986261
Africa O 0 0.01686326041817665
. O 0 0.01118481159210205

Meningococcal B-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999997615814209
is O 0 0.010901792906224728
endemic O 1 0.9966938495635986
in O 0 0.0021658639889210463
the O 0 0.0028747671749442816
Cape O 0 0.17679142951965332
and O 0 0.001536126364953816
almost O 0 0.0034056908916682005
all O 0 0.001508695655502379
pedigrees O 0 0.043730247765779495
of O 0 0.0039322772063314915
total O 0 0.023623565211892128
C6 B-Disease 1 0.9999977350234985
deficiency I-Disease 1 0.9999995231628418
( O 0 0.024719085544347763
C6Q0 O 1 0.9991674423217773
) O 0 0.005163964815437794
have O 0 0.0021186871454119682
been O 0 0.003909356892108917
ascertained O 0 0.28263068199157715
because O 0 0.007487913127988577
of O 0 0.006896097678691149
recurrent O 1 0.9999892711639404
disease O 1 0.9999967813491821
. O 0 0.020360486581921577

We O 0 0.006509340368211269
have O 0 0.004092162009328604
sequenced O 0 0.037258706986904144
the O 0 0.0033360428642481565
expressed O 0 0.008493440225720406
exons O 0 0.041554443538188934
of O 0 0.00300445593893528
the O 0 0.0070823985151946545
C6 O 1 0.9998449087142944
gene O 1 0.8927382826805115
from O 0 0.003407952608540654
selected O 0 0.0039094495587050915
cases O 0 0.004910782910883427
and O 0 0.0008839608635753393
have O 0 0.0010618717642500997
found O 0 0.0028692856431007385
three O 0 0.0024432032369077206
molecular O 0 0.04788965731859207
defects O 1 0.9995589852333069
leading O 0 0.008430339395999908
to O 0 0.003327204380184412
total O 0 0.017273662611842155
deficiency O 1 0.9999996423721313
879delG O 1 0.9994142055511475
, O 0 0.002740380121394992
which O 0 0.0016322721494361758
is O 0 0.0021096407435834408
the O 0 0.0024158682208508253
common O 0 0.012638776563107967
defect O 1 0.9960538148880005
in O 0 0.002054010285064578
the O 0 0.002732374705374241
Cape O 0 0.03771538659930229
and O 0 0.002802901202812791
hitherto O 0 0.37890729308128357
unreported O 0 0.06599690765142441
, O 0 0.002450481988489628
and O 0 0.002644785214215517
1195delC O 1 0.9930779337882996
and O 0 0.003730952739715576
1936delG O 1 0.9890391826629639
, O 0 0.0021583018824458122
which O 0 0.0014037885703146458
have O 0 0.0014403000241145492
been O 0 0.002475449815392494
previously O 0 0.0045212940312922
reported O 0 0.007662505377084017
in O 0 0.0028642003890126944
African O 0 0.019085977226495743
- O 0 0.03312449902296066
Americans O 0 0.019253302365541458
. O 0 0.011357933282852173

We O 0 0.004729513544589281
also O 0 0.0018686808180063963
show O 0 0.003569299355149269
that O 0 0.0010575528722256422
the O 0 0.002843723399564624
879delG O 1 0.9982883334159851
and O 0 0.0062544746324419975
1195delC O 1 0.9993675351142883
defects O 1 0.9996473789215088
are O 0 0.002840850269421935
associated O 0 0.007649960462003946
with O 0 0.004265383817255497
characteristic O 1 0.8438431620597839
C6 O 1 0.999893307685852
/ O 1 0.9405383467674255
C7 O 1 0.9980637431144714
region O 0 0.0300290584564209
DNA O 0 0.061957187950611115
marker O 0 0.46020716428756714
haplotypes O 1 0.9912843704223633
, O 0 0.003579234005883336
although O 0 0.004415784031152725
small O 0 0.005102095194160938
variations O 0 0.009515471756458282
were O 0 0.002605413319543004
observed O 0 0.01648866944015026
. O 0 0.008424295112490654

The O 0 0.01713045872747898
1936delG O 1 0.9978305697441101
defect O 1 0.9956570863723755
was O 0 0.008602919057011604
observed O 0 0.011226036585867405
only O 0 0.002006171504035592
once O 0 0.0035621298011392355
in O 0 0.0015563990455120802
the O 0 0.002708740998059511
Cape O 0 0.20290511846542358
, O 0 0.0018315511988475919
but O 0 0.0017589251510798931
its O 0 0.002979474375024438
associated O 0 0.011995216831564903
haplotype O 1 0.9973157048225403
could O 0 0.005110566504299641
be O 0 0.0032331037800759077
deduced O 0 0.034591492265462875
. O 0 0.012135615572333336

The O 0 0.005413065664470196
data O 0 0.004528425168246031
from O 0 0.003287637373432517
the O 0 0.00480954023078084
haplotypes O 1 0.9898619651794434
indicate O 0 0.008695610798895359
that O 0 0.0014075541403144598
these O 0 0.0011297082528471947
three O 0 0.0027669682167470455
molecular O 0 0.03046623058617115
defects O 1 0.9987401366233826
account O 0 0.004395198542624712
for O 0 0.0015152741689234972
the O 0 0.0037078200839459896
defects O 1 0.9997120499610901
in O 0 0.0015828211326152086
all O 0 0.001258985954336822
the O 0 0.0025325596798211336
38 O 0 0.01979895308613777
unrelated O 0 0.396655410528183
C6Q0 O 1 0.9996356964111328
individuals O 0 0.006511715240776539
we O 0 0.0016015939181670547
have O 0 0.0016726553440093994
studied O 0 0.003779134713113308
from O 0 0.0023903888650238514
the O 0 0.004872750956565142
Cape O 0 0.061211951076984406
. O 0 0.013398295268416405

We O 0 0.004601859487593174
have O 0 0.002581414533779025
also O 0 0.0023788181133568287
observed O 0 0.009171896614134312
the O 0 0.005252442322671413
879delG O 1 0.9981600642204285
defect O 1 0.9865955114364624
in O 0 0.0025250765029340982
two O 0 0.002871223958209157
Dutch O 1 0.5724415183067322
C6 B-Disease 1 0.9999816417694092
- I-Disease 1 0.9348527789115906
deficient I-Disease 1 0.9997859597206116
kindreds O 1 0.9949946403503418
, O 0 0.002712138695642352
but O 0 0.0021375359501689672
the O 0 0.004292223136872053
879delG O 1 0.9994646906852722
defect O 1 0.9971866011619568
in O 0 0.0027836132794618607
the O 0 0.003592277877032757
Cape O 1 0.6657528877258301
probably O 0 0.0070707183331251144
did O 0 0.002002545865252614
not O 0 0.0012171899434179068
come O 0 0.00240308977663517
from O 0 0.0019923371728509665
The O 0 0.0027940324507653713
Netherlands O 0 0.01332340482622385
. O 0 0.004208224825561047
. O 0 0.008406038396060467

Complement B-Disease 1 0.9704861640930176
C7 I-Disease 1 0.9999948740005493
deficiency I-Disease 1 0.9999984502792358
: O 0 0.00914600770920515
seven O 0 0.005363293457776308
further O 0 0.009063256904482841
molecular O 0 0.13301622867584229
defects O 1 0.9985290765762329
and O 0 0.0018909131176769733
their O 0 0.003398112254217267
associated O 0 0.016119450330734253
marker O 0 0.2820764183998108
haplotypes O 1 0.9786137938499451
. O 0 0.01619623601436615

Seven O 0 0.01133363414555788
further O 0 0.008843997493386269
molecular O 0 0.024667324498295784
bases O 0 0.011652279645204544
of O 0 0.010500757023692131
C7 B-Disease 1 0.9999979734420776
deficiency I-Disease 1 0.9999992847442627
are O 0 0.004708034917712212
described O 0 0.01783420704305172
. O 0 0.010310022160410881

All O 0 0.0033481011632829905
these O 0 0.0024104886688292027
new O 0 0.005073235835880041
molecular O 0 0.04640309885144234
defects O 1 0.9975353479385376
involve O 0 0.014291307888925076
single O 0 0.014789429493248463
- O 0 0.02663966827094555
nucleotide O 0 0.04628114774823189
events O 0 0.006453306879848242
, O 0 0.003091769525781274
deletions O 0 0.09833652526140213
and O 0 0.0022701178677380085
substitutions O 0 0.011864552274346352
, O 0 0.0015225890092551708
some O 0 0.0011741627240553498
of O 0 0.0012526969658210874
which O 0 0.0028167911805212498
alter O 0 0.08833253383636475
splice O 1 0.6658462882041931
sites O 0 0.00543168094009161
, O 0 0.0018393559148535132
and O 0 0.0021798342932015657
others O 0 0.007941066287457943
codons O 0 0.09694243967533112
. O 0 0.01163450162857771

They O 0 0.003629985498264432
are O 0 0.0017789840931072831
distributed O 0 0.007244918495416641
along O 0 0.0047707101330161095
the O 0 0.008234377019107342
C7 O 1 0.9998874664306641
gene O 1 0.9930021166801453
, O 0 0.0033118685241788626
but O 0 0.0024294599425047636
predominantly O 0 0.008052143268287182
towards O 0 0.005379288922995329
the O 0 0.0035118034575134516
3 O 0 0.011858254671096802
end O 0 0.015426651574671268
. O 0 0.010837502777576447

All O 0 0.003204543609172106
were O 0 0.002225564792752266
found O 0 0.004751281812787056
in O 0 0.003598654642701149
compound O 0 0.03443411737680435
heterozygous O 1 0.9904019236564636
individuals O 0 0.017451008781790733
. O 0 0.01198408380150795

The O 0 0.02564389817416668
C6 O 1 0.9997572302818298
/ O 1 0.9851421117782593
C7 O 1 0.9987779259681702
marker O 0 0.4719354510307312
haplotypes O 1 0.977846086025238
associated O 0 0.013828372582793236
with O 0 0.004499785136431456
most O 0 0.010318992659449577
C7 B-Disease 1 0.9999808073043823
defects I-Disease 1 0.9998290538787842
are O 0 0.0038739279843866825
tabulated O 0 0.01650690659880638
. O 0 0.004834938794374466
. O 0 0.008959111757576466

A O 0 0.028899062424898148
genome O 0 0.21020351350307465
- O 0 0.023714100942015648
wide O 0 0.013648840598762035
search O 0 0.01230938546359539
for O 0 0.00701149320229888
chromosomal O 1 0.9994854927062988
loci O 1 0.9977927207946777
linked O 0 0.2731541395187378
to O 0 0.006560356356203556
mental O 1 0.9996671676635742
health O 1 0.9854308366775513
wellness O 1 0.9934141635894775
in O 0 0.0041923681274056435
relatives O 0 0.01601005531847477
at O 0 0.004877275787293911
high O 0 0.009200777858495712
risk O 1 0.9891791343688965
for O 0 0.015370347537100315
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999990463256836
disorder I-Disease 1 0.9999996423721313
among O 0 0.006085407920181751
the O 0 0.0032970039173960686
Old O 0 0.012826357036828995
Order O 0 0.009759117849171162
Amish O 0 0.06552654504776001
. O 0 0.011749538592994213

Bipolar B-Disease 1 0.9999991655349731
affective I-Disease 1 0.9999896287918091
disorder I-Disease 1 0.9999995231628418
( O 0 0.2581944763660431
BPAD B-Disease 1 0.9999908208847046
; O 0 0.2873753309249878
manic B-Disease 1 0.9999984502792358
- I-Disease 1 0.99985671043396
depressive I-Disease 1 0.9999998807907104
illness I-Disease 1 0.9999982118606567
) O 0 0.006898857653141022
is O 0 0.003928557503968477
characterized O 0 0.03231225907802582
by O 0 0.00375443440862
episodes O 0 0.015866320580244064
of O 0 0.0043688551522791386
mania B-Disease 1 0.9999419450759888
and O 0 0.005074051674455404
/ O 1 0.9385123252868652
or O 0 0.012132554315030575
hypomania B-Disease 1 0.9999408721923828
interspersed O 0 0.033526789397001266
with O 0 0.004443662706762552
periods O 0 0.016734274104237556
of O 0 0.006648175418376923
depression B-Disease 1 0.9999455213546753
. O 0 0.01638925075531006

Compelling O 0 0.023054689168930054
evidence O 0 0.007115514483302832
supports O 0 0.01066915225237608
a O 0 0.0059115649200975895
significant O 0 0.010024490766227245
genetic O 0 0.148822620511055
component O 0 0.013816801831126213
in O 0 0.0021117667201906443
the O 0 0.005002735648304224
susceptibility O 1 0.9995195865631104
to O 0 0.005834993440657854
develop O 0 0.04188910871744156
BPAD B-Disease 1 0.9980928301811218
. O 0 0.01844332180917263

To O 0 0.005177364684641361
date O 0 0.005549730267375708
, O 0 0.0018280778313055634
however O 0 0.0027035828679800034
, O 0 0.0021083832252770662
linkage O 0 0.05400100722908974
studies O 0 0.005297129042446613
have O 0 0.0015338266966864467
attempted O 0 0.006359124556183815
only O 0 0.0015781342517584562
to O 0 0.002254665596410632
identify O 0 0.021922538056969643
chromosomal O 1 0.9997383952140808
loci O 1 0.9993358254432678
that O 0 0.003699716879054904
cause O 1 0.6063306927680969
or O 0 0.003208335256204009
increase O 0 0.005835107062011957
the O 0 0.0042588356882333755
risk O 0 0.22491151094436646
of O 0 0.004659334663301706
developing O 0 0.04696565493941307
BPAD B-Disease 1 0.9997311234474182
. O 0 0.018450455740094185

To O 0 0.004852325655519962
determine O 0 0.006304594688117504
whether O 0 0.0028774680104106665
there O 0 0.001684684306383133
could O 0 0.002886299043893814
be O 0 0.004045296460390091
protective O 1 0.9824895858764648
alleles O 1 0.9985054731369019
that O 0 0.0035104905255138874
prevent O 0 0.026269476860761642
or O 0 0.004611211363226175
reduce O 0 0.012334578670561314
the O 0 0.003573461901396513
risk O 1 0.6688264608383179
of O 0 0.003228475572541356
developing O 0 0.031233102083206177
BPAD B-Disease 1 0.9999134540557861
, O 0 0.0023771068081259727
similar O 0 0.00341885257512331
to O 0 0.001201010076329112
what O 0 0.0015604738146066666
is O 0 0.0023199529387056828
observed O 0 0.006169354543089867
in O 0 0.001683182897977531
other O 0 0.003226600820198655
genetic B-Disease 1 0.9999854564666748
disorders I-Disease 1 0.9999998807907104
, O 0 0.002164996461942792
we O 0 0.001668621669523418
used O 0 0.003848162479698658
mental O 1 0.999923586845398
health O 1 0.998918890953064
wellness O 1 0.9988303780555725
( O 0 0.006209040060639381
absence O 0 0.01011041458696127
of O 0 0.002166678197681904
any O 0 0.007970748469233513
psychiatric B-Disease 1 0.9999920129776001
disorder I-Disease 1 0.9999991655349731
) O 0 0.00452875392511487
as O 0 0.0019318857230246067
the O 0 0.0035792903508991003
phenotype O 1 0.9998452663421631
in O 0 0.003101169131696224
our O 0 0.006230594590306282
genome O 1 0.746715247631073
- O 0 0.029371321201324463
wide O 0 0.022598983719944954
linkage O 0 0.09021180123090744
scan O 0 0.13812333345413208
of O 0 0.002394122304394841
several O 0 0.003064136253669858
large O 0 0.008506105281412601
multigeneration O 1 0.9391010999679565
Old O 0 0.015425560064613819
Order O 0 0.010253071784973145
Amish O 0 0.06774327903985977
pedigrees O 0 0.3066861927509308
exhibiting O 0 0.0498187318444252
an O 0 0.005574892275035381
extremely O 0 0.020670531317591667
high O 0 0.012804337777197361
incidence O 1 0.9970194697380066
of O 0 0.00789566244930029
BPAD B-Disease 1 0.999874472618103
. O 0 0.015274533070623875

We O 0 0.004583981819450855
have O 0 0.0021933706011623144
found O 0 0.003244534833356738
strong O 0 0.0034760627895593643
evidence O 0 0.0022918402682989836
for O 0 0.0018756934441626072
a O 0 0.00768236443400383
locus O 1 0.9714744687080383
on O 0 0.011619037948548794
chromosome O 1 0.9982811212539673
4p O 1 0.9822041392326355
at O 0 0.013041451573371887
D4S2949 O 1 0.7837611436843872
( O 0 0.00997888669371605
maximum O 0 0.021734634414315224
GENEHUNTER O 1 0.9905624985694885
- O 0 0.04094558209180832
PLUS O 0 0.03649704158306122
nonparametric O 0 0.12151293456554413
linkage O 0 0.060016293078660965
score O 0 0.014273845590651035
= O 0 0.034374259412288666
4 O 0 0.009979989379644394
. O 0 0.004211410414427519
05 O 0 0.07672292739152908
, O 0 0.0064238072372972965
P O 0 0.1589229702949524
= O 0 0.0295515526086092
5 O 0 0.0072710029780864716
. O 0 0.0027298606000840664
22 O 0 0.009314575232565403
x O 0 0.02503581903874874
10 O 0 0.006088136695325375
( O 0 0.005732061807066202
- O 0 0.013845699839293957
4 O 0 0.009356257505714893
) O 0 0.005070805083960295
; O 0 0.006954512093216181
SIBPAL O 1 0.985704779624939
Pempirical O 1 0.9053042531013489
value O 0 0.015605929307639599
< O 1 0.6078438758850098
3 O 0 0.013050438836216927
x O 0 0.025506705045700073
10 O 0 0.007799056824296713
( O 0 0.005967542063444853
- O 0 0.015525680035352707
5 O 0 0.007460756227374077
) O 0 0.003639351110905409
) O 0 0.002621373860165477
and O 0 0.0018472151132300496
suggestive O 0 0.023774782195687294
evidence O 0 0.0028441871982067823
for O 0 0.0020503217820078135
a O 0 0.009386132471263409
locus O 1 0.986028254032135
on O 0 0.012407769449055195
chromosome O 1 0.9996939897537231
4q O 1 0.9981271624565125
at O 0 0.012937571853399277
D4S397 O 1 0.9496409893035889
( O 0 0.01004863902926445
maximum O 0 0.020129309967160225
GENEHUNTER O 1 0.9915687441825867
- O 0 0.040831681340932846
PLUS O 0 0.03300929442048073
nonparametric O 0 0.1076192855834961
linkage O 0 0.051967889070510864
score O 0 0.01354821678251028
= O 0 0.030066413804888725
3 O 0 0.0075580100528895855
. O 0 0.003597830655053258
29 O 0 0.01089573185890913
, O 0 0.004443727899342775
P O 0 0.06765579432249069
= O 0 0.02928713895380497
2 O 0 0.00768140098080039
. O 0 0.003393413033336401
57 O 0 0.019561147317290306
x O 0 0.027643391862511635
10 O 0 0.007231863681226969
( O 0 0.007666083984076977
- O 0 0.018735595047473907
3 O 0 0.010459428653120995
) O 0 0.00563068175688386
; O 0 0.006472602486610413
SIBPAL O 1 0.9843605160713196
Pempirical O 1 0.8156014084815979
value O 0 0.018372127786278725
< O 0 0.30271679162979126
1 O 0 0.01394912414252758
x O 0 0.028860198333859444
10 O 0 0.006711822003126144
( O 0 0.00635847682133317
- O 0 0.01566738449037075
3 O 0 0.007680568378418684
) O 0 0.003185660345479846
) O 0 0.0017658788710832596
that O 0 0.0009356130613014102
are O 0 0.0013730392092838883
linked O 0 0.026497848331928253
to O 0 0.004973172675818205
mental O 1 0.9994400143623352
health O 1 0.9918398857116699
wellness O 1 0.9964834451675415
. O 0 0.014410021714866161

These O 0 0.005254697520285845
findings O 0 0.008839498274028301
are O 0 0.0012230782303959131
consistent O 0 0.004307994619011879
with O 0 0.0010956096230074763
the O 0 0.001865062746219337
hypothesis O 0 0.013120967894792557
that O 0 0.001558242947794497
certain O 0 0.005107366945594549
alleles O 1 0.9995535016059875
could O 0 0.004731006920337677
prevent O 0 0.017187193036079407
or O 0 0.0050906031392514706
modify O 0 0.01866942271590233
the O 0 0.00391173642128706
clinical O 1 0.987066924571991
manifestations O 1 0.8991207480430603
of O 0 0.004087098874151707
BPAD B-Disease 1 0.9999823570251465
and O 0 0.002347499132156372
perhaps O 0 0.00725532416254282
other O 0 0.0030948042403906584
related O 0 0.05454201623797417
affective B-Disease 1 0.9999760389328003
disorders I-Disease 1 0.9999973773956299
. O 0 0.017144683748483658

Segregation O 1 0.5413863062858582
distortion O 1 0.8560965061187744
in O 0 0.030299300327897072
myotonic B-Disease 1 0.9999966621398926
dystrophy I-Disease 1 0.9999992847442627
. O 0 0.03040463849902153

Myotonic B-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999997615814209
( O 0 0.35277894139289856
DM B-Disease 1 0.9999959468841553
) O 0 0.007382107432931662
is O 0 0.00446146447211504
an O 0 0.008665245957672596
autosomal B-Disease 1 0.9999990463256836
dominant I-Disease 1 0.999881386756897
disease I-Disease 1 0.9999997615814209
which O 0 0.002554824575781822
, O 0 0.0011069935280829668
in O 0 0.0009779009269550443
the O 0 0.0023359116166830063
typical O 0 0.1406465619802475
pedigree O 1 0.8639807105064392
, O 0 0.0019172882894054055
shows O 0 0.004555594641715288
a O 0 0.0037326831370592117
three O 0 0.0033939452841877937
generation O 0 0.027737103402614594
anticipation O 0 0.04604252800345421
cascade O 0 0.1985694020986557
. O 0 0.014524332247674465

This O 0 0.0067609683610498905
results O 0 0.011266668327152729
in O 0 0.007885311730206013
infertility B-Disease 1 0.9999958276748657
and O 0 0.39915308356285095
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.10650435835123062
CDM B-Disease 1 0.9990509152412415
) O 0 0.0044140382669866085
with O 0 0.0017837230116128922
the O 0 0.002626872155815363
disappearance O 0 0.06969329714775085
of O 0 0.006390439346432686
DM B-Disease 1 0.999993085861206
in O 0 0.005245791748166084
that O 0 0.005256481934338808
pedigree O 0 0.44931402802467346
. O 0 0.013917271979153156

The O 0 0.005234919488430023
concept O 0 0.007388724945485592
of O 0 0.003289164276793599
segregation O 1 0.5818009972572327
distortion O 0 0.4547293484210968
, O 0 0.002109111752361059
where O 0 0.002284822054207325
there O 0 0.0017620868748053908
is O 0 0.0026933031622320414
preferential O 0 0.024727100506424904
transmission O 0 0.026990635320544243
of O 0 0.0018777159275487065
the O 0 0.0027887511532753706
larger O 0 0.011525237932801247
allele O 1 0.9908972382545471
at O 0 0.006378545891493559
the O 0 0.010697758756577969
DM B-Disease 1 0.999992847442627
locus O 1 0.9993284940719604
, O 0 0.003957130014896393
has O 0 0.002882869215682149
been O 0 0.002364864805713296
put O 0 0.00407958310097456
forward O 0 0.004687182605266571
to O 0 0.002010913332924247
explain O 0 0.011028092354536057
partially O 0 0.01911565475165844
the O 0 0.0034207026474177837
maintenance O 0 0.017866084352135658
of O 0 0.004836042411625385
DM B-Disease 1 0.9999730587005615
in O 0 0.003631144529208541
the O 0 0.004858486820012331
population O 0 0.01674799434840679
. O 0 0.011926001869142056

In O 0 0.005110665690153837
a O 0 0.009003606624901295
survey O 0 0.013016624376177788
of O 0 0.006208275444805622
DM B-Disease 1 0.9999364614486694
in O 0 0.004169875755906105
Northern O 0 0.010256048291921616
Ireland O 0 0.010953448712825775
, O 0 0.003976160194724798
59 O 0 0.021538011729717255
pedigrees O 0 0.4428237974643707
were O 0 0.004984487779438496
ascertained O 0 0.30391883850097656
. O 0 0.012058316729962826

Sibships O 1 0.8940737843513489
where O 0 0.004627791233360767
the O 0 0.002296456368640065
status O 0 0.0042533427476882935
of O 0 0.0010417257435619831
all O 0 0.0009129224345088005
the O 0 0.001555442693643272
members O 0 0.002280360786244273
had O 0 0.0027559874579310417
been O 0 0.0026919497177004814
identified O 0 0.006021708715707064
were O 0 0.0014232959365472198
examined O 0 0.009743627160787582
to O 0 0.0012329216115176678
determine O 0 0.002989365952089429
the O 0 0.002370291156694293
transmission O 0 0.02314579300582409
of O 0 0.002045422326773405
the O 0 0.006475506816059351
DM B-Disease 1 0.9999957084655762
expansion O 0 0.017939366400241852
from O 0 0.005659948568791151
affected O 0 0.1864520013332367
parents O 0 0.011530555784702301
to O 0 0.002567284507676959
their O 0 0.005713232792913914
offspring O 1 0.8513922691345215
. O 0 0.014172473922371864

Where O 0 0.008659510873258114
the O 0 0.0062356991693377495
transmitting O 0 0.38902580738067627
parent O 1 0.5637061595916748
was O 0 0.008713592775166035
male O 0 0.04028163477778435
, O 0 0.005152388475835323
58 O 0 0.02975269965827465
. O 0 0.011761665344238281

3 O 0 0.014660856686532497
% O 0 0.004968497436493635
of O 0 0.0016819791635498405
the O 0 0.003295309143140912
offspring O 1 0.8351396918296814
were O 0 0.002982109785079956
affected O 0 0.0280628465116024
, O 0 0.0015987000660970807
and O 0 0.0008259573369286954
in O 0 0.0010737716220319271
the O 0 0.0014507032465189695
case O 0 0.003264796221628785
of O 0 0.001760758925229311
a O 0 0.006234153173863888
female O 0 0.027917321771383286
transmitting O 1 0.8259406685829163
parent O 0 0.46244901418685913
, O 0 0.005233401898294687
68 O 0 0.02980712056159973
. O 0 0.01269458793103695

7 O 0 0.02493898756802082
% O 0 0.010846391320228577
were O 0 0.004815532825887203
affected O 0 0.04150508716702461
. O 0 0.01206106599420309

Studies O 0 0.0200337003916502
on O 0 0.007242880761623383
meiotic O 1 0.9928125739097595
drive O 0 0.023541010916233063
in O 0 0.008208943530917168
DM B-Disease 1 0.9999775886535645
have O 0 0.00437096506357193
shown O 0 0.0075706313364207745
increased O 0 0.011202237568795681
transmission O 0 0.02456321381032467
of O 0 0.0016041221097111702
the O 0 0.0033720871433615685
larger O 0 0.01475964579731226
allele O 1 0.991676926612854
at O 0 0.005536915268748999
the O 0 0.00950884073972702
DM B-Disease 1 0.9999626874923706
locus O 1 0.9918861389160156
in O 0 0.007511249277740717
non O 0 0.03004271723330021
- O 1 0.8911155462265015
DM O 1 0.999980092048645
heterozygotes O 1 0.9973390698432922
for O 0 0.010665293782949448
CTGn O 1 0.9801738262176514
. O 0 0.019332299008965492

This O 0 0.006283321417868137
study O 0 0.0073655531741678715
provides O 0 0.0057715848088264465
further O 0 0.0029545645229518414
evidence O 0 0.0028864501509815454
that O 0 0.001983033027499914
the O 0 0.006529223173856735
DM B-Disease 1 0.9999712705612183
expansion O 0 0.02070792019367218
tends O 0 0.024226997047662735
to O 0 0.002641278551891446
be O 0 0.004617014434188604
transmitted O 1 0.6674947142601013
preferentially O 0 0.13523335754871368
. O 0 0.01592107303440571

Diagnosis O 1 0.9997938275337219
of O 0 0.021786000579595566
hemochromatosis B-Disease 1 0.9999972581863403
. O 0 0.022895244881510735

If O 0 0.02949633076786995
untreated O 1 0.9998810291290283
, O 0 0.015626095235347748
hemochromatosis B-Disease 1 0.9999985694885254
can O 0 0.018425369635224342
cause O 1 0.9998737573623657
serious O 1 0.9999141693115234
illness O 1 0.9999979734420776
and O 0 0.0029205740429461002
early B-Disease 0 0.00811502244323492
death I-Disease 0 0.31427398324012756
, O 0 0.0017478216905146837
but O 0 0.002277449704706669
the O 0 0.0054715839214622974
disease O 1 0.9999997615814209
is O 0 0.0031424309127032757
still O 0 0.00430995412170887
substantially O 0 0.028681734576821327
under O 0 0.010288723744452
- O 1 0.9964171648025513
diagnosed O 1 0.9999964237213135
. O 0 0.020952774211764336

The O 0 0.007723301183432341
cornerstone O 0 0.021774953231215477
of O 0 0.003573684487491846
screening O 0 0.031063562259078026
and O 0 0.0017268946394324303
case O 0 0.006141481921076775
detection O 0 0.01865837350487709
is O 0 0.0020723931957036257
the O 0 0.0018761880928650498
measurement O 0 0.009389813058078289
of O 0 0.0036825460847467184
serum O 1 0.9978417158126831
transferrin O 1 0.9937577247619629
saturation O 0 0.30861058831214905
and O 0 0.002790705068036914
the O 0 0.00611621281132102
serum O 1 0.9849786162376404
ferritin O 1 0.9694265723228455
level O 0 0.01665276102721691
. O 0 0.013611548580229282

Once O 0 0.018371468409895897
the O 0 0.009035875089466572
diagnosis O 1 0.9999403953552246
is O 0 0.005285609047859907
suspected O 0 0.025759579613804817
, O 0 0.0036115283146500587
physicians O 0 0.19440920650959015
must O 0 0.00455077737569809
use O 0 0.005713519640266895
serum O 1 0.9946315288543701
ferritin O 1 0.9885739088058472
levels O 0 0.019133420661091805
and O 0 0.00697947246953845
hepatic O 1 0.9999834299087524
iron O 0 0.2612929046154022
stores O 0 0.021436896175146103
on O 0 0.011892194859683514
liver O 1 0.9999988079071045
biopsy O 1 0.9999834299087524
specimens O 0 0.05100337043404579
to O 0 0.0035284245386719704
assess O 0 0.19981345534324646
patients O 1 0.9988648891448975
for O 0 0.0016145893605425954
the O 0 0.0024783292319625616
presence O 0 0.008397616446018219
of O 0 0.0039459350518882275
iron B-Disease 1 0.8346284627914429
overload I-Disease 1 0.9986060261726379
. O 0 0.013184908777475357

Liver O 1 0.9999984502792358
biopsy O 1 0.9999265670776367
is O 0 0.0037290886975824833
also O 0 0.001316669280640781
used O 0 0.001185532659292221
to O 0 0.0010259764967486262
establish O 0 0.003968967590481043
the O 0 0.002012422075495124
presence O 0 0.008129075169563293
or O 0 0.003964896313846111
absence O 0 0.015204391442239285
of O 0 0.0057651144452393055
cirrhosis B-Disease 1 0.9999985694885254
, O 0 0.002958020893856883
which O 0 0.0026649944484233856
can O 0 0.006298079155385494
affect O 1 0.5437917113304138
prognosis O 1 0.9999785423278809
and O 0 0.00386777613312006
management O 0 0.018288085237145424
. O 0 0.009900686331093311

A O 0 0.023915940895676613
DNA O 0 0.04458288848400116
- O 0 0.016471071168780327
based O 0 0.0038385449443012476
test O 0 0.005536411888897419
for O 0 0.002052783500403166
the O 0 0.007174479775130749
HFE O 1 0.9999619722366333
gene O 1 0.986684262752533
is O 0 0.004488094709813595
commercially O 0 0.009094043634831905
available O 0 0.00214603403583169
, O 0 0.0009973453124985099
but O 0 0.0009970332030206919
its O 0 0.001236885436810553
place O 0 0.0016315830871462822
in O 0 0.0014316486194729805
the O 0 0.004080069717019796
diagnosis O 1 0.9999672174453735
of O 0 0.007249000482261181
hemochromatosis B-Disease 1 0.9999991655349731
is O 0 0.006445045117288828
still O 0 0.0057871583849191666
being O 0 0.007240701466798782
evaluated O 0 0.03982757776975632
. O 0 0.010649657808244228

Currently O 0 0.007936090230941772
, O 0 0.0018896186957135797
the O 0 0.0018794010393321514
most O 0 0.002130973618477583
useful O 0 0.0035960928071290255
role O 0 0.003506577806547284
for O 0 0.0011050669709220529
this O 0 0.0015875176759436727
test O 0 0.004594088066369295
is O 0 0.001531065790913999
in O 0 0.0009769655298441648
the O 0 0.002640772145241499
detection O 0 0.02685462310910225
of O 0 0.005147394258528948
hemochromatosis B-Disease 1 0.999997615814209
in O 0 0.00237365928478539
the O 0 0.0020966860465705395
family O 0 0.007262729108333588
members O 0 0.0030939250718802214
of O 0 0.0027596987783908844
patients O 1 0.9998418092727661
with O 0 0.0025282211136072874
a O 0 0.0052397786639630795
proven O 0 0.015813760459423065
case O 0 0.0055784303694963455
of O 0 0.0027152267284691334
the O 0 0.008623612113296986
disease O 1 0.9999982118606567
. O 0 0.013950028456747532

It O 0 0.004349741619080305
is O 0 0.0032854743767529726
crucial O 0 0.0107842106372118
to O 0 0.008758778683841228
diagnose O 1 0.9999959468841553
hemochromatosis B-Disease 1 0.9999992847442627
before O 1 0.5870053172111511
hepatic B-Disease 1 0.9999994039535522
cirrhosis I-Disease 1 0.9999991655349731
develops O 1 0.9987540245056152
because O 0 0.033134445548057556
phlebotomy O 1 0.9997739195823669
therapy O 1 0.9997231364250183
can O 0 0.015193984843790531
avert O 1 0.9998331069946289
serious O 1 0.999994158744812
chronic O 1 1.0
disease O 1 1.0
and O 0 0.003164895810186863
can O 0 0.003158159088343382
even O 0 0.0026798381004482508
lead O 0 0.00488681485876441
to O 0 0.002378940349444747
normal O 0 0.015588386915624142
life O 0 0.01277984119951725
expectancy O 1 0.7708427309989929
. O 0 0.00549633102491498
. O 0 0.009486708790063858

Prevalence O 1 0.9678648710250854
of O 0 0.005079646594822407
the O 0 0.009894129820168018
I1307K O 1 0.9988621473312378
APC B-Disease 1 0.9996410608291626
gene O 1 0.9971320629119873
variant O 1 0.6062815189361572
in O 0 0.0023316883016377687
Israeli O 0 0.005941832438111305
Jews O 0 0.004033353179693222
of O 0 0.0017054666532203555
differing O 0 0.007909326814115047
ethnic O 0 0.007957815192639828
origin O 0 0.008122722618281841
and O 0 0.004181179217994213
risk O 1 0.9985880255699158
for O 0 0.15505947172641754
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.022330572828650475

BACKGROUND O 0 0.03835143893957138
& O 0 0.027062546461820602
AIMS O 0 0.021108929067850113
Israeli O 0 0.009345673024654388
Jews O 0 0.0052312701009213924
of O 0 0.00196312228217721
European O 0 0.007747875526547432
birth O 1 0.6609339714050293
, O 0 0.00287607847712934
i O 0 0.004401372279971838
. O 0 0.002148953266441822
e O 0 0.013826870359480381
. O 0 0.0021121439058333635
, O 0 0.0029149262700229883
Ashkenazim O 1 0.9519966244697571
, O 0 0.0017629500944167376
have O 0 0.0018516900017857552
the O 0 0.004190368577837944
highest O 1 0.9959056377410889
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.999954104423523
of O 0 0.002491313498467207
any O 0 0.003028016071766615
Israeli O 0 0.008517703041434288
ethnic O 0 0.011509961448609829
group O 0 0.010231315158307552
. O 0 0.010896405205130577

The O 0 0.01957416534423828
I1307K O 1 0.996822714805603
APC B-Disease 1 0.9993170499801636
gene O 1 0.997962236404419
variant O 1 0.9034854769706726
was O 0 0.005266931839287281
found O 0 0.005345869343727827
in O 0 0.003011647379025817
6 O 0 0.011777020990848541
. O 0 0.008514804765582085

1 O 0 0.016820238903164864
% O 0 0.0058435965329408646
of O 0 0.0020147121977061033
American O 0 0.005352731794118881
Jews O 0 0.0054491558112204075
, O 0 0.0019748753402382135
28 O 0 0.006362265441566706
% O 0 0.003420263295993209
of O 0 0.0024635447189211845
their O 0 0.0164125207811594
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.8832220435142517
, O 0 0.0020163352601230145
but O 0 0.00153436791151762
not O 0 0.0013774563558399677
in O 0 0.0021210175473243
non O 0 0.010743419639766216
- O 0 0.019377324730157852
Jews O 0 0.015526686795055866
. O 0 0.010906112380325794

We O 0 0.006989884190261364
assessed O 0 0.021704675629734993
the O 0 0.007464404683560133
I1307K O 1 0.9991793036460876
prevalence O 1 0.9983676075935364
in O 0 0.0034701989497989416
Israeli O 0 0.008200745098292828
Jews O 0 0.0051745702512562275
of O 0 0.0019811217207461596
differing O 0 0.008575031533837318
ethnic O 0 0.008417720906436443
origin O 0 0.008714546449482441
and O 0 0.004155541304498911
risk O 1 0.9963775277137756
for O 0 0.07960007339715958
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.01968860998749733

METHODS O 0 0.025297805666923523
DNA O 0 0.03848879039287567
samples O 0 0.015330757945775986
from O 0 0.004135927651077509
500 O 0 0.012499925680458546
unrelated O 0 0.019282875582575798
Jews O 0 0.00580440042540431
of O 0 0.0018644087249413133
European O 0 0.005031991750001907
or O 0 0.005230783950537443
non O 0 0.010734857991337776
- O 0 0.013854101300239563
European O 0 0.00477807130664587
origin O 0 0.00513676181435585
, O 0 0.0014813371235504746
with O 0 0.001538739656098187
or O 0 0.0025011443067342043
without O 0 0.002943356754258275
a O 0 0.004029939416795969
personal O 0 0.006810159422457218
and O 0 0.002648359863087535
/ O 0 0.3148026466369629
or O 0 0.0040962472558021545
family O 0 0.007200166117399931
history O 0 0.004967774264514446
of O 0 0.004371969029307365
neoplasia B-Disease 1 0.999977707862854
, O 0 0.002040058607235551
were O 0 0.0015032041119411588
examined O 0 0.010532757267355919
for O 0 0.0017688367515802383
the O 0 0.0043826778419315815
I1307K O 1 0.9940387010574341
variant O 0 0.39872780442237854
by O 0 0.006250819191336632
the O 0 0.007070256397128105
allele O 1 0.983828067779541
- O 0 0.031094085425138474
specific O 0 0.0129385469481349
oligonucleotide O 0 0.48245155811309814
( O 0 0.01431654579937458
ASO O 1 0.9450414776802063
) O 0 0.008368502371013165
method O 0 0.015447866171598434
. O 0 0.010138146579265594

RESULTS O 0 0.020683933049440384
In O 0 0.003888585837557912
persons O 0 0.008222940377891064
at O 0 0.004669790156185627
average O 0 0.01902414858341217
risk O 1 0.9972791075706482
for O 0 0.14768086373806
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.009321669116616249
I1307K O 1 0.9988184571266174
was O 0 0.0054990919306874275
found O 0 0.005899004638195038
in O 0 0.0033745127730071545
5 O 0 0.013138515874743462
. O 0 0.008496036753058434

0 O 0 0.028491636738181114
% O 0 0.005700631532818079
of O 0 0.0022838632576167583
120 O 0 0.006940704770386219
European O 0 0.004768971353769302
and O 0 0.0025079932529479265
1 O 0 0.0108609264716506
. O 0 0.009371064603328705

6 O 0 0.019363321363925934
% O 0 0.00658219400793314
of O 0 0.0028132156003266573
188 O 0 0.02901494689285755
non O 0 0.014719344675540924
- O 0 0.0179376769810915
European O 0 0.007294175215065479
Jews O 0 0.010640827938914299
( O 0 0.011192000471055508
P O 0 0.12341582775115967
= O 0 0.04568980634212494
0 O 0 0.021847644820809364
. O 0 0.005750540643930435
08 O 0 0.05875464901328087
) O 0 0.01088772900402546
. O 0 0.009935939684510231

It O 0 0.008127563633024693
occurred O 0 0.020690327510237694
in O 0 0.0044951289892196655
15 O 0 0.013084410689771175
. O 0 0.012909743003547192

4 O 0 0.016186531633138657
% O 0 0.00681810500100255
of O 0 0.003130015917122364
52 O 0 0.02129318192601204
Ashkenazi O 1 0.9623436331748962
Israelis O 0 0.03212369978427887
with O 0 0.011208508163690567
familial O 1 0.9999985694885254
cancer B-Disease 1 0.9999995231628418
( O 0 0.02215779945254326
P O 1 0.950000524520874
= O 0 0.04976663738489151
0 O 0 0.021197481080889702
. O 0 0.004797103814780712
02 O 1 0.9635493755340576
) O 0 0.003620408708229661
and O 0 0.0012567692901939154
was O 0 0.0021599929314106703
not O 0 0.0022681583650410175
detected O 0 0.024448176845908165
in O 0 0.0026839603669941425
51 O 0 0.015687406063079834
non O 0 0.010877341032028198
- O 0 0.01332033984363079
European O 0 0.005692048463970423
Jews O 0 0.007257529534399509
at O 0 0.007326984312385321
increased O 1 0.5497613549232483
cancer B-Disease 1 0.999994158744812
risk O 1 0.9955675005912781
. O 0 0.01478126272559166

Colorectal B-Disease 1 0.9999988079071045
neoplasia I-Disease 1 0.9999229907989502
occurred O 0 0.06040172278881073
personally O 0 0.02471420168876648
or O 0 0.004115744028240442
in O 0 0.0018625401426106691
the O 0 0.001748052192851901
families O 0 0.0038998632226139307
of O 0 0.0014174894895404577
13 O 0 0.004617104306817055
of O 0 0.0023012440651655197
20 O 0 0.01093157846480608
Ashkenazi O 1 0.9964321851730347
I1307K O 1 0.9993282556533813
carriers O 0 0.12495093047618866
, O 0 0.0023785026278346777
8 O 0 0.005022699013352394
of O 0 0.0017076071817427874
whom O 0 0.006583138834685087
also O 0 0.0014252448454499245
had O 0 0.002173089887946844
a O 0 0.0035048339050263166
personal O 0 0.005363655276596546
or O 0 0.003379142377525568
family O 0 0.007806181441992521
history O 0 0.006061381194740534
of O 0 0.006865708157420158
noncolonic O 1 0.9996403455734253
neoplasia B-Disease 1 0.999915361404419
. O 0 0.02356201969087124

CONCLUSIONS O 0 0.03190238028764725
The O 0 0.012049906887114048
I1307K O 1 0.9971421360969543
APC O 1 0.999748170375824
variant O 1 0.9919227957725525
may O 0 0.007458945270627737
represent O 0 0.006294490769505501
a O 0 0.012901488691568375
susceptibility O 1 0.9997530579566956
gene O 1 0.9977151155471802
for O 0 0.008382974192500114
colorectal B-Disease 1 0.9999997615814209
, I-Disease 0 0.0036119369324296713
or I-Disease 0 0.003453867742791772
other I-Disease 0 0.001833816641010344
, I-Disease 0 0.004826097283512354
cancers I-Disease 1 0.9999938011169434
in O 0 0.004642387852072716
Ashkenazi O 1 0.9877904653549194
Jews O 0 0.006490460596978664
, O 0 0.002183449687436223
and O 0 0.001798067009076476
partially O 0 0.02630683034658432
explains O 0 0.01222192496061325
the O 0 0.0028277281671762466
higher O 0 0.014680813066661358
incidence O 1 0.9999481439590454
of O 0 0.16607679426670074
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
in O 0 0.005813054274767637
European O 0 0.009355545975267887
Israelis O 0 0.026124263182282448
. O 0 0.012968311086297035

Systematic O 0 0.04515868425369263
analysis O 0 0.01348047610372305
of O 0 0.008057165890932083
coproporphyrinogen O 1 0.9985203146934509
oxidase O 1 0.9985673427581787
gene O 1 0.9976060390472412
defects O 1 0.9989854693412781
in O 0 0.00919966772198677
hereditary B-Disease 1 0.9996688365936279
coproporphyria I-Disease 1 0.9973015189170837
and O 0 0.012048925273120403
mutation O 1 0.9995577931404114
update O 0 0.06730472296476364
. O 0 0.01653636246919632

Hereditary B-Disease 1 0.9995766282081604
coproporphyria I-Disease 1 0.9936830997467041
( O 0 0.01877368427813053
HC B-Disease 1 0.9386422038078308
) O 0 0.005792742129415274
is O 0 0.004029809031635523
an O 0 0.007942670956254005
acute O 1 0.9999984502792358
hepatic B-Disease 1 0.9999998807907104
porphyria I-Disease 1 0.9999997615814209
with O 0 0.08782237023115158
autosomal O 1 0.999998927116394
dominant O 1 0.9983857870101929
inheritance O 1 0.999849796295166
caused O 1 0.9975704550743103
by O 0 0.008314807899296284
deficient B-Disease 1 0.9934011101722717
activity I-Disease 0 0.013554266653954983
of I-Disease 0 0.005395690444856882
coproporphyrinogen I-Disease 1 0.9983628392219543
III I-Disease 1 0.9890772104263306
oxidase I-Disease 1 0.9823362231254578
( O 0 0.021690992638468742
CPO O 0 0.2054263949394226
) O 0 0.01108939852565527
. O 0 0.012308928184211254

Clinical O 1 0.9684443473815918
manifestations O 0 0.12820877134799957
of O 0 0.0034962294157594442
the O 0 0.008130697533488274
disease O 1 0.9999995231628418
are O 0 0.0033666265662759542
characterized O 1 0.9166629314422607
by O 0 0.007650936953723431
acute O 1 0.9999982118606567
attacks O 0 0.3112785816192627
of O 0 0.014322361908853054
neurological B-Disease 1 0.9999998807907104
dysfunction I-Disease 1 0.9999995231628418
often O 0 0.03215232118964195
precipitated O 1 0.9995457530021667
by O 0 0.007017318159341812
drugs O 0 0.4121064245700836
, O 0 0.004519959911704063
fasting O 1 0.9304811954498291
, O 0 0.00690328236669302
cyclical O 1 0.9997627139091492
hormonal O 1 0.9999401569366455
changes O 0 0.011574841104447842
, O 0 0.0037334526423364878
or O 0 0.01895228959619999
infectious B-Disease 1 0.9999979734420776
diseases I-Disease 1 0.9999983310699463
. O 0 0.014075725339353085

Skin O 1 0.9999934434890747
photosensitivity O 1 0.9999381303787231
may O 0 0.016598157584667206
also O 0 0.003296610666438937
be O 0 0.002477603266015649
present O 0 0.005704078357666731
. O 0 0.008816486224532127

The O 0 0.006416273303329945
seven O 0 0.007662139367312193
exons O 0 0.062175653874874115
, O 0 0.002834235318005085
the O 0 0.004876625258475542
exon O 1 0.9810298681259155
/ O 1 0.5514054894447327
intron O 1 0.9129733443260193
boundaries O 0 0.00475596496835351
and O 0 0.0012378530809655786
part O 0 0.002795088803395629
of O 0 0.001916785491630435
3 O 0 0.00894037913531065
noncoding O 0 0.10256468504667282
sequence O 0 0.011998043395578861
of O 0 0.0018842177232727408
the O 0 0.004737227689474821
CPO O 1 0.712446928024292
gene O 0 0.2867031991481781
were O 0 0.0030055027455091476
systematically O 0 0.01611156389117241
analyzed O 0 0.010979992337524891
by O 0 0.0024433890357613564
an O 0 0.0035441950894892216
exon O 1 0.6206797361373901
- O 0 0.019696742296218872
by O 0 0.006408534944057465
- O 0 0.045395560562610626
exon O 1 0.5540260672569275
denaturing O 1 0.976298987865448
gradient O 1 0.5136443376541138
gel O 1 0.9840706586837769
electrophoresis O 1 0.8247999548912048
( O 0 0.015417927876114845
DGGE O 1 0.9918094277381897
) O 0 0.00556317251175642
strategy O 0 0.010941754095256329
followed O 0 0.005892638117074966
by O 0 0.002509591169655323
direct O 0 0.00692018773406744
sequencing O 0 0.023075951263308525
in O 0 0.002529662102460861
seven O 0 0.006003487389534712
unrelated O 1 0.6784549355506897
heterozygous O 1 0.999789297580719
HC B-Disease 1 0.9997870326042175
patients O 1 0.9999312162399292
from O 0 0.005603087600320578
France O 0 0.016926079988479614
, O 0 0.003186587244272232
Holland O 0 0.02915647067129612
, O 0 0.0022418119478970766
and O 0 0.002216359367594123
Czech O 0 0.0162416510283947
Republic O 0 0.015040424652397633
. O 0 0.011033589951694012

Seven O 0 0.019074706360697746
novel O 0 0.0411694310605526
mutations O 1 0.9985511898994446
and O 0 0.002047365764155984
two O 0 0.0018290220759809017
new O 0 0.0049180700443685055
polymorphisms O 1 0.965498149394989
were O 0 0.004341858439147472
detected O 0 0.1369178295135498
. O 0 0.00896814651787281

Among O 0 0.012118810787796974
these O 0 0.0047888788394629955
mutations O 1 0.993259608745575
two O 0 0.0029551475308835506
are O 0 0.0036317913327366114
missense O 1 0.9962552785873413
( O 0 0.014637008309364319
G197W O 1 0.9787960648536682
, O 0 0.006434723734855652
W427R O 1 0.9523321390151978
) O 0 0.0039128088392317295
, O 0 0.0015681269578635693
two O 0 0.0014373863814398646
are O 0 0.0018918422283604741
nonsense O 0 0.0331692174077034
( O 0 0.00922621414065361
Q306X O 1 0.9693294167518616
, O 0 0.006287992000579834
Q385X O 1 0.9284313321113586
) O 0 0.0037135016173124313
, O 0 0.0012784413993358612
two O 0 0.0014036621432751417
are O 0 0.0015205482486635447
small O 0 0.007087721023708582
deletions O 1 0.6766425371170044
( O 0 0.011241167783737183
662de14bp O 1 0.9434033632278442
; O 0 0.010927892290055752
1168del3bp O 1 0.8366785049438477
removing O 0 0.02381238341331482
a O 0 0.009067033417522907
glycine O 0 0.05249759182333946
at O 0 0.0038727079518139362
position O 0 0.005747984163463116
390 O 0 0.024572378024458885
) O 0 0.00301283597946167
, O 0 0.0011183854658156633
and O 0 0.0010127249406650662
one O 0 0.001460395404137671
is O 0 0.002924124011769891
a O 0 0.008469082415103912
splicing O 1 0.5007060170173645
mutation O 1 0.9987307190895081
( O 0 0.01974583975970745
IVS1 O 1 0.9947911500930786
- O 0 0.10357498377561569
15c O 1 0.9927070736885071
- O 0 0.07506386190652847
- O 0 0.085306316614151
> O 1 0.9331623911857605
g O 0 0.05369407683610916
) O 0 0.004741944372653961
which O 0 0.0022558877244591713
creates O 0 0.014358784072101116
a O 0 0.006045607849955559
new O 0 0.008717509917914867
acceptor O 0 0.14193947613239288
splice O 0 0.39640605449676514
site O 0 0.023805955424904823
. O 0 0.011292326264083385

The O 0 0.009966730140149593
pathological O 1 0.5065153241157532
significance O 0 0.005992673337459564
of O 0 0.0015955778071656823
the O 0 0.002481534145772457
point O 0 0.00852685235440731
mutations O 1 0.999742329120636
G197W O 1 0.9988786578178406
, O 0 0.005642944015562534
W427R O 1 0.9901106953620911
, O 0 0.0022855980787426233
and O 0 0.0011014515766873956
the O 0 0.0015805050497874618
in O 0 0.0024568571243435144
- O 0 0.022161303088068962
frame O 0 0.02599184773862362
deletion O 1 0.9934778213500977
390delGly O 1 0.8969444036483765
were O 0 0.002288882154971361
assessed O 0 0.010580942034721375
by O 0 0.0021006036549806595
their O 0 0.001945293857716024
respective O 0 0.006715141236782074
expression O 0 0.012605870142579079
in O 0 0.0017592322546988726
a O 0 0.004845701158046722
prokaryotic O 0 0.035736702382564545
system O 0 0.006544319447129965
using O 0 0.0046693915501236916
site O 0 0.010532946325838566
- O 0 0.027081463485956192
directed O 0 0.02197512798011303
mutagenesis O 0 0.4157092571258545
. O 0 0.020795734599232674

These O 0 0.011041647754609585
mutations O 1 0.9980860948562622
resulted O 0 0.016644369810819626
in O 0 0.0019352168310433626
the O 0 0.0026174394879490137
absence O 0 0.011011732742190361
or O 0 0.0034465703647583723
a O 0 0.004876146093010902
dramatic O 0 0.021495716646313667
decrease O 0 0.02654345892369747
of O 0 0.004519803449511528
CPO O 0 0.3946595788002014
activity O 0 0.024572396650910378
. O 0 0.010824241675436497

The O 0 0.006773211527615786
two O 0 0.005171686876565218
polymorphisms O 1 0.9564120769500732
were O 0 0.004080069717019796
localized O 1 0.6154884099960327
in O 0 0.004728196654468775
noncoding O 0 0.10952617228031158
part O 0 0.004107211250811815
of O 0 0.0015774259809404612
the O 0 0.004127394873648882
gene O 1 0.8256890773773193
1 O 0 0.009445318952202797
) O 0 0.003905518911778927
a O 0 0.011031195521354675
C O 0 0.05961579084396362
/ O 0 0.18396249413490295
G O 0 0.2701086103916168
polymorphism O 0 0.056556399911642075
in O 0 0.0031160125508904457
the O 0 0.005135706160217524
promotor O 1 0.9946509003639221
region O 0 0.01366250216960907
, O 0 0.004017243627458811
142 O 0 0.03632817417383194
bp O 0 0.03980332985520363
upstream O 0 0.0242153387516737
from O 0 0.0033689122647047043
the O 0 0.003744088113307953
transcriptional O 0 0.07752901315689087
initiation O 0 0.04738135263323784
site O 0 0.01048542931675911
( O 0 0.010421405546367168
- O 0 0.04620099812746048
142C O 1 0.9968583583831787
/ O 1 0.8789759278297424
G O 0 0.2576017379760742
) O 0 0.004162154626101255
, O 0 0.0014818210620433092
and O 0 0.0012016810942441225
2 O 0 0.0053093330934643745
) O 0 0.0030028277542442083
a O 0 0.005881625693291426
6 O 0 0.013763845898211002
bp O 0 0.057493146508932114
deletion O 1 0.9810996651649475
polymorphism O 0 0.0786367878317833
in O 0 0.0026999381370842457
the O 0 0.003002198413014412
3 O 0 0.01012085285037756
noncoding O 0 0.0676310658454895
part O 0 0.003942619077861309
of O 0 0.001978276763111353
the O 0 0.005525183863937855
CPO O 1 0.9602342247962952
gene O 1 0.937646746635437
, O 0 0.0055617825128138065
574 O 1 0.7423029541969299
bp O 0 0.035423606634140015
downstream O 0 0.017539020627737045
of O 0 0.0014644056791439652
the O 0 0.0020027593709528446
last O 0 0.004191010724753141
base O 0 0.004893985576927662
of O 0 0.0015832154313102365
the O 0 0.003834378905594349
normal O 0 0.029675781726837158
termination O 1 0.7208678722381592
codon O 1 0.6298311948776245
( O 0 0.017393143847584724
+ O 0 0.09561996161937714
574 O 1 0.9701349139213562
delATTCTT O 1 0.9547597765922546
) O 0 0.011655186302959919
. O 0 0.011110245250165462

Five O 0 0.025120669975876808
intragenic O 1 0.9954467415809631
dimorphisms O 1 0.9904252886772156
are O 0 0.00275385077111423
now O 0 0.0038954298943281174
well O 0 0.003063068725168705
characterized O 0 0.019116200506687164
and O 0 0.0013436818262562156
the O 0 0.0015899817226454616
high O 0 0.004523363430052996
degree O 0 0.005947377532720566
of O 0 0.0042710378766059875
allelic O 1 0.9925414323806763
heterogeneity O 1 0.9440742135047913
in O 0 0.005593080073595047
HC B-Disease 1 0.9891169667243958
is O 0 0.004011059179902077
demonstrated O 0 0.007255043368786573
with O 0 0.0014136058744043112
seven O 0 0.002582379849627614
new O 0 0.002379969460889697
different O 0 0.0028729827608913183
mutations O 1 0.983637273311615
making O 0 0.0026169863995164633
a O 0 0.002925087697803974
total O 0 0.002925714710727334
of O 0 0.0023270912934094667
nineteen O 0 0.06140189990401268
CPO O 1 0.9925859570503235
gene B-Disease 1 0.9984291195869446
defects I-Disease 1 0.9998131394386292
reported O 0 0.01753626950085163
so O 0 0.004649252165108919
far O 0 0.006345664616674185
. O 0 0.004041527397930622
. O 0 0.008465313352644444

Coincidence O 0 0.032960571348667145
of O 0 0.0027194623835384846
two O 0 0.003392800223082304
novel O 0 0.020147209987044334
arylsulfatase O 1 0.9976087808609009
A O 0 0.020791981369256973
alleles O 1 0.9946646690368652
and O 0 0.009313519112765789
mutation O 1 0.9987443685531616
459 O 1 0.9815725088119507
+ O 1 0.8573142290115356
1G O 1 0.9988935589790344
> O 1 0.559323787689209
A O 0 0.007287159096449614
within O 0 0.003555878298357129
a O 0 0.005103073548525572
family O 0 0.011744041927158833
with O 0 0.007833161391317844
metachromatic B-Disease 1 0.9997753500938416
leukodystrophy I-Disease 1 0.9999707937240601
: O 0 0.011444058269262314
molecular O 0 0.019672608003020287
basis O 0 0.0033756981138139963
of O 0 0.0050931451842188835
phenotypic O 1 0.9973132014274597
heterogeneity O 1 0.9862138628959656
. O 0 0.01361034531146288

In O 0 0.005847659427672625
a O 0 0.007585323881357908
family O 0 0.009240775369107723
with O 0 0.0023809275589883327
three O 0 0.0033313543535768986
siblings O 0 0.12413326650857925
, O 0 0.00165845756419003
one O 0 0.0021867642644792795
developed O 0 0.008482042700052261
classical O 0 0.008747612126171589
late O 0 0.03135338053107262
infantile O 1 0.9999964237213135
metachromatic B-Disease 1 0.999967098236084
leukodystrophy I-Disease 1 0.9999874830245972
( O 0 0.03924664109945297
MLD B-Disease 1 0.9999233484268188
) O 0 0.011456525884568691
, O 0 0.005772334989160299
fatal O 1 0.9998006224632263
at O 0 0.00496528297662735
age O 0 0.010433142073452473
5 O 0 0.006488945335149765
years O 0 0.003155285492539406
, O 0 0.0020755967125296593
with O 0 0.004624201450496912
deficient O 1 0.9986728429794312
arylsulfatase O 1 0.9919978976249695
A O 0 0.02110286056995392
( O 0 0.014880484901368618
ARSA O 1 0.998439371585846
) O 0 0.00614478625357151
activity O 0 0.008863413706421852
and O 0 0.0027014126535505056
increased O 0 0.01807352900505066
galactosylsulfatide O 1 0.987855851650238
( O 0 0.02054688334465027
GS O 1 0.9973708391189575
) O 0 0.014167936518788338
excretion O 1 0.9868919253349304
. O 0 0.014061670750379562

The O 0 0.0051049282774329185
two O 0 0.0029562523122876883
other O 0 0.00235424074344337
siblings O 0 0.18494150042533875
, O 0 0.00416709715500474
apparently O 0 0.021082144230604172
healthy O 1 0.625407874584198
at O 0 0.0050946553237736225
12 O 0 0.006502412259578705
( O 0 0.005815428216010332
1 O 0 0.010303971357643604
/ O 0 0.03031078353524208
2 O 0 0.007585733663290739
) O 0 0.0026315185241401196
and O 0 0.001474188407883048
15 O 0 0.004414449445903301
years O 0 0.0024066842161118984
, O 0 0.0014041542308405042
respectively O 0 0.003140233224257827
, O 0 0.0011508933966979384
and O 0 0.0009672263986431062
their O 0 0.0019073334988206625
father O 0 0.01236923597753048
, O 0 0.0029454638715833426
apparently O 0 0.019376110285520554
healthy O 0 0.3398515582084656
as O 0 0.0021098856814205647
well O 0 0.001938613597303629
, O 0 0.002246781252324581
presented O 0 0.00896261353045702
ARSA O 1 0.9996333122253418
and O 0 0.005407427903264761
GS O 1 0.9971004128456116
values O 0 0.006751176901161671
within O 0 0.0036584504414349794
the O 0 0.003112172707915306
range O 0 0.008350088261067867
of O 0 0.008945945650339127
MLD B-Disease 1 0.9999693632125854
patients O 1 0.999725878238678
. O 0 0.01712971180677414

Mutation O 1 0.9995585083961487
screening O 0 0.07380735874176025
and O 0 0.0031221078243106604
sequence O 0 0.012774278409779072
analysis O 0 0.00625451048836112
disclosed O 0 0.01108306273818016
the O 0 0.0023955816868692636
involvement O 0 0.009684272110462189
of O 0 0.0016479429323226213
three O 0 0.0030409502796828747
different O 0 0.005814637057483196
ARSA O 1 0.9999393224716187
mutations O 1 0.9987425208091736
being O 0 0.003919593989849091
the O 0 0.0034472469706088305
molecular O 0 0.015127403661608696
basis O 0 0.0034297325182706118
of O 0 0.0044014849700033665
intrafamilial O 1 0.9977675676345825
phenotypic O 1 0.9970048069953918
heterogeneity O 1 0.982566773891449
. O 0 0.018585173413157463

The O 0 0.01078987866640091
late O 0 0.05080939456820488
infantile O 1 0.9999969005584717
patient O 1 0.9999821186065674
inherited O 1 0.9997206330299377
from O 0 0.004188953898847103
his O 0 0.004567802418023348
mother O 0 0.020197661593556404
the O 0 0.0039398339577019215
frequent O 0 0.040001280605793
0 O 0 0.027145233005285263
- O 0 0.052074532955884933
type O 0 0.280157208442688
mutation O 1 0.9989780187606812
459 O 1 0.9670082330703735
+ O 1 0.6784500479698181
1G O 1 0.9980477094650269
> O 1 0.9275221824645996
A O 0 0.008939639665186405
, O 0 0.0018684087553992867
and O 0 0.0012170925037935376
from O 0 0.002198615809902549
his O 0 0.0033389455638825893
father O 0 0.01057241391390562
a O 0 0.005744940135627985
novel O 0 0.012246725149452686
, O 0 0.0032689261715859175
single O 0 0.015537170693278313
basepair O 1 0.9807149171829224
microdeletion O 0 0.4518736004829407
of O 0 0.005454959813505411
guanine O 0 0.04592149704694748
at O 0 0.007024446502327919
nucleotide O 0 0.04774084687232971
7 O 0 0.010763482190668583
in O 0 0.004544879775494337
exon O 0 0.1558917611837387
1 O 0 0.018994450569152832
( O 0 0.012981024570763111
7delG O 1 0.6717269420623779
) O 0 0.011866414919495583
. O 0 0.00980282574892044

The O 0 0.00750066339969635
two O 0 0.007343591190874577
clinically O 1 0.9971861243247986
unaffected O 1 0.9851839542388916
siblings O 0 0.2004324346780777
carried O 0 0.010899587534368038
the O 0 0.007588260341435671
maternal O 1 0.9985811710357666
mutation O 1 0.9998276233673096
459 O 1 0.9906638860702515
+ O 1 0.9073997139930725
1G O 1 0.9989732503890991
> O 1 0.9421735405921936
A O 0 0.007619158364832401
and O 0 0.0015575301367789507
, O 0 0.0014614235842600465
on O 0 0.001587707200087607
their O 0 0.0033752117305994034
paternal O 1 0.9969491362571716
allele O 1 0.9988447427749634
, O 0 0.0027522393502295017
a O 0 0.006075477227568626
novel O 0 0.01954541727900505
cytosine O 0 0.06709695607423782
to O 0 0.005532407201826572
thymidine O 0 0.19554024934768677
transition O 0 0.02598068304359913
at O 0 0.009543727152049541
nucleotide O 0 0.08225002139806747
2435 O 1 0.9715853929519653
in O 0 0.006813720799982548
exon O 0 0.2641644775867462
8 O 0 0.009905421175062656
, O 0 0.0022426440846174955
resulting O 0 0.013933294452726841
in O 0 0.001972187077626586
substitution O 0 0.015803594142198563
of O 0 0.0038877378683537245
alanine O 0 0.3746522068977356
464 O 0 0.3582587242126465
by O 0 0.009051889181137085
valine O 1 0.9845173954963684
( O 0 0.014473799616098404
A464V O 1 0.98758465051651
) O 0 0.011859086342155933
. O 0 0.010784180834889412

The O 0 0.013731797225773335
fathers O 0 0.13491354882717133
genotype O 1 0.9965992569923401
thus O 0 0.015177303925156593
was O 0 0.013651972636580467
7delG O 1 0.9963627457618713
/ O 1 0.8594992756843567
A464V O 1 0.9754469990730286
. O 0 0.016349375247955322

Mutation O 1 0.9994379878044128
A464V O 1 0.9938578009605408
was O 0 0.006400942336767912
not O 0 0.0020938003435730934
found O 0 0.003473526332527399
in O 0 0.0024076378904283047
18 O 0 0.012075386010110378
unrelated O 1 0.8825427889823914
MLD B-Disease 1 0.9999790191650391
patients O 1 0.9998804330825806
and O 0 0.0040933904238045216
50 O 0 0.010122993029654026
controls O 0 0.023931754752993584
. O 0 0.010985848493874073

A464V O 1 0.9865956902503967
, O 0 0.005692906677722931
although O 0 0.0068473597057163715
clearly O 0 0.012925959192216396
modifying O 0 0.45256468653678894
ARSA O 1 0.9997697472572327
and O 0 0.009241098538041115
GS O 1 0.9991074204444885
levels O 0 0.017090043053030968
, O 0 0.0037875857669860125
apparently O 0 0.016337690874934196
bears O 0 0.0196093637496233
little O 0 0.00841586571186781
significance O 0 0.007389480248093605
for O 0 0.003854429814964533
clinical O 1 0.8846638202667236
manifestation O 1 0.8191038370132446
of O 0 0.00594343850389123
MLD B-Disease 1 0.9999830722808838
, O 0 0.006388950161635876
mimicking O 1 0.5959485769271851
the O 0 0.009458494372665882
frequent O 1 0.6361324787139893
ARSA O 1 0.9997958540916443
pseudodeficiency O 1 0.9988839030265808
allele O 1 0.9950764775276184
. O 0 0.019216319546103477

Our O 0 0.009868727065622807
results O 0 0.008121012710034847
demonstrate O 0 0.005777563899755478
that O 0 0.0010012900456786156
in O 0 0.001446214155294001
certain O 0 0.004780355840921402
genetic O 1 0.9797491431236267
conditions O 0 0.16028253734111786
MLD B-Disease 1 0.999969482421875
- O 0 0.2934960424900055
like O 0 0.01679893769323826
ARSA O 1 0.9998573064804077
and O 0 0.006894575897604227
GS O 1 0.9988123178482056
values O 0 0.006269910838454962
need O 0 0.0031548207625746727
not O 0 0.0013026915257796645
be O 0 0.0015704251127317548
paralleled O 0 0.032788485288619995
by O 0 0.006484004203230143
clinical O 1 0.9999630451202393
disease O 1 0.9999996423721313
, O 0 0.0025358626153320074
a O 0 0.004216983448714018
finding O 0 0.007265431806445122
with O 0 0.004566475749015808
serious O 1 0.97625732421875
diagnostic O 1 0.9794883728027344
and O 0 0.006572248414158821
prognostic O 1 0.9994277358055115
implications O 0 0.35500892996788025
. O 0 0.013289240188896656

Moreover O 0 0.031111644580960274
, O 0 0.006482824683189392
further O 0 0.016769468784332275
ARSA O 1 0.999841570854187
alleles O 1 0.9993485808372498
functionally O 1 0.8308919668197632
similar O 0 0.009128077886998653
to O 0 0.004123996011912823
A464V O 1 0.9943406581878662
might O 0 0.007748278323560953
exist O 0 0.0034618652425706387
which O 0 0.0012181189376860857
, O 0 0.0010695673990994692
together O 0 0.0016057296888902783
with O 0 0.002512700157240033
0 O 0 0.02001519314944744
- O 0 0.033692218363285065
type O 0 0.35535886883735657
mutations O 1 0.9995482563972473
, O 0 0.003999227192252874
may O 0 0.012017706409096718
cause O 1 0.9977499842643738
pathological O 1 0.9997172951698303
ARSA O 1 0.9999222755432129
and O 0 0.00941319391131401
GS O 1 0.999854326248169
levels O 0 0.014001908712089062
, O 0 0.0017124905716627836
but O 0 0.0016958960331976414
not O 0 0.002570481738075614
clinical O 1 0.9956430196762085
outbreak O 1 0.9999600648880005
of O 0 0.00407160259783268
the O 0 0.011421805247664452
disease O 1 0.9999997615814209
. O 0 0.00739592220634222
. O 0 0.009031926281750202

Human O 1 0.7317583560943604
MLH1 O 1 0.9999780654907227
deficiency O 1 0.9999991655349731
predisposes O 1 0.9999635219573975
to O 0 0.017193356528878212
hematological B-Disease 1 0.9999669790267944
malignancy I-Disease 1 0.9999938011169434
and O 0 0.025407137349247932
neurofibromatosis B-Disease 1 0.9999991655349731
type I-Disease 0 0.4391269385814667
1 I-Disease 0 0.014319110661745071
. O 0 0.008629357442259789

Heterozygous O 1 0.995726466178894
germ O 1 0.9873537421226501
- O 0 0.05175662040710449
line O 0 0.02202426828444004
mutations O 1 0.9835589528083801
in O 0 0.002435613190755248
the O 0 0.0038105547428131104
DNA O 0 0.04944925382733345
mismatch O 1 0.9964473843574524
repair O 1 0.9817447066307068
genes O 1 0.7831432223320007
lead O 0 0.015571224503219128
to O 0 0.00872670765966177
hereditary B-Disease 1 0.9999808073043823
nonpolyposis I-Disease 1 0.9999932050704956
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.023798653855919838

The O 0 0.033961594104766846
disease O 1 0.9999994039535522
susceptibility O 1 0.9998687505722046
of O 0 0.0024733145255595446
individuals O 0 0.005450311116874218
who O 0 0.00396636500954628
constitutionally O 0 0.07097942382097244
lack O 0 0.008453558199107647
both O 0 0.003260544501245022
wild O 0 0.06827836483716965
- O 0 0.13587667047977448
type O 0 0.22684653103351593
alleles O 1 0.9952227473258972
is O 0 0.007745015900582075
unknown O 0 0.020778680220246315
. O 0 0.010299810208380222

We O 0 0.004849644377827644
have O 0 0.003147524083033204
identified O 0 0.007034494075924158
three O 0 0.002886021975427866
offspring O 0 0.2782929539680481
in O 0 0.003121214220300317
a O 0 0.012017475441098213
hereditary B-Disease 1 0.9999884366989136
nonpolyposis I-Disease 1 0.9999985694885254
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.2891523838043213
who O 0 0.00974875409156084
developed O 1 0.6438369154930115
hematological B-Disease 1 0.9999953508377075
malignancy I-Disease 1 0.9999978542327881
at O 0 0.005002588499337435
a O 0 0.004926994908601046
very O 0 0.0036624851636588573
early O 0 0.005526532884687185
age O 0 0.006326049100607634
, O 0 0.0012199204647913575
and O 0 0.0009376084199175239
at O 0 0.0016949912533164024
least O 0 0.0027857383247464895
two O 0 0.0008591804653406143
of O 0 0.0010964693501591682
them O 0 0.0017237901920452714
displayed O 0 0.007707409560680389
signs O 0 0.018803082406520844
of O 0 0.008939594961702824
neurofibromatosis B-Disease 1 0.9999974966049194
type I-Disease 0 0.2025005966424942
1 I-Disease 0 0.018085584044456482
( O 0 0.015828358009457588
NF1 B-Disease 1 0.9993762373924255
) O 0 0.01073336973786354
. O 0 0.009469397366046906

DNA O 0 0.054479312151670456
sequence O 0 0.02279529720544815
analysis O 0 0.00800182856619358
and O 0 0.0050069717690348625
allele O 1 0.9942998886108398
- O 0 0.02312479540705681
specific O 0 0.007259972859174013
amplification O 0 0.03330320492386818
in O 0 0.002151796594262123
two O 0 0.002358874073252082
siblings O 0 0.10406926274299622
revealed O 0 0.020150966942310333
a O 0 0.014457279816269875
homozygous O 1 0.9991717338562012
MLH1 O 1 0.9998928308486938
mutation O 1 0.9992178678512573
( O 0 0.026112621650099754
C676T O 1 0.9958329796791077
- O 0 0.10917100310325623
- O 0 0.09381148219108582
> O 1 0.8855737447738647
Arg226Stop O 1 0.9032650589942932
) O 0 0.015162522904574871
. O 0 0.01275716908276081

Thus O 0 0.014897474087774754
, O 0 0.004323349799960852
a O 0 0.01333251129835844
homozygous O 1 0.9974299073219299
germ O 1 0.9866053462028503
- O 0 0.053762879222631454
line O 0 0.03277090564370155
MLH1 O 1 0.9997556805610657
mutation O 1 0.9996472597122192
and O 0 0.0090345349162817
consequent O 1 0.9992007613182068
mismatch O 1 0.9998445510864258
repair O 1 0.9998748302459717
deficiency O 1 0.9999973773956299
results O 0 0.012503569014370441
in O 0 0.0032709098886698484
a O 0 0.015560204163193703
mutator O 1 0.999886155128479
phenotype O 1 0.9999711513519287
characterized O 1 0.957685649394989
by O 0 0.01579231210052967
leukemia B-Disease 1 0.9999996423721313
and O 0 0.007118626963347197
/ O 1 0.9979203343391418
or O 0 0.3785373866558075
lymphoma B-Disease 1 1.0
associated O 0 0.0276485588401556
with O 0 0.014109001494944096
neurofibromatosis B-Disease 1 0.9999991655349731
type I-Disease 1 0.5308579802513123
1 I-Disease 0 0.012717059813439846
. O 0 0.005173249635845423
. O 0 0.009062746539711952

Missense O 1 0.9989399313926697
mutations O 1 0.995037853717804
in O 0 0.003061391646042466
the O 0 0.0022896926384419203
most O 0 0.0027163063641637564
ancient O 0 0.004968964494764805
residues O 0 0.01435952726751566
of O 0 0.0024959533475339413
the O 0 0.0077827381901443005
PAX6 O 1 0.9996178150177002
paired O 0 0.20667634904384613
domain O 0 0.03449881076812744
underlie O 1 0.7369929552078247
a O 0 0.00944263394922018
spectrum O 0 0.027753593400120735
of O 0 0.006404607091099024
human O 1 0.9922433495521545
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999957084655762
malformations I-Disease 1 0.9999890327453613
. O 0 0.017217593267560005

Mutations O 1 0.9952104687690735
of O 0 0.0041870842687785625
the O 0 0.006948048714548349
human O 0 0.03449955955147743
PAX6 O 1 0.9998852014541626
gene O 1 0.9989821314811707
underlie O 1 0.9996463060379028
aniridia B-Disease 1 0.9999165534973145
( O 0 0.13026723265647888
congenital B-Disease 1 0.9999997615814209
absence I-Disease 0 0.02536807768046856
of I-Disease 0 0.0024266208056360483
the I-Disease 0 0.005830839276313782
iris I-Disease 1 0.9997881054878235
) O 0 0.0044256942346692085
, O 0 0.002075704513117671
a O 0 0.006345303729176521
rare O 0 0.20734935998916626
dominant O 1 0.9756012558937073
malformation B-Disease 1 0.9999656677246094
of I-Disease 0 0.003776003373786807
the I-Disease 0 0.007304973900318146
eye I-Disease 1 0.9996032118797302
. O 0 0.013098563067615032

The O 0 0.00929505005478859
spectrum O 0 0.03754744678735733
of O 0 0.008922862820327282
PAX6 O 1 0.9999743700027466
mutations O 1 0.9998056292533875
in O 0 0.011924494989216328
aniridia B-Disease 1 0.9999651908874512
patients O 1 0.999940037727356
is O 0 0.004836603999137878
highly O 0 0.010746744461357594
biased O 0 0.012587721459567547
, O 0 0.001943435869179666
with O 0 0.002281505847349763
92 O 0 0.01527467742562294
% O 0 0.00375229655764997
of O 0 0.0013952876906841993
all O 0 0.002093349350616336
reported O 0 0.01879977248609066
mutations O 1 0.997750461101532
leading O 0 0.010853935033082962
to O 0 0.004957194905728102
premature O 1 0.9951131939888
truncation O 0 0.2536134719848633
of O 0 0.002499029040336609
the O 0 0.003966465126723051
protein O 0 0.03156184405088425
( O 0 0.0063291676342487335
nonsense O 0 0.021816689521074295
, O 0 0.0036061981227248907
splicing O 0 0.04838957637548447
, O 0 0.004470374435186386
insertions O 0 0.10987881571054459
and O 0 0.003419824643060565
deletions O 1 0.5412793755531311
) O 0 0.0028925170190632343
and O 0 0.0012846989557147026
just O 0 0.003559095086529851
2 O 0 0.005505635868757963
% O 0 0.00393271679058671
leading O 0 0.004222132731229067
to O 0 0.0015474306419491768
substitution O 0 0.010750573128461838
of O 0 0.0017770013073459268
one O 0 0.0035709093790501356
amino O 0 0.02511151321232319
acid O 0 0.03443468362092972
by O 0 0.003608700120821595
another O 0 0.009375767782330513
( O 0 0.011674491688609123
missense O 1 0.9668505191802979
) O 0 0.009807168506085873
. O 0 0.009028539061546326

The O 0 0.006764501333236694
extraordinary O 0 0.01187894493341446
conservation O 0 0.008361992426216602
of O 0 0.0023838821798563004
the O 0 0.007112038321793079
PAX6 O 1 0.9995170831680298
protein O 0 0.037428177893161774
at O 0 0.0038485152181237936
the O 0 0.00382823683321476
amino O 0 0.0314401239156723
acid O 0 0.04399794712662697
level O 0 0.007312913425266743
amongst O 0 0.01517078559845686
vertebrates O 1 0.5643302798271179
predicts O 0 0.03438950702548027
that O 0 0.004817889537662268
pathological O 1 0.9998169541358948
missense O 1 0.999957799911499
mutations O 1 0.9998050332069397
should O 0 0.002786157187074423
in O 0 0.0014456297503784299
fact O 0 0.003240638878196478
be O 0 0.0016960276989266276
common O 0 0.005155500024557114
even O 0 0.002776052337139845
though O 0 0.0027620645705610514
they O 0 0.001216655713506043
are O 0 0.0013175285421311855
hardly O 0 0.012051689438521862
ever O 0 0.007426499389111996
seen O 0 0.00963831227272749
in O 0 0.007364681921899319
aniridia B-Disease 1 0.9999574422836304
patients O 1 0.999870777130127
. O 0 0.014783482998609543

This O 0 0.0061752391047775745
indicates O 0 0.013391701504588127
that O 0 0.0015478779096156359
there O 0 0.0016623851843178272
is O 0 0.0023855429608374834
a O 0 0.007473527453839779
heavy O 0 0.03461293876171112
ascertainment O 1 0.9982095956802368
bias O 0 0.028210710734128952
in O 0 0.0019917020108550787
the O 0 0.00200795941054821
selection O 0 0.006150348111987114
of O 0 0.0032921608071774244
patients O 1 0.9997982382774353
for O 0 0.006216270849108696
PAX6 O 1 0.9999690055847168
mutation O 1 0.9997298121452332
analysis O 0 0.006988464388996363
and O 0 0.000985792139545083
that O 0 0.0010852059349417686
the O 0 0.0030505629256367683
missing O 0 0.15156695246696472
PAX6 O 1 0.9999562501907349
missense O 1 0.999904990196228
mutations O 1 0.9998038411140442
frequently O 0 0.02322038821876049
may O 0 0.019174719229340553
underlie O 1 0.9901778101921082
phenotypes O 1 0.9960504174232483
distinct O 0 0.025175297632813454
from O 0 0.010992116294801235
textbook O 1 0.7384759783744812
aniridia B-Disease 1 0.9972684383392334
. O 0 0.019296983256936073

Here O 0 0.004563204012811184
we O 0 0.002045601373538375
present O 0 0.0031924238428473473
four O 0 0.004989785607904196
novel O 0 0.04472210630774498
PAX6 O 1 0.9998948574066162
missense O 1 0.9997237324714661
mutations O 1 0.9992275238037109
, O 0 0.0029571715276688337
two O 0 0.001743860892020166
in O 0 0.00200621853582561
association O 0 0.008401354774832726
with O 0 0.0061027370393276215
atypical O 1 0.999958872795105
phenotypes O 1 0.9999107122421265
ectopia B-Disease 1 0.9994999170303345
pupillae I-Disease 1 0.9971777200698853
( O 0 0.012878652662038803
displaced B-Disease 0 0.06710046529769897
pupils I-Disease 0 0.027371879667043686
) O 0 0.007951592095196247
and O 0 0.009452429600059986
congenital B-Disease 1 0.9999998807907104
nystagmus I-Disease 1 0.9999887943267822
( O 0 0.01630026288330555
searching B-Disease 0 0.03554060310125351
gaze I-Disease 1 0.8841512799263
) O 0 0.00399725092574954
, O 0 0.0013234406942501664
and O 0 0.0007992080063559115
two O 0 0.0009297648211941123
in O 0 0.001483085216023028
association O 0 0.004893873818218708
with O 0 0.002245519310235977
more O 0 0.00519994180649519
recognizable O 1 0.9822809100151062
aniridia B-Disease 1 0.9994975328445435
phenotypes O 1 0.9990394711494446
. O 0 0.017673704773187637

Strikingly O 0 0.058495569974184036
, O 0 0.0032160989940166473
all O 0 0.0020759899634867907
four O 0 0.005656018387526274
mutations O 1 0.9933457374572754
are O 0 0.0019919921178370714
located O 0 0.004366441164165735
within O 0 0.0037995995953679085
the O 0 0.006944417022168636
PAX6 O 1 0.9997261166572571
paired O 0 0.0621151477098465
domain O 0 0.02097494900226593
and O 0 0.0031846824567764997
affect O 0 0.021907001733779907
amino O 0 0.03363555297255516
acids O 0 0.019095024093985558
which O 0 0.0020066567230969667
are O 0 0.0015273175667971373
highly O 0 0.007602281868457794
conserved O 0 0.013567573390901089
in O 0 0.0016773719107732177
all O 0 0.002107225591316819
known O 0 0.008895239792764187
paired O 0 0.0304412879049778
domain O 0 0.02909436821937561
proteins O 0 0.028205953538417816
. O 0 0.009583053179085255

Our O 0 0.009035120718181133
results O 0 0.00801010336726904
support O 0 0.003907038364559412
the O 0 0.0030872842762619257
hypothesis O 0 0.01619328185915947
that O 0 0.0013047426473349333
the O 0 0.0016586532583460212
under O 0 0.0030763521790504456
- O 0 0.009999697096645832
representation O 0 0.006010209675878286
of O 0 0.004463262390345335
missense O 1 0.9998550415039062
mutations O 1 0.9994018077850342
is O 0 0.007007049396634102
caused O 1 0.8457664251327515
by O 0 0.006613851524889469
ascertainment O 1 0.9995675683021545
bias O 0 0.12018619477748871
and O 0 0.0017008292488753796
suggest O 0 0.005207840818911791
that O 0 0.0014384811511263251
a O 0 0.005118146073073149
substantial O 0 0.01475971657782793
burden O 0 0.47017577290534973
of O 0 0.007702040020376444
PAX6 B-Disease 1 0.9999849796295166
- I-Disease 1 0.9594414830207825
related I-Disease 1 0.7707607746124268
disease I-Disease 1 0.9999994039535522
remains O 0 0.010795055888593197
to O 0 0.0022157318890094757
be O 0 0.0021563598420470953
uncovered O 0 0.018981242552399635
. O 0 0.0039998008869588375
. O 0 0.008169710636138916

The O 0 0.013057554140686989
chromosomal O 1 0.9969704151153564
order O 0 0.006051724776625633
of O 0 0.0042695170268416405
genes O 1 0.58583003282547
controlling O 0 0.17840337753295898
the O 0 0.007090336177498102
major O 0 0.028958240523934364
histocompatibility O 1 0.9997574687004089
complex O 0 0.01830078847706318
, O 0 0.006658716592937708
properdin O 1 0.9950672388076782
factor O 0 0.08377446979284286
B O 0 0.1028350219130516
, O 0 0.002842230023816228
and O 0 0.003536832518875599
deficiency B-Disease 1 0.9999940395355225
of I-Disease 0 0.0016446529189124703
the I-Disease 0 0.0019752776715904474
second I-Disease 0 0.005169037729501724
component I-Disease 0 0.012186059728264809
of I-Disease 0 0.003162058535963297
complement I-Disease 0 0.024131394922733307
. O 0 0.009817141108214855

The O 0 0.006416588556021452
relationship O 0 0.010117991827428341
of O 0 0.002006483729928732
the O 0 0.004263237584382296
genes O 1 0.5372507572174072
coding O 0 0.04916498064994812
for O 0 0.0043907309882342815
HLA O 1 0.9997544884681702
to O 0 0.0023613316006958485
those O 0 0.00272948807105422
coding O 0 0.03417425602674484
for O 0 0.004537919070571661
properdin O 1 0.995509147644043
Factor O 0 0.349627286195755
B O 1 0.5374565720558167
allotypes O 1 0.9820080995559692
and O 0 0.0030980485025793314
for O 0 0.0044561889953911304
deficiency B-Disease 1 0.9999767541885376
of I-Disease 0 0.0016168741276487708
the I-Disease 0 0.002083190716803074
second I-Disease 0 0.005211629904806614
component I-Disease 0 0.010699788108468056
of I-Disease 0 0.002724921563640237
complement I-Disease 0 0.025072159245610237
( O 0 0.01277395524084568
C2 O 1 0.99935382604599
) O 0 0.0039167506620287895
was O 0 0.0028504335787147284
studied O 0 0.0033585121855139732
in O 0 0.001482482417486608
families O 0 0.005204985849559307
of O 0 0.004209885373711586
patients O 1 0.999944806098938
with O 0 0.015425600111484528
connective O 1 0.9999985694885254
tissue O 1 0.9999991655349731
disorders O 1 0.9999992847442627
. O 0 0.016297737136483192

Patients O 1 0.9991948008537292
were O 0 0.002737157978117466
selected O 0 0.004296637140214443
because O 0 0.0032135886140167713
they O 0 0.001554506248794496
were O 0 0.0024379673413932323
heterozygous O 1 0.9650874733924866
or O 0 0.010839640162885189
homozygous O 1 0.9967024922370911
for O 0 0.01752225123345852
C2 B-Disease 1 0.9999746084213257
deficiency I-Disease 1 0.9999947547912598
. O 0 0.02613908052444458

12 O 0 0.014951775781810284
families O 0 0.010067777708172798
with O 0 0.0045247748494148254
15 O 0 0.014277261681854725
matings O 1 0.6099536418914795
informative O 0 0.03628751263022423
for O 0 0.017925560474395752
C2 B-Disease 1 0.9999781847000122
deficiency I-Disease 1 0.9999972581863403
were O 0 0.005602627526968718
found O 0 0.012358913198113441
. O 0 0.012400276958942413

Of O 0 0.008777122013270855
57 O 0 0.03148394450545311
informative O 0 0.03440665826201439
meioses O 1 0.9359560608863831
, O 0 0.003102980088442564
two O 0 0.0028205036651343107
crossovers O 0 0.021129708737134933
were O 0 0.0014682553010061383
noted O 0 0.0038851851131767035
between O 0 0.0034069858957082033
the O 0 0.011592712253332138
C2 B-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999998807907104
gene O 1 0.9956271648406982
and O 0 0.0036514578387141228
the O 0 0.007699121255427599
HLA O 1 0.9999600648880005
- O 1 0.5561178922653198
B O 1 0.8852582573890686
gene O 1 0.7388080358505249
, O 0 0.0026617744006216526
with O 0 0.002358445432037115
a O 0 0.007005636114627123
recombinant O 0 0.0689963549375534
fraction O 0 0.026836344972252846
of O 0 0.004513634834438562
0 O 0 0.026886068284511566
. O 0 0.009256234392523766

035 O 1 0.9817407131195068
. O 0 0.029688484966754913

A O 0 0.02714894898235798
lod O 0 0.13906359672546387
score O 0 0.00786681566387415
of O 0 0.0028489800170063972
13 O 0 0.006263841409236193
was O 0 0.0030685500241816044
calculated O 0 0.006540571805089712
for O 0 0.0025587596464902163
linkage O 0 0.049687523394823074
between O 0 0.01720300503075123
C2 B-Disease 1 0.9999949932098389
deficiency I-Disease 1 0.9999992847442627
and O 0 0.012378414161503315
HLA O 1 0.9999793767929077
- O 0 0.15361881256103516
B O 0 0.05091279372572899
at O 0 0.0035840109921991825
a O 0 0.004634722135961056
maximum O 0 0.008242164738476276
likelihood O 0 0.016130147501826286
value O 0 0.002536266576498747
of O 0 0.0013604530831798911
the O 0 0.0035889800637960434
recombinant O 0 0.055208511650562286
fraction O 0 0.020809326320886612
of O 0 0.004971570335328579
0 O 0 0.02936285175383091
. O 0 0.010450593195855618

04 O 0 0.4302019774913788
. O 0 0.024066653102636337

18 O 0 0.015150671824812889
families O 0 0.007509763818234205
with O 0 0.00288519449532032
21 O 0 0.011356247588992119
informative O 0 0.022577140480279922
matings O 0 0.39497876167297363
for O 0 0.0024032997898757458
both O 0 0.003961182665079832
properdin O 1 0.9932762384414673
Factor O 0 0.2042832374572754
B O 1 0.632768988609314
allotype O 1 0.9958778619766235
and O 0 0.008811687119305134
HLA O 1 0.9999597072601318
- O 0 0.16725674271583557
B O 0 0.05269680917263031
were O 0 0.0029047951102256775
found O 0 0.008347813040018082
. O 0 0.008417068049311638

Of O 0 0.008917993865907192
72 O 0 0.031189998611807823
informative O 0 0.034387823194265366
meioses O 1 0.9451296925544739
, O 0 0.0028238168451935053
three O 0 0.0037754939403384924
recombinants O 1 0.933711588382721
were O 0 0.0019259811379015446
found O 0 0.003770335577428341
, O 0 0.0017572513315826654
giving O 0 0.006032781675457954
a O 0 0.00781417079269886
recombinant O 0 0.06150943040847778
fraction O 0 0.024609733372926712
of O 0 0.005032507237046957
0 O 0 0.0287250354886055
. O 0 0.011099541559815407

042 O 1 0.9468186497688293
. O 0 0.02283446304500103

A O 0 0.028774134814739227
lod O 0 0.085240937769413
score O 0 0.006497503723949194
of O 0 0.002210738603025675
16 O 0 0.007697238586843014
between O 0 0.009163555689156055
HLA O 1 0.9999485015869141
- O 0 0.05443406105041504
B O 0 0.05312268063426018
and O 0 0.004352611489593983
Factor O 0 0.13272370398044586
B O 1 0.5927397608757019
allotypes O 1 0.9606865048408508
was O 0 0.005437578074634075
calculated O 0 0.008295856416225433
at O 0 0.002977237105369568
a O 0 0.005194737575948238
maximum O 0 0.012124371714890003
likelihood O 0 0.01841793581843376
value O 0 0.003020390635356307
of O 0 0.0017112918430939317
the O 0 0.0038667928893119097
recombinant O 0 0.06731044501066208
fraction O 0 0.023645056411623955
of O 0 0.005081328563392162
0 O 0 0.02681919001042843
. O 0 0.011058562435209751

04 O 0 0.37508904933929443
. O 0 0.03032943233847618

A O 0 0.022508611902594566
crossover O 0 0.044817004352808
was O 0 0.0055902861058712006
shown O 0 0.005584849044680595
to O 0 0.0014626509509980679
have O 0 0.0021930953953415155
occurred O 0 0.009469524957239628
between O 0 0.003970168996602297
genes O 0 0.036144647747278214
for O 0 0.003556942567229271
Factor O 0 0.0403541624546051
B O 0 0.07908324897289276
and O 0 0.00761431735008955
HLA O 1 0.9999594688415527
- O 0 0.12484697997570038
D O 0 0.25246384739875793
, O 0 0.00224981177598238
in O 0 0.0021088970825076103
which O 0 0.0047338660806417465
HLA O 1 0.9999632835388184
- O 1 0.5046355724334717
D O 1 0.9465672969818115
segregared O 1 0.9814307689666748
with O 0 0.009424743242561817
HLA O 1 0.9998918771743774
- O 0 0.02909727580845356
A O 0 0.012592465616762638
and O 0 0.004762185271829367
B O 0 0.0656902939081192
. O 0 0.011920030228793621

These O 0 0.005549001041799784
studies O 0 0.008237422443926334
suggest O 0 0.0065498799085617065
that O 0 0.0015135289868339896
the O 0 0.0027823930140584707
genes O 0 0.036152247339487076
for O 0 0.0034802411682903767
Factor O 0 0.10533485561609268
B O 0 0.468982458114624
and O 0 0.009914456866681576
C2 B-Disease 1 0.9999980926513672
deficiency I-Disease 1 0.9999992847442627
are O 0 0.002749195322394371
located O 0 0.004276277031749487
outside O 0 0.0023029374424368143
those O 0 0.0017601855797693133
for O 0 0.002895193174481392
HLA O 1 0.9999817609786987
, O 0 0.00160827802028507
that O 0 0.0008077591191977262
the O 0 0.0011910774046555161
order O 0 0.002158557530492544
of O 0 0.002371329814195633
genese O 1 0.9956507086753845
is O 0 0.010140365920960903
HLA O 1 0.9998764991760254
- O 0 0.023232534527778625
A O 0 0.00952054187655449
, O 0 0.004199545364826918
- O 0 0.025193816050887108
B O 0 0.0467873215675354
, O 0 0.005271012894809246
- O 0 0.03329586982727051
D O 0 0.18009693920612335
, O 0 0.004558934830129147
Factor O 0 0.048574548214673996
B O 1 0.6381542682647705
allotype O 1 0.9978571534156799
, O 0 0.016883129253983498
C2 B-Disease 1 0.9999961853027344
deficiency I-Disease 1 0.9999997615814209
, O 0 0.0027699328493326902
that O 0 0.0015387696912512183
the O 0 0.0039353808388113976
genes O 0 0.49792778491973877
coding O 0 0.2813408672809601
for O 0 0.00976915005594492
C2 B-Disease 1 0.9999938011169434
deficiency I-Disease 1 0.9999988079071045
and O 0 0.007234307937324047
Factor O 0 0.07973332703113556
B O 1 0.6264958381652832
allotypes O 1 0.7776881456375122
are O 0 0.0020381214562803507
approximately O 0 0.006343298591673374
3 O 0 0.009389236569404602
- O 0 0.022353749722242355
- O 0 0.020364118739962578
5 O 0 0.01210065372288227
centimorgans O 0 0.2613844573497772
from O 0 0.004078674595803022
the O 0 0.00745140528306365
HLA O 1 0.9992654919624329
- O 0 0.024945562705397606
A O 0 0.012160297483205795
and O 0 0.0078396862372756
HLA O 1 0.9999037981033325
- O 0 0.3658004701137543
B O 1 0.7236896753311157
loci O 1 0.9806946516036987
, O 0 0.0022017627488821745
and O 0 0.0011000812519341707
that O 0 0.0010946523398160934
the O 0 0.0023441582452505827
apparent O 0 0.02952319011092186
lack O 0 0.008679439313709736
of O 0 0.0027588787488639355
recombinants O 1 0.992362380027771
between O 0 0.0032422749791294336
the O 0 0.004102104809135199
Factor O 0 0.111490398645401
B O 1 0.7213400602340698
gene O 1 0.9945782423019409
and O 0 0.015330234542489052
C2 B-Disease 1 0.9999967813491821
deficiency I-Disease 1 0.9999998807907104
gene O 1 0.9996746778488159
suggests O 0 0.012510060332715511
that O 0 0.0011919273529201746
these O 0 0.001306823338381946
two O 0 0.0022492175921797752
genes O 0 0.16927631199359894
lie O 0 0.007403914351016283
in O 0 0.0022362256422638893
close O 0 0.006490163039416075
proximity O 0 0.009034049697220325
to O 0 0.0017388543346896768
one O 0 0.003005099715664983
another O 0 0.010221603326499462
. O 0 0.009643401950597763

Distribution O 0 0.02073027938604355
of O 0 0.006278179120272398
emerin O 1 0.9788082838058472
and O 0 0.006102314684540033
lamins O 1 0.9915995597839355
in O 0 0.003597106086090207
the O 0 0.005405745934695005
heart O 1 0.9960860013961792
and O 0 0.0030626014340668917
implications O 0 0.029949676245450974
for O 0 0.00659968052059412
Emery B-Disease 1 0.9989026784896851
- I-Disease 1 0.9964810609817505
Dreifuss I-Disease 1 0.9999836683273315
muscular I-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.999998927116394
. O 0 0.02728261426091194

Emerin O 1 0.9697378873825073
is O 0 0.0063872491009533405
a O 0 0.007086282595992088
nuclear O 0 0.011887769214808941
membrane O 0 0.03863231837749481
protein O 0 0.023983867838978767
which O 0 0.002179756760597229
is O 0 0.002455551875755191
missing O 0 0.0139474431052804
or O 0 0.00650963606312871
defective O 1 0.9553613066673279
in O 0 0.006251782178878784
Emery B-Disease 1 0.998428463935852
- I-Disease 1 0.9983559250831604
Dreifuss I-Disease 1 0.9999974966049194
muscular I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.2376406341791153
EDMD B-Disease 1 0.999764621257782
) O 0 0.015133606269955635
. O 0 0.010674599558115005

It O 0 0.005431659985333681
is O 0 0.0028626699931919575
one O 0 0.0020628387574106455
member O 0 0.003072171239182353
of O 0 0.001383401919156313
a O 0 0.0045099081471562386
family O 0 0.0096793994307518
of O 0 0.004720317665487528
lamina O 1 0.9989468455314636
- O 0 0.029529472813010216
associated O 0 0.011237750761210918
proteins O 0 0.011961854062974453
which O 0 0.002389229368418455
includes O 0 0.006315295584499836
LAP1 O 1 0.9978227615356445
, O 0 0.006522075738757849
LAP2 O 1 0.9916099905967712
and O 0 0.01078536082059145
lamin O 1 0.997593104839325
B O 1 0.7678837776184082
receptor O 1 0.9641116261482239
( O 0 0.023982172831892967
LBR O 1 0.9956859350204468
) O 0 0.013495780527591705
. O 0 0.010899674147367477

A O 0 0.01737481728196144
panel O 0 0.011765805073082447
of O 0 0.004057123325765133
16 O 0 0.021260088309645653
monoclonal O 1 0.994426965713501
antibodies O 1 0.9955146908760071
( O 0 0.01752179116010666
mAbs O 1 0.9952539205551147
) O 0 0.0047907112166285515
has O 0 0.0026877231430262327
been O 0 0.0025385862682014704
mapped O 0 0.010619654320180416
to O 0 0.001289338688366115
six O 0 0.0022370077203959227
specific O 0 0.0030848942697048187
sites O 0 0.0037708731833845377
throughout O 0 0.0035275660920888186
the O 0 0.004136770498007536
emerin O 1 0.9811230301856995
molecule O 0 0.049882762134075165
using O 0 0.014072964899241924
phage O 1 0.9948424696922302
- O 0 0.0387454479932785
displayed O 0 0.017270224168896675
peptide O 0 0.07941802591085434
libraries O 0 0.007711145561188459
and O 0 0.00156151142437011
has O 0 0.0024046516045928
been O 0 0.002098947064951062
used O 0 0.0019487827084958553
to O 0 0.003409916302189231
localize O 1 0.8675866723060608
emerin O 1 0.9232800602912903
in O 0 0.005064960569143295
human O 0 0.013891720212996006
and O 0 0.006217150948941708
rabbit O 1 0.999832034111023
heart O 1 0.999313473701477
. O 0 0.013950632885098457

Several O 0 0.015174646861851215
mAbs O 1 0.9468836784362793
against O 0 0.00710922060534358
different O 0 0.0074422527104616165
emerin O 1 0.9951097369194031
epitopes O 1 0.98698490858078
did O 0 0.004958371166139841
not O 0 0.002856070874258876
recognize O 0 0.01873808167874813
intercalated O 1 0.8600941300392151
discs O 0 0.01656448282301426
in O 0 0.001809651032090187
the O 0 0.0035998912062495947
heart O 1 0.9998743534088135
, O 0 0.0017897996585816145
though O 0 0.0033704079687595367
they O 0 0.0017638357821851969
recognized O 0 0.013913841918110847
cardiomyocyte O 1 0.9977739453315735
nuclei O 0 0.033801715821027756
strongly O 0 0.007679583039134741
, O 0 0.0014752642018720508
both O 0 0.0015454164240509272
at O 0 0.0022074661683291197
the O 0 0.0029677250422537327
rim O 0 0.02144811674952507
and O 0 0.002481869189068675
in O 0 0.00431790528818965
intranuclear O 1 0.9721859097480774
spots O 0 0.03447960317134857
or O 0 0.009506667964160442
channels O 0 0.02143169194459915
. O 0 0.011767114512622356

A O 0 0.06570315361022949
polyclonal O 1 0.9943907856941223
rabbit O 1 0.9976733326911926
antiserum O 1 0.9951947331428528
against O 0 0.013906588777899742
emerin O 1 0.993504524230957
did O 0 0.006589693482965231
recognize O 0 0.012462093494832516
both O 0 0.00291543360799551
nuclear O 0 0.007161472458392382
membrane O 0 0.023848211392760277
and O 0 0.002894862787798047
intercalated O 1 0.781670093536377
discs O 0 0.021277574822306633
but O 0 0.002766392892226577
, O 0 0.0020836133044213057
after O 0 0.0072815739549696445
affinity O 0 0.02587713487446308
purification O 0 0.01874687522649765
against O 0 0.003793734824284911
a O 0 0.005772233474999666
pure O 0 0.016695251688361168
- O 0 0.032440584152936935
emerin O 1 0.9206472039222717
band O 0 0.014163188636302948
on O 0 0.0023212810046970844
a O 0 0.004640195984393358
western O 0 0.009095758199691772
blot O 1 0.9705477356910706
, O 0 0.0026629227213561535
it O 0 0.003051875624805689
stained O 1 0.7500811219215393
only O 0 0.0025190769229084253
the O 0 0.003207602072507143
nuclear O 0 0.012554014101624489
membrane O 0 0.060486432164907455
. O 0 0.01398561056703329

These O 0 0.003492831951007247
results O 0 0.006648867856711149
would O 0 0.0016860674368217587
not O 0 0.0011094199726358056
be O 0 0.0012464034371078014
expected O 0 0.0036278266925364733
if O 0 0.004347990732640028
immunostaining O 1 0.9252310991287231
at O 0 0.006294782739132643
intercalated O 0 0.34667766094207764
discs O 0 0.01585264876484871
were O 0 0.0017305334331467748
due O 0 0.004203255753964186
to O 0 0.0012705582194030285
a O 0 0.0033871796913444996
product O 0 0.004624605644494295
of O 0 0.0017244531773030758
the O 0 0.00522855157032609
emerin O 1 0.9990467429161072
gene O 1 0.9668203592300415
and O 0 0.0019673185888677835
, O 0 0.0016983390087261796
therefore O 0 0.0035081678070127964
, O 0 0.0015806442825123668
cast O 0 0.003997382242232561
some O 0 0.001825622282922268
doubt O 0 0.0054139974527060986
upon O 0 0.0032387729734182358
the O 0 0.0027130802627652884
hypothesis O 0 0.02704537659883499
that O 0 0.00747572910040617
cardiac B-Disease 1 0.9999983310699463
defects I-Disease 1 0.9999456405639648
in O 0 0.005575360730290413
EDMD B-Disease 1 0.9999783039093018
are O 0 0.0033304207026958466
caused O 1 0.8637340068817139
by O 0 0.0033787908032536507
absence O 0 0.0145283667370677
of O 0 0.004133196547627449
emerin O 1 0.981149435043335
from O 0 0.011652867309749126
intercalated O 1 0.7654522657394409
discs O 0 0.052959658205509186
. O 0 0.015229973010718822

Although O 0 0.020157672464847565
emerin O 1 0.9690127968788147
was O 0 0.005478427279740572
abundant O 0 0.008616676554083824
in O 0 0.0020806489046663046
the O 0 0.004163973964750767
membranes O 0 0.08773607760667801
of O 0 0.004306818824261427
cardiomyocyte O 1 0.9975847005844116
nuclei O 0 0.03881664201617241
, O 0 0.0026552025228738785
it O 0 0.0018351329490542412
was O 0 0.003427539486438036
absent O 0 0.01543192658573389
from O 0 0.003054003231227398
many O 0 0.003062328789383173
non O 0 0.01894451677799225
- O 0 0.14311851561069489
myocyte O 1 0.9991519451141357
cells O 0 0.16182294487953186
in O 0 0.004649115260690451
the O 0 0.007895823568105698
heart O 1 0.9991831183433533
. O 0 0.01436245534569025

This O 0 0.006351944990456104
distribution O 0 0.008189091458916664
of O 0 0.0038056164048612118
emerin O 1 0.9923283457756042
was O 0 0.003932509105652571
similar O 0 0.0030540090519934893
to O 0 0.0011381512740626931
that O 0 0.0012135965516790748
of O 0 0.0025234504137188196
lamin O 1 0.998775064945221
A O 0 0.007577140349894762
, O 0 0.002069368027150631
a O 0 0.00501549756154418
candidate O 0 0.015434135682880878
gene O 1 0.6053950786590576
for O 0 0.003511930350214243
an O 0 0.0064753140322864056
autosomal O 1 0.9999630451202393
form O 0 0.01167202740907669
of O 0 0.007961937226355076
EDMD B-Disease 1 0.9995025396347046
. O 0 0.017678912729024887

In O 0 0.008469652384519577
contrast O 0 0.02136801742017269
, O 0 0.00888370256870985
lamin O 1 0.9984775185585022
B1 O 1 0.9977245926856995
was O 0 0.011099405586719513
absent O 0 0.028946589678525925
from O 0 0.006953985430300236
cardiomyocyte O 1 0.9956222176551819
nuclei O 0 0.030635546892881393
, O 0 0.0026709854137152433
showing O 0 0.010490535758435726
that O 0 0.0056405202485620975
lamin O 1 0.9995766282081604
B1 O 1 0.9992812275886536
is O 0 0.003711776342242956
not O 0 0.0014327610842883587
essential O 0 0.0031500838231295347
for O 0 0.001623813295736909
localization O 0 0.025367053225636482
of O 0 0.003670318517833948
emerin O 1 0.6397750973701477
to O 0 0.0028066637460142374
the O 0 0.0043886261992156506
nuclear O 0 0.015821360051631927
lamina O 1 0.9871137142181396
. O 0 0.019308067858219147

Lamin O 1 0.9980574250221252
B1 O 1 0.9964742064476013
is O 0 0.005763204302638769
also O 0 0.003032353473827243
almost O 0 0.006495404057204723
completely O 0 0.015089839696884155
absent O 0 0.04800129309296608
from O 0 0.010639120824635029
skeletal O 1 0.9998985528945923
muscle O 1 0.9998974800109863
nuclei O 0 0.0717020034790039
. O 0 0.01409987173974514

In O 0 0.013113586232066154
EDMD B-Disease 1 0.9978092312812805
, O 0 0.0034011625684797764
the O 0 0.002229467034339905
additional O 0 0.004841228947043419
absence O 0 0.013479843735694885
of O 0 0.006477833725512028
lamin O 1 0.9996875524520874
B1 O 1 0.9996067881584167
from O 0 0.009507928974926472
heart O 1 0.9994946718215942
and O 0 0.006342571694403887
skeletal O 1 0.9999921321868896
muscle O 1 0.9999879598617554
nuclei O 0 0.07344507426023483
which O 0 0.0024033822119235992
already O 0 0.007233588490635157
lack O 0 0.02397470735013485
emerin O 1 0.9995480179786682
may O 0 0.007558052893728018
offer O 0 0.0035840196069329977
an O 0 0.0020685293711721897
alternative O 0 0.0071016037836670876
explanation O 0 0.007066638674587011
of O 0 0.0019343070453032851
why O 0 0.0071457247249782085
these O 0 0.0032130414620041847
tissues O 1 0.994640588760376
are O 0 0.0030559345614165068
particularly O 0 0.011438865214586258
affected O 0 0.062423598021268845
. O 0 0.004678426310420036
. O 0 0.008737195283174515

Genetic O 0 0.09545879811048508
mapping O 0 0.019145479425787926
of O 0 0.0026436385232955217
the O 0 0.005101344548165798
copper B-Disease 0 0.04809023439884186
toxicosis I-Disease 1 0.9994502663612366
locus O 1 0.9965961575508118
in O 0 0.008610873483121395
Bedlington O 1 0.9995294809341431
terriers O 1 0.9973356127738953
to O 0 0.008548516780138016
dog O 1 0.9988783001899719
chromosome O 1 0.9988992214202881
10 O 0 0.005139215849339962
, O 0 0.00152440438978374
in O 0 0.0016412509139627218
a O 0 0.0050207399763166904
region O 0 0.013086823746562004
syntenic O 1 0.945141077041626
to O 0 0.005313762463629246
human O 0 0.030409645289182663
chromosome O 1 0.9973194003105164
region O 0 0.03719444200396538
2p13 O 1 0.9954720735549927
- O 0 0.1767617166042328
p16 O 1 0.9928193688392639
. O 0 0.02092578448355198

Abnormal O 1 0.9993618130683899
hepatic B-Disease 1 0.9999756813049316
copper I-Disease 0 0.16588769853115082
accumulation I-Disease 0 0.39187341928482056
is O 0 0.00555475102737546
recognized O 0 0.009343983605504036
as O 0 0.003124465234577656
an O 0 0.00673337047919631
inherited B-Disease 1 0.9999938011169434
disorder I-Disease 1 0.9999996423721313
in O 0 0.0046869670040905476
man O 0 0.08076076209545135
, O 0 0.0056025926023721695
mouse O 1 0.9988700747489929
, O 0 0.0070941876620054245
rat O 1 0.9985910058021545
and O 0 0.007056875620037317
dog O 1 0.9650760293006897
. O 0 0.01484063919633627

The O 0 0.009064159356057644
major O 0 0.017070693895220757
cause O 0 0.27158984541893005
of O 0 0.009573404677212238
hepatic B-Disease 1 0.9999881982803345
copper I-Disease 0 0.057907186448574066
accumulation I-Disease 0 0.4309167265892029
in O 0 0.0030537666752934456
man O 0 0.010690348222851753
is O 0 0.004131964407861233
a O 0 0.010248563252389431
dysfunctional O 1 0.9996127486228943
ATP7B O 1 0.9998714923858643
gene O 1 0.9978256821632385
, O 0 0.009823944419622421
causing O 1 0.9990664124488831
Wilson B-Disease 1 0.9991545677185059
disease I-Disease 1 0.9999992847442627
( O 0 0.05467183515429497
WD B-Disease 1 0.9998295307159424
) O 0 0.015088626183569431
. O 0 0.011461765505373478

Mutations O 1 0.9966193437576294
in O 0 0.00437545171007514
the O 0 0.006573440972715616
ATP7B O 1 0.9997323155403137
genes O 1 0.8421943187713623
have O 0 0.002800760557875037
also O 0 0.0017028107540681958
been O 0 0.0027707861736416817
demonstrated O 0 0.01118225883692503
in O 0 0.0040429094806313515
mouse O 1 0.9965062141418457
and O 0 0.007672188803553581
rat O 1 0.9949315190315247
. O 0 0.01652185246348381

The O 0 0.016893548890948296
ATP7B O 1 0.9994018077850342
gene O 1 0.9784926772117615
has O 0 0.005783845204859972
been O 0 0.004516099579632282
excluded O 0 0.010509833693504333
in O 0 0.0020280550234019756
the O 0 0.0028355317190289497
much O 0 0.008827649056911469
rarer O 1 0.9913928508758545
human O 0 0.038226474076509476
copper B-Disease 1 0.6493522524833679
overload I-Disease 1 0.9999258518218994
disease O 1 0.9999984502792358
non B-Disease 0 0.025612715631723404
- I-Disease 0 0.0409916490316391
Indian I-Disease 0 0.021635813638567924
childhood I-Disease 1 0.9996705055236816
cirrhosis I-Disease 1 0.9999970197677612
, O 0 0.006532131228595972
indicating O 0 0.06166292726993561
genetic O 1 0.9738693833351135
heterogeneity O 1 0.9587031006813049
. O 0 0.012753812596201897

By O 0 0.008069850504398346
investigating O 0 0.02087586186826229
the O 0 0.008495020680129528
common O 0 0.11900557577610016
autosomal O 1 0.9999955892562866
recessive O 1 0.9999988079071045
copper B-Disease 1 0.9916931986808777
toxicosis I-Disease 1 0.9999716281890869
( O 0 0.03953041508793831
CT B-Disease 1 0.9997394680976868
) O 0 0.0056422133930027485
in O 0 0.004732627887278795
Bedlington O 1 0.9993107318878174
terriers O 1 0.9976274371147156
, O 0 0.0026569559704512358
we O 0 0.0013373843394219875
have O 0 0.0015180079499259591
identified O 0 0.006093685049563646
a O 0 0.004065719433128834
new O 0 0.004846538417041302
locus O 1 0.9972946047782898
involved O 0 0.012568681500852108
in O 0 0.00763097545132041
progressive O 1 0.9999518394470215
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.01900753378868103

We O 0 0.0070473626255989075
examined O 0 0.021152375265955925
whether O 0 0.006936131976544857
the O 0 0.00927940383553505
WD B-Disease 1 0.9998325109481812
gene O 1 0.9955390095710754
ATP7B O 1 0.9981100559234619
was O 0 0.0060062226839363575
also O 0 0.0035371126141399145
causative O 1 0.9465520977973938
for O 0 0.0046595241874456406
CT B-Disease 1 0.9993058443069458
by O 0 0.004208414349704981
investigating O 0 0.014727450907230377
the O 0 0.007992254570126534
chromosomal O 1 0.99871826171875
co O 0 0.04199587181210518
- O 0 0.032663293182849884
localization O 0 0.042683836072683334
of O 0 0.0056448145769536495
ATP7B O 1 0.998536229133606
and O 0 0.004253813065588474
C04107 O 1 0.9850289225578308
, O 0 0.0028188356664031744
using O 0 0.005979264620691538
fluorescence O 0 0.05747855454683304
in O 0 0.006412935443222523
situ O 1 0.5889972448348999
hybridization O 0 0.06858169287443161
( O 0 0.012941433116793633
FISH O 0 0.025599278509616852
) O 0 0.007798675913363695
. O 0 0.008691181428730488

C04107 O 1 0.9129546284675598
is O 0 0.006290128454566002
an O 0 0.004723323043435812
anonymous O 0 0.03628614544868469
microsatellite O 1 0.9387685060501099
marker O 0 0.06559856235980988
closely O 0 0.017076358199119568
linked O 0 0.041610054671764374
to O 0 0.011229953728616238
CT B-Disease 1 0.9974156618118286
. O 0 0.016483351588249207

However O 0 0.011154512874782085
, O 0 0.007951182313263416
BAC O 1 0.9975814819335938
clones O 1 0.8933049440383911
containing O 0 0.021437089890241623
ATP7B O 1 0.995958149433136
and O 0 0.004963236395269632
C04107 O 1 0.919536828994751
mapped O 0 0.02134023793041706
to O 0 0.003503813175484538
the O 0 0.00802801363170147
canine O 1 0.9994726777076721
chromosome O 1 0.9990884065628052
regions O 0 0.03334764391183853
CFA22q11 O 1 0.9886302947998047
and O 0 0.00466454541310668
CFA10q26 O 1 0.9904780387878418
, O 0 0.0031256121583282948
respectively O 0 0.005405853968113661
, O 0 0.002347262343391776
demonstrating O 0 0.010613343678414822
that O 0 0.004369296599179506
WD B-Disease 1 0.9999252557754517
cannot O 0 0.008118624798953533
be O 0 0.003631328698247671
homologous O 0 0.10866918414831161
to O 0 0.007751174736768007
CT B-Disease 1 0.99908447265625
. O 0 0.012872215360403061

The O 0 0.011469066143035889
copper O 0 0.033815622329711914
transport O 0 0.023257972672581673
genes O 1 0.897129237651825
CTR1 O 1 0.9977753758430481
and O 0 0.005815879907459021
CTR2 O 1 0.9960665106773376
were O 0 0.002353799296543002
also O 0 0.002472567604854703
excluded O 0 0.012672184035182
as O 0 0.0031874445267021656
candidate O 0 0.014998436905443668
genes O 0 0.258520245552063
for O 0 0.00523165799677372
CT B-Disease 1 0.9994795918464661
since O 0 0.006378315854817629
they O 0 0.0014674459816887975
both O 0 0.0020172754302620888
mapped O 0 0.01951851136982441
to O 0 0.006776432506740093
canine O 1 0.9995651841163635
chromosome O 1 0.9987233281135559
region O 0 0.039941977709531784
CFA11q22 O 1 0.9930458664894104
. O 0 0.017109261825680733

2 O 0 0.027775296941399574
- O 0 0.03501439839601517
22 O 0 0.022514836862683296
. O 0 0.01326968427747488

5 O 0 0.03516140207648277
. O 0 0.01785324327647686

A O 0 0.020344600081443787
transcribed O 0 0.040204890072345734
sequence O 0 0.02192961610853672
identified O 0 0.008295387029647827
from O 0 0.0027674927841871977
the O 0 0.0042699165642261505
C04107 O 1 0.9870039820671082
- O 0 0.028283078223466873
containing O 0 0.015527566894888878
BAC O 1 0.9992658495903015
was O 0 0.004205014556646347
found O 0 0.004092465620487928
to O 0 0.0014466074062511325
be O 0 0.002059775637462735
homologous O 0 0.038600318133831024
to O 0 0.0023094608914107084
a O 0 0.009033968672156334
gene O 0 0.38070032000541687
expressed O 0 0.008679386228322983
from O 0 0.006039902567863464
human O 0 0.027928365394473076
chromosome O 1 0.9998266100883484
2p13 O 1 0.9987296462059021
- O 0 0.2649710476398468
p16 O 1 0.9966590404510498
, O 0 0.0040938048623502254
a O 0 0.0064147221855819225
region O 0 0.01268531009554863
devoid O 0 0.02175794541835785
of O 0 0.0024566128849983215
any O 0 0.004590908065438271
positional O 0 0.056883517652750015
candidate O 0 0.03623940050601959
genes O 0 0.2509445250034332
. O 0 0.013011613860726357

Molecular O 0 0.04149950295686722
analysis O 0 0.0072904303669929504
of O 0 0.0022178550716489553
the O 0 0.005820361897349358
APC B-Disease 1 0.9992949962615967
gene O 1 0.9800554513931274
in O 0 0.0037261846009641886
205 O 0 0.030312389135360718
families O 0 0.009669416584074497
: O 0 0.005627923645079136
extended O 0 0.018254859372973442
genotype O 1 0.9995766282081604
- O 1 0.8126019835472107
phenotype O 1 0.9998282194137573
correlations O 0 0.13130106031894684
in O 0 0.005969859194010496
FAP B-Disease 1 0.9999645948410034
and O 0 0.0022858374286442995
evidence O 0 0.002566919196397066
for O 0 0.001120144734159112
the O 0 0.001938561093993485
role O 0 0.005833273287862539
of O 0 0.0046929726377129555
APC B-Disease 1 0.9949796795845032
amino O 0 0.05517302453517914
acid O 0 0.4990469217300415
changes O 0 0.01755695976316929
in O 0 0.025023328140378
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.9999680519104004
. O 0 0.020901881158351898

BACKGROUND O 0 0.05201009660959244
/ O 0 0.05978190898895264
AIMS O 0 0.01894429512321949
The O 0 0.00392936123535037
development O 0 0.007442815694957972
of O 0 0.015998205170035362
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 0.002875122707337141
a O 0 0.006655185483396053
variable O 0 0.024476712569594383
range O 0 0.00590511504560709
of O 0 0.004750244785100222
extracolonic O 1 0.9986987113952637
manifestations O 1 0.9948418736457825
in O 0 0.017444198951125145
familial B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.6883441209793091
FAP B-Disease 1 0.9999785423278809
) O 0 0.00621915515512228
is O 0 0.001899856491945684
the O 0 0.0018706545233726501
result O 0 0.004556243307888508
of O 0 0.0012274669716134667
the O 0 0.0033691010903567076
dominant O 0 0.3359313905239105
inheritance O 1 0.9905781745910645
of O 0 0.0382031612098217
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999991655349731
( O 0 0.182761088013649
APC B-Disease 1 0.9997708201408386
) O 0 0.02181517705321312
gene O 1 0.9986293315887451
mutations O 1 0.9985978007316589
. O 0 0.013469732366502285

In O 0 0.004093635827302933
this O 0 0.0025753958616405725
study O 0 0.005175468511879444
, O 0 0.0023760157637298107
direct O 0 0.011582324281334877
mutation O 1 0.9983415603637695
analysis O 0 0.005506275221705437
of O 0 0.002053129021078348
the O 0 0.006042250897735357
APC B-Disease 1 0.999636173248291
gene O 1 0.9357710480690002
was O 0 0.005136598367244005
performed O 0 0.00676026102155447
to O 0 0.002375059761106968
determine O 0 0.013370933942496777
genotype O 1 0.9987311959266663
- O 0 0.47700440883636475
phenotype O 1 0.9989519119262695
correlations O 0 0.03297042101621628
for O 0 0.0033188010565936565
nine O 0 0.011742320843040943
extracolonic O 1 0.9961956739425659
manifestations O 0 0.22781363129615784
and O 0 0.0016875038854777813
to O 0 0.0014408042188733816
investigate O 0 0.00840503815561533
the O 0 0.004438953939825296
incidence O 1 0.9996938705444336
of O 0 0.005236419849097729
APC B-Disease 1 0.9998981952667236
mutations O 1 0.9988872408866882
in O 0 0.006189894862473011
non O 0 0.06809873878955841
- O 1 0.9991787075996399
FAP O 1 0.9999992847442627
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.027812860906124115

METHODS O 0 0.024643203243613243
The O 0 0.01288573443889618
APC B-Disease 1 0.997925877571106
gene O 1 0.8517684936523438
was O 0 0.007538006640970707
analysed O 0 0.023060930892825127
in O 0 0.0036438792012631893
190 O 0 0.029480116441845894
unrelated O 0 0.1362486183643341
FAP B-Disease 1 0.9999210834503174
and O 0 0.004061993211507797
15 O 0 0.010689238086342812
non O 0 0.09231793880462646
- O 1 0.9994232654571533
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9998750686645508
using O 0 0.01960425265133381
denaturing O 1 0.996466875076294
gradient O 1 0.9403687119483948
gel O 1 0.9695712327957153
electrophoresis O 0 0.10952772200107574
, O 0 0.003565574064850807
the O 0 0.003573358291760087
protein O 0 0.04143112897872925
truncation O 1 0.8882099390029907
test O 0 0.010463367216289043
, O 0 0.0020751631818711758
and O 0 0.002228986471891403
direct O 0 0.011885377578437328
sequencing O 0 0.05061473697423935
. O 0 0.011629934422671795

RESULTS O 0 0.0463385134935379
Chain O 1 0.6182103157043457
terminating O 0 0.08164595067501068
signals O 0 0.014337663538753986
were O 0 0.0015515965642407537
only O 0 0.002474075648933649
identified O 0 0.008863761089742184
in O 0 0.003854660550132394
patients O 1 0.9988277554512024
belonging O 0 0.012811072170734406
to O 0 0.0032939466182142496
the O 0 0.007762019522488117
FAP B-Disease 1 0.9999151229858398
group O 0 0.015654653310775757
( O 0 0.012226494960486889
105 O 0 0.05940359830856323
patients O 1 0.9996292591094971
) O 0 0.009603077545762062
. O 0 0.00976425688713789

Amino O 0 0.09155353903770447
acid O 0 0.08668649196624756
changes O 0 0.00879740621894598
were O 0 0.0018536996794864535
identified O 0 0.006555119529366493
in O 0 0.0020733156707137823
four O 0 0.00442472193390131
patients O 1 0.9997925162315369
, O 0 0.001230156747624278
three O 0 0.0012348054442554712
of O 0 0.0014078731182962656
whom O 0 0.006597985979169607
belonged O 0 0.008134405128657818
to O 0 0.0016754198586568236
the O 0 0.003193219192326069
non O 0 0.016109514981508255
- O 0 0.1705172210931778
FAP O 1 0.9998788833618164
group O 0 0.018842771649360657
of O 0 0.07254689931869507
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999709129333496
. O 0 0.016684720292687416

Genotype O 1 0.9994221925735474
- O 1 0.7385300397872925
phenotype O 1 0.9990994930267334
correlations O 0 0.058598533272743225
identified O 0 0.017181266099214554
significant O 0 0.007315800990909338
differences O 0 0.005916044116020203
in O 0 0.0013936979230493307
the O 0 0.001881981734186411
nature O 0 0.004428815562278032
of O 0 0.0019350398797541857
certain O 0 0.006495293229818344
extracolonic O 1 0.998906135559082
manifestations O 1 0.9789931774139404
in O 0 0.011450554244220257
FAP B-Disease 1 0.9999973773956299
patients O 1 0.9999390840530396
belonging O 0 0.013518532738089561
to O 0 0.0032177013345062733
three O 0 0.007473453879356384
mutation O 1 0.9997010231018066
subgroups O 0 0.2694457471370697
. O 0 0.01190799567848444

CONCLUSIONS O 0 0.041067082434892654
Extended O 0 0.04851069673895836
genotype O 1 0.9994574189186096
- O 1 0.8944869637489319
phenotype O 1 0.9999169111251831
correlations O 0 0.036244966089725494
made O 0 0.0018764971755445004
in O 0 0.0015661221696063876
this O 0 0.0016921994974836707
study O 0 0.0044762142933905125
may O 0 0.003852258902043104
have O 0 0.0011281928746029735
the O 0 0.0014992699725553393
potential O 0 0.004530917387455702
to O 0 0.001258599222637713
determine O 0 0.0028597628697752953
the O 0 0.0015310847666114569
most O 0 0.002055955585092306
appropriate O 0 0.005236197728663683
surveillance O 0 0.016857925802469254
and O 0 0.0046731820330023766
prophylactic O 1 0.9994879961013794
treatment O 1 0.9985174536705017
regimens O 1 0.9983589053153992
for O 0 0.003937955480068922
those O 0 0.006542307790368795
patients O 1 0.9997730851173401
with O 0 0.006058596074581146
mutations O 1 0.9997133612632751
associated O 0 0.010632532648742199
with O 0 0.0035548326559364796
life O 0 0.016047479584813118
threatening O 1 0.9912534356117249
conditions O 0 0.022276565432548523
. O 0 0.013548236340284348

This O 0 0.005899343173950911
study O 0 0.007248290348798037
also O 0 0.0018001013668254018
provided O 0 0.002333664568141103
evidence O 0 0.002461519557982683
for O 0 0.0014205733314156532
the O 0 0.0029469525907188654
pathological O 1 0.9540318846702576
nature O 0 0.0058244504034519196
of O 0 0.002892987336963415
amino O 0 0.035838931798934937
acid O 0 0.11487706005573273
changes O 0 0.010127772577106953
in O 0 0.00447978125885129
APC O 1 0.9949765205383301
associated O 0 0.008434903807938099
with O 0 0.0023386667016893625
both O 0 0.005080417729914188
FAP B-Disease 1 0.9999209642410278
and O 0 0.005973626859486103
non O 0 0.3136250376701355
- O 1 0.999445378780365
FAP O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999901056289673
. O 0 0.00812296848744154
. O 0 0.01058113668113947

Inherited B-Disease 1 0.9999914169311523
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.6813961267471313
cancer B-Disease 1 0.9999997615814209
risk O 1 0.9849029183387756
of O 0 0.0037137113977223635
the O 0 0.009926295839250088
APC O 1 0.9994915723800659
I1307K O 1 0.9981377124786377
polymorphism O 1 0.9743631482124329
. O 0 0.01905134879052639

Germ O 1 0.9698120951652527
- O 0 0.03811207041144371
line O 0 0.01259514968842268
and O 0 0.005352261941879988
somatic O 1 0.9625762104988098
truncating O 1 0.9924271702766418
mutations O 1 0.9921131134033203
of O 0 0.0036480212584137917
the O 0 0.007256866432726383
APC B-Disease 1 0.9995772242546082
gene O 1 0.9909732937812805
are O 0 0.0022697970271110535
thought O 0 0.006502307485789061
to O 0 0.004537214525043964
initiate O 1 0.9951862692832947
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999963045120239
formation O 0 0.16710229218006134
in O 0 0.019253475591540337
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.08682582527399063
sporadic O 1 0.9998218417167664
colorectal O 1 1.0
carcinogenesis O 1 0.9999843835830688
, O 0 0.007230600342154503
respectively O 0 0.012740382924675941
. O 0 0.009292375296354294

Recently O 0 0.020783623680472374
, O 0 0.003943617455661297
an O 0 0.005853766575455666
isoleucine O 1 0.9419655203819275
- O 0 0.06691580265760422
- O 0 0.06721716374158859
> O 1 0.8761581778526306
lysine O 1 0.7188372015953064
polymorphism O 0 0.1187606230378151
at O 0 0.013349255546927452
codon O 0 0.4261719584465027
1307 O 1 0.9554953575134277
( O 0 0.013652012683451176
I1307K O 0 0.46094635128974915
) O 0 0.003901141695678234
of O 0 0.0023454499896615744
the O 0 0.005869215354323387
APC B-Disease 1 0.9993218183517456
gene O 1 0.9923589825630188
has O 0 0.003558151191100478
been O 0 0.0027105524204671383
identified O 0 0.006442667450755835
in O 0 0.002194385277107358
6 O 0 0.006169328931719065
% O 0 0.005880248732864857
- O 0 0.012653018347918987
7 O 0 0.007680986076593399
% O 0 0.003502453211694956
of O 0 0.0016451533883810043
the O 0 0.00425907364115119
Ashkenazi O 1 0.7908923029899597
Jewish O 0 0.017495928332209587
population O 0 0.01907246932387352
. O 0 0.012917323969304562

To O 0 0.006662948057055473
assess O 0 0.021428540349006653
the O 0 0.004342412576079369
risk O 0 0.05565605312585831
of O 0 0.0022620910312980413
this O 0 0.0036578387953341007
common O 0 0.020196396857500076
APC B-Disease 1 0.9997766613960266
allelic O 1 0.9996110796928406
variant O 1 0.9971676468849182
in O 0 0.0164346806704998
colorectal O 1 1.0
carcinogenesis O 1 0.9999799728393555
, O 0 0.003215399105101824
we O 0 0.0015696348855271935
have O 0 0.0017072716727852821
analyzed O 0 0.00788418110460043
a O 0 0.004375343676656485
large O 0 0.006077594123780727
cohort O 0 0.10767088085412979
of O 0 0.004679214209318161
unselected O 1 0.961564838886261
Ashkenazi O 1 0.8438994884490967
Jewish O 0 0.017297720536589622
subjects O 0 0.01943540759384632
with O 0 0.013430231250822544
adenomatous B-Disease 1 0.9999995231628418
polyps I-Disease 1 0.9999949932098389
and O 0 0.004263031296432018
. O 0 0.006230412051081657
or O 1 0.5893866419792175
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, I-Disease 0 0.0035239073913544416
for O 0 0.0028352111112326384
the O 0 0.008031200617551804
APC O 1 0.9987032413482666
I1307K O 1 0.9967626333236694
polymorphism O 1 0.7733112573623657
. O 0 0.017211293801665306

The O 0 0.02212643064558506
APC O 1 0.9977070093154907
I1307K O 1 0.9962524771690369
allele O 1 0.9973284006118774
was O 0 0.0073890988714993
identified O 0 0.011519300751388073
in O 0 0.0025068267714232206
48 O 0 0.011022569611668587
( O 0 0.004308203235268593
10 O 0 0.0035075810737907887
. O 0 0.001942947506904602
1 O 0 0.005404943600296974
% O 0 0.00445591052994132
) O 0 0.003907626960426569
of O 0 0.005515498109161854
476 O 1 0.9893787503242493
patients O 1 0.9995648264884949
. O 0 0.012761891819536686

Compared O 0 0.017275825142860413
with O 0 0.0024756486527621746
the O 0 0.0027880361303687096
frequency O 0 0.012727716006338596
in O 0 0.0013841378968209028
two O 0 0.0014640250010415912
separate O 0 0.0037205698899924755
population O 0 0.007912388071417809
control O 0 0.010053517296910286
groups O 0 0.004148549400269985
, O 0 0.00206315191462636
the O 0 0.005209024995565414
APC O 1 0.9998051524162292
I1307K O 1 0.9994195699691772
allele O 1 0.9987163543701172
is O 0 0.005122275557368994
associated O 0 0.006061571184545755
with O 0 0.0016207509906962514
an O 0 0.002181874355301261
estimated O 0 0.011558638885617256
relative O 0 0.016532432287931442
risk O 0 0.3976675271987915
of O 0 0.0036483227740973234
1 O 0 0.012970886193215847
. O 0 0.008660193532705307

5 O 0 0.03659161552786827
- O 0 0.040679462254047394
1 O 0 0.01614617556333542
. O 0 0.010549732483923435

7 O 0 0.03490767627954483
for O 0 0.020988918840885162
colorectal B-Disease 1 0.9999992847442627
neoplasia I-Disease 1 0.9999195337295532
( O 0 0.013122900389134884
both O 0 0.0075876545161008835
P O 1 0.7500668168067932
= O 0 0.041469987481832504
. O 0 0.007861997000873089
01 O 1 0.9753962755203247
) O 0 0.009460621513426304
. O 0 0.010959241539239883

Furthermore O 0 0.028197184205055237
, O 0 0.004023585934191942
compared O 0 0.010369052179157734
with O 0 0.0049162269569933414
noncarriers O 1 0.990924596786499
, O 0 0.009027591906487942
APC O 1 0.999566376209259
I1307K O 1 0.9990639090538025
carriers O 0 0.29436981678009033
had O 0 0.0056899795308709145
increased O 0 0.009645278565585613
numbers O 0 0.006032615900039673
of O 0 0.004577226005494595
adenomas B-Disease 1 0.9999688863754272
and O 0 0.06505515426397324
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999985694885254
per O 0 0.017884332686662674
patient O 1 0.9997788071632385
( O 0 0.015496473759412766
P O 1 0.9726051092147827
= O 0 0.034732937812805176
. O 0 0.004244227893650532
03 O 1 0.5478538870811462
) O 0 0.003951673861593008
, O 0 0.0014521869597956538
as O 0 0.001233728602528572
well O 0 0.0012165234657004476
as O 0 0.0016493407310917974
a O 0 0.00565043231472373
younger O 0 0.1468142867088318
age O 0 0.016870124265551567
at O 0 0.012888086028397083
diagnosis O 1 0.9996516704559326
. O 0 0.016390381380915642

We O 0 0.006086725741624832
conclude O 0 0.013442430645227432
that O 0 0.0022426890209317207
the O 0 0.005305731203407049
APC O 1 0.9992930889129639
I1307K O 1 0.9988582134246826
variant O 1 0.9857856631278992
leads O 0 0.02044731192290783
to O 0 0.004908539820462465
increased O 0 0.038470156490802765
adenoma B-Disease 1 0.9999828338623047
formation O 0 0.03027263842523098
and O 0 0.0029541628900915384
directly O 0 0.007796517573297024
contributes O 0 0.02660115621984005
to O 0 0.002964031882584095
3 O 0 0.00851701945066452
% O 0 0.006797058042138815
- O 0 0.013241760432720184
4 O 0 0.007129261270165443
% O 0 0.003502015257254243
of O 0 0.0017808038974180818
all O 0 0.003759022569283843
Ashkenazi O 1 0.9983662962913513
Jewish O 1 0.9823756814002991
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 0.02365982159972191

The O 0 0.008496973663568497
estimated O 0 0.018619954586029053
relative O 0 0.022695958614349365
risk O 1 0.560172975063324
for O 0 0.0045843771658837795
carriers O 1 0.6336870193481445
may O 0 0.007879065349698067
justify O 0 0.015404636040329933
specific O 0 0.00996723398566246
clinical O 1 0.9510982036590576
screening O 0 0.03250797465443611
for O 0 0.0014473708579316735
the O 0 0.002351621398702264
360 O 0 0.014713604934513569
, O 0 0.0023869527503848076
000 O 0 0.016974221915006638
Americans O 0 0.0073319971561431885
expected O 0 0.003583886893466115
to O 0 0.0022423516493290663
harbor O 0 0.016290048137307167
this O 0 0.003775885095819831
allele O 1 0.9938446283340454
, O 0 0.0022490848787128925
and O 0 0.0020310422405600548
genetic O 0 0.42418354749679565
testing O 0 0.008830604143440723
in O 0 0.0012743540573865175
the O 0 0.0013753577368333936
setting O 0 0.0034880980383604765
of O 0 0.0020632550586014986
long O 0 0.010751845315098763
- O 0 0.02029508724808693
term O 0 0.012317012995481491
- O 0 0.016910282894968987
outcome O 0 0.011898069642484188
studies O 0 0.00752759026363492
may O 0 0.007036309689283371
impact O 0 0.01616658642888069
significantly O 0 0.1636391580104828
on O 0 0.02996543049812317
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
prevention O 1 0.9991449117660522
in O 0 0.0031917255837470293
this O 0 0.003344960045069456
population O 0 0.013267450034618378
. O 0 0.009063229896128178

Localization O 0 0.07296397536993027
of O 0 0.006928449496626854
human O 0 0.03487761318683624
BRCA1 O 1 0.9999748468399048
and O 0 0.0026683041360229254
its O 0 0.003475421806797385
loss O 0 0.015968777239322662
in O 0 0.0020632450468838215
high O 0 0.005619873758405447
- O 0 0.01565607078373432
grade O 0 0.012636033818125725
, O 0 0.004078771453350782
non B-Disease 0 0.021435249596834183
- I-Disease 1 0.8810030817985535
inherited I-Disease 1 0.9999641180038452
breast I-Disease 1 0.9999986886978149
carcinomas I-Disease 1 0.9999940395355225
. O 0 0.018729956820607185

Although O 0 0.007941141724586487
the O 0 0.002966816071420908
link O 0 0.013082754798233509
between O 0 0.005473506636917591
the O 0 0.012285981327295303
BRCA1 O 1 0.999998927116394
tumour B-Disease 1 0.9999990463256836
- O 1 0.9927703738212585
suppressor O 1 0.9999585151672363
gene O 1 0.9965384006500244
and O 0 0.009363286197185516
hereditary B-Disease 1 0.9999979734420776
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9639679193496704
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
is O 0 0.003791100811213255
established O 0 0.0037320288829505444
, O 0 0.0010992944007739425
the O 0 0.0013995369663462043
role O 0 0.004131171386688948
, O 0 0.0011764208320528269
if O 0 0.0015501959715038538
any O 0 0.0015525823691859841
, O 0 0.0013552989112213254
of O 0 0.0033112657256424427
BRCA1 O 1 0.9999878406524658
in O 0 0.004824144300073385
non B-Disease 0 0.029770778492093086
- I-Disease 1 0.985503077507019
familial I-Disease 1 0.999997615814209
cancers I-Disease 1 0.9999946355819702
is O 0 0.011189911514520645
unclear O 0 0.022043537348508835
. O 0 0.010392844676971436

BRCA1 O 1 0.9999866485595703
mutations O 1 0.9998049139976501
are O 0 0.0037648610305041075
rare O 0 0.01806720346212387
in O 0 0.004323255270719528
sporadic B-Disease 1 0.9971169233322144
cancers I-Disease 1 0.9999972581863403
, O 0 0.002555085578933358
but O 0 0.002706375904381275
loss O 0 0.03163059428334236
of O 0 0.0051658437587320805
BRCA1 O 1 0.9999961853027344
resulting O 0 0.16209980845451355
from O 0 0.005214577075093985
reduced O 0 0.02241406962275505
expression O 0 0.0234222374856472
or O 0 0.004850274883210659
incorrect O 0 0.023058662191033363
subcellular O 0 0.062200237065553665
localization O 0 0.04021181911230087
is O 0 0.003947550430893898
postulated O 0 0.01910349912941456
to O 0 0.0013486548559740186
be O 0 0.000957009382545948
important O 0 0.0017713624984025955
in O 0 0.0021883773151785135
non B-Disease 0 0.019863443449139595
- I-Disease 1 0.9862014651298523
familial I-Disease 1 0.9999979734420776
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.863163948059082
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999995231628418
. O 0 0.018238693475723267

Epigenetic O 1 0.9974804520606995
loss O 1 0.6137406826019287
, O 0 0.0035462183877825737
however O 0 0.003460393287241459
, O 0 0.00151875673327595
has O 0 0.0019756329711526632
not O 0 0.0014706369256600738
received O 0 0.005524974782019854
general O 0 0.006211818661540747
acceptance O 0 0.019932541996240616
due O 0 0.00670008547604084
to O 0 0.0020064255222678185
controversy O 0 0.013624775223433971
regarding O 0 0.004422376397997141
the O 0 0.002663443563506007
subcellular O 0 0.04539923369884491
localization O 0 0.03517714515328407
of O 0 0.005689866375178099
BRCA1 O 1 0.9999949932098389
proteins O 0 0.024683410301804543
, O 0 0.002486288547515869
reports O 0 0.0035727370996028185
of O 0 0.0011755985906347632
which O 0 0.0019246323499828577
have O 0 0.0024541402235627174
ranged O 0 0.013332497328519821
from O 0 0.0026924912817776203
exclusively O 0 0.00576550280675292
nuclear O 0 0.004495546687394381
, O 0 0.001511014997959137
to O 0 0.0021446803584694862
conditionally O 0 0.033312298357486725
nuclear O 0 0.003987230360507965
, O 0 0.001332653220742941
to O 0 0.001652612816542387
the O 0 0.006016212049871683
ER O 1 0.9987261891365051
/ O 1 0.6184322237968445
golgi O 1 0.8068274855613708
, O 0 0.003901682561263442
to O 0 0.003977247979491949
cytoplasmic O 1 0.7720690965652466
invaginations O 1 0.9278891682624817
into O 0 0.006351936608552933
the O 0 0.006146571598947048
nucleus O 0 0.059405066072940826
. O 0 0.011700683273375034

In O 0 0.004524965304881334
an O 0 0.0030161822214722633
attempt O 0 0.00843221228569746
to O 0 0.0019404274644330144
resolve O 0 0.010577128268778324
this O 0 0.0020963067654520273
issue O 0 0.003562666242942214
, O 0 0.001391959609463811
we O 0 0.0015233951853588223
have O 0 0.002440485404804349
comprehensively O 0 0.04046546667814255
characterized O 0 0.07568797469139099
19 O 0 0.019699404016137123
anti O 1 0.7879207730293274
- O 1 0.9918940663337708
BRCA1 O 1 0.9999932050704956
antibodies O 1 0.994936466217041
. O 0 0.019701024517416954

These O 0 0.009736076928675175
reagents O 0 0.05086104944348335
detect O 0 0.04572383686900139
a O 0 0.01052037626504898
220 O 0 0.02998811937868595
- O 0 0.05268172547221184
kD O 1 0.7743450999259949
protein O 0 0.07143077254295349
localized O 0 0.12004245817661285
in O 0 0.0037892211694270372
discrete O 0 0.02352471649646759
nuclear O 0 0.009389394894242287
foci O 0 0.06718873977661133
in O 0 0.0029129909817129374
all O 0 0.00411419989541173
epithelial O 1 0.9995132684707642
cell O 0 0.20220080018043518
lines O 0 0.010908283293247223
, O 0 0.0017913122428581119
including O 0 0.0018930509686470032
those O 0 0.002766948426142335
derived O 0 0.016191810369491577
from O 0 0.01752021722495556
breast B-Disease 1 0.9999955892562866
malignancies I-Disease 1 0.9996733665466309
. O 0 0.017842186614871025

Immunohistochemical O 1 0.9847272634506226
staining O 1 0.8106159567832947
of O 0 0.009716621600091457
human O 1 0.5293003916740417
breast O 1 0.9999920129776001
specimens O 0 0.046475499868392944
also O 0 0.004180556163191795
revealed O 0 0.033412277698516846
BRCA1 O 1 0.9999464750289917
nuclear O 0 0.01815267838537693
foci O 1 0.9371200799942017
in O 0 0.00872601568698883
benign O 1 0.9999918937683105
breast O 1 0.999998927116394
, O 0 0.029812444001436234
invasive B-Disease 1 0.9999986886978149
lobular I-Disease 1 0.9999995231628418
cancers I-Disease 1 0.9999982118606567
and O 0 0.005170636344701052
low B-Disease 0 0.0393076054751873
- I-Disease 0 0.14421451091766357
grade I-Disease 0 0.2217361181974411
ductal I-Disease 1 0.9999779462814331
carcinomas I-Disease 1 0.9999730587005615
. O 0 0.023609312251210213

Conversely O 0 0.32326430082321167
, O 0 0.01186454202979803
BRCA1 O 1 0.999976634979248
expression O 0 0.121534064412117
was O 0 0.006409895606338978
reduced O 0 0.01863066852092743
or O 0 0.005785594694316387
undetectable O 1 0.6248559951782227
in O 0 0.0017589612398296595
the O 0 0.0018524719635024667
majority O 0 0.005013106856495142
of O 0 0.0018049146747216582
high O 0 0.006335390266031027
- O 0 0.02218269743025303
grade O 0 0.022351009771227837
, O 0 0.010158413089811802
ductal B-Disease 1 0.9999971389770508
carcinomas I-Disease 1 0.9999942779541016
, O 0 0.0044168997555971146
suggesting O 0 0.012023319490253925
that O 0 0.0022590248845517635
absence O 0 0.01250021904706955
of O 0 0.005359870847314596
BRCA1 O 1 0.9999985694885254
may O 0 0.00937024224549532
contribute O 0 0.00846125464886427
to O 0 0.0014839237555861473
the O 0 0.0033777339849621058
pathogenesis O 1 0.9972827434539795
of O 0 0.002162599703297019
a O 0 0.004839424043893814
significant O 0 0.006664611399173737
percentage O 0 0.010333266109228134
of O 0 0.0052517373114824295
sporadic B-Disease 1 0.9997279047966003
breast I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999966621398926
. O 0 0.00757541274651885
. O 0 0.008900192566215992

